data_2msw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2msw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.637 0.256 . . . . 2.1800000000000002 111.063 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.57 145.83 59.45 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.455 2.77 . . . . 0.55000000000000004 111.689 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -89.73 106.73 18.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.94 0.4 . . . . 1.48 109.931 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 60.1 t -100.49 137.36 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.91 -0.586 . . . . 1.05 111.062 -175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.3 tp -111.11 116.92 31.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.305 -0.407 . . . . 1.5 110.323 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 t -100.77 121.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.261 0.553 . . . . 1.03 111.362 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.89 104.11 14.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.937 -1.029 . . . . 1.05 108.658 172.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -161.21 113.47 1.87 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.903 -0.589 . . . . 1.4099999999999999 109.862 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.531 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 33.6 t70 -84.08 -12.56 54.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.086 -0.506 . . . . 1.27 109.865 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.28 100.37 1.38 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.347 -0.612 . . . . 2.5600000000000001 109.347 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.9 Cg_exo -60.18 -30.58 91.61 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.839 2.36 . . . . 0.35999999999999999 113.676 -171.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.62 -49.44 73.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.276 -0.638 . . . . 2.2799999999999998 109.276 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.97 -44.74 92.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.686 -0.688 . . . . 1.7 111.059 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.72 75.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 1.02 110.905 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.5 ttp -60.6 -42.66 97.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.923 -0.581 . . . . 1.28 110.871 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.423 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.0 m-80 -66.43 -40.3 89.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.027 -0.533 . . . . 1.3600000000000001 111.164 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.2 mt -62.98 -42.62 99.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.399 -0.364 . . . . 1.0700000000000001 110.443 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.46 ' CG ' ' HB ' ' A' ' 32' ' ' VAL . 1.5 tt0 -58.07 -50.95 71.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.166 -0.47 . . . . 1.7 109.809 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -56.07 -36.26 67.9 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.024 -0.535 . . . . 1.1799999999999999 111.109 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.6 45.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 1.05 111.105 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 45.9 m-85 -64.81 -43.4 93.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.246 -0.434 . . . . 0.16 110.699 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 47.4 mt-10 -61.89 -35.08 77.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.279 . . . . 0.68999999999999995 110.553 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -32.12 72.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.497 . . . . 0.51000000000000001 110.592 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.978 0.418 . . . . 0.65000000000000002 110.375 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.73 49.74 1.25 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.85 -0.613 . . . . 0.28999999999999998 112.232 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 26' ' ' GLU . . . -139.99 165.93 26.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.646 0.26 . . . . 1.03 111.254 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -108.67 142.87 38.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.818 -0.808 . . . . 2.1400000000000001 108.818 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HB ' ' CG ' ' A' ' 22' ' ' GLN . 7.0 t -125.9 133.57 68.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.238 0.459 . . . . 1.0800000000000001 112.238 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 44' ' ' SER . 27.5 t -104.26 124.61 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.844 -0.798 . . . . 1.05 108.844 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.49 121.63 49.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.915 0.388 . . . . 1.6499999999999999 110.824 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 40' ' ' GLN . . . -130.57 134.24 46.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.958 -0.565 . . . . 1.03 110.369 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.66 21.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.059 -0.519 . . . . 1.04 110.8 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 p -128.86 158.85 37.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 1.0800000000000001 110.86 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.6 m -64.27 -32.92 74.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.943 -0.392 . . . . 1.6599999999999999 109.943 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.1 -46.39 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.142 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 35' ' ' ALA . 36.0 mt-30 -60.31 -42.64 96.0 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.336 0.589 . . . . 1.4099999999999999 110.436 175.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.492 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -61.85 -52.58 63.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.107 -0.951 . . . . 1.04 111.732 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -63.87 -29.53 70.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.041 -0.527 . . . . 1.53 110.568 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.97 -50.57 61.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.195 -0.668 . . . . 2.9100000000000001 109.195 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.42 ' HG ' HG12 ' A' ' 33' ' ' VAL . 8.7 t -65.45 -31.79 73.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.235 -0.439 . . . . 1.6399999999999999 110.466 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -42.93 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.8400000000000001 110.544 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.74 20.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 1.1599999999999999 111.383 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.04 -37.36 58.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.62 111.45 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -123.89 161.07 48.77 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.163 -0.472 . . . . 0.47999999999999998 110.34 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -92.34 85.52 0.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.142 2.562 . . . . 0.31 111.363 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.62 117.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.79 . . . . 1.03 111.507 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.561 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.8 m-20 -83.67 -33.49 25.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.28999999999999998 110.265 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.8 p -160.58 155.38 3.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 1.03 109.574 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -136.3 166.92 22.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.312 0.577 . . . . 0.97999999999999998 111.266 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -141.17 120.75 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.682 -1.229 . . . . 1.5700000000000001 107.682 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.647 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -122.29 118.82 29.43 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.47 0.545 . . . . 1.02 112.47 -166.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.05 128.03 32.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.086 -0.709 . . . . 1.77 109.086 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.582 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 34.6 t -86.19 -22.52 7.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.655 -0.702 . . . . 1.3600000000000001 111.118 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -108.68 62.36 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.189 -0.46 . . . . 2.6400000000000001 110.639 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.0 -34.26 77.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.388 0.613 . . . . 1.3100000000000001 110.376 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.4 -173.84 36.63 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.87 111.384 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -36.22 91.14 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.038 2.492 . . . . 1.3899999999999999 112.655 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 1.3 tmtp? -119.67 -34.74 3.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.868 0.366 . . . . 4.0 110.185 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 p -69.51 127.46 33.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.593 0.711 . . . . 1.3700000000000001 111.472 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -145.36 150.14 36.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.261 -0.881 . . . . 0.58999999999999997 109.847 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 30.7 p -69.7 87.03 0.49 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.18 -0.674 . . . . 2.1899999999999999 109.18 171.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.33 -68.44 0.41 Allowed Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.384 -0.912 . . . . 0.28000000000000003 112.282 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.453 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 48.3 Cg_exo -52.95 -28.46 39.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.268 1.978 . . . . 0.28000000000000003 111.532 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.453 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.7 t -68.56 -49.12 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.407 0.622 . . . . 1.01 110.05 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.37 88.57 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.887 -1.051 . . . . 1.01 110.292 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 20.8 t70 -66.01 -40.18 90.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.567 -0.742 . . . . 2.0299999999999998 110.516 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.29 74.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.514 0.673 . . . . 1.0700000000000001 110.637 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.28 -44.12 80.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.015 -0.993 . . . . 1.05 110.373 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -57.88 -37.13 73.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 2.5800000000000001 111.413 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 77.4 mt-30 -61.8 -47.88 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 3.0299999999999998 111.23 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -90.9 5.62 47.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 1.95 111.582 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 31.29 19.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 1.1899999999999999 111.544 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.3 mt -81.49 131.48 58.2 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.627 -0.508 . . . . 1.05 109.627 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -72.95 143.14 36.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.293 1.996 . . . . 0.23000000000000001 112.208 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 23.9 p90 -160.9 158.5 28.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.761 -0.654 . . . . 0.23999999999999999 110.619 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.9 mt -123.6 138.23 54.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.329 -0.85 . . . . 1.0700000000000001 109.837 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 2.6 mm? -88.22 108.19 19.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.626 -0.509 . . . . 1.05 109.626 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.597 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 22.3 t-160 -102.22 84.22 2.45 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.375 -0.602 . . . . 0.59999999999999998 109.375 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 7.2 t -125.47 152.34 45.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.445 -0.798 . . . . 1.1399999999999999 111.242 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.04 -8.16 55.63 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.317 -0.713 . . . . 1.1000000000000001 111.317 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 2.7 m-20 -126.98 124.05 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.747 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.13 -51.97 2.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.048 -0.524 . . . . 2.1800000000000002 110.535 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.55 -26.31 68.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 2.6299999999999999 111.388 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.435 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 18.1 mmm180 -64.69 -20.03 66.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 5.1200000000000001 111.858 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -144.31 40.01 1.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 1.3500000000000001 111.319 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.37 -38.67 96.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.095 -0.574 . . . . 1.0600000000000001 112.783 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 6.2 pt-20 -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.449 . . . . 2.5 110.986 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.517 ' O ' HG13 ' A' ' 96' ' ' ILE . 18.9 tp -64.75 -46.97 79.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 1.22 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.0 mt -59.35 -38.26 79.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.588 -0.733 . . . . 2.1899999999999999 111.673 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 10.9 ptt180 -67.69 -25.84 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 5.0 110.626 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 95.7 mttt -81.05 -37.71 28.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.131 0.491 . . . . 2.8999999999999999 110.278 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 92' ' ' LEU . 72.7 mt -65.01 -57.57 10.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 1.0800000000000001 110.455 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 57.03 76.54 0.31 Allowed 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.874 0.734 . . . . 1.0900000000000001 110.802 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.04 163.22 25.27 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.618 -0.719 . . . . 1.0800000000000001 109.726 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.09 140.85 86.33 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.933 2.422 . . . . 0.29999999999999999 112.151 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 1.1 m -127.64 149.64 32.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.191 0.52 . . . . 1.3 110.824 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 74.0 mmm -121.47 107.9 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 1.04 108.373 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -71.69 147.75 47.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.405 -0.361 . . . . 1.2 111.446 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.5 mttt -90.92 141.61 26.8 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.05 -0.523 . . . . 1.27 109.866 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -73.29 148.19 91.5 Favored 'Cis proline' 0 C--O 1.234 0.28 0 C-N-CA 123.477 -1.468 . . . . 0.88 112.849 2.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.597 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -144.78 136.25 25.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.416 -0.811 . . . . 0.39000000000000001 109.328 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.8 t70 -70.69 127.46 32.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.445 -0.946 . . . . 0.51000000000000001 108.445 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.423 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.4 p -62.56 -22.32 66.25 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.035 -0.984 . . . . 1.04 112.233 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 78.9 p -68.74 -42.26 77.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.82 -0.437 . . . . 1.8899999999999999 109.82 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.75 -38.64 87.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.091 0.472 . . . . 0.62 110.054 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 54' ' ' VAL . 33.5 t -64.19 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.283 -0.871 . . . . 1.04 110.106 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -68.47 -47.83 66.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.629 -0.714 . . . . 1.01 111.468 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 7.5 mtmp? -56.35 -55.32 34.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 2.4300000000000002 111.174 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 35.6 mmt180 -62.1 -31.75 72.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.675 0.274 . . . . 2.73 111.578 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.85 70.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 1.02 110.188 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 52' ' ' VAL . 84.3 mt -70.68 -26.29 63.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.141 -0.481 . . . . 1.04 111.695 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 8.0 mm-40 -60.64 -34.38 74.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 2.79 110.61 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 47.9 mtm -82.46 -13.62 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.597 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 53.1 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.544 . . . . 1.95 110.748 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.539 0.209 . . . . 2.1800000000000002 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.2 Cg_endo -71.65 141.37 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.236 1.957 . . . . 0.55000000000000004 110.86 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -86.65 103.15 14.85 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.451 -0.574 . . . . 1.48 109.451 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.477 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.9 t -100.09 134.51 39.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.721 -0.672 . . . . 1.05 110.726 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.2 tp -111.54 113.44 25.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.863 0.363 . . . . 1.5 110.74 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -93.82 124.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.21 0.529 . . . . 1.03 111.599 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -105.59 101.37 10.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.057 -0.974 . . . . 1.05 108.921 173.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -159.5 129.52 5.59 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.805 -0.634 . . . . 1.4099999999999999 109.782 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 28.8 t70 -90.3 -20.4 22.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.325 -0.398 . . . . 1.27 110.499 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -84.86 107.82 12.94 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 109.308 -0.627 . . . . 2.5600000000000001 109.308 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 35.7 Cg_exo -57.96 -29.68 87.41 Favored 'Trans proline' 0 CA--C 1.517 -0.35 0 C-N-CA 122.723 2.282 . . . . 0.35999999999999999 112.264 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.97 -51.33 64.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.456 -0.572 . . . . 2.2799999999999998 109.456 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.25 -43.38 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 1.7 110.437 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.69 76.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.886 -0.597 . . . . 1.02 110.925 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.6 -35.93 79.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.93 -0.577 . . . . 1.28 111.072 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.403 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.6 m-20 -66.02 -41.9 90.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.461 -0.336 . . . . 1.3600000000000001 110.748 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.43 -44.35 91.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.823 0.344 . . . . 1.0700000000000001 110.145 173.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.482 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 59.6 tt0 -52.71 -53.02 53.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 1.7 110.343 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.79 -29.37 70.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 1.1799999999999999 111.701 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.19 -46.22 61.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 1.05 110.76 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.4 m-85 -67.93 -41.66 82.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.107 -0.497 . . . . 0.16 110.599 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.79 -30.21 71.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.68999999999999995 110.728 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 110.374 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -82.49 8.17 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.65000000000000002 110.746 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.42 51.23 8.63 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.136 -0.554 . . . . 0.28999999999999998 112.448 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.517 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -132.64 164.86 25.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.862 0.363 . . . . 1.03 111.375 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -108.08 125.97 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.173 -0.677 . . . . 2.1400000000000001 109.173 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.482 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.9 t -114.07 140.72 33.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 112.509 0.559 . . . . 1.0800000000000001 112.509 -168.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 t -112.41 140.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.637 -0.875 . . . . 1.05 108.637 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.26 124.7 68.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.773 0.321 . . . . 1.6499999999999999 110.92 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 40' ' ' GLN . . . -135.6 134.09 38.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.146 -0.479 . . . . 1.03 110.725 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.525 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.54 -3.23 28.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.019 0.438 . . . . 1.04 110.674 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -137.71 159.83 40.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 1.0800000000000001 110.719 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 87.6 m -60.32 -34.25 73.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.038 -0.528 . . . . 1.6599999999999999 110.208 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.14 -47.83 81.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.656 . . . . 0.69999999999999996 111.012 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.525 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 38.5 mt-30 -60.56 -37.98 83.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.374 0.607 . . . . 1.4099999999999999 110.696 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.481 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -65.78 -51.01 62.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.232 -0.894 . . . . 1.04 111.708 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.8 mt -60.88 -29.95 69.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.105 0.479 . . . . 1.53 110.472 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -64.85 -52.22 57.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.654 -0.703 . . . . 2.9100000000000001 110.158 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 t -67.71 -34.26 76.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.926 -0.579 . . . . 1.6399999999999999 110.304 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.43 HD22 HG13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -58.68 -42.0 87.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 1.8400000000000001 110.324 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.51 -33.92 28.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 1.1599999999999999 111.513 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.75 -37.49 27.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.62 111.623 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.95 164.6 20.18 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.849 0.357 . . . . 0.47999999999999998 110.873 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -95.05 86.96 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.47 2.78 . . . . 0.31 111.441 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.43 HG13 HD22 ' A' ' 45' ' ' LEU . 45.2 mm -65.39 123.34 18.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.664 -0.698 . . . . 1.03 111.252 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.495 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 45.8 m-20 -93.18 -27.26 16.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.28999999999999998 110.726 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.477 ' CG1' HG22 ' A' ' 8' ' ' VAL . 13.3 p -164.16 157.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.493 -0.558 . . . . 1.03 109.493 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.82 165.48 27.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 0.97999999999999998 112.006 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.62 111.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.254 -0.884 . . . . 1.5700000000000001 109.165 176.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 8.8 mp -113.32 119.25 37.04 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.064 0.394 . . . . 1.02 112.064 -168.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -74.69 132.49 41.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.231 -1.025 . . . . 1.77 108.231 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.528 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 22.9 t -86.21 -10.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.386 0.612 . . . . 1.3600000000000001 110.029 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -129.2 73.27 1.51 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.814 -0.63 . . . . 2.6400000000000001 110.056 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 64' ' ' HIS . 4.0 mm? -56.28 -51.43 68.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.864 -0.607 . . . . 1.3100000000000001 109.711 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.61 -157.62 7.87 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.312 -0.858 . . . . 0.87 111.184 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -55.12 -45.1 43.21 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.727 2.285 . . . . 1.3899999999999999 112.567 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -119.82 -33.87 3.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 4.0 111.208 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 20.1 m -65.5 126.56 28.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.997 0.427 . . . . 1.3700000000000001 110.99 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.522 ' C ' HD22 ' A' ' 59' ' ' LEU . 11.1 p80 -144.86 163.26 34.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.96 -0.564 . . . . 0.58999999999999997 110.253 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 57' ' ' VAL . 26.4 p -75.28 88.32 2.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.315 0.579 . . . . 2.1899999999999999 109.955 175.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 -77.81 1.01 Allowed Glycine 0 C--O 1.228 -0.27 0 C-N-CA 120.091 -1.052 . . . . 0.28000000000000003 111.979 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.6 Cg_exo -51.65 -24.76 18.3 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.024 2.482 . . . . 0.28000000000000003 112.749 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.52 HG21 ' SG ' ' A' ' 38' ' ' CYS . 13.8 t -67.37 -48.58 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 1.01 110.117 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -43.98 84.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.958 -1.019 . . . . 1.01 109.804 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 10.9 m-20 -64.63 -46.66 81.64 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.459 -0.792 . . . . 2.0299999999999998 110.519 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.53 -45.9 69.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.536 0.684 . . . . 1.0700000000000001 110.697 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.06 -46.89 72.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.952 -1.022 . . . . 1.05 110.404 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 24.4 mmtp -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.874 -0.603 . . . . 2.5800000000000001 111.977 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 80.6 mm-40 -69.7 -26.21 64.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.577 -0.283 . . . . 3.0299999999999998 111.405 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -106.95 8.79 30.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.663 0.268 . . . . 1.95 111.244 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.31 35.2 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.837 -0.619 . . . . 1.1899999999999999 111.705 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.3 mt -84.8 132.82 45.03 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 109.894 -0.41 . . . . 1.05 109.894 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.36 141.65 25.88 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.312 2.008 . . . . 0.23000000000000001 112.015 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -157.93 161.95 38.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.835 -0.62 . . . . 0.23999999999999999 110.735 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.61 141.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.25 -0.886 . . . . 1.0700000000000001 109.561 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.8 mm? -88.1 109.63 20.02 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 1.05 109.669 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.508 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 15.4 t-160 -101.35 77.62 1.8 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.816 0.817 . . . . 0.59999999999999998 109.188 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.495 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 10.2 t -115.0 158.28 22.29 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.501 -1.227 . . . . 1.1399999999999999 110.127 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.716 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -108.34 -3.26 33.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.22 -0.752 . . . . 1.1000000000000001 111.22 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 11.0 m-20 -126.22 66.6 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.304 0.573 . . . . 2.3300000000000001 110.075 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.04 -54.72 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.367 -0.833 . . . . 2.1800000000000002 111.129 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.52 -20.42 64.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.322 -0.399 . . . . 2.6299999999999999 111.401 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 1.1 mmp_? -74.16 -26.27 60.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.16 -0.473 . . . . 5.1200000000000001 110.927 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.431 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.6 m-70 -123.17 35.28 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 1.3500000000000001 111.174 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.408 ' HA2' HD13 ' A' ' 93' ' ' LEU . . . -59.67 -41.42 97.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.031 -0.604 . . . . 1.0600000000000001 113.01 -175.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.25 -37.8 81.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.656 0.265 . . . . 2.5 110.609 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.522 HD23 ' CG1' ' A' ' 57' ' ' VAL . 34.8 tp -68.43 -39.98 81.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 1.22 110.412 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.6 mt -58.96 -42.08 89.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 2.1899999999999999 110.729 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.91 -27.42 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 5.0 110.964 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.75 -42.29 50.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.012 -0.54 . . . . 2.8999999999999999 110.614 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.7 mt -67.76 -52.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.506 -0.77 . . . . 1.0800000000000001 111.18 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 t70 61.26 77.49 0.33 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0900000000000001 111.037 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -163.89 163.42 15.78 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.717 . . . . 1.0800000000000001 109.896 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.517 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.8 Cg_exo -56.97 149.82 59.45 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.804 2.336 . . . . 0.29999999999999999 112.847 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.74 132.4 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 1.3 111.076 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.8 mmm -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.121 -0.696 . . . . 1.04 109.121 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.15 132.15 48.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.2 111.884 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.716 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 14.4 ptpt -97.2 150.33 36.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 1.27 110.051 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.625 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 32.8 Cg_exo -60.05 127.96 3.93 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.952 -1.27 . . . . 0.88 113.268 2.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -129.74 134.25 47.51 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.39000000000000001 109.253 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 110' ' ' VAL . 13.1 t70 -67.21 121.96 16.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.904 -0.776 . . . . 0.51000000000000001 108.904 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.403 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.5 p -62.13 -24.37 67.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.26 -0.882 . . . . 1.04 112.474 -170.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.798 -0.445 . . . . 1.8899999999999999 109.798 177.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.56 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 25.6 m-20 -69.17 -37.79 78.38 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.937 -0.574 . . . . 0.62 109.972 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 106' ' ' ASP . 34.0 t -64.31 -46.07 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.676 -0.693 . . . . 1.04 110.253 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -60.37 -48.69 80.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.584 -0.735 . . . . 1.01 111.571 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.689 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 59.6 mtpt -59.12 -55.03 40.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 2.4300000000000002 110.989 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 5.9 mpt_? -51.63 -43.14 62.49 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.028 0.381 . . . . 2.73 112.028 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.69 -50.33 69.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 1.02 110.725 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.441 HD22 HG12 ' A' ' 52' ' ' VAL . 81.1 mt -65.91 -26.3 67.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.509 . . . . 1.04 111.572 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 24.2 mm-40 -60.75 -43.43 97.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.678 0.275 . . . . 2.79 110.965 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.517 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 48.9 mtm -71.14 -29.78 65.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.962 0.411 . . . . 1.0 110.5 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 35.6 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.787 -0.642 . . . . 1.95 110.691 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.5 mtp . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.57 -0.53 . . . . 2.1800000000000002 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.42 136.26 66.6 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.939 2.426 . . . . 0.55000000000000004 111.989 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -82.86 104.54 13.16 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.312 -0.625 . . . . 1.48 109.312 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 49.9 t -100.02 135.1 37.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.514 -0.766 . . . . 1.05 110.559 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.99 111.84 23.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 1.5 110.644 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -93.65 121.78 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.369 0.604 . . . . 1.03 111.332 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.38 106.79 17.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 1.05 108.857 172.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -165.36 125.15 1.8 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 109.663 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.9 -26.5 34.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.863 -0.608 . . . . 1.27 109.607 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -78.71 108.65 8.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.68 -0.691 . . . . 2.5600000000000001 110.59 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.19 -35.09 98.26 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.026 2.484 . . . . 0.35999999999999999 112.949 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.88 -48.81 75.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.35 . . . . 2.2799999999999998 110.278 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.5 -45.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 1.7 110.541 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.93 78.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.848 -0.614 . . . . 1.02 110.902 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.21 -40.2 93.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.959 -0.564 . . . . 1.28 111.08 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.456 ' HB3' HG22 ' A' ' 107' ' ' THR . 5.5 m-20 -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 1.3600000000000001 110.797 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.72 -44.91 96.0 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.806 0.336 . . . . 1.0700000000000001 110.368 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.468 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.4 tt0 -53.32 -49.88 66.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.526 -0.761 . . . . 1.7 110.43 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -58.86 -37.85 77.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.318 -0.401 . . . . 1.1799999999999999 111.466 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.39 -46.09 70.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 1.05 110.889 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 66.1 m-85 -67.55 -43.8 79.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 0.16 110.938 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -59.78 -35.12 73.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.68999999999999995 110.675 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.14 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.51000000000000001 110.767 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.12 -10.54 59.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.65000000000000002 110.979 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.4 49.34 2.21 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.837 -0.697 . . . . 0.28999999999999998 112.279 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.09 163.69 29.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.357 -0.238 . . . . 1.03 110.357 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -110.0 123.69 50.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.605 -0.517 . . . . 2.1400000000000001 109.605 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.468 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.2 t -106.65 138.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.526 0.565 . . . . 1.0800000000000001 112.526 -168.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.61 133.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.377 -0.971 . . . . 1.05 108.377 170.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.18 130.79 58.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.77 0.319 . . . . 1.6499999999999999 111.025 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.76 144.36 35.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 1.03 110.367 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.79 16.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.572 -0.285 . . . . 1.04 111.432 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.723 ' HG1' ' NE2' ' A' ' 40' ' ' GLN . 29.9 p -134.18 176.6 8.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.086 -0.246 . . . . 1.0800000000000001 110.677 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.647 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 1.5 p -68.37 -48.08 65.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.755 -0.461 . . . . 1.6599999999999999 109.755 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.25 -50.2 74.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.439 -0.801 . . . . 0.69999999999999996 111.779 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.723 ' NE2' ' HG1' ' A' ' 37' ' ' THR . 1.3 mp0 -58.69 -37.81 76.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.893 0.378 . . . . 1.4099999999999999 111.582 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.511 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -70.93 -49.46 45.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.259 -0.428 . . . . 1.04 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 73.7 mt -61.63 -26.27 67.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.619 -0.718 . . . . 1.53 110.502 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -62.74 -56.7 15.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 2.9100000000000001 110.309 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.8 t -70.32 -17.8 63.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.462 -0.336 . . . . 1.6399999999999999 111.094 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -41.48 80.79 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.259 -0.645 . . . . 1.8400000000000001 109.259 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.22 12.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.48 . . . . 1.1599999999999999 111.209 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.86 -37.19 73.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.037 -0.528 . . . . 0.62 111.619 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 91.1 m-20 -114.57 150.04 43.24 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.47999999999999998 110.863 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 73.0 Cg_endo -86.21 81.14 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.322 2.682 . . . . 0.31 111.767 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.1 mm -62.72 123.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.38 -0.827 . . . . 1.03 111.51 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.4 m-20 -90.66 -37.79 13.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.633 -0.712 . . . . 0.28999999999999998 110.063 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 11.3 p -157.35 155.66 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.761 -0.654 . . . . 1.03 109.619 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.78 162.62 35.0 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.431 0.634 . . . . 0.97999999999999998 112.063 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.72 111.69 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.092 -0.958 . . . . 1.5700000000000001 109.053 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.764 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.6 mp -112.96 114.99 27.71 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.238 0.458 . . . . 1.02 112.238 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 27.5 t70 -77.46 123.38 26.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.576 -0.898 . . . . 1.77 108.576 168.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.488 ' CG1' HD22 ' A' ' 92' ' ' LEU . 20.2 t -88.3 -10.8 10.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.876 -0.602 . . . . 1.3600000000000001 110.363 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.7 56.28 0.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.824 -0.625 . . . . 2.6400000000000001 109.967 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.15 -26.82 67.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.744 -0.662 . . . . 1.3100000000000001 109.917 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.29 -168.43 31.27 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.57 -1.012 . . . . 0.87 110.57 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.62 -43.1 62.15 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.662 2.241 . . . . 1.3899999999999999 111.737 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -115.26 -33.28 5.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 4.0 110.755 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -58.05 123.52 16.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.265 0.555 . . . . 1.3700000000000001 111.253 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -144.59 149.97 36.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.513 -0.767 . . . . 0.58999999999999997 110.268 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -73.38 86.03 1.49 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.208 -0.664 . . . . 2.1899999999999999 109.208 171.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.82 -71.57 0.81 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.396 -0.907 . . . . 0.28000000000000003 112.264 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -54.1 -25.77 38.71 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.54 2.16 . . . . 0.28000000000000003 111.926 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.6 t -69.17 -48.25 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.061 -0.518 . . . . 1.01 110.165 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.47 86.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.242 -0.89 . . . . 1.01 109.906 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.626 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 35.2 t70 -61.87 -42.94 99.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.207 -0.906 . . . . 2.0299999999999998 110.44 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.63 79.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.448 0.642 . . . . 1.0700000000000001 110.903 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.48 -46.38 83.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 1.05 110.188 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 73' ' ' LYS . 11.1 mmmm -58.85 -33.85 70.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.612 -0.722 . . . . 2.5800000000000001 111.486 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.626 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 99.0 mt-30 -57.84 -47.85 81.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 3.0299999999999998 110.979 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -92.15 6.41 46.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.196 -0.456 . . . . 1.95 110.939 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.15 31.84 21.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 1.1899999999999999 111.343 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -75.63 135.24 71.86 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.685 -0.487 . . . . 1.05 109.685 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.401 ' CG ' ' HB2' ' A' ' 118' ' ' CYS . 30.2 Cg_endo -75.56 138.65 21.97 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.132 1.888 . . . . 0.23000000000000001 111.687 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -157.19 159.32 37.6 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.573 -0.739 . . . . 0.23999999999999999 110.285 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mt -122.91 139.25 50.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.67 -0.695 . . . . 1.0700000000000001 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.84 108.37 19.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.611 -0.514 . . . . 1.05 109.611 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.623 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 21.4 t-160 -103.0 71.8 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.775 -0.824 . . . . 0.59999999999999998 108.775 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.523 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 4.9 t -100.87 153.99 19.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.693 -1.14 . . . . 1.1399999999999999 111.99 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -91.95 -6.58 65.12 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.59 -0.732 . . . . 1.1000000000000001 112.348 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 2.3300000000000001 110.762 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.17 -4.35 11.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.894 -0.594 . . . . 2.1800000000000002 109.852 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.39 -59.82 2.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 2.6299999999999999 111.19 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -70.96 -41.55 70.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.389 0.614 . . . . 5.1200000000000001 110.781 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.527 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.2 m-70 -87.58 14.57 8.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.46 -0.791 . . . . 1.3500000000000001 110.732 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -57.56 -49.92 69.53 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.441 -0.409 . . . . 1.0600000000000001 113.332 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.29 -40.04 96.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 2.5 110.332 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.488 HD22 ' CG1' ' A' ' 57' ' ' VAL . 33.1 tp -59.67 -42.61 93.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 1.22 110.303 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.4 mt -60.39 -35.45 75.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 2.1899999999999999 111.336 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 19.1 mmm180 -71.44 -27.42 63.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.095 0.474 . . . . 5.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.22 -33.44 63.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.831 -0.622 . . . . 2.8999999999999999 109.955 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 92' ' ' LEU . 81.3 mt -71.42 -56.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.324 -0.853 . . . . 1.0800000000000001 110.999 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 59.97 78.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.536 0.684 . . . . 1.0900000000000001 110.879 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -161.11 163.14 21.06 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 1.0800000000000001 109.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.23 141.44 96.68 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.589 2.193 . . . . 0.29999999999999999 112.437 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -119.7 133.66 65.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.14 0.495 . . . . 1.3 111.274 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.8 mmm -118.94 91.28 3.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.712 -0.847 . . . . 1.04 108.712 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.31 154.1 36.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.895 -0.593 . . . . 1.2 111.735 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 96.4 mttt -90.75 143.84 29.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 1.27 109.747 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 140.4 66.03 Favored 'Cis proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.561 -1.433 . . . . 0.88 112.607 2.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.623 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -137.16 129.46 29.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.807 -0.633 . . . . 0.39000000000000001 110.273 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.506 ' O ' HG21 ' A' ' 110' ' ' VAL . 10.3 t70 -72.28 129.69 39.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.966 -0.753 . . . . 0.51000000000000001 108.966 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 20' ' ' ASN . 21.3 p -63.46 -22.67 67.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.271 -0.877 . . . . 1.04 112.542 -171.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.6 p -68.77 -42.9 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 1.8899999999999999 109.927 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 45.4 m-20 -68.18 -41.26 81.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.62 109.548 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 106' ' ' ASP . 24.7 t -61.86 -44.59 99.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.556 -0.747 . . . . 1.04 110.519 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.15 -50.59 65.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 1.01 111.637 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 108' ' ' SER . 30.6 mtpp -64.25 -40.67 96.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 2.4300000000000002 111.61 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.562 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 10.2 mpt_? -63.55 -32.1 73.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.886 0.374 . . . . 2.73 111.77 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.55 -51.33 10.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 1.02 111.053 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.498 HD21 HG11 ' A' ' 52' ' ' VAL . 64.4 mt -63.5 -26.01 68.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.107 0.78 . . . . 1.04 113.107 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -25.78 62.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.62 -0.432 . . . . 2.79 110.914 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.6 mtm -71.61 -25.68 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.161 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 45.2 t . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 1.95 110.974 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 80.2 mtp . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.183 -0.673 . . . . 2.1800000000000002 109.183 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 33.6 Cg_exo -59.53 134.79 60.38 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.479 2.119 . . . . 0.55000000000000004 111.823 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 14.4 tptp -83.64 103.81 13.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.326 -0.62 . . . . 1.48 109.326 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.3 t -99.5 130.47 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.815 -0.63 . . . . 1.05 110.779 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.04 112.46 25.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.852 -0.613 . . . . 1.5 110.295 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -92.97 122.8 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.077 0.465 . . . . 1.03 111.613 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -103.44 101.04 10.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.284 -0.871 . . . . 1.05 109.284 173.274 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.24 127.18 5.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.448 -0.796 . . . . 1.4099999999999999 109.8 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -89.41 -16.56 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.78 -0.645 . . . . 1.27 110.125 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -88.36 108.39 21.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 2.5600000000000001 110.301 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.93 -34.94 99.33 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.748 2.299 . . . . 0.35999999999999999 112.982 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 59.8 tp -62.94 -49.7 73.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 2.2799999999999998 110.513 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.95 -45.32 97.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 1.7 110.624 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.54 -52.21 66.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 1.02 110.784 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.432 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 36.7 ttp -62.55 -37.29 85.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 1.28 111.008 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' HB3' HG22 ' A' ' 107' ' ' THR . 8.0 t-20 -65.69 -47.8 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.3600000000000001 110.501 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 53.1 mt -60.26 -45.56 92.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.936 -0.575 . . . . 1.0700000000000001 109.888 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.527 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 57.7 tt0 -51.8 -50.42 60.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.131 -0.941 . . . . 1.7 111.063 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 17.5 m-85 -67.17 -32.38 73.43 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.139 -0.224 . . . . 1.1799999999999999 111.249 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.85 85.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.84 0.353 . . . . 1.05 110.827 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -68.08 -45.76 72.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.46 . . . . 0.16 110.644 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 45.8 mt-10 -61.9 -30.19 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.474 -0.33 . . . . 0.68999999999999995 110.765 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.01 -41.56 95.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.149 -0.478 . . . . 0.51000000000000001 110.549 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -74.71 -15.62 60.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 0.65000000000000002 110.84 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.76 44.92 1.46 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.833 -0.699 . . . . 0.28999999999999998 112.559 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -134.21 153.62 51.74 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.771 -0.253 . . . . 1.03 110.437 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.28 142.49 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.527 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 44.4 t -123.72 143.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.48 0.548 . . . . 1.0800000000000001 112.48 -170.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' OG ' ' A' ' 44' ' ' SER . 14.9 t -118.44 132.28 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.758 . . . . 1.05 108.955 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -96.56 130.39 45.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.028 0.442 . . . . 1.6499999999999999 111.601 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 40' ' ' GLN . . . -142.23 134.63 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 1.03 110.701 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.14 17.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 1.04 111.003 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.0 p -124.79 162.05 25.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.114 -0.494 . . . . 1.0800000000000001 110.648 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 67.1 m -66.32 -33.67 76.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.56 -0.533 . . . . 1.6599999999999999 109.56 175.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.27 -48.4 78.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.513 -0.767 . . . . 0.69999999999999996 111.045 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.425 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 38.9 mt-30 -58.28 -42.09 85.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.243 0.544 . . . . 1.4099999999999999 110.574 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.478 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -61.3 -53.01 62.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.142 -0.935 . . . . 1.04 111.522 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 86.9 mt -61.54 -28.68 69.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.071 0.462 . . . . 1.53 110.96 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.55 -53.47 22.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 2.9100000000000001 109.748 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.492 ' OG ' HG11 ' A' ' 33' ' ' VAL . 22.7 t -65.95 -34.77 78.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.6399999999999999 110.372 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.51 -35.56 78.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 1.8400000000000001 110.776 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.52 -33.84 28.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.378 -0.374 . . . . 1.1599999999999999 111.118 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.43 -38.12 35.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.62 111.611 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -114.94 163.55 19.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.46 . . . . 0.47999999999999998 110.753 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.65 83.03 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.434 2.756 . . . . 0.31 111.309 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.461 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 37.1 mm -65.74 122.21 16.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.562 -0.745 . . . . 1.03 111.754 -174.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.757 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 32.5 m-20 -91.09 -32.47 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.115 -0.948 . . . . 0.28999999999999998 110.771 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.4 p -160.2 158.3 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 1.03 109.836 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.19 161.09 39.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.156 0.503 . . . . 0.97999999999999998 111.907 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.09 112.41 19.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.7 . . . . 1.5700000000000001 109.682 174.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.782 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -112.47 121.8 45.86 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.23 -0.441 . . . . 1.02 112.083 -170.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.675 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.8 t0 -81.66 114.98 20.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.86 -0.792 . . . . 1.77 108.86 168.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 17.2 t -76.53 -7.91 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.038 -0.983 . . . . 1.3600000000000001 110.43 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.13 65.93 1.21 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 2.6400000000000001 109.778 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.08 -29.5 70.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.581 -0.736 . . . . 1.3100000000000001 109.621 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 -162.54 12.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.151 -0.931 . . . . 0.87 111.09 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.0 -38.76 93.19 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.89 2.393 . . . . 1.3899999999999999 112.676 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 4.5 ttmp? -126.35 -34.43 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.468 -0.333 . . . . 4.0 110.792 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 p -60.48 127.61 32.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.476 0.655 . . . . 1.3700000000000001 111.054 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -144.29 156.02 44.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.412 -0.813 . . . . 0.58999999999999997 110.8 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.8 p -70.49 86.79 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.894 -0.78 . . . . 2.1899999999999999 108.894 168.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.16 -74.82 1.04 Allowed Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 120.191 -1.004 . . . . 0.28000000000000003 112.374 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.9 Cg_exo -53.37 -26.19 34.22 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.488 2.125 . . . . 0.28000000000000003 111.981 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 10.7 t -69.33 -44.79 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 1.01 110.381 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -52.69 64.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.828 . . . . 1.01 109.956 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 33.3 t70 -60.99 -38.18 85.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.107 -0.951 . . . . 2.0299999999999998 110.495 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.1 78.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.355 0.597 . . . . 1.0700000000000001 111.03 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.38 -39.7 85.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.402 -0.817 . . . . 1.05 110.095 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -59.55 -39.03 82.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.622 -0.717 . . . . 2.5800000000000001 111.171 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 55.0 mt-30 -65.56 -43.18 90.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 3.0299999999999998 111.216 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -87.85 2.18 52.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.828 0.347 . . . . 1.95 110.813 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.01 31.22 19.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.538 -0.756 . . . . 1.1899999999999999 111.454 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.99 131.9 49.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 1.05 109.775 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 25.6 Cg_endo -73.7 138.47 26.51 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.166 1.911 . . . . 0.23000000000000001 111.62 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.02 157.39 34.59 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.609 -0.723 . . . . 0.23999999999999999 110.387 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.7 mt -122.31 141.06 44.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.609 -0.723 . . . . 1.0700000000000001 109.888 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -89.33 108.23 19.51 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.78 -0.452 . . . . 1.05 109.78 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.605 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 20.6 t-160 -103.02 72.28 1.17 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.512 -0.921 . . . . 0.59999999999999998 108.512 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.675 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 10.2 t -99.77 155.01 17.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.276 -1.329 . . . . 1.1399999999999999 111.784 -170.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 0.9 59.39 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.734 -0.666 . . . . 1.1000000000000001 112.898 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -154.78 121.08 5.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 2.3300000000000001 110.258 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 86' ' ' LEU . 6.3 mp -106.47 -22.89 12.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.183 -0.462 . . . . 2.1800000000000002 111.606 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -83.87 -30.65 26.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.9 -0.32 . . . . 2.6299999999999999 111.213 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -79.85 -10.08 59.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.348 0.594 . . . . 5.1200000000000001 110.348 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.525 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 99.5 m-70 -131.35 24.11 4.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 1.3500000000000001 111.225 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.73 -42.01 98.75 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.851 -0.69 . . . . 1.0600000000000001 112.879 -175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 33.1 mt-10 -71.66 -25.37 62.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 2.5 110.369 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.477 HD21 ' CG1' ' A' ' 57' ' ' VAL . 55.5 tp -74.53 -43.59 55.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.207 -0.451 . . . . 1.22 110.224 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.1 mt -58.38 -37.7 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 2.1899999999999999 111.834 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 36.5 ptt180 -65.24 -26.57 68.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 5.0 110.912 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -76.12 -35.27 59.36 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.157 0.503 . . . . 2.8999999999999999 110.136 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 55.8 mt -69.9 -52.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.228 -0.897 . . . . 1.0800000000000001 110.445 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 55.51 70.37 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.465 0.65 . . . . 1.0900000000000001 110.579 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -155.96 162.38 27.54 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.368 -0.833 . . . . 1.0800000000000001 109.349 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.24 141.22 94.53 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.666 2.244 . . . . 0.29999999999999999 112.62 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.7 t -118.62 134.68 61.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 1.3 111.289 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 78.6 mmm -119.44 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.656 -0.868 . . . . 1.04 108.656 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.69 152.53 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.018 -0.537 . . . . 1.2 111.691 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 95.8 mttt -90.29 144.81 31.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.723 -0.671 . . . . 1.27 109.844 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.6 Cg_exo -71.12 142.15 71.92 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.561 -1.433 . . . . 0.88 112.433 0.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.605 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -139.83 130.18 25.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.83 -0.623 . . . . 0.39000000000000001 110.266 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.597 ' O ' HG21 ' A' ' 110' ' ' VAL . 13.8 t70 -66.11 124.31 22.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.51000000000000001 109.404 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 20' ' ' ASN . 21.4 p -62.56 -27.63 69.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.432 -0.803 . . . . 1.04 112.238 -172.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 t -70.02 -40.1 75.41 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.615 -0.513 . . . . 1.8899999999999999 109.615 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -65.27 -43.98 89.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.086 0.469 . . . . 0.62 109.803 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 106' ' ' ASP . 23.4 t -60.75 -43.7 95.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.307 -0.86 . . . . 1.04 110.428 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.46 -50.53 67.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 1.01 111.171 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 54.9 mtpt -56.33 -55.53 32.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 2.4300000000000002 111.341 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 35.5 mmt180 -60.03 -35.46 75.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 2.73 111.374 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.31 47.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.509 . . . . 1.02 110.541 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.469 HD22 HG12 ' A' ' 52' ' ' VAL . 80.7 mt -63.52 -25.5 68.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.631 . . . . 1.04 111.848 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 35.0 mm-40 -60.42 -26.53 66.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.694 0.283 . . . . 2.79 111.236 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 67.9 mtm -85.81 -1.67 57.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.369 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 49.2 t . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.167 0.508 . . . . 1.95 110.044 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 90.8 mtp . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 110.032 -0.359 . . . . 2.1800000000000002 110.032 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.24 137.73 44.66 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.165 2.577 . . . . 0.55000000000000004 111.928 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HZ3' ' HB2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -84.97 107.3 17.04 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.342 -0.614 . . . . 1.48 109.342 176.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.475 HG21 ' CG1' ' A' ' 52' ' ' VAL . 47.1 t -100.09 138.86 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 1.05 110.809 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 41' ' ' ALA . 48.3 tp -111.23 115.66 29.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.398 -0.365 . . . . 1.5 110.276 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.17 123.47 51.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.231 0.539 . . . . 1.03 111.024 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 0.8 OUTLIER -103.78 106.01 16.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.214 -0.903 . . . . 1.05 109.326 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -168.34 123.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.044 -0.526 . . . . 1.4099999999999999 109.761 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.5 t70 -87.1 -19.99 27.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.661 . . . . 1.27 110.1 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -81.22 104.86 3.25 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 115.878 -0.601 . . . . 2.5600000000000001 109.963 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.0 Cg_exo -58.07 -29.5 87.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.919 2.413 . . . . 0.35999999999999999 113.427 -172.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt -69.61 -50.74 41.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.879 -0.415 . . . . 2.2799999999999998 109.879 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -63.3 -44.08 98.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.7 109.736 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.64 -49.17 78.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.359 -0.837 . . . . 1.02 110.557 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.0 ttp -59.33 -42.27 91.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.797 -0.638 . . . . 1.28 111.068 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HG21 ' A' ' 107' ' ' THR . 0.7 OUTLIER -64.38 -47.55 78.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 1.3600000000000001 111.083 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.9 mt -60.11 -46.1 90.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.39 -0.368 . . . . 1.0700000000000001 110.449 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.495 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 49.3 tt0 -54.47 -51.03 66.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.818 -0.628 . . . . 1.7 110.917 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.857 -0.337 . . . . 1.1799999999999999 110.887 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.68 -46.32 72.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.941 0.401 . . . . 1.05 110.277 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.515 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 m-85 -66.9 -44.03 81.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.16 110.803 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.02 -28.04 67.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.537 -0.301 . . . . 0.68999999999999995 111.015 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.32 -27.81 65.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.314 0.578 . . . . 0.51000000000000001 109.983 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -84.71 2.45 41.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.67 . . . . 0.65000000000000002 111.05 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.92 47.15 6.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.922 -0.656 . . . . 0.28999999999999998 112.632 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.98 8.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.633 0.254 . . . . 1.03 110.363 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.82 134.29 55.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.514 -0.55 . . . . 2.1400000000000001 109.514 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.495 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -116.07 135.79 55.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.319 0.489 . . . . 1.0800000000000001 112.319 -168.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.46 122.74 63.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 1.05 107.925 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.57 124.73 55.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.721 -0.392 . . . . 1.6499999999999999 110.697 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -130.11 139.31 50.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.934 -0.576 . . . . 1.03 110.702 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.83 -11.35 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 1.04 111.252 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -130.68 170.53 14.19 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.954 -0.298 . . . . 1.0800000000000001 111.492 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.2 p -60.84 -49.47 77.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.6599999999999999 109.646 171.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -52.24 -50.01 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.667 -1.151 . . . . 0.69999999999999996 111.764 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.503 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 75.6 mt-30 -59.81 -37.02 77.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 1.4099999999999999 111.187 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.451 ' HB2' HD23 ' A' ' 11' ' ' LEU . . . -71.38 -49.46 41.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.67 -0.695 . . . . 1.04 111.225 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 72.8 mt -63.5 -28.98 70.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.731 -0.668 . . . . 1.53 110.158 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 7.5 tmtm? -63.93 -50.69 67.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.385 -0.598 . . . . 2.9100000000000001 109.385 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 t -64.65 -32.02 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.219 -0.446 . . . . 1.6399999999999999 110.878 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 -41.81 89.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.123 0.487 . . . . 1.8400000000000001 110.376 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.19 -38.26 20.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 1.1599999999999999 111.54 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.33 -36.47 58.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.065 -0.516 . . . . 0.62 111.408 -174.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -122.16 162.11 39.23 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.345 -0.389 . . . . 0.47999999999999998 110.428 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -92.82 88.24 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.303 2.669 . . . . 0.31 111.149 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mm -67.4 119.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.715 -0.675 . . . . 1.03 111.52 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -91.06 -30.75 16.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.924 -0.58 . . . . 0.28999999999999998 110.197 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.475 ' CG1' HG21 ' A' ' 8' ' ' VAL . 12.0 p -160.88 157.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.731 . . . . 1.03 109.409 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -140.84 166.02 25.92 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.456 0.646 . . . . 0.97999999999999998 111.239 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.9 120.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.747 -1.205 . . . . 1.5700000000000001 107.747 174.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.9 mp -116.36 109.17 16.99 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.729 -0.388 . . . . 1.02 111.301 -170.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.772 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -80.67 97.78 7.41 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.8 -0.815 . . . . 1.77 108.8 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 64' ' ' HIS . 46.8 t -50.71 -31.18 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.212 -0.904 . . . . 1.3600000000000001 112.44 -170.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -95.75 80.08 3.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.934 0.397 . . . . 2.6400000000000001 110.392 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.83 -14.45 59.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.563 0.697 . . . . 1.3100000000000001 110.09 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.88 -166.27 35.82 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.754 -0.938 . . . . 0.87 110.754 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.71 -45.36 41.64 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.916 2.411 . . . . 1.3899999999999999 112.311 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -120.85 -22.14 6.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.371 -0.377 . . . . 4.0 110.812 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.7 m -63.4 129.12 38.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.112 0.482 . . . . 1.3700000000000001 111.147 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 15.5 p80 -144.0 153.27 42.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.58999999999999997 110.282 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.5 m -79.1 86.44 4.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.827 -0.805 . . . . 2.1899999999999999 108.827 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.55 -66.47 0.7 Allowed Glycine 0 C--N 1.328 0.132 0 C-N-CA 120.62 -0.8 . . . . 0.28000000000000003 112.392 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.67 -23.76 50.87 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.396 2.064 . . . . 0.28000000000000003 111.621 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.5 t -68.17 -47.74 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.96 -0.564 . . . . 1.01 109.774 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.06 -47.73 80.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.99 -1.005 . . . . 1.01 110.087 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 19.3 t70 -64.09 -36.41 83.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 2.0299999999999998 110.571 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -62.93 -40.48 97.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.409 0.623 . . . . 1.0700000000000001 110.888 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.69 -43.87 62.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 1.05 110.529 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 28.2 mmmt -57.33 -39.58 76.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.565 -0.743 . . . . 2.5800000000000001 111.166 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.667 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 6.8 pt20 -64.88 -37.76 88.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.533 -0.758 . . . . 3.0299999999999998 110.957 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HG3' ' CG ' ' A' ' 74' ' ' GLN . 96.3 mtt180 -99.47 7.57 45.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 1.95 111.899 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.94 23.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.133 -0.485 . . . . 1.1899999999999999 111.734 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.8 mt -83.54 132.7 48.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 1.05 109.744 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -72.62 140.67 33.07 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.354 2.036 . . . . 0.23000000000000001 112.302 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 12.2 p90 -161.25 156.9 24.78 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.23999999999999999 110.417 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 mt -119.6 138.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.591 -0.731 . . . . 1.0700000000000001 109.869 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.19 109.71 20.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.17 -0.678 . . . . 1.05 109.17 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.772 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 19.3 t-160 -102.05 117.54 35.01 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.638 -0.875 . . . . 0.59999999999999998 108.638 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.721 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 8.9 t -171.33 154.21 3.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.733 0.301 . . . . 1.1399999999999999 110.586 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.2 33.13 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.465 -0.654 . . . . 1.1000000000000001 111.465 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -111.21 60.44 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.353 0.597 . . . . 2.3300000000000001 109.928 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.69 -48.78 58.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.408 -0.815 . . . . 2.1800000000000002 110.871 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -63.55 -33.62 76.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 2.6299999999999999 110.783 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 4.9 mmp_? -71.82 -15.4 62.14 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 5.1200000000000001 111.9 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.437 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 87.3 m-70 -134.25 31.59 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.745 0.276 . . . . 1.3500000000000001 111.745 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.01 -28.48 71.69 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.835 -0.698 . . . . 1.0600000000000001 112.469 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.556 ' HA ' ' HE ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -76.45 -26.1 55.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 2.5 110.34 178.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 tp -76.95 -47.51 20.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.85 -0.614 . . . . 1.22 109.864 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 79.2 mt -57.3 -39.59 76.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.861 -0.608 . . . . 2.1899999999999999 112.082 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' A' ' 91' ' ' GLU . 11.1 ptp180 -66.17 -25.28 66.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.668 0.27 . . . . 5.0 111.343 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -73.38 -30.16 63.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.398 0.618 . . . . 2.8999999999999999 110.14 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 55.4 mt -82.72 -53.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.18 -0.918 . . . . 1.0800000000000001 110.877 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.02 74.22 0.34 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.718 0.77 . . . . 1.0900000000000001 110.831 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.31 168.56 11.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 114.789 -1.096 . . . . 1.0800000000000001 108.503 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.83 135.85 71.67 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.097 1.865 . . . . 0.29999999999999999 112.338 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 t -123.75 117.47 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 1.3 110.726 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.603 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.4 mtp -103.05 116.75 33.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 1.04 109.941 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.97 148.87 37.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.814 -0.63 . . . . 1.2 111.594 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.545 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 76.8 mttt -90.68 143.18 28.61 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 1.27 109.779 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -74.04 144.55 81.33 Favored 'Cis proline' 0 C--O 1.234 0.299 0 C-N-CA 123.282 -1.549 . . . . 0.88 112.925 1.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.638 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -138.66 131.88 30.01 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.347 -0.842 . . . . 0.39000000000000001 108.936 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.476 ' O ' HG21 ' A' ' 110' ' ' VAL . 11.3 t70 -73.08 129.42 38.04 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.964 -0.754 . . . . 0.51000000000000001 108.964 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.3 p -62.18 -21.05 64.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.375 -0.829 . . . . 1.04 112.758 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.7 p -69.02 -43.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.874 -0.417 . . . . 1.8899999999999999 109.874 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.82 -39.9 87.84 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.134 -0.484 . . . . 0.62 110.166 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.603 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.8 t -61.87 -47.76 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.754 -0.657 . . . . 1.04 110.333 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.515 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.16 -48.37 78.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 1.01 111.21 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.28 -41.18 98.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 2.4300000000000002 111.271 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -68.1 -27.38 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.745 0.307 . . . . 2.73 111.66 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -49.89 12.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.921 0.391 . . . . 1.02 110.233 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.516 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 71.1 mt -65.08 -27.09 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.85 0.685 . . . . 1.04 112.85 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.56 -26.92 66.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.732 -0.387 . . . . 2.79 110.946 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 69.8 mtm -73.84 -33.04 63.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.06 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.5 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.32 0.581 . . . . 1.95 110.522 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 54.6 mtt . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.8 0.333 . . . . 2.1800000000000002 110.963 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.485 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 1.5 Cg_endo -70.84 142.91 44.27 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.846 2.364 . . . . 0.55000000000000004 112.428 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -90.05 105.63 17.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 1.48 109.004 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.3 t -99.73 136.27 31.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.987 -0.551 . . . . 1.05 111.27 -173.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.5 tp -109.31 112.0 23.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.134 -0.485 . . . . 1.5 110.273 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.62 122.86 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.298 0.57 . . . . 1.03 111.641 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -103.76 111.94 24.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.7 -1.136 . . . . 1.05 108.704 172.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -170.16 127.23 0.84 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.38 -0.6 . . . . 1.4099999999999999 109.38 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.6 t70 -85.24 -25.58 27.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.27 110.324 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -75.55 106.57 3.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 2.5600000000000001 110.555 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 33.1 Cg_exo -59.64 -31.7 94.74 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.771 2.314 . . . . 0.35999999999999999 112.982 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.47 -49.59 68.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.329 -0.619 . . . . 2.2799999999999998 109.329 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.2 mt -66.24 -47.08 85.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.374 -0.83 . . . . 1.7 111.27 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.56 82.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 1.02 110.654 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -58.96 -44.74 91.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.727 -0.67 . . . . 1.28 110.924 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.438 ' HB3' HG23 ' A' ' 107' ' ' THR . 2.1 m-80 -68.2 -37.35 80.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.751 -0.659 . . . . 1.3600000000000001 111.394 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.65 -45.04 88.48 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.506 -0.315 . . . . 1.0700000000000001 110.379 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.561 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 62.4 tt0 -55.25 -53.05 61.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 1.7 110.311 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -64.16 -27.72 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 1.1799999999999999 111.563 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.66 -46.36 63.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.766 0.317 . . . . 1.05 110.73 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.694 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 54.0 m-85 -67.26 -42.3 84.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.367 -0.379 . . . . 0.16 110.526 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 50.4 mt-10 -61.58 -31.79 71.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.68999999999999995 110.039 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -35.52 76.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.756 -0.656 . . . . 0.51000000000000001 110.694 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -75.76 -20.55 58.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.142 0.496 . . . . 0.65000000000000002 110.305 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 56.27 0.7 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.705 -0.679 . . . . 0.28999999999999998 111.748 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.16 171.37 15.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.728 0.299 . . . . 1.03 110.803 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.99 150.25 25.09 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.561 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 47.1 t -134.27 138.49 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.389 0.514 . . . . 1.0800000000000001 112.389 -172.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG12 ' OG ' ' A' ' 44' ' ' SER . 12.0 t -115.58 126.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.058 -0.719 . . . . 1.05 109.058 168.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.46 130.64 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.076 0.465 . . . . 1.6499999999999999 111.278 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 40' ' ' GLN . . . -141.25 134.48 29.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 1.03 110.662 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.46 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.11 -10.73 20.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.451 . . . . 1.04 111.078 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.632 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 38.3 p -127.34 168.4 14.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.395 . . . . 1.0800000000000001 110.757 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.539 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.6 m -70.95 -35.33 72.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.292 -0.413 . . . . 1.6599999999999999 110.047 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.69999999999999996 111.219 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.632 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 17.2 mt-30 -61.87 -37.99 86.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.255 0.55 . . . . 1.4099999999999999 110.57 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -63.65 -51.44 65.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.328 -0.851 . . . . 1.04 111.388 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.7 mt -62.53 -30.2 71.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.538 . . . . 1.53 111.021 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -49.16 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 2.9100000000000001 109.776 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.405 ' OG ' HG12 ' A' ' 33' ' ' VAL . 43.7 t -64.57 -38.12 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.037 -0.529 . . . . 1.6399999999999999 110.7 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.25 -32.27 72.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.284 0.564 . . . . 1.8400000000000001 110.688 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.33 -41.43 16.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 1.1599999999999999 111.348 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.93 -34.49 59.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.0 -0.545 . . . . 0.62 111.629 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -118.32 161.49 34.88 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.47999999999999998 110.503 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.61 84.28 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.388 2.726 . . . . 0.31 111.495 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.7 mm -64.62 123.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.651 -0.704 . . . . 1.03 111.736 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.522 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 37.7 m-20 -92.58 -30.63 15.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.483 -0.781 . . . . 0.28999999999999998 110.277 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.5 p -159.81 155.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.111 -0.495 . . . . 1.03 109.807 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 164.06 29.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.359 0.6 . . . . 0.97999999999999998 111.49 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -135.33 112.39 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.512 -0.767 . . . . 1.5700000000000001 108.944 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.644 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -109.05 108.36 19.03 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.667 -0.413 . . . . 1.02 111.723 -170.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.802 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.0 t70 -78.82 126.21 30.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.598 -0.89 . . . . 1.77 108.598 172.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.509 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 21.3 t -73.96 -16.44 16.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.596 -0.729 . . . . 1.3600000000000001 110.862 -173.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -99.03 85.23 3.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.278 0.561 . . . . 2.6400000000000001 110.566 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.7 mt -99.88 -4.52 30.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.513 0.673 . . . . 1.3100000000000001 109.503 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.07 -174.47 40.99 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.895 -1.048 . . . . 0.87 110.731 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.09 -45.41 31.97 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.696 2.264 . . . . 1.3899999999999999 111.98 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -107.29 -32.8 7.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.859 -0.61 . . . . 4.0 110.129 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.7 m -65.56 126.91 29.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 1.3700000000000001 111.96 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -144.5 152.72 41.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.29 -0.868 . . . . 0.58999999999999997 109.413 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 28.5 p -67.44 87.67 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.296 0.569 . . . . 2.1899999999999999 109.876 173.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.4 -69.78 0.43 Allowed Glycine 0 C--O 1.224 -0.496 0 C-N-CA 120.669 -0.777 . . . . 0.28000000000000003 112.119 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.9 Cg_exo -51.91 -30.56 39.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.594 2.196 . . . . 0.28000000000000003 112.134 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -66.33 -39.15 83.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.451 0.643 . . . . 1.01 110.068 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.83 -47.18 75.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.091 -0.959 . . . . 1.01 110.093 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 2.7 m-20 -60.45 -42.77 96.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 2.0299999999999998 109.968 176.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.53 63.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 1.0700000000000001 111.249 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.55 -40.77 89.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.417 -0.81 . . . . 1.05 110.579 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 62.8 mmtt -59.67 -35.21 74.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.5800000000000001 111.079 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 46.4 mt-30 -70.39 -37.32 74.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 3.0299999999999998 111.171 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -93.04 4.67 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.681 0.277 . . . . 1.95 111.231 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.59 33.73 22.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 1.1899999999999999 111.617 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.18 133.87 32.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.144 -0.48 . . . . 1.05 110.063 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.98 143.95 29.74 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.525 2.15 . . . . 0.23000000000000001 112.32 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 41.7 p90 -158.53 160.24 36.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.552 -0.749 . . . . 0.23999999999999999 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 mt -125.07 139.53 50.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.161 -0.927 . . . . 1.0700000000000001 109.639 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mm? -88.94 113.62 24.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.302 0.572 . . . . 1.05 109.465 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.802 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 17.2 t-160 -101.63 130.03 47.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.386 -0.968 . . . . 0.59999999999999998 108.386 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 11.1 t -178.72 162.14 1.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.9 -0.32 . . . . 1.1399999999999999 110.703 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.74 13.8 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.335 -1.106 . . . . 1.1000000000000001 110.335 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.5 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -114.29 49.56 1.0 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.136 -0.532 . . . . 2.3300000000000001 110.137 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.85 -30.6 65.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 2.1800000000000002 111.944 -173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.77 -34.48 24.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.292 0.568 . . . . 2.6299999999999999 109.867 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.5 ' HD3' ' OD2' ' A' ' 85' ' ' ASP . 44.6 ttt180 -67.32 -34.91 78.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.313 -0.858 . . . . 5.1200000000000001 111.128 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.432 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.0 m-70 -118.62 28.66 8.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 1.3500000000000001 111.473 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.65 95.88 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.001 -0.618 . . . . 1.0600000000000001 112.756 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 29.5 mt-10 -61.37 -45.57 93.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 2.5 110.154 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.84 -44.94 95.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 1.22 110.572 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 73.5 mt -59.6 -38.62 81.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 2.1899999999999999 111.372 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -71.26 -27.03 63.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.399 -0.364 . . . . 5.0 111.18 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 66.9 mttm -74.21 -43.74 55.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.333 0.587 . . . . 2.8999999999999999 110.032 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.548 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 83.5 mt -62.45 -51.34 73.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.189 -0.914 . . . . 1.0800000000000001 110.581 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.7 t70 62.47 75.58 0.4 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.425 0.631 . . . . 1.0900000000000001 110.828 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 81' ' ' LEU . . . -161.12 167.41 13.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 1.0800000000000001 109.339 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.24 142.69 97.51 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.399 2.066 . . . . 0.29999999999999999 112.667 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -124.24 124.36 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 1.3 111.054 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.14 110.5 22.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.28 -0.637 . . . . 1.04 109.28 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.21 146.66 41.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.015 -0.539 . . . . 1.2 111.91 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.46 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 86.8 mttt -91.19 142.52 27.28 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 1.27 109.709 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.5 Cg_exo -71.14 139.59 59.39 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.505 -1.456 . . . . 0.88 112.992 3.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.56 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -132.79 136.44 46.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.39000000000000001 109.619 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 110' ' ' VAL . 10.5 t70 -79.38 131.58 36.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.472 -0.936 . . . . 0.51000000000000001 108.472 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 20' ' ' ASN . 23.3 p -64.84 -23.56 67.27 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.672 -0.695 . . . . 1.04 112.24 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -72.68 -33.31 66.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.551 -0.537 . . . . 1.8899999999999999 109.551 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -70.49 -45.8 64.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.809 -0.632 . . . . 0.62 109.36 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 106' ' ' ASP . 30.6 t -60.12 -43.44 92.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.227 -0.897 . . . . 1.04 110.264 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.694 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -61.89 -50.06 73.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.702 -0.681 . . . . 1.01 111.369 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.5 mttp -59.79 -49.95 75.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 2.4300000000000002 111.167 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -59.7 -38.36 81.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 2.73 111.475 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.67 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 1.02 110.603 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 52' ' ' VAL . 63.0 mt -65.26 -25.44 67.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 1.04 112.167 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 20.5 mm-40 -59.16 -30.23 68.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 2.79 111.208 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.5 mtm -88.81 1.94 54.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.992 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 51.1 t . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 116.146 -0.479 . . . . 1.95 111.573 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 91.2 mtp . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.98 0.419 . . . . 2.1800000000000002 110.811 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.642 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -63.94 142.22 80.83 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.413 2.742 . . . . 0.55000000000000004 112.224 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -87.93 103.04 15.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.904 -0.776 . . . . 1.48 108.904 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.442 HG22 ' CG1' ' A' ' 52' ' ' VAL . 54.9 t -99.23 135.49 34.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.003 -0.544 . . . . 1.05 110.859 -173.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.4 tp -110.96 111.21 22.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.184 -0.462 . . . . 1.5 110.573 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -92.6 125.65 45.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 1.03 111.324 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.621 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 0.7 OUTLIER -107.33 104.17 13.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.023 -0.989 . . . . 1.05 109.231 173.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -165.16 123.23 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.88 -0.6 . . . . 1.4099999999999999 110.075 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.5 t70 -83.42 -22.06 32.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.798 -0.637 . . . . 1.27 110.781 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.81 107.0 9.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.119 -0.326 . . . . 2.5600000000000001 110.119 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.2 Cg_exo -58.5 -28.86 86.95 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.35999999999999999 113.484 -174.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 tp -64.64 -49.96 68.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.998 0.428 . . . . 2.2799999999999998 110.115 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.18 -41.37 89.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.834 -0.621 . . . . 1.7 110.559 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.17 82.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 1.02 110.854 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.3 ttp -62.08 -42.8 99.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.862 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -64.21 -40.9 97.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.848 -0.615 . . . . 1.3600000000000001 111.432 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 38.8 mt -64.56 -45.02 88.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.612 0.244 . . . . 1.0700000000000001 110.525 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.534 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.2 tt0 -55.6 -50.28 70.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.974 -0.557 . . . . 1.7 110.466 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -65.04 -27.17 68.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 1.1799999999999999 111.508 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.18 -45.02 58.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 1.05 110.643 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -70.45 -42.16 71.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.112 -0.495 . . . . 0.16 110.917 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.46 -35.92 78.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.916 0.389 . . . . 0.68999999999999995 110.032 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.92 -31.86 73.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.633 -0.712 . . . . 0.51000000000000001 110.732 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -86.19 5.66 33.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.65000000000000002 111.159 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.76 52.7 5.31 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.948 -0.644 . . . . 0.28999999999999998 112.46 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.401 ' CB ' ' HD2' ' A' ' 6' ' ' PRO . . . -138.4 163.54 31.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.692 0.282 . . . . 1.03 110.658 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -101.91 144.26 30.76 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.985 -0.746 . . . . 2.1400000000000001 108.985 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.534 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -127.58 143.75 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.027 0.441 . . . . 1.0800000000000001 111.843 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.461 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.7 t -117.7 128.61 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.805 -0.813 . . . . 1.05 108.805 168.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -97.23 122.75 49.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.548 -0.461 . . . . 1.6499999999999999 110.986 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -134.14 135.41 43.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.626 -0.716 . . . . 1.03 109.819 176.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.42 -21.61 14.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.331 -0.395 . . . . 1.04 110.922 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.47 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 17.1 p -115.39 170.99 7.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.991 0.424 . . . . 1.0800000000000001 111.125 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.582 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 22.3 p -65.06 -47.62 76.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.477 0.656 . . . . 1.6599999999999999 109.367 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -55.91 -45.72 78.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.279 -1.328 . . . . 0.69999999999999996 111.997 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.499 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 55.6 mt-30 -59.54 -45.31 92.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.426 0.631 . . . . 1.4099999999999999 110.304 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.515 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -61.12 -50.84 71.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.062 -0.972 . . . . 1.04 111.141 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 57.7 mt -63.14 -31.34 72.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.761 -0.654 . . . . 1.53 110.83 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -68.59 -53.44 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 2.9100000000000001 109.841 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.461 ' OG ' HG11 ' A' ' 33' ' ' VAL . 33.3 t -65.45 -32.91 74.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.894 0.378 . . . . 1.6399999999999999 110.621 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.3 tp -65.4 -33.51 76.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.8400000000000001 110.797 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.32 -35.95 30.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.896 -0.593 . . . . 1.1599999999999999 111.258 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.98 -38.07 32.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.62 111.524 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -112.62 164.69 14.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.984 -0.553 . . . . 0.47999999999999998 110.89 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -94.78 78.29 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.571 2.847 . . . . 0.31 111.594 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.5 mm -64.04 119.29 7.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.751 -0.659 . . . . 1.03 111.236 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.527 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.4 m-20 -87.75 -29.67 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.726 -0.67 . . . . 0.28999999999999998 110.457 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.46 HG11 HD22 ' A' ' 115' ' ' LEU . 14.3 p -160.53 156.49 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 1.03 110.349 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.05 165.56 27.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.281 0.562 . . . . 0.97999999999999998 112.059 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.66 112.11 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.427 -0.806 . . . . 1.5700000000000001 109.583 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 9.7 mp -112.52 116.93 31.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.296 0.48 . . . . 1.02 112.296 -168.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.11 107.1 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 1.77 109.637 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 92' ' ' LEU . 12.9 t -68.82 -9.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.041 -0.527 . . . . 1.3600000000000001 111.964 -172.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -114.96 63.27 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 2.6400000000000001 110.981 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.422 HD11 ' SG ' ' A' ' 65' ' ' CYS . 97.5 mt -64.52 -27.85 69.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.265 0.555 . . . . 1.3100000000000001 110.874 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.22 32.22 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.192 -0.763 . . . . 0.87 111.192 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.54 -40.66 82.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.931 2.421 . . . . 1.3899999999999999 112.513 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -123.83 -31.55 3.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.655 0.264 . . . . 4.0 110.783 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -65.95 127.03 30.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.058 0.456 . . . . 1.3700000000000001 111.706 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -144.57 153.38 41.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.707 -0.678 . . . . 0.58999999999999997 110.061 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 2.6 m -73.7 85.94 1.65 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.984 -0.747 . . . . 2.1899999999999999 108.984 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.47 -63.93 0.54 Allowed Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.841 -0.695 . . . . 0.28000000000000003 111.842 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.45 -24.91 37.68 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.348 2.032 . . . . 0.28000000000000003 111.381 173.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -68.45 -45.01 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.748 -0.66 . . . . 1.01 109.995 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.49 -49.41 77.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 1.01 110.165 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 50.7 m-20 -61.95 -41.6 98.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 2.0299999999999998 110.238 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.63 -44.16 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.019 -0.537 . . . . 1.0700000000000001 111.256 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.11 -42.19 76.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.56 -0.745 . . . . 1.05 110.268 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.577 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.9 mmtt -59.88 -36.74 77.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.681 -0.691 . . . . 2.5800000000000001 111.447 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 71.2 mt-30 -63.29 -39.07 93.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 3.0299999999999998 111.237 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -96.02 6.14 49.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.29 -0.414 . . . . 1.95 111.235 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 35.57 22.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.797 -0.638 . . . . 1.1899999999999999 111.754 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.0 mt -89.12 133.79 34.5 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 116.501 -0.318 . . . . 1.05 110.441 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -74.2 141.46 29.21 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.49 2.127 . . . . 0.23000000000000001 111.765 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -159.16 160.58 35.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.675 -0.693 . . . . 0.23999999999999999 110.225 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.421 HG22 ' HG2' ' A' ' 101' ' ' MET . 16.0 mt -125.52 141.42 45.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.482 -0.781 . . . . 1.0700000000000001 109.987 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.84 108.71 19.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.309 -0.626 . . . . 1.05 109.309 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.643 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 21.9 t-160 -103.66 74.01 1.22 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.481 0.658 . . . . 0.59999999999999998 109.261 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 t -105.86 163.56 12.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.646 -1.161 . . . . 1.1399999999999999 111.048 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 -4.99 57.7 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.901 -0.59 . . . . 1.1000000000000001 112.31 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -137.95 132.72 32.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.108 0.48 . . . . 2.3300000000000001 109.826 172.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.429 HD11 ' N ' ' A' ' 86' ' ' LEU . 6.1 mp -111.83 -25.85 9.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 2.1800000000000002 110.856 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.18 -45.97 12.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.126 0.489 . . . . 2.6299999999999999 110.898 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.34 -40.15 95.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.513 -0.767 . . . . 5.1200000000000001 110.938 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.518 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 49.7 m-70 -102.31 25.19 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.565 -0.288 . . . . 1.3500000000000001 111.163 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.74 -37.88 95.56 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.967 -0.635 . . . . 1.0600000000000001 112.975 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 11.7 tt0 -66.94 -39.8 87.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 2.5 110.258 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 96' ' ' ILE . 41.4 tp -68.12 -40.01 82.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.227 -0.442 . . . . 1.22 109.863 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 89.0 mt -59.15 -39.6 82.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.453 -0.34 . . . . 2.1899999999999999 111.189 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 24.4 ptt180 -73.95 -26.05 60.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 5.0 110.584 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -70.34 -34.15 72.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.295 0.569 . . . . 2.8999999999999999 110.163 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.577 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 95.8 mt -77.36 -53.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.366 -0.834 . . . . 1.0800000000000001 110.677 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.0 t70 64.47 75.26 0.38 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.764 0.792 . . . . 1.0900000000000001 110.917 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.87 162.11 25.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.902 -1.044 . . . . 1.0800000000000001 109.383 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.75 147.19 89.48 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.658 2.239 . . . . 0.29999999999999999 112.539 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.1 t -124.25 134.97 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.202 -0.454 . . . . 1.3 110.971 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.421 ' HG2' HG22 ' A' ' 80' ' ' ILE . 92.2 mmm -114.77 107.47 15.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.286 -0.635 . . . . 1.04 109.286 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -73.04 143.86 47.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.944 -0.571 . . . . 1.2 111.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 94.0 mttt -91.45 146.74 33.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.046 -0.525 . . . . 1.27 110.186 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.19 127.31 13.8 Favored 'Cis proline' 0 C--O 1.234 0.278 0 C-N-CA 123.619 -1.409 . . . . 0.88 112.699 2.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.643 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -119.35 130.04 55.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.728 -0.669 . . . . 0.39000000000000001 110.297 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.15 129.97 38.87 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.04 -1.096 . . . . 0.51000000000000001 108.04 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 39.9 p -64.28 -20.47 66.09 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.875 0.695 . . . . 1.04 112.875 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 76.1 p -65.87 -42.32 90.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.995 0.426 . . . . 1.8899999999999999 110.176 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 -39.79 84.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.159 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.44 -45.14 98.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 1.04 110.327 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.31 -48.81 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.554 -0.748 . . . . 1.01 111.479 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 2.4300000000000002 111.269 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.8 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 2.73 111.402 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.2 -46.81 17.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.49 . . . . 1.02 110.392 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.46 HD22 HG11 ' A' ' 52' ' ' VAL . 77.1 mt -70.59 -26.08 63.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.634 0.605 . . . . 1.04 112.634 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -63.07 -33.19 74.92 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.815 -0.354 . . . . 2.79 110.415 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.3 mtm -76.08 -30.69 58.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.193 0.52 . . . . 1.0 110.139 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.5 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 1.95 111.033 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.793 0.33 . . . . 2.1800000000000002 111.662 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HG2' HD21 ' A' ' 115' ' ' LEU . 17.3 Cg_exo -70.45 136.06 30.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.045 2.496 . . . . 0.55000000000000004 110.984 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -85.98 109.48 18.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.431 -0.581 . . . . 1.48 109.431 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 38.0 t -100.14 130.79 48.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.9 -0.591 . . . . 1.05 110.916 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.1 tp -105.04 112.14 25.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.83 0.348 . . . . 1.5 110.306 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.3 t -93.12 121.03 43.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.118 0.485 . . . . 1.03 111.507 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.1 mm? -102.45 101.11 11.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.297 -0.865 . . . . 1.05 108.889 171.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -159.51 120.98 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.479 -0.782 . . . . 1.4099999999999999 109.921 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 19.0 t70 -87.49 -19.03 28.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.9 -0.591 . . . . 1.27 109.941 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -83.51 105.65 5.89 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 2.5600000000000001 109.835 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.1 Cg_exo -59.03 -32.97 98.49 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.736 2.291 . . . . 0.35999999999999999 113.063 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.37 -49.19 78.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.621 -0.511 . . . . 2.2799999999999998 109.621 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.23 -46.04 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 1.7 110.88 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.59 72.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.069 0.461 . . . . 1.02 110.783 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.0 ttp -63.27 -44.92 93.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.553 -0.749 . . . . 1.28 111.231 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -67.68 -36.78 81.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.098 -0.501 . . . . 1.3600000000000001 111.497 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.4 mt -65.54 -46.14 80.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.739 0.304 . . . . 1.0700000000000001 110.188 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.539 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 48.2 tt0 -55.17 -48.38 73.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 1.7 110.406 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -63.48 -37.88 89.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.441 -0.345 . . . . 1.1799999999999999 111.199 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.54 -49.36 69.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.435 -0.348 . . . . 1.05 111.275 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -63.96 -45.73 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.86 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.66 -28.42 69.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.366 -0.379 . . . . 0.68999999999999995 111.164 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.8 -33.33 66.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.51000000000000001 110.229 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.78 -14.73 59.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.65000000000000002 110.817 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 53.11 0.8 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 112.373 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.4 175.95 9.13 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.872 -0.193 . . . . 1.03 110.683 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.45 129.91 49.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.064 -0.717 . . . . 2.1400000000000001 109.064 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.3 t -118.25 142.15 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 112.664 0.616 . . . . 1.0800000000000001 112.664 -164.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 44' ' ' SER . 10.4 t -114.38 136.38 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.867 -0.79 . . . . 1.05 108.867 169.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.02 125.09 58.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 1.6499999999999999 111.191 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -134.78 139.53 45.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.109 -0.496 . . . . 1.03 110.424 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.94 -13.16 15.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.347 -0.388 . . . . 1.04 111.2 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.0 p -127.79 167.44 16.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.485 -0.325 . . . . 1.0800000000000001 110.555 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.631 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 74.6 m -68.73 -34.19 75.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.845 -0.428 . . . . 1.6599999999999999 109.845 175.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.37 -48.01 81.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.69999999999999996 110.613 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.459 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . 71.8 mt-30 -59.08 -41.03 87.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.353 0.596 . . . . 1.4099999999999999 110.621 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.504 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -62.0 -54.75 37.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.15 -0.932 . . . . 1.04 111.419 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 62.7 mt -64.46 -30.7 71.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.013 -0.54 . . . . 1.53 110.767 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -64.43 -47.43 79.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.292 -0.633 . . . . 2.9100000000000001 109.292 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.432 ' HB3' HG13 ' A' ' 33' ' ' VAL . 11.0 m -72.28 -30.46 64.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.922 -0.581 . . . . 1.6399999999999999 110.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.1 -35.93 80.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 1.8400000000000001 110.637 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.24 -35.15 48.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.055 -0.52 . . . . 1.1599999999999999 110.814 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.53 -36.28 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.745 -0.661 . . . . 0.62 111.17 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.59 148.56 48.24 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.358 0.599 . . . . 0.47999999999999998 111.284 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.65 88.59 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.321 2.681 . . . . 0.31 111.498 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.56 127.95 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 1.03 111.663 -175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -98.89 -27.03 14.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.28999999999999998 110.414 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 11.7 p -159.48 159.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 1.03 109.49 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.71 165.84 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.376 0.607 . . . . 0.97999999999999998 112.128 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.14 111.76 7.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.221 -0.899 . . . . 1.5700000000000001 109.192 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.613 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -114.43 124.08 51.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.329 0.492 . . . . 1.02 112.329 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.642 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.5 t0 -85.1 115.1 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.815 0.817 . . . . 1.77 109.336 169.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 65.8 t -59.97 -24.17 29.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.588 -1.187 . . . . 1.3600000000000001 110.96 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 7.7 t30 -113.01 75.53 0.92 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 2.6400000000000001 110.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.3 -29.57 67.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.809 0.814 . . . . 1.3100000000000001 109.052 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.37 -172.22 34.28 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.567 -1.197 . . . . 0.87 110.241 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 62' ' ' LYS . 86.1 Cg_exo -52.92 -44.52 47.9 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.905 2.403 . . . . 1.3899999999999999 112.399 176.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -109.59 -34.1 6.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 4.0 110.563 177.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.8 m -65.89 127.46 32.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.351 0.596 . . . . 1.3700000000000001 111.146 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -144.23 149.89 37.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 0.58999999999999997 110.34 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -71.74 86.57 0.94 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.514 0.674 . . . . 2.1899999999999999 109.431 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.65 -73.06 0.7 Allowed Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.355 -0.926 . . . . 0.28000000000000003 112.164 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.8 Cg_exo -53.29 -25.3 30.08 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.583 2.189 . . . . 0.28000000000000003 112.221 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 11' ' ' LEU . 12.6 t -72.12 -46.72 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.228 0.537 . . . . 1.01 110.365 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.42 -51.81 67.93 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.314 -0.857 . . . . 1.01 109.802 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 26.4 t70 -62.28 -37.34 85.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 110.49 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 67' ' ' PRO . . . -56.96 -48.23 78.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.409 0.623 . . . . 1.0700000000000001 110.969 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.04 -41.61 77.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.399 -0.818 . . . . 1.05 110.402 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 29.9 mmmt -57.89 -39.39 77.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.585 -0.734 . . . . 2.5800000000000001 110.807 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 44.0 mt-30 -62.64 -46.68 87.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.688 . . . . 3.0299999999999998 111.462 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -86.41 2.8 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 1.95 111.086 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.0 33.16 21.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.763 -0.653 . . . . 1.1899999999999999 111.308 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.74 131.39 47.45 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 116.085 -0.507 . . . . 1.05 109.845 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.2 Cg_endo -72.72 139.39 30.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.17 1.913 . . . . 0.23000000000000001 111.616 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -156.44 155.28 31.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.902 -0.59 . . . . 0.23999999999999999 110.719 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.34 139.61 44.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.538 -0.756 . . . . 1.0700000000000001 109.505 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.5 mm? -88.69 107.45 18.94 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.281 -0.637 . . . . 1.05 109.281 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 101' ' ' MET . 14.7 t-160 -103.46 72.52 1.15 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.275 -1.009 . . . . 0.59999999999999998 108.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.642 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 9.7 t -103.52 159.63 15.42 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 113.989 -1.46 . . . . 1.1399999999999999 111.401 -171.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.66 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -106.24 9.42 42.41 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.623 -0.799 . . . . 1.1000000000000001 111.42 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 17.7 t70 -137.06 141.31 42.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.877 0.37 . . . . 2.3300000000000001 110.861 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.6 mt -130.08 -31.88 1.87 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.079 -0.51 . . . . 2.1800000000000002 110.71 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.54 -39.39 16.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.478 0.548 . . . . 2.6299999999999999 112.478 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -70.16 -52.58 22.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.692 0.282 . . . . 5.1200000000000001 111.141 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -97.21 29.1 3.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.426 -0.352 . . . . 1.3500000000000001 110.304 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.18 -34.08 62.1 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.448 -0.406 . . . . 1.0600000000000001 113.796 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.88 -26.04 68.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 2.5 111.259 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.567 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.3 tp -74.96 -47.87 27.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.22 -0.445 . . . . 1.22 110.954 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -60.48 -36.37 78.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.911 0.386 . . . . 2.1899999999999999 110.955 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.43 -34.12 73.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.311 -0.859 . . . . 5.0 111.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -81.34 -29.36 34.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 2.8999999999999999 111.063 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 92' ' ' LEU . 70.7 mt -67.71 -50.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.798 -0.637 . . . . 1.0800000000000001 111.327 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.21 75.96 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.413 0.625 . . . . 1.0900000000000001 110.617 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -162.71 161.99 19.07 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.437 -0.802 . . . . 1.0800000000000001 109.44 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 31.8 Cg_exo -59.99 137.3 75.07 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.79 2.327 . . . . 0.29999999999999999 112.465 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.9 135.33 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.891 -0.595 . . . . 1.3 110.904 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.581 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.6 mtp -127.24 90.91 3.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.294 -0.632 . . . . 1.04 109.294 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.62 139.78 57.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.739 -0.664 . . . . 1.2 111.62 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.66 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 15.3 ptpt -91.56 149.84 40.06 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.594 -0.73 . . . . 1.27 109.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 16.7 Cg_exo -66.54 138.43 39.56 Favored 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 123.534 -1.444 . . . . 0.88 113.118 3.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -142.07 133.93 27.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.253 -0.885 . . . . 0.39000000000000001 108.778 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.569 ' O ' HG23 ' A' ' 110' ' ' VAL . 12.9 t70 -65.09 123.36 19.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.585 -0.524 . . . . 0.51000000000000001 109.585 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.9 p -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.495 -0.775 . . . . 1.04 112.555 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -70.81 -39.74 72.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.455 -0.572 . . . . 1.8899999999999999 109.455 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -67.01 -44.26 80.76 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.62 109.84 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.581 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 25.4 t -59.95 -42.11 88.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.197 -0.911 . . . . 1.04 110.378 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.85 -50.47 66.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.598 -0.728 . . . . 1.01 111.558 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.85 -41.1 99.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 2.4300000000000002 111.538 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -71.82 -24.91 61.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.7 0.285 . . . . 2.73 111.492 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 -48.98 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 1.02 110.279 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.603 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 69.0 mt -64.55 -26.82 68.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.931 0.715 . . . . 1.04 112.931 -175.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.69 -28.98 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.779 -0.368 . . . . 2.79 110.969 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.431 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 57.7 mtm -75.21 -21.81 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 1.0 111.03 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 25.4 p . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.06 0.457 . . . . 1.95 110.529 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 12.1 ptp . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.811 0.815 . . . . 2.1800000000000002 112.554 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -69.53 141.13 45.3 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.153 1.902 . . . . 0.55000000000000004 112.743 -176.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -89.56 105.92 18.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.635 -0.711 . . . . 1.48 109.087 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.6 t -100.66 134.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 1.05 111.228 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 tp -110.55 113.31 25.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.008 -0.542 . . . . 1.5 110.564 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -95.05 129.11 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.962 0.411 . . . . 1.03 111.113 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.5 OUTLIER -110.0 101.54 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.563 -0.744 . . . . 1.05 109.982 176.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -165.14 133.25 3.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.658 -0.497 . . . . 1.4099999999999999 109.658 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -87.47 -31.95 19.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.884 -0.598 . . . . 1.27 110.497 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.1 111.46 13.7 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.22 -0.289 . . . . 2.5600000000000001 110.22 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.48 -31.92 95.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.998 2.465 . . . . 0.35999999999999999 113.027 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.81 -49.64 69.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.891 -0.411 . . . . 2.2799999999999998 109.891 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.08 -47.69 86.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 1.7 110.415 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.76 -49.43 77.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.49 -0.777 . . . . 1.02 111.477 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.5 ttp -66.22 -34.12 77.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.382 -0.372 . . . . 1.28 111.093 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.477 ' HB3' HG23 ' A' ' 107' ' ' THR . 3.2 m-20 -66.77 -43.88 82.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.311 -0.404 . . . . 1.3600000000000001 110.609 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.39 -44.06 97.35 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.184 -0.462 . . . . 1.0700000000000001 110.021 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 56.6 tt0 -52.18 -53.83 38.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 1.7 110.684 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -63.76 -33.35 75.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.777 0.323 . . . . 1.1799999999999999 111.138 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.87 71.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.215 -0.448 . . . . 1.05 111.046 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.709 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.3 m-85 -66.95 -40.41 87.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.16 110.849 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.6 mt-10 -61.6 -35.66 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.68999999999999995 110.539 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.73 -29.25 67.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.52 . . . . 0.51000000000000001 110.761 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -82.78 -2.0 53.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.65000000000000002 110.923 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.16 50.54 3.62 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.878 -0.677 . . . . 0.28999999999999998 112.404 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.87 162.32 35.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.204 -0.295 . . . . 1.03 110.204 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.78 132.98 51.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.572 -0.529 . . . . 2.1400000000000001 109.572 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 22' ' ' GLN . 21.8 t -113.78 139.95 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.014 0.375 . . . . 1.0800000000000001 112.014 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.475 HG12 ' OG ' ' A' ' 44' ' ' SER . 10.2 t -114.45 127.29 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.588 -0.893 . . . . 1.05 108.588 167.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.61 123.4 50.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.727 -0.389 . . . . 1.6499999999999999 110.769 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.441 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -129.36 134.32 47.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.064 -0.516 . . . . 1.03 109.994 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.02 -18.95 19.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.833 -0.621 . . . . 1.04 110.909 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.2 p -125.12 164.89 19.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.705 -0.398 . . . . 1.0800000000000001 111.163 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.634 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 76.5 m -65.16 -35.46 81.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.838 -0.619 . . . . 1.6599999999999999 109.681 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.6 -46.91 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.984 -0.553 . . . . 0.69999999999999996 110.641 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.441 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 71.1 mt-30 -61.42 -41.65 97.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.955 -0.566 . . . . 1.4099999999999999 110.822 176.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.458 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -63.46 -49.65 72.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.559 -0.746 . . . . 1.04 111.484 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 81.7 mt -60.58 -33.42 72.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.192 -0.458 . . . . 1.53 110.885 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.436 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 6.8 tmtm? -66.73 -52.58 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.814 -0.63 . . . . 2.9100000000000001 109.945 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.475 ' OG ' HG12 ' A' ' 33' ' ' VAL . 14.1 t -65.4 -34.42 78.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.367 -0.379 . . . . 1.6399999999999999 110.44 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.05 -36.44 81.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 1.8400000000000001 110.852 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.05 -39.84 22.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 1.1599999999999999 111.194 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.58 -37.79 65.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.62 111.397 -176.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -115.29 163.14 21.14 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.47999999999999998 110.411 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.84 82.54 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.446 2.764 . . . . 0.31 111.531 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mm -63.96 122.43 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.463 -0.79 . . . . 1.03 111.526 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -90.22 -34.71 15.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.56 -0.746 . . . . 0.28999999999999998 110.32 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.44 HG13 HD22 ' A' ' 115' ' ' LEU . 14.6 p -154.7 154.27 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 1.03 109.987 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 79' ' ' PHE . . . -137.21 162.89 32.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.374 0.606 . . . . 0.97999999999999998 111.657 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.17 112.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.411 -0.813 . . . . 1.5700000000000001 109.185 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mp -107.54 97.95 7.62 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.442 0.639 . . . . 1.02 110.975 -172.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.702 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -74.22 82.98 1.85 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.929 -1.032 . . . . 1.77 109.35 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -42.46 -42.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 114.541 -1.208 . . . . 1.3600000000000001 113.71 -169.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.35 74.43 4.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.014 0.435 . . . . 2.6400000000000001 110.755 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.7 mt -78.52 -22.85 46.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.55 0.691 . . . . 1.3100000000000001 109.444 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.8 -174.39 45.95 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.904 -1.044 . . . . 0.87 110.503 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.49 -40.13 87.2 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.598 2.199 . . . . 1.3899999999999999 112.339 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -118.06 -23.69 7.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.088 -0.506 . . . . 4.0 110.723 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.9 m -70.32 124.74 24.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.214 0.53 . . . . 1.3700000000000001 110.973 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -144.97 148.31 33.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.726 -0.67 . . . . 0.58999999999999997 110.353 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.486 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -76.44 87.32 3.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.857 -0.794 . . . . 2.1899999999999999 108.857 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.71 -67.52 0.56 Allowed Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.47 -0.871 . . . . 0.28000000000000003 112.541 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.587 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 38.9 Cg_exo -53.96 -21.35 20.86 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.354 2.036 . . . . 0.28000000000000003 111.902 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.437 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 38.5 t -70.17 -42.67 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.889 -0.596 . . . . 1.01 110.071 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.99 -45.68 91.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.564 -0.744 . . . . 1.01 109.905 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.0 m-20 -61.74 -43.78 98.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.0299999999999998 109.804 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.4 -48.71 76.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 1.0700000000000001 111.165 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.11 -41.44 97.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.514 -0.766 . . . . 1.05 110.297 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -60.94 -34.47 74.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.829 -0.623 . . . . 2.5800000000000001 111.757 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 15.8 mm100 -65.47 -35.5 81.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.457 -0.338 . . . . 3.0299999999999998 110.929 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -100.24 7.93 44.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 1.95 111.421 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.89 36.31 27.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.798 -0.637 . . . . 1.1899999999999999 111.694 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.82 133.41 35.82 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.413 -0.358 . . . . 1.05 110.152 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 34.6 Cg_endo -76.9 141.35 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.607 2.205 . . . . 0.23000000000000001 112.113 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 21.8 p90 -156.7 157.9 35.98 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.378 -0.828 . . . . 0.23999999999999999 110.453 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 mt -120.05 139.05 48.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.246 -0.888 . . . . 1.0700000000000001 109.646 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.23 108.01 19.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.905 -0.776 . . . . 1.05 108.905 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.71 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 12.0 t-160 -101.77 102.59 13.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.359 0.599 . . . . 0.59999999999999998 110.111 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 7.9 t -164.21 149.96 10.74 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.964 -0.46 . . . . 1.1399999999999999 110.423 -173.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.3 -13.32 36.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.483 -1.047 . . . . 1.1000000000000001 110.483 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 33.0 t70 -94.36 103.81 15.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.815 -0.809 . . . . 2.3300000000000001 108.815 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.41 -62.14 1.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.216 -0.447 . . . . 2.1800000000000002 112.036 -171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.13 -29.86 68.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.051 0.453 . . . . 2.6299999999999999 111.17 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.427 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 65.6 ttt180 -67.81 -18.73 64.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 5.1200000000000001 110.944 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -131.25 33.18 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.511 . . . . 1.3500000000000001 110.289 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.589 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.43 -41.8 98.72 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.887 -0.597 . . . . 1.0600000000000001 113.012 -175.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.89 -37.08 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.695 0.284 . . . . 2.5 111.108 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' HG13 ' A' ' 96' ' ' ILE . 24.2 tp -64.08 -49.53 71.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.264 0.554 . . . . 1.22 110.052 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.7 mt -61.47 -31.32 71.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.133 -0.939 . . . . 2.1899999999999999 111.252 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 95.9 mtt180 -63.97 -37.98 89.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 5.0 110.866 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -66.33 -47.4 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.53 0.681 . . . . 2.8999999999999999 110.273 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 92' ' ' LEU . 41.2 mt -66.31 -56.33 14.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.519 -1.219 . . . . 1.0800000000000001 111.215 -175.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.9 t70 47.99 59.55 4.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.882 0.848 . . . . 1.0900000000000001 110.715 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . 0.41 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . -132.66 168.98 15.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.077 -0.965 . . . . 1.0800000000000001 109.336 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 78.3 Cg_exo -51.67 136.64 50.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.238 1.959 . . . . 0.29999999999999999 112.756 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.1 t -123.14 136.26 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.352 -0.84 . . . . 1.3 110.146 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.674 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 94.5 mtp -118.35 106.06 12.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.343 -0.614 . . . . 1.04 109.343 173.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.67 153.04 44.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.474 -0.785 . . . . 1.2 110.842 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.49 ' HZ3' ' HA ' ' A' ' 83' ' ' THR . 57.5 mttp -91.04 146.32 33.42 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 1.27 109.838 177.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.52 148.65 89.58 Favored 'Cis proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.548 -1.438 . . . . 0.88 112.858 0.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.71 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -140.61 135.97 32.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.695 -0.684 . . . . 0.39000000000000001 109.615 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.537 ' O ' HG21 ' A' ' 110' ' ' VAL . 9.9 t0 -75.93 132.55 40.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.8 -0.815 . . . . 0.51000000000000001 108.8 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 20' ' ' ASN . 23.7 p -67.7 -21.17 65.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.707 -0.679 . . . . 1.04 112.189 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.9 p -76.0 -29.08 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.154 0.502 . . . . 1.8899999999999999 109.672 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.97 -45.5 49.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.62 109.57 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.674 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 23.2 t -59.03 -44.59 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 1.04 110.428 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.709 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -59.11 -52.68 64.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 1.01 111.346 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 37.3 mtmm -62.96 -47.03 84.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.033 -0.53 . . . . 2.4300000000000002 111.039 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -56.49 -37.65 70.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.325 . . . . 2.73 111.513 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.46 48.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 1.02 110.794 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.44 HD22 HG13 ' A' ' 52' ' ' VAL . 74.6 mt -64.02 -25.29 68.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 1.04 112.0 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 42.5 mm-40 -59.31 -31.09 68.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.642 0.258 . . . . 2.79 111.066 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.475 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 62.0 mtm -84.96 -23.07 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.402 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.152 0.501 . . . . 1.95 110.119 178.901 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.453 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.7 mtt . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 110.184 -0.302 . . . . 2.1800000000000002 110.184 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.5 Cg_exo -66.36 136.93 45.33 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.643 2.229 . . . . 0.55000000000000004 111.741 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HD2' ' HD2' ' A' ' 49' ' ' PRO . 9.3 mttp -84.22 109.67 17.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 1.48 110.839 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 39.1 t -101.66 117.83 47.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 1.05 110.515 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 41' ' ' ALA . 58.2 tp -97.66 109.9 22.56 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.698 -0.683 . . . . 1.5 110.432 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.08 123.86 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.199 0.523 . . . . 1.03 111.479 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.2 mm? -101.72 106.2 17.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.095 -0.957 . . . . 1.05 108.897 172.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -165.5 131.28 2.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.889 -0.596 . . . . 1.4099999999999999 109.873 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 24.4 t70 -94.13 -21.25 19.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.418 -0.81 . . . . 1.27 109.722 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' HD11 ' A' ' 17' ' ' ILE . 9.6 mm-40 -81.81 105.58 4.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 2.5600000000000001 110.193 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 34.5 Cg_exo -59.81 -25.19 78.57 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.771 2.314 . . . . 0.35999999999999999 113.366 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.32 -52.04 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.312 -0.625 . . . . 2.2799999999999998 109.312 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.416 HD11 ' HB3' ' A' ' 14' ' ' GLU . 2.9 mp -63.85 -43.8 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.55 . . . . 1.7 110.069 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.27 66.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.622 -0.717 . . . . 1.02 110.715 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.424 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 42.2 ttp -62.96 -38.77 92.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.691 -0.686 . . . . 1.28 111.257 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.409 ' HB3' HG23 ' A' ' 107' ' ' THR . 7.3 m-20 -65.11 -42.56 93.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.21 -0.45 . . . . 1.3600000000000001 111.289 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.465 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 52.8 mt -65.21 -43.8 90.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.984 0.421 . . . . 1.0700000000000001 109.967 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -52.86 -50.93 62.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.163 -0.926 . . . . 1.7 110.662 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -64.5 -33.37 75.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 1.1799999999999999 111.629 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.17 -49.29 61.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 1.05 111.061 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 73.2 m-85 -66.93 -42.09 85.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.16 110.967 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -64.84 -26.96 68.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.576 -0.284 . . . . 0.68999999999999995 110.703 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.51000000000000001 110.951 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.06 -12.15 59.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.65000000000000002 111.223 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.89 51.74 1.35 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.785 -0.722 . . . . 0.28999999999999998 112.135 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.7 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.209 -0.293 . . . . 1.03 110.209 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.08 130.58 55.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.654 -0.499 . . . . 2.1400000000000001 109.654 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.7 t -109.01 138.37 36.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.173 -0.467 . . . . 1.0800000000000001 111.71 -171.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.63 123.39 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.771 -0.826 . . . . 1.05 108.771 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.5 p -92.85 128.68 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 1.6499999999999999 111.17 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -138.8 135.05 34.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 1.03 110.605 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.08 -10.91 20.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.292 -0.413 . . . . 1.04 111.37 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -130.26 166.1 21.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 1.0800000000000001 111.075 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 85.9 m -66.36 -34.92 79.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 1.6599999999999999 110.301 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -61.08 -51.57 68.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.69999999999999996 110.578 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.451 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 36.8 mt-30 -55.93 -37.07 68.45 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.999 -0.546 . . . . 1.4099999999999999 111.245 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.478 ' HB2' HD23 ' A' ' 11' ' ' LEU . . . -69.28 -52.74 24.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.542 -0.753 . . . . 1.04 111.133 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.73 -34.96 70.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.87 -0.604 . . . . 1.53 110.873 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -52.74 63.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.469 . . . . 2.9100000000000001 110.557 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 -36.74 84.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.88 -0.6 . . . . 1.6399999999999999 110.481 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.9 -36.09 80.29 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.074 0.464 . . . . 1.8400000000000001 110.939 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.47 -35.91 45.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.426 . . . . 1.1599999999999999 111.442 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -85.88 -31.47 22.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.059 0.457 . . . . 0.62 111.106 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -123.25 162.8 37.71 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.614 . . . . 0.47999999999999998 111.415 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' HD2' ' A' ' 7' ' ' LYS . 89.2 Cg_endo -95.47 90.55 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.68 2.92 . . . . 0.31 111.383 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 7' ' ' LYS . 40.4 mm -73.94 123.85 30.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.784 -0.644 . . . . 1.03 111.329 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.517 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 24.8 m-20 -88.75 -28.48 20.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.552 -0.749 . . . . 0.28999999999999998 110.884 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -164.05 158.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.979 -0.378 . . . . 1.03 109.979 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -139.8 167.13 22.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.97999999999999998 111.806 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.58 112.26 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 1.5700000000000001 109.028 176.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.65 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.7 mp -111.22 119.59 39.45 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.43 0.53 . . . . 1.02 112.43 -167.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -85.02 141.67 30.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.861 -0.792 . . . . 1.77 108.861 167.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.429 HG22 HD23 ' A' ' 93' ' ' LEU . 13.1 t -100.89 2.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.584 0.707 . . . . 1.3600000000000001 111.148 -170.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -124.37 62.7 1.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.682 -0.69 . . . . 2.6400000000000001 109.862 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.54 -15.84 60.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.833 -0.621 . . . . 1.3100000000000001 110.24 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.31 -171.5 41.7 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.105 -0.798 . . . . 0.87 111.105 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -50.83 -45.55 35.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.061 2.507 . . . . 1.3899999999999999 112.148 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -117.95 -26.67 6.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 4.0 110.106 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -62.47 125.16 22.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.481 0.658 . . . . 1.3700000000000001 111.402 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -143.97 157.0 44.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.439 -0.8 . . . . 0.58999999999999997 109.647 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.65 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -71.4 87.48 0.86 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.388 0.613 . . . . 2.1899999999999999 109.493 171.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.24 -72.68 0.63 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.468 -0.872 . . . . 0.28000000000000003 112.19 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.658 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 44.0 Cg_exo -53.62 -26.39 37.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.565 2.176 . . . . 0.28000000000000003 112.212 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.3 t -68.66 -43.35 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.097 0.475 . . . . 1.01 110.201 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.77 -48.05 82.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.344 -0.844 . . . . 1.01 109.823 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.35 -40.5 93.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.47 -0.786 . . . . 2.0299999999999998 110.484 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.22 -47.98 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.398 0.618 . . . . 1.0700000000000001 110.955 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.65 -42.26 71.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.215 -0.902 . . . . 1.05 110.733 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -59.22 -36.56 75.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.599 . . . . 2.5800000000000001 111.225 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -64.82 -37.4 87.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 3.0299999999999998 111.574 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -97.56 5.31 49.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.397 -0.365 . . . . 1.95 111.397 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 31.09 20.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.971 -0.558 . . . . 1.1899999999999999 111.399 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.8 mt -83.36 130.08 57.93 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 109.595 -0.52 . . . . 1.05 109.595 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.28 142.95 38.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.309 2.006 . . . . 0.23000000000000001 111.362 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 25.6 p90 -159.3 157.16 30.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.124 0.487 . . . . 0.23999999999999999 110.621 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.8 mt -121.39 138.59 51.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.311 -0.859 . . . . 1.0700000000000001 109.853 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.34 108.68 19.46 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.758 -0.83 . . . . 1.05 108.758 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.587 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 17.4 t-160 -105.82 85.33 2.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.369 0.604 . . . . 0.59999999999999998 109.476 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 t -134.05 160.49 37.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.841 -1.072 . . . . 1.1399999999999999 110.212 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.08 2.27 38.05 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.569 -1.013 . . . . 1.1000000000000001 110.569 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.29 51.09 1.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.545 . . . . 2.3300000000000001 110.692 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.66 -41.45 96.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.702 -0.681 . . . . 2.1800000000000002 111.145 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.01 -40.81 17.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.562 -0.29 . . . . 2.6299999999999999 110.793 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -43.59 80.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.102 -0.499 . . . . 5.1200000000000001 111.521 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -119.46 32.04 6.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 1.3500000000000001 111.149 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.13 -41.09 96.44 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.999 -0.619 . . . . 1.0600000000000001 112.809 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.61 -47.17 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.134 0.493 . . . . 2.5 110.624 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.3 tp -60.29 -45.69 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.602 -0.727 . . . . 1.22 110.32 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.429 HD23 HG22 ' A' ' 57' ' ' VAL . 74.2 mt -58.64 -39.93 81.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 2.1899999999999999 111.368 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 4.7 mmp_? -64.26 -33.46 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 5.0 111.361 178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.8 -34.12 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 2.8999999999999999 111.069 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 92' ' ' LEU . 80.8 mt -64.76 -52.82 49.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.089 -0.505 . . . . 1.0800000000000001 110.314 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.51 76.0 0.36 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.815 0.697 . . . . 1.0900000000000001 110.787 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -157.6 162.3 27.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.403 -0.817 . . . . 1.0800000000000001 108.95 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.689 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -57.26 136.19 74.82 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.448 2.098 . . . . 0.29999999999999999 112.429 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.91 132.6 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 1.3 110.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.9 mmm -113.04 105.54 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.895 -0.78 . . . . 1.04 108.895 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 146.14 55.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.003 -0.544 . . . . 1.2 111.475 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.53 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.3 mttt -91.05 141.61 26.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 1.27 109.473 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.57 156.41 99.23 Favored 'Cis proline' 0 CA--C 1.528 0.217 0 C-N-CA 123.413 -1.494 . . . . 0.88 113.339 2.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.587 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -152.76 135.1 15.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.39000000000000001 109.915 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -70.94 130.23 41.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.897 -1.149 . . . . 0.51000000000000001 107.897 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 33.5 p -65.05 -18.35 65.22 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.737 0.643 . . . . 1.04 112.737 -171.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.3 p -71.15 -38.81 72.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.459 -0.496 . . . . 1.8899999999999999 109.689 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.38 -46.76 87.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.412 0.625 . . . . 0.62 109.575 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.72 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.853 -1.067 . . . . 1.04 110.394 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.64 -50.03 72.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 1.01 111.518 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -59.59 -43.32 93.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 2.4300000000000002 111.349 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 117' ' ' MET . 23.9 mmt180 -68.16 -31.79 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.965 0.412 . . . . 2.73 111.321 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.67 -48.53 25.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.354 -0.385 . . . . 1.02 110.473 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.449 HD23 HG11 ' A' ' 52' ' ' VAL . 70.1 mt -66.42 -32.09 73.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.489 0.551 . . . . 1.04 112.489 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -70.2 -22.16 62.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.599 -0.441 . . . . 2.79 110.978 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.689 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 56.5 mtm -77.55 -16.35 58.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 1.0 110.613 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 43.2 t . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 121.265 0.555 . . . . 1.95 109.64 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 CA--C 1.531 0.25 0 N-CA-C 112.595 0.591 . . . . 2.1800000000000002 112.595 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.86 138.8 65.05 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.917 2.411 . . . . 0.55000000000000004 112.04 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -87.17 105.09 16.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.48 -0.563 . . . . 1.48 109.48 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.488 HG21 ' CG1' ' A' ' 52' ' ' VAL . 50.2 t -99.88 135.34 35.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.903 -0.59 . . . . 1.05 110.939 -174.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.1 tp -110.54 111.94 23.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.198 -0.455 . . . . 1.5 110.709 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.97 122.43 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.215 0.531 . . . . 1.03 111.467 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -102.19 101.27 11.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.172 -0.922 . . . . 1.05 108.642 172.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -159.03 120.0 3.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.866 -0.606 . . . . 1.4099999999999999 109.956 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.544 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 36.8 t70 -88.41 -16.9 31.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.307 -0.406 . . . . 1.27 110.332 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HB3' HD11 ' A' ' 17' ' ' ILE . 42.9 mt-10 -82.95 103.16 2.23 Favored Pre-proline 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 2.5600000000000001 109.421 173.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.9 Cg_exo -58.48 -29.04 87.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.667 2.244 . . . . 0.35999999999999999 113.07 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -51.28 57.21 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.682 -0.488 . . . . 2.2799999999999998 109.682 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp -64.25 -43.4 97.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 1.7 110.182 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.42 -47.53 81.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.825 -0.625 . . . . 1.02 110.678 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.7 ttp -64.28 -39.32 93.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.516 -0.765 . . . . 1.28 110.874 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -66.32 -47.04 74.82 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.969 -0.56 . . . . 1.3600000000000001 111.207 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.3 mt -60.01 -45.32 93.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.039 -0.356 . . . . 1.0700000000000001 110.039 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.452 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -52.19 -50.6 61.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 1.7 110.535 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -68.82 -31.21 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 1.1799999999999999 111.522 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.8 -43.09 76.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.833 0.349 . . . . 1.05 110.838 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 50.1 m-85 -69.37 -42.68 74.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 0.16 110.881 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 43.3 mt-10 -62.51 -32.02 72.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.68999999999999995 110.24 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.31 -35.13 79.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.51000000000000001 110.818 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -83.98 6.52 21.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.65000000000000002 110.625 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 57.38 2.85 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.28999999999999998 112.485 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.27 170.48 15.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 1.03 111.051 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -115.92 132.54 56.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.186 -0.672 . . . . 2.1400000000000001 109.186 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.452 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.5 t -117.12 137.29 51.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.749 0.648 . . . . 1.0800000000000001 112.749 -166.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -110.91 135.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.464 -0.939 . . . . 1.05 108.464 169.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.28 128.74 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.911 0.386 . . . . 1.6499999999999999 110.754 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.577 . . . . 1.03 110.41 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.408 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -103.17 -6.54 22.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.492 . . . . 1.04 110.769 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -132.31 163.95 27.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.876 -0.602 . . . . 1.0800000000000001 110.315 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 79.6 m -68.46 -33.05 73.5 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.744 -0.382 . . . . 1.6599999999999999 110.139 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.66 -39.38 84.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.69999999999999996 111.176 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.474 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 36.7 mt-30 -62.45 -36.67 83.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.258 0.552 . . . . 1.4099999999999999 110.473 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 11' ' ' LEU . . . -67.88 -53.22 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.405 -0.816 . . . . 1.04 111.267 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 79.0 mt -59.45 -33.2 70.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.1 -0.5 . . . . 1.53 110.663 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -63.97 -49.71 71.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.936 -0.394 . . . . 2.9100000000000001 109.936 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 m -67.21 -27.04 66.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.958 -0.565 . . . . 1.6399999999999999 111.319 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.2 -35.79 69.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 1.8400000000000001 111.052 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.12 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 1.1599999999999999 111.06 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -83.01 -28.24 29.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.86 -0.609 . . . . 0.62 111.464 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -131.66 160.2 68.5 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 110.109 -0.33 . . . . 0.47999999999999998 110.109 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -94.47 89.3 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.484 2.789 . . . . 0.31 111.552 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.2 mm -67.78 123.29 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.655 -0.702 . . . . 1.03 111.801 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.32 -34.81 18.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 110.296 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.488 ' CG1' HG21 ' A' ' 8' ' ' VAL . 14.6 p -159.13 158.74 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 1.03 110.082 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.78 166.01 25.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.203 0.525 . . . . 0.97999999999999998 112.069 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.75 112.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.334 -0.848 . . . . 1.5700000000000001 109.302 176.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.725 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -113.58 121.86 45.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.432 0.53 . . . . 1.02 112.432 -167.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -80.49 109.96 15.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.809 0.814 . . . . 1.77 108.959 169.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.68 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 17.3 t -59.05 -19.65 16.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.353 -1.294 . . . . 1.3600000000000001 112.253 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -123.88 80.41 1.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 2.6400000000000001 110.573 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.28 -32.3 62.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.751 -0.659 . . . . 1.3100000000000001 110.01 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -169.66 28.71 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.233 -0.747 . . . . 0.87 111.233 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.47 -37.76 96.29 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.165 2.577 . . . . 1.3899999999999999 112.599 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 62' ' ' LYS . 13.8 tmtt? -113.57 -34.31 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.695 -0.483 . . . . 4.0 109.695 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -63.52 124.52 21.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 1.3700000000000001 111.65 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.94 149.8 35.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.34 -0.845 . . . . 0.58999999999999997 109.598 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.1 p -71.47 87.15 0.87 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.491 0.663 . . . . 2.1899999999999999 109.257 171.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.94 -71.6 0.55 Allowed Glycine 0 CA--C 1.509 -0.303 0 C-N-CA 120.451 -0.88 . . . . 0.28000000000000003 112.045 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 52.4 Cg_exo -52.34 -25.14 23.3 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.625 2.217 . . . . 0.28000000000000003 112.064 174.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.4 t -71.74 -44.7 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 1.01 110.24 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.78 -49.43 77.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.281 -0.872 . . . . 1.01 110.118 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 17.5 m-20 -62.08 -40.18 94.96 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.678 -0.692 . . . . 2.0299999999999998 110.28 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.24 -50.01 74.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.279 0.562 . . . . 1.0700000000000001 111.073 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.22 -42.74 96.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.492 -0.776 . . . . 1.05 110.312 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 64.0 mmtt -61.41 -33.48 73.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.588 -0.733 . . . . 2.5800000000000001 111.498 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 79.4 mm-40 -71.62 -37.44 70.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.16 -0.473 . . . . 3.0299999999999998 111.358 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -90.1 2.14 55.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 1.95 111.256 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 36.47 17.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.489 -0.778 . . . . 1.1899999999999999 111.205 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.06 134.06 30.78 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.072 -0.513 . . . . 1.05 110.274 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.38 140.85 24.9 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.351 2.034 . . . . 0.23000000000000001 111.728 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -156.74 161.92 39.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 0.23999999999999999 110.662 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -125.62 140.77 47.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.364 -0.835 . . . . 1.0700000000000001 109.913 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.91 109.07 19.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.03 0.443 . . . . 1.05 110.027 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.588 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 21.2 t-160 -109.43 86.11 2.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.223 0.535 . . . . 0.59999999999999998 109.798 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.504 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -126.75 160.15 31.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.341 -0.845 . . . . 1.1399999999999999 111.217 -172.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.55 16.19 52.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.082 -0.58 . . . . 1.1000000000000001 112.541 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -149.99 113.53 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.876 0.37 . . . . 2.3300000000000001 110.785 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.7 -5.03 15.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.25 -0.432 . . . . 2.1800000000000002 110.677 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . 0.426 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 14.2 t70 -83.18 -53.59 5.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.126 -0.488 . . . . 2.6299999999999999 111.082 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 5.2 mpt_? -80.35 -3.4 49.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.174 0.511 . . . . 5.1200000000000001 110.852 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.536 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 96.9 m-70 -119.17 16.57 13.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.94 -0.573 . . . . 1.3500000000000001 111.226 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -55.49 -44.84 85.49 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.852 -0.69 . . . . 1.0600000000000001 112.474 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 43.8 tt0 -63.28 -42.68 99.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.956 0.408 . . . . 2.5 110.669 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.453 HD23 ' CG1' ' A' ' 57' ' ' VAL . 32.8 tp -64.09 -40.19 95.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.796 -0.638 . . . . 1.22 110.462 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 76.6 mt -61.06 -34.88 75.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 2.1899999999999999 111.338 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 65.1 mtm-85 -72.5 -26.19 61.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 5.0 110.414 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.79 -26.47 54.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 2.8999999999999999 110.284 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.412 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 77.9 mt -83.28 -63.26 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.74 -0.664 . . . . 1.0800000000000001 110.746 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.2 t70 61.4 83.11 0.15 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.734 -0.666 . . . . 1.0900000000000001 110.622 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.38 165.11 13.28 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.694 -0.685 . . . . 1.0800000000000001 109.735 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.58 140.36 93.13 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.841 2.361 . . . . 0.29999999999999999 112.85 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.96 133.68 65.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 1.3 111.357 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 83.5 mmm -121.08 92.37 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.418 -0.956 . . . . 1.04 108.418 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.48 154.84 40.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.104 -0.498 . . . . 1.2 111.786 -173.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 94.8 mttt -89.96 142.85 29.21 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 1.27 109.475 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 10.8 Cg_exo -71.71 145.61 83.35 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.487 -1.464 . . . . 0.88 112.909 0.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.588 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 134.32 25.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.39000000000000001 109.965 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.564 ' O ' HG22 ' A' ' 110' ' ' VAL . 16.7 t70 -73.44 128.25 34.98 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.417 -0.586 . . . . 0.51000000000000001 109.417 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.7 p -65.64 -21.52 66.57 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.75 . . . . 1.04 112.823 -170.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.8 t -72.9 -41.09 64.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.527 -0.545 . . . . 1.8899999999999999 109.527 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.93 -40.7 91.63 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.118 0.485 . . . . 0.62 110.056 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 106' ' ' ASP . 24.8 t -63.82 -42.5 96.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.443 -0.799 . . . . 1.04 110.375 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.64 -48.65 68.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.798 -0.637 . . . . 1.01 111.58 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -60.46 -45.56 93.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.183 -0.462 . . . . 2.4300000000000002 111.453 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.463 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 34.1 mmt180 -67.49 -25.4 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 2.73 111.391 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.23 -51.47 9.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.002 0.429 . . . . 1.02 110.43 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.485 HD21 HG12 ' A' ' 52' ' ' VAL . 75.4 mt -64.54 -27.54 69.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.869 0.692 . . . . 1.04 112.869 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.463 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 9.3 pt-20 -67.44 -32.06 72.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.442 -0.503 . . . . 2.79 110.719 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.8 mtm -72.6 -29.53 63.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.285 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 17.8 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.954 0.407 . . . . 1.95 110.757 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 109.037 -0.727 . . . . 2.1800000000000002 109.037 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 26.0 Cg_exo -62.6 134.47 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.678 2.252 . . . . 0.55000000000000004 111.799 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -87.12 107.1 18.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.388 0.614 . . . . 1.48 109.405 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 58.7 t -99.93 130.83 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.216 -0.902 . . . . 1.05 111.033 -172.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 50' ' ' ILE . 49.4 tp -105.61 111.24 23.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 1.5 110.357 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.37 123.36 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 1.03 111.422 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -103.48 106.04 16.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.21 -0.905 . . . . 1.05 108.57 171.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.21 125.61 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.195 0.522 . . . . 1.4099999999999999 110.444 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 t70 -90.72 -13.8 33.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.564 -0.744 . . . . 1.27 109.895 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -89.74 104.02 7.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 2.5600000000000001 109.89 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.7 Cg_exo -59.44 -31.53 94.91 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.919 2.412 . . . . 0.35999999999999999 113.045 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.59 -49.88 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.593 -0.521 . . . . 2.2799999999999998 109.593 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -67.24 -44.07 87.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 1.7 110.888 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -51.28 68.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 1.02 110.737 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.2 ttp -61.46 -43.33 99.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.665 -0.698 . . . . 1.28 111.358 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' A' ' 107' ' ' THR . 7.1 m-20 -67.47 -39.02 85.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.341 -0.39 . . . . 1.3600000000000001 111.227 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 51.4 mt -62.91 -45.78 90.92 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 110.071 -0.344 . . . . 1.0700000000000001 110.071 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 36.4 tt0 -54.31 -52.68 60.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.547 -0.752 . . . . 1.7 110.314 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -64.77 -30.34 71.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.467 -0.333 . . . . 1.1799999999999999 111.416 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.47 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 1.05 110.82 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 63.7 m-85 -68.46 -41.48 80.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.16 110.682 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.11 -32.52 73.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 0.68999999999999995 110.525 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.49 -32.71 73.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.089 0.471 . . . . 0.51000000000000001 110.231 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -84.03 1.25 44.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.65000000000000002 111.167 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 50.73 3.95 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.28999999999999998 112.539 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.37 167.16 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.246 -0.279 . . . . 1.03 110.246 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -113.44 132.3 55.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.297 -0.631 . . . . 2.1400000000000001 109.297 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.558 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 4.8 t -121.79 147.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.852 0.686 . . . . 1.0800000000000001 112.852 -167.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 t -120.44 143.34 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.348 -0.842 . . . . 1.05 108.793 168.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -111.85 126.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 1.6499999999999999 111.123 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB1' ' CB ' ' A' ' 40' ' ' GLN . . . -135.53 142.98 45.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.702 -0.681 . . . . 1.03 110.139 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.86 -2.92 15.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.682 0.277 . . . . 1.04 111.402 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -136.9 169.95 16.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.52 -0.309 . . . . 1.0800000000000001 111.046 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.517 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 18.6 p -59.99 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.579 . . . . 1.6599999999999999 109.536 172.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.77 -49.91 69.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.597 -1.183 . . . . 0.69999999999999996 111.813 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.466 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 41.1 mt-30 -59.31 -38.57 80.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.107 0.48 . . . . 1.4099999999999999 111.092 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.514 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -68.75 -51.35 42.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.694 . . . . 1.04 111.18 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 67.3 mt -63.97 -28.19 69.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.642 -0.708 . . . . 1.53 110.733 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -66.77 -51.28 57.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.521 . . . . 2.9100000000000001 110.123 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.3 t -65.48 -34.11 77.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 1.6399999999999999 110.907 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.94 -33.16 73.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.232 0.539 . . . . 1.8400000000000001 110.211 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.56 22.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 1.1599999999999999 111.065 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.35 -37.97 56.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.546 . . . . 0.62 111.108 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -123.5 159.44 55.21 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.096 -0.502 . . . . 0.47999999999999998 110.091 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -93.22 86.67 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.358 2.705 . . . . 0.31 111.075 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 9' ' ' LEU . 41.6 mm -63.94 122.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.537 -0.756 . . . . 1.03 111.485 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.421 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 43.2 m-20 -92.57 -29.97 15.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.558 -0.746 . . . . 0.28999999999999998 110.142 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.0 p -158.41 156.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 1.03 109.716 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.39 168.99 18.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.355 0.597 . . . . 0.97999999999999998 112.146 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.38 112.61 4.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.206 -0.906 . . . . 1.5700000000000001 109.207 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.601 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -112.81 116.91 30.81 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.531 0.567 . . . . 1.02 112.531 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.91 133.7 38.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.217 -0.66 . . . . 1.77 109.217 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 t -93.8 -10.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.771 -0.649 . . . . 1.3600000000000001 111.249 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -116.32 53.82 0.86 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 2.6400000000000001 110.551 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.66 -41.26 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.262 0.553 . . . . 1.3100000000000001 110.473 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.82 -172.99 29.92 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.96 -0.856 . . . . 0.87 110.96 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.59 -43.76 52.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.827 2.351 . . . . 1.3899999999999999 112.263 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.552 ' HB3' ' HZ3' ' A' ' 62' ' ' LYS . 9.9 mtpm? -113.42 -27.96 7.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.24 -0.436 . . . . 4.0 110.879 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.7 m -68.54 123.95 22.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 1.3700000000000001 111.3 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.3 152.26 40.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.099 -0.955 . . . . 0.58999999999999997 109.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.2 p -68.76 86.31 0.33 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.406 0.622 . . . . 2.1899999999999999 109.521 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.3 -66.47 0.3 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.791 -0.718 . . . . 0.28000000000000003 112.023 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.47 -28.14 53.06 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.234 1.956 . . . . 0.28000000000000003 111.541 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -71.11 -44.37 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 1.01 110.195 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.99 87.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.29 -0.868 . . . . 1.01 110.092 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 21.7 t70 -61.52 -43.67 98.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.359 -0.837 . . . . 2.0299999999999998 110.395 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.34 72.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.836 -0.62 . . . . 1.0700000000000001 111.036 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.66 -43.39 89.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.421 -0.808 . . . . 1.05 110.656 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 56.2 mmtt -60.65 -32.98 72.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.675 -0.693 . . . . 2.5800000000000001 111.397 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 14.4 mm100 -71.55 -33.48 69.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 3.0299999999999998 111.526 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -93.23 1.07 57.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.678 -0.237 . . . . 1.95 111.131 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.16 34.5 13.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.7 -0.682 . . . . 1.1899999999999999 111.307 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.4 mt -87.55 133.9 37.12 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.439 . . . . 1.05 110.223 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 27.5 Cg_endo -75.36 143.37 27.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.373 2.049 . . . . 0.23000000000000001 112.051 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.452 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 28.7 p90 -159.65 159.29 32.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.748 -0.66 . . . . 0.23999999999999999 110.462 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -124.0 139.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.408 -0.815 . . . . 1.0700000000000001 109.728 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mm? -88.43 109.69 20.22 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.451 -0.574 . . . . 1.05 109.451 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.611 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 19.7 t-160 -102.25 90.88 4.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.987 -0.552 . . . . 0.59999999999999998 109.732 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 9.3 t -139.63 160.98 38.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.364 -0.835 . . . . 1.1399999999999999 110.409 -174.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.07 9.47 20.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.89 -0.671 . . . . 1.1000000000000001 111.82 175.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.62 60.26 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.195 0.521 . . . . 2.3300000000000001 110.822 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.68 -41.39 79.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.566 -0.743 . . . . 2.1800000000000002 110.08 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.3 -20.14 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.603 -0.726 . . . . 2.6299999999999999 111.371 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.577 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 3.6 tpm_? -90.56 -22.07 21.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 5.1200000000000001 110.761 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.488 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.1 m-70 -126.01 28.86 6.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 1.3500000000000001 111.637 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . -58.17 -37.99 88.32 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.119 -0.562 . . . . 1.0600000000000001 112.602 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.0 -46.01 75.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.855 0.36 . . . . 2.5 110.699 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 96' ' ' ILE . 56.8 tp -60.89 -39.66 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 1.22 110.501 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.9 mt -61.78 -32.77 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 2.1899999999999999 111.067 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -72.53 -38.54 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.88 0.372 . . . . 5.0 110.297 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.91 -42.26 89.22 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.532 0.682 . . . . 2.8999999999999999 110.233 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.48 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 84.7 mt -72.07 -58.79 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.892 -1.049 . . . . 1.0800000000000001 111.067 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.3 t70 62.54 82.07 0.19 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.618 0.723 . . . . 1.0900000000000001 111.093 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -163.45 162.09 17.48 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 1.0800000000000001 108.986 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.504 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -58.27 146.25 89.88 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.57 2.18 . . . . 0.29999999999999999 112.528 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.7 t -123.05 132.4 71.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 1.3 111.028 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.6 mmm -113.87 106.25 14.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 1.04 109.129 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.03 146.35 53.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.984 -0.553 . . . . 1.2 111.938 -174.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.6 mttt -91.59 145.11 30.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.827 -0.624 . . . . 1.27 110.204 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.22 142.61 75.04 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 123.572 -1.428 . . . . 0.88 112.422 -0.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.611 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -133.08 135.44 45.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.867 -0.606 . . . . 0.39000000000000001 109.806 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 110' ' ' VAL . 13.4 t0 -70.38 127.31 32.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.287 -1.005 . . . . 0.51000000000000001 108.287 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 20' ' ' ASN . 22.9 p -63.22 -20.5 65.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.348 -0.842 . . . . 1.04 112.646 -172.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -70.53 -40.29 73.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.8899999999999999 109.943 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.34 -39.56 81.85 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.62 109.903 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 106' ' ' ASP . 21.6 t -65.15 -45.31 94.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 1.04 110.09 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.661 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.14 -50.42 71.95 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.685 -0.689 . . . . 1.01 111.374 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 67.9 mttm -57.42 -51.5 69.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 2.4300000000000002 111.304 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -61.26 -39.46 90.44 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.112 0.257 . . . . 2.73 111.686 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.94 79.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 1.02 110.172 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.455 HD22 HG12 ' A' ' 52' ' ' VAL . 85.1 mt -67.02 -25.34 66.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 1.04 111.768 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 36.7 mm-40 -60.79 -38.47 85.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.986 0.422 . . . . 2.79 110.692 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.504 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.4 mtm -79.59 -10.66 59.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.717 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 36.7 t . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 1.95 110.202 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.423 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 16.7 mmt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.807 -0.442 . . . . 2.1800000000000002 109.807 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.4 Cg_endo -68.06 135.68 35.54 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.609 1.539 . . . . 0.55000000000000004 110.635 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -84.63 104.53 14.69 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.724 -0.472 . . . . 1.48 109.724 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.44 HG23 ' CG1' ' A' ' 52' ' ' VAL . 46.7 t -100.14 128.97 51.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.84 -0.618 . . . . 1.05 110.978 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 tp -107.43 119.01 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.451 -0.34 . . . . 1.5 110.462 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.17 124.93 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.149 0.5 . . . . 1.03 111.43 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -104.51 106.41 16.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.284 -0.871 . . . . 1.05 109.013 172.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -167.3 128.95 1.59 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.975 -0.557 . . . . 1.4099999999999999 109.687 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.5 t70 -84.58 -28.88 26.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 1.27 109.661 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.2 mp0 -74.07 109.55 7.15 Favored Pre-proline 0 N--CA 1.462 0.147 0 CA-C-N 116.249 -0.432 . . . . 2.5600000000000001 110.583 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.6 Cg_exo -60.39 -29.59 89.11 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.527 2.151 . . . . 0.35999999999999999 112.733 -178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -52.47 42.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.059 -0.349 . . . . 2.2799999999999998 110.059 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 14' ' ' GLU . 2.5 mp -62.69 -42.6 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 1.7 109.927 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.09 71.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.502 -0.772 . . . . 1.02 110.832 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.478 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 47.6 ttp -65.05 -38.37 90.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.647 -0.706 . . . . 1.28 111.202 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -64.82 -44.07 91.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.047 -0.524 . . . . 1.3600000000000001 110.982 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 39.3 mt -61.91 -44.99 95.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.437 -0.347 . . . . 1.0700000000000001 110.253 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.591 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 43.4 tt0 -53.44 -51.18 63.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.633 -0.712 . . . . 1.7 110.815 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -63.43 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 1.1799999999999999 111.33 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.19 78.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.306 -0.406 . . . . 1.05 110.95 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.517 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 57.0 m-85 -71.19 -42.09 69.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.422 . . . . 0.16 110.874 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 46.0 mt-10 -65.4 -28.24 69.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.996 0.427 . . . . 0.68999999999999995 110.079 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.8 -32.18 70.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.51000000000000001 110.616 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -83.97 -2.5 56.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.227 0.537 . . . . 0.65000000000000002 110.461 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 62.76 1.61 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.601 -0.727 . . . . 0.28999999999999998 111.998 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -145.32 172.16 13.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 1.03 111.359 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -114.57 137.24 52.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.938 -0.573 . . . . 2.1400000000000001 109.612 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.591 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 5.1 t -120.19 146.91 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 1.0800000000000001 111.913 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' OG ' ' A' ' 44' ' ' SER . 24.1 t -119.6 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.464 -0.789 . . . . 1.05 108.919 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t -97.24 124.72 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 1.6499999999999999 110.885 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -134.59 134.64 41.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.007 -0.542 . . . . 1.03 110.415 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.48 -11.02 20.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.97 0.414 . . . . 1.04 110.792 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.3 p -129.87 160.77 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 1.0800000000000001 110.732 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.586 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.1 m -63.92 -35.5 80.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.736 -0.468 . . . . 1.6599999999999999 109.736 174.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.0 -47.87 84.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.69999999999999996 111.19 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.461 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 39.4 mt-30 -59.01 -41.24 87.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.642 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.497 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -63.36 -51.77 64.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.274 -0.875 . . . . 1.04 111.444 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.9 mt -62.24 -32.23 72.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.067 -0.515 . . . . 1.53 110.894 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.27 -50.64 69.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 2.9100000000000001 110.219 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.425 ' OG ' HG11 ' A' ' 33' ' ' VAL . 23.2 t -68.5 -35.07 76.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 1.6399999999999999 110.551 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.3 -39.67 76.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.8400000000000001 109.817 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.82 30.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 1.1599999999999999 111.408 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.84 -38.34 58.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.998 0.428 . . . . 0.62 111.777 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -114.48 163.94 17.83 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.47999999999999998 110.758 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -96.0 76.01 0.13 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.494 2.796 . . . . 0.31 111.341 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.78 120.24 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.228 -0.896 . . . . 1.03 111.725 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.779 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 16.8 m-20 -90.09 -31.19 17.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.372 -0.831 . . . . 0.28999999999999998 110.629 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.44 ' CG1' HG23 ' A' ' 8' ' ' VAL . 14.6 p -160.34 156.7 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 1.03 109.914 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.81 160.92 39.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.46 0.648 . . . . 0.97999999999999998 112.168 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.07 112.04 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 1.5700000000000001 109.243 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.678 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -111.78 117.73 33.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.986 0.422 . . . . 1.02 112.039 -170.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.87 129.96 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.839 -0.8 . . . . 1.77 108.839 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.97 -35.72 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.139 -0.482 . . . . 1.3600000000000001 111.475 -171.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.68 60.66 4.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.072 0.463 . . . . 2.6400000000000001 111.382 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.362 0.601 . . . . 1.3100000000000001 110.148 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.69 -171.58 32.05 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.65 -0.98 . . . . 0.87 110.65 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.11 -36.83 96.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.856 2.371 . . . . 1.3899999999999999 113.104 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -127.24 -21.76 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 4.0 111.557 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 p -73.54 126.41 30.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.483 0.658 . . . . 1.3700000000000001 110.709 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -144.93 155.09 43.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.363 -0.835 . . . . 0.58999999999999997 110.301 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.5 p -69.49 87.27 0.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.488 -0.56 . . . . 2.1899999999999999 109.488 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.78 -69.88 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.504 -0.855 . . . . 0.28000000000000003 112.499 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.522 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 50.9 Cg_exo -51.47 -27.51 24.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.8 2.333 . . . . 0.28000000000000003 111.979 175.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' A' ' 11' ' ' LEU . 14.3 t -69.28 -44.75 80.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 1.01 110.042 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.55 93.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.143 -0.935 . . . . 1.01 110.156 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 37.8 m-20 -64.12 -42.07 96.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.447 . . . . 2.0299999999999998 110.345 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.54 -46.81 70.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.389 0.614 . . . . 1.0700000000000001 110.881 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.66 -46.72 71.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.023 -0.989 . . . . 1.05 110.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -56.53 -36.02 68.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.515 -0.766 . . . . 2.5800000000000001 111.849 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.1 mt-30 -61.42 -44.39 97.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 3.0299999999999998 111.696 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -94.59 7.14 46.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.569 -0.287 . . . . 1.95 111.214 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.14 34.79 21.18 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.626 . . . . 1.1899999999999999 111.264 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.79 133.38 55.35 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 116.234 -0.439 . . . . 1.05 109.984 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 13.3 Cg_endo -73.81 137.02 23.97 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.117 1.878 . . . . 0.23000000000000001 111.423 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -156.49 158.85 37.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.937 -0.574 . . . . 0.23999999999999999 110.617 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.0 mt -124.24 140.9 46.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.21 -0.904 . . . . 1.0700000000000001 109.795 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.97 107.94 19.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.041 -0.725 . . . . 1.05 109.041 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.597 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 21.7 t-160 -101.61 78.95 1.89 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.995 -0.742 . . . . 0.59999999999999998 108.995 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.7 t -118.32 158.76 24.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.788 -1.096 . . . . 1.1399999999999999 110.915 -171.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.36 -1.35 55.66 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.012 -0.613 . . . . 1.1000000000000001 111.883 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.95 120.45 26.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.771 0.32 . . . . 2.3300000000000001 110.783 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 mp -114.38 -6.85 12.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 2.1800000000000002 109.904 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -84.39 -60.92 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 2.6299999999999999 111.387 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -40.24 78.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.092 0.472 . . . . 5.1200000000000001 110.421 -174.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -92.27 22.4 4.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.211 -0.449 . . . . 1.3500000000000001 111.256 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.55 -41.83 98.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.121 -0.561 . . . . 1.0600000000000001 112.698 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.06 -45.8 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 2.5 110.678 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.26 -44.24 92.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 1.22 110.472 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.97 -31.48 71.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.838 -0.619 . . . . 2.1899999999999999 111.239 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 25.4 mtm180 -70.55 -32.6 70.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.4 -0.364 . . . . 5.0 110.622 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.05 -39.4 50.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.997 -0.547 . . . . 2.8999999999999999 110.375 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.92 -52.89 43.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.612 -0.722 . . . . 1.0800000000000001 110.014 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.74 74.36 0.41 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.593 -0.73 . . . . 1.0900000000000001 110.952 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -153.13 163.79 22.44 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.152 -0.931 . . . . 1.0800000000000001 109.22 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.682 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 66.3 Cg_exo -54.96 141.08 79.27 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.491 2.127 . . . . 0.29999999999999999 112.768 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.56 140.26 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.806 -0.633 . . . . 1.3 110.621 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.3 mmm -121.32 95.32 4.64 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 1.04 108.887 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.3 147.07 52.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.953 -0.567 . . . . 1.2 111.466 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 85.9 mttt -91.17 147.0 34.64 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.708 . . . . 1.27 110.434 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.6 Cg_exo -73.05 152.25 98.06 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.483 -1.466 . . . . 0.88 112.459 1.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.597 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -148.57 129.34 14.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.39000000000000001 110.511 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 110' ' ' VAL . 16.4 t70 -66.28 128.96 38.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.51000000000000001 109.143 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.411 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 20.4 p -64.83 -24.7 67.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.59 -0.732 . . . . 1.04 112.581 -170.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 32.3 t -68.13 -40.91 82.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.651 -0.5 . . . . 1.8899999999999999 109.651 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -40.76 92.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.076 0.465 . . . . 0.62 110.097 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 106' ' ' ASP . 22.0 t -64.36 -42.57 95.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.579 -0.737 . . . . 1.04 110.475 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.34 -48.5 72.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.727 -0.67 . . . . 1.01 111.349 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 108' ' ' SER . 99.0 mttt -60.39 -46.48 89.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 2.4300000000000002 110.887 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.489 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.3 mmt180 -62.4 -28.55 69.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.126 -0.488 . . . . 2.73 111.309 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.37 -51.65 9.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 1.02 110.576 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.403 HD21 HG11 ' A' ' 52' ' ' VAL . 88.3 mt -65.41 -29.35 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.493 0.553 . . . . 1.04 112.493 -176.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.489 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.3 pt-20 -67.44 -25.8 66.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.8 0.333 . . . . 2.79 111.255 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.682 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 43.5 mtm -81.53 -14.54 56.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.019 0.438 . . . . 1.0 110.711 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 46.9 t . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 115.897 -0.592 . . . . 1.95 111.609 -174.148 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.2 ptm . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 109.737 -0.468 . . . . 2.1800000000000002 109.737 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -73.01 143.96 37.22 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.271 1.981 . . . . 0.55000000000000004 112.426 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 34.5 tptt -90.23 105.54 17.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.738 -0.665 . . . . 1.48 109.271 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.61 137.61 27.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.138 -0.483 . . . . 1.05 111.153 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.2 tm? -115.66 110.76 19.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.596 -0.729 . . . . 1.5 109.906 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.04 128.83 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.235 0.54 . . . . 1.03 111.039 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -108.12 100.8 10.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.197 -0.91 . . . . 1.05 108.884 175.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -164.17 134.77 4.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.172 0.51 . . . . 1.4099999999999999 110.101 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -97.16 -23.83 16.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.468 -0.787 . . . . 1.27 109.993 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.449 ' CB ' HD11 ' A' ' 17' ' ' ILE . 42.0 mt-10 -76.03 108.15 5.61 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.658 -0.497 . . . . 2.5600000000000001 109.658 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' GLU . 32.2 Cg_exo -57.48 -35.84 98.8 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 123.073 2.515 . . . . 0.35999999999999999 113.537 -171.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.0 -50.85 64.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.813 -0.44 . . . . 2.2799999999999998 109.813 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.449 HD11 ' CB ' ' A' ' 14' ' ' GLU . 3.0 mp -62.02 -46.97 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.498 . . . . 1.7 109.814 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.239 -0.891 . . . . 1.02 110.824 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 38.2 ttp -63.41 -44.86 93.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.669 -0.696 . . . . 1.28 111.083 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.7 t-20 -65.28 -42.56 93.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 1.3600000000000001 110.425 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.5 mt -64.39 -43.48 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.194 -0.457 . . . . 1.0700000000000001 110.227 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.463 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.6 tt0 -53.22 -50.57 64.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.663 -0.699 . . . . 1.7 110.318 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 14.4 m-85 -63.18 -34.96 78.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 1.1799999999999999 111.206 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.53 71.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.919 0.39 . . . . 1.05 110.656 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.666 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 55.0 m-85 -66.96 -41.9 86.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.123 -0.49 . . . . 0.16 110.613 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.75 -36.8 79.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.68999999999999995 110.632 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.73 -33.22 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.51000000000000001 110.835 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -80.41 -1.41 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.65000000000000002 110.531 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.15 50.48 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 116.004 -0.544 . . . . 0.28999999999999998 112.414 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.74 158.99 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.323 . . . . 1.03 110.783 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.46 138.81 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.988 -0.745 . . . . 2.1400000000000001 108.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.4 t -120.86 132.14 71.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.482 . . . . 1.0800000000000001 111.988 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.38 136.1 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 1.05 108.338 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.1 t -111.02 123.97 67.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.631 -0.428 . . . . 1.6499999999999999 111.002 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HB1' ' CB ' ' A' ' 40' ' ' GLN . . . -127.26 134.92 50.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.867 -0.606 . . . . 1.03 110.338 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.48 -11.85 18.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.998 0.428 . . . . 1.04 111.147 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.9 p -128.83 173.39 10.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.169 -0.468 . . . . 1.0800000000000001 110.227 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.595 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 75.5 m -73.63 -32.08 63.86 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.598 . . . . 1.6599999999999999 109.387 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.13 -51.04 70.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.913 -0.585 . . . . 0.69999999999999996 110.912 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.445 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 31.8 mt-30 -55.89 -42.13 75.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.864 -0.607 . . . . 1.4099999999999999 110.7 176.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB3' HD23 ' A' ' 11' ' ' LEU . . . -62.66 -52.93 61.38 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.434 -0.803 . . . . 1.04 111.278 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.6 mt -59.43 -29.16 67.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.961 -0.563 . . . . 1.53 110.942 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.1 tmtp? -65.6 -55.7 16.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.773 -0.454 . . . . 2.9100000000000001 109.773 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.9 t -64.55 -35.26 80.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 1.6399999999999999 110.55 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 HD21 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.937 -0.574 . . . . 1.8400000000000001 110.984 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.55 -38.17 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 1.1599999999999999 111.237 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.19 -37.65 61.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.883 -0.598 . . . . 0.62 111.598 -175.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 43.9 m-80 -120.09 165.22 18.64 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.05 -0.523 . . . . 0.47999999999999998 111.214 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -95.45 86.15 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.625 2.883 . . . . 0.31 111.466 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -65.07 118.37 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.329 -0.85 . . . . 1.03 111.258 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -84.27 -32.38 24.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.28999999999999998 110.23 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.449 HG11 HD21 ' A' ' 115' ' ' LEU . 14.3 p -158.65 154.02 5.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.928 -0.578 . . . . 1.03 110.2 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 162.57 33.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.515 0.674 . . . . 0.97999999999999998 111.61 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.14 111.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.739 -0.837 . . . . 1.5700000000000001 108.739 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 11' ' ' LEU . 10.5 mp -106.42 98.42 8.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.268 0.556 . . . . 1.02 111.084 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.855 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -76.14 93.35 3.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.079 -0.964 . . . . 1.77 109.448 174.077 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.1 t -54.29 -25.94 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.971 -1.013 . . . . 1.3600000000000001 111.945 -172.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.01 68.9 5.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.076 -0.511 . . . . 2.6400000000000001 111.456 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 -32.65 22.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.176 0.513 . . . . 1.3100000000000001 110.311 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.39 -174.02 40.1 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.678 -0.692 . . . . 0.87 111.599 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.51 -35.13 96.51 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.076 2.517 . . . . 1.3899999999999999 112.741 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -123.4 -29.42 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.933 -0.576 . . . . 4.0 110.253 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.7 m -64.97 125.67 25.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.791 -0.64 . . . . 1.3700000000000001 111.656 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -144.57 154.78 43.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 0.58999999999999997 110.079 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.46 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -78.7 87.85 4.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.297 -0.631 . . . . 2.1899999999999999 109.297 174.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.21 -72.66 0.87 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.689 -0.767 . . . . 0.28000000000000003 112.363 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.445 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.3 Cg_exo -52.82 -24.58 24.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.83 2.353 . . . . 0.28000000000000003 112.331 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.443 HG11 ' CD2' ' A' ' 11' ' ' LEU . 30.3 t -64.42 -40.08 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.542 0.687 . . . . 1.01 110.014 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.93 98.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.854 -1.067 . . . . 1.01 110.159 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.12 -47.18 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.81 -0.632 . . . . 2.0299999999999998 109.972 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -50.3 -49.93 52.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.605 0.716 . . . . 1.0700000000000001 110.848 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 45' ' ' LEU . 97.6 mt -66.12 -47.83 72.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.045 -0.98 . . . . 1.05 111.015 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -59.13 -34.52 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.583 . . . . 2.5800000000000001 111.787 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -69.43 -34.68 74.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.316 -0.402 . . . . 3.0299999999999998 111.347 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 75' ' ' ARG . 55.5 mtt180 -95.71 7.53 46.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 1.95 111.077 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.06 34.11 23.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.694 -0.685 . . . . 1.1899999999999999 111.563 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.41 132.67 38.43 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.489 -0.323 . . . . 1.05 110.295 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.16 139.77 24.26 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.59 2.193 . . . . 0.23000000000000001 112.2 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 39.2 p90 -155.42 156.91 36.18 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.726 -0.67 . . . . 0.23999999999999999 110.402 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -117.84 138.39 48.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.404 -0.816 . . . . 1.0700000000000001 109.401 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -88.78 107.96 19.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.492 -0.929 . . . . 1.05 108.492 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.855 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 11.7 t-160 -101.34 123.16 44.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.41 -0.959 . . . . 0.59999999999999998 108.41 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 5.4 t -163.12 144.0 9.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.073 -0.651 . . . . 1.1399999999999999 111.947 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 103' ' ' LYS . . . -89.68 -6.77 69.77 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.573 -0.74 . . . . 1.1000000000000001 111.398 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 88' ' ' ARG . 9.7 t70 -112.57 114.72 27.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.564 -0.532 . . . . 2.3300000000000001 109.564 177.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.7 mt -115.53 -17.93 11.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.343 -0.39 . . . . 2.1800000000000002 111.268 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -85.76 -52.01 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.88 -0.328 . . . . 2.6299999999999999 111.464 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.415 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -67.69 -33.2 74.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.03 0.443 . . . . 5.1200000000000001 110.382 -177.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 93.0 m-70 -102.11 16.51 25.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.273 -0.421 . . . . 1.3500000000000001 111.347 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.409 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -60.52 -49.94 73.11 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.943 -0.646 . . . . 1.0600000000000001 113.056 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 3.1 mp0 -60.55 -40.59 92.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.078 -0.341 . . . . 2.5 110.078 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 tp -60.17 -43.35 95.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.931 -0.577 . . . . 1.22 110.892 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 67.6 mt -57.87 -37.39 73.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 2.1899999999999999 110.893 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.406 ' NH2' ' HG3' ' A' ' 91' ' ' GLU . 48.3 mtm105 -78.43 -26.9 46.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 5.0 111.225 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 96.7 mttt -69.11 -39.21 79.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.448 0.642 . . . . 2.8999999999999999 109.826 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.09 -54.12 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.008 -0.997 . . . . 1.0800000000000001 110.621 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 64.74 78.8 0.27 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.686 0.755 . . . . 1.0900000000000001 111.206 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -162.01 169.29 9.64 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.942 -1.026 . . . . 1.0800000000000001 108.721 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 32.3 Cg_exo -58.45 137.27 79.45 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.164 1.91 . . . . 0.29999999999999999 112.331 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.5 t -119.78 130.71 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 1.3 110.757 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 91.9 mtp -115.89 124.2 50.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.574 . . . . 1.04 109.449 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -82.5 152.88 25.86 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.238 -0.437 . . . . 1.2 111.201 -175.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.731 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 89.7 mttt -91.27 141.8 26.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.704 -0.48 . . . . 1.27 109.704 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.27 153.5 97.25 Favored 'Cis proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.074 -1.636 . . . . 0.88 112.788 1.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.594 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -145.45 130.73 18.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.39000000000000001 109.461 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.447 ' O ' HG21 ' A' ' 110' ' ' VAL . 15.5 t70 -67.11 127.62 33.31 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.974 -0.75 . . . . 0.51000000000000001 108.974 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.0 p -63.57 -25.12 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.777 . . . . 1.04 112.269 -170.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 34.4 t -70.95 -36.53 72.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.565 -0.532 . . . . 1.8899999999999999 109.565 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -66.54 -46.2 76.89 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.512 -0.551 . . . . 0.62 109.512 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.3 t -60.14 -41.22 85.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 1.04 110.472 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.666 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.29 -51.4 60.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.566 -0.743 . . . . 1.01 111.446 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 108' ' ' SER . 57.7 mtpt -65.67 -38.72 90.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.244 -0.434 . . . . 2.4300000000000002 111.251 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.501 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.9 mmt180 -66.83 -28.64 68.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.43 . . . . 2.73 111.432 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -47.17 16.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.08 0.467 . . . . 1.02 110.108 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.553 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 78.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.935 0.717 . . . . 1.04 112.935 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.501 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.4 pt-20 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 2.79 110.677 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.449 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 63.5 mtm -76.09 -29.48 57.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.352 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 10.7 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 121.027 0.441 . . . . 1.95 110.192 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.426 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 18.3 mmt . . . . . 0 C--O 1.234 0.281 0 N-CA-C 110.541 -0.17 . . . . 2.1800000000000002 110.541 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 27.4 Cg_exo -62.64 132.22 36.83 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.306 2.004 . . . . 0.55000000000000004 110.881 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -86.68 103.31 15.03 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.399 -0.593 . . . . 1.48 109.399 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.6 t -99.49 128.31 51.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.549 -0.75 . . . . 1.05 110.616 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.2 tp -104.33 115.39 30.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.802 0.335 . . . . 1.5 111.034 178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.43 122.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.294 0.569 . . . . 1.03 111.324 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.635 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 1.5 mm? -101.65 118.98 38.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.549 -1.278 . . . . 1.05 107.549 169.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.694 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -161.43 158.43 26.7 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.952 -0.299 . . . . 1.4099999999999999 110.368 -174.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.44 -5.36 8.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.904 0.383 . . . . 1.27 110.635 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 42.2 mm-40 -109.82 103.18 52.7 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 2.5600000000000001 110.574 175.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.29 -26.85 72.42 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.058 2.506 . . . . 0.35999999999999999 113.235 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.58 -47.59 72.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.968 -0.753 . . . . 2.2799999999999998 108.968 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.59 -46.22 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.371 -0.831 . . . . 1.7 111.005 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . 0.694 ' HB3' ' CD ' ' A' ' 12' ' ' GLU . . . -56.17 -49.84 72.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.285 -0.416 . . . . 1.02 111.053 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.6 ttp -55.96 -42.4 76.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.588 -0.733 . . . . 1.28 110.695 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.482 ' HB3' HG22 ' A' ' 107' ' ' THR . 3.8 m-80 -68.95 -42.54 76.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 1.3600000000000001 111.412 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.68 -44.96 88.65 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.611 0.243 . . . . 1.0700000000000001 110.538 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.452 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -55.65 -50.73 69.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.941 -0.572 . . . . 1.7 109.991 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.4 -27.75 66.49 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.133 -0.485 . . . . 1.1799999999999999 111.363 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.08 -49.12 60.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.869 0.366 . . . . 1.05 110.527 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -66.26 -43.45 86.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.16 110.867 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 30.9 mt-10 -65.38 -28.6 69.39 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.936 -0.306 . . . . 0.68999999999999995 110.635 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.58 -32.96 66.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.51000000000000001 110.593 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -77.78 -20.16 53.8 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.042 0.449 . . . . 0.65000000000000002 110.417 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.46 62.24 0.63 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.575 -0.739 . . . . 0.28999999999999998 112.377 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -148.71 177.28 9.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.799 0.333 . . . . 1.03 111.255 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 129.36 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.388 -0.597 . . . . 2.1400000000000001 109.388 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.452 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 15.1 t -115.04 135.55 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.584 0.587 . . . . 1.0800000000000001 112.584 -167.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.44 141.92 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.825 -0.806 . . . . 1.05 108.825 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.2 t -112.74 126.01 70.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.537 0.208 . . . . 1.6499999999999999 110.709 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -140.49 134.77 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 1.03 111.047 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' GLU . . . -97.64 -22.67 16.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.282 0.563 . . . . 1.04 111.082 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.3 p -117.31 159.76 22.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.856 -0.611 . . . . 1.0800000000000001 110.668 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.611 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 m -64.36 -31.27 72.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.293 -0.632 . . . . 1.6599999999999999 109.293 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.52 -52.88 63.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 0.69999999999999996 110.96 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.452 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . 38.0 mt-30 -57.79 -39.87 78.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.263 0.554 . . . . 1.4099999999999999 110.954 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HB3' HD23 ' A' ' 11' ' ' LEU . . . -65.59 -50.49 64.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.374 -0.83 . . . . 1.04 111.333 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.2 mt -63.47 -30.4 71.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.137 -0.483 . . . . 1.53 111.08 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -66.76 -48.21 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.124 0.488 . . . . 2.9100000000000001 109.686 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -66.09 -33.48 75.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 1.6399999999999999 110.452 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -39.08 78.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.272 0.558 . . . . 1.8400000000000001 110.135 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.65 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.831 -0.622 . . . . 1.1599999999999999 111.563 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.55 -36.51 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.62 111.355 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -118.12 163.65 23.84 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.218 -0.447 . . . . 0.47999999999999998 110.615 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -96.88 85.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 123.6 2.866 . . . . 0.31 111.302 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.32 119.95 7.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 1.03 111.552 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 23.2 m-20 -89.2 -30.52 18.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.675 -0.693 . . . . 0.28999999999999998 110.629 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.5 p -163.83 156.34 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.693 -0.685 . . . . 1.03 109.285 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.29 160.17 40.56 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.557 0.694 . . . . 0.97999999999999998 112.291 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.0 112.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.838 -1.074 . . . . 1.5700000000000001 109.124 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.805 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.7 mp -109.72 104.63 13.65 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.095 0.474 . . . . 1.02 111.943 -170.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -71.64 93.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.39 -0.823 . . . . 1.77 109.232 172.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.594 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 40.9 t -58.63 -27.41 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.552 . . . . 1.3600000000000001 111.499 -175.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.43 51.97 1.54 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.761 -0.654 . . . . 2.6400000000000001 112.397 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt -70.11 -24.48 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 1.3100000000000001 110.475 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.07 -178.12 46.05 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.97 -0.852 . . . . 0.87 110.97 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.64 -36.13 97.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.613 2.209 . . . . 1.3899999999999999 112.015 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -114.51 -34.39 5.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 4.0 110.122 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.0 m -65.64 125.81 26.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.899 -0.591 . . . . 1.3700000000000001 111.163 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -146.54 151.18 36.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.886 -0.597 . . . . 0.58999999999999997 110.812 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -74.89 87.34 2.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.916 -0.772 . . . . 2.1899999999999999 108.916 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.83 -70.34 0.61 Allowed Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.369 -0.919 . . . . 0.28000000000000003 112.472 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.544 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.2 Cg_exo -52.62 -23.53 20.04 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.604 2.203 . . . . 0.28000000000000003 112.049 175.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.446 HG11 ' CD2' ' A' ' 11' ' ' LEU . 24.5 t -70.3 -45.22 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.326 0.584 . . . . 1.01 110.123 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.67 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.162 -0.926 . . . . 1.01 110.104 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.48 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 31.1 m-20 -63.53 -40.17 96.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.667 . . . . 2.0299999999999998 110.175 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.39 -49.17 75.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.512 0.672 . . . . 1.0700000000000001 110.601 176.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.58 -40.59 92.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.105 -0.952 . . . . 1.05 110.526 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -59.29 -38.56 80.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.572 -0.74 . . . . 2.5800000000000001 111.157 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 13.0 mm100 -62.3 -45.6 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 3.0299999999999998 111.487 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -92.95 7.51 43.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 1.95 111.391 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.79 24.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 1.1899999999999999 111.427 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.64 134.43 50.83 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.552 -0.536 . . . . 1.05 109.552 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 15.2 Cg_endo -73.25 139.52 29.37 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.076 1.851 . . . . 0.23000000000000001 111.406 177.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -160.82 156.66 25.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.054 -0.521 . . . . 0.23999999999999999 110.385 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -123.42 141.05 45.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.403 -0.817 . . . . 1.0700000000000001 109.881 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 96' ' ' ILE . 2.0 mm? -88.79 108.78 19.69 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.097 -0.705 . . . . 1.05 109.097 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.814 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 15.1 t-160 -101.27 104.66 15.69 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.128 -0.693 . . . . 0.59999999999999998 109.128 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 4.3 t -151.85 151.86 31.86 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.32 -0.552 . . . . 1.1399999999999999 111.679 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.17 9.13 63.16 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.551 -0.75 . . . . 1.1000000000000001 111.471 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -149.89 122.33 8.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.853 0.358 . . . . 2.3300000000000001 111.429 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.41 HD11 ' CD2' ' A' ' 93' ' ' LEU . 3.2 mm? -118.68 7.66 11.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.386 -0.598 . . . . 2.1800000000000002 109.386 172.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -85.04 -54.62 4.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 111.566 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 8.0 mpt_? -77.47 -11.83 59.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.102 0.477 . . . . 5.1200000000000001 111.113 -173.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -125.26 26.03 6.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 1.3500000000000001 109.794 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.96 -38.61 95.74 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.108 -0.496 . . . . 1.0600000000000001 113.447 -173.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.8 -25.87 68.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 2.5 110.709 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.68 -42.48 86.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.908 -0.587 . . . . 1.22 110.85 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.437 ' H ' HD21 ' A' ' 93' ' ' LEU . 2.3 mm? -60.41 -26.92 67.05 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.441 -0.345 . . . . 2.1899999999999999 111.108 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -66.66 -33.2 75.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 5.0 111.026 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.42 -27.45 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 2.8999999999999999 110.287 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.418 HG22 HD21 ' A' ' 81' ' ' LEU . 62.2 mt -79.74 -63.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.447 -0.797 . . . . 1.0800000000000001 111.115 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.0 t70 55.87 74.15 0.4 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.743 0.782 . . . . 1.0900000000000001 110.788 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.77 165.82 16.68 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.141 -0.936 . . . . 1.0800000000000001 109.225 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 43.4 Cg_exo -59.16 141.25 97.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.535 2.156 . . . . 0.29999999999999999 112.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.13 121.01 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.039 -0.528 . . . . 1.3 111.16 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.445 ' O ' ' HD2' ' A' ' 82' ' ' HIS . 73.9 mmm -102.41 99.02 9.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.151 -0.685 . . . . 1.04 109.151 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -74.97 159.5 31.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.169 -0.468 . . . . 1.2 111.04 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 98.3 mttt -93.1 153.35 41.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.782 -0.644 . . . . 1.27 110.469 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 15.5 Cg_exo -69.18 136.07 35.77 Favored 'Cis proline' 0 C--N 1.343 0.237 0 C-N-CA 123.648 -1.397 . . . . 0.88 112.328 -1.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.638 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -128.69 133.53 48.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.39000000000000001 110.038 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.522 ' O ' HG23 ' A' ' 110' ' ' VAL . 17.1 t70 -78.54 129.67 35.1 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 0.51000000000000001 108.616 176.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 20' ' ' ASN . 19.9 p -64.11 -22.39 66.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.696 -0.683 . . . . 1.04 112.236 -172.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 t -70.98 -40.68 71.77 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.452 -0.573 . . . . 1.8899999999999999 109.452 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.56 -44.27 91.27 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.149 -0.478 . . . . 0.62 109.967 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.7 t -61.62 -44.32 98.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.355 -0.839 . . . . 1.04 110.396 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.67 -51.43 67.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.749 -0.66 . . . . 1.01 111.215 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.7 mtpt -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 2.4300000000000002 110.735 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -55.38 -40.03 70.84 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.314 0.384 . . . . 2.73 111.452 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.4 63.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 1.02 110.845 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.41 -25.87 66.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.04 111.988 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 mm-40 -57.18 -47.72 80.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.958 0.409 . . . . 2.79 110.395 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.503 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 52.8 mtm -72.34 -28.5 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.718 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 50.5 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.809 -0.632 . . . . 1.95 110.493 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.6 mtt . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.506 0.193 . . . . 2.1800000000000002 110.798 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.0 Cg_exo -63.25 138.26 65.57 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.801 2.334 . . . . 0.55000000000000004 111.411 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -88.53 105.43 17.63 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.754 -0.461 . . . . 1.48 109.754 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.8 t -100.18 135.72 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.695 -0.684 . . . . 1.05 110.905 -175.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -110.4 113.22 25.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.903 0.383 . . . . 1.5 110.482 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.83 120.04 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.342 0.592 . . . . 1.03 111.589 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.3 mm? -102.33 101.12 11.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.872 -1.058 . . . . 1.05 108.89 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.55 118.43 3.2 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.389 -0.823 . . . . 1.4099999999999999 109.732 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.551 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 25.8 t70 -83.76 -19.76 34.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.068 -0.515 . . . . 1.27 110.068 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -84.2 102.87 2.37 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.537 -0.542 . . . . 2.5600000000000001 109.537 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 36.6 Cg_exo -58.9 -31.15 94.88 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.878 2.385 . . . . 0.35999999999999999 113.026 -173.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.39 -49.26 78.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 2.2799999999999998 109.77 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.12 -43.49 78.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.653 -0.703 . . . . 1.7 110.67 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.84 74.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.506 . . . . 1.02 110.732 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.4 ttp -64.6 -41.65 96.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.665 -0.698 . . . . 1.28 111.315 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.462 ' HB3' HG22 ' A' ' 107' ' ' THR . 16.9 m-20 -65.12 -46.44 80.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.297 -0.411 . . . . 1.3600000000000001 110.977 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 45.7 mt -59.78 -46.43 89.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.464 -0.335 . . . . 1.0700000000000001 110.267 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.543 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 64.0 tt0 -52.29 -48.49 65.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.673 -0.694 . . . . 1.7 110.356 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -69.32 -31.89 70.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 1.1799999999999999 111.761 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.942 0.401 . . . . 1.05 110.535 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 49.5 m-85 -67.4 -44.49 78.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.001 -0.545 . . . . 0.16 110.849 177.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 28.2 mt-10 -62.98 -32.62 74.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.618 0.247 . . . . 0.68999999999999995 110.602 177.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.32 -35.19 80.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 110.163 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -81.08 -0.07 38.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 110.886 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 50.0 4.2 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.991 -0.623 . . . . 0.28999999999999998 112.322 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.22 167.34 21.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.829 0.347 . . . . 1.03 110.903 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -108.01 144.68 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.156 -0.683 . . . . 2.1400000000000001 109.156 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.543 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 31.3 t -128.8 139.95 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 1.0800000000000001 112.24 -170.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 t -111.71 136.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.665 -0.865 . . . . 1.05 108.665 169.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.62 124.41 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.829 0.347 . . . . 1.6499999999999999 110.71 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.428 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -138.56 138.05 37.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.09 -0.504 . . . . 1.03 110.342 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.43 -5.55 16.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.395 -0.366 . . . . 1.04 111.193 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.3 p -133.78 166.26 23.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.537 -0.302 . . . . 1.0800000000000001 111.309 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.6 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 19.6 p -59.21 -49.28 78.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.334 -0.617 . . . . 1.6599999999999999 109.334 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -49.83 -55.36 14.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.42 -1.264 . . . . 0.69999999999999996 111.944 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . 44.7 mt-30 -55.17 -46.44 75.79 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 110.876 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.521 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -63.11 -46.18 88.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.279 -0.873 . . . . 1.04 111.838 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -66.0 -30.46 71.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.209 -0.451 . . . . 1.53 110.451 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -67.32 -54.88 16.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 2.9100000000000001 109.48 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -62.29 -30.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.492 -0.322 . . . . 1.6399999999999999 111.373 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -62.12 -42.22 99.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 1.8400000000000001 110.201 178.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.54 -32.03 22.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.411 . . . . 1.1599999999999999 111.265 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.18 -35.57 61.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.62 111.062 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -120.48 162.95 31.6 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.47999999999999998 110.427 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -95.39 82.96 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.34 2.693 . . . . 0.31 111.363 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.25 127.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.815 -0.63 . . . . 1.03 111.452 -175.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.0 m-20 -99.25 -28.41 13.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 0.28999999999999998 110.703 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -162.11 157.09 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.587 -0.523 . . . . 1.03 109.587 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.03 165.63 27.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.97999999999999998 112.32 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.49 112.19 9.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 115.2 -0.909 . . . . 1.5700000000000001 109.533 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.746 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.1 mp -116.0 120.06 37.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.189 0.441 . . . . 1.02 112.189 -167.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -83.24 130.54 35.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.097 -0.705 . . . . 1.77 109.097 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' H ' ' HB ' ' A' ' 83' ' ' THR . 12.7 t -87.47 -6.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.16 -0.927 . . . . 1.3600000000000001 110.365 -173.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -121.87 73.47 1.08 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.088 0.47 . . . . 2.6400000000000001 109.966 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.65 -24.09 59.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.506 0.669 . . . . 1.3100000000000001 109.468 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.42 -175.3 41.07 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.681 -0.967 . . . . 0.87 110.681 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -52.6 -38.81 76.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.119 2.546 . . . . 1.3899999999999999 112.715 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -117.97 -34.57 4.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.486 -0.325 . . . . 4.0 111.361 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -68.61 128.0 35.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 1.3700000000000001 111.488 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -144.32 157.15 44.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.71 -0.677 . . . . 0.58999999999999997 110.104 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 27.6 p -70.89 86.62 0.7 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.686 0.755 . . . . 2.1899999999999999 109.549 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.38 -63.94 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.559 -0.829 . . . . 0.28000000000000003 112.009 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.24 -26.87 72.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.246 1.964 . . . . 0.28000000000000003 111.254 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.9 t -69.75 -45.92 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.627 -0.715 . . . . 1.01 110.171 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.34 90.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.162 -0.926 . . . . 1.01 110.29 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.6 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.5 t70 -69.05 -41.7 77.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 2.0299999999999998 110.205 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.7 77.99 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.297 0.57 . . . . 1.0700000000000001 110.715 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.02 -46.33 78.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.3 -0.863 . . . . 1.05 110.51 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -59.26 -28.7 66.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.065 -0.516 . . . . 2.5800000000000001 112.011 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 76.2 mt-30 -63.63 -48.06 78.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.768 0.318 . . . . 3.0299999999999998 110.974 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.05 7.66 39.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.34 -0.391 . . . . 1.95 111.361 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.54 42.69 20.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.863 -0.608 . . . . 1.1899999999999999 111.031 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -88.33 132.34 39.61 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.148 -0.478 . . . . 1.05 110.142 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.3 Cg_endo -74.85 140.05 25.42 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.477 2.118 . . . . 0.23000000000000001 111.759 177.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -157.22 160.86 39.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.969 -0.56 . . . . 0.23999999999999999 110.695 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -124.33 138.88 52.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.442 -0.799 . . . . 1.0700000000000001 110.013 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.0 mm? -89.15 108.7 19.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.367 -0.605 . . . . 1.05 109.367 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.566 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 14.7 t-160 -103.08 84.39 2.34 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.558 0.694 . . . . 0.59999999999999998 109.51 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 13.3 t -129.81 165.12 22.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.563 -1.199 . . . . 1.1399999999999999 110.329 -172.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.53 6.82 28.18 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.149 -0.78 . . . . 1.1000000000000001 111.149 173.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 2.2 m-20 -114.87 71.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 2.3300000000000001 110.48 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.0 mp -84.7 -33.27 23.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 2.1800000000000002 110.354 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.38 -34.51 36.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 2.6299999999999999 110.655 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -75.64 -23.05 56.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 5.1200000000000001 110.589 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.504 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 11.3 m170 -124.46 24.12 8.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.503 0.557 . . . . 1.3500000000000001 112.503 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.4 -36.72 90.25 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.792 -0.718 . . . . 1.0600000000000001 112.486 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 44.2 mt-10 -63.18 -51.7 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 2.5 110.501 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.9 tp -60.46 -42.79 96.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.061 -0.518 . . . . 1.22 110.472 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 77.1 mt -60.27 -38.3 83.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 2.1899999999999999 111.692 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 7.8 ptm180 -72.45 -26.9 62.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.815 0.34 . . . . 5.0 110.463 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -78.3 -41.05 34.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.248 0.547 . . . . 2.8999999999999999 110.001 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 92' ' ' LEU . 76.9 mt -60.61 -44.52 97.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.177 -0.92 . . . . 1.0800000000000001 110.529 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 39.0 t70 55.43 77.09 0.24 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.443 0.639 . . . . 1.0900000000000001 111.161 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.56 160.7 15.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.979 -1.01 . . . . 1.0800000000000001 109.113 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.403 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 36.4 Cg_exo -60.17 147.33 93.79 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.675 2.25 . . . . 0.29999999999999999 112.451 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.97 130.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 1.3 110.915 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 82.5 mmm -114.3 107.54 15.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.782 -0.822 . . . . 1.04 108.782 174.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.43 150.17 48.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.822 0.344 . . . . 1.2 111.613 -176.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.07 139.96 25.85 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.586 -0.524 . . . . 1.27 109.586 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.17 158.54 96.15 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.665 -1.39 . . . . 0.88 112.515 1.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.566 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -152.75 132.62 13.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.39000000000000001 110.097 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.458 ' O ' HG21 ' A' ' 110' ' ' VAL . 13.2 t70 -65.49 127.91 33.77 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.89 -0.781 . . . . 0.51000000000000001 108.89 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 20' ' ' ASN . 19.3 p -64.67 -21.05 66.64 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.485 -0.78 . . . . 1.04 112.444 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.53 -37.79 65.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.339 -0.615 . . . . 1.8899999999999999 109.339 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.02 -44.81 91.45 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.62 109.53 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 106' ' ' ASP . 21.3 t -63.24 -42.4 96.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 1.04 110.629 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.43 -50.53 67.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 1.01 111.454 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.63 -42.64 98.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.977 -0.556 . . . . 2.4300000000000002 111.212 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 113' ' ' ARG . 15.5 mmm180 -62.42 -31.07 71.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 2.73 111.247 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.57 -49.38 12.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.233 -0.44 . . . . 1.02 111.016 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.464 HD22 HG11 ' A' ' 52' ' ' VAL . 67.4 mt -66.58 -26.16 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.884 0.698 . . . . 1.04 112.884 -175.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 117' ' ' MET . 4.1 pt-20 -62.39 -33.47 74.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.12 0.486 . . . . 2.79 109.927 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.428 ' N ' ' HG3' ' A' ' 116' ' ' GLU . 47.6 mtm -77.47 -14.17 59.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.893 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.1 t . . . . . 0 C--N 1.321 -0.653 0 CA-C-O 121.283 0.563 . . . . 1.95 109.799 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.439 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.546 0.212 . . . . 2.1800000000000002 111.21 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.8 Cg_exo -67.03 135.45 37.58 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.792 2.328 . . . . 0.55000000000000004 111.222 175.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -85.92 106.14 16.9 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.513 -0.551 . . . . 1.48 109.513 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.3 t -99.92 134.82 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.935 -0.575 . . . . 1.05 110.979 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.7 tp -109.57 111.94 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.11 -0.496 . . . . 1.5 110.471 176.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.7 t -94.44 122.55 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.275 0.56 . . . . 1.03 111.736 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -102.75 102.93 13.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.921 -1.036 . . . . 1.05 109.022 173.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -160.57 121.74 3.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.043 -0.526 . . . . 1.4099999999999999 110.289 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.493 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 38.3 t70 -92.85 -11.75 32.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 1.27 110.169 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.451 ' HB3' HD12 ' A' ' 17' ' ' ILE . 42.0 mt-10 -85.73 101.71 2.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.075 -0.713 . . . . 2.5600000000000001 109.075 171.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.0 Cg_exo -59.74 -28.87 88.3 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.752 2.301 . . . . 0.35999999999999999 113.459 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 3.5 tm? -65.76 -51.02 62.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.344 -0.613 . . . . 2.2799999999999998 109.344 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -64.18 -43.78 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.91 -0.586 . . . . 1.7 110.055 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.82 63.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.672 -0.695 . . . . 1.02 111.035 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.427 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 41.7 ttp -64.07 -39.28 93.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.597 -0.729 . . . . 1.28 110.947 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.616 ' HB3' HG22 ' A' ' 107' ' ' THR . 11.5 t-20 -65.28 -41.19 94.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.11 -0.496 . . . . 1.3600000000000001 110.377 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.8 mt -62.6 -43.84 97.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.056 -0.52 . . . . 1.0700000000000001 110.407 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.1 tt0 -53.64 -51.43 63.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 1.7 110.062 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 29.4 m-85 -58.18 -39.35 78.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 1.1799999999999999 111.437 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.87 58.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.475 -0.329 . . . . 1.05 110.994 -174.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 43.7 m-85 -63.27 -43.94 96.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.37 -0.377 . . . . 0.16 110.385 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.21 -39.23 82.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.005 0.431 . . . . 0.68999999999999995 110.575 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.83 -28.6 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.51000000000000001 110.812 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -84.04 4.43 30.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.99 0.424 . . . . 0.65000000000000002 110.513 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . 82.87 48.63 5.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.905 -0.665 . . . . 0.28999999999999998 112.432 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -135.75 175.8 9.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.705 0.288 . . . . 1.03 111.135 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -113.23 145.64 40.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.77 -0.826 . . . . 2.1400000000000001 108.77 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.497 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.3 t -131.72 135.97 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.618 0.599 . . . . 1.0800000000000001 112.618 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.54 136.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.549 -0.908 . . . . 1.05 108.549 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.79 126.96 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.938 0.399 . . . . 1.6499999999999999 110.863 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 40' ' ' GLN . . . -133.48 134.53 43.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.908 -0.587 . . . . 1.03 110.285 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.409 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -100.62 -10.24 21.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.126 0.488 . . . . 1.04 110.806 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.513 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 70.7 p -127.64 165.53 19.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.853 -0.612 . . . . 1.0800000000000001 110.185 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.575 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 78.1 m -72.1 -30.89 65.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.829 -0.434 . . . . 1.6599999999999999 109.829 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.2 -44.17 84.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.69999999999999996 111.031 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.513 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 18.4 mt-30 -62.99 -35.8 81.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.308 0.575 . . . . 1.4099999999999999 110.31 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.466 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -64.74 -54.66 27.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.433 -0.803 . . . . 1.04 111.401 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.9 mt -59.33 -33.42 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 1.53 110.263 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -61.88 -53.85 50.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.454 -0.794 . . . . 2.9100000000000001 110.433 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.0 t -63.85 -38.72 92.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.934 -0.575 . . . . 1.6399999999999999 110.616 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.25 -36.28 81.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.126 0.489 . . . . 1.8400000000000001 110.692 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.5 37.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.219 -0.446 . . . . 1.1599999999999999 111.319 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -80.46 -37.94 30.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.898 0.38 . . . . 0.62 111.637 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -110.75 160.07 30.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.302 -0.408 . . . . 0.47999999999999998 110.448 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -94.85 84.32 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 123.5 2.8 . . . . 0.31 111.695 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mm -67.81 128.29 30.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.698 -0.683 . . . . 1.03 111.499 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -95.4 -32.9 12.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.28999999999999998 110.362 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 12.4 p -158.08 158.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 1.03 109.382 -178.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -140.26 168.03 20.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.421 0.629 . . . . 0.97999999999999998 111.476 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -140.69 121.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.853 -1.166 . . . . 1.5700000000000001 107.853 176.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -123.78 122.61 38.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.1 0.407 . . . . 1.02 112.1 -167.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.65 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 53.4 t0 -85.18 119.17 25.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 1.77 109.553 170.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.483 HG12 HD22 ' A' ' 92' ' ' LEU . 95.8 t -69.49 -28.84 39.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.052 -0.976 . . . . 1.3600000000000001 110.391 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -99.72 62.05 1.17 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.846 -0.616 . . . . 2.6400000000000001 110.393 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.81 -28.31 68.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.318 0.58 . . . . 1.3100000000000001 109.626 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.43 -171.94 41.44 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.559 -1.016 . . . . 0.87 110.559 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.1 -45.37 41.18 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.556 2.17 . . . . 1.3899999999999999 111.858 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' A' ' 62' ' ' LYS . 5.0 ttmp? -107.18 -34.32 7.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 4.0 110.454 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -68.55 125.27 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.227 0.537 . . . . 1.3700000000000001 111.364 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -146.6 148.52 32.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.778 -0.646 . . . . 0.58999999999999997 110.309 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.8 p -71.43 86.64 0.85 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.395 0.617 . . . . 2.1899999999999999 109.734 172.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.85 -72.15 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.364 -0.922 . . . . 0.28000000000000003 112.407 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.9 Cg_exo -53.31 -26.38 34.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.731 2.287 . . . . 0.28000000000000003 112.023 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 11' ' ' LEU . 13.9 t -69.2 -48.32 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.113 0.483 . . . . 1.01 110.158 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.21 80.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.256 -0.884 . . . . 1.01 110.173 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.3 t70 -63.3 -39.05 93.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 2.0299999999999998 110.81 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 1.0700000000000001 110.905 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.87 -41.18 95.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 1.05 110.162 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 2.7 mmpt? -59.37 -33.75 71.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.477 -0.783 . . . . 2.5800000000000001 111.195 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 24.1 mt-30 -64.09 -47.51 79.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 3.0299999999999998 110.964 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.88 5.58 39.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 1.95 111.089 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.01 32.6 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.689 -0.687 . . . . 1.1899999999999999 111.392 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.7 mt -82.11 133.07 51.74 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.925 -0.579 . . . . 1.05 109.798 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 25.1 Cg_endo -72.9 142.04 34.4 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.229 1.953 . . . . 0.23000000000000001 111.884 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 35.0 p90 -157.23 153.25 27.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.834 -0.621 . . . . 0.23999999999999999 110.449 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -117.39 138.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.565 -0.743 . . . . 1.0700000000000001 109.526 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.5 mm? -88.48 108.09 19.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.113 -0.699 . . . . 1.05 109.113 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.564 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 20.2 t-160 -101.47 76.87 1.72 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.804 -0.813 . . . . 0.59999999999999998 108.804 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.65 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 6.5 t -111.7 155.02 24.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.683 -1.144 . . . . 1.1399999999999999 111.795 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.56 2.16 58.78 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.543 -0.753 . . . . 1.1000000000000001 111.355 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 127.68 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.915 0.388 . . . . 2.3300000000000001 111.779 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 86' ' ' LEU . 4.3 mp -117.72 0.63 12.06 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.083 -0.71 . . . . 2.1800000000000002 109.083 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.54 -61.47 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 2.6299999999999999 111.51 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -66.33 -37.77 86.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.546 . . . . 5.1200000000000001 110.213 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -104.22 33.02 3.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.125 -0.489 . . . . 1.3500000000000001 110.355 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.404 ' HA2' HD22 ' A' ' 93' ' ' LEU . . . -62.53 -31.5 79.93 Favored Glycine 0 CA--C 1.511 -0.179 0 C-N-CA 121.15 -0.547 . . . . 1.0600000000000001 113.282 -176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.45 -27.84 69.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.127 0.489 . . . . 2.5 110.021 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.8 tp -71.32 -42.87 68.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.767 -0.651 . . . . 1.22 110.419 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.404 HD22 ' HA2' ' A' ' 90' ' ' GLY . 3.1 mm? -55.61 -40.34 71.97 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.068 0.461 . . . . 2.1899999999999999 110.241 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.94 -26.63 66.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 5.0 111.821 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.65 -37.03 36.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.256 0.55 . . . . 2.8999999999999999 110.239 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 92' ' ' LEU . 69.5 mt -75.98 -62.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.293 -0.867 . . . . 1.0800000000000001 111.876 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.23 81.56 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.676 -173.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.8 169.09 10.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 1.0800000000000001 109.341 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 33.7 Cg_exo -61.57 136.26 61.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.286 1.991 . . . . 0.29999999999999999 112.118 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.418 HG11 HD23 ' A' ' 86' ' ' LEU . 40.0 t -124.17 130.09 73.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.325 -0.398 . . . . 1.3 110.994 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 98.1 mtp -117.05 106.43 13.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.445 -0.576 . . . . 1.04 109.445 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.16 152.98 43.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 1.2 111.507 -176.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.7 mttt -90.98 142.82 27.78 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.868 -0.605 . . . . 1.27 110.032 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.15 158.66 93.6 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.457 -1.476 . . . . 0.88 112.711 1.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -152.62 131.16 12.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.39000000000000001 109.184 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.482 ' O ' HG22 ' A' ' 110' ' ' VAL . 36.6 t70 -68.05 128.23 35.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.42 -0.585 . . . . 0.51000000000000001 109.42 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 20' ' ' ASN . 21.1 p -59.01 -27.99 65.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.815 -1.084 . . . . 1.04 112.544 -172.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.683 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -64.9 -45.62 85.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.634 -0.506 . . . . 1.8899999999999999 109.634 176.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -61.68 -45.57 93.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.721 -0.474 . . . . 0.62 109.721 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.526 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 20.2 t -59.27 -43.09 89.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 1.04 110.423 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.62 -50.35 65.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.626 -0.716 . . . . 1.01 111.354 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.683 ' HG3' ' O ' ' A' ' 108' ' ' SER . 19.7 mtpp -60.19 -42.2 94.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 2.4300000000000002 111.073 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 32.0 mmt180 -71.81 -28.11 63.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 2.73 111.403 -177.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.31 -48.49 17.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.368 . . . . 1.02 110.119 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 52' ' ' VAL . 82.1 mt -65.1 -26.29 68.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.862 0.69 . . . . 1.04 112.862 -176.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -25.02 59.54 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.31 -0.556 . . . . 2.79 110.982 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.458 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 70.2 mtm -69.55 -36.08 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.75 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.7 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.147 0.498 . . . . 1.95 110.397 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.6 ptp . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.937 0.399 . . . . 2.1800000000000002 110.753 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.65 148.01 28.64 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.659 2.239 . . . . 0.55000000000000004 113.1 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -95.78 107.82 20.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.437 -0.801 . . . . 1.48 109.243 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.451 HG21 ' CG1' ' A' ' 52' ' ' VAL . 57.1 t -100.6 133.56 43.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.096 -0.502 . . . . 1.05 111.057 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -108.76 114.68 28.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.927 0.394 . . . . 1.5 110.402 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.3 t -95.82 120.76 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.34 0.59 . . . . 1.03 111.433 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.656 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 0.7 OUTLIER -102.05 100.68 10.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.828 -1.078 . . . . 1.05 108.873 172.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.436 ' CD ' ' HZ2' ' A' ' 103' ' ' LYS . 10.7 tp10 -157.4 117.48 3.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.408 -0.815 . . . . 1.4099999999999999 109.668 -174.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.2 t70 -81.37 -20.91 39.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.062 -0.517 . . . . 1.27 110.225 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -82.31 105.44 4.72 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.573 -0.529 . . . . 2.5600000000000001 109.573 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.7 Cg_exo -58.32 -30.76 92.09 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.619 2.213 . . . . 0.35999999999999999 112.455 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.38 -49.89 73.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.048 0.451 . . . . 2.2799999999999998 109.869 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.1 mt -69.39 -43.68 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 1.7 111.169 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.92 -45.23 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.47 . . . . 1.02 110.303 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' MET . . . . . 0.407 ' HE3' ' HB3' ' A' ' 19' ' ' MET . 39.8 ttp -61.95 -46.71 88.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.384 -0.826 . . . . 1.28 111.214 177.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.414 ' HB3' HG22 ' A' ' 107' ' ' THR . 3.4 m-80 -65.27 -40.99 94.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.136 -0.484 . . . . 1.3600000000000001 111.372 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.88 -44.57 95.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.357 -0.383 . . . . 1.0700000000000001 110.266 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -56.36 -49.59 73.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 1.7 110.2 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -62.76 -34.37 77.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.204 -0.453 . . . . 1.1799999999999999 111.201 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -69.02 -51.03 43.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 1.05 110.82 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.681 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 53.7 m-85 -63.54 -42.08 98.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.344 -0.389 . . . . 0.16 110.834 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.92 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.96 -0.296 . . . . 0.68999999999999995 110.626 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.8 -26.94 61.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.51000000000000001 110.818 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 69.6 mm-40 -82.51 -10.22 59.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.65000000000000002 110.356 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.32 51.36 1.59 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.28999999999999998 112.421 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.04 167.9 21.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 1.03 110.958 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -106.35 141.89 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.943 -0.762 . . . . 2.1400000000000001 108.943 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -125.83 136.88 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.191 0.441 . . . . 1.0800000000000001 112.191 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.27 132.42 56.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.917 -0.771 . . . . 1.05 108.917 168.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.14 124.0 56.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.964 0.412 . . . . 1.6499999999999999 111.088 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.441 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -136.89 143.61 43.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.029 -0.532 . . . . 1.03 110.344 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . 0.443 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -112.09 -8.59 14.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.461 -0.336 . . . . 1.04 111.308 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 p -131.18 168.11 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.472 -0.331 . . . . 1.0800000000000001 111.33 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.541 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.5 p -59.22 -50.08 75.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.379 0.609 . . . . 1.6599999999999999 109.434 172.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.05 -54.12 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.423 -1.262 . . . . 0.69999999999999996 112.215 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 44.0 mt-30 -56.91 -41.18 77.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.25 0.547 . . . . 1.4099999999999999 111.173 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.521 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -68.23 -45.9 72.0 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.43 -0.805 . . . . 1.04 111.496 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.4 mt -66.52 -28.13 68.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 1.53 110.481 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -66.76 -51.65 53.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 2.9100000000000001 109.831 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.3 t -63.56 -37.89 89.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.6399999999999999 110.792 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -39.88 77.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 1.8400000000000001 110.366 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.82 -34.87 30.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.801 -0.636 . . . . 1.1599999999999999 111.39 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -80.21 -38.44 31.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.62 111.568 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -116.13 161.29 31.87 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.188 -0.46 . . . . 0.47999999999999998 110.679 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -93.6 82.29 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.59 2.86 . . . . 0.31 110.839 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.6 mm -64.84 116.1 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.348 -0.842 . . . . 1.03 111.563 -174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.73 -32.53 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.28999999999999998 110.375 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.462 HG13 HD22 ' A' ' 115' ' ' LEU . 15.0 p -160.59 155.53 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 1.03 109.77 -176.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.11 167.8 21.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.325 0.583 . . . . 0.97999999999999998 111.677 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.4 111.18 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.447 -0.797 . . . . 1.5700000000000001 109.285 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.2 mp -115.09 123.41 48.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.141 0.423 . . . . 1.02 112.141 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.99 107.94 15.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.781 0.801 . . . . 1.77 109.816 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.462 ' H ' ' HB ' ' A' ' 83' ' ' THR . 38.2 t -59.17 -19.56 16.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.803 -1.09 . . . . 1.3600000000000001 111.868 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -122.0 70.03 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.531 . . . . 2.6400000000000001 110.72 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.446 HD12 ' SG ' ' A' ' 65' ' ' CYS . 94.9 mt -67.37 -27.85 67.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 1.3100000000000001 110.295 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.24 -160.7 16.54 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.763 -0.653 . . . . 0.87 111.684 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.62 -46.03 36.47 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.897 2.398 . . . . 1.3899999999999999 112.203 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -126.22 -19.75 4.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.137 -0.483 . . . . 4.0 110.271 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.6 m -63.47 125.89 25.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.985 -0.552 . . . . 1.3700000000000001 110.988 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -145.71 153.51 41.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.959 -0.564 . . . . 0.58999999999999997 110.643 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 15.3 m -77.47 85.81 3.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.637 -0.875 . . . . 2.1899999999999999 108.637 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.76 -65.47 0.62 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.837 -0.697 . . . . 0.28000000000000003 112.689 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -54.77 -25.18 41.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.361 2.041 . . . . 0.28000000000000003 111.247 174.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -69.03 -46.91 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.723 -0.671 . . . . 1.01 109.998 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -58.2 -47.72 82.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.099 -0.955 . . . . 1.01 109.862 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.24 -39.26 94.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.786 -0.643 . . . . 2.0299999999999998 110.555 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -58.61 -44.62 89.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 1.0700000000000001 111.05 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.58 -46.24 66.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.631 -0.713 . . . . 1.05 110.293 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 30.1 mmmt -56.06 -35.83 67.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 2.5800000000000001 111.582 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 1.5 pt20 -63.97 -41.46 97.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.908 -0.587 . . . . 3.0299999999999998 110.76 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 96.5 mtt180 -95.51 4.69 52.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.883 -0.598 . . . . 1.95 111.027 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.05 32.95 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.628 -0.715 . . . . 1.1899999999999999 111.266 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.0 mt -80.17 131.65 62.03 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 109.396 -0.594 . . . . 1.05 109.396 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 43.2 Cg_endo -76.09 142.19 24.42 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.287 1.992 . . . . 0.23000000000000001 112.014 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -158.38 154.67 27.36 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.369 -0.832 . . . . 0.23999999999999999 110.185 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 mt -117.07 138.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.463 -0.79 . . . . 1.0700000000000001 109.781 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.6 mm? -88.5 109.86 20.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.987 -0.551 . . . . 1.05 109.702 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.598 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 20.9 t-160 -104.88 86.52 2.47 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.387 0.613 . . . . 0.59999999999999998 109.756 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 8.8 t -135.85 161.7 34.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.001 -1.0 . . . . 1.1399999999999999 110.577 -172.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.34 22.16 9.01 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.604 -0.808 . . . . 1.1000000000000001 112.409 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.622 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 19.8 t70 -141.69 74.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.337 0.589 . . . . 2.3300000000000001 109.484 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.472 HD11 ' N ' ' A' ' 86' ' ' LEU . 3.3 mp -92.42 -22.94 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.823 -0.626 . . . . 2.1800000000000002 110.887 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -73.86 -48.29 32.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.93 0.395 . . . . 2.6299999999999999 110.625 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.622 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -75.88 -38.64 57.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.169 -0.469 . . . . 5.1200000000000001 110.74 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.453 ' O ' HD11 ' A' ' 93' ' ' LEU . 73.6 m-70 -89.48 17.29 6.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.978 -0.289 . . . . 1.3500000000000001 110.984 177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -52.56 -42.51 58.03 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.39 -0.434 . . . . 1.0600000000000001 113.478 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.94 -34.71 65.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.939 0.4 . . . . 2.5 110.693 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.489 ' O ' HG13 ' A' ' 96' ' ' ILE . 35.3 tp -72.64 -54.18 9.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.042 -0.526 . . . . 1.22 111.514 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -65.66 -27.65 68.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.973 -0.691 . . . . 2.1899999999999999 111.823 -176.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 27.2 mmm180 -64.17 -46.35 84.37 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.849 -0.614 . . . . 5.0 110.961 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.68 -36.14 83.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 2.8999999999999999 110.755 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 92' ' ' LEU . 79.0 mt -64.08 -49.42 81.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 1.0800000000000001 110.503 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.5 t70 58.76 74.52 0.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.607 0.718 . . . . 1.0900000000000001 110.897 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.94 21.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.916 -1.038 . . . . 1.0800000000000001 109.165 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.442 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 39.3 Cg_exo -58.74 143.83 98.55 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.455 2.103 . . . . 0.29999999999999999 112.452 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.61 132.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.238 -0.437 . . . . 1.3 111.226 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.4 mmm -114.51 106.7 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.857 -0.794 . . . . 1.04 108.857 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -67.9 147.61 52.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.023 0.439 . . . . 1.2 112.161 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.436 ' HZ2' ' CD ' ' A' ' 12' ' ' GLU . 90.4 mttt -90.85 141.98 27.23 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.848 -0.614 . . . . 1.27 110.116 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.16 155.82 99.76 Favored 'Cis proline' 0 C--O 1.231 0.142 0 C-N-CA 123.137 -1.61 . . . . 0.88 112.389 -0.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.598 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -146.14 139.97 26.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 0.39000000000000001 109.969 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 110' ' ' VAL . 18.7 t70 -70.51 128.24 35.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.251 -0.648 . . . . 0.51000000000000001 109.251 174.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -68.86 -19.39 64.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.718 -0.674 . . . . 1.04 112.756 -170.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 t -73.94 -37.49 64.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.206 -0.664 . . . . 1.8899999999999999 109.206 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -65.66 -46.48 79.0 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.112 -0.495 . . . . 0.62 109.779 175.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 106' ' ' ASP . 21.5 t -58.88 -43.52 88.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.377 -0.829 . . . . 1.04 110.647 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.681 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.23 -54.03 39.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.853 -0.612 . . . . 1.01 111.454 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 61.7 mttp -57.5 -48.06 80.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 2.4300000000000002 111.289 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 26.2 mmt180 -63.82 -34.71 78.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 2.73 111.415 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -46.71 70.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.058 0.456 . . . . 1.02 110.27 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.462 HD22 HG13 ' A' ' 52' ' ' VAL . 86.8 mt -66.12 -25.6 67.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 1.04 111.877 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 32.8 mm-40 -54.48 -41.04 69.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.537 -0.302 . . . . 2.79 111.388 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.442 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 77.6 mtm -70.89 -29.41 65.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.031 0.443 . . . . 1.95 110.433 -176.18 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 54.5 mtt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.568 0.223 . . . . 2.1800000000000002 111.365 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.625 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -61.99 140.59 85.46 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.104 2.536 . . . . 0.55000000000000004 111.714 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -86.62 103.51 15.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.001 0.429 . . . . 1.48 109.899 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.465 HG21 ' CG1' ' A' ' 52' ' ' VAL . 46.9 t -100.26 136.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.773 -0.649 . . . . 1.05 110.977 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -112.02 113.49 25.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.256 -0.429 . . . . 1.5 110.59 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.3 t -94.34 122.53 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.39 0.614 . . . . 1.03 111.164 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -101.79 107.42 18.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.812 -1.085 . . . . 1.05 108.341 172.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -166.38 134.47 2.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 109.956 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.6 t70 -99.55 -23.58 15.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.383 -0.826 . . . . 1.27 110.069 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . 0.465 ' CB ' HD12 ' A' ' 17' ' ' ILE . 33.9 mt-10 -80.31 104.81 2.85 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 109.345 -0.613 . . . . 2.5600000000000001 109.345 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.2 Cg_exo -58.0 -32.68 95.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.014 2.476 . . . . 0.35999999999999999 113.435 -171.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.66 -49.68 74.17 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.697 -0.483 . . . . 2.2799999999999998 109.697 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.465 HD12 ' CB ' ' A' ' 14' ' ' GLU . 3.3 mp -66.32 -47.59 83.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.544 -0.753 . . . . 1.7 110.126 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.83 74.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.525 -0.761 . . . . 1.02 111.228 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.4 ttp -64.46 -37.08 86.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.013 -0.539 . . . . 1.28 110.949 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.439 ' HB3' HG22 ' A' ' 107' ' ' THR . 2.6 m-80 -69.16 -37.0 78.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.25 -0.432 . . . . 1.3600000000000001 110.915 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.11 -45.89 83.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.42 -0.354 . . . . 1.0700000000000001 110.058 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 35.9 tt0 -51.86 -56.8 11.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.765 -0.652 . . . . 1.7 110.205 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -63.55 -27.65 69.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.859 -0.61 . . . . 1.1799999999999999 111.894 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.9 54.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.834 0.35 . . . . 1.05 110.314 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 47.0 m-85 -66.08 -41.1 91.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 0.16 111.031 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.3 mt-10 -61.29 -37.04 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.68999999999999995 110.582 178.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.44 -29.78 68.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 0.51000000000000001 110.338 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -79.48 -13.48 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.65000000000000002 110.66 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.49 50.19 1.58 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.092 -0.575 . . . . 0.28999999999999998 112.399 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.81 165.52 26.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.591 0.234 . . . . 1.03 110.898 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -109.27 128.2 54.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.261 -0.644 . . . . 2.1400000000000001 109.261 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 37.8 t -113.23 133.98 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.787 0.662 . . . . 1.0800000000000001 112.787 -167.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.97 139.91 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.169 -1.049 . . . . 1.05 108.169 167.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.1 t -114.67 125.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.626 -0.43 . . . . 1.6499999999999999 110.879 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.49 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -133.54 136.39 44.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.878 -0.601 . . . . 1.03 110.174 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.16 -10.8 21.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.869 0.366 . . . . 1.04 111.287 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.2 p -131.23 163.37 27.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.199 -0.455 . . . . 1.0800000000000001 110.751 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.6 m -63.41 -33.76 76.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.757 -0.46 . . . . 1.6599999999999999 109.757 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.43 -51.61 67.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 110.618 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.49 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . 46.8 mt-30 -58.98 -39.12 80.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.122 0.487 . . . . 1.4099999999999999 110.805 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.505 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -64.74 -49.83 69.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 1.04 111.718 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.4 mt -63.25 -27.86 69.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 1.53 110.497 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -67.42 -50.29 60.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.787 -0.642 . . . . 2.9100000000000001 109.769 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -65.47 -33.45 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 1.6399999999999999 110.586 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -37.51 77.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 1.8400000000000001 110.656 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.8 -41.8 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 1.1599999999999999 111.212 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.16 -37.19 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 0.62 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -122.72 162.5 38.28 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.166 -0.47 . . . . 0.47999999999999998 110.724 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -93.28 86.05 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.255 2.637 . . . . 0.31 111.018 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -64.01 119.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 1.03 111.523 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 41.5 m-20 -87.24 -35.7 18.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.28999999999999998 110.28 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.465 ' CG1' HG21 ' A' ' 8' ' ' VAL . 14.5 p -156.31 155.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.753 -0.658 . . . . 1.03 109.581 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -138.24 163.51 31.57 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.451 0.643 . . . . 0.97999999999999998 111.519 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -134.84 111.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.511 -0.922 . . . . 1.5700000000000001 108.511 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.702 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -108.01 107.31 17.94 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.711 -0.396 . . . . 1.02 111.802 -169.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.832 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.1 t70 -84.97 139.04 32.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.098 -0.704 . . . . 1.77 109.098 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 65' ' ' CYS . 14.4 t -93.93 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.731 -0.668 . . . . 1.3600000000000001 110.287 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -89.96 60.18 4.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.715 0.769 . . . . 2.6400000000000001 110.164 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.3 mt -89.77 -23.85 21.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.87 -0.605 . . . . 1.3100000000000001 110.067 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.68 -173.13 44.49 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.029 -0.828 . . . . 0.87 111.029 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.58 -43.52 57.08 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.565 2.177 . . . . 1.3899999999999999 111.91 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.11 -23.55 6.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.918 -0.583 . . . . 4.0 110.404 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -61.91 122.35 15.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 1.3700000000000001 111.068 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -144.39 154.22 42.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.495 -0.775 . . . . 0.58999999999999997 109.993 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -70.05 87.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 2.1899999999999999 109.866 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.57 -74.71 0.74 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.525 -0.845 . . . . 0.28000000000000003 112.523 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 46.5 Cg_exo -53.35 -24.76 28.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.695 2.264 . . . . 0.28000000000000003 112.302 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.2 t -66.33 -44.54 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.375 0.607 . . . . 1.01 109.918 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.43 92.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.918 -1.037 . . . . 1.01 109.966 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.88 -45.59 93.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.514 -0.766 . . . . 2.0299999999999998 110.458 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.05 -41.65 68.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.459 0.647 . . . . 1.0700000000000001 111.366 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.58 -44.84 56.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.375 -0.83 . . . . 1.05 110.561 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -54.29 -41.37 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.455 -0.793 . . . . 2.5800000000000001 110.861 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.512 HE21 ' HA ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -59.89 -46.44 89.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.708 -0.678 . . . . 3.0299999999999998 111.483 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -92.93 12.06 25.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 1.95 111.451 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.43 37.44 27.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.692 -0.685 . . . . 1.1899999999999999 111.66 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.25 133.53 38.49 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.282 -0.417 . . . . 1.05 109.944 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 22.2 Cg_endo -74.99 142.11 27.47 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.298 1.999 . . . . 0.23000000000000001 112.04 177.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 18.7 p90 -159.34 154.94 25.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.834 -0.621 . . . . 0.23999999999999999 110.562 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.4 mt -117.74 137.03 52.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.358 -0.837 . . . . 1.0700000000000001 109.624 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.03 109.4 20.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.238 -0.653 . . . . 1.05 109.238 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.832 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 t-160 -97.87 126.85 43.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.904 -1.147 . . . . 0.59999999999999998 107.904 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -169.39 151.23 4.44 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.753 -0.592 . . . . 1.1399999999999999 111.529 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.83 -8.78 59.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.896 -0.669 . . . . 1.1000000000000001 111.565 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -116.32 112.39 21.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.725 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.04 -10.31 15.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.807 -0.633 . . . . 2.1800000000000002 110.057 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -84.03 -60.33 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 2.6299999999999999 111.457 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -71.78 -40.67 69.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 5.1200000000000001 110.778 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . 0.477 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 89.8 m-70 -92.48 21.78 5.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.334 -0.394 . . . . 1.3500000000000001 111.676 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.41 -39.12 97.4 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.924 -0.655 . . . . 1.0600000000000001 112.475 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.42 -41.61 97.43 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.936 0.398 . . . . 2.5 110.346 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 96' ' ' ILE . 63.8 tp -59.77 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 1.22 110.502 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 40.6 mt -60.32 -40.84 92.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.819 -0.628 . . . . 2.1899999999999999 111.122 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -69.78 -25.53 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 5.0 111.21 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.15 -32.01 56.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.445 0.641 . . . . 2.8999999999999999 110.232 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 92' ' ' LEU . 93.6 mt -77.35 -54.44 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 1.0800000000000001 110.912 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.95 76.58 0.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.839 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.93 168.16 12.97 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.157 -0.929 . . . . 1.0800000000000001 108.941 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 47.8 Cg_exo -58.74 140.57 95.55 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.425 2.083 . . . . 0.29999999999999999 112.625 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.85 142.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 1.3 110.873 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 82' ' ' HIS . 80.9 mmm -125.57 110.01 13.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.389 -0.597 . . . . 1.04 109.389 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.67 150.2 37.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 1.2 111.849 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.558 ' HE3' ' OD2' ' A' ' 56' ' ' ASP . 77.8 mttt -91.18 140.97 25.9 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 1.27 110.154 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 2.9 Cg_exo -75.35 146.93 87.5 Favored 'Cis proline' 0 C--O 1.233 0.247 0 C-N-CA 123.472 -1.47 . . . . 0.88 112.641 3.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -136.41 132.58 35.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 0.39000000000000001 110.275 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.7 t70 -73.32 128.07 34.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.51000000000000001 108.486 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 20' ' ' ASN . 35.9 p -65.96 -17.77 64.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.876 -0.602 . . . . 1.04 112.294 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.5 p -71.92 -41.78 67.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.947 -0.39 . . . . 1.8899999999999999 109.947 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.5 -42.16 87.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.139 0.495 . . . . 0.62 110.01 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 106' ' ' ASP . 20.5 t -62.62 -44.11 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.383 -0.826 . . . . 1.04 110.182 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.7 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.63 -51.33 57.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.619 -0.719 . . . . 1.01 111.854 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 52.8 mtpt -60.03 -48.16 82.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 2.4300000000000002 111.244 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -62.46 -35.82 80.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.68 0.276 . . . . 2.73 111.399 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.84 75.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.94 0.4 . . . . 1.02 110.041 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.64 -26.36 65.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.132 -0.486 . . . . 1.04 111.887 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 50.7 mm-40 -56.78 -46.94 81.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.116 0.484 . . . . 2.79 110.375 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.56 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.1 mtm -76.06 -26.69 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.76 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 53.4 t . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 1.95 111.146 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' MET . . . . . 0.41 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 86.3 mtp . . . . . 0 CA--C 1.514 -0.418 0 N-CA-C 108.708 -0.849 . . . . 2.1800000000000002 108.708 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 8.8 Cg_exo -63.52 131.42 31.62 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.854 1.703 . . . . 0.55000000000000004 111.372 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -86.01 102.94 14.25 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.507 -0.923 . . . . 1.48 108.507 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.44 HG23 ' CG1' ' A' ' 52' ' ' VAL . 49.8 t -99.69 126.81 53.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.037 -0.529 . . . . 1.05 111.087 -172.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.478 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.5 tm? -102.2 112.24 24.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.578 -0.737 . . . . 1.5 109.476 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.4 t -96.83 125.82 49.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.113 0.482 . . . . 1.03 111.409 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . 0.484 HD23 ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -105.96 100.53 10.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.694 -0.854 . . . . 1.05 108.694 173.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -157.5 118.17 3.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.907 -0.588 . . . . 1.4099999999999999 109.626 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 32.9 t70 -77.27 -21.2 53.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.848 -0.615 . . . . 1.27 110.223 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -88.05 106.88 13.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.905 -0.589 . . . . 2.5600000000000001 111.117 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 39.2 Cg_exo -58.53 -28.89 87.2 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.86 2.374 . . . . 0.35999999999999999 112.914 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -49.67 68.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.516 -0.55 . . . . 2.2799999999999998 109.516 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 17' ' ' ILE . 65.5 mt -66.37 -45.47 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.733 -0.667 . . . . 1.7 110.514 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.35 73.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 1.02 110.82 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.6 ttp -59.37 -43.84 92.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.654 -0.703 . . . . 1.28 111.238 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.431 ' HB3' HG23 ' A' ' 107' ' ' THR . 4.9 m-80 -67.86 -38.71 83.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.926 -0.579 . . . . 1.3600000000000001 111.34 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 mt -65.31 -44.83 86.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.928 0.394 . . . . 1.0700000000000001 110.297 172.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLN . . . . . 0.578 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 52.2 tt0 -54.49 -51.89 63.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.563 -0.744 . . . . 1.7 110.466 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.09 -34.38 74.83 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.612 -0.267 . . . . 1.1799999999999999 111.116 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.9 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.504 -0.317 . . . . 1.05 110.699 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.9 m-85 -68.64 -42.5 77.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.242 -0.435 . . . . 0.16 110.994 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 44.1 mt-10 -61.79 -35.54 78.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.586 -0.279 . . . . 0.68999999999999995 110.461 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.49 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.51000000000000001 110.657 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.81 -10.0 59.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.65000000000000002 110.455 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.63 50.56 1.81 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.28999999999999998 112.399 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -139.79 165.14 28.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 1.03 110.833 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.86 134.97 53.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.422 -0.584 . . . . 2.1400000000000001 109.422 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . 0.578 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.4 t -117.39 140.74 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.41 0.522 . . . . 1.0800000000000001 112.41 -167.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.43 131.53 64.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.544 -0.91 . . . . 1.05 108.544 168.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.6 t -105.43 121.15 57.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 1.6499999999999999 111.609 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -126.39 142.66 51.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.819 -0.628 . . . . 1.03 110.471 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.76 -12.6 15.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.899 -0.591 . . . . 1.04 110.54 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 32.8 p -124.89 174.96 7.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 1.0800000000000001 110.955 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' CYS . . . . . 0.612 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.9 m -75.11 -37.0 61.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.033 0.444 . . . . 1.6599999999999999 110.263 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.15 -41.19 90.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.69999999999999996 111.161 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' GLN . . . . . 0.471 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 86.5 mt-30 -59.83 -37.29 78.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.078 0.466 . . . . 1.4099999999999999 110.857 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB1' HD23 ' A' ' 11' ' ' LEU . . . -71.46 -48.43 49.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.995 -0.548 . . . . 1.04 110.879 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mp -56.02 -37.34 69.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 1.53 110.68 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -63.1 -54.07 43.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 2.9100000000000001 110.444 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -63.99 -29.18 70.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.713 -0.676 . . . . 1.6399999999999999 111.711 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.4 -30.64 69.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.342 0.591 . . . . 1.8400000000000001 110.513 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.53 -28.57 24.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.4 0.619 . . . . 1.1599999999999999 111.07 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -87.04 -21.68 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 0.62 111.52 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -137.68 163.67 46.69 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 0.47999999999999998 111.115 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -96.32 87.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.767 2.978 . . . . 0.31 111.388 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 9' ' ' LEU . 37.9 mm -66.08 124.36 20.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.594 -0.73 . . . . 1.03 111.631 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.689 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 14.3 m-20 -89.48 -34.67 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.542 -0.754 . . . . 0.28999999999999998 110.421 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 115' ' ' LEU . 13.6 p -159.67 157.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.805 -0.634 . . . . 1.03 109.871 -176.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.8 164.53 29.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.359 0.599 . . . . 0.97999999999999998 112.008 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.65 110.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.353 -0.84 . . . . 1.5700000000000001 109.301 175.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.647 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.5 mp -112.7 121.86 45.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.415 -0.357 . . . . 1.02 111.631 -169.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.88 116.49 22.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 1.77 109.645 171.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' VAL . . . . . 0.42 ' H ' ' HB ' ' A' ' 83' ' ' THR . 92.9 t -67.37 -23.74 30.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.061 -0.972 . . . . 1.3600000000000001 110.463 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.38 56.94 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.544 -0.753 . . . . 2.6400000000000001 110.695 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.35 -37.32 85.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.939 -0.763 . . . . 1.3100000000000001 108.939 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.85 -171.61 29.29 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.149 -1.18 . . . . 0.87 110.149 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.0 -46.26 34.92 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.498 2.132 . . . . 1.3899999999999999 111.862 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.99 -34.93 6.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.409 -0.36 . . . . 4.0 110.874 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -62.33 123.56 18.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.325 0.584 . . . . 1.3700000000000001 110.92 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -144.79 152.27 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.551 -0.75 . . . . 0.58999999999999997 110.616 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -73.82 87.5 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.283 0.564 . . . . 2.1899999999999999 109.811 173.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLY . . . . . 0.438 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -106.51 -73.52 0.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.278 -0.963 . . . . 0.28000000000000003 112.598 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.4 Cg_exo -52.19 -27.1 28.68 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.28000000000000003 112.082 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 17.0 t -68.23 -44.07 84.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 1.01 110.195 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.79 82.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.28 -0.873 . . . . 1.01 110.268 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.52 -42.47 98.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 110.253 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.37 69.34 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.51 0.672 . . . . 1.0700000000000001 110.92 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.6 -42.7 70.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.22 -0.9 . . . . 1.05 110.642 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' LYS . . . . . 0.575 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.8 mmtt -60.47 -37.95 82.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.809 -0.632 . . . . 2.5800000000000001 111.11 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.52 -39.06 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 3.0299999999999998 111.441 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -97.46 10.98 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.257 -0.429 . . . . 1.95 111.159 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.82 33.18 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 1.1899999999999999 112.02 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.73 132.67 39.75 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.228 -0.442 . . . . 1.05 110.071 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 18.6 Cg_endo -74.41 140.06 26.74 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.391 2.06 . . . . 0.23000000000000001 111.421 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -157.34 161.16 39.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.831 -0.622 . . . . 0.23999999999999999 110.493 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' ILE . . . . . 0.432 HG22 ' HG2' ' A' ' 101' ' ' MET . 41.0 mt -124.21 140.95 46.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.288 -0.869 . . . . 1.0700000000000001 109.784 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.4 mm? -88.69 108.01 19.24 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.91 -0.774 . . . . 1.05 108.91 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' HIS . . . . . 0.582 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 17.7 t-160 -99.49 82.42 2.65 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.593 0.711 . . . . 0.59999999999999998 109.722 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.621 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -137.98 157.97 45.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.426 -1.261 . . . . 1.1399999999999999 109.257 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.23 4.61 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.362 -0.923 . . . . 1.1000000000000001 111.955 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -137.09 69.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 2.3300000000000001 111.458 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.422 HD11 HG13 ' A' ' 100' ' ' VAL . 82.2 mt -63.04 -34.77 78.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 2.1800000000000002 110.254 174.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -63.81 -29.17 70.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 2.6299999999999999 111.745 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -21.6 61.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.232 0.539 . . . . 5.1200000000000001 110.508 -177.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -137.45 45.65 2.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 1.3500000000000001 110.072 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -59.67 -27.06 63.35 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 116.005 -0.543 . . . . 1.0600000000000001 113.263 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.68 -25.16 63.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 2.5 110.642 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 96' ' ' ILE . 27.5 tp -77.22 -52.74 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 1.22 111.884 -174.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LEU . . . . . 0.479 ' CD1' ' HA2' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -63.78 -23.94 67.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.178 0.513 . . . . 2.1899999999999999 111.545 -177.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 99.6 mtt180 -62.57 -34.26 76.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.186 -0.915 . . . . 5.0 110.762 173.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -81.93 -33.68 30.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 2.8999999999999999 110.447 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ILE . . . . . 0.575 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 59.4 mt -74.34 -62.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.485 -0.78 . . . . 1.0800000000000001 111.606 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.13 76.81 0.21 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.408 0.623 . . . . 1.0900000000000001 111.471 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.42 164.83 19.37 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 1.0800000000000001 109.238 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.661 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.7 Cg_exo -56.52 144.26 85.14 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.668 2.245 . . . . 0.29999999999999999 113.003 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . 0.422 HG13 HD11 ' A' ' 86' ' ' LEU . 46.5 t -121.99 137.74 54.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.915 -0.584 . . . . 1.3 110.751 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' MET . . . . . 0.432 ' HG2' HG22 ' A' ' 80' ' ' ILE . 86.6 mmm -117.56 105.55 12.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.702 -0.851 . . . . 1.04 108.702 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.13 145.3 56.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.98 -0.554 . . . . 1.2 111.861 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 87.4 mttt -91.34 140.89 25.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.27 109.897 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.6 154.11 97.21 Favored 'Cis proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.567 -1.431 . . . . 0.88 112.472 2.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' ALA . . . . . 0.582 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 137.29 29.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.033 -0.531 . . . . 0.39000000000000001 110.216 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ASP . . . . . 0.477 ' O ' HG22 ' A' ' 110' ' ' VAL . 11.4 t70 -71.43 129.71 39.48 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.51000000000000001 108.468 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' THR . . . . . 0.431 HG23 ' HB3' ' A' ' 20' ' ' ASN . 17.9 p -67.18 -22.37 65.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.554 -0.748 . . . . 1.04 112.542 -170.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 91.6 p -71.19 -37.42 72.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.653 -0.499 . . . . 1.8899999999999999 109.653 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -63.4 -46.68 85.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.323 0.583 . . . . 0.62 109.556 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 106' ' ' ASP . 21.1 t -62.0 -44.88 99.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.991 -1.004 . . . . 1.04 110.62 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.46 -47.79 80.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 1.01 111.461 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 108' ' ' SER . 95.2 mttt -62.75 -44.76 95.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 2.4300000000000002 111.403 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 33.4 mmt180 -64.1 -32.72 74.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.104 0.478 . . . . 2.73 111.091 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.57 -47.9 44.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.088 0.47 . . . . 1.02 110.463 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LEU . . . . . 0.455 HD23 HG13 ' A' ' 52' ' ' VAL . 80.8 mt -69.75 -30.03 67.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.785 0.661 . . . . 1.04 112.785 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.96 -31.61 72.62 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.763 -0.375 . . . . 2.79 110.715 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' MET . . . . . 0.661 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 55.7 mtm -70.79 -32.3 69.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 1.0 110.802 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 42.0 t . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 1.95 110.486 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 112.388 -0.285 . . . . 9.2100000000000009 112.388 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.97 -9.55 15.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.409 . . . . 7.1500000000000004 110.408 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.5 mtp -85.0 -17.2 38.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.076 -0.511 . . . . 7.6699999999999999 110.32 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.07 -142.52 4.95 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.915 -0.874 . . . . 2.4399999999999999 110.915 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.16 123.3 71.88 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.637 0.256 . . . . 2.1800000000000002 111.063 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.57 145.83 59.45 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.455 2.77 . . . . 0.55000000000000004 111.689 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -89.73 106.73 18.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.94 0.4 . . . . 1.48 109.931 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.488 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 60.1 t -100.49 137.36 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.91 -0.586 . . . . 1.05 111.062 -175.435 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 47.3 tp -111.11 116.92 31.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.305 -0.407 . . . . 1.5 110.323 174.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 t -100.77 121.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.261 0.553 . . . . 1.03 111.362 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.528 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -101.89 104.11 14.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.937 -1.029 . . . . 1.05 108.658 172.915 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -161.21 113.47 1.87 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.903 -0.589 . . . . 1.4099999999999999 109.862 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.531 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 33.6 t70 -84.08 -12.56 54.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.086 -0.506 . . . . 1.27 109.865 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.28 100.37 1.38 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.347 -0.612 . . . . 2.5600000000000001 109.347 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.531 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.9 Cg_exo -60.18 -30.58 91.61 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.839 2.36 . . . . 0.35999999999999999 113.676 -171.353 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.62 -49.44 73.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.276 -0.638 . . . . 2.2799999999999998 109.276 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.97 -44.74 92.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.686 -0.688 . . . . 1.7 111.059 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.72 75.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 1.02 110.905 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.5 ttp -60.6 -42.66 97.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.923 -0.581 . . . . 1.28 110.871 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.423 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.0 m-80 -66.43 -40.3 89.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.027 -0.533 . . . . 1.3600000000000001 111.164 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.2 mt -62.98 -42.62 99.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.399 -0.364 . . . . 1.0700000000000001 110.443 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.46 ' CG ' ' HB ' ' A' ' 32' ' ' VAL . 1.5 tt0 -58.07 -50.95 71.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.166 -0.47 . . . . 1.7 109.809 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -56.07 -36.26 67.9 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.024 -0.535 . . . . 1.1799999999999999 111.109 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.6 45.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 1.05 111.105 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.533 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 45.9 m-85 -64.81 -43.4 93.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.246 -0.434 . . . . 0.16 110.699 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 47.4 mt-10 -61.89 -35.08 77.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.279 . . . . 0.68999999999999995 110.553 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -32.12 72.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.497 . . . . 0.51000000000000001 110.592 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.978 0.418 . . . . 0.65000000000000002 110.375 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.73 49.74 1.25 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.85 -0.613 . . . . 0.28999999999999998 112.232 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.43 ' O ' ' HA ' ' A' ' 26' ' ' GLU . . . -139.99 165.93 26.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.646 0.26 . . . . 1.03 111.254 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -108.67 142.87 38.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.818 -0.808 . . . . 2.1400000000000001 108.818 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.46 ' HB ' ' CG ' ' A' ' 22' ' ' GLN . 7.0 t -125.9 133.57 68.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.238 0.459 . . . . 1.0800000000000001 112.238 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.42 HG12 ' HG ' ' A' ' 44' ' ' SER . 27.5 t -104.26 124.61 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.844 -0.798 . . . . 1.05 108.844 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.49 121.63 49.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.915 0.388 . . . . 1.6499999999999999 110.824 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.439 ' HB2' ' HB2' ' A' ' 40' ' ' GLN . . . -130.57 134.24 46.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.958 -0.565 . . . . 1.03 110.369 178.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.66 21.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.059 -0.519 . . . . 1.04 110.8 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 p -128.86 158.85 37.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 1.0800000000000001 110.86 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.535 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.6 m -64.27 -32.92 74.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.943 -0.392 . . . . 1.6599999999999999 109.943 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.1 -46.39 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.142 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.439 ' HB2' ' HB2' ' A' ' 35' ' ' ALA . 36.0 mt-30 -60.31 -42.64 96.0 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.336 0.589 . . . . 1.4099999999999999 110.436 175.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.492 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -61.85 -52.58 63.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.107 -0.951 . . . . 1.04 111.732 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -63.87 -29.53 70.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.041 -0.527 . . . . 1.53 110.568 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.97 -50.57 61.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.195 -0.668 . . . . 2.9100000000000001 109.195 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.42 ' HG ' HG12 ' A' ' 33' ' ' VAL . 8.7 t -65.45 -31.79 73.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.235 -0.439 . . . . 1.6399999999999999 110.466 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -42.93 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.8400000000000001 110.544 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.74 20.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 1.1599999999999999 111.383 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.04 -37.36 58.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.62 111.45 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -123.89 161.07 48.77 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.163 -0.472 . . . . 0.47999999999999998 110.34 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -92.34 85.52 0.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.142 2.562 . . . . 0.31 111.363 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 40.2 mm -64.62 117.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.79 . . . . 1.03 111.507 -175.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.561 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.8 m-20 -83.67 -33.49 25.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.28999999999999998 110.265 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.8 p -160.58 155.38 3.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 1.03 109.574 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.438 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -136.3 166.92 22.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.312 0.577 . . . . 0.97999999999999998 111.266 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.444 HG22 HG13 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -141.17 120.75 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.682 -1.229 . . . . 1.5700000000000001 107.682 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.647 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -122.29 118.82 29.43 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.47 0.545 . . . . 1.02 112.47 -166.774 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.05 128.03 32.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.086 -0.709 . . . . 1.77 109.086 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.582 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 34.6 t -86.19 -22.52 7.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.655 -0.702 . . . . 1.3600000000000001 111.118 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -108.68 62.36 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.189 -0.46 . . . . 2.6400000000000001 110.639 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.0 -34.26 77.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.388 0.613 . . . . 1.3100000000000001 110.376 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.4 -173.84 36.63 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.87 111.384 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -36.22 91.14 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.038 2.492 . . . . 1.3899999999999999 112.655 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 1.3 tmtp? -119.67 -34.74 3.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.868 0.366 . . . . 4.0 110.185 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 p -69.51 127.46 33.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.593 0.711 . . . . 1.3700000000000001 111.472 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -145.36 150.14 36.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.261 -0.881 . . . . 0.58999999999999997 109.847 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 30.7 p -69.7 87.03 0.49 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.18 -0.674 . . . . 2.1899999999999999 109.18 171.008 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.33 -68.44 0.41 Allowed Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.384 -0.912 . . . . 0.28000000000000003 112.282 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.453 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 48.3 Cg_exo -52.95 -28.46 39.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.268 1.978 . . . . 0.28000000000000003 111.532 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.453 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.7 t -68.56 -49.12 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.407 0.622 . . . . 1.01 110.05 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.37 88.57 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.887 -1.051 . . . . 1.01 110.292 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.515 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 20.8 t70 -66.01 -40.18 90.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.567 -0.742 . . . . 2.0299999999999998 110.516 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.29 74.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.514 0.673 . . . . 1.0700000000000001 110.637 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.28 -44.12 80.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.015 -0.993 . . . . 1.05 110.373 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -57.88 -37.13 73.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 2.5800000000000001 111.413 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.515 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 77.4 mt-30 -61.8 -47.88 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 3.0299999999999998 111.23 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -90.9 5.62 47.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 1.95 111.582 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 31.29 19.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 1.1899999999999999 111.544 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.3 mt -81.49 131.48 58.2 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.627 -0.508 . . . . 1.05 109.627 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -72.95 143.14 36.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.293 1.996 . . . . 0.23000000000000001 112.208 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.438 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 23.9 p90 -160.9 158.5 28.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.761 -0.654 . . . . 0.23999999999999999 110.619 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.9 mt -123.6 138.23 54.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.329 -0.85 . . . . 1.0700000000000001 109.837 179.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.525 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 2.6 mm? -88.22 108.19 19.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.626 -0.509 . . . . 1.05 109.626 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.597 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 22.3 t-160 -102.22 84.22 2.45 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.375 -0.602 . . . . 0.59999999999999998 109.375 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.455 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 7.2 t -125.47 152.34 45.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.445 -0.798 . . . . 1.1399999999999999 111.242 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.04 -8.16 55.63 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.317 -0.713 . . . . 1.1000000000000001 111.317 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.435 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 2.7 m-20 -126.98 124.05 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.747 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.13 -51.97 2.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.048 -0.524 . . . . 2.1800000000000002 110.535 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.55 -26.31 68.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 2.6299999999999999 111.388 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.435 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 18.1 mmm180 -64.69 -20.03 66.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 5.1200000000000001 111.858 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -144.31 40.01 1.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 1.3500000000000001 111.319 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.37 -38.67 96.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.095 -0.574 . . . . 1.0600000000000001 112.783 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 6.2 pt-20 -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.449 . . . . 2.5 110.986 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.517 ' O ' HG13 ' A' ' 96' ' ' ILE . 18.9 tp -64.75 -46.97 79.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 1.22 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 36.0 mt -59.35 -38.26 79.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.588 -0.733 . . . . 2.1899999999999999 111.673 -178.115 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.598 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 10.9 ptt180 -67.69 -25.84 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 5.0 110.626 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.427 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 95.7 mttt -81.05 -37.71 28.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.131 0.491 . . . . 2.8999999999999999 110.278 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.517 HG13 ' O ' ' A' ' 92' ' ' LEU . 72.7 mt -65.01 -57.57 10.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 1.0800000000000001 110.455 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 57.03 76.54 0.31 Allowed 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.874 0.734 . . . . 1.0900000000000001 110.802 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.04 163.22 25.27 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.618 -0.719 . . . . 1.0800000000000001 109.726 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.09 140.85 86.33 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.933 2.422 . . . . 0.29999999999999999 112.151 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.525 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 1.1 m -127.64 149.64 32.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.191 0.52 . . . . 1.3 110.824 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.403 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 74.0 mmm -121.47 107.9 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 1.04 108.373 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -71.69 147.75 47.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.405 -0.361 . . . . 1.2 111.446 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.502 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.5 mttt -90.92 141.61 26.8 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.05 -0.523 . . . . 1.27 109.866 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -73.29 148.19 91.5 Favored 'Cis proline' 0 C--O 1.234 0.28 0 C-N-CA 123.477 -1.468 . . . . 0.88 112.849 2.073 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.597 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -144.78 136.25 25.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.416 -0.811 . . . . 0.39000000000000001 109.328 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.41 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.8 t70 -70.69 127.46 32.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.445 -0.946 . . . . 0.51000000000000001 108.445 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.423 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.4 p -62.56 -22.32 66.25 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.035 -0.984 . . . . 1.04 112.233 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.453 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 78.9 p -68.74 -42.26 77.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.82 -0.437 . . . . 1.8899999999999999 109.82 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.75 -38.64 87.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.091 0.472 . . . . 0.62 110.054 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.444 HG13 HG22 ' A' ' 54' ' ' VAL . 33.5 t -64.19 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.283 -0.871 . . . . 1.04 110.106 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.533 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -68.47 -47.83 66.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.629 -0.714 . . . . 1.01 111.468 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.569 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 7.5 mtmp? -56.35 -55.32 34.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 2.4300000000000002 111.174 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.423 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 35.6 mmt180 -62.1 -31.75 72.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.675 0.274 . . . . 2.73 111.578 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.85 70.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 1.02 110.188 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.452 HD22 HG13 ' A' ' 52' ' ' VAL . 84.3 mt -70.68 -26.29 63.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.141 -0.481 . . . . 1.04 111.695 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.569 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 8.0 mm-40 -60.64 -34.38 74.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 2.79 110.61 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 47.9 mtm -82.46 -13.62 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 1.0 110.597 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.561 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 53.1 t -86.6 -49.32 7.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.544 . . . . 1.95 110.748 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.75 158.76 12.26 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.583 -0.818 . . . . 2.5699999999999998 112.044 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -167.17 -79.15 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 111.344 -0.702 . . . . 4.4800000000000004 111.344 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -149.43 108.26 3.86 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.861 -0.422 . . . . 6.4199999999999999 109.861 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt 71.01 115.74 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.841 0.713 . . . . 9.5099999999999998 111.351 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -61.45 129.41 91.06 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.651 -0.704 . . . . 9.5999999999999996 110.413 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.59 62.52 7.13 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.484 2.122 . . . . 11.17 112.11 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.449 -0.786 . . . . 13.279999999999999 110.2 179.455 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.066 -0.414 . . . . 9.2100000000000009 112.066 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.78 141.52 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.262 0.625 . . . . 7.1500000000000004 111.386 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -72.98 128.88 36.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 7.6699999999999999 110.306 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.52 123.16 5.06 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.765 -0.731 . . . . 2.4399999999999999 111.708 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 64.7 mtt -75.94 134.9 71.09 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 120.539 0.209 . . . . 2.1800000000000002 110.936 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.517 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.2 Cg_endo -71.65 141.37 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.236 1.957 . . . . 0.55000000000000004 110.86 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -86.65 103.15 14.85 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.451 -0.574 . . . . 1.48 109.451 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.477 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.9 t -100.09 134.51 39.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.721 -0.672 . . . . 1.05 110.726 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 48.2 tp -111.54 113.44 25.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.863 0.363 . . . . 1.5 110.74 177.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -93.82 124.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.21 0.529 . . . . 1.03 111.599 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -105.59 101.37 10.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.057 -0.974 . . . . 1.05 108.921 173.673 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -159.5 129.52 5.59 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.805 -0.634 . . . . 1.4099999999999999 109.782 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.488 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 28.8 t70 -90.3 -20.4 22.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.325 -0.398 . . . . 1.27 110.499 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -84.86 107.82 12.94 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 109.308 -0.627 . . . . 2.5600000000000001 109.308 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 35.7 Cg_exo -57.96 -29.68 87.41 Favored 'Trans proline' 0 CA--C 1.517 -0.35 0 C-N-CA 122.723 2.282 . . . . 0.35999999999999999 112.264 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.97 -51.33 64.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.456 -0.572 . . . . 2.2799999999999998 109.456 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.25 -43.38 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 1.7 110.437 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.55 -49.69 76.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.886 -0.597 . . . . 1.02 110.925 179.381 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.6 -35.93 79.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.93 -0.577 . . . . 1.28 111.072 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.403 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.6 m-20 -66.02 -41.9 90.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.461 -0.336 . . . . 1.3600000000000001 110.748 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.43 -44.35 91.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.823 0.344 . . . . 1.0700000000000001 110.145 173.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.482 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 59.6 tt0 -52.71 -53.02 53.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 1.7 110.343 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.79 -29.37 70.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 1.1799999999999999 111.701 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.19 -46.22 61.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 1.05 110.76 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.4 m-85 -67.93 -41.66 82.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.107 -0.497 . . . . 0.16 110.599 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.79 -30.21 71.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.68999999999999995 110.728 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 110.374 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -82.49 8.17 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.65000000000000002 110.746 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.42 51.23 8.63 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.136 -0.554 . . . . 0.28999999999999998 112.448 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.517 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -132.64 164.86 25.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.862 0.363 . . . . 1.03 111.375 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -108.08 125.97 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.173 -0.677 . . . . 2.1400000000000001 109.173 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.482 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.9 t -114.07 140.72 33.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 112.509 0.559 . . . . 1.0800000000000001 112.509 -168.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 t -112.41 140.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.637 -0.875 . . . . 1.05 108.637 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.1 t -111.26 124.7 68.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.773 0.321 . . . . 1.6499999999999999 110.92 -178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB2' ' HB2' ' A' ' 40' ' ' GLN . . . -135.6 134.09 38.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.146 -0.479 . . . . 1.03 110.725 177.589 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.525 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.54 -3.23 28.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.019 0.438 . . . . 1.04 110.674 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -137.71 159.83 40.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 1.0800000000000001 110.719 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.633 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 87.6 m -60.32 -34.25 73.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.038 -0.528 . . . . 1.6599999999999999 110.208 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.14 -47.83 81.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.656 . . . . 0.69999999999999996 111.012 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.525 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 38.5 mt-30 -60.56 -37.98 83.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.374 0.607 . . . . 1.4099999999999999 110.696 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.481 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -65.78 -51.01 62.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.232 -0.894 . . . . 1.04 111.708 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.584 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.8 mt -60.88 -29.95 69.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.105 0.479 . . . . 1.53 110.472 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -64.85 -52.22 57.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.654 -0.703 . . . . 2.9100000000000001 110.158 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 t -67.71 -34.26 76.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.926 -0.579 . . . . 1.6399999999999999 110.304 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.43 HD22 HG13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -58.68 -42.0 87.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 1.8400000000000001 110.324 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.51 -33.92 28.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 1.1599999999999999 111.513 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.75 -37.49 27.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.62 111.623 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.95 164.6 20.18 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.849 0.357 . . . . 0.47999999999999998 110.873 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -95.05 86.96 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.47 2.78 . . . . 0.31 111.441 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.43 HG13 HD22 ' A' ' 45' ' ' LEU . 45.2 mm -65.39 123.34 18.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.664 -0.698 . . . . 1.03 111.252 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.495 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 45.8 m-20 -93.18 -27.26 16.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.28999999999999998 110.726 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.477 ' CG1' HG22 ' A' ' 8' ' ' VAL . 13.3 p -164.16 157.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.493 -0.558 . . . . 1.03 109.493 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.82 165.48 27.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 0.97999999999999998 112.006 -177.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.62 111.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.254 -0.884 . . . . 1.5700000000000001 109.165 176.277 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.549 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 8.8 mp -113.32 119.25 37.04 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.064 0.394 . . . . 1.02 112.064 -168.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -74.69 132.49 41.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.231 -1.025 . . . . 1.77 108.231 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.528 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 22.9 t -86.21 -10.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.386 0.612 . . . . 1.3600000000000001 110.029 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -129.2 73.27 1.51 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.814 -0.63 . . . . 2.6400000000000001 110.056 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.522 HD22 ' C ' ' A' ' 64' ' ' HIS . 4.0 mm? -56.28 -51.43 68.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.864 -0.607 . . . . 1.3100000000000001 109.711 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.61 -157.62 7.87 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.312 -0.858 . . . . 0.87 111.184 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -55.12 -45.1 43.21 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.727 2.285 . . . . 1.3899999999999999 112.567 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -119.82 -33.87 3.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 4.0 111.208 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' SER . . . . . 0.47 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 20.1 m -65.5 126.56 28.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.997 0.427 . . . . 1.3700000000000001 110.99 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.522 ' C ' HD22 ' A' ' 59' ' ' LEU . 11.1 p80 -144.86 163.26 34.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.96 -0.564 . . . . 0.58999999999999997 110.253 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.528 ' SG ' ' HA ' ' A' ' 57' ' ' VAL . 26.4 p -75.28 88.32 2.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.315 0.579 . . . . 2.1899999999999999 109.955 175.619 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 -77.81 1.01 Allowed Glycine 0 C--O 1.228 -0.27 0 C-N-CA 120.091 -1.052 . . . . 0.28000000000000003 111.979 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.633 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.6 Cg_exo -51.65 -24.76 18.3 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.024 2.482 . . . . 0.28000000000000003 112.749 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.52 HG21 ' SG ' ' A' ' 38' ' ' CYS . 13.8 t -67.37 -48.58 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 1.01 110.117 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -43.98 84.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.958 -1.019 . . . . 1.01 109.804 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.497 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 10.9 m-20 -64.63 -46.66 81.64 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.459 -0.792 . . . . 2.0299999999999998 110.519 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.53 -45.9 69.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.536 0.684 . . . . 1.0700000000000001 110.697 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.06 -46.89 72.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.952 -1.022 . . . . 1.05 110.404 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.442 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 24.4 mmtp -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.874 -0.603 . . . . 2.5800000000000001 111.977 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.497 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 80.6 mm-40 -69.7 -26.21 64.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.577 -0.283 . . . . 3.0299999999999998 111.405 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -106.95 8.79 30.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.663 0.268 . . . . 1.95 111.244 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.31 35.2 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.837 -0.619 . . . . 1.1899999999999999 111.705 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.3 mt -84.8 132.82 45.03 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 109.894 -0.41 . . . . 1.05 109.894 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.36 141.65 25.88 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.312 2.008 . . . . 0.23000000000000001 112.015 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 35.2 p90 -157.93 161.95 38.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.835 -0.62 . . . . 0.23999999999999999 110.735 179.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.61 141.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.25 -0.886 . . . . 1.0700000000000001 109.561 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.545 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.8 mm? -88.1 109.63 20.02 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 1.05 109.669 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.508 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 15.4 t-160 -101.35 77.62 1.8 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.816 0.817 . . . . 0.59999999999999998 109.188 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.495 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 10.2 t -115.0 158.28 22.29 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.501 -1.227 . . . . 1.1399999999999999 110.127 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.716 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -108.34 -3.26 33.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.22 -0.752 . . . . 1.1000000000000001 111.22 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.488 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 11.0 m-20 -126.22 66.6 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.304 0.573 . . . . 2.3300000000000001 110.075 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.04 -54.72 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.367 -0.833 . . . . 2.1800000000000002 111.129 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.52 -20.42 64.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.322 -0.399 . . . . 2.6299999999999999 111.401 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.488 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 1.1 mmp_? -74.16 -26.27 60.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.16 -0.473 . . . . 5.1200000000000001 110.927 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.431 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.6 m-70 -123.17 35.28 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 1.3500000000000001 111.174 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.408 ' HA2' HD13 ' A' ' 93' ' ' LEU . . . -59.67 -41.42 97.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.031 -0.604 . . . . 1.0600000000000001 113.01 -175.707 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.25 -37.8 81.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.656 0.265 . . . . 2.5 110.609 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.522 HD23 ' CG1' ' A' ' 57' ' ' VAL . 34.8 tp -68.43 -39.98 81.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 1.22 110.412 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.6 mt -58.96 -42.08 89.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 2.1899999999999999 110.729 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.91 -27.42 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 5.0 110.964 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.75 -42.29 50.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.012 -0.54 . . . . 2.8999999999999999 110.614 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 78.7 mt -67.76 -52.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.506 -0.77 . . . . 1.0800000000000001 111.18 -179.662 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 t70 61.26 77.49 0.33 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0900000000000001 111.037 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -163.89 163.42 15.78 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.717 . . . . 1.0800000000000001 109.896 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.517 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.8 Cg_exo -56.97 149.82 59.45 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.804 2.336 . . . . 0.29999999999999999 112.847 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.74 132.4 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 1.3 111.076 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.8 mmm -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.121 -0.696 . . . . 1.04 109.121 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.455 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.15 132.15 48.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 1.2 111.884 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.716 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 14.4 ptpt -97.2 150.33 36.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 1.27 110.051 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.625 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 32.8 Cg_exo -60.05 127.96 3.93 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.952 -1.27 . . . . 0.88 113.268 2.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.508 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -129.74 134.25 47.51 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.39000000000000001 109.253 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.474 ' O ' HG22 ' A' ' 110' ' ' VAL . 13.1 t70 -67.21 121.96 16.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.904 -0.776 . . . . 0.51000000000000001 108.904 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.403 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.5 p -62.13 -24.37 67.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.26 -0.882 . . . . 1.04 112.474 -170.759 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.403 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.798 -0.445 . . . . 1.8899999999999999 109.798 177.446 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.56 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 25.6 m-20 -69.17 -37.79 78.38 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.937 -0.574 . . . . 0.62 109.972 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.474 HG22 ' O ' ' A' ' 106' ' ' ASP . 34.0 t -64.31 -46.07 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.676 -0.693 . . . . 1.04 110.253 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -60.37 -48.69 80.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.584 -0.735 . . . . 1.01 111.571 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.689 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 59.6 mtpt -59.12 -55.03 40.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 2.4300000000000002 110.989 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.56 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 5.9 mpt_? -51.63 -43.14 62.49 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.028 0.381 . . . . 2.73 112.028 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.69 -50.33 69.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 1.02 110.725 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.441 HD22 HG12 ' A' ' 52' ' ' VAL . 81.1 mt -65.91 -26.3 67.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.509 . . . . 1.04 111.572 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.689 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 24.2 mm-40 -60.75 -43.43 97.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.678 0.275 . . . . 2.79 110.965 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.517 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 48.9 mtm -71.14 -29.78 65.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.962 0.411 . . . . 1.0 110.5 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.495 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 35.6 t -77.42 -54.04 6.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.787 -0.642 . . . . 1.95 110.691 -178.421 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.83 67.05 0.13 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.924 -0.655 . . . . 2.5699999999999998 112.224 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -82.86 -73.34 1.24 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.895 -0.669 . . . . 4.4800000000000004 112.215 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.01 17.44 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.109 0.48 . . . . 6.4199999999999999 110.858 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -143.19 120.87 11.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.767 -0.651 . . . . 9.5099999999999998 110.535 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -79.38 127.85 77.34 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.576 -0.528 . . . . 9.5999999999999996 109.576 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.74 140.17 50.36 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.402 2.068 . . . . 11.17 112.119 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.423 -0.799 . . . . 13.279999999999999 110.753 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.982 -0.447 . . . . 9.2100000000000009 111.982 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.94 45.19 2.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.101 0.477 . . . . 7.1500000000000004 111.042 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.404 ' HE3' ' O ' ' A' ' 5' ' ' MET . 38.4 ttp -74.11 164.39 26.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.516 . . . . 7.6699999999999999 109.644 176.539 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.43 -70.69 0.8 Allowed Glycine 0 CA--C 1.511 -0.16 0 O-C-N 123.488 0.493 . . . . 2.4399999999999999 112.433 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.404 ' O ' ' HE3' ' A' ' 3' ' ' MET . 79.5 mtp -102.77 119.98 54.08 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.57 -0.53 . . . . 2.1800000000000002 109.57 174.669 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.42 136.26 66.6 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.939 2.426 . . . . 0.55000000000000004 111.989 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -82.86 104.54 13.16 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.312 -0.625 . . . . 1.48 109.312 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 49.9 t -100.02 135.1 37.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.514 -0.766 . . . . 1.05 110.559 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 46.4 tp -111.99 111.84 23.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 1.5 110.644 177.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -93.65 121.78 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.369 0.604 . . . . 1.03 111.332 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.38 106.79 17.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 1.05 108.857 172.618 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -165.36 125.15 1.8 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 109.663 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.9 -26.5 34.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.863 -0.608 . . . . 1.27 109.607 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -78.71 108.65 8.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.68 -0.691 . . . . 2.5600000000000001 110.59 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.19 -35.09 98.26 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.026 2.484 . . . . 0.35999999999999999 112.949 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.88 -48.81 75.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.35 . . . . 2.2799999999999998 110.278 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.5 -45.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 1.7 110.541 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.93 78.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.848 -0.614 . . . . 1.02 110.902 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.21 -40.2 93.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.959 -0.564 . . . . 1.28 111.08 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.456 ' HB3' HG22 ' A' ' 107' ' ' THR . 5.5 m-20 -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 1.3600000000000001 110.797 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.72 -44.91 96.0 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.806 0.336 . . . . 1.0700000000000001 110.368 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.468 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.4 tt0 -53.32 -49.88 66.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.526 -0.761 . . . . 1.7 110.43 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -58.86 -37.85 77.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.318 -0.401 . . . . 1.1799999999999999 111.466 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.39 -46.09 70.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 1.05 110.889 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.587 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 66.1 m-85 -67.55 -43.8 79.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 0.16 110.938 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -59.78 -35.12 73.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.68999999999999995 110.675 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.14 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.51000000000000001 110.767 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.12 -10.54 59.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.65000000000000002 110.979 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.4 49.34 2.21 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.837 -0.697 . . . . 0.28999999999999998 112.279 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.09 163.69 29.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.357 -0.238 . . . . 1.03 110.357 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -110.0 123.69 50.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.605 -0.517 . . . . 2.1400000000000001 109.605 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.468 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.2 t -106.65 138.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.526 0.565 . . . . 1.0800000000000001 112.526 -168.19 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.61 133.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.377 -0.971 . . . . 1.05 108.377 170.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.18 130.79 58.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.77 0.319 . . . . 1.6499999999999999 111.025 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.76 144.36 35.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 1.03 110.367 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.79 16.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.572 -0.285 . . . . 1.04 111.432 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.723 ' HG1' ' NE2' ' A' ' 40' ' ' GLN . 29.9 p -134.18 176.6 8.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.086 -0.246 . . . . 1.0800000000000001 110.677 -176.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.647 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 1.5 p -68.37 -48.08 65.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.755 -0.461 . . . . 1.6599999999999999 109.755 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.25 -50.2 74.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.439 -0.801 . . . . 0.69999999999999996 111.779 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.723 ' NE2' ' HG1' ' A' ' 37' ' ' THR . 1.3 mp0 -58.69 -37.81 76.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.893 0.378 . . . . 1.4099999999999999 111.582 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.511 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -70.93 -49.46 45.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.259 -0.428 . . . . 1.04 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.647 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 73.7 mt -61.63 -26.27 67.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.619 -0.718 . . . . 1.53 110.502 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -62.74 -56.7 15.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 2.9100000000000001 110.309 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 28.8 t -70.32 -17.8 63.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.462 -0.336 . . . . 1.6399999999999999 111.094 179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -68.32 -41.48 80.79 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.259 -0.645 . . . . 1.8400000000000001 109.259 175.918 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.22 12.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.48 . . . . 1.1599999999999999 111.209 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.86 -37.19 73.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.037 -0.528 . . . . 0.62 111.619 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.403 ' HA ' ' HD3' ' A' ' 49' ' ' PRO . 91.1 m-20 -114.57 150.04 43.24 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.47999999999999998 110.863 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 73.0 Cg_endo -86.21 81.14 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.322 2.682 . . . . 0.31 111.767 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 44.1 mm -62.72 123.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.38 -0.827 . . . . 1.03 111.51 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.408 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.4 m-20 -90.66 -37.79 13.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.633 -0.712 . . . . 0.28999999999999998 110.063 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.543 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 11.3 p -157.35 155.66 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.761 -0.654 . . . . 1.03 109.619 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.78 162.62 35.0 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.431 0.634 . . . . 0.97999999999999998 112.063 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -134.72 111.69 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.092 -0.958 . . . . 1.5700000000000001 109.053 175.36 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.764 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.6 mp -112.96 114.99 27.71 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.238 0.458 . . . . 1.02 112.238 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.523 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 27.5 t70 -77.46 123.38 26.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.576 -0.898 . . . . 1.77 108.576 168.143 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.488 ' CG1' HD22 ' A' ' 92' ' ' LEU . 20.2 t -88.3 -10.8 10.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.876 -0.602 . . . . 1.3600000000000001 110.363 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.7 56.28 0.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.824 -0.625 . . . . 2.6400000000000001 109.967 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.15 -26.82 67.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.744 -0.662 . . . . 1.3100000000000001 109.917 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.29 -168.43 31.27 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.57 -1.012 . . . . 0.87 110.57 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.62 -43.1 62.15 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.662 2.241 . . . . 1.3899999999999999 111.737 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -115.26 -33.28 5.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 4.0 110.755 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -58.05 123.52 16.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.265 0.555 . . . . 1.3700000000000001 111.253 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -144.59 149.97 36.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.513 -0.767 . . . . 0.58999999999999997 110.268 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.764 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -73.38 86.03 1.49 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.208 -0.664 . . . . 2.1899999999999999 109.208 171.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.82 -71.57 0.81 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.396 -0.907 . . . . 0.28000000000000003 112.264 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -54.1 -25.77 38.71 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.54 2.16 . . . . 0.28000000000000003 111.926 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.472 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.6 t -69.17 -48.25 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.061 -0.518 . . . . 1.01 110.165 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.47 86.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.242 -0.89 . . . . 1.01 109.906 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.626 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 35.2 t70 -61.87 -42.94 99.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.207 -0.906 . . . . 2.0299999999999998 110.44 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.33 -46.63 79.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.448 0.642 . . . . 1.0700000000000001 110.903 178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.48 -46.38 83.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 1.05 110.188 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.433 ' HD2' ' HA ' ' A' ' 73' ' ' LYS . 11.1 mmmm -58.85 -33.85 70.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.612 -0.722 . . . . 2.5800000000000001 111.486 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.626 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 99.0 mt-30 -57.84 -47.85 81.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 3.0299999999999998 110.979 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -92.15 6.41 46.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.196 -0.456 . . . . 1.95 110.939 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.15 31.84 21.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 1.1899999999999999 111.343 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -75.63 135.24 71.86 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.685 -0.487 . . . . 1.05 109.685 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.401 ' CG ' ' HB2' ' A' ' 118' ' ' CYS . 30.2 Cg_endo -75.56 138.65 21.97 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.132 1.888 . . . . 0.23000000000000001 111.687 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -157.19 159.32 37.6 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.573 -0.739 . . . . 0.23999999999999999 110.285 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mt -122.91 139.25 50.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.67 -0.695 . . . . 1.0700000000000001 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.84 108.37 19.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.611 -0.514 . . . . 1.05 109.611 178.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.623 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 21.4 t-160 -103.0 71.8 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.775 -0.824 . . . . 0.59999999999999998 108.775 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.523 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 4.9 t -100.87 153.99 19.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.693 -1.14 . . . . 1.1399999999999999 111.99 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -91.95 -6.58 65.12 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.59 -0.732 . . . . 1.1000000000000001 112.348 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 2.3300000000000001 110.762 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.17 -4.35 11.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.894 -0.594 . . . . 2.1800000000000002 109.852 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.39 -59.82 2.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 2.6299999999999999 111.19 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -70.96 -41.55 70.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.389 0.614 . . . . 5.1200000000000001 110.781 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.527 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.2 m-70 -87.58 14.57 8.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.46 -0.791 . . . . 1.3500000000000001 110.732 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.484 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -57.56 -49.92 69.53 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.441 -0.409 . . . . 1.0600000000000001 113.332 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.29 -40.04 96.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 2.5 110.332 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.488 HD22 ' CG1' ' A' ' 57' ' ' VAL . 33.1 tp -59.67 -42.61 93.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 1.22 110.303 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.527 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.4 mt -60.39 -35.45 75.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 2.1899999999999999 111.336 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 19.1 mmm180 -71.44 -27.42 63.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.095 0.474 . . . . 5.0 110.904 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.22 -33.44 63.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.831 -0.622 . . . . 2.8999999999999999 109.955 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.438 HG13 ' O ' ' A' ' 92' ' ' LEU . 81.3 mt -71.42 -56.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.324 -0.853 . . . . 1.0800000000000001 110.999 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 59.97 78.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.536 0.684 . . . . 1.0900000000000001 110.879 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -161.11 163.14 21.06 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 1.0800000000000001 109.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.23 141.44 96.68 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.589 2.193 . . . . 0.29999999999999999 112.437 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -119.7 133.66 65.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.14 0.495 . . . . 1.3 111.274 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.44 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.8 mmm -118.94 91.28 3.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.712 -0.847 . . . . 1.04 108.712 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.462 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.31 154.1 36.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.895 -0.593 . . . . 1.2 111.735 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 96.4 mttt -90.75 143.84 29.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 1.27 109.747 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 140.4 66.03 Favored 'Cis proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.561 -1.433 . . . . 0.88 112.607 2.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.623 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -137.16 129.46 29.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.807 -0.633 . . . . 0.39000000000000001 110.273 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.506 ' O ' HG21 ' A' ' 110' ' ' VAL . 10.3 t70 -72.28 129.69 39.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.966 -0.753 . . . . 0.51000000000000001 108.966 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.456 HG22 ' HB3' ' A' ' 20' ' ' ASN . 21.3 p -63.46 -22.67 67.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.271 -0.877 . . . . 1.04 112.542 -171.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.438 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.6 p -68.77 -42.9 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 1.8899999999999999 109.927 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.562 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 45.4 m-20 -68.18 -41.26 81.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.62 109.548 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.506 HG21 ' O ' ' A' ' 106' ' ' ASP . 24.7 t -61.86 -44.59 99.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.556 -0.747 . . . . 1.04 110.519 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.587 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.15 -50.59 65.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 1.01 111.637 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.438 ' HG3' ' O ' ' A' ' 108' ' ' SER . 30.6 mtpp -64.25 -40.67 96.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 2.4300000000000002 111.61 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.562 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 10.2 mpt_? -63.55 -32.1 73.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.886 0.374 . . . . 2.73 111.77 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.55 -51.33 10.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 1.02 111.053 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.498 HD21 HG11 ' A' ' 52' ' ' VAL . 64.4 mt -63.5 -26.01 68.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.107 0.78 . . . . 1.04 113.107 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -25.78 62.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.62 -0.432 . . . . 2.79 110.914 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.6 mtm -71.61 -25.68 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 1.0 111.161 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.408 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 45.2 t -151.43 67.96 0.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 1.95 110.974 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -112.61 -5.41 24.23 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.035 -0.826 . . . . 2.5699999999999998 111.035 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.69 -33.53 4.24 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.132 -0.556 . . . . 4.4800000000000004 111.726 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.04 103.45 8.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.831 0.348 . . . . 6.4199999999999999 110.542 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -106.18 150.04 26.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.108 -0.496 . . . . 9.5099999999999998 110.321 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.24 115.59 61.9 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.035 -0.529 . . . . 9.5999999999999996 111.021 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.42 171.59 9.85 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.709 2.273 . . . . 11.17 111.782 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.559 -0.734 . . . . 13.279999999999999 110.514 178.494 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 112.053 -0.419 . . . . 9.2100000000000009 112.053 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.38 102.56 3.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.789 0.328 . . . . 7.1500000000000004 111.047 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 ttt -103.02 -21.17 13.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.323 0.583 . . . . 7.6699999999999999 110.548 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.31 -35.95 5.57 Favored Glycine 0 CA--C 1.509 -0.303 0 N-CA-C 111.362 -0.695 . . . . 2.4399999999999999 111.362 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 80.2 mtp -92.24 130.98 35.94 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.183 -0.673 . . . . 2.1800000000000002 109.183 175.175 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 33.6 Cg_exo -59.53 134.79 60.38 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.479 2.119 . . . . 0.55000000000000004 111.823 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.461 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 14.4 tptp -83.64 103.81 13.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.326 -0.62 . . . . 1.48 109.326 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.525 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.3 t -99.5 130.47 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.815 -0.63 . . . . 1.05 110.779 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.9 tp -106.04 112.46 25.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.852 -0.613 . . . . 1.5 110.295 178.039 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -92.97 122.8 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.077 0.465 . . . . 1.03 111.613 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.523 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -103.44 101.04 10.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.284 -0.871 . . . . 1.05 109.284 173.274 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.24 127.18 5.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.448 -0.796 . . . . 1.4099999999999999 109.8 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -89.41 -16.56 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.78 -0.645 . . . . 1.27 110.125 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -88.36 108.39 21.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 2.5600000000000001 110.301 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.93 -34.94 99.33 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.748 2.299 . . . . 0.35999999999999999 112.982 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.457 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 59.8 tp -62.94 -49.7 73.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 2.2799999999999998 110.513 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.95 -45.32 97.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 1.7 110.624 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.54 -52.21 66.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 1.02 110.784 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.432 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 36.7 ttp -62.55 -37.29 85.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 1.28 111.008 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' HB3' HG22 ' A' ' 107' ' ' THR . 8.0 t-20 -65.69 -47.8 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.3600000000000001 110.501 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 53.1 mt -60.26 -45.56 92.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.936 -0.575 . . . . 1.0700000000000001 109.888 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.527 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 57.7 tt0 -51.8 -50.42 60.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.131 -0.941 . . . . 1.7 111.063 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 17.5 m-85 -67.17 -32.38 73.43 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.139 -0.224 . . . . 1.1799999999999999 111.249 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.85 85.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.84 0.353 . . . . 1.05 110.827 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.594 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -68.08 -45.76 72.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.46 . . . . 0.16 110.644 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.425 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 45.8 mt-10 -61.9 -30.19 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.474 -0.33 . . . . 0.68999999999999995 110.765 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.01 -41.56 95.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.149 -0.478 . . . . 0.51000000000000001 110.549 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -74.71 -15.62 60.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 0.65000000000000002 110.84 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.76 44.92 1.46 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.833 -0.699 . . . . 0.28999999999999998 112.559 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.437 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -134.21 153.62 51.74 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.771 -0.253 . . . . 1.03 110.437 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.28 142.49 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.527 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 44.4 t -123.72 143.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.48 0.548 . . . . 1.0800000000000001 112.48 -170.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.492 HG11 ' OG ' ' A' ' 44' ' ' SER . 14.9 t -118.44 132.28 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.758 . . . . 1.05 108.955 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 12.7 p -96.56 130.39 45.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.028 0.442 . . . . 1.6499999999999999 111.601 179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.425 ' HB1' ' CB ' ' A' ' 40' ' ' GLN . . . -142.23 134.63 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 1.03 110.701 174.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.14 17.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 1.04 111.003 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.0 p -124.79 162.05 25.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.114 -0.494 . . . . 1.0800000000000001 110.648 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.676 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 67.1 m -66.32 -33.67 76.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.56 -0.533 . . . . 1.6599999999999999 109.56 175.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.27 -48.4 78.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.513 -0.767 . . . . 0.69999999999999996 111.045 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.425 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 38.9 mt-30 -58.28 -42.09 85.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.243 0.544 . . . . 1.4099999999999999 110.574 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.478 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -61.3 -53.01 62.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.142 -0.935 . . . . 1.04 111.522 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.589 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 86.9 mt -61.54 -28.68 69.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.071 0.462 . . . . 1.53 110.96 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.55 -53.47 22.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 2.9100000000000001 109.748 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.492 ' OG ' HG11 ' A' ' 33' ' ' VAL . 22.7 t -65.95 -34.77 78.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.6399999999999999 110.372 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.51 -35.56 78.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 1.8400000000000001 110.776 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.52 -33.84 28.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.378 -0.374 . . . . 1.1599999999999999 111.118 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.43 -38.12 35.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.62 111.611 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -114.94 163.55 19.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.46 . . . . 0.47999999999999998 110.753 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.65 83.03 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.434 2.756 . . . . 0.31 111.309 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.461 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 37.1 mm -65.74 122.21 16.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.562 -0.745 . . . . 1.03 111.754 -174.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.757 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 32.5 m-20 -91.09 -32.47 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.115 -0.948 . . . . 0.28999999999999998 110.771 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.525 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.4 p -160.2 158.3 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 1.03 109.836 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.19 161.09 39.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.156 0.503 . . . . 0.97999999999999998 111.907 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -132.09 112.41 19.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.7 . . . . 1.5700000000000001 109.682 174.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.782 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -112.47 121.8 45.86 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.23 -0.441 . . . . 1.02 112.083 -170.053 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.675 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.8 t0 -81.66 114.98 20.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.86 -0.792 . . . . 1.77 108.86 168.94 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.48 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 17.2 t -76.53 -7.91 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.038 -0.983 . . . . 1.3600000000000001 110.43 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.13 65.93 1.21 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 2.6400000000000001 109.778 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.08 -29.5 70.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.581 -0.736 . . . . 1.3100000000000001 109.621 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 -162.54 12.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.151 -0.931 . . . . 0.87 111.09 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.0 -38.76 93.19 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.89 2.393 . . . . 1.3899999999999999 112.676 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.492 ' HB2' ' HZ3' ' A' ' 62' ' ' LYS . 4.5 ttmp? -126.35 -34.43 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.468 -0.333 . . . . 4.0 110.792 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 p -60.48 127.61 32.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.476 0.655 . . . . 1.3700000000000001 111.054 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -144.29 156.02 44.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.412 -0.813 . . . . 0.58999999999999997 110.8 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.782 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.8 p -70.49 86.79 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.894 -0.78 . . . . 2.1899999999999999 108.894 168.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.16 -74.82 1.04 Allowed Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 120.191 -1.004 . . . . 0.28000000000000003 112.374 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.676 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.9 Cg_exo -53.37 -26.19 34.22 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.488 2.125 . . . . 0.28000000000000003 111.981 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.496 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 10.7 t -69.33 -44.79 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 1.01 110.381 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -52.69 64.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.828 . . . . 1.01 109.956 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.5 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 33.3 t70 -60.99 -38.18 85.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.107 -0.951 . . . . 2.0299999999999998 110.495 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.1 78.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.355 0.597 . . . . 1.0700000000000001 111.03 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.38 -39.7 85.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.402 -0.817 . . . . 1.05 110.095 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -59.55 -39.03 82.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.622 -0.717 . . . . 2.5800000000000001 111.171 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.5 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 55.0 mt-30 -65.56 -43.18 90.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 3.0299999999999998 111.216 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -87.85 2.18 52.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.828 0.347 . . . . 1.95 110.813 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.01 31.22 19.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.538 -0.756 . . . . 1.1899999999999999 111.454 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.99 131.9 49.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 1.05 109.775 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 25.6 Cg_endo -73.7 138.47 26.51 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.166 1.911 . . . . 0.23000000000000001 111.62 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.02 157.39 34.59 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.609 -0.723 . . . . 0.23999999999999999 110.387 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.7 mt -122.31 141.06 44.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.609 -0.723 . . . . 1.0700000000000001 109.888 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.2 mm? -89.33 108.23 19.51 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.78 -0.452 . . . . 1.05 109.78 179.025 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.605 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 20.6 t-160 -103.02 72.28 1.17 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.512 -0.921 . . . . 0.59999999999999998 108.512 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.675 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 10.2 t -99.77 155.01 17.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.276 -1.329 . . . . 1.1399999999999999 111.784 -170.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.403 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 0.9 59.39 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.734 -0.666 . . . . 1.1000000000000001 112.898 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -154.78 121.08 5.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 2.3300000000000001 110.258 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' N ' HD13 ' A' ' 86' ' ' LEU . 6.3 mp -106.47 -22.89 12.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.183 -0.462 . . . . 2.1800000000000002 111.606 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -83.87 -30.65 26.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.9 -0.32 . . . . 2.6299999999999999 111.213 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -79.85 -10.08 59.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.348 0.594 . . . . 5.1200000000000001 110.348 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.525 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 99.5 m-70 -131.35 24.11 4.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 1.3500000000000001 111.225 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.73 -42.01 98.75 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.851 -0.69 . . . . 1.0600000000000001 112.879 -175.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.624 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 33.1 mt-10 -71.66 -25.37 62.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 2.5 110.369 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.477 HD21 ' CG1' ' A' ' 57' ' ' VAL . 55.5 tp -74.53 -43.59 55.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.207 -0.451 . . . . 1.22 110.224 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.525 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.1 mt -58.38 -37.7 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 2.1899999999999999 111.834 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.624 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 36.5 ptt180 -65.24 -26.57 68.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 5.0 110.912 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -76.12 -35.27 59.36 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.157 0.503 . . . . 2.8999999999999999 110.136 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 55.8 mt -69.9 -52.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.228 -0.897 . . . . 1.0800000000000001 110.445 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 55.51 70.37 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.465 0.65 . . . . 1.0900000000000001 110.579 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -155.96 162.38 27.54 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.368 -0.833 . . . . 1.0800000000000001 109.349 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.24 141.22 94.53 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.666 2.244 . . . . 0.29999999999999999 112.62 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.7 t -118.62 134.68 61.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 1.3 111.289 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.442 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 78.6 mmm -119.44 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.656 -0.868 . . . . 1.04 108.656 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.49 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.69 152.53 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.018 -0.537 . . . . 1.2 111.691 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 95.8 mttt -90.29 144.81 31.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.723 -0.671 . . . . 1.27 109.844 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.6 Cg_exo -71.12 142.15 71.92 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.561 -1.433 . . . . 0.88 112.433 0.697 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.605 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -139.83 130.18 25.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.83 -0.623 . . . . 0.39000000000000001 110.266 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.597 ' O ' HG21 ' A' ' 110' ' ' VAL . 13.8 t70 -66.11 124.31 22.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.51000000000000001 109.404 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.541 HG22 ' HB3' ' A' ' 20' ' ' ASN . 21.4 p -62.56 -27.63 69.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.432 -0.803 . . . . 1.04 112.238 -172.277 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 t -70.02 -40.1 75.41 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.615 -0.513 . . . . 1.8899999999999999 109.615 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.489 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -65.27 -43.98 89.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.086 0.469 . . . . 0.62 109.803 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.597 HG21 ' O ' ' A' ' 106' ' ' ASP . 23.4 t -60.75 -43.7 95.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.307 -0.86 . . . . 1.04 110.428 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.594 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.46 -50.53 67.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 1.01 111.171 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.609 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 54.9 mtpt -56.33 -55.53 32.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 2.4300000000000002 111.341 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.489 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 35.5 mmt180 -60.03 -35.46 75.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 2.73 111.374 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.31 47.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.509 . . . . 1.02 110.541 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.469 HD22 HG12 ' A' ' 52' ' ' VAL . 80.7 mt -63.52 -25.5 68.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.631 . . . . 1.04 111.848 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.609 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 35.0 mm-40 -60.42 -26.53 66.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.694 0.283 . . . . 2.79 111.236 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 67.9 mtm -85.81 -1.67 57.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.49 -0.323 . . . . 1.0 111.369 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 49.2 t -135.59 73.63 1.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.167 0.508 . . . . 1.95 110.044 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.26 31.19 7.34 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.702 -0.761 . . . . 2.5699999999999998 112.371 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -107.76 42.79 1.84 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.929 -0.653 . . . . 4.4800000000000004 112.005 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.1 t70 73.3 154.51 0.15 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.471 0.708 . . . . 6.4199999999999999 110.933 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 57.3 tttp 63.45 63.84 0.85 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.326 0.584 . . . . 9.5099999999999998 110.375 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -78.07 122.52 85.49 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.743 -0.662 . . . . 9.5999999999999996 110.359 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.53 159.02 54.24 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.505 2.136 . . . . 11.17 112.136 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.544 -0.741 . . . . 13.279999999999999 110.697 -178.437 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.833 -0.507 . . . . 9.2100000000000009 111.833 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.56 138.6 56.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.835 0.35 . . . . 7.1500000000000004 110.669 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.3 ttt -66.48 -27.37 67.74 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.668 -0.696 . . . . 7.6699999999999999 110.887 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.72 -139.71 3.49 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.791 -0.923 . . . . 2.4399999999999999 110.791 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 90.8 mtp -114.32 119.79 39.52 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 110.032 -0.359 . . . . 2.1800000000000002 110.032 176.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.24 137.73 44.66 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.165 2.577 . . . . 0.55000000000000004 111.928 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.436 ' HZ3' ' HB2' ' A' ' 7' ' ' LYS . 0.5 OUTLIER -84.97 107.3 17.04 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.342 -0.614 . . . . 1.48 109.342 176.916 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.475 HG21 ' CG1' ' A' ' 52' ' ' VAL . 47.1 t -100.09 138.86 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 1.05 110.809 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.417 HD22 ' HB3' ' A' ' 41' ' ' ALA . 48.3 tp -111.23 115.66 29.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.398 -0.365 . . . . 1.5 110.276 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.17 123.47 51.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.231 0.539 . . . . 1.03 111.024 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.522 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 0.8 OUTLIER -103.78 106.01 16.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.214 -0.903 . . . . 1.05 109.326 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -168.34 123.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.044 -0.526 . . . . 1.4099999999999999 109.761 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.481 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.5 t70 -87.1 -19.99 27.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.661 . . . . 1.27 110.1 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 44.5 mm-40 -81.22 104.86 3.25 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 115.878 -0.601 . . . . 2.5600000000000001 109.963 175.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.481 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.0 Cg_exo -58.07 -29.5 87.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.919 2.413 . . . . 0.35999999999999999 113.427 -172.772 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt -69.61 -50.74 41.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.879 -0.415 . . . . 2.2799999999999998 109.879 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.424 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -63.3 -44.08 98.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.7 109.736 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.64 -49.17 78.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.359 -0.837 . . . . 1.02 110.557 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.0 ttp -59.33 -42.27 91.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.797 -0.638 . . . . 1.28 111.068 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HG21 ' A' ' 107' ' ' THR . 0.7 OUTLIER -64.38 -47.55 78.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 1.3600000000000001 111.083 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.9 mt -60.11 -46.1 90.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.39 -0.368 . . . . 1.0700000000000001 110.449 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.495 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 49.3 tt0 -54.47 -51.03 66.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.818 -0.628 . . . . 1.7 110.917 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.857 -0.337 . . . . 1.1799999999999999 110.887 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.68 -46.32 72.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.941 0.401 . . . . 1.05 110.277 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.515 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 m-85 -66.9 -44.03 81.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.16 110.803 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.02 -28.04 67.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.537 -0.301 . . . . 0.68999999999999995 111.015 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.32 -27.81 65.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.314 0.578 . . . . 0.51000000000000001 109.983 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -84.71 2.45 41.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.67 . . . . 0.65000000000000002 111.05 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 81.92 47.15 6.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.922 -0.656 . . . . 0.28999999999999998 112.632 178.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.98 8.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.633 0.254 . . . . 1.03 110.363 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.82 134.29 55.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.514 -0.55 . . . . 2.1400000000000001 109.514 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.495 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -116.07 135.79 55.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.319 0.489 . . . . 1.0800000000000001 112.319 -168.816 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.46 122.74 63.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 1.05 107.925 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.57 124.73 55.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.721 -0.392 . . . . 1.6499999999999999 110.697 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.503 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -130.11 139.31 50.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.934 -0.576 . . . . 1.03 110.702 -179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.83 -11.35 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 1.04 111.252 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -130.68 170.53 14.19 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.954 -0.298 . . . . 1.0800000000000001 111.492 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.545 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.2 p -60.84 -49.47 77.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.6599999999999999 109.646 171.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -52.24 -50.01 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.667 -1.151 . . . . 0.69999999999999996 111.764 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.503 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 75.6 mt-30 -59.81 -37.02 77.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 1.4099999999999999 111.187 178.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.451 ' HB2' HD23 ' A' ' 11' ' ' LEU . . . -71.38 -49.46 41.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.67 -0.695 . . . . 1.04 111.225 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.545 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 72.8 mt -63.5 -28.98 70.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.731 -0.668 . . . . 1.53 110.158 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.412 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 7.5 tmtm? -63.93 -50.69 67.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.385 -0.598 . . . . 2.9100000000000001 109.385 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 t -64.65 -32.02 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.219 -0.446 . . . . 1.6399999999999999 110.878 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 -41.81 89.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.123 0.487 . . . . 1.8400000000000001 110.376 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.19 -38.26 20.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 1.1599999999999999 111.54 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.33 -36.47 58.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.065 -0.516 . . . . 0.62 111.408 -174.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -122.16 162.11 39.23 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.345 -0.389 . . . . 0.47999999999999998 110.428 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -92.82 88.24 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.303 2.669 . . . . 0.31 111.149 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mm -67.4 119.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.715 -0.675 . . . . 1.03 111.52 -174.592 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -91.06 -30.75 16.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.924 -0.58 . . . . 0.28999999999999998 110.197 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.475 ' CG1' HG21 ' A' ' 8' ' ' VAL . 12.0 p -160.88 157.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.731 . . . . 1.03 109.409 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.45 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -140.84 166.02 25.92 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.456 0.646 . . . . 0.97999999999999998 111.239 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -137.9 120.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.747 -1.205 . . . . 1.5700000000000001 107.747 174.301 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.505 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.9 mp -116.36 109.17 16.99 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.729 -0.388 . . . . 1.02 111.301 -170.272 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.772 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -80.67 97.78 7.41 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.8 -0.815 . . . . 1.77 108.8 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.406 ' O ' ' HA ' ' A' ' 64' ' ' HIS . 46.8 t -50.71 -31.18 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.212 -0.904 . . . . 1.3600000000000001 112.44 -170.815 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -95.75 80.08 3.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.934 0.397 . . . . 2.6400000000000001 110.392 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.83 -14.45 59.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.563 0.697 . . . . 1.3100000000000001 110.09 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.88 -166.27 35.82 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.754 -0.938 . . . . 0.87 110.754 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.71 -45.36 41.64 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.916 2.411 . . . . 1.3899999999999999 112.311 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -120.85 -22.14 6.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.371 -0.377 . . . . 4.0 110.812 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.7 m -63.4 129.12 38.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.112 0.482 . . . . 1.3700000000000001 111.147 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . 0.406 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 15.5 p80 -144.0 153.27 42.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.58999999999999997 110.282 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.5 m -79.1 86.44 4.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.827 -0.805 . . . . 2.1899999999999999 108.827 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.55 -66.47 0.7 Allowed Glycine 0 C--N 1.328 0.132 0 C-N-CA 120.62 -0.8 . . . . 0.28000000000000003 112.392 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.67 -23.76 50.87 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.396 2.064 . . . . 0.28000000000000003 111.621 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.467 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.5 t -68.17 -47.74 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.96 -0.564 . . . . 1.01 109.774 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.408 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.06 -47.73 80.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.99 -1.005 . . . . 1.01 110.087 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.419 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 19.3 t70 -64.09 -36.41 83.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 2.0299999999999998 110.571 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -62.93 -40.48 97.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.409 0.623 . . . . 1.0700000000000001 110.888 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.69 -43.87 62.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 1.05 110.529 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.408 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 28.2 mmmt -57.33 -39.58 76.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.565 -0.743 . . . . 2.5800000000000001 111.166 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.667 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 6.8 pt20 -64.88 -37.76 88.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.533 -0.758 . . . . 3.0299999999999998 110.957 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.495 ' HG3' ' CG ' ' A' ' 74' ' ' GLN . 96.3 mtt180 -99.47 7.57 45.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 1.95 111.899 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.94 23.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.133 -0.485 . . . . 1.1899999999999999 111.734 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 81.8 mt -83.54 132.7 48.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 1.05 109.744 178.29 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -72.62 140.67 33.07 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.354 2.036 . . . . 0.23000000000000001 112.302 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.45 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 12.2 p90 -161.25 156.9 24.78 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.23999999999999999 110.417 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 mt -119.6 138.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.591 -0.731 . . . . 1.0700000000000001 109.869 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -89.19 109.71 20.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.17 -0.678 . . . . 1.05 109.17 177.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.772 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 19.3 t-160 -102.05 117.54 35.01 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.638 -0.875 . . . . 0.59999999999999998 108.638 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.721 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 8.9 t -171.33 154.21 3.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.733 0.301 . . . . 1.1399999999999999 110.586 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.2 33.13 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.465 -0.654 . . . . 1.1000000000000001 111.465 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -111.21 60.44 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.353 0.597 . . . . 2.3300000000000001 109.928 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.69 -48.78 58.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.408 -0.815 . . . . 2.1800000000000002 110.871 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -63.55 -33.62 76.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 2.6299999999999999 110.783 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.445 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 4.9 mmp_? -71.82 -15.4 62.14 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 5.1200000000000001 111.9 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.437 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 87.3 m-70 -134.25 31.59 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.745 0.276 . . . . 1.3500000000000001 111.745 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.01 -28.48 71.69 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.835 -0.698 . . . . 1.0600000000000001 112.469 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.556 ' HA ' ' HE ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -76.45 -26.1 55.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 2.5 110.34 178.996 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 tp -76.95 -47.51 20.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.85 -0.614 . . . . 1.22 109.864 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.437 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 79.2 mt -57.3 -39.59 76.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.861 -0.608 . . . . 2.1899999999999999 112.082 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.556 ' HE ' ' HA ' ' A' ' 91' ' ' GLU . 11.1 ptp180 -66.17 -25.28 66.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.668 0.27 . . . . 5.0 111.343 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -73.38 -30.16 63.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.398 0.618 . . . . 2.8999999999999999 110.14 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 55.4 mt -82.72 -53.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.18 -0.918 . . . . 1.0800000000000001 110.877 -177.25 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.02 74.22 0.34 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.718 0.77 . . . . 1.0900000000000001 110.831 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.31 168.56 11.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 114.789 -1.096 . . . . 1.0800000000000001 108.503 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.83 135.85 71.67 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.097 1.865 . . . . 0.29999999999999999 112.338 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 t -123.75 117.47 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 1.3 110.726 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.603 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.4 mtp -103.05 116.75 33.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 1.04 109.941 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.721 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.97 148.87 37.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.814 -0.63 . . . . 1.2 111.594 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.545 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 76.8 mttt -90.68 143.18 28.61 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 1.27 109.779 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -74.04 144.55 81.33 Favored 'Cis proline' 0 C--O 1.234 0.299 0 C-N-CA 123.282 -1.549 . . . . 0.88 112.925 1.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.638 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -138.66 131.88 30.01 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.347 -0.842 . . . . 0.39000000000000001 108.936 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.476 ' O ' HG21 ' A' ' 110' ' ' VAL . 11.3 t70 -73.08 129.42 38.04 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.964 -0.754 . . . . 0.51000000000000001 108.964 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.3 p -62.18 -21.05 64.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.375 -0.829 . . . . 1.04 112.758 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.7 p -69.02 -43.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.874 -0.417 . . . . 1.8899999999999999 109.874 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.82 -39.9 87.84 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.134 -0.484 . . . . 0.62 110.166 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.603 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.8 t -61.87 -47.76 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.754 -0.657 . . . . 1.04 110.333 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.515 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.16 -48.37 78.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 1.01 111.21 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.28 -41.18 98.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 2.4300000000000002 111.271 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -68.1 -27.38 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.745 0.307 . . . . 2.73 111.66 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -49.89 12.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.921 0.391 . . . . 1.02 110.233 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.516 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 71.1 mt -65.08 -27.09 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.85 0.685 . . . . 1.04 112.85 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.56 -26.92 66.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.732 -0.387 . . . . 2.79 110.946 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 69.8 mtm -73.84 -33.04 63.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.416 -0.356 . . . . 1.0 111.06 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.516 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.5 p -91.69 -1.57 57.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.32 0.581 . . . . 1.95 110.522 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -104.18 16.49 49.55 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.83 -0.908 . . . . 2.5699999999999998 110.83 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -163.76 65.16 0.24 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.286 -0.726 . . . . 4.4800000000000004 111.286 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.06 15.57 8.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.236 0.541 . . . . 6.4199999999999999 110.501 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -110.42 144.67 38.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.544 -0.753 . . . . 9.5099999999999998 109.887 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -67.9 134.48 92.03 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.1 -0.5 . . . . 9.5999999999999996 110.549 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.73 49.14 1.46 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.934 2.423 . . . . 11.17 112.307 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.51 -0.757 . . . . 13.279999999999999 109.861 -178.436 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.898 -0.481 . . . . 9.2100000000000009 111.898 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.83 85.83 7.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.94 0.4 . . . . 7.1500000000000004 110.918 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.65 157.59 18.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.073 -0.512 . . . . 7.6699999999999999 109.704 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.93 100.83 0.84 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.842 -0.694 . . . . 2.4399999999999999 111.945 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 54.6 mtt -74.66 128.64 85.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.8 0.333 . . . . 2.1800000000000002 110.963 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.485 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 1.5 Cg_endo -70.84 142.91 44.27 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.846 2.364 . . . . 0.55000000000000004 112.428 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -90.05 105.63 17.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 1.48 109.004 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.3 t -99.73 136.27 31.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.987 -0.551 . . . . 1.05 111.27 -173.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 42.5 tp -109.31 112.0 23.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.134 -0.485 . . . . 1.5 110.273 176.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.62 122.86 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.298 0.57 . . . . 1.03 111.641 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.565 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -103.76 111.94 24.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.7 -1.136 . . . . 1.05 108.704 172.686 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -170.16 127.23 0.84 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.38 -0.6 . . . . 1.4099999999999999 109.38 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.6 t70 -85.24 -25.58 27.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.27 110.324 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -75.55 106.57 3.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 2.5600000000000001 110.555 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 33.1 Cg_exo -59.64 -31.7 94.74 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.771 2.314 . . . . 0.35999999999999999 112.982 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.47 -49.59 68.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.329 -0.619 . . . . 2.2799999999999998 109.329 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.2 mt -66.24 -47.08 85.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.374 -0.83 . . . . 1.7 111.27 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.56 82.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 1.02 110.654 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -58.96 -44.74 91.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.727 -0.67 . . . . 1.28 110.924 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.438 ' HB3' HG23 ' A' ' 107' ' ' THR . 2.1 m-80 -68.2 -37.35 80.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.751 -0.659 . . . . 1.3600000000000001 111.394 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.65 -45.04 88.48 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.506 -0.315 . . . . 1.0700000000000001 110.379 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.561 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 62.4 tt0 -55.25 -53.05 61.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 1.7 110.311 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -64.16 -27.72 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 1.1799999999999999 111.563 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.66 -46.36 63.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.766 0.317 . . . . 1.05 110.73 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.694 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 54.0 m-85 -67.26 -42.3 84.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.367 -0.379 . . . . 0.16 110.526 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.407 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 50.4 mt-10 -61.58 -31.79 71.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.68999999999999995 110.039 175.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -35.52 76.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.756 -0.656 . . . . 0.51000000000000001 110.694 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -75.76 -20.55 58.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.142 0.496 . . . . 0.65000000000000002 110.305 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 56.27 0.7 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.705 -0.679 . . . . 0.28999999999999998 111.748 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.16 171.37 15.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.728 0.299 . . . . 1.03 110.803 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.99 150.25 25.09 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.561 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 47.1 t -134.27 138.49 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.389 0.514 . . . . 1.0800000000000001 112.389 -172.615 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG12 ' OG ' ' A' ' 44' ' ' SER . 12.0 t -115.58 126.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.058 -0.719 . . . . 1.05 109.058 168.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.46 130.64 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.076 0.465 . . . . 1.6499999999999999 111.278 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.522 ' HB2' ' HB2' ' A' ' 40' ' ' GLN . . . -141.25 134.48 29.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 1.03 110.662 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.46 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.11 -10.73 20.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.451 . . . . 1.04 111.078 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.632 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 38.3 p -127.34 168.4 14.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.395 . . . . 1.0800000000000001 110.757 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.539 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.6 m -70.95 -35.33 72.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.292 -0.413 . . . . 1.6599999999999999 110.047 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.69999999999999996 111.219 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.632 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 17.2 mt-30 -61.87 -37.99 86.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.255 0.55 . . . . 1.4099999999999999 110.57 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -63.65 -51.44 65.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.328 -0.851 . . . . 1.04 111.388 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.7 mt -62.53 -30.2 71.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.538 . . . . 1.53 111.021 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -49.16 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 2.9100000000000001 109.776 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.405 ' OG ' HG12 ' A' ' 33' ' ' VAL . 43.7 t -64.57 -38.12 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.037 -0.529 . . . . 1.6399999999999999 110.7 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.25 -32.27 72.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.284 0.564 . . . . 1.8400000000000001 110.688 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.33 -41.43 16.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 1.1599999999999999 111.348 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.93 -34.49 59.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.0 -0.545 . . . . 0.62 111.629 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -118.32 161.49 34.88 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.47999999999999998 110.503 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.61 84.28 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.388 2.726 . . . . 0.31 111.495 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.7 mm -64.62 123.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.651 -0.704 . . . . 1.03 111.736 -174.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.522 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 37.7 m-20 -92.58 -30.63 15.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.483 -0.781 . . . . 0.28999999999999998 110.277 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.517 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.5 p -159.81 155.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.111 -0.495 . . . . 1.03 109.807 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 164.06 29.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.359 0.6 . . . . 0.97999999999999998 111.49 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.439 HG22 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -135.33 112.39 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.512 -0.767 . . . . 1.5700000000000001 108.944 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.644 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -109.05 108.36 19.03 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.667 -0.413 . . . . 1.02 111.723 -170.637 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.802 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.0 t70 -78.82 126.21 30.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.598 -0.89 . . . . 1.77 108.598 172.332 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.509 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 21.3 t -73.96 -16.44 16.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.596 -0.729 . . . . 1.3600000000000001 110.862 -173.532 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -99.03 85.23 3.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.278 0.561 . . . . 2.6400000000000001 110.566 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.7 mt -99.88 -4.52 30.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.513 0.673 . . . . 1.3100000000000001 109.503 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.07 -174.47 40.99 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.895 -1.048 . . . . 0.87 110.731 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.09 -45.41 31.97 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.696 2.264 . . . . 1.3899999999999999 111.98 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -107.29 -32.8 7.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.859 -0.61 . . . . 4.0 110.129 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.7 m -65.56 126.91 29.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 1.3700000000000001 111.96 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -144.5 152.72 41.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.29 -0.868 . . . . 0.58999999999999997 109.413 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.644 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 28.5 p -67.44 87.67 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.296 0.569 . . . . 2.1899999999999999 109.876 173.403 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.4 -69.78 0.43 Allowed Glycine 0 C--O 1.224 -0.496 0 C-N-CA 120.669 -0.777 . . . . 0.28000000000000003 112.119 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.405 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.9 Cg_exo -51.91 -30.56 39.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.594 2.196 . . . . 0.28000000000000003 112.134 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 22.6 t -66.33 -39.15 83.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.451 0.643 . . . . 1.01 110.068 177.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.83 -47.18 75.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.091 -0.959 . . . . 1.01 110.093 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 2.7 m-20 -60.45 -42.77 96.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 2.0299999999999998 109.968 176.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.53 63.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 1.0700000000000001 111.249 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.55 -40.77 89.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.417 -0.81 . . . . 1.05 110.579 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.548 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 62.8 mmtt -59.67 -35.21 74.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.5800000000000001 111.079 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.442 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 46.4 mt-30 -70.39 -37.32 74.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 3.0299999999999998 111.171 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -93.04 4.67 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.681 0.277 . . . . 1.95 111.231 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.59 33.73 22.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 1.1899999999999999 111.617 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.18 133.87 32.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.144 -0.48 . . . . 1.05 110.063 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.98 143.95 29.74 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.525 2.15 . . . . 0.23000000000000001 112.32 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 41.7 p90 -158.53 160.24 36.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.552 -0.749 . . . . 0.23999999999999999 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 mt -125.07 139.53 50.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.161 -0.927 . . . . 1.0700000000000001 109.639 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.409 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mm? -88.94 113.62 24.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.302 0.572 . . . . 1.05 109.465 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.802 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 17.2 t-160 -101.63 130.03 47.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.386 -0.968 . . . . 0.59999999999999998 108.386 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.436 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 11.1 t -178.72 162.14 1.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.9 -0.32 . . . . 1.1399999999999999 110.703 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.74 13.8 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.335 -1.106 . . . . 1.1000000000000001 110.335 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.5 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -114.29 49.56 1.0 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.136 -0.532 . . . . 2.3300000000000001 110.137 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.85 -30.6 65.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 2.1800000000000002 111.944 -173.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.77 -34.48 24.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.292 0.568 . . . . 2.6299999999999999 109.867 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.5 ' HD3' ' OD2' ' A' ' 85' ' ' ASP . 44.6 ttt180 -67.32 -34.91 78.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.313 -0.858 . . . . 5.1200000000000001 111.128 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.432 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.0 m-70 -118.62 28.66 8.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 1.3500000000000001 111.473 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.65 95.88 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.001 -0.618 . . . . 1.0600000000000001 112.756 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.458 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 29.5 mt-10 -61.37 -45.57 93.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 2.5 110.154 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.84 -44.94 95.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 1.22 110.572 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.432 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 73.5 mt -59.6 -38.62 81.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 2.1899999999999999 111.372 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -71.26 -27.03 63.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.399 -0.364 . . . . 5.0 111.18 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.458 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 66.9 mttm -74.21 -43.74 55.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.333 0.587 . . . . 2.8999999999999999 110.032 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.548 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 83.5 mt -62.45 -51.34 73.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.189 -0.914 . . . . 1.0800000000000001 110.581 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.7 t70 62.47 75.58 0.4 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.425 0.631 . . . . 1.0900000000000001 110.828 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.407 ' HB1' ' CD2' ' A' ' 81' ' ' LEU . . . -161.12 167.41 13.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 1.0800000000000001 109.339 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.24 142.69 97.51 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.399 2.066 . . . . 0.29999999999999999 112.667 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -124.24 124.36 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 1.3 111.054 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.14 110.5 22.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.28 -0.637 . . . . 1.04 109.28 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.436 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.21 146.66 41.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.015 -0.539 . . . . 1.2 111.91 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.46 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 86.8 mttt -91.19 142.52 27.28 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 1.27 109.709 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.5 Cg_exo -71.14 139.59 59.39 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.505 -1.456 . . . . 0.88 112.992 3.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.56 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -132.79 136.44 46.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.39000000000000001 109.619 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.443 ' O ' HG22 ' A' ' 110' ' ' VAL . 10.5 t70 -79.38 131.58 36.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.472 -0.936 . . . . 0.51000000000000001 108.472 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.438 HG23 ' HB3' ' A' ' 20' ' ' ASN . 23.3 p -64.84 -23.56 67.27 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.672 -0.695 . . . . 1.04 112.24 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -72.68 -33.31 66.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.551 -0.537 . . . . 1.8899999999999999 109.551 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -70.49 -45.8 64.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.809 -0.632 . . . . 0.62 109.36 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.443 HG22 ' O ' ' A' ' 106' ' ' ASP . 30.6 t -60.12 -43.44 92.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.227 -0.897 . . . . 1.04 110.264 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.694 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -61.89 -50.06 73.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.702 -0.681 . . . . 1.01 111.369 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.536 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.5 mttp -59.79 -49.95 75.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 2.4300000000000002 111.167 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -59.7 -38.36 81.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 2.73 111.475 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.67 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 1.02 110.603 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.491 HD21 HG11 ' A' ' 52' ' ' VAL . 63.0 mt -65.26 -25.44 67.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 1.04 112.167 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.536 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 20.5 mm-40 -59.16 -30.23 68.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 2.79 111.208 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.5 mtm -88.81 1.94 54.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 1.0 110.992 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.522 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 51.1 t -118.69 -50.03 2.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.146 -0.479 . . . . 1.95 111.573 -177.152 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.05 98.24 1.32 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.036 -0.602 . . . . 2.5699999999999998 112.408 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.06 -90.16 1.58 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.819 -0.705 . . . . 4.4800000000000004 111.832 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.468 ' CG ' ' H ' ' A' ' 122' ' ' LYS . 24.1 t70 56.67 -156.96 0.28 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.647 0.379 . . . . 6.4199999999999999 109.986 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.51 ' H ' ' HD3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -114.5 121.27 43.01 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.989 -0.445 . . . . 9.5099999999999998 110.26 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.69 118.2 68.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.096 -0.502 . . . . 9.5999999999999996 110.699 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.98 173.19 14.87 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.742 2.295 . . . . 11.17 112.346 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.461 -0.781 . . . . 13.279999999999999 110.239 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.98 -0.448 . . . . 9.2100000000000009 111.98 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.78 117.39 22.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.981 -0.377 . . . . 7.1500000000000004 109.981 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.7 mtm -77.96 115.77 17.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.318 -0.401 . . . . 7.6699999999999999 110.541 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.23 86.2 1.49 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.001 -0.84 . . . . 2.4399999999999999 111.001 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.418 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 91.2 mtp -87.0 118.56 70.22 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.98 0.419 . . . . 2.1800000000000002 110.811 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.642 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -63.94 142.22 80.83 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.413 2.742 . . . . 0.55000000000000004 112.224 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -87.93 103.04 15.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.904 -0.776 . . . . 1.48 108.904 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.442 HG22 ' CG1' ' A' ' 52' ' ' VAL . 54.9 t -99.23 135.49 34.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.003 -0.544 . . . . 1.05 110.859 -173.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 40.4 tp -110.96 111.21 22.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.184 -0.462 . . . . 1.5 110.573 178.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -92.6 125.65 45.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 1.03 111.324 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.621 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 0.7 OUTLIER -107.33 104.17 13.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.023 -0.989 . . . . 1.05 109.231 173.69 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -165.16 123.23 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.88 -0.6 . . . . 1.4099999999999999 110.075 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.449 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.5 t70 -83.42 -22.06 32.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.798 -0.637 . . . . 1.27 110.781 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.81 107.0 9.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.119 -0.326 . . . . 2.5600000000000001 110.119 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.449 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.2 Cg_exo -58.5 -28.86 86.95 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.35999999999999999 113.484 -174.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 tp -64.64 -49.96 68.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.998 0.428 . . . . 2.2799999999999998 110.115 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.18 -41.37 89.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.834 -0.621 . . . . 1.7 110.559 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.17 82.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 1.02 110.854 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.3 ttp -62.08 -42.8 99.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.919 -0.582 . . . . 1.28 110.862 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -64.21 -40.9 97.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.848 -0.615 . . . . 1.3600000000000001 111.432 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.412 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 38.8 mt -64.56 -45.02 88.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.612 0.244 . . . . 1.0700000000000001 110.525 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.534 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.2 tt0 -55.6 -50.28 70.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.974 -0.557 . . . . 1.7 110.466 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -65.04 -27.17 68.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 1.1799999999999999 111.508 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.18 -45.02 58.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 1.05 110.643 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.519 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -70.45 -42.16 71.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.112 -0.495 . . . . 0.16 110.917 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.46 -35.92 78.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.916 0.389 . . . . 0.68999999999999995 110.032 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.92 -31.86 73.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.633 -0.712 . . . . 0.51000000000000001 110.732 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -86.19 5.66 33.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.65000000000000002 111.159 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.76 52.7 5.31 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.948 -0.644 . . . . 0.28999999999999998 112.46 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.401 ' CB ' ' HD2' ' A' ' 6' ' ' PRO . . . -138.4 163.54 31.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.692 0.282 . . . . 1.03 110.658 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -101.91 144.26 30.76 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.985 -0.746 . . . . 2.1400000000000001 108.985 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.534 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -127.58 143.75 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.027 0.441 . . . . 1.0800000000000001 111.843 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.461 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.7 t -117.7 128.61 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.805 -0.813 . . . . 1.05 108.805 168.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -97.23 122.75 49.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.548 -0.461 . . . . 1.6499999999999999 110.986 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.499 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -134.14 135.41 43.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.626 -0.716 . . . . 1.03 109.819 176.533 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.42 -21.61 14.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.331 -0.395 . . . . 1.04 110.922 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.47 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 17.1 p -115.39 170.99 7.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.991 0.424 . . . . 1.0800000000000001 111.125 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.582 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 22.3 p -65.06 -47.62 76.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.477 0.656 . . . . 1.6599999999999999 109.367 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -55.91 -45.72 78.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.279 -1.328 . . . . 0.69999999999999996 111.997 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.499 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 55.6 mt-30 -59.54 -45.31 92.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.426 0.631 . . . . 1.4099999999999999 110.304 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.515 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -61.12 -50.84 71.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.062 -0.972 . . . . 1.04 111.141 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.582 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 57.7 mt -63.14 -31.34 72.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.761 -0.654 . . . . 1.53 110.83 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -68.59 -53.44 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 2.9100000000000001 109.841 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.461 ' OG ' HG11 ' A' ' 33' ' ' VAL . 33.3 t -65.45 -32.91 74.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.894 0.378 . . . . 1.6399999999999999 110.621 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.3 tp -65.4 -33.51 76.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.8400000000000001 110.797 178.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.32 -35.95 30.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.896 -0.593 . . . . 1.1599999999999999 111.258 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.98 -38.07 32.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.62 111.524 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -112.62 164.69 14.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.984 -0.553 . . . . 0.47999999999999998 110.89 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -94.78 78.29 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.571 2.847 . . . . 0.31 111.594 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.5 mm -64.04 119.29 7.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.751 -0.659 . . . . 1.03 111.236 -176.592 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.527 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.4 m-20 -87.75 -29.67 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.726 -0.67 . . . . 0.28999999999999998 110.457 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.46 HG11 HD22 ' A' ' 115' ' ' LEU . 14.3 p -160.53 156.49 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 1.03 110.349 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.05 165.56 27.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.281 0.562 . . . . 0.97999999999999998 112.059 -178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.66 112.11 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.427 -0.806 . . . . 1.5700000000000001 109.583 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.508 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 9.7 mp -112.52 116.93 31.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.296 0.48 . . . . 1.02 112.296 -168.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.11 107.1 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 1.77 109.637 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.43 ' CG1' HD22 ' A' ' 92' ' ' LEU . 12.9 t -68.82 -9.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.041 -0.527 . . . . 1.3600000000000001 111.964 -172.087 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -114.96 63.27 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 2.6400000000000001 110.981 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.422 HD11 ' SG ' ' A' ' 65' ' ' CYS . 97.5 mt -64.52 -27.85 69.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.265 0.555 . . . . 1.3100000000000001 110.874 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.22 32.22 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.192 -0.763 . . . . 0.87 111.192 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.54 -40.66 82.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.931 2.421 . . . . 1.3899999999999999 112.513 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -123.83 -31.55 3.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.655 0.264 . . . . 4.0 110.783 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -65.95 127.03 30.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.058 0.456 . . . . 1.3700000000000001 111.706 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -144.57 153.38 41.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.707 -0.678 . . . . 0.58999999999999997 110.061 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.621 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 2.6 m -73.7 85.94 1.65 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.984 -0.747 . . . . 2.1899999999999999 108.984 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.47 -63.93 0.54 Allowed Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.841 -0.695 . . . . 0.28000000000000003 111.842 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.45 -24.91 37.68 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.348 2.032 . . . . 0.28000000000000003 111.381 173.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 20.9 t -68.45 -45.01 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.748 -0.66 . . . . 1.01 109.995 176.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.49 -49.41 77.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 1.01 110.165 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.479 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 50.7 m-20 -61.95 -41.6 98.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 2.0299999999999998 110.238 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.63 -44.16 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.019 -0.537 . . . . 1.0700000000000001 111.256 178.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.11 -42.19 76.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.56 -0.745 . . . . 1.05 110.268 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.577 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.9 mmtt -59.88 -36.74 77.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.681 -0.691 . . . . 2.5800000000000001 111.447 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.479 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 71.2 mt-30 -63.29 -39.07 93.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 3.0299999999999998 111.237 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -96.02 6.14 49.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.29 -0.414 . . . . 1.95 111.235 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 35.57 22.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.797 -0.638 . . . . 1.1899999999999999 111.754 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.0 mt -89.12 133.79 34.5 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 116.501 -0.318 . . . . 1.05 110.441 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -74.2 141.46 29.21 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.49 2.127 . . . . 0.23000000000000001 111.765 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 16.9 p90 -159.16 160.58 35.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.675 -0.693 . . . . 0.23999999999999999 110.225 -179.772 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.421 HG22 ' HG2' ' A' ' 101' ' ' MET . 16.0 mt -125.52 141.42 45.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.482 -0.781 . . . . 1.0700000000000001 109.987 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.84 108.71 19.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.309 -0.626 . . . . 1.05 109.309 177.752 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.643 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 21.9 t-160 -103.66 74.01 1.22 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.481 0.658 . . . . 0.59999999999999998 109.261 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.5 t -105.86 163.56 12.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.646 -1.161 . . . . 1.1399999999999999 111.048 -172.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 -4.99 57.7 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.901 -0.59 . . . . 1.1000000000000001 112.31 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -137.95 132.72 32.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.108 0.48 . . . . 2.3300000000000001 109.826 172.728 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.429 HD11 ' N ' ' A' ' 86' ' ' LEU . 6.1 mp -111.83 -25.85 9.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 2.1800000000000002 110.856 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.18 -45.97 12.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.126 0.489 . . . . 2.6299999999999999 110.898 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.34 -40.15 95.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.513 -0.767 . . . . 5.1200000000000001 110.938 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.518 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 49.7 m-70 -102.31 25.19 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.565 -0.288 . . . . 1.3500000000000001 111.163 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.74 -37.88 95.56 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.967 -0.635 . . . . 1.0600000000000001 112.975 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 11.7 tt0 -66.94 -39.8 87.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 2.5 110.258 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 96' ' ' ILE . 41.4 tp -68.12 -40.01 82.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.227 -0.442 . . . . 1.22 109.863 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.518 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 89.0 mt -59.15 -39.6 82.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.453 -0.34 . . . . 2.1899999999999999 111.189 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.615 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 24.4 ptt180 -73.95 -26.05 60.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 5.0 110.584 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -70.34 -34.15 72.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.295 0.569 . . . . 2.8999999999999999 110.163 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.577 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 95.8 mt -77.36 -53.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.366 -0.834 . . . . 1.0800000000000001 110.677 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.0 t70 64.47 75.26 0.38 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.764 0.792 . . . . 1.0900000000000001 110.917 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.87 162.11 25.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.902 -1.044 . . . . 1.0800000000000001 109.383 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.75 147.19 89.48 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.658 2.239 . . . . 0.29999999999999999 112.539 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.1 t -124.25 134.97 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.202 -0.454 . . . . 1.3 110.971 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.421 ' HG2' HG22 ' A' ' 80' ' ' ILE . 92.2 mmm -114.77 107.47 15.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.286 -0.635 . . . . 1.04 109.286 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.437 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -73.04 143.86 47.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.944 -0.571 . . . . 1.2 111.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.418 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 94.0 mttt -91.45 146.74 33.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.046 -0.525 . . . . 1.27 110.186 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.19 127.31 13.8 Favored 'Cis proline' 0 C--O 1.234 0.278 0 C-N-CA 123.619 -1.409 . . . . 0.88 112.699 2.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.643 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -119.35 130.04 55.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.728 -0.669 . . . . 0.39000000000000001 110.297 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.15 129.97 38.87 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.04 -1.096 . . . . 0.51000000000000001 108.04 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.412 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 39.9 p -64.28 -20.47 66.09 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.875 0.695 . . . . 1.04 112.875 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 76.1 p -65.87 -42.32 90.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.995 0.426 . . . . 1.8899999999999999 110.176 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 -39.79 84.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.159 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.44 -45.14 98.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 1.04 110.327 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.519 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.31 -48.81 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.554 -0.748 . . . . 1.01 111.479 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 2.4300000000000002 111.269 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.8 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 2.73 111.402 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.2 -46.81 17.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.49 . . . . 1.02 110.392 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.46 HD22 HG11 ' A' ' 52' ' ' VAL . 77.1 mt -70.59 -26.08 63.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.634 0.605 . . . . 1.04 112.634 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -63.07 -33.19 74.92 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.815 -0.354 . . . . 2.79 110.415 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.3 mtm -76.08 -30.69 58.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.193 0.52 . . . . 1.0 110.139 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.642 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.5 t -73.27 -46.73 48.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 1.95 111.033 -178.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.64 11.79 70.64 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.813 -0.708 . . . . 2.5699999999999998 112.31 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.65 72.35 0.21 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.794 -0.717 . . . . 4.4800000000000004 112.239 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.15 117.75 21.96 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.876 -0.416 . . . . 6.4199999999999999 109.876 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.47 163.04 36.94 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.795 -0.639 . . . . 9.5099999999999998 110.82 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -78.69 117.24 65.37 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.76 -0.655 . . . . 9.5999999999999996 109.429 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.41 113.79 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.328 2.685 . . . . 11.17 113.136 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.572 -0.728 . . . . 13.279999999999999 110.044 178.494 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.767 -0.533 . . . . 9.2100000000000009 111.767 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.03 59.88 3.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.228 0.537 . . . . 7.1500000000000004 110.643 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.489 ' HB2' ' SD ' ' A' ' 5' ' ' MET . 17.7 ptp -96.89 125.45 41.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 7.6699999999999999 111.013 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.54 74.28 0.24 Allowed Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.632 -0.713 . . . . 2.4399999999999999 111.713 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' A' ' 3' ' ' MET . 0.1 OUTLIER -63.45 134.18 95.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.793 0.33 . . . . 2.1800000000000002 111.662 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.435 ' HG2' HD21 ' A' ' 115' ' ' LEU . 17.3 Cg_exo -70.45 136.06 30.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.045 2.496 . . . . 0.55000000000000004 110.984 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -85.98 109.48 18.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.431 -0.581 . . . . 1.48 109.431 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.507 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 38.0 t -100.14 130.79 48.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.9 -0.591 . . . . 1.05 110.916 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.1 tp -105.04 112.14 25.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.83 0.348 . . . . 1.5 110.306 175.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.3 t -93.12 121.03 43.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.118 0.485 . . . . 1.03 111.507 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.544 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.1 mm? -102.45 101.11 11.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.297 -0.865 . . . . 1.05 108.889 171.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -159.51 120.98 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.479 -0.782 . . . . 1.4099999999999999 109.921 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.472 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 19.0 t70 -87.49 -19.03 28.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.9 -0.591 . . . . 1.27 109.941 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -83.51 105.65 5.89 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 2.5600000000000001 109.835 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.472 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.1 Cg_exo -59.03 -32.97 98.49 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.736 2.291 . . . . 0.35999999999999999 113.063 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.37 -49.19 78.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.621 -0.511 . . . . 2.2799999999999998 109.621 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.23 -46.04 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 1.7 110.88 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.59 72.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.069 0.461 . . . . 1.02 110.783 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.0 ttp -63.27 -44.92 93.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.553 -0.749 . . . . 1.28 111.231 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 10.9 m-20 -67.68 -36.78 81.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.098 -0.501 . . . . 1.3600000000000001 111.497 -176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.4 mt -65.54 -46.14 80.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.739 0.304 . . . . 1.0700000000000001 110.188 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.539 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 48.2 tt0 -55.17 -48.38 73.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 1.7 110.406 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -63.48 -37.88 89.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.441 -0.345 . . . . 1.1799999999999999 111.199 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.54 -49.36 69.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.435 -0.348 . . . . 1.05 111.275 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.586 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -63.96 -45.73 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.247 -0.433 . . . . 0.16 110.86 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.66 -28.42 69.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.366 -0.379 . . . . 0.68999999999999995 111.164 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.8 -33.33 66.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.51000000000000001 110.229 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.78 -14.73 59.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.65000000000000002 110.817 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 53.11 0.8 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 112.373 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.4 175.95 9.13 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.872 -0.193 . . . . 1.03 110.683 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.45 129.91 49.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.064 -0.717 . . . . 2.1400000000000001 109.064 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.539 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.3 t -118.25 142.15 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 112.664 0.616 . . . . 1.0800000000000001 112.664 -164.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.432 HG13 ' HB3' ' A' ' 44' ' ' SER . 10.4 t -114.38 136.38 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.867 -0.79 . . . . 1.05 108.867 169.544 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.02 125.09 58.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 1.6499999999999999 111.191 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.459 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -134.78 139.53 45.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.109 -0.496 . . . . 1.03 110.424 175.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.94 -13.16 15.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.347 -0.388 . . . . 1.04 111.2 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.0 p -127.79 167.44 16.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.485 -0.325 . . . . 1.0800000000000001 110.555 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.631 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 74.6 m -68.73 -34.19 75.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.845 -0.428 . . . . 1.6599999999999999 109.845 175.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.37 -48.01 81.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.69999999999999996 110.613 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.459 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . 71.8 mt-30 -59.08 -41.03 87.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.353 0.596 . . . . 1.4099999999999999 110.621 175.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -62.0 -54.75 37.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.15 -0.932 . . . . 1.04 111.419 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.484 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 62.7 mt -64.46 -30.7 71.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.013 -0.54 . . . . 1.53 110.767 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -64.43 -47.43 79.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.292 -0.633 . . . . 2.9100000000000001 109.292 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.432 ' HB3' HG13 ' A' ' 33' ' ' VAL . 11.0 m -72.28 -30.46 64.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.922 -0.581 . . . . 1.6399999999999999 110.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 21.6 tp -67.1 -35.93 80.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 1.8400000000000001 110.637 177.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.24 -35.15 48.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.055 -0.52 . . . . 1.1599999999999999 110.814 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.53 -36.28 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.745 -0.661 . . . . 0.62 111.17 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.59 148.56 48.24 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.358 0.599 . . . . 0.47999999999999998 111.284 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.65 88.59 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.321 2.681 . . . . 0.31 111.498 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.6 mm -68.56 127.95 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 1.03 111.663 -175.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -98.89 -27.03 14.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.28999999999999998 110.414 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.507 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 11.7 p -159.48 159.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 1.03 109.49 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -145.71 165.84 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.376 0.607 . . . . 0.97999999999999998 112.128 -178.314 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.14 111.76 7.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.221 -0.899 . . . . 1.5700000000000001 109.192 175.899 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -114.43 124.08 51.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.329 0.492 . . . . 1.02 112.329 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.642 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.5 t0 -85.1 115.1 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.815 0.817 . . . . 1.77 109.336 169.231 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.568 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 65.8 t -59.97 -24.17 29.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.588 -1.187 . . . . 1.3600000000000001 110.96 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.454 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 7.7 t30 -113.01 75.53 0.92 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 2.6400000000000001 110.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.3 -29.57 67.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.809 0.814 . . . . 1.3100000000000001 109.052 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.37 -172.22 34.28 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.567 -1.197 . . . . 0.87 110.241 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . 0.411 ' HB2' ' HD2' ' A' ' 62' ' ' LYS . 86.1 Cg_exo -52.92 -44.52 47.9 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.905 2.403 . . . . 1.3899999999999999 112.399 176.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HD2' ' HB2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -109.59 -34.1 6.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 4.0 110.563 177.572 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.8 m -65.89 127.46 32.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.351 0.596 . . . . 1.3700000000000001 111.146 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -144.23 149.89 37.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 0.58999999999999997 110.34 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -71.74 86.57 0.94 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.514 0.674 . . . . 2.1899999999999999 109.431 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.65 -73.06 0.7 Allowed Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.355 -0.926 . . . . 0.28000000000000003 112.164 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.631 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.8 Cg_exo -53.29 -25.3 30.08 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.583 2.189 . . . . 0.28000000000000003 112.221 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.471 HG11 ' CD2' ' A' ' 11' ' ' LEU . 12.6 t -72.12 -46.72 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.228 0.537 . . . . 1.01 110.365 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.491 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.42 -51.81 67.93 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.314 -0.857 . . . . 1.01 109.802 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.406 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 26.4 t70 -62.28 -37.34 85.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 110.49 179.267 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.402 ' HB3' ' O ' ' A' ' 67' ' ' PRO . . . -56.96 -48.23 78.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.409 0.623 . . . . 1.0700000000000001 110.969 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.04 -41.61 77.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.399 -0.818 . . . . 1.05 110.402 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 29.9 mmmt -57.89 -39.39 77.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.585 -0.734 . . . . 2.5800000000000001 110.807 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 44.0 mt-30 -62.64 -46.68 87.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.688 . . . . 3.0299999999999998 111.462 177.731 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -86.41 2.8 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 1.95 111.086 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.0 33.16 21.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.763 -0.653 . . . . 1.1899999999999999 111.308 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.74 131.39 47.45 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 116.085 -0.507 . . . . 1.05 109.845 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.414 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.2 Cg_endo -72.72 139.39 30.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.17 1.913 . . . . 0.23000000000000001 111.616 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 12.5 p90 -156.44 155.28 31.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.902 -0.59 . . . . 0.23999999999999999 110.719 -179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.34 139.61 44.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.538 -0.756 . . . . 1.0700000000000001 109.505 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.43 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.5 mm? -88.69 107.45 18.94 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.281 -0.637 . . . . 1.05 109.281 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.457 ' HA ' ' O ' ' A' ' 101' ' ' MET . 14.7 t-160 -103.46 72.52 1.15 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.275 -1.009 . . . . 0.59999999999999998 108.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.642 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 9.7 t -103.52 159.63 15.42 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 113.989 -1.46 . . . . 1.1399999999999999 111.401 -171.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.66 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -106.24 9.42 42.41 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.623 -0.799 . . . . 1.1000000000000001 111.42 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.454 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 17.7 t70 -137.06 141.31 42.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.877 0.37 . . . . 2.3300000000000001 110.861 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.6 mt -130.08 -31.88 1.87 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.079 -0.51 . . . . 2.1800000000000002 110.71 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.54 -39.39 16.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.478 0.548 . . . . 2.6299999999999999 112.478 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -70.16 -52.58 22.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.692 0.282 . . . . 5.1200000000000001 111.141 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -97.21 29.1 3.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.426 -0.352 . . . . 1.3500000000000001 110.304 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.509 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.18 -34.08 62.1 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.448 -0.406 . . . . 1.0600000000000001 113.796 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.88 -26.04 68.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 2.5 111.259 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.567 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.3 tp -74.96 -47.87 27.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.22 -0.445 . . . . 1.22 110.954 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.509 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -60.48 -36.37 78.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.911 0.386 . . . . 2.1899999999999999 110.955 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.43 -34.12 73.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.311 -0.859 . . . . 5.0 111.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -81.34 -29.36 34.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 2.8999999999999999 111.063 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 92' ' ' LEU . 70.7 mt -67.71 -50.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.798 -0.637 . . . . 1.0800000000000001 111.327 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.21 75.96 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.413 0.625 . . . . 1.0900000000000001 110.617 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -162.71 161.99 19.07 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.437 -0.802 . . . . 1.0800000000000001 109.44 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 31.8 Cg_exo -59.99 137.3 75.07 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.79 2.327 . . . . 0.29999999999999999 112.465 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.9 135.33 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.891 -0.595 . . . . 1.3 110.904 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.581 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.6 mtp -127.24 90.91 3.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.294 -0.632 . . . . 1.04 109.294 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.62 139.78 57.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.739 -0.664 . . . . 1.2 111.62 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.66 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 15.3 ptpt -91.56 149.84 40.06 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.594 -0.73 . . . . 1.27 109.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.545 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 16.7 Cg_exo -66.54 138.43 39.56 Favored 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 123.534 -1.444 . . . . 0.88 113.118 3.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.402 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -142.07 133.93 27.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.253 -0.885 . . . . 0.39000000000000001 108.778 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.569 ' O ' HG23 ' A' ' 110' ' ' VAL . 12.9 t70 -65.09 123.36 19.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.585 -0.524 . . . . 0.51000000000000001 109.585 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 28.9 p -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.495 -0.775 . . . . 1.04 112.555 -171.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -70.81 -39.74 72.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.455 -0.572 . . . . 1.8899999999999999 109.455 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -67.01 -44.26 80.76 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.62 109.84 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.581 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 25.4 t -59.95 -42.11 88.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.197 -0.911 . . . . 1.04 110.378 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.586 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.85 -50.47 66.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.598 -0.728 . . . . 1.01 111.558 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.85 -41.1 99.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 2.4300000000000002 111.538 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.1 mmt180 -71.82 -24.91 61.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.7 0.285 . . . . 2.73 111.492 -179.414 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 -48.98 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 1.02 110.279 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.603 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 69.0 mt -64.55 -26.82 68.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.931 0.715 . . . . 1.04 112.931 -175.562 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.69 -28.98 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.779 -0.368 . . . . 2.79 110.969 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.431 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 57.7 mtm -75.21 -21.81 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 1.0 111.03 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.603 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 25.4 p -106.54 25.27 11.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.06 0.457 . . . . 1.95 110.529 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.11 -32.32 83.78 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.699 -0.682 . . . . 2.5699999999999998 112.113 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.36 64.14 0.7 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.731 -0.747 . . . . 4.4800000000000004 112.13 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -88.18 52.81 2.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.529 0.681 . . . . 6.4199999999999999 109.955 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -83.29 70.31 10.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.143 -0.935 . . . . 9.5099999999999998 110.106 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -98.62 127.0 37.08 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.612 -0.722 . . . . 9.5999999999999996 110.223 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.14 118.68 5.71 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.581 2.188 . . . . 11.17 112.079 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.52 -0.753 . . . . 13.279999999999999 110.317 -179.598 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 112.523 -0.231 . . . . 9.2100000000000009 112.523 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.36 25.17 14.52 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.88 0.472 . . . . 7.1500000000000004 111.242 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt -123.45 171.2 9.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.167 -0.469 . . . . 7.6699999999999999 110.009 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.597 ' O ' ' HG2' ' A' ' 5' ' ' MET . . . 90.91 -37.86 3.31 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.007 -0.616 . . . . 2.4399999999999999 112.314 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.597 ' HG2' ' O ' ' A' ' 4' ' ' GLY . 12.1 ptp 56.74 141.38 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 125.317 1.447 . . . . 2.1800000000000002 112.554 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.403 ' HG3' ' CA ' ' A' ' 119' ' ' GLY . 1.1 Cg_endo -69.53 141.13 45.3 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.153 1.902 . . . . 0.55000000000000004 112.743 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -89.56 105.92 18.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.635 -0.711 . . . . 1.48 109.087 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.435 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.6 t -100.66 134.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 1.05 111.228 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 tp -110.55 113.31 25.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.008 -0.542 . . . . 1.5 110.564 176.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -95.05 129.11 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.962 0.411 . . . . 1.03 111.113 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.538 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.5 OUTLIER -110.0 101.54 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.563 -0.744 . . . . 1.05 109.982 176.349 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -165.14 133.25 3.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.658 -0.497 . . . . 1.4099999999999999 109.658 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -87.47 -31.95 19.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.884 -0.598 . . . . 1.27 110.497 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.1 111.46 13.7 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.22 -0.289 . . . . 2.5600000000000001 110.22 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.48 -31.92 95.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.998 2.465 . . . . 0.35999999999999999 113.027 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.81 -49.64 69.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.891 -0.411 . . . . 2.2799999999999998 109.891 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.08 -47.69 86.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 1.7 110.415 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.76 -49.43 77.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.49 -0.777 . . . . 1.02 111.477 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.5 ttp -66.22 -34.12 77.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.382 -0.372 . . . . 1.28 111.093 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.477 ' HB3' HG23 ' A' ' 107' ' ' THR . 3.2 m-20 -66.77 -43.88 82.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.311 -0.404 . . . . 1.3600000000000001 110.609 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.39 -44.06 97.35 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.184 -0.462 . . . . 1.0700000000000001 110.021 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.445 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 56.6 tt0 -52.18 -53.83 38.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 1.7 110.684 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -63.76 -33.35 75.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.777 0.323 . . . . 1.1799999999999999 111.138 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.87 71.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.215 -0.448 . . . . 1.05 111.046 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.709 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.3 m-85 -66.95 -40.41 87.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.16 110.849 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.6 mt-10 -61.6 -35.66 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.68999999999999995 110.539 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.73 -29.25 67.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.52 . . . . 0.51000000000000001 110.761 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -82.78 -2.0 53.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.65000000000000002 110.923 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.16 50.54 3.62 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.878 -0.677 . . . . 0.28999999999999998 112.404 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.87 162.32 35.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.204 -0.295 . . . . 1.03 110.204 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.78 132.98 51.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.572 -0.529 . . . . 2.1400000000000001 109.572 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.44 HG13 ' HA ' ' A' ' 22' ' ' GLN . 21.8 t -113.78 139.95 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.014 0.375 . . . . 1.0800000000000001 112.014 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.475 HG12 ' OG ' ' A' ' 44' ' ' SER . 10.2 t -114.45 127.29 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.588 -0.893 . . . . 1.05 108.588 167.281 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.61 123.4 50.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.727 -0.389 . . . . 1.6499999999999999 110.769 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.441 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -129.36 134.32 47.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.064 -0.516 . . . . 1.03 109.994 175.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.02 -18.95 19.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.833 -0.621 . . . . 1.04 110.909 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.2 p -125.12 164.89 19.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.705 -0.398 . . . . 1.0800000000000001 111.163 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.634 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 76.5 m -65.16 -35.46 81.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.838 -0.619 . . . . 1.6599999999999999 109.681 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.6 -46.91 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.984 -0.553 . . . . 0.69999999999999996 110.641 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.441 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 71.1 mt-30 -61.42 -41.65 97.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.955 -0.566 . . . . 1.4099999999999999 110.822 176.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.458 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -63.46 -49.65 72.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.559 -0.746 . . . . 1.04 111.484 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.634 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 81.7 mt -60.58 -33.42 72.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.192 -0.458 . . . . 1.53 110.885 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.436 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 6.8 tmtm? -66.73 -52.58 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.814 -0.63 . . . . 2.9100000000000001 109.945 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.475 ' OG ' HG12 ' A' ' 33' ' ' VAL . 14.1 t -65.4 -34.42 78.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.367 -0.379 . . . . 1.6399999999999999 110.44 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -62.05 -36.44 81.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 1.8400000000000001 110.852 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.05 -39.84 22.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 1.1599999999999999 111.194 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.58 -37.79 65.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.62 111.397 -176.551 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -115.29 163.14 21.14 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.47999999999999998 110.411 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.84 82.54 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.446 2.764 . . . . 0.31 111.531 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.7 mm -63.96 122.43 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.463 -0.79 . . . . 1.03 111.526 -176.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -90.22 -34.71 15.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.56 -0.746 . . . . 0.28999999999999998 110.32 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.44 HG13 HD22 ' A' ' 115' ' ' LEU . 14.6 p -154.7 154.27 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 1.03 109.987 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.46 ' HB2' ' HB3' ' A' ' 79' ' ' PHE . . . -137.21 162.89 32.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.374 0.606 . . . . 0.97999999999999998 111.657 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.17 112.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.411 -0.813 . . . . 1.5700000000000001 109.185 176.774 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.459 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mp -107.54 97.95 7.62 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.442 0.639 . . . . 1.02 110.975 -172.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.702 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -74.22 82.98 1.85 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.929 -1.032 . . . . 1.77 109.35 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 60.5 t -42.46 -42.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 114.541 -1.208 . . . . 1.3600000000000001 113.71 -169.62 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.35 74.43 4.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.014 0.435 . . . . 2.6400000000000001 110.755 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.7 mt -78.52 -22.85 46.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.55 0.691 . . . . 1.3100000000000001 109.444 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.8 -174.39 45.95 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.904 -1.044 . . . . 0.87 110.503 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.49 -40.13 87.2 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.598 2.199 . . . . 1.3899999999999999 112.339 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -118.06 -23.69 7.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.088 -0.506 . . . . 4.0 110.723 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.9 m -70.32 124.74 24.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.214 0.53 . . . . 1.3700000000000001 110.973 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -144.97 148.31 33.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.726 -0.67 . . . . 0.58999999999999997 110.353 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.486 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -76.44 87.32 3.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.857 -0.794 . . . . 2.1899999999999999 108.857 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.71 -67.52 0.56 Allowed Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.47 -0.871 . . . . 0.28000000000000003 112.541 -176.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.587 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 38.9 Cg_exo -53.96 -21.35 20.86 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.354 2.036 . . . . 0.28000000000000003 111.902 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.437 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 38.5 t -70.17 -42.67 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.889 -0.596 . . . . 1.01 110.071 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.99 -45.68 91.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.564 -0.744 . . . . 1.01 109.905 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.642 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.0 m-20 -61.74 -43.78 98.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.0299999999999998 109.804 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.4 -48.71 76.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 1.0700000000000001 111.165 178.65 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.11 -41.44 97.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.514 -0.766 . . . . 1.05 110.297 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -60.94 -34.47 74.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.829 -0.623 . . . . 2.5800000000000001 111.757 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.642 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 15.8 mm100 -65.47 -35.5 81.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.457 -0.338 . . . . 3.0299999999999998 110.929 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -100.24 7.93 44.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 1.95 111.421 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.89 36.31 27.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.798 -0.637 . . . . 1.1899999999999999 111.694 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.82 133.41 35.82 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.413 -0.358 . . . . 1.05 110.152 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.419 ' HB2' ' HE2' ' A' ' 117' ' ' MET . 34.6 Cg_endo -76.9 141.35 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.607 2.205 . . . . 0.23000000000000001 112.113 178.289 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.46 ' HB3' ' HB2' ' A' ' 53' ' ' ALA . 21.8 p90 -156.7 157.9 35.98 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.378 -0.828 . . . . 0.23999999999999999 110.453 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 mt -120.05 139.05 48.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.246 -0.888 . . . . 1.0700000000000001 109.646 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -89.23 108.01 19.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.905 -0.776 . . . . 1.05 108.905 177.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.71 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 12.0 t-160 -101.77 102.59 13.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.359 0.599 . . . . 0.59999999999999998 110.111 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.607 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 7.9 t -164.21 149.96 10.74 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.964 -0.46 . . . . 1.1399999999999999 110.423 -173.72 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.3 -13.32 36.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.483 -1.047 . . . . 1.1000000000000001 110.483 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.427 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 33.0 t70 -94.36 103.81 15.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.815 -0.809 . . . . 2.3300000000000001 108.815 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.41 -62.14 1.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.216 -0.447 . . . . 2.1800000000000002 112.036 -171.098 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.13 -29.86 68.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.051 0.453 . . . . 2.6299999999999999 111.17 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.427 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 65.6 ttt180 -67.81 -18.73 64.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 5.1200000000000001 110.944 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -131.25 33.18 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.511 . . . . 1.3500000000000001 110.289 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.589 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.43 -41.8 98.72 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.887 -0.597 . . . . 1.0600000000000001 113.012 -175.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.89 -37.08 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.695 0.284 . . . . 2.5 111.108 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' HG13 ' A' ' 96' ' ' ILE . 24.2 tp -64.08 -49.53 71.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.264 0.554 . . . . 1.22 110.052 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.7 mt -61.47 -31.32 71.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.133 -0.939 . . . . 2.1899999999999999 111.252 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.589 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 95.9 mtt180 -63.97 -37.98 89.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 5.0 110.866 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -66.33 -47.4 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.53 0.681 . . . . 2.8999999999999999 110.273 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.498 HG13 ' O ' ' A' ' 92' ' ' LEU . 41.2 mt -66.31 -56.33 14.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.519 -1.219 . . . . 1.0800000000000001 111.215 -175.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.9 t70 47.99 59.55 4.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.882 0.848 . . . . 1.0900000000000001 110.715 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . 0.41 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . -132.66 168.98 15.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.077 -0.965 . . . . 1.0800000000000001 109.336 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.475 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 78.3 Cg_exo -51.67 136.64 50.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.238 1.959 . . . . 0.29999999999999999 112.756 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.1 t -123.14 136.26 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.352 -0.84 . . . . 1.3 110.146 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.674 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 94.5 mtp -118.35 106.06 12.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.343 -0.614 . . . . 1.04 109.343 173.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.607 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.67 153.04 44.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.474 -0.785 . . . . 1.2 110.842 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.49 ' HZ3' ' HA ' ' A' ' 83' ' ' THR . 57.5 mttp -91.04 146.32 33.42 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 1.27 109.838 177.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.52 148.65 89.58 Favored 'Cis proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.548 -1.438 . . . . 0.88 112.858 0.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.71 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -140.61 135.97 32.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.695 -0.684 . . . . 0.39000000000000001 109.615 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.537 ' O ' HG21 ' A' ' 110' ' ' VAL . 9.9 t0 -75.93 132.55 40.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.8 -0.815 . . . . 0.51000000000000001 108.8 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.477 HG23 ' HB3' ' A' ' 20' ' ' ASN . 23.7 p -67.7 -21.17 65.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.707 -0.679 . . . . 1.04 112.189 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.9 p -76.0 -29.08 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.154 0.502 . . . . 1.8899999999999999 109.672 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.97 -45.5 49.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.62 109.57 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.674 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 23.2 t -59.03 -44.59 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 1.04 110.428 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.709 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -59.11 -52.68 64.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 1.01 111.346 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.664 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 37.3 mtmm -62.96 -47.03 84.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.033 -0.53 . . . . 2.4300000000000002 111.039 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -56.49 -37.65 70.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.325 . . . . 2.73 111.513 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.46 48.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 1.02 110.794 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.44 HD22 HG13 ' A' ' 52' ' ' VAL . 74.6 mt -64.02 -25.29 68.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 1.04 112.0 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.664 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 42.5 mm-40 -59.31 -31.09 68.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.642 0.258 . . . . 2.79 111.066 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.475 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 62.0 mtm -84.96 -23.07 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 1.0 111.402 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 49.4 t -175.73 98.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.152 0.501 . . . . 1.95 110.119 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.403 ' CA ' ' HG3' ' A' ' 6' ' ' PRO . . . -179.29 71.67 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.249 -0.741 . . . . 2.5699999999999998 111.249 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.52 -47.27 3.03 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.287 -1.125 . . . . 4.4800000000000004 110.287 -172.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 68.76 -177.92 0.22 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.33 0.652 . . . . 6.4199999999999999 111.698 173.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -121.23 53.2 1.16 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.41 -0.814 . . . . 9.5099999999999998 109.676 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -77.9 127.74 81.04 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.365 -0.834 . . . . 9.5999999999999996 110.078 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.42 73.48 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.964 2.443 . . . . 11.17 112.285 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.434 -0.793 . . . . 13.279999999999999 110.538 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.893 -0.483 . . . . 9.2100000000000009 111.893 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.423 ' O ' ' HB2' ' A' ' 3' ' ' MET . . . -142.74 160.85 39.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.649 0.224 . . . . 7.1500000000000004 110.673 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.423 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 1.8 mpt? 74.26 -23.46 0.23 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.64 0.776 . . . . 7.6699999999999999 112.274 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.401 ' H ' ' C ' ' A' ' 2' ' ' ALA . . . 85.05 -88.58 1.58 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.232 -0.747 . . . . 2.4399999999999999 111.232 -175.514 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.453 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.7 mtt -103.61 131.17 22.3 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.184 -0.302 . . . . 2.1800000000000002 110.184 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.453 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.5 Cg_exo -66.36 136.93 45.33 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.643 2.229 . . . . 0.55000000000000004 111.741 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.445 ' HD2' ' HD2' ' A' ' 49' ' ' PRO . 9.3 mttp -84.22 109.67 17.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 1.48 110.839 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 39.1 t -101.66 117.83 47.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 1.05 110.515 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.44 HD21 ' HB3' ' A' ' 41' ' ' ALA . 58.2 tp -97.66 109.9 22.56 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.698 -0.683 . . . . 1.5 110.432 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.08 123.86 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.199 0.523 . . . . 1.03 111.479 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.549 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.2 mm? -101.72 106.2 17.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.095 -0.957 . . . . 1.05 108.897 172.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -165.5 131.28 2.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.889 -0.596 . . . . 1.4099999999999999 109.873 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 24.4 t70 -94.13 -21.25 19.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.418 -0.81 . . . . 1.27 109.722 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.416 ' HB3' HD11 ' A' ' 17' ' ' ILE . 9.6 mm-40 -81.81 105.58 4.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 2.5600000000000001 110.193 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 34.5 Cg_exo -59.81 -25.19 78.57 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.771 2.314 . . . . 0.35999999999999999 113.366 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.32 -52.04 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.312 -0.625 . . . . 2.2799999999999998 109.312 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.416 HD11 ' HB3' ' A' ' 14' ' ' GLU . 2.9 mp -63.85 -43.8 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.55 . . . . 1.7 110.069 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.27 66.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.622 -0.717 . . . . 1.02 110.715 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.424 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 42.2 ttp -62.96 -38.77 92.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.691 -0.686 . . . . 1.28 111.257 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.409 ' HB3' HG23 ' A' ' 107' ' ' THR . 7.3 m-20 -65.11 -42.56 93.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.21 -0.45 . . . . 1.3600000000000001 111.289 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.465 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 52.8 mt -65.21 -43.8 90.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.984 0.421 . . . . 1.0700000000000001 109.967 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 38.6 tt0 -52.86 -50.93 62.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.163 -0.926 . . . . 1.7 110.662 178.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.424 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -64.5 -33.37 75.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 1.1799999999999999 111.629 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.17 -49.29 61.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 1.05 111.061 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.639 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 73.2 m-85 -66.93 -42.09 85.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.16 110.967 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -64.84 -26.96 68.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.576 -0.284 . . . . 0.68999999999999995 110.703 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.51000000000000001 110.951 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.06 -12.15 59.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.65000000000000002 111.223 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.89 51.74 1.35 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.785 -0.722 . . . . 0.28999999999999998 112.135 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.7 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.209 -0.293 . . . . 1.03 110.209 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.08 130.58 55.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.654 -0.499 . . . . 2.1400000000000001 109.654 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 40.7 t -109.01 138.37 36.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.173 -0.467 . . . . 1.0800000000000001 111.71 -171.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.63 123.39 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.771 -0.826 . . . . 1.05 108.771 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.5 p -92.85 128.68 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 1.6499999999999999 111.17 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.451 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -138.8 135.05 34.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 1.03 110.605 177.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.08 -10.91 20.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.292 -0.413 . . . . 1.04 111.37 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -130.26 166.1 21.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 1.0800000000000001 111.075 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.658 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 85.9 m -66.36 -34.92 79.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 1.6599999999999999 110.301 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -61.08 -51.57 68.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.69999999999999996 110.578 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.451 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 36.8 mt-30 -55.93 -37.07 68.45 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.999 -0.546 . . . . 1.4099999999999999 111.245 179.218 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.478 ' HB2' HD23 ' A' ' 11' ' ' LEU . . . -69.28 -52.74 24.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.542 -0.753 . . . . 1.04 111.133 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.73 -34.96 70.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.87 -0.604 . . . . 1.53 110.873 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -52.74 63.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.469 . . . . 2.9100000000000001 110.557 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 -36.74 84.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.88 -0.6 . . . . 1.6399999999999999 110.481 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.9 -36.09 80.29 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.074 0.464 . . . . 1.8400000000000001 110.939 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.47 -35.91 45.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.426 . . . . 1.1599999999999999 111.442 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -85.88 -31.47 22.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.059 0.457 . . . . 0.62 111.106 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -123.25 162.8 37.71 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.614 . . . . 0.47999999999999998 111.415 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.445 ' HD2' ' HD2' ' A' ' 7' ' ' LYS . 89.2 Cg_endo -95.47 90.55 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.68 2.92 . . . . 0.31 111.383 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.428 HD12 ' HB3' ' A' ' 7' ' ' LYS . 40.4 mm -73.94 123.85 30.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.784 -0.644 . . . . 1.03 111.329 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.517 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 24.8 m-20 -88.75 -28.48 20.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.552 -0.749 . . . . 0.28999999999999998 110.884 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.528 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -164.05 158.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.979 -0.378 . . . . 1.03 109.979 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.411 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -139.8 167.13 22.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.97999999999999998 111.806 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.412 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.58 112.26 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 1.5700000000000001 109.028 176.351 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.65 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.7 mp -111.22 119.59 39.45 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.43 0.53 . . . . 1.02 112.43 -167.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -85.02 141.67 30.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.861 -0.792 . . . . 1.77 108.861 167.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.429 HG22 HD23 ' A' ' 93' ' ' LEU . 13.1 t -100.89 2.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.584 0.707 . . . . 1.3600000000000001 111.148 -170.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -124.37 62.7 1.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.682 -0.69 . . . . 2.6400000000000001 109.862 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.54 -15.84 60.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.833 -0.621 . . . . 1.3100000000000001 110.24 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.31 -171.5 41.7 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.105 -0.798 . . . . 0.87 111.105 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -50.83 -45.55 35.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.061 2.507 . . . . 1.3899999999999999 112.148 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -117.95 -26.67 6.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 4.0 110.106 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -62.47 125.16 22.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.481 0.658 . . . . 1.3700000000000001 111.402 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -143.97 157.0 44.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.439 -0.8 . . . . 0.58999999999999997 109.647 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.65 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -71.4 87.48 0.86 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.388 0.613 . . . . 2.1899999999999999 109.493 171.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.24 -72.68 0.63 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.468 -0.872 . . . . 0.28000000000000003 112.19 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.658 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 44.0 Cg_exo -53.62 -26.39 37.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.565 2.176 . . . . 0.28000000000000003 112.212 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.497 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.3 t -68.66 -43.35 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.097 0.475 . . . . 1.01 110.201 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.77 -48.05 82.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.344 -0.844 . . . . 1.01 109.823 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -65.35 -40.5 93.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.47 -0.786 . . . . 2.0299999999999998 110.484 178.021 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.22 -47.98 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.398 0.618 . . . . 1.0700000000000001 110.955 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.65 -42.26 71.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.215 -0.902 . . . . 1.05 110.733 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -59.22 -36.56 75.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.599 . . . . 2.5800000000000001 111.225 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.4 mm100 -64.82 -37.4 87.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 3.0299999999999998 111.574 178.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -97.56 5.31 49.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.397 -0.365 . . . . 1.95 111.397 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 31.09 20.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.971 -0.558 . . . . 1.1899999999999999 111.399 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.8 mt -83.36 130.08 57.93 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 109.595 -0.52 . . . . 1.05 109.595 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.28 142.95 38.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.309 2.006 . . . . 0.23000000000000001 111.362 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.411 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 25.6 p90 -159.3 157.16 30.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.124 0.487 . . . . 0.23999999999999999 110.621 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 34.8 mt -121.39 138.59 51.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.311 -0.859 . . . . 1.0700000000000001 109.853 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.34 108.68 19.46 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.758 -0.83 . . . . 1.05 108.758 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.587 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 17.4 t-160 -105.82 85.33 2.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.369 0.604 . . . . 0.59999999999999998 109.476 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 9.6 t -134.05 160.49 37.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.841 -1.072 . . . . 1.1399999999999999 110.212 -173.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.08 2.27 38.05 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.569 -1.013 . . . . 1.1000000000000001 110.569 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.29 51.09 1.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.545 . . . . 2.3300000000000001 110.692 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.66 -41.45 96.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.702 -0.681 . . . . 2.1800000000000002 111.145 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.01 -40.81 17.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.562 -0.29 . . . . 2.6299999999999999 110.793 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -43.59 80.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.102 -0.499 . . . . 5.1200000000000001 111.521 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -119.46 32.04 6.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 1.3500000000000001 111.149 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.13 -41.09 96.44 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.999 -0.619 . . . . 1.0600000000000001 112.809 -177.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.61 -47.17 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.134 0.493 . . . . 2.5 110.624 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.44 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.3 tp -60.29 -45.69 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.602 -0.727 . . . . 1.22 110.32 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.429 HD23 HG22 ' A' ' 57' ' ' VAL . 74.2 mt -58.64 -39.93 81.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 2.1899999999999999 111.368 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.478 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 4.7 mmp_? -64.26 -33.46 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 5.0 111.361 178.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.8 -34.12 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 2.8999999999999999 111.069 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.44 HG13 ' O ' ' A' ' 92' ' ' LEU . 80.8 mt -64.76 -52.82 49.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.089 -0.505 . . . . 1.0800000000000001 110.314 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.51 76.0 0.36 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.815 0.697 . . . . 1.0900000000000001 110.787 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -157.6 162.3 27.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.403 -0.817 . . . . 1.0800000000000001 108.95 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.689 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -57.26 136.19 74.82 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.448 2.098 . . . . 0.29999999999999999 112.429 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.91 132.6 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 1.3 110.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.435 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.9 mmm -113.04 105.54 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.895 -0.78 . . . . 1.04 108.895 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 146.14 55.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.003 -0.544 . . . . 1.2 111.475 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.53 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.3 mttt -91.05 141.61 26.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 1.27 109.473 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.57 156.41 99.23 Favored 'Cis proline' 0 CA--C 1.528 0.217 0 C-N-CA 123.413 -1.494 . . . . 0.88 113.339 2.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.587 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -152.76 135.1 15.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.39000000000000001 109.915 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -70.94 130.23 41.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.897 -1.149 . . . . 0.51000000000000001 107.897 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.465 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 33.5 p -65.05 -18.35 65.22 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.737 0.643 . . . . 1.04 112.737 -171.084 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.3 p -71.15 -38.81 72.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.459 -0.496 . . . . 1.8899999999999999 109.689 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.38 -46.76 87.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.412 0.625 . . . . 0.62 109.575 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.72 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.853 -1.067 . . . . 1.04 110.394 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.639 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.64 -50.03 72.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 1.01 111.518 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -59.59 -43.32 93.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 2.4300000000000002 111.349 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.435 ' O ' ' HG3' ' A' ' 117' ' ' MET . 23.9 mmt180 -68.16 -31.79 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.965 0.412 . . . . 2.73 111.321 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.67 -48.53 25.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.354 -0.385 . . . . 1.02 110.473 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.449 HD23 HG11 ' A' ' 52' ' ' VAL . 70.1 mt -66.42 -32.09 73.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.489 0.551 . . . . 1.04 112.489 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -70.2 -22.16 62.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.599 -0.441 . . . . 2.79 110.978 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.689 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 56.5 mtm -77.55 -16.35 58.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 1.0 110.613 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.517 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 43.2 t -90.7 -42.74 10.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.265 0.555 . . . . 1.95 109.64 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.64 -104.86 0.93 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.64 -0.709 . . . . 2.5699999999999998 111.331 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.75 -29.47 2.99 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.003 -0.618 . . . . 4.4800000000000004 113.063 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.4 t70 68.71 16.99 8.94 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.573 0.702 . . . . 6.4199999999999999 110.045 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -165.53 135.56 3.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.746 -0.661 . . . . 9.5099999999999998 110.723 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -104.55 137.36 19.2 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.086 -0.506 . . . . 9.5999999999999996 110.028 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.34 129.73 13.27 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.37 2.046 . . . . 11.17 112.13 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.511 -0.757 . . . . 13.279999999999999 110.501 179.483 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.861 -0.496 . . . . 9.2100000000000009 111.861 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.66 34.13 17.74 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.826 0.451 . . . . 7.1500000000000004 111.329 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.6 mtm -95.09 135.15 36.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.135 -0.484 . . . . 7.6699999999999999 109.974 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.413 ' O ' ' HB2' ' A' ' 5' ' ' MET . . . -163.07 62.38 0.26 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.846 -0.692 . . . . 2.4399999999999999 112.027 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.413 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 56.4 mtt 68.22 131.55 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.483 0.713 . . . . 2.1800000000000002 112.595 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.86 138.8 65.05 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.917 2.411 . . . . 0.55000000000000004 112.04 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -87.17 105.09 16.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.48 -0.563 . . . . 1.48 109.48 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.488 HG21 ' CG1' ' A' ' 52' ' ' VAL . 50.2 t -99.88 135.34 35.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.903 -0.59 . . . . 1.05 110.939 -174.037 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 52.1 tp -110.54 111.94 23.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.198 -0.455 . . . . 1.5 110.709 177.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.97 122.43 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.215 0.531 . . . . 1.03 111.467 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.536 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -102.19 101.27 11.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.172 -0.922 . . . . 1.05 108.642 172.129 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -159.03 120.0 3.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.866 -0.606 . . . . 1.4099999999999999 109.956 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.544 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 36.8 t70 -88.41 -16.9 31.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.307 -0.406 . . . . 1.27 110.332 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.414 ' HB3' HD11 ' A' ' 17' ' ' ILE . 42.9 mt-10 -82.95 103.16 2.23 Favored Pre-proline 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 2.5600000000000001 109.421 173.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.9 Cg_exo -58.48 -29.04 87.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.667 2.244 . . . . 0.35999999999999999 113.07 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -51.28 57.21 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.682 -0.488 . . . . 2.2799999999999998 109.682 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.423 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.8 mp -64.25 -43.4 97.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 1.7 110.182 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.42 -47.53 81.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.825 -0.625 . . . . 1.02 110.678 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.7 ttp -64.28 -39.32 93.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.516 -0.765 . . . . 1.28 110.874 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 60.7 m-20 -66.32 -47.04 74.82 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.969 -0.56 . . . . 1.3600000000000001 111.207 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.3 mt -60.01 -45.32 93.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.039 -0.356 . . . . 1.0700000000000001 110.039 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.452 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -52.19 -50.6 61.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 1.7 110.535 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -68.82 -31.21 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 1.1799999999999999 111.522 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.8 -43.09 76.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.833 0.349 . . . . 1.05 110.838 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.537 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 50.1 m-85 -69.37 -42.68 74.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 0.16 110.881 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.435 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 43.3 mt-10 -62.51 -32.02 72.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.68999999999999995 110.24 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.31 -35.13 79.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.51000000000000001 110.818 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -83.98 6.52 21.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.65000000000000002 110.625 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 57.38 2.85 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.28999999999999998 112.485 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.27 170.48 15.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 1.03 111.051 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -115.92 132.54 56.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.186 -0.672 . . . . 2.1400000000000001 109.186 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.452 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.5 t -117.12 137.29 51.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.749 0.648 . . . . 1.0800000000000001 112.749 -166.833 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -110.91 135.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.464 -0.939 . . . . 1.05 108.464 169.668 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.28 128.74 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.911 0.386 . . . . 1.6499999999999999 110.754 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.474 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.577 . . . . 1.03 110.41 176.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.408 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -103.17 -6.54 22.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.492 . . . . 1.04 110.769 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -132.31 163.95 27.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.876 -0.602 . . . . 1.0800000000000001 110.315 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.579 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 79.6 m -68.46 -33.05 73.5 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.744 -0.382 . . . . 1.6599999999999999 110.139 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.66 -39.38 84.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.69999999999999996 111.176 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.474 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 36.7 mt-30 -62.45 -36.67 83.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.258 0.552 . . . . 1.4099999999999999 110.473 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.474 ' HB2' HD23 ' A' ' 11' ' ' LEU . . . -67.88 -53.22 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.405 -0.816 . . . . 1.04 111.267 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 79.0 mt -59.45 -33.2 70.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.1 -0.5 . . . . 1.53 110.663 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -63.97 -49.71 71.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.936 -0.394 . . . . 2.9100000000000001 109.936 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 m -67.21 -27.04 66.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.958 -0.565 . . . . 1.6399999999999999 111.319 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.2 -35.79 69.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 1.8400000000000001 111.052 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.12 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 1.1599999999999999 111.06 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -83.01 -28.24 29.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.86 -0.609 . . . . 0.62 111.464 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -131.66 160.2 68.5 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 110.109 -0.33 . . . . 0.47999999999999998 110.109 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -94.47 89.3 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.484 2.789 . . . . 0.31 111.552 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.2 mm -67.78 123.29 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.655 -0.702 . . . . 1.03 111.801 -175.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.32 -34.81 18.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 110.296 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.488 ' CG1' HG21 ' A' ' 8' ' ' VAL . 14.6 p -159.13 158.74 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 1.03 110.082 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -141.78 166.01 25.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.203 0.525 . . . . 0.97999999999999998 112.069 -178.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.75 112.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.334 -0.848 . . . . 1.5700000000000001 109.302 176.359 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.725 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -113.58 121.86 45.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.432 0.53 . . . . 1.02 112.432 -167.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -80.49 109.96 15.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.809 0.814 . . . . 1.77 108.959 169.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.68 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 17.3 t -59.05 -19.65 16.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.353 -1.294 . . . . 1.3600000000000001 112.253 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -123.88 80.41 1.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 2.6400000000000001 110.573 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.28 -32.3 62.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.751 -0.659 . . . . 1.3100000000000001 110.01 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -169.66 28.71 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.233 -0.747 . . . . 0.87 111.233 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.47 -37.76 96.29 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.165 2.577 . . . . 1.3899999999999999 112.599 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 62' ' ' LYS . 13.8 tmtt? -113.57 -34.31 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.695 -0.483 . . . . 4.0 109.695 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -63.52 124.52 21.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 1.3700000000000001 111.65 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.94 149.8 35.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.34 -0.845 . . . . 0.58999999999999997 109.598 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.725 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.1 p -71.47 87.15 0.87 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.491 0.663 . . . . 2.1899999999999999 109.257 171.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.94 -71.6 0.55 Allowed Glycine 0 CA--C 1.509 -0.303 0 C-N-CA 120.451 -0.88 . . . . 0.28000000000000003 112.045 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.579 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 52.4 Cg_exo -52.34 -25.14 23.3 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.625 2.217 . . . . 0.28000000000000003 112.064 174.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.422 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.4 t -71.74 -44.7 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 1.01 110.24 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.78 -49.43 77.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.281 -0.872 . . . . 1.01 110.118 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.513 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 17.5 m-20 -62.08 -40.18 94.96 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.678 -0.692 . . . . 2.0299999999999998 110.28 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.24 -50.01 74.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.279 0.562 . . . . 1.0700000000000001 111.073 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.22 -42.74 96.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.492 -0.776 . . . . 1.05 110.312 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.412 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 64.0 mmtt -61.41 -33.48 73.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.588 -0.733 . . . . 2.5800000000000001 111.498 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.513 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 79.4 mm-40 -71.62 -37.44 70.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.16 -0.473 . . . . 3.0299999999999998 111.358 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -90.1 2.14 55.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 1.95 111.256 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 36.47 17.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.489 -0.778 . . . . 1.1899999999999999 111.205 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.06 134.06 30.78 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.072 -0.513 . . . . 1.05 110.274 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.38 140.85 24.9 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.351 2.034 . . . . 0.23000000000000001 111.728 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -156.74 161.92 39.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 0.23999999999999999 110.662 179.52 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -125.62 140.77 47.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.364 -0.835 . . . . 1.0700000000000001 109.913 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.91 109.07 19.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.03 0.443 . . . . 1.05 110.027 178.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.588 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 21.2 t-160 -109.43 86.11 2.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.223 0.535 . . . . 0.59999999999999998 109.798 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.504 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -126.75 160.15 31.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.341 -0.845 . . . . 1.1399999999999999 111.217 -172.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.55 16.19 52.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.082 -0.58 . . . . 1.1000000000000001 112.541 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -149.99 113.53 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.876 0.37 . . . . 2.3300000000000001 110.785 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.7 -5.03 15.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.25 -0.432 . . . . 2.1800000000000002 110.677 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . 0.426 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 14.2 t70 -83.18 -53.59 5.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.126 -0.488 . . . . 2.6299999999999999 111.082 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.454 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 5.2 mpt_? -80.35 -3.4 49.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.174 0.511 . . . . 5.1200000000000001 110.852 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.536 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 96.9 m-70 -119.17 16.57 13.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.94 -0.573 . . . . 1.3500000000000001 111.226 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.49 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -55.49 -44.84 85.49 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.852 -0.69 . . . . 1.0600000000000001 112.474 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.448 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 43.8 tt0 -63.28 -42.68 99.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.956 0.408 . . . . 2.5 110.669 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.453 HD23 ' CG1' ' A' ' 57' ' ' VAL . 32.8 tp -64.09 -40.19 95.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.796 -0.638 . . . . 1.22 110.462 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.536 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 76.6 mt -61.06 -34.88 75.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 2.1899999999999999 111.338 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.49 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 65.1 mtm-85 -72.5 -26.19 61.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 5.0 110.414 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.79 -26.47 54.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 2.8999999999999999 110.284 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.412 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 77.9 mt -83.28 -63.26 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.74 -0.664 . . . . 1.0800000000000001 110.746 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.2 t70 61.4 83.11 0.15 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.734 -0.666 . . . . 1.0900000000000001 110.622 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.38 165.11 13.28 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.694 -0.685 . . . . 1.0800000000000001 109.735 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.58 140.36 93.13 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.841 2.361 . . . . 0.29999999999999999 112.85 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.96 133.68 65.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 1.3 111.357 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 83.5 mmm -121.08 92.37 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.418 -0.956 . . . . 1.04 108.418 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.434 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.48 154.84 40.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.104 -0.498 . . . . 1.2 111.786 -173.967 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.409 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 94.8 mttt -89.96 142.85 29.21 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 1.27 109.475 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 10.8 Cg_exo -71.71 145.61 83.35 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.487 -1.464 . . . . 0.88 112.909 0.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.588 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 134.32 25.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.39000000000000001 109.965 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.564 ' O ' HG22 ' A' ' 110' ' ' VAL . 16.7 t70 -73.44 128.25 34.98 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.417 -0.586 . . . . 0.51000000000000001 109.417 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' THR . . . . . . . . . . . . . 18.7 p -65.64 -21.52 66.57 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.75 . . . . 1.04 112.823 -170.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.8 t -72.9 -41.09 64.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.527 -0.545 . . . . 1.8899999999999999 109.527 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.93 -40.7 91.63 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.118 0.485 . . . . 0.62 110.056 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.564 HG22 ' O ' ' A' ' 106' ' ' ASP . 24.8 t -63.82 -42.5 96.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.443 -0.799 . . . . 1.04 110.375 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.537 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.64 -48.65 68.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.798 -0.637 . . . . 1.01 111.58 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -60.46 -45.56 93.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.183 -0.462 . . . . 2.4300000000000002 111.453 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.463 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 34.1 mmt180 -67.49 -25.4 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 2.73 111.391 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.23 -51.47 9.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.002 0.429 . . . . 1.02 110.43 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.485 HD21 HG12 ' A' ' 52' ' ' VAL . 75.4 mt -64.54 -27.54 69.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.869 0.692 . . . . 1.04 112.869 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.463 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 9.3 pt-20 -67.44 -32.06 72.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.442 -0.503 . . . . 2.79 110.719 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.8 mtm -72.6 -29.53 63.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.246 -0.434 . . . . 1.0 111.285 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.425 ' HB3' ' HB ' ' A' ' 52' ' ' VAL . 17.8 p -86.13 0.48 53.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.954 0.407 . . . . 1.95 110.757 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.17 -20.5 75.0 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.997 -0.841 . . . . 2.5699999999999998 110.997 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -136.82 -134.73 3.32 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.879 -0.888 . . . . 4.4800000000000004 110.879 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -156.63 -157.59 0.71 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.541 -0.54 . . . . 6.4199999999999999 109.541 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.09 111.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.107 0.479 . . . . 9.5099999999999998 110.966 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.55 138.17 77.58 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.697 -0.683 . . . . 9.5999999999999996 110.558 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.59 158.07 47.9 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.3 2.0 . . . . 11.17 111.588 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.511 -0.756 . . . . 13.279999999999999 110.181 178.735 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 112.215 -0.354 . . . . 9.2100000000000009 112.215 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.23 54.79 3.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.48 . . . . 7.1500000000000004 110.729 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.0 tpt -146.57 127.44 14.46 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.112 -0.699 . . . . 7.6699999999999999 109.112 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.8 -56.8 4.94 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.845 -0.902 . . . . 2.4399999999999999 110.845 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp -81.9 124.67 79.01 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.037 -0.727 . . . . 2.1800000000000002 109.037 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.443 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 26.0 Cg_exo -62.6 134.47 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.678 2.252 . . . . 0.55000000000000004 111.799 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -87.12 107.1 18.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.388 0.614 . . . . 1.48 109.405 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 58.7 t -99.93 130.83 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.216 -0.902 . . . . 1.05 111.033 -172.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.418 ' HB2' ' CD1' ' A' ' 50' ' ' ILE . 49.4 tp -105.61 111.24 23.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 1.5 110.357 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.37 123.36 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 1.03 111.422 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -103.48 106.04 16.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.21 -0.905 . . . . 1.05 108.57 171.489 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.21 125.61 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.195 0.522 . . . . 1.4099999999999999 110.444 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 t70 -90.72 -13.8 33.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.564 -0.744 . . . . 1.27 109.895 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -89.74 104.02 7.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 2.5600000000000001 109.89 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.465 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.7 Cg_exo -59.44 -31.53 94.91 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.919 2.412 . . . . 0.35999999999999999 113.045 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.59 -49.88 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.593 -0.521 . . . . 2.2799999999999998 109.593 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -67.24 -44.07 87.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 1.7 110.888 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -51.28 68.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 1.02 110.737 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.2 ttp -61.46 -43.33 99.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.665 -0.698 . . . . 1.28 111.358 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.416 ' HB3' HG22 ' A' ' 107' ' ' THR . 7.1 m-20 -67.47 -39.02 85.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.341 -0.39 . . . . 1.3600000000000001 111.227 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.417 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 51.4 mt -62.91 -45.78 90.92 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 110.071 -0.344 . . . . 1.0700000000000001 110.071 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 36.4 tt0 -54.31 -52.68 60.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.547 -0.752 . . . . 1.7 110.314 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -64.77 -30.34 71.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.467 -0.333 . . . . 1.1799999999999999 111.416 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.47 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 1.05 110.82 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.661 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 63.7 m-85 -68.46 -41.48 80.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.16 110.682 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.11 -32.52 73.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 0.68999999999999995 110.525 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.49 -32.71 73.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.089 0.471 . . . . 0.51000000000000001 110.231 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -84.03 1.25 44.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.65000000000000002 111.167 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 50.73 3.95 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.28999999999999998 112.539 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.37 167.16 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.246 -0.279 . . . . 1.03 110.246 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -113.44 132.3 55.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.297 -0.631 . . . . 2.1400000000000001 109.297 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.558 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 4.8 t -121.79 147.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.852 0.686 . . . . 1.0800000000000001 112.852 -167.111 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 t -120.44 143.34 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.348 -0.842 . . . . 1.05 108.793 168.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -111.85 126.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 1.6499999999999999 111.123 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.466 ' HB1' ' CB ' ' A' ' 40' ' ' GLN . . . -135.53 142.98 45.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.702 -0.681 . . . . 1.03 110.139 177.833 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.86 -2.92 15.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.682 0.277 . . . . 1.04 111.402 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -136.9 169.95 16.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.52 -0.309 . . . . 1.0800000000000001 111.046 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.517 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 18.6 p -59.99 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.579 . . . . 1.6599999999999999 109.536 172.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.77 -49.91 69.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.597 -1.183 . . . . 0.69999999999999996 111.813 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.466 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 41.1 mt-30 -59.31 -38.57 80.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.107 0.48 . . . . 1.4099999999999999 111.092 178.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.514 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -68.75 -51.35 42.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.694 . . . . 1.04 111.18 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.517 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 67.3 mt -63.97 -28.19 69.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.642 -0.708 . . . . 1.53 110.733 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -66.77 -51.28 57.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.521 . . . . 2.9100000000000001 110.123 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.3 t -65.48 -34.11 77.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 1.6399999999999999 110.907 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 14.6 tp -61.94 -33.16 73.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.232 0.539 . . . . 1.8400000000000001 110.211 177.926 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.56 22.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 1.1599999999999999 111.065 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.35 -37.97 56.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.546 . . . . 0.62 111.108 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -123.5 159.44 55.21 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.096 -0.502 . . . . 0.47999999999999998 110.091 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -93.22 86.67 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.358 2.705 . . . . 0.31 111.075 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.418 ' CD1' ' HB2' ' A' ' 9' ' ' LEU . 41.6 mm -63.94 122.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.537 -0.756 . . . . 1.03 111.485 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.421 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 43.2 m-20 -92.57 -29.97 15.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.558 -0.746 . . . . 0.28999999999999998 110.142 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.0 p -158.41 156.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 1.03 109.716 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.452 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.39 168.99 18.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.355 0.597 . . . . 0.97999999999999998 112.146 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -140.38 112.61 4.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.206 -0.906 . . . . 1.5700000000000001 109.207 177.507 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.601 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -112.81 116.91 30.81 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.531 0.567 . . . . 1.02 112.531 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.91 133.7 38.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.217 -0.66 . . . . 1.77 109.217 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 19.8 t -93.8 -10.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.771 -0.649 . . . . 1.3600000000000001 111.249 -170.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -116.32 53.82 0.86 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 2.6400000000000001 110.551 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.66 -41.26 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.262 0.553 . . . . 1.3100000000000001 110.473 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.82 -172.99 29.92 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.96 -0.856 . . . . 0.87 110.96 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.59 -43.76 52.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.827 2.351 . . . . 1.3899999999999999 112.263 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.552 ' HB3' ' HZ3' ' A' ' 62' ' ' LYS . 9.9 mtpm? -113.42 -27.96 7.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.24 -0.436 . . . . 4.0 110.879 177.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.7 m -68.54 123.95 22.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 1.3700000000000001 111.3 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.3 152.26 40.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.099 -0.955 . . . . 0.58999999999999997 109.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.601 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.2 p -68.76 86.31 0.33 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.406 0.622 . . . . 2.1899999999999999 109.521 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.3 -66.47 0.3 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.791 -0.718 . . . . 0.28000000000000003 112.023 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.47 -28.14 53.06 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.234 1.956 . . . . 0.28000000000000003 111.541 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -71.11 -44.37 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 1.01 110.195 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.99 87.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.29 -0.868 . . . . 1.01 110.092 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.445 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 21.7 t70 -61.52 -43.67 98.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.359 -0.837 . . . . 2.0299999999999998 110.395 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.19 -49.34 72.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.836 -0.62 . . . . 1.0700000000000001 111.036 178.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.66 -43.39 89.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.421 -0.808 . . . . 1.05 110.656 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.48 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 56.2 mmtt -60.65 -32.98 72.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.675 -0.693 . . . . 2.5800000000000001 111.397 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.445 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 14.4 mm100 -71.55 -33.48 69.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 3.0299999999999998 111.526 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -93.23 1.07 57.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.678 -0.237 . . . . 1.95 111.131 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.16 34.5 13.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.7 -0.682 . . . . 1.1899999999999999 111.307 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.4 mt -87.55 133.9 37.12 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.439 . . . . 1.05 110.223 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 27.5 Cg_endo -75.36 143.37 27.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.373 2.049 . . . . 0.23000000000000001 112.051 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.452 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 28.7 p90 -159.65 159.29 32.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.748 -0.66 . . . . 0.23999999999999999 110.462 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -124.0 139.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.408 -0.815 . . . . 1.0700000000000001 109.728 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.459 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mm? -88.43 109.69 20.22 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.451 -0.574 . . . . 1.05 109.451 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.611 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 19.7 t-160 -102.25 90.88 4.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.987 -0.552 . . . . 0.59999999999999998 109.732 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.545 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 9.3 t -139.63 160.98 38.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.364 -0.835 . . . . 1.1399999999999999 110.409 -174.109 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.07 9.47 20.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.89 -0.671 . . . . 1.1000000000000001 111.82 175.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.62 60.26 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.195 0.521 . . . . 2.3300000000000001 110.822 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.68 -41.39 79.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.566 -0.743 . . . . 2.1800000000000002 110.08 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.3 -20.14 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.603 -0.726 . . . . 2.6299999999999999 111.371 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.577 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 3.6 tpm_? -90.56 -22.07 21.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 5.1200000000000001 110.761 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.488 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.1 m-70 -126.01 28.86 6.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 1.3500000000000001 111.637 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.411 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . -58.17 -37.99 88.32 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.119 -0.562 . . . . 1.0600000000000001 112.602 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.0 -46.01 75.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.855 0.36 . . . . 2.5 110.699 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.41 ' O ' HG13 ' A' ' 96' ' ' ILE . 56.8 tp -60.89 -39.66 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 1.22 110.501 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.488 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.9 mt -61.78 -32.77 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 2.1899999999999999 111.067 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -72.53 -38.54 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.88 0.372 . . . . 5.0 110.297 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.91 -42.26 89.22 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.532 0.682 . . . . 2.8999999999999999 110.233 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.48 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 84.7 mt -72.07 -58.79 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.892 -1.049 . . . . 1.0800000000000001 111.067 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.3 t70 62.54 82.07 0.19 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.618 0.723 . . . . 1.0900000000000001 111.093 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -163.45 162.09 17.48 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 1.0800000000000001 108.986 178.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.504 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -58.27 146.25 89.88 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.57 2.18 . . . . 0.29999999999999999 112.528 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.7 t -123.05 132.4 71.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 1.3 111.028 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.6 mmm -113.87 106.25 14.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 1.04 109.129 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.545 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.03 146.35 53.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.984 -0.553 . . . . 1.2 111.938 -174.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.45 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.6 mttt -91.59 145.11 30.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.827 -0.624 . . . . 1.27 110.204 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.22 142.61 75.04 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 123.572 -1.428 . . . . 0.88 112.422 -0.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.611 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -133.08 135.44 45.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.867 -0.606 . . . . 0.39000000000000001 109.806 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.427 ' O ' HG22 ' A' ' 110' ' ' VAL . 13.4 t0 -70.38 127.31 32.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.287 -1.005 . . . . 0.51000000000000001 108.287 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.416 HG22 ' HB3' ' A' ' 20' ' ' ASN . 22.9 p -63.22 -20.5 65.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.348 -0.842 . . . . 1.04 112.646 -172.272 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -70.53 -40.29 73.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.8899999999999999 109.943 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.34 -39.56 81.85 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.62 109.903 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.427 HG22 ' O ' ' A' ' 106' ' ' ASP . 21.6 t -65.15 -45.31 94.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 1.04 110.09 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.661 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.14 -50.42 71.95 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.685 -0.689 . . . . 1.01 111.374 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.623 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 67.9 mttm -57.42 -51.5 69.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 2.4300000000000002 111.304 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -61.26 -39.46 90.44 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.112 0.257 . . . . 2.73 111.686 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.94 79.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 1.02 110.172 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.455 HD22 HG12 ' A' ' 52' ' ' VAL . 85.1 mt -67.02 -25.34 66.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 1.04 111.768 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.623 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 36.7 mm-40 -60.79 -38.47 85.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.986 0.422 . . . . 2.79 110.692 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.504 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.4 mtm -79.59 -10.66 59.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 1.0 110.717 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.443 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 36.7 t -88.86 18.57 4.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 1.95 110.202 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.62 85.89 0.53 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.436 -0.666 . . . . 2.5699999999999998 111.436 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.48 -90.96 0.84 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.225 -0.75 . . . . 4.4800000000000004 111.225 -176.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -155.67 24.19 0.39 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.362 0.601 . . . . 6.4199999999999999 109.761 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.441 ' HA ' ' HZ1' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -140.07 129.71 24.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.924 -0.58 . . . . 9.5099999999999998 111.145 -174.732 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.43 139.94 92.25 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.619 -0.719 . . . . 9.5999999999999996 109.448 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.93 89.27 0.37 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.585 2.19 . . . . 11.17 112.405 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.573 -0.727 . . . . 13.279999999999999 110.734 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.411 -0.675 . . . . 9.2100000000000009 111.411 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.14 49.34 1.24 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.251 0.548 . . . . 7.1500000000000004 110.255 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.9 mmm -103.4 -4.67 23.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.771 -0.65 . . . . 7.6699999999999999 110.352 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.16 -53.52 0.79 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.173 -0.771 . . . . 2.4399999999999999 111.173 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.423 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 16.7 mmt -123.83 141.29 36.43 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.807 -0.442 . . . . 2.1800000000000002 109.807 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.507 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.4 Cg_endo -68.06 135.68 35.54 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.609 1.539 . . . . 0.55000000000000004 110.635 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 34.1 tptt -84.63 104.53 14.69 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.724 -0.472 . . . . 1.48 109.724 -178.452 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.44 HG23 ' CG1' ' A' ' 52' ' ' VAL . 46.7 t -100.14 128.97 51.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.84 -0.618 . . . . 1.05 110.978 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 50.5 tp -107.43 119.01 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.451 -0.34 . . . . 1.5 110.462 176.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.5 t -100.17 124.93 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.149 0.5 . . . . 1.03 111.43 178.272 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.546 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -104.51 106.41 16.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.284 -0.871 . . . . 1.05 109.013 172.841 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -167.3 128.95 1.59 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.975 -0.557 . . . . 1.4099999999999999 109.687 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.5 t70 -84.58 -28.88 26.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 1.27 109.661 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.459 ' HB3' HD11 ' A' ' 17' ' ' ILE . 1.2 mp0 -74.07 109.55 7.15 Favored Pre-proline 0 N--CA 1.462 0.147 0 CA-C-N 116.249 -0.432 . . . . 2.5600000000000001 110.583 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.6 Cg_exo -60.39 -29.59 89.11 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.527 2.151 . . . . 0.35999999999999999 112.733 -178.467 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -52.47 42.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.059 -0.349 . . . . 2.2799999999999998 110.059 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.459 HD11 ' HB3' ' A' ' 14' ' ' GLU . 2.5 mp -62.69 -42.6 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 1.7 109.927 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.09 71.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.502 -0.772 . . . . 1.02 110.832 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.478 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 47.6 ttp -65.05 -38.37 90.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.647 -0.706 . . . . 1.28 111.202 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . . . . . . . . . 6.3 m-20 -64.82 -44.07 91.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.047 -0.524 . . . . 1.3600000000000001 110.982 179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.411 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 39.3 mt -61.91 -44.99 95.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.437 -0.347 . . . . 1.0700000000000001 110.253 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.591 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 43.4 tt0 -53.44 -51.18 63.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.633 -0.712 . . . . 1.7 110.815 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.478 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -63.43 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 1.1799999999999999 111.33 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.19 78.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.306 -0.406 . . . . 1.05 110.95 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.517 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 57.0 m-85 -71.19 -42.09 69.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.422 . . . . 0.16 110.874 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.412 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 46.0 mt-10 -65.4 -28.24 69.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.996 0.427 . . . . 0.68999999999999995 110.079 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.8 -32.18 70.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.51000000000000001 110.616 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -83.97 -2.5 56.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.227 0.537 . . . . 0.65000000000000002 110.461 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 62.76 1.61 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.601 -0.727 . . . . 0.28999999999999998 111.998 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.507 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -145.32 172.16 13.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 1.03 111.359 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -114.57 137.24 52.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.938 -0.573 . . . . 2.1400000000000001 109.612 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.591 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 5.1 t -120.19 146.91 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 1.0800000000000001 111.913 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.425 HG11 ' OG ' ' A' ' 44' ' ' SER . 24.1 t -119.6 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.464 -0.789 . . . . 1.05 108.919 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t -97.24 124.72 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 1.6499999999999999 110.885 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.461 ' HB3' ' CB ' ' A' ' 40' ' ' GLN . . . -134.59 134.64 41.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.007 -0.542 . . . . 1.03 110.415 177.255 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.48 -11.02 20.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.97 0.414 . . . . 1.04 110.792 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.3 p -129.87 160.77 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 1.0800000000000001 110.732 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.586 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.1 m -63.92 -35.5 80.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.736 -0.468 . . . . 1.6599999999999999 109.736 174.366 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.0 -47.87 84.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.69999999999999996 111.19 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.461 ' CB ' ' HB3' ' A' ' 35' ' ' ALA . 39.4 mt-30 -59.01 -41.24 87.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.642 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.497 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -63.36 -51.77 64.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.274 -0.875 . . . . 1.04 111.444 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.586 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.9 mt -62.24 -32.23 72.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.067 -0.515 . . . . 1.53 110.894 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.27 -50.64 69.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 2.9100000000000001 110.219 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.425 ' OG ' HG11 ' A' ' 33' ' ' VAL . 23.2 t -68.5 -35.07 76.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 1.6399999999999999 110.551 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -57.3 -39.67 76.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.8400000000000001 109.817 177.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.82 30.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 1.1599999999999999 111.408 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.84 -38.34 58.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.998 0.428 . . . . 0.62 111.777 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -114.48 163.94 17.83 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.47999999999999998 110.758 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -96.0 76.01 0.13 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.494 2.796 . . . . 0.31 111.341 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 39.2 mm -56.78 120.24 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.228 -0.896 . . . . 1.03 111.725 -174.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.779 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 16.8 m-20 -90.09 -31.19 17.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.372 -0.831 . . . . 0.28999999999999998 110.629 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.44 ' CG1' HG23 ' A' ' 8' ' ' VAL . 14.6 p -160.34 156.7 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 1.03 109.914 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.81 160.92 39.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.46 0.648 . . . . 0.97999999999999998 112.168 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -133.07 112.04 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 1.5700000000000001 109.243 174.782 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.678 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -111.78 117.73 33.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.986 0.422 . . . . 1.02 112.039 -170.026 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.87 129.96 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.839 -0.8 . . . . 1.77 108.839 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 61.8 t -88.97 -35.72 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.139 -0.482 . . . . 1.3600000000000001 111.475 -171.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.68 60.66 4.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.072 0.463 . . . . 2.6400000000000001 111.382 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.362 0.601 . . . . 1.3100000000000001 110.148 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.69 -171.58 32.05 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.65 -0.98 . . . . 0.87 110.65 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.11 -36.83 96.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.856 2.371 . . . . 1.3899999999999999 113.104 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -127.24 -21.76 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 4.0 111.557 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 p -73.54 126.41 30.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.483 0.658 . . . . 1.3700000000000001 110.709 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -144.93 155.09 43.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.363 -0.835 . . . . 0.58999999999999997 110.301 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.678 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.5 p -69.49 87.27 0.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.488 -0.56 . . . . 2.1899999999999999 109.488 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.78 -69.88 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.504 -0.855 . . . . 0.28000000000000003 112.499 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.522 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 50.9 Cg_exo -51.47 -27.51 24.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.8 2.333 . . . . 0.28000000000000003 111.979 175.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.474 HG11 ' CD2' ' A' ' 11' ' ' LEU . 14.3 t -69.28 -44.75 80.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 1.01 110.042 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.55 93.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.143 -0.935 . . . . 1.01 110.156 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.453 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 37.8 m-20 -64.12 -42.07 96.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.447 . . . . 2.0299999999999998 110.345 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.54 -46.81 70.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.389 0.614 . . . . 1.0700000000000001 110.881 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.66 -46.72 71.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.023 -0.989 . . . . 1.05 110.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -56.53 -36.02 68.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.515 -0.766 . . . . 2.5800000000000001 111.849 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.453 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.1 mt-30 -61.42 -44.39 97.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 3.0299999999999998 111.696 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -94.59 7.14 46.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.569 -0.287 . . . . 1.95 111.214 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.14 34.79 21.18 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.626 . . . . 1.1899999999999999 111.264 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.79 133.38 55.35 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 116.234 -0.439 . . . . 1.05 109.984 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 13.3 Cg_endo -73.81 137.02 23.97 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.117 1.878 . . . . 0.23000000000000001 111.423 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -156.49 158.85 37.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.937 -0.574 . . . . 0.23999999999999999 110.617 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.0 mt -124.24 140.9 46.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.21 -0.904 . . . . 1.0700000000000001 109.795 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.97 107.94 19.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.041 -0.725 . . . . 1.05 109.041 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.597 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 21.7 t-160 -101.61 78.95 1.89 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.995 -0.742 . . . . 0.59999999999999998 108.995 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 4.7 t -118.32 158.76 24.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.788 -1.096 . . . . 1.1399999999999999 110.915 -171.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.36 -1.35 55.66 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.012 -0.613 . . . . 1.1000000000000001 111.883 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.95 120.45 26.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.771 0.32 . . . . 2.3300000000000001 110.783 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 7.1 mp -114.38 -6.85 12.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 2.1800000000000002 109.904 173.577 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -84.39 -60.92 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 2.6299999999999999 111.387 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -40.24 78.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.092 0.472 . . . . 5.1200000000000001 110.421 -174.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 97.3 m-70 -92.27 22.4 4.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.211 -0.449 . . . . 1.3500000000000001 111.256 -179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.52 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.55 -41.83 98.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.121 -0.561 . . . . 1.0600000000000001 112.698 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.06 -45.8 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 2.5 110.678 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.26 -44.24 92.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 1.22 110.472 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 63.2 mt -61.97 -31.48 71.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.838 -0.619 . . . . 2.1899999999999999 111.239 179.947 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.52 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 25.4 mtm180 -70.55 -32.6 70.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.4 -0.364 . . . . 5.0 110.622 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.05 -39.4 50.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.997 -0.547 . . . . 2.8999999999999999 110.375 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.92 -52.89 43.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.612 -0.722 . . . . 1.0800000000000001 110.014 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.74 74.36 0.41 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.593 -0.73 . . . . 1.0900000000000001 110.952 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -153.13 163.79 22.44 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.152 -0.931 . . . . 1.0800000000000001 109.22 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.682 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 66.3 Cg_exo -54.96 141.08 79.27 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.491 2.127 . . . . 0.29999999999999999 112.768 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.56 140.26 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.806 -0.633 . . . . 1.3 110.621 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.3 mmm -121.32 95.32 4.64 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 1.04 108.887 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.3 147.07 52.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.953 -0.567 . . . . 1.2 111.466 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 85.9 mttt -91.17 147.0 34.64 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.708 . . . . 1.27 110.434 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.6 Cg_exo -73.05 152.25 98.06 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.483 -1.466 . . . . 0.88 112.459 1.565 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.597 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -148.57 129.34 14.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.39000000000000001 110.511 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.488 ' O ' HG22 ' A' ' 110' ' ' VAL . 16.4 t70 -66.28 128.96 38.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.51000000000000001 109.143 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.411 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 20.4 p -64.83 -24.7 67.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.59 -0.732 . . . . 1.04 112.581 -170.498 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 32.3 t -68.13 -40.91 82.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.651 -0.5 . . . . 1.8899999999999999 109.651 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -40.76 92.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.076 0.465 . . . . 0.62 110.097 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.488 HG22 ' O ' ' A' ' 106' ' ' ASP . 22.0 t -64.36 -42.57 95.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.579 -0.737 . . . . 1.04 110.475 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.517 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.34 -48.5 72.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.727 -0.67 . . . . 1.01 111.349 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 108' ' ' SER . 99.0 mttt -60.39 -46.48 89.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 2.4300000000000002 110.887 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.489 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.3 mmt180 -62.4 -28.55 69.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.126 -0.488 . . . . 2.73 111.309 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.37 -51.65 9.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 1.02 110.576 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.403 HD21 HG11 ' A' ' 52' ' ' VAL . 88.3 mt -65.41 -29.35 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.493 0.553 . . . . 1.04 112.493 -176.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.489 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.3 pt-20 -67.44 -25.8 66.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.8 0.333 . . . . 2.79 111.255 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.682 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 43.5 mtm -81.53 -14.54 56.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.019 0.438 . . . . 1.0 110.711 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.779 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 46.9 t -102.53 -55.67 2.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.897 -0.592 . . . . 1.95 111.609 -174.148 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -128.74 17.21 5.79 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.544 -0.836 . . . . 2.5699999999999998 112.821 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.95 -25.26 60.29 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.758 -0.734 . . . . 4.4800000000000004 111.682 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.5 101.28 13.17 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.463 -0.569 . . . . 6.4199999999999999 109.463 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -141.18 131.39 24.91 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 9.5099999999999998 110.241 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.57 119.56 77.3 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.235 -0.439 . . . . 9.5999999999999996 109.971 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.87 74.52 1.77 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.796 2.331 . . . . 11.17 112.541 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-N 115.719 -0.673 . . . . 13.279999999999999 109.985 -179.523 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 112.292 -0.323 . . . . 9.2100000000000009 112.292 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.47 -49.48 6.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 7.1500000000000004 111.269 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.1 mtt -79.53 -25.75 41.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.682 0.754 . . . . 7.6699999999999999 109.722 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.36 -109.74 0.3 Allowed Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.85 -1.068 . . . . 2.4399999999999999 111.243 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 7.2 ptm -151.01 138.03 11.77 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.737 -0.468 . . . . 2.1800000000000002 109.737 178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -73.01 143.96 37.22 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.271 1.981 . . . . 0.55000000000000004 112.426 178.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.43 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 34.5 tptt -90.23 105.54 17.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.738 -0.665 . . . . 1.48 109.271 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 49.7 t -100.61 137.61 27.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.138 -0.483 . . . . 1.05 111.153 -174.406 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.2 tm? -115.66 110.76 19.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.596 -0.729 . . . . 1.5 109.906 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.04 128.83 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.235 0.54 . . . . 1.03 111.039 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.527 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 0.1 OUTLIER -108.12 100.8 10.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.197 -0.91 . . . . 1.05 108.884 175.852 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -164.17 134.77 4.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.172 0.51 . . . . 1.4099999999999999 110.101 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -97.16 -23.83 16.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.468 -0.787 . . . . 1.27 109.993 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.449 ' CB ' HD11 ' A' ' 17' ' ' ILE . 42.0 mt-10 -76.03 108.15 5.61 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.658 -0.497 . . . . 2.5600000000000001 109.658 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 14' ' ' GLU . 32.2 Cg_exo -57.48 -35.84 98.8 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 123.073 2.515 . . . . 0.35999999999999999 113.537 -171.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 4.7 tt -65.0 -50.85 64.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.813 -0.44 . . . . 2.2799999999999998 109.813 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.449 HD11 ' CB ' ' A' ' 14' ' ' GLU . 3.0 mp -62.02 -46.97 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.498 . . . . 1.7 109.814 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.239 -0.891 . . . . 1.02 110.824 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.41 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 38.2 ttp -63.41 -44.86 93.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.669 -0.696 . . . . 1.28 111.083 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.573 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.7 t-20 -65.28 -42.56 93.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 1.3600000000000001 110.425 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.5 mt -64.39 -43.48 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.194 -0.457 . . . . 1.0700000000000001 110.227 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.463 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.6 tt0 -53.22 -50.57 64.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.663 -0.699 . . . . 1.7 110.318 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.41 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 14.4 m-85 -63.18 -34.96 78.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 1.1799999999999999 111.206 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.53 71.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.919 0.39 . . . . 1.05 110.656 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.666 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 55.0 m-85 -66.96 -41.9 86.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.123 -0.49 . . . . 0.16 110.613 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.75 -36.8 79.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.68999999999999995 110.632 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.73 -33.22 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.51000000000000001 110.835 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -80.41 -1.41 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.65000000000000002 110.531 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.15 50.48 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 116.004 -0.544 . . . . 0.28999999999999998 112.414 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.74 158.99 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.323 . . . . 1.03 110.783 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.46 138.81 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.988 -0.745 . . . . 2.1400000000000001 108.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.463 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.4 t -120.86 132.14 71.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.482 . . . . 1.0800000000000001 111.988 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.38 136.1 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 1.05 108.338 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.1 t -111.02 123.97 67.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.631 -0.428 . . . . 1.6499999999999999 111.002 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.445 ' HB1' ' CB ' ' A' ' 40' ' ' GLN . . . -127.26 134.92 50.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.867 -0.606 . . . . 1.03 110.338 177.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.48 -11.85 18.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.998 0.428 . . . . 1.04 111.147 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.9 p -128.83 173.39 10.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.169 -0.468 . . . . 1.0800000000000001 110.227 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.595 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 75.5 m -73.63 -32.08 63.86 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.598 . . . . 1.6599999999999999 109.387 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.13 -51.04 70.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.913 -0.585 . . . . 0.69999999999999996 110.912 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.445 ' CB ' ' HB1' ' A' ' 35' ' ' ALA . 31.8 mt-30 -55.89 -42.13 75.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.864 -0.607 . . . . 1.4099999999999999 110.7 176.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' HB3' HD23 ' A' ' 11' ' ' LEU . . . -62.66 -52.93 61.38 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.434 -0.803 . . . . 1.04 111.278 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.595 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.6 mt -59.43 -29.16 67.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.961 -0.563 . . . . 1.53 110.942 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . 0.447 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.1 tmtp? -65.6 -55.7 16.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.773 -0.454 . . . . 2.9100000000000001 109.773 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.9 t -64.55 -35.26 80.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 1.6399999999999999 110.55 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.41 HD12 HD21 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.937 -0.574 . . . . 1.8400000000000001 110.984 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.55 -38.17 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 1.1599999999999999 111.237 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.19 -37.65 61.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.883 -0.598 . . . . 0.62 111.598 -175.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . 0.43 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 43.9 m-80 -120.09 165.22 18.64 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.05 -0.523 . . . . 0.47999999999999998 111.214 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -95.45 86.15 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.625 2.883 . . . . 0.31 111.466 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -65.07 118.37 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.329 -0.85 . . . . 1.03 111.258 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -84.27 -32.38 24.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.28999999999999998 110.23 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.449 HG11 HD21 ' A' ' 115' ' ' LEU . 14.3 p -158.65 154.02 5.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.928 -0.578 . . . . 1.03 110.2 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.496 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 162.57 33.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.515 0.674 . . . . 0.97999999999999998 111.61 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -135.14 111.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.739 -0.837 . . . . 1.5700000000000001 108.739 176.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.404 ' HA ' ' CB ' ' A' ' 11' ' ' LEU . 10.5 mp -106.42 98.42 8.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.268 0.556 . . . . 1.02 111.084 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.855 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -76.14 93.35 3.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.079 -0.964 . . . . 1.77 109.448 174.077 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.1 t -54.29 -25.94 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.971 -1.013 . . . . 1.3600000000000001 111.945 -172.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -79.01 68.9 5.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.076 -0.511 . . . . 2.6400000000000001 111.456 178.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 -32.65 22.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.176 0.513 . . . . 1.3100000000000001 110.311 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.39 -174.02 40.1 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.678 -0.692 . . . . 0.87 111.599 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.51 -35.13 96.51 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.076 2.517 . . . . 1.3899999999999999 112.741 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -123.4 -29.42 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.933 -0.576 . . . . 4.0 110.253 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.7 m -64.97 125.67 25.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.791 -0.64 . . . . 1.3700000000000001 111.656 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -144.57 154.78 43.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 0.58999999999999997 110.079 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.46 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -78.7 87.85 4.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.297 -0.631 . . . . 2.1899999999999999 109.297 174.737 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.21 -72.66 0.87 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.689 -0.767 . . . . 0.28000000000000003 112.363 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.445 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.3 Cg_exo -52.82 -24.58 24.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.83 2.353 . . . . 0.28000000000000003 112.331 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.443 HG11 ' CD2' ' A' ' 11' ' ' LEU . 30.3 t -64.42 -40.08 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.542 0.687 . . . . 1.01 110.014 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.58 -41.93 98.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.854 -1.067 . . . . 1.01 110.159 179.06 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.12 -47.18 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.81 -0.632 . . . . 2.0299999999999998 109.972 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -50.3 -49.93 52.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.605 0.716 . . . . 1.0700000000000001 110.848 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . 0.41 HD21 HD12 ' A' ' 45' ' ' LEU . 97.6 mt -66.12 -47.83 72.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.045 -0.98 . . . . 1.05 111.015 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -59.13 -34.52 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.583 . . . . 2.5800000000000001 111.787 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -69.43 -34.68 74.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.316 -0.402 . . . . 3.0299999999999998 111.347 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.4 HH11 ' HD3' ' A' ' 75' ' ' ARG . 55.5 mtt180 -95.71 7.53 46.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 1.95 111.077 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.06 34.11 23.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.694 -0.685 . . . . 1.1899999999999999 111.563 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.41 132.67 38.43 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.489 -0.323 . . . . 1.05 110.295 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.16 139.77 24.26 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.59 2.193 . . . . 0.23000000000000001 112.2 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 39.2 p90 -155.42 156.91 36.18 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.726 -0.67 . . . . 0.23999999999999999 110.402 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -117.84 138.39 48.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.404 -0.816 . . . . 1.0700000000000001 109.401 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -88.78 107.96 19.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.492 -0.929 . . . . 1.05 108.492 174.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.855 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 11.7 t-160 -101.34 123.16 44.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.41 -0.959 . . . . 0.59999999999999998 108.41 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.471 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 5.4 t -163.12 144.0 9.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.073 -0.651 . . . . 1.1399999999999999 111.947 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' A' ' 103' ' ' LYS . . . -89.68 -6.77 69.77 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.573 -0.74 . . . . 1.1000000000000001 111.398 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 88' ' ' ARG . 9.7 t70 -112.57 114.72 27.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.564 -0.532 . . . . 2.3300000000000001 109.564 177.165 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.7 mt -115.53 -17.93 11.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.343 -0.39 . . . . 2.1800000000000002 111.268 -177.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -85.76 -52.01 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.88 -0.328 . . . . 2.6299999999999999 111.464 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.415 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -67.69 -33.2 74.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.03 0.443 . . . . 5.1200000000000001 110.382 -177.761 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.56 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 93.0 m-70 -102.11 16.51 25.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.273 -0.421 . . . . 1.3500000000000001 111.347 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.409 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -60.52 -49.94 73.11 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.943 -0.646 . . . . 1.0600000000000001 113.056 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.553 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 3.1 mp0 -60.55 -40.59 92.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.078 -0.341 . . . . 2.5 110.078 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 tp -60.17 -43.35 95.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.931 -0.577 . . . . 1.22 110.892 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.56 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 67.6 mt -57.87 -37.39 73.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 2.1899999999999999 110.893 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.406 ' NH2' ' HG3' ' A' ' 91' ' ' GLU . 48.3 mtm105 -78.43 -26.9 46.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 5.0 111.225 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . 0.553 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 96.7 mttt -69.11 -39.21 79.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.448 0.642 . . . . 2.8999999999999999 109.826 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 95.8 mt -69.09 -54.12 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.008 -0.997 . . . . 1.0800000000000001 110.621 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 64.74 78.8 0.27 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.686 0.755 . . . . 1.0900000000000001 111.206 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -162.01 169.29 9.64 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.942 -1.026 . . . . 1.0800000000000001 108.721 177.032 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.449 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 32.3 Cg_exo -58.45 137.27 79.45 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.164 1.91 . . . . 0.29999999999999999 112.331 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.5 t -119.78 130.71 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 1.3 110.757 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.505 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 91.9 mtp -115.89 124.2 50.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.574 . . . . 1.04 109.449 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.471 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -82.5 152.88 25.86 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.238 -0.437 . . . . 1.2 111.201 -175.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.731 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 89.7 mttt -91.27 141.8 26.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.704 -0.48 . . . . 1.27 109.704 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.27 153.5 97.25 Favored 'Cis proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.074 -1.636 . . . . 0.88 112.788 1.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.594 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -145.45 130.73 18.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.39000000000000001 109.461 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.447 ' O ' HG21 ' A' ' 110' ' ' VAL . 15.5 t70 -67.11 127.62 33.31 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.974 -0.75 . . . . 0.51000000000000001 108.974 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.573 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.0 p -63.57 -25.12 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.777 . . . . 1.04 112.269 -170.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.408 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 34.4 t -70.95 -36.53 72.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.565 -0.532 . . . . 1.8899999999999999 109.565 176.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 15.4 m-20 -66.54 -46.2 76.89 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.512 -0.551 . . . . 0.62 109.512 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.5 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.3 t -60.14 -41.22 85.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 1.04 110.472 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.666 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.29 -51.4 60.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.566 -0.743 . . . . 1.01 111.446 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.408 ' HG3' ' O ' ' A' ' 108' ' ' SER . 57.7 mtpt -65.67 -38.72 90.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.244 -0.434 . . . . 2.4300000000000002 111.251 -177.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.501 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.9 mmt180 -66.83 -28.64 68.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.43 . . . . 2.73 111.432 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -47.17 16.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.08 0.467 . . . . 1.02 110.108 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.553 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 78.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.935 0.717 . . . . 1.04 112.935 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.501 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.4 pt-20 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 2.79 110.677 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.449 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 63.5 mtm -76.09 -29.48 57.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.277 -0.42 . . . . 1.0 111.352 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.553 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 10.7 p -89.35 -21.03 23.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.027 0.441 . . . . 1.95 110.192 176.576 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -67.53 -15.1 65.71 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 111.464 -0.654 . . . . 2.5699999999999998 111.464 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -145.87 57.47 0.51 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.541 -1.023 . . . . 4.4800000000000004 110.541 174.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.59 145.89 55.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.172 0.51 . . . . 6.4199999999999999 111.334 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -162.94 166.53 23.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.4 -0.818 . . . . 9.5099999999999998 109.007 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.9 mt-10 -59.39 129.83 87.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 O-C-N 123.073 0.233 . . . . 9.5999999999999996 110.398 177.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_exo -71.42 47.09 0.82 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.962 2.441 . . . . 11.17 112.57 176.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.603 -0.713 . . . . 13.279999999999999 110.166 -177.735 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 112.123 -0.391 . . . . 9.2100000000000009 112.123 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.53 56.14 5.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.175 0.512 . . . . 7.1500000000000004 111.192 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.2 ttm -104.49 80.49 1.69 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.037 -0.529 . . . . 7.6699999999999999 110.903 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.14 -29.83 27.1 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.871 -0.891 . . . . 2.4399999999999999 110.871 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.426 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 18.3 mmt -68.46 144.14 96.13 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.057 -0.572 . . . . 2.1800000000000002 110.541 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.42 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 27.4 Cg_exo -62.64 132.22 36.83 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.306 2.004 . . . . 0.55000000000000004 110.881 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -86.68 103.31 15.03 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.399 -0.593 . . . . 1.48 109.399 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.485 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.6 t -99.49 128.31 51.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.549 -0.75 . . . . 1.05 110.616 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 55.2 tp -104.33 115.39 30.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.802 0.335 . . . . 1.5 111.034 178.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.43 122.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.294 0.569 . . . . 1.03 111.324 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.635 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 1.5 mm? -101.65 118.98 38.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.549 -1.278 . . . . 1.05 107.549 169.429 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.694 ' CD ' ' HB3' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -161.43 158.43 26.7 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.952 -0.299 . . . . 1.4099999999999999 110.368 -174.328 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.44 -5.36 8.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.904 0.383 . . . . 1.27 110.635 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.421 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 42.2 mm-40 -109.82 103.18 52.7 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 2.5600000000000001 110.574 175.444 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.29 -26.85 72.42 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.058 2.506 . . . . 0.35999999999999999 113.235 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.58 -47.59 72.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.968 -0.753 . . . . 2.2799999999999998 108.968 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.59 -46.22 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.371 -0.831 . . . . 1.7 111.005 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . 0.694 ' HB3' ' CD ' ' A' ' 12' ' ' GLU . . . -56.17 -49.84 72.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.285 -0.416 . . . . 1.02 111.053 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.6 ttp -55.96 -42.4 76.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.588 -0.733 . . . . 1.28 110.695 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.482 ' HB3' HG22 ' A' ' 107' ' ' THR . 3.8 m-80 -68.95 -42.54 76.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 1.3600000000000001 111.412 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.68 -44.96 88.65 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.611 0.243 . . . . 1.0700000000000001 110.538 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.452 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -55.65 -50.73 69.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.941 -0.572 . . . . 1.7 109.991 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.4 -27.75 66.49 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.133 -0.485 . . . . 1.1799999999999999 111.363 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.08 -49.12 60.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.869 0.366 . . . . 1.05 110.527 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.616 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -66.26 -43.45 86.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.16 110.867 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 30.9 mt-10 -65.38 -28.6 69.39 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.936 -0.306 . . . . 0.68999999999999995 110.635 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.58 -32.96 66.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.51000000000000001 110.593 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -77.78 -20.16 53.8 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.042 0.449 . . . . 0.65000000000000002 110.417 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.46 62.24 0.63 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.575 -0.739 . . . . 0.28999999999999998 112.377 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -148.71 177.28 9.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.799 0.333 . . . . 1.03 111.255 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 129.36 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.388 -0.597 . . . . 2.1400000000000001 109.388 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.452 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 15.1 t -115.04 135.55 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.584 0.587 . . . . 1.0800000000000001 112.584 -167.31 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.44 141.92 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.825 -0.806 . . . . 1.05 108.825 170.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.2 t -112.74 126.01 70.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.537 0.208 . . . . 1.6499999999999999 110.709 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.452 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -140.49 134.77 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 1.03 111.047 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' GLU . . . -97.64 -22.67 16.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.282 0.563 . . . . 1.04 111.082 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.3 p -117.31 159.76 22.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.856 -0.611 . . . . 1.0800000000000001 110.668 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.611 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 m -64.36 -31.27 72.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.293 -0.632 . . . . 1.6599999999999999 109.293 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.52 -52.88 63.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 0.69999999999999996 110.96 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.452 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . 38.0 mt-30 -57.79 -39.87 78.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.263 0.554 . . . . 1.4099999999999999 110.954 177.55 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.449 ' HB3' HD23 ' A' ' 11' ' ' LEU . . . -65.59 -50.49 64.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.374 -0.83 . . . . 1.04 111.333 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.611 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.2 mt -63.47 -30.4 71.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.137 -0.483 . . . . 1.53 111.08 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -66.76 -48.21 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.124 0.488 . . . . 2.9100000000000001 109.686 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.3 t -66.09 -33.48 75.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 1.6399999999999999 110.452 179.457 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -39.08 78.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.272 0.558 . . . . 1.8400000000000001 110.135 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.65 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.831 -0.622 . . . . 1.1599999999999999 111.563 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.55 -36.51 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.62 111.355 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -118.12 163.65 23.84 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.218 -0.447 . . . . 0.47999999999999998 110.615 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -96.88 85.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 123.6 2.866 . . . . 0.31 111.302 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.3 mm -62.32 119.95 7.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 1.03 111.552 -175.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.463 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 23.2 m-20 -89.2 -30.52 18.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.675 -0.693 . . . . 0.28999999999999998 110.629 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.485 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.5 p -163.83 156.34 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.693 -0.685 . . . . 1.03 109.285 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.29 160.17 40.56 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.557 0.694 . . . . 0.97999999999999998 112.291 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -132.0 112.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.838 -1.074 . . . . 1.5700000000000001 109.124 175.813 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.805 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.7 mp -109.72 104.63 13.65 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.095 0.474 . . . . 1.02 111.943 -170.403 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -71.64 93.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.39 -0.823 . . . . 1.77 109.232 172.271 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.594 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 40.9 t -58.63 -27.41 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.552 . . . . 1.3600000000000001 111.499 -175.521 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -80.43 51.97 1.54 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.761 -0.654 . . . . 2.6400000000000001 112.397 -176.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt -70.11 -24.48 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 1.3100000000000001 110.475 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.07 -178.12 46.05 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.97 -0.852 . . . . 0.87 110.97 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.64 -36.13 97.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.613 2.209 . . . . 1.3899999999999999 112.015 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -114.51 -34.39 5.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 4.0 110.122 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.0 m -65.64 125.81 26.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.899 -0.591 . . . . 1.3700000000000001 111.163 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -146.54 151.18 36.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.886 -0.597 . . . . 0.58999999999999997 110.812 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.805 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -74.89 87.34 2.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.916 -0.772 . . . . 2.1899999999999999 108.916 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.83 -70.34 0.61 Allowed Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.369 -0.919 . . . . 0.28000000000000003 112.472 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.544 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.2 Cg_exo -52.62 -23.53 20.04 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.604 2.203 . . . . 0.28000000000000003 112.049 175.153 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.446 HG11 ' CD2' ' A' ' 11' ' ' LEU . 24.5 t -70.3 -45.22 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.326 0.584 . . . . 1.01 110.123 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.67 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.162 -0.926 . . . . 1.01 110.104 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.48 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 31.1 m-20 -63.53 -40.17 96.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.667 . . . . 2.0299999999999998 110.175 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.39 -49.17 75.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.512 0.672 . . . . 1.0700000000000001 110.601 176.59 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.58 -40.59 92.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.105 -0.952 . . . . 1.05 110.526 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 16.3 mmmt -59.29 -38.56 80.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.572 -0.74 . . . . 2.5800000000000001 111.157 175.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.48 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 13.0 mm100 -62.3 -45.6 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 3.0299999999999998 111.487 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -92.95 7.51 43.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 1.95 111.391 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.79 24.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 1.1899999999999999 111.427 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.64 134.43 50.83 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.552 -0.536 . . . . 1.05 109.552 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.45 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 15.2 Cg_endo -73.25 139.52 29.37 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.076 1.851 . . . . 0.23000000000000001 111.406 177.846 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -160.82 156.66 25.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.054 -0.521 . . . . 0.23999999999999999 110.385 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -123.42 141.05 45.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.403 -0.817 . . . . 1.0700000000000001 109.881 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.418 HD21 HG22 ' A' ' 96' ' ' ILE . 2.0 mm? -88.79 108.78 19.69 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.097 -0.705 . . . . 1.05 109.097 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.814 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 15.1 t-160 -101.27 104.66 15.69 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.128 -0.693 . . . . 0.59999999999999998 109.128 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.499 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 4.3 t -151.85 151.86 31.86 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.32 -0.552 . . . . 1.1399999999999999 111.679 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.17 9.13 63.16 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.551 -0.75 . . . . 1.1000000000000001 111.471 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -149.89 122.33 8.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.853 0.358 . . . . 2.3300000000000001 111.429 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.41 HD11 ' CD2' ' A' ' 93' ' ' LEU . 3.2 mm? -118.68 7.66 11.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.386 -0.598 . . . . 2.1800000000000002 109.386 172.549 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -85.04 -54.62 4.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 111.566 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.466 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 8.0 mpt_? -77.47 -11.83 59.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.102 0.477 . . . . 5.1200000000000001 111.113 -173.745 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -125.26 26.03 6.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 1.3500000000000001 109.794 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -60.96 -38.61 95.74 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.108 -0.496 . . . . 1.0600000000000001 113.447 -173.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.8 -25.87 68.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 2.5 110.709 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.68 -42.48 86.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.908 -0.587 . . . . 1.22 110.85 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.437 ' H ' HD21 ' A' ' 93' ' ' LEU . 2.3 mm? -60.41 -26.92 67.05 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.441 -0.345 . . . . 2.1899999999999999 111.108 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -66.66 -33.2 75.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 5.0 111.026 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.42 -27.45 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 2.8999999999999999 110.287 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.418 HG22 HD21 ' A' ' 81' ' ' LEU . 62.2 mt -79.74 -63.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.447 -0.797 . . . . 1.0800000000000001 111.115 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.0 t70 55.87 74.15 0.4 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.743 0.782 . . . . 1.0900000000000001 110.788 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.77 165.82 16.68 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.141 -0.936 . . . . 1.0800000000000001 109.225 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.503 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 43.4 Cg_exo -59.16 141.25 97.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.535 2.156 . . . . 0.29999999999999999 112.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.13 121.01 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.039 -0.528 . . . . 1.3 111.16 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.445 ' O ' ' HD2' ' A' ' 82' ' ' HIS . 73.9 mmm -102.41 99.02 9.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.151 -0.685 . . . . 1.04 109.151 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.499 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -74.97 159.5 31.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.169 -0.468 . . . . 1.2 111.04 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.429 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 98.3 mttt -93.1 153.35 41.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.782 -0.644 . . . . 1.27 110.469 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.429 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 15.5 Cg_exo -69.18 136.07 35.77 Favored 'Cis proline' 0 C--N 1.343 0.237 0 C-N-CA 123.648 -1.397 . . . . 0.88 112.328 -1.666 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.638 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -128.69 133.53 48.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.39000000000000001 110.038 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.522 ' O ' HG23 ' A' ' 110' ' ' VAL . 17.1 t70 -78.54 129.67 35.1 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 0.51000000000000001 108.616 176.628 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.482 HG22 ' HB3' ' A' ' 20' ' ' ASN . 19.9 p -64.11 -22.39 66.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.696 -0.683 . . . . 1.04 112.236 -172.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 t -70.98 -40.68 71.77 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.452 -0.573 . . . . 1.8899999999999999 109.452 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.56 -44.27 91.27 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.149 -0.478 . . . . 0.62 109.967 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.522 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.7 t -61.62 -44.32 98.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.355 -0.839 . . . . 1.04 110.396 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.616 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.67 -51.43 67.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.749 -0.66 . . . . 1.01 111.215 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.634 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.7 mtpt -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 2.4300000000000002 110.735 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -55.38 -40.03 70.84 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.314 0.384 . . . . 2.73 111.452 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.4 63.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 1.02 110.845 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.41 -25.87 66.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 1.04 111.988 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.634 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 mm-40 -57.18 -47.72 80.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.958 0.409 . . . . 2.79 110.395 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.503 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 52.8 mtm -72.34 -28.5 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 1.0 110.718 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.463 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 50.5 t -65.99 -43.76 86.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.809 -0.632 . . . . 1.95 110.493 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.05 71.2 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.776 -0.726 . . . . 2.5699999999999998 111.848 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.71 -150.04 20.81 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.672 -0.775 . . . . 4.4800000000000004 111.859 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.91 98.57 10.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.129 0.49 . . . . 6.4199999999999999 110.524 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -107.45 82.86 1.72 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.783 -0.644 . . . . 9.5099999999999998 109.554 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . 0.405 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 40.6 mt-10 -82.35 124.82 77.8 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.727 -0.669 . . . . 9.5999999999999996 110.784 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 123' ' ' GLU . 24.5 Cg_exo -64.23 99.69 0.3 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.751 2.301 . . . . 11.17 111.866 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.528 -0.749 . . . . 13.279999999999999 110.267 179.081 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.868 -0.493 . . . . 9.2100000000000009 111.868 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.22 35.78 18.2 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.895 0.478 . . . . 7.1500000000000004 111.435 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.6 mtt -135.33 10.14 3.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 7.6699999999999999 110.783 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.4 -70.18 2.66 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.887 -0.673 . . . . 2.4399999999999999 112.276 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.6 mtt -97.08 135.82 21.79 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.506 0.193 . . . . 2.1800000000000002 110.798 179.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.0 Cg_exo -63.25 138.26 65.57 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.801 2.334 . . . . 0.55000000000000004 111.411 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -88.53 105.43 17.63 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.754 -0.461 . . . . 1.48 109.754 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.8 t -100.18 135.72 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.695 -0.684 . . . . 1.05 110.905 -175.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.1 tp -110.4 113.22 25.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.903 0.383 . . . . 1.5 110.482 177.267 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.83 120.04 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.342 0.592 . . . . 1.03 111.589 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.551 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.3 mm? -102.33 101.12 11.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.872 -1.058 . . . . 1.05 108.89 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.55 118.43 3.2 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.389 -0.823 . . . . 1.4099999999999999 109.732 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.551 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 25.8 t70 -83.76 -19.76 34.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.068 -0.515 . . . . 1.27 110.068 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -84.2 102.87 2.37 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.537 -0.542 . . . . 2.5600000000000001 109.537 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.551 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 36.6 Cg_exo -58.9 -31.15 94.88 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.878 2.385 . . . . 0.35999999999999999 113.026 -173.076 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.39 -49.26 78.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 2.2799999999999998 109.77 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.12 -43.49 78.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.653 -0.703 . . . . 1.7 110.67 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.84 74.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.506 . . . . 1.02 110.732 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.4 ttp -64.6 -41.65 96.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.665 -0.698 . . . . 1.28 111.315 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.462 ' HB3' HG22 ' A' ' 107' ' ' THR . 16.9 m-20 -65.12 -46.44 80.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.297 -0.411 . . . . 1.3600000000000001 110.977 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 45.7 mt -59.78 -46.43 89.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.464 -0.335 . . . . 1.0700000000000001 110.267 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.543 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 64.0 tt0 -52.29 -48.49 65.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.673 -0.694 . . . . 1.7 110.356 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -69.32 -31.89 70.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 1.1799999999999999 111.761 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.942 0.401 . . . . 1.05 110.535 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.611 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 49.5 m-85 -67.4 -44.49 78.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.001 -0.545 . . . . 0.16 110.849 177.825 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.415 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 28.2 mt-10 -62.98 -32.62 74.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.618 0.247 . . . . 0.68999999999999995 110.602 177.388 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.32 -35.19 80.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 110.163 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -81.08 -0.07 38.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 110.886 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 50.0 4.2 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.991 -0.623 . . . . 0.28999999999999998 112.322 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.22 167.34 21.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.829 0.347 . . . . 1.03 110.903 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -108.01 144.68 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.156 -0.683 . . . . 2.1400000000000001 109.156 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.543 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 31.3 t -128.8 139.95 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 1.0800000000000001 112.24 -170.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 14.2 t -111.71 136.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.665 -0.865 . . . . 1.05 108.665 169.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.62 124.41 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.829 0.347 . . . . 1.6499999999999999 110.71 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.428 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -138.56 138.05 37.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.09 -0.504 . . . . 1.03 110.342 176.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.43 -5.55 16.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.395 -0.366 . . . . 1.04 111.193 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.3 p -133.78 166.26 23.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.537 -0.302 . . . . 1.0800000000000001 111.309 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.6 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 19.6 p -59.21 -49.28 78.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.334 -0.617 . . . . 1.6599999999999999 109.334 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -49.83 -55.36 14.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.42 -1.264 . . . . 0.69999999999999996 111.944 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . 44.7 mt-30 -55.17 -46.44 75.79 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 110.876 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.521 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -63.11 -46.18 88.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.279 -0.873 . . . . 1.04 111.838 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.6 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -66.0 -30.46 71.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.209 -0.451 . . . . 1.53 110.451 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -67.32 -54.88 16.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 2.9100000000000001 109.48 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 15.1 m -62.29 -30.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.492 -0.322 . . . . 1.6399999999999999 111.373 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . 0.425 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -62.12 -42.22 99.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 1.8400000000000001 110.201 178.221 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.54 -32.03 22.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.411 . . . . 1.1599999999999999 111.265 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.18 -35.57 61.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.62 111.062 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -120.48 162.95 31.6 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.47999999999999998 110.427 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -95.39 82.96 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.34 2.693 . . . . 0.31 111.363 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 45.9 mm -66.25 127.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.815 -0.63 . . . . 1.03 111.452 -175.304 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.475 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.0 m-20 -99.25 -28.41 13.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 0.28999999999999998 110.703 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.496 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -162.11 157.09 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.587 -0.523 . . . . 1.03 109.587 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -144.03 165.63 27.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.97999999999999998 112.32 -176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.49 112.19 9.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 115.2 -0.909 . . . . 1.5700000000000001 109.533 176.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.746 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.1 mp -116.0 120.06 37.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.189 0.441 . . . . 1.02 112.189 -167.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -83.24 130.54 35.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.097 -0.705 . . . . 1.77 109.097 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' H ' ' HB ' ' A' ' 83' ' ' THR . 12.7 t -87.47 -6.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.16 -0.927 . . . . 1.3600000000000001 110.365 -173.055 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 53.3 t-20 -121.87 73.47 1.08 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.088 0.47 . . . . 2.6400000000000001 109.966 174.714 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.65 -24.09 59.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.506 0.669 . . . . 1.3100000000000001 109.468 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.42 -175.3 41.07 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.681 -0.967 . . . . 0.87 110.681 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -52.6 -38.81 76.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.119 2.546 . . . . 1.3899999999999999 112.715 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -117.97 -34.57 4.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.486 -0.325 . . . . 4.0 111.361 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -68.61 128.0 35.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 1.3700000000000001 111.488 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -144.32 157.15 44.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.71 -0.677 . . . . 0.58999999999999997 110.104 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.746 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 27.6 p -70.89 86.62 0.7 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.686 0.755 . . . . 2.1899999999999999 109.549 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.38 -63.94 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.559 -0.829 . . . . 0.28000000000000003 112.009 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.24 -26.87 72.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.246 1.964 . . . . 0.28000000000000003 111.254 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.447 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.9 t -69.75 -45.92 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.627 -0.715 . . . . 1.01 110.171 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.34 90.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.162 -0.926 . . . . 1.01 110.29 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.6 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.5 t70 -69.05 -41.7 77.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 2.0299999999999998 110.205 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.7 77.99 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.297 0.57 . . . . 1.0700000000000001 110.715 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 91.4 mt -66.02 -46.33 78.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.3 -0.863 . . . . 1.05 110.51 176.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -59.26 -28.7 66.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.065 -0.516 . . . . 2.5800000000000001 112.011 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.6 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 76.2 mt-30 -63.63 -48.06 78.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.768 0.318 . . . . 3.0299999999999998 110.974 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.05 7.66 39.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.34 -0.391 . . . . 1.95 111.361 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.54 42.69 20.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.863 -0.608 . . . . 1.1899999999999999 111.031 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.6 mt -88.33 132.34 39.61 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.148 -0.478 . . . . 1.05 110.142 178.192 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.3 Cg_endo -74.85 140.05 25.42 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.477 2.118 . . . . 0.23000000000000001 111.759 177.402 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 25.7 p90 -157.22 160.86 39.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.969 -0.56 . . . . 0.23999999999999999 110.695 -179.473 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -124.33 138.88 52.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.442 -0.799 . . . . 1.0700000000000001 110.013 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.462 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.0 mm? -89.15 108.7 19.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.367 -0.605 . . . . 1.05 109.367 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.566 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 14.7 t-160 -103.08 84.39 2.34 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.558 0.694 . . . . 0.59999999999999998 109.51 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.5 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 13.3 t -129.81 165.12 22.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.563 -1.199 . . . . 1.1399999999999999 110.329 -172.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.53 6.82 28.18 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.149 -0.78 . . . . 1.1000000000000001 111.149 173.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.439 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 2.2 m-20 -114.87 71.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 2.3300000000000001 110.48 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.404 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.0 mp -84.7 -33.27 23.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 2.1800000000000002 110.354 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.38 -34.51 36.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 2.6299999999999999 110.655 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -75.64 -23.05 56.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 5.1200000000000001 110.589 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.504 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 11.3 m170 -124.46 24.12 8.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.503 0.557 . . . . 1.3500000000000001 112.503 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.4 -36.72 90.25 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.792 -0.718 . . . . 1.0600000000000001 112.486 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.629 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 44.2 mt-10 -63.18 -51.7 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 2.5 110.501 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.439 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.9 tp -60.46 -42.79 96.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.061 -0.518 . . . . 1.22 110.472 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.504 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 77.1 mt -60.27 -38.3 83.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 2.1899999999999999 111.692 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.629 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 7.8 ptm180 -72.45 -26.9 62.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.815 0.34 . . . . 5.0 110.463 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -78.3 -41.05 34.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.248 0.547 . . . . 2.8999999999999999 110.001 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.439 HG13 ' O ' ' A' ' 92' ' ' LEU . 76.9 mt -60.61 -44.52 97.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.177 -0.92 . . . . 1.0800000000000001 110.529 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 39.0 t70 55.43 77.09 0.24 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.443 0.639 . . . . 1.0900000000000001 111.161 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.56 160.7 15.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.979 -1.01 . . . . 1.0800000000000001 109.113 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.403 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 36.4 Cg_exo -60.17 147.33 93.79 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.675 2.25 . . . . 0.29999999999999999 112.451 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.97 130.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 1.3 110.915 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.495 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 82.5 mmm -114.3 107.54 15.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.782 -0.822 . . . . 1.04 108.782 174.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.5 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.43 150.17 48.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.822 0.344 . . . . 1.2 111.613 -176.482 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.07 139.96 25.85 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.586 -0.524 . . . . 1.27 109.586 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.17 158.54 96.15 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.665 -1.39 . . . . 0.88 112.515 1.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.566 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -152.75 132.62 13.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.39000000000000001 110.097 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.458 ' O ' HG21 ' A' ' 110' ' ' VAL . 13.2 t70 -65.49 127.91 33.77 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.89 -0.781 . . . . 0.51000000000000001 108.89 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.462 HG22 ' HB3' ' A' ' 20' ' ' ASN . 19.3 p -64.67 -21.05 66.64 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.485 -0.78 . . . . 1.04 112.444 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.53 -37.79 65.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.339 -0.615 . . . . 1.8899999999999999 109.339 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.02 -44.81 91.45 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.62 109.53 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 106' ' ' ASP . 21.3 t -63.24 -42.4 96.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 1.04 110.629 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.611 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.43 -50.53 67.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 1.01 111.454 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.63 -42.64 98.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.977 -0.556 . . . . 2.4300000000000002 111.212 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.414 ' HA ' ' HD2' ' A' ' 113' ' ' ARG . 15.5 mmm180 -62.42 -31.07 71.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 2.73 111.247 178.214 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.57 -49.38 12.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.233 -0.44 . . . . 1.02 111.016 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.464 HD22 HG11 ' A' ' 52' ' ' VAL . 67.4 mt -66.58 -26.16 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.884 0.698 . . . . 1.04 112.884 -175.093 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.428 ' HG3' ' N ' ' A' ' 117' ' ' MET . 4.1 pt-20 -62.39 -33.47 74.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.12 0.486 . . . . 2.79 109.927 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.438 ' HG2' ' HG3' ' A' ' 122' ' ' LYS . 47.6 mtm -77.47 -14.17 59.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.925 -0.58 . . . . 1.0 110.893 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.1 t -86.63 -6.98 58.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.283 0.563 . . . . 1.95 109.799 177.087 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -116.31 -165.01 14.02 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.893 -0.67 . . . . 2.5699999999999998 111.959 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.43 8.5 48.1 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.958 -0.639 . . . . 4.4800000000000004 112.608 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -106.07 21.04 18.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.252 0.548 . . . . 6.4199999999999999 110.654 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . 0.438 ' HG3' ' HG2' ' A' ' 117' ' ' MET . 1.7 tmtp? -76.81 121.52 23.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.531 -0.759 . . . . 9.5099999999999998 111.028 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -88.88 135.63 31.71 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.425 -0.584 . . . . 9.5999999999999996 109.425 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.53 104.4 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.822 2.348 . . . . 11.17 112.539 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.661 -0.685 . . . . 13.279999999999999 110.252 -179.478 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.961 0 N-CA-C 112.035 -0.426 . . . . 9.2100000000000009 112.035 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.2 -42.47 79.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 7.1500000000000004 111.762 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.5 mtp -91.96 -7.3 49.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.156 0.503 . . . . 7.6699999999999999 110.572 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.33 148.29 4.81 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.998 -0.62 . . . . 2.4399999999999999 111.799 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.439 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -62.75 130.85 94.08 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-O 120.546 0.212 . . . . 2.1800000000000002 111.21 176.573 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.439 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.8 Cg_exo -67.03 135.45 37.58 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.792 2.328 . . . . 0.55000000000000004 111.222 175.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 39.8 tptt -85.92 106.14 16.9 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.513 -0.551 . . . . 1.48 109.513 -179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.566 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.3 t -99.92 134.82 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.935 -0.575 . . . . 1.05 110.979 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.7 tp -109.57 111.94 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.11 -0.496 . . . . 1.5 110.471 176.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.7 t -94.44 122.55 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.275 0.56 . . . . 1.03 111.736 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.497 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.7 OUTLIER -102.75 102.93 13.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.921 -1.036 . . . . 1.05 109.022 173.317 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -160.57 121.74 3.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.043 -0.526 . . . . 1.4099999999999999 110.289 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.493 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 38.3 t70 -92.85 -11.75 32.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 1.27 110.169 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.451 ' HB3' HD12 ' A' ' 17' ' ' ILE . 42.0 mt-10 -85.73 101.71 2.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.075 -0.713 . . . . 2.5600000000000001 109.075 171.603 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.493 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.0 Cg_exo -59.74 -28.87 88.3 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.752 2.301 . . . . 0.35999999999999999 113.459 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . 0.485 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 3.5 tm? -65.76 -51.02 62.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.344 -0.613 . . . . 2.2799999999999998 109.344 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.451 HD12 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -64.18 -43.78 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.91 -0.586 . . . . 1.7 110.055 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.82 63.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.672 -0.695 . . . . 1.02 111.035 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.427 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 41.7 ttp -64.07 -39.28 93.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.597 -0.729 . . . . 1.28 110.947 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.616 ' HB3' HG22 ' A' ' 107' ' ' THR . 11.5 t-20 -65.28 -41.19 94.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.11 -0.496 . . . . 1.3600000000000001 110.377 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.8 mt -62.6 -43.84 97.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.056 -0.52 . . . . 1.0700000000000001 110.407 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.1 tt0 -53.64 -51.43 63.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 1.7 110.062 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.427 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 29.4 m-85 -58.18 -39.35 78.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 1.1799999999999999 111.437 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.87 58.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.475 -0.329 . . . . 1.05 110.994 -174.071 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.576 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 43.7 m-85 -63.27 -43.94 96.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.37 -0.377 . . . . 0.16 110.385 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.21 -39.23 82.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.005 0.431 . . . . 0.68999999999999995 110.575 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.83 -28.6 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.51000000000000001 110.812 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -84.04 4.43 30.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.99 0.424 . . . . 0.65000000000000002 110.513 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . 82.87 48.63 5.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.905 -0.665 . . . . 0.28999999999999998 112.432 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -135.75 175.8 9.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.705 0.288 . . . . 1.03 111.135 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -113.23 145.64 40.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.77 -0.826 . . . . 2.1400000000000001 108.77 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.497 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.3 t -131.72 135.97 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.618 0.599 . . . . 1.0800000000000001 112.618 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.54 136.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.549 -0.908 . . . . 1.05 108.549 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.79 126.96 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.938 0.399 . . . . 1.6499999999999999 110.863 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.493 ' HB2' ' HB2' ' A' ' 40' ' ' GLN . . . -133.48 134.53 43.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.908 -0.587 . . . . 1.03 110.285 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.409 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -100.62 -10.24 21.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.126 0.488 . . . . 1.04 110.806 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.513 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 70.7 p -127.64 165.53 19.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.853 -0.612 . . . . 1.0800000000000001 110.185 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.575 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 78.1 m -72.1 -30.89 65.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.829 -0.434 . . . . 1.6599999999999999 109.829 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.2 -44.17 84.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.69999999999999996 111.031 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.513 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 18.4 mt-30 -62.99 -35.8 81.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.308 0.575 . . . . 1.4099999999999999 110.31 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -64.74 -54.66 27.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.433 -0.803 . . . . 1.04 111.401 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.9 mt -59.33 -33.42 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 1.53 110.263 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -61.88 -53.85 50.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.454 -0.794 . . . . 2.9100000000000001 110.433 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.0 t -63.85 -38.72 92.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.934 -0.575 . . . . 1.6399999999999999 110.616 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.25 -36.28 81.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.126 0.489 . . . . 1.8400000000000001 110.692 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.5 37.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.219 -0.446 . . . . 1.1599999999999999 111.319 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -80.46 -37.94 30.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.898 0.38 . . . . 0.62 111.637 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 24.0 m-80 -110.75 160.07 30.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.302 -0.408 . . . . 0.47999999999999998 110.448 -176.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -94.85 84.32 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 123.5 2.8 . . . . 0.31 111.695 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mm -67.81 128.29 30.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.698 -0.683 . . . . 1.03 111.499 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -95.4 -32.9 12.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.28999999999999998 110.362 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.566 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 12.4 p -158.08 158.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 1.03 109.382 -178.352 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.486 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -140.26 168.03 20.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.421 0.629 . . . . 0.97999999999999998 111.476 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.445 HG23 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -140.69 121.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.853 -1.166 . . . . 1.5700000000000001 107.853 176.155 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.605 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -123.78 122.61 38.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.1 0.407 . . . . 1.02 112.1 -167.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.65 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 53.4 t0 -85.18 119.17 25.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 1.77 109.553 170.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.483 HG12 HD22 ' A' ' 92' ' ' LEU . 95.8 t -69.49 -28.84 39.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.052 -0.976 . . . . 1.3600000000000001 110.391 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -99.72 62.05 1.17 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.846 -0.616 . . . . 2.6400000000000001 110.393 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.81 -28.31 68.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.318 0.58 . . . . 1.3100000000000001 109.626 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.43 -171.94 41.44 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.559 -1.016 . . . . 0.87 110.559 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.1 -45.37 41.18 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.556 2.17 . . . . 1.3899999999999999 111.858 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . 0.576 ' HB2' ' HZ2' ' A' ' 62' ' ' LYS . 5.0 ttmp? -107.18 -34.32 7.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 4.0 110.454 179.574 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -68.55 125.27 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.227 0.537 . . . . 1.3700000000000001 111.364 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 16.8 p80 -146.6 148.52 32.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.778 -0.646 . . . . 0.58999999999999997 110.309 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.605 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.8 p -71.43 86.64 0.85 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.395 0.617 . . . . 2.1899999999999999 109.734 172.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.85 -72.15 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.364 -0.922 . . . . 0.28000000000000003 112.407 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.575 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.9 Cg_exo -53.31 -26.38 34.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.731 2.287 . . . . 0.28000000000000003 112.023 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.483 HG11 ' CD2' ' A' ' 11' ' ' LEU . 13.9 t -69.2 -48.32 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.113 0.483 . . . . 1.01 110.158 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.21 80.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.256 -0.884 . . . . 1.01 110.173 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.3 t70 -63.3 -39.05 93.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 2.0299999999999998 110.81 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 1.0700000000000001 110.905 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.87 -41.18 95.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 1.05 110.162 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.514 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 2.7 mmpt? -59.37 -33.75 71.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.477 -0.783 . . . . 2.5800000000000001 111.195 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.464 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 24.1 mt-30 -64.09 -47.51 79.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 3.0299999999999998 110.964 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.88 5.58 39.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 1.95 111.089 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.01 32.6 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.689 -0.687 . . . . 1.1899999999999999 111.392 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.7 mt -82.11 133.07 51.74 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.925 -0.579 . . . . 1.05 109.798 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.422 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 25.1 Cg_endo -72.9 142.04 34.4 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.229 1.953 . . . . 0.23000000000000001 111.884 178.563 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.486 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 35.0 p90 -157.23 153.25 27.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.834 -0.621 . . . . 0.23999999999999999 110.449 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -117.39 138.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.565 -0.743 . . . . 1.0700000000000001 109.526 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.552 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.5 mm? -88.48 108.09 19.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.113 -0.699 . . . . 1.05 109.113 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.564 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 20.2 t-160 -101.47 76.87 1.72 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.804 -0.813 . . . . 0.59999999999999998 108.804 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.65 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 6.5 t -111.7 155.02 24.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.683 -1.144 . . . . 1.1399999999999999 111.795 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.56 2.16 58.78 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.543 -0.753 . . . . 1.1000000000000001 111.355 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 127.68 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.915 0.388 . . . . 2.3300000000000001 111.779 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.431 ' N ' HD13 ' A' ' 86' ' ' LEU . 4.3 mp -117.72 0.63 12.06 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.083 -0.71 . . . . 2.1800000000000002 109.083 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.54 -61.47 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 2.6299999999999999 111.51 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -66.33 -37.77 86.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.546 . . . . 5.1200000000000001 110.213 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -104.22 33.02 3.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.125 -0.489 . . . . 1.3500000000000001 110.355 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' HA2' HD22 ' A' ' 93' ' ' LEU . . . -62.53 -31.5 79.93 Favored Glycine 0 CA--C 1.511 -0.179 0 C-N-CA 121.15 -0.547 . . . . 1.0600000000000001 113.282 -176.406 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.45 -27.84 69.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.127 0.489 . . . . 2.5 110.021 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.544 ' O ' HG13 ' A' ' 96' ' ' ILE . 15.8 tp -71.32 -42.87 68.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.767 -0.651 . . . . 1.22 110.419 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.404 HD22 ' HA2' ' A' ' 90' ' ' GLY . 3.1 mm? -55.61 -40.34 71.97 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.068 0.461 . . . . 2.1899999999999999 110.241 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.94 -26.63 66.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 5.0 111.821 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.65 -37.03 36.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.256 0.55 . . . . 2.8999999999999999 110.239 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.544 HG13 ' O ' ' A' ' 92' ' ' LEU . 69.5 mt -75.98 -62.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.293 -0.867 . . . . 1.0800000000000001 111.876 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.23 81.56 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.676 -173.821 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.8 169.09 10.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 1.0800000000000001 109.341 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 33.7 Cg_exo -61.57 136.26 61.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.286 1.991 . . . . 0.29999999999999999 112.118 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.418 HG11 HD23 ' A' ' 86' ' ' LEU . 40.0 t -124.17 130.09 73.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.325 -0.398 . . . . 1.3 110.994 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.526 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 98.1 mtp -117.05 106.43 13.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.445 -0.576 . . . . 1.04 109.445 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.16 152.98 43.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 1.2 111.507 -176.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.539 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.7 mttt -90.98 142.82 27.78 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.868 -0.605 . . . . 1.27 110.032 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.15 158.66 93.6 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.457 -1.476 . . . . 0.88 112.711 1.654 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.564 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -152.62 131.16 12.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.39000000000000001 109.184 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.482 ' O ' HG22 ' A' ' 110' ' ' VAL . 36.6 t70 -68.05 128.23 35.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.42 -0.585 . . . . 0.51000000000000001 109.42 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.616 HG22 ' HB3' ' A' ' 20' ' ' ASN . 21.1 p -59.01 -27.99 65.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.815 -1.084 . . . . 1.04 112.544 -172.052 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.683 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -64.9 -45.62 85.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.634 -0.506 . . . . 1.8899999999999999 109.634 176.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -61.68 -45.57 93.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.721 -0.474 . . . . 0.62 109.721 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.526 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 20.2 t -59.27 -43.09 89.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 1.04 110.423 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.576 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.62 -50.35 65.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.626 -0.716 . . . . 1.01 111.354 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.683 ' HG3' ' O ' ' A' ' 108' ' ' SER . 19.7 mtpp -60.19 -42.2 94.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 2.4300000000000002 111.073 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.43 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 32.0 mmt180 -71.81 -28.11 63.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 2.73 111.403 -177.248 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.31 -48.49 17.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.368 . . . . 1.02 110.119 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.477 HD21 HG12 ' A' ' 52' ' ' VAL . 82.1 mt -65.1 -26.29 68.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.862 0.69 . . . . 1.04 112.862 -176.994 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -25.02 59.54 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.31 -0.556 . . . . 2.79 110.982 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.458 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 70.2 mtm -69.55 -36.08 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 1.0 110.75 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.425 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.7 p -94.36 12.28 27.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.147 0.498 . . . . 1.95 110.397 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.9 52.86 4.79 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.995 -0.548 . . . . 2.5699999999999998 112.266 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.97 -80.21 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.855 -0.688 . . . . 4.4800000000000004 111.621 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -160.81 160.39 31.11 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.005 -0.369 . . . . 6.4199999999999999 110.005 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.67 111.1 10.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.094 -0.503 . . . . 9.5099999999999998 110.366 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -72.31 124.4 90.76 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.578 -0.527 . . . . 9.5999999999999996 109.578 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.27 95.7 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.8 2.333 . . . . 11.17 112.877 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.375 -0.821 . . . . 13.279999999999999 109.67 176.023 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.897 -0.481 . . . . 9.2100000000000009 111.897 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.76 -25.85 18.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.665 0.269 . . . . 7.1500000000000004 111.589 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -157.0 171.05 21.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.016 0.436 . . . . 7.6699999999999999 111.259 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.75 46.36 1.0 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.947 -0.861 . . . . 2.4399999999999999 110.947 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.6 ptp -106.06 155.41 38.5 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 2.1800000000000002 110.753 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.65 148.01 28.64 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.659 2.239 . . . . 0.55000000000000004 113.1 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -95.78 107.82 20.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.437 -0.801 . . . . 1.48 109.243 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.451 HG21 ' CG1' ' A' ' 52' ' ' VAL . 57.1 t -100.6 133.56 43.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.096 -0.502 . . . . 1.05 111.057 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 43.5 tp -108.76 114.68 28.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.927 0.394 . . . . 1.5 110.402 175.701 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.3 t -95.82 120.76 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.34 0.59 . . . . 1.03 111.433 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.656 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 0.7 OUTLIER -102.05 100.68 10.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.828 -1.078 . . . . 1.05 108.873 172.383 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.436 ' CD ' ' HZ2' ' A' ' 103' ' ' LYS . 10.7 tp10 -157.4 117.48 3.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.408 -0.815 . . . . 1.4099999999999999 109.668 -174.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.2 t70 -81.37 -20.91 39.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.062 -0.517 . . . . 1.27 110.225 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -82.31 105.44 4.72 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.573 -0.529 . . . . 2.5600000000000001 109.573 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.7 Cg_exo -58.32 -30.76 92.09 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.619 2.213 . . . . 0.35999999999999999 112.455 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.38 -49.89 73.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.048 0.451 . . . . 2.2799999999999998 109.869 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.1 mt -69.39 -43.68 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 1.7 111.169 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.92 -45.23 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.47 . . . . 1.02 110.303 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' MET . . . . . 0.407 ' HE3' ' HB3' ' A' ' 19' ' ' MET . 39.8 ttp -61.95 -46.71 88.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.384 -0.826 . . . . 1.28 111.214 177.186 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.414 ' HB3' HG22 ' A' ' 107' ' ' THR . 3.4 m-80 -65.27 -40.99 94.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.136 -0.484 . . . . 1.3600000000000001 111.372 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.88 -44.57 95.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.357 -0.383 . . . . 1.0700000000000001 110.266 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -56.36 -49.59 73.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 1.7 110.2 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -62.76 -34.37 77.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.204 -0.453 . . . . 1.1799999999999999 111.201 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . 0.476 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -69.02 -51.03 43.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 1.05 110.82 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.681 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 53.7 m-85 -63.54 -42.08 98.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.344 -0.389 . . . . 0.16 110.834 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.92 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.96 -0.296 . . . . 0.68999999999999995 110.626 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.8 -26.94 61.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.51000000000000001 110.818 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . 0.476 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 69.6 mm-40 -82.51 -10.22 59.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.65000000000000002 110.356 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.32 51.36 1.59 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.28999999999999998 112.421 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.04 167.9 21.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 1.03 110.958 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -106.35 141.89 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.943 -0.762 . . . . 2.1400000000000001 108.943 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -125.83 136.88 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.191 0.441 . . . . 1.0800000000000001 112.191 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 26.2 t -108.27 132.42 56.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.917 -0.771 . . . . 1.05 108.917 168.723 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.14 124.0 56.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.964 0.412 . . . . 1.6499999999999999 111.088 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.441 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -136.89 143.61 43.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.029 -0.532 . . . . 1.03 110.344 178.044 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . 0.443 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -112.09 -8.59 14.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.461 -0.336 . . . . 1.04 111.308 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 p -131.18 168.11 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.472 -0.331 . . . . 1.0800000000000001 111.33 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.541 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.5 p -59.22 -50.08 75.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.379 0.609 . . . . 1.6599999999999999 109.434 172.554 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.05 -54.12 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.423 -1.262 . . . . 0.69999999999999996 112.215 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.443 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 44.0 mt-30 -56.91 -41.18 77.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.25 0.547 . . . . 1.4099999999999999 111.173 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.521 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -68.23 -45.9 72.0 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.43 -0.805 . . . . 1.04 111.496 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.541 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.4 mt -66.52 -28.13 68.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 1.53 110.481 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -66.76 -51.65 53.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 2.9100000000000001 109.831 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 17.3 t -63.56 -37.89 89.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.6399999999999999 110.792 179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -57.51 -39.88 77.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 1.8400000000000001 110.366 178.048 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.82 -34.87 30.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.801 -0.636 . . . . 1.1599999999999999 111.39 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -80.21 -38.44 31.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.62 111.568 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -116.13 161.29 31.87 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.188 -0.46 . . . . 0.47999999999999998 110.679 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -93.6 82.29 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.59 2.86 . . . . 0.31 110.839 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 43.6 mm -64.84 116.1 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.348 -0.842 . . . . 1.03 111.563 -174.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.73 -32.53 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.28999999999999998 110.375 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.462 HG13 HD22 ' A' ' 115' ' ' LEU . 15.0 p -160.59 155.53 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 1.03 109.77 -176.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.11 167.8 21.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.325 0.583 . . . . 0.97999999999999998 111.677 -179.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -139.4 111.18 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.447 -0.797 . . . . 1.5700000000000001 109.285 177.735 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.476 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.2 mp -115.09 123.41 48.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.141 0.423 . . . . 1.02 112.141 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.99 107.94 15.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.781 0.801 . . . . 1.77 109.816 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.462 ' H ' ' HB ' ' A' ' 83' ' ' THR . 38.2 t -59.17 -19.56 16.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.803 -1.09 . . . . 1.3600000000000001 111.868 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -122.0 70.03 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.531 . . . . 2.6400000000000001 110.72 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.446 HD12 ' SG ' ' A' ' 65' ' ' CYS . 94.9 mt -67.37 -27.85 67.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 1.3100000000000001 110.295 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.24 -160.7 16.54 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.763 -0.653 . . . . 0.87 111.684 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.62 -46.03 36.47 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.897 2.398 . . . . 1.3899999999999999 112.203 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -126.22 -19.75 4.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.137 -0.483 . . . . 4.0 110.271 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.6 m -63.47 125.89 25.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.985 -0.552 . . . . 1.3700000000000001 110.988 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -145.71 153.51 41.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.959 -0.564 . . . . 0.58999999999999997 110.643 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.656 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 15.3 m -77.47 85.81 3.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.637 -0.875 . . . . 2.1899999999999999 108.637 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.76 -65.47 0.62 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.837 -0.697 . . . . 0.28000000000000003 112.689 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -54.77 -25.18 41.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.361 2.041 . . . . 0.28000000000000003 111.247 174.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.524 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -69.03 -46.91 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.723 -0.671 . . . . 1.01 109.998 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . 0.445 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -58.2 -47.72 82.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.099 -0.955 . . . . 1.01 109.862 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.24 -39.26 94.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.786 -0.643 . . . . 2.0299999999999998 110.555 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . 0.542 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -58.61 -44.62 89.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 1.0700000000000001 111.05 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.7 mt -69.58 -46.24 66.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.631 -0.713 . . . . 1.05 110.293 177.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 30.1 mmmt -56.06 -35.83 67.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 2.5800000000000001 111.582 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.542 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 1.5 pt20 -63.97 -41.46 97.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.908 -0.587 . . . . 3.0299999999999998 110.76 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . 0.461 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 96.5 mtt180 -95.51 4.69 52.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.883 -0.598 . . . . 1.95 111.027 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.05 32.95 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.628 -0.715 . . . . 1.1899999999999999 111.266 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.0 mt -80.17 131.65 62.03 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 109.396 -0.594 . . . . 1.05 109.396 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.434 ' HB2' ' HE1' ' A' ' 117' ' ' MET . 43.2 Cg_endo -76.09 142.19 24.42 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.287 1.992 . . . . 0.23000000000000001 112.014 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 9.3 p90 -158.38 154.67 27.36 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.369 -0.832 . . . . 0.23999999999999999 110.185 -179.44 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 mt -117.07 138.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.463 -0.79 . . . . 1.0700000000000001 109.781 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.403 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.6 mm? -88.5 109.86 20.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.987 -0.551 . . . . 1.05 109.702 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.598 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 20.9 t-160 -104.88 86.52 2.47 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.387 0.613 . . . . 0.59999999999999998 109.756 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.474 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 8.8 t -135.85 161.7 34.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.001 -1.0 . . . . 1.1399999999999999 110.577 -172.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.34 22.16 9.01 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.604 -0.808 . . . . 1.1000000000000001 112.409 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.622 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 19.8 t70 -141.69 74.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.337 0.589 . . . . 2.3300000000000001 109.484 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.472 HD11 ' N ' ' A' ' 86' ' ' LEU . 3.3 mp -92.42 -22.94 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.823 -0.626 . . . . 2.1800000000000002 110.887 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -73.86 -48.29 32.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.93 0.395 . . . . 2.6299999999999999 110.625 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.622 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -75.88 -38.64 57.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.169 -0.469 . . . . 5.1200000000000001 110.74 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.453 ' O ' HD11 ' A' ' 93' ' ' LEU . 73.6 m-70 -89.48 17.29 6.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.978 -0.289 . . . . 1.3500000000000001 110.984 177.371 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.606 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -52.56 -42.51 58.03 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.39 -0.434 . . . . 1.0600000000000001 113.478 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.94 -34.71 65.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.939 0.4 . . . . 2.5 110.693 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.489 ' O ' HG13 ' A' ' 96' ' ' ILE . 35.3 tp -72.64 -54.18 9.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.042 -0.526 . . . . 1.22 111.514 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.453 HD11 ' O ' ' A' ' 89' ' ' HIS . 0.0 OUTLIER -65.66 -27.65 68.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.973 -0.691 . . . . 2.1899999999999999 111.823 -176.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.606 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 27.2 mmm180 -64.17 -46.35 84.37 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.849 -0.614 . . . . 5.0 110.961 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.68 -36.14 83.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 2.8999999999999999 110.755 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.489 HG13 ' O ' ' A' ' 92' ' ' LEU . 79.0 mt -64.08 -49.42 81.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 1.0800000000000001 110.503 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.5 t70 58.76 74.52 0.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.607 0.718 . . . . 1.0900000000000001 110.897 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.94 21.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.916 -1.038 . . . . 1.0800000000000001 109.165 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.442 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 39.3 Cg_exo -58.74 143.83 98.55 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.455 2.103 . . . . 0.29999999999999999 112.452 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.61 132.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.238 -0.437 . . . . 1.3 111.226 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.483 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.4 mmm -114.51 106.7 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.857 -0.794 . . . . 1.04 108.857 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.474 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -67.9 147.61 52.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.023 0.439 . . . . 1.2 112.161 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.436 ' HZ2' ' CD ' ' A' ' 12' ' ' GLU . 90.4 mttt -90.85 141.98 27.23 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.848 -0.614 . . . . 1.27 110.116 175.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.16 155.82 99.76 Favored 'Cis proline' 0 C--O 1.231 0.142 0 C-N-CA 123.137 -1.61 . . . . 0.88 112.389 -0.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.598 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -146.14 139.97 26.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 0.39000000000000001 109.969 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.539 ' O ' HG22 ' A' ' 110' ' ' VAL . 18.7 t70 -70.51 128.24 35.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.251 -0.648 . . . . 0.51000000000000001 109.251 174.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.414 HG22 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -68.86 -19.39 64.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.718 -0.674 . . . . 1.04 112.756 -170.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 t -73.94 -37.49 64.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.206 -0.664 . . . . 1.8899999999999999 109.206 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -65.66 -46.48 79.0 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.112 -0.495 . . . . 0.62 109.779 175.779 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.539 HG22 ' O ' ' A' ' 106' ' ' ASP . 21.5 t -58.88 -43.52 88.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.377 -0.829 . . . . 1.04 110.647 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.681 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.23 -54.03 39.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.853 -0.612 . . . . 1.01 111.454 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.554 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 61.7 mttp -57.5 -48.06 80.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 2.4300000000000002 111.289 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.523 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 26.2 mmt180 -63.82 -34.71 78.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 2.73 111.415 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -46.71 70.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.058 0.456 . . . . 1.02 110.27 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.462 HD22 HG13 ' A' ' 52' ' ' VAL . 86.8 mt -66.12 -25.6 67.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 1.04 111.877 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.554 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 32.8 mm-40 -54.48 -41.04 69.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.537 -0.302 . . . . 2.79 111.388 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.442 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 77.6 mtm -70.89 -29.41 65.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.105 0.409 . . . . 1.0 112.105 -176.365 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.7 t -179.92 104.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.031 0.443 . . . . 1.95 110.433 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 141.21 -39.86 1.39 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.517 -0.849 . . . . 2.5699999999999998 112.156 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.6 -59.33 9.99 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.809 -0.71 . . . . 4.4800000000000004 111.427 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.6 t70 54.8 36.8 27.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.685 0.755 . . . . 6.4199999999999999 110.403 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -93.98 129.32 40.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 9.5099999999999998 110.548 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -63.02 126.09 88.22 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.579 -0.737 . . . . 9.5999999999999996 110.018 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.6 72.74 4.9 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.616 2.21 . . . . 11.17 112.256 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.5 -0.762 . . . . 13.279999999999999 110.282 179.859 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.423 -0.271 . . . . 9.2100000000000009 112.423 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . 0.571 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . 49.2 71.82 0.35 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.268 0.556 . . . . 7.1500000000000004 111.569 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -72.81 -19.92 61.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.27 0.557 . . . . 7.6699999999999999 110.34 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.05 59.0 0.47 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.57 -0.741 . . . . 2.4399999999999999 111.478 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.571 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 54.5 mtt -62.05 130.41 92.74 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.568 0.223 . . . . 2.1800000000000002 111.365 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.625 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -61.99 140.59 85.46 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.104 2.536 . . . . 0.55000000000000004 111.714 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -86.62 103.51 15.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.001 0.429 . . . . 1.48 109.899 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.465 HG21 ' CG1' ' A' ' 52' ' ' VAL . 46.9 t -100.26 136.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.773 -0.649 . . . . 1.05 110.977 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 53.7 tp -112.02 113.49 25.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.256 -0.429 . . . . 1.5 110.59 176.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.3 t -94.34 122.53 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.39 0.614 . . . . 1.03 111.164 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.552 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 0.6 OUTLIER -101.79 107.42 18.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.812 -1.085 . . . . 1.05 108.341 172.94 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -166.38 134.47 2.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 109.956 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.428 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.6 t70 -99.55 -23.58 15.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.383 -0.826 . . . . 1.27 110.069 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . 0.465 ' CB ' HD12 ' A' ' 17' ' ' ILE . 33.9 mt-10 -80.31 104.81 2.85 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 109.345 -0.613 . . . . 2.5600000000000001 109.345 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.2 Cg_exo -58.0 -32.68 95.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.014 2.476 . . . . 0.35999999999999999 113.435 -171.416 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.66 -49.68 74.17 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.697 -0.483 . . . . 2.2799999999999998 109.697 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.465 HD12 ' CB ' ' A' ' 14' ' ' GLU . 3.3 mp -66.32 -47.59 83.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.544 -0.753 . . . . 1.7 110.126 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.83 74.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.525 -0.761 . . . . 1.02 111.228 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.4 ttp -64.46 -37.08 86.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.013 -0.539 . . . . 1.28 110.949 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.439 ' HB3' HG22 ' A' ' 107' ' ' THR . 2.6 m-80 -69.16 -37.0 78.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.25 -0.432 . . . . 1.3600000000000001 110.915 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.11 -45.89 83.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.42 -0.354 . . . . 1.0700000000000001 110.058 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.474 ' O ' ' HG3' ' A' ' 26' ' ' GLU . 35.9 tt0 -51.86 -56.8 11.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.765 -0.652 . . . . 1.7 110.205 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -63.55 -27.65 69.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.859 -0.61 . . . . 1.1799999999999999 111.894 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.9 54.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.834 0.35 . . . . 1.05 110.314 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.7 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 47.0 m-85 -66.08 -41.1 91.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 0.16 111.031 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.474 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.3 mt-10 -61.29 -37.04 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.68999999999999995 110.582 178.283 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.44 -29.78 68.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 0.51000000000000001 110.338 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -79.48 -13.48 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.65000000000000002 110.66 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.49 50.19 1.58 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.092 -0.575 . . . . 0.28999999999999998 112.399 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.81 165.52 26.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.591 0.234 . . . . 1.03 110.898 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -109.27 128.2 54.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.261 -0.644 . . . . 2.1400000000000001 109.261 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.418 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 37.8 t -113.23 133.98 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.787 0.662 . . . . 1.0800000000000001 112.787 -167.821 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.97 139.91 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.169 -1.049 . . . . 1.05 108.169 167.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.1 t -114.67 125.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.626 -0.43 . . . . 1.6499999999999999 110.879 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.49 ' HB2' ' CB ' ' A' ' 40' ' ' GLN . . . -133.54 136.39 44.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.878 -0.601 . . . . 1.03 110.174 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.16 -10.8 21.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.869 0.366 . . . . 1.04 111.287 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.2 p -131.23 163.37 27.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.199 -0.455 . . . . 1.0800000000000001 110.751 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.63 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.6 m -63.41 -33.76 76.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.757 -0.46 . . . . 1.6599999999999999 109.757 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.43 -51.61 67.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 110.618 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.49 ' CB ' ' HB2' ' A' ' 35' ' ' ALA . 46.8 mt-30 -58.98 -39.12 80.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.122 0.487 . . . . 1.4099999999999999 110.805 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.505 ' CB ' HD23 ' A' ' 11' ' ' LEU . . . -64.74 -49.83 69.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 1.04 111.718 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.4 mt -63.25 -27.86 69.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 1.53 110.497 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -67.42 -50.29 60.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.787 -0.642 . . . . 2.9100000000000001 109.769 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -65.47 -33.45 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 1.6399999999999999 110.586 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -37.51 77.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 1.8400000000000001 110.656 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.8 -41.8 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 1.1599999999999999 111.212 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.16 -37.19 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 0.62 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -122.72 162.5 38.28 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.166 -0.47 . . . . 0.47999999999999998 110.724 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -93.28 86.05 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.255 2.637 . . . . 0.31 111.018 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 42.4 mm -64.01 119.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 1.03 111.523 -175.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.417 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 41.5 m-20 -87.24 -35.7 18.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.28999999999999998 110.28 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.465 ' CG1' HG21 ' A' ' 8' ' ' VAL . 14.5 p -156.31 155.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.753 -0.658 . . . . 1.03 109.581 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -138.24 163.51 31.57 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.451 0.643 . . . . 0.97999999999999998 111.519 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.421 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -134.84 111.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.511 -0.922 . . . . 1.5700000000000001 108.511 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.702 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -108.01 107.31 17.94 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.711 -0.396 . . . . 1.02 111.802 -169.673 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.832 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.1 t70 -84.97 139.04 32.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.098 -0.704 . . . . 1.77 109.098 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.46 HG23 ' SG ' ' A' ' 65' ' ' CYS . 14.4 t -93.93 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.731 -0.668 . . . . 1.3600000000000001 110.287 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -89.96 60.18 4.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.715 0.769 . . . . 2.6400000000000001 110.164 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.3 mt -89.77 -23.85 21.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.87 -0.605 . . . . 1.3100000000000001 110.067 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.68 -173.13 44.49 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.029 -0.828 . . . . 0.87 111.029 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.58 -43.52 57.08 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.565 2.177 . . . . 1.3899999999999999 111.91 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.11 -23.55 6.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.918 -0.583 . . . . 4.0 110.404 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -61.91 122.35 15.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 1.3700000000000001 111.068 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.0 p80 -144.39 154.22 42.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.495 -0.775 . . . . 0.58999999999999997 109.993 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.702 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -70.05 87.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 2.1899999999999999 109.866 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.57 -74.71 0.74 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.525 -0.845 . . . . 0.28000000000000003 112.523 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.63 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 46.5 Cg_exo -53.35 -24.76 28.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.695 2.264 . . . . 0.28000000000000003 112.302 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.47 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.2 t -66.33 -44.54 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.375 0.607 . . . . 1.01 109.918 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.43 92.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.918 -1.037 . . . . 1.01 109.966 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.88 -45.59 93.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.514 -0.766 . . . . 2.0299999999999998 110.458 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.05 -41.65 68.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.459 0.647 . . . . 1.0700000000000001 111.366 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.58 -44.84 56.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.375 -0.83 . . . . 1.05 110.561 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -54.29 -41.37 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.455 -0.793 . . . . 2.5800000000000001 110.861 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.512 HE21 ' HA ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -59.89 -46.44 89.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.708 -0.678 . . . . 3.0299999999999998 111.483 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -92.93 12.06 25.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 1.95 111.451 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.43 37.44 27.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.692 -0.685 . . . . 1.1899999999999999 111.66 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.25 133.53 38.49 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.282 -0.417 . . . . 1.05 109.944 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.417 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 22.2 Cg_endo -74.99 142.11 27.47 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.298 1.999 . . . . 0.23000000000000001 112.04 177.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 18.7 p90 -159.34 154.94 25.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.834 -0.621 . . . . 0.23999999999999999 110.562 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.4 mt -117.74 137.03 52.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.358 -0.837 . . . . 1.0700000000000001 109.624 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 mm? -89.03 109.4 20.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.238 -0.653 . . . . 1.05 109.238 179.54 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.832 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 t-160 -97.87 126.85 43.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.904 -1.147 . . . . 0.59999999999999998 107.904 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.614 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -169.39 151.23 4.44 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.753 -0.592 . . . . 1.1399999999999999 111.529 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.83 -8.78 59.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.896 -0.669 . . . . 1.1000000000000001 111.565 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -116.32 112.39 21.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.725 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.04 -10.31 15.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.807 -0.633 . . . . 2.1800000000000002 110.057 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -84.03 -60.33 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 2.6299999999999999 111.457 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -71.78 -40.67 69.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 5.1200000000000001 110.778 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . 0.477 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 89.8 m-70 -92.48 21.78 5.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.334 -0.394 . . . . 1.3500000000000001 111.676 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.41 -39.12 97.4 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.924 -0.655 . . . . 1.0600000000000001 112.475 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.42 -41.61 97.43 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.936 0.398 . . . . 2.5 110.346 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.424 ' O ' HG13 ' A' ' 96' ' ' ILE . 63.8 tp -59.77 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 1.22 110.502 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.477 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 40.6 mt -60.32 -40.84 92.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.819 -0.628 . . . . 2.1899999999999999 111.122 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -69.78 -25.53 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 5.0 111.21 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.15 -32.01 56.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.445 0.641 . . . . 2.8999999999999999 110.232 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.424 HG13 ' O ' ' A' ' 92' ' ' LEU . 93.6 mt -77.35 -54.44 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 1.0800000000000001 110.912 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.95 76.58 0.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.839 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.93 168.16 12.97 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.157 -0.929 . . . . 1.0800000000000001 108.941 178.592 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 47.8 Cg_exo -58.74 140.57 95.55 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.425 2.083 . . . . 0.29999999999999999 112.625 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.85 142.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 1.3 110.873 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.408 ' O ' ' HD2' ' A' ' 82' ' ' HIS . 80.9 mmm -125.57 110.01 13.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.389 -0.597 . . . . 1.04 109.389 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.614 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.67 150.2 37.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 1.2 111.849 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.558 ' HE3' ' OD2' ' A' ' 56' ' ' ASP . 77.8 mttt -91.18 140.97 25.9 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 1.27 110.154 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 2.9 Cg_exo -75.35 146.93 87.5 Favored 'Cis proline' 0 C--O 1.233 0.247 0 C-N-CA 123.472 -1.47 . . . . 0.88 112.641 3.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.509 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -136.41 132.58 35.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 0.39000000000000001 110.275 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.487 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.7 t70 -73.32 128.07 34.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.51000000000000001 108.486 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.439 HG22 ' HB3' ' A' ' 20' ' ' ASN . 35.9 p -65.96 -17.77 64.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.876 -0.602 . . . . 1.04 112.294 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.425 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.5 p -71.92 -41.78 67.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.947 -0.39 . . . . 1.8899999999999999 109.947 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.5 -42.16 87.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.139 0.495 . . . . 0.62 110.01 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.487 HG23 ' O ' ' A' ' 106' ' ' ASP . 20.5 t -62.62 -44.11 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.383 -0.826 . . . . 1.04 110.182 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.7 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.63 -51.33 57.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.619 -0.719 . . . . 1.01 111.854 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.491 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 52.8 mtpt -60.03 -48.16 82.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 2.4300000000000002 111.244 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -62.46 -35.82 80.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.68 0.276 . . . . 2.73 111.399 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.32 -46.84 75.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.94 0.4 . . . . 1.02 110.041 177.326 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.64 -26.36 65.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.132 -0.486 . . . . 1.04 111.887 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . 0.491 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 50.7 mm-40 -56.78 -46.94 81.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.116 0.484 . . . . 2.79 110.375 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.56 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.1 mtm -76.06 -26.69 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 1.0 110.76 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 53.4 t -58.64 -52.73 64.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 1.95 111.146 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -146.26 129.91 3.52 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.47 -0.871 . . . . 2.5699999999999998 112.055 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.88 -28.97 74.11 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.158 -0.777 . . . . 4.4800000000000004 111.158 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.41 128.75 38.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.915 -0.402 . . . . 6.4199999999999999 109.915 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -83.85 155.94 22.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.484 -0.325 . . . . 9.5099999999999998 110.27 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -72.5 115.41 39.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 9.5999999999999996 110.109 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.7 37.64 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.978 2.452 . . . . 11.17 112.772 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.726 0 CA-C-O 118.568 -0.73 . . . . 13.279999999999999 110.483 -178.287 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.681 -0.568 . . . . 9.2100000000000009 111.681 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.39 -43.37 71.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.517 0.562 . . . . 7.1500000000000004 112.517 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -102.09 27.23 6.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.741 0.305 . . . . 7.6699999999999999 111.289 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.47 20.34 78.28 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 121.005 -0.617 . . . . 2.4399999999999999 111.948 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' MET . . . . . 0.41 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 86.3 mtp -143.2 139.41 16.63 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 108.708 -0.849 . . . . 2.1800000000000002 108.708 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 8.8 Cg_exo -63.52 131.42 31.62 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.854 1.703 . . . . 0.55000000000000004 111.372 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -86.01 102.94 14.25 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.507 -0.923 . . . . 1.48 108.507 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.44 HG23 ' CG1' ' A' ' 52' ' ' VAL . 49.8 t -99.69 126.81 53.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.037 -0.529 . . . . 1.05 111.087 -172.326 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.478 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.5 tm? -102.2 112.24 24.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.578 -0.737 . . . . 1.5 109.476 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.4 t -96.83 125.82 49.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.113 0.482 . . . . 1.03 111.409 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . 0.484 HD23 ' HB1' ' A' ' 41' ' ' ALA . 0.2 OUTLIER -105.96 100.53 10.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.694 -0.854 . . . . 1.05 108.694 173.002 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -157.5 118.17 3.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.907 -0.588 . . . . 1.4099999999999999 109.626 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.479 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 32.9 t70 -77.27 -21.2 53.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.848 -0.615 . . . . 1.27 110.223 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -88.05 106.88 13.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.905 -0.589 . . . . 2.5600000000000001 111.117 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' PRO . . . . . 0.479 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 39.2 Cg_exo -58.53 -28.89 87.2 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.86 2.374 . . . . 0.35999999999999999 112.914 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -49.67 68.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.516 -0.55 . . . . 2.2799999999999998 109.516 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.414 HD13 HG23 ' A' ' 17' ' ' ILE . 65.5 mt -66.37 -45.47 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.733 -0.667 . . . . 1.7 110.514 176.697 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.35 73.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 1.02 110.82 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.6 ttp -59.37 -43.84 92.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.654 -0.703 . . . . 1.28 111.238 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.431 ' HB3' HG23 ' A' ' 107' ' ' THR . 4.9 m-80 -67.86 -38.71 83.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.926 -0.579 . . . . 1.3600000000000001 111.34 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 mt -65.31 -44.83 86.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.928 0.394 . . . . 1.0700000000000001 110.297 172.243 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLN . . . . . 0.578 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 52.2 tt0 -54.49 -51.89 63.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.563 -0.744 . . . . 1.7 110.466 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.09 -34.38 74.83 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.612 -0.267 . . . . 1.1799999999999999 111.116 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.9 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.504 -0.317 . . . . 1.05 110.699 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.603 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.9 m-85 -68.64 -42.5 77.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.242 -0.435 . . . . 0.16 110.994 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 44.1 mt-10 -61.79 -35.54 78.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.586 -0.279 . . . . 0.68999999999999995 110.461 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.49 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.51000000000000001 110.657 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.81 -10.0 59.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.65000000000000002 110.455 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.63 50.56 1.81 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.28999999999999998 112.399 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.459 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -139.79 165.14 28.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 1.03 110.833 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.86 134.97 53.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.422 -0.584 . . . . 2.1400000000000001 109.422 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . 0.578 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.4 t -117.39 140.74 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.41 0.522 . . . . 1.0800000000000001 112.41 -167.815 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.43 131.53 64.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.544 -0.91 . . . . 1.05 108.544 168.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.6 t -105.43 121.15 57.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 1.6499999999999999 111.609 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.471 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -126.39 142.66 51.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.819 -0.628 . . . . 1.03 110.471 177.437 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.76 -12.6 15.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.899 -0.591 . . . . 1.04 110.54 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' THR . . . . . 0.423 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 32.8 p -124.89 174.96 7.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 1.0800000000000001 110.955 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' CYS . . . . . 0.612 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.9 m -75.11 -37.0 61.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.033 0.444 . . . . 1.6599999999999999 110.263 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.15 -41.19 90.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.69999999999999996 111.161 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . 0.471 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 86.5 mt-30 -59.83 -37.29 78.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.078 0.466 . . . . 1.4099999999999999 110.857 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.484 ' HB1' HD23 ' A' ' 11' ' ' LEU . . . -71.46 -48.43 49.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.995 -0.548 . . . . 1.04 110.879 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mp -56.02 -37.34 69.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 1.53 110.68 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -63.1 -54.07 43.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 2.9100000000000001 110.444 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -63.99 -29.18 70.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.713 -0.676 . . . . 1.6399999999999999 111.711 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.4 -30.64 69.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.342 0.591 . . . . 1.8400000000000001 110.513 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.53 -28.57 24.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.4 0.619 . . . . 1.1599999999999999 111.07 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -87.04 -21.68 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 0.62 111.52 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -137.68 163.67 46.69 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 0.47999999999999998 111.115 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -96.32 87.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.767 2.978 . . . . 0.31 111.388 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.478 HD12 ' HB2' ' A' ' 9' ' ' LEU . 37.9 mm -66.08 124.36 20.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.594 -0.73 . . . . 1.03 111.631 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.689 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 14.3 m-20 -89.48 -34.67 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.542 -0.754 . . . . 0.28999999999999998 110.421 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.455 HG13 HD23 ' A' ' 115' ' ' LEU . 13.6 p -159.67 157.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.805 -0.634 . . . . 1.03 109.871 -176.306 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.8 164.53 29.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.359 0.599 . . . . 0.97999999999999998 112.008 -178.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -137.65 110.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.353 -0.84 . . . . 1.5700000000000001 109.301 175.635 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.647 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.5 mp -112.7 121.86 45.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.415 -0.357 . . . . 1.02 111.631 -169.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.88 116.49 22.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 1.77 109.645 171.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' VAL . . . . . 0.42 ' H ' ' HB ' ' A' ' 83' ' ' THR . 92.9 t -67.37 -23.74 30.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.061 -0.972 . . . . 1.3600000000000001 110.463 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.38 56.94 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.544 -0.753 . . . . 2.6400000000000001 110.695 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.35 -37.32 85.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.939 -0.763 . . . . 1.3100000000000001 108.939 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.85 -171.61 29.29 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.149 -1.18 . . . . 0.87 110.149 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.0 -46.26 34.92 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.498 2.132 . . . . 1.3899999999999999 111.862 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.99 -34.93 6.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.409 -0.36 . . . . 4.0 110.874 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -62.33 123.56 18.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.325 0.584 . . . . 1.3700000000000001 110.92 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -144.79 152.27 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.551 -0.75 . . . . 0.58999999999999997 110.616 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' CYS . . . . . 0.647 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -73.82 87.5 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.283 0.564 . . . . 2.1899999999999999 109.811 173.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLY . . . . . 0.438 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -106.51 -73.52 0.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.278 -0.963 . . . . 0.28000000000000003 112.598 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' PRO . . . . . 0.612 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.4 Cg_exo -52.19 -27.1 28.68 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.28000000000000003 112.082 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.553 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 17.0 t -68.23 -44.07 84.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 1.01 110.195 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.79 82.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.28 -0.873 . . . . 1.01 110.268 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.52 -42.47 98.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 110.253 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.37 69.34 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.51 0.672 . . . . 1.0700000000000001 110.92 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.6 -42.7 70.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.22 -0.9 . . . . 1.05 110.642 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' LYS . . . . . 0.575 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.8 mmtt -60.47 -37.95 82.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.809 -0.632 . . . . 2.5800000000000001 111.11 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.52 -39.06 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 3.0299999999999998 111.441 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -97.46 10.98 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.257 -0.429 . . . . 1.95 111.159 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.82 33.18 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 1.1899999999999999 112.02 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.73 132.67 39.75 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.228 -0.442 . . . . 1.05 110.071 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PRO . . . . . 0.407 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 18.6 Cg_endo -74.41 140.06 26.74 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.391 2.06 . . . . 0.23000000000000001 111.421 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 23.6 p90 -157.34 161.16 39.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.831 -0.622 . . . . 0.23999999999999999 110.493 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ILE . . . . . 0.432 HG22 ' HG2' ' A' ' 101' ' ' MET . 41.0 mt -124.21 140.95 46.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.288 -0.869 . . . . 1.0700000000000001 109.784 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.467 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.4 mm? -88.69 108.01 19.24 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.91 -0.774 . . . . 1.05 108.91 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' HIS . . . . . 0.582 ' NE2' ' HB1' ' A' ' 105' ' ' ALA . 17.7 t-160 -99.49 82.42 2.65 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.593 0.711 . . . . 0.59999999999999998 109.722 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.621 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -137.98 157.97 45.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.426 -1.261 . . . . 1.1399999999999999 109.257 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.23 4.61 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.362 -0.923 . . . . 1.1000000000000001 111.955 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 12.9 m-20 -137.09 69.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 2.3300000000000001 111.458 -176.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.422 HD11 HG13 ' A' ' 100' ' ' VAL . 82.2 mt -63.04 -34.77 78.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 2.1800000000000002 110.254 174.378 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -63.81 -29.17 70.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 2.6299999999999999 111.745 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -72.34 -21.6 61.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.232 0.539 . . . . 5.1200000000000001 110.508 -177.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -137.45 45.65 2.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 1.3500000000000001 110.072 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLY . . . . . 0.48 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -59.67 -27.06 63.35 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 116.005 -0.543 . . . . 1.0600000000000001 113.263 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.68 -25.16 63.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 2.5 110.642 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' LEU . . . . . 0.463 ' O ' HG13 ' A' ' 96' ' ' ILE . 27.5 tp -77.22 -52.74 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 1.22 111.884 -174.499 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LEU . . . . . 0.479 ' CD1' ' HA2' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -63.78 -23.94 67.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.178 0.513 . . . . 2.1899999999999999 111.545 -177.041 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' ARG . . . . . 0.48 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 99.6 mtt180 -62.57 -34.26 76.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.186 -0.915 . . . . 5.0 110.762 173.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -81.93 -33.68 30.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 2.8999999999999999 110.447 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ILE . . . . . 0.575 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 59.4 mt -74.34 -62.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.485 -0.78 . . . . 1.0800000000000001 111.606 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.13 76.81 0.21 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.408 0.623 . . . . 1.0900000000000001 111.471 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.42 164.83 19.37 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 1.0800000000000001 109.238 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.661 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.7 Cg_exo -56.52 144.26 85.14 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.668 2.245 . . . . 0.29999999999999999 113.003 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . 0.422 HG13 HD11 ' A' ' 86' ' ' LEU . 46.5 t -121.99 137.74 54.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.915 -0.584 . . . . 1.3 110.751 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' MET . . . . . 0.432 ' HG2' HG22 ' A' ' 80' ' ' ILE . 86.6 mmm -117.56 105.55 12.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.702 -0.851 . . . . 1.04 108.702 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ALA . . . . . 0.621 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.13 145.3 56.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.98 -0.554 . . . . 1.2 111.861 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' LYS . . . . . 0.524 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 87.4 mttt -91.34 140.89 25.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 1.27 109.897 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.6 154.11 97.21 Favored 'Cis proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.567 -1.431 . . . . 0.88 112.472 2.024 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' ALA . . . . . 0.582 ' HB1' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 137.29 29.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.033 -0.531 . . . . 0.39000000000000001 110.216 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ASP . . . . . 0.477 ' O ' HG22 ' A' ' 110' ' ' VAL . 11.4 t70 -71.43 129.71 39.48 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.51000000000000001 108.468 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' THR . . . . . 0.431 HG23 ' HB3' ' A' ' 20' ' ' ASN . 17.9 p -67.18 -22.37 65.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.554 -0.748 . . . . 1.04 112.542 -170.244 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . 0.431 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 91.6 p -71.19 -37.42 72.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.653 -0.499 . . . . 1.8899999999999999 109.653 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ASP . . . . . 0.403 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -63.4 -46.68 85.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.323 0.583 . . . . 0.62 109.556 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 106' ' ' ASP . 21.1 t -62.0 -44.88 99.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.991 -1.004 . . . . 1.04 110.62 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . 0.603 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.46 -47.79 80.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 1.01 111.461 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LYS . . . . . 0.431 ' HG3' ' O ' ' A' ' 108' ' ' SER . 95.2 mttt -62.75 -44.76 95.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 2.4300000000000002 111.403 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' ARG . . . . . 0.403 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 33.4 mmt180 -64.1 -32.72 74.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.104 0.478 . . . . 2.73 111.091 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.57 -47.9 44.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.088 0.47 . . . . 1.02 110.463 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LEU . . . . . 0.455 HD23 HG13 ' A' ' 52' ' ' VAL . 80.8 mt -69.75 -30.03 67.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.785 0.661 . . . . 1.04 112.785 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.96 -31.61 72.62 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.763 -0.375 . . . . 2.79 110.715 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' MET . . . . . 0.661 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 55.7 mtm -70.79 -32.3 69.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 1.0 110.802 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 42.0 t -76.45 -42.09 45.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 1.95 110.486 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.81 -73.27 2.64 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.044 -0.598 . . . . 2.5699999999999998 112.704 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 155.85 71.39 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.07 -0.586 . . . . 4.4800000000000004 111.645 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -84.71 133.12 34.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.87 0.367 . . . . 6.4199999999999999 110.423 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -124.39 126.77 46.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.155 -0.475 . . . . 9.5099999999999998 110.057 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -96.6 109.87 50.28 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.851 -0.426 . . . . 9.5999999999999996 109.851 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.78 52.59 4.28 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.957 2.438 . . . . 11.17 112.267 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.667 -0.683 . . . . 13.279999999999999 110.15 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.637 0.256 . . . . 1.6499999999999999 111.063 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.57 145.83 59.45 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.455 2.77 . . . . 0.33000000000000002 111.689 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -89.73 106.73 18.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.94 0.4 . . . . 0.89000000000000001 109.931 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 60.1 t -100.49 137.36 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.91 -0.586 . . . . 0.20000000000000001 111.062 -175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB2' HD12 ' A' ' 50' ' ' ILE . 47.3 tp -111.11 116.92 31.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.305 -0.407 . . . . 0.75 110.323 174.848 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 t -100.77 121.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.261 0.553 . . . . 0.13 111.362 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -101.89 104.11 14.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.937 -1.029 . . . . 0.20999999999999999 108.658 172.915 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -161.21 113.47 1.87 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.903 -0.589 . . . . 1.4099999999999999 109.862 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 33.6 t70 -84.08 -12.56 54.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.086 -0.506 . . . . 1.27 109.865 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.28 100.37 1.38 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.347 -0.612 . . . . 2.5600000000000001 109.347 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.9 Cg_exo -60.18 -30.58 91.61 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.839 2.36 . . . . 0.32000000000000001 113.676 -171.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.62 -49.44 73.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.276 -0.638 . . . . 1.51 109.276 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.97 -44.74 92.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.686 -0.688 . . . . 1.01 111.059 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.72 75.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.20999999999999999 110.905 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.5 ttp -60.6 -42.66 97.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.923 -0.581 . . . . 0.60999999999999999 110.871 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.475 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.0 m-80 -66.43 -40.3 89.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.027 -0.533 . . . . 1.22 111.164 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.2 mt -62.98 -42.62 99.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.17999999999999999 110.443 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.465 ' CG ' ' HB ' ' A' ' 32' ' ' VAL . 1.5 tt0 -58.07 -50.95 71.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.166 -0.47 . . . . 1.04 109.809 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -56.07 -36.26 67.9 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.024 -0.535 . . . . 0.78000000000000003 111.109 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.6 45.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.14000000000000001 111.105 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 45.9 m-85 -64.81 -43.4 93.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.246 -0.434 . . . . 0.13 110.699 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 47.4 mt-10 -61.89 -35.08 77.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.279 . . . . 0.68999999999999995 110.553 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -32.12 72.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.497 . . . . 0.51000000000000001 110.592 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.978 0.418 . . . . 0.65000000000000002 110.375 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.73 49.74 1.25 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.85 -0.613 . . . . 0.28999999999999998 112.232 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 26' ' ' GLU . . . -139.99 165.93 26.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.646 0.26 . . . . 0.23000000000000001 111.254 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -108.67 142.87 38.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.818 -0.808 . . . . 2.1400000000000001 108.818 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 22' ' ' GLN . 7.0 t -125.9 133.57 68.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.238 0.459 . . . . 0.19 112.238 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.5 t -104.26 124.61 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.844 -0.798 . . . . 0.23000000000000001 108.844 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.49 121.63 49.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.915 0.388 . . . . 0.94999999999999996 110.824 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.57 134.24 46.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.958 -0.565 . . . . 0.16 110.369 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.66 21.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.059 -0.519 . . . . 0.23999999999999999 110.8 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 p -128.86 158.85 37.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.25 110.86 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.538 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.6 m -64.27 -32.92 74.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.943 -0.392 . . . . 1.6000000000000001 109.943 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.1 -46.39 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.142 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -60.31 -42.64 96.0 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.336 0.589 . . . . 1.4099999999999999 110.436 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.85 -52.58 63.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.107 -0.951 . . . . 0.17999999999999999 111.732 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -63.87 -29.53 70.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.041 -0.527 . . . . 0.82999999999999996 110.568 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.97 -50.57 61.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.195 -0.668 . . . . 2.4100000000000001 109.195 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.417 ' OG ' HG11 ' A' ' 33' ' ' VAL . 8.7 t -65.45 -31.79 73.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.235 -0.439 . . . . 1.1299999999999999 110.466 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -42.93 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.23 110.544 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.74 20.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.42999999999999999 111.383 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.04 -37.36 58.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.62 111.45 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -123.89 161.07 48.77 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.163 -0.472 . . . . 0.41999999999999998 110.34 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -92.34 85.52 0.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.142 2.562 . . . . 0.23999999999999999 111.363 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 9' ' ' LEU . 40.2 mm -64.62 117.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.79 . . . . 0.22 111.507 -175.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.8 m-20 -83.67 -33.49 25.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.28999999999999998 110.265 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.528 HG11 HD23 ' A' ' 115' ' ' LEU . 14.8 p -160.58 155.38 3.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.12 109.574 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -136.3 166.92 22.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.312 0.577 . . . . 0.14000000000000001 111.266 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.567 HG21 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -141.17 120.75 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.682 -1.229 . . . . 0.95999999999999996 107.682 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.657 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -122.29 118.82 29.43 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.47 0.545 . . . . 0.16 112.47 -166.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.05 128.03 32.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.086 -0.709 . . . . 1.77 109.086 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.584 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 34.6 t -86.19 -22.52 7.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.655 -0.702 . . . . 0.80000000000000004 111.118 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -108.68 62.36 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 110.639 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.0 -34.26 77.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.84999999999999998 110.376 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.4 -173.84 36.63 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.81999999999999995 111.384 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -36.22 91.14 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.038 2.492 . . . . 1.1799999999999999 112.655 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 1.3 tmtp? -119.67 -34.74 3.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.868 0.366 . . . . 3.5299999999999998 110.185 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 p -69.51 127.46 33.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.593 0.711 . . . . 0.95999999999999996 111.472 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -145.36 150.14 36.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.261 -0.881 . . . . 0.48999999999999999 109.847 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 30.7 p -69.7 87.03 0.49 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.18 -0.674 . . . . 1.3 109.18 171.008 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.33 -68.44 0.41 Allowed Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.384 -0.912 . . . . 0.23000000000000001 112.282 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 48.3 Cg_exo -52.95 -28.46 39.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.268 1.978 . . . . 0.23999999999999999 111.532 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.7 t -68.56 -49.12 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.407 0.622 . . . . 0.12 110.05 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.37 88.57 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.887 -1.051 . . . . 0.16 110.292 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 20.8 t70 -66.01 -40.18 90.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.567 -0.742 . . . . 2.0299999999999998 110.516 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.29 74.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.514 0.673 . . . . 0.23000000000000001 110.637 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.28 -44.12 80.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.015 -0.993 . . . . 0.20000000000000001 110.373 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -57.88 -37.13 73.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 2.0099999999999998 111.413 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 77.4 mt-30 -61.8 -47.88 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 2.3700000000000001 111.23 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -90.9 5.62 47.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 1.49 111.582 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 31.29 19.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.33000000000000002 111.544 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.3 mt -81.49 131.48 58.2 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.627 -0.508 . . . . 0.17000000000000001 109.627 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -72.95 143.14 36.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.293 1.996 . . . . 0.20999999999999999 112.208 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 23.9 p90 -160.9 158.5 28.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.761 -0.654 . . . . 0.17999999999999999 110.619 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.43 HG21 ' HG2' ' A' ' 101' ' ' MET . 34.9 mt -123.6 138.23 54.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.329 -0.85 . . . . 0.23999999999999999 109.837 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 2.6 mm? -88.22 108.19 19.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.626 -0.509 . . . . 0.20999999999999999 109.626 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.615 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 22.3 t-160 -102.22 84.22 2.45 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.375 -0.602 . . . . 0.59999999999999998 109.375 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.523 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 7.2 t -125.47 152.34 45.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.445 -0.798 . . . . 0.60999999999999999 111.242 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.04 -8.16 55.63 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.317 -0.713 . . . . 0.93999999999999995 111.317 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 2.7 m-20 -126.98 124.05 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.747 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.13 -51.97 2.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.048 -0.524 . . . . 1.6100000000000001 110.535 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.55 -26.31 68.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 2.6299999999999999 111.388 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 18.1 mmm180 -64.69 -20.03 66.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 4.4199999999999999 111.858 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -144.31 40.01 1.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 1.05 111.319 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.37 -38.67 96.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.095 -0.574 . . . . 0.97999999999999998 112.783 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 6.2 pt-20 -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.449 . . . . 2.5 110.986 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.523 ' O ' HG13 ' A' ' 96' ' ' ILE . 18.9 tp -64.75 -46.97 79.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.70999999999999996 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 57' ' ' VAL . 36.0 mt -59.35 -38.26 79.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.588 -0.733 . . . . 1.5800000000000001 111.673 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 10.9 ptt180 -67.69 -25.84 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 4.3799999999999999 110.626 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 95.7 mttt -81.05 -37.71 28.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.131 0.491 . . . . 2.4500000000000002 110.278 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 92' ' ' LEU . 72.7 mt -65.01 -57.57 10.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.45000000000000001 110.455 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 57.03 76.54 0.31 Allowed 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.874 0.734 . . . . 1.0900000000000001 110.802 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.04 163.22 25.27 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.618 -0.719 . . . . 0.28999999999999998 109.726 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.09 140.85 86.33 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.933 2.422 . . . . 0.26000000000000001 112.151 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 1.1 m -127.64 149.64 32.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.191 0.52 . . . . 0.64000000000000001 110.824 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG2' HG21 ' A' ' 80' ' ' ILE . 74.0 mmm -121.47 107.9 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.82999999999999996 108.373 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -71.69 147.75 47.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.405 -0.361 . . . . 0.54000000000000004 111.446 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.5 mttt -90.92 141.61 26.8 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.05 -0.523 . . . . 0.67000000000000004 109.866 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -73.29 148.19 91.5 Favored 'Cis proline' 0 C--O 1.234 0.28 0 C-N-CA 123.477 -1.468 . . . . 0.75 112.849 2.073 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.615 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -144.78 136.25 25.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.416 -0.811 . . . . 0.34999999999999998 109.328 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.8 t70 -70.69 127.46 32.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.445 -0.946 . . . . 0.51000000000000001 108.445 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.4 p -62.56 -22.32 66.25 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.035 -0.984 . . . . 0.26000000000000001 112.233 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 78.9 p -68.74 -42.26 77.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.82 -0.437 . . . . 1.3200000000000001 109.82 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.75 -38.64 87.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.091 0.472 . . . . 0.62 110.054 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.567 HG12 HG21 ' A' ' 54' ' ' VAL . 33.5 t -64.19 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.283 -0.871 . . . . 0.13 110.106 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -68.47 -47.83 66.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.629 -0.714 . . . . 0.13 111.468 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 7.5 mtmp? -56.35 -55.32 34.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 1.95 111.174 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 35.6 mmt180 -62.1 -31.75 72.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.675 0.274 . . . . 2.23 111.578 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.85 70.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.14000000000000001 110.188 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.528 HD23 HG11 ' A' ' 52' ' ' VAL . 84.3 mt -70.68 -26.29 63.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.141 -0.481 . . . . 0.27000000000000002 111.695 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 8.0 mm-40 -60.64 -34.38 74.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 2.79 110.61 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 47.9 mtm -82.46 -13.62 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.42999999999999999 110.597 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 53.1 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.748 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.539 0.209 . . . . 1.6499999999999999 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.2 Cg_endo -71.65 141.37 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.236 1.957 . . . . 0.33000000000000002 110.86 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HG3' HD13 ' A' ' 50' ' ' ILE . 48.6 tptt -86.65 103.15 14.85 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.451 -0.574 . . . . 0.89000000000000001 109.451 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.9 t -100.09 134.51 39.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.721 -0.672 . . . . 0.20000000000000001 110.726 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.501 ' HB2' HD12 ' A' ' 50' ' ' ILE . 48.2 tp -111.54 113.44 25.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.863 0.363 . . . . 0.75 110.74 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -93.82 124.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.21 0.529 . . . . 0.13 111.599 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.773 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -105.59 101.37 10.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.057 -0.974 . . . . 0.20999999999999999 108.921 173.673 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -159.5 129.52 5.59 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.805 -0.634 . . . . 1.4099999999999999 109.782 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 28.8 t70 -90.3 -20.4 22.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.325 -0.398 . . . . 1.27 110.499 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -84.86 107.82 12.94 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 109.308 -0.627 . . . . 2.5600000000000001 109.308 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 35.7 Cg_exo -57.96 -29.68 87.41 Favored 'Trans proline' 0 CA--C 1.517 -0.35 0 C-N-CA 122.723 2.282 . . . . 0.32000000000000001 112.264 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.97 -51.33 64.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.456 -0.572 . . . . 1.51 109.456 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.25 -43.38 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 1.01 110.437 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG13 ' A' ' 34' ' ' VAL . . . -58.55 -49.69 76.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.886 -0.597 . . . . 0.20999999999999999 110.925 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.6 -35.93 79.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.93 -0.577 . . . . 0.60999999999999999 111.072 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.6 m-20 -66.02 -41.9 90.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.461 -0.336 . . . . 1.22 110.748 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.43 -44.35 91.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.823 0.344 . . . . 0.17999999999999999 110.145 173.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.518 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 59.6 tt0 -52.71 -53.02 53.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 1.04 110.343 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.79 -29.37 70.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.78000000000000003 111.701 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.19 -46.22 61.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 0.14000000000000001 110.76 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.4 m-85 -67.93 -41.66 82.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.107 -0.497 . . . . 0.13 110.599 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.79 -30.21 71.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.68999999999999995 110.728 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 110.374 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -82.49 8.17 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.65000000000000002 110.746 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.42 51.23 8.63 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.136 -0.554 . . . . 0.28999999999999998 112.448 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -132.64 164.86 25.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.862 0.363 . . . . 0.23000000000000001 111.375 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -108.08 125.97 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.173 -0.677 . . . . 2.1400000000000001 109.173 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.518 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.9 t -114.07 140.72 33.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 112.509 0.559 . . . . 0.19 112.509 -168.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 t -112.41 140.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.637 -0.875 . . . . 0.23000000000000001 108.637 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.431 HG13 ' HB1' ' A' ' 18' ' ' ALA . 84.1 t -111.26 124.7 68.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.773 0.321 . . . . 0.94999999999999996 110.92 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.6 134.09 38.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.146 -0.479 . . . . 0.16 110.725 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.54 -3.23 28.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.019 0.438 . . . . 0.23999999999999999 110.674 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -137.71 159.83 40.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 0.25 110.719 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 87.6 m -60.32 -34.25 73.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.038 -0.528 . . . . 1.6000000000000001 110.208 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.14 -47.83 81.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.656 . . . . 0.69999999999999996 111.012 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.56 -37.98 83.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.374 0.607 . . . . 1.4099999999999999 110.696 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.773 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -65.78 -51.01 62.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.232 -0.894 . . . . 0.17999999999999999 111.708 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.8 mt -60.88 -29.95 69.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.105 0.479 . . . . 0.82999999999999996 110.472 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -64.85 -52.22 57.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.654 -0.703 . . . . 2.4100000000000001 110.158 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 t -67.71 -34.26 76.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.926 -0.579 . . . . 1.1299999999999999 110.304 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -58.68 -42.0 87.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 1.23 110.324 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.51 -33.92 28.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.42999999999999999 111.513 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.75 -37.49 27.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.62 111.623 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.95 164.6 20.18 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.849 0.357 . . . . 0.41999999999999998 110.873 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -95.05 86.96 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.47 2.78 . . . . 0.23999999999999999 111.441 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.2 mm -65.39 123.34 18.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.664 -0.698 . . . . 0.22 111.252 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 45.8 m-20 -93.18 -27.26 16.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.28999999999999998 110.726 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.49 ' CG1' HG22 ' A' ' 8' ' ' VAL . 13.3 p -164.16 157.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.493 -0.558 . . . . 0.12 109.493 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -142.82 165.48 27.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 0.14000000000000001 112.006 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.62 111.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.254 -0.884 . . . . 0.95999999999999996 109.165 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 8.8 mp -113.32 119.25 37.04 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.064 0.394 . . . . 0.16 112.064 -168.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -74.69 132.49 41.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.231 -1.025 . . . . 1.77 108.231 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.596 ' H ' ' HB ' ' A' ' 83' ' ' THR . 22.9 t -86.21 -10.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.386 0.612 . . . . 0.80000000000000004 110.029 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -129.2 73.27 1.51 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.814 -0.63 . . . . 2.3700000000000001 110.056 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 64' ' ' HIS . 4.0 mm? -56.28 -51.43 68.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.864 -0.607 . . . . 0.84999999999999998 109.711 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.61 -157.62 7.87 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.312 -0.858 . . . . 0.81999999999999995 111.184 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -55.12 -45.1 43.21 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.727 2.285 . . . . 1.1799999999999999 112.567 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -119.82 -33.87 3.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 3.5299999999999998 111.208 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 20.1 m -65.5 126.56 28.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.95999999999999996 110.99 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.679 ' HA ' HD23 ' A' ' 59' ' ' LEU . 11.1 p80 -144.86 163.26 34.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.96 -0.564 . . . . 0.48999999999999999 110.253 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 57' ' ' VAL . 26.4 p -75.28 88.32 2.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.315 0.579 . . . . 1.3 109.955 175.619 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 -77.81 1.01 Allowed Glycine 0 C--O 1.228 -0.27 0 C-N-CA 120.091 -1.052 . . . . 0.23000000000000001 111.979 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.6 Cg_exo -51.65 -24.76 18.3 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.024 2.482 . . . . 0.23999999999999999 112.749 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 13.8 t -67.37 -48.58 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 0.12 110.117 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -43.98 84.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.958 -1.019 . . . . 0.16 109.804 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 10.9 m-20 -64.63 -46.66 81.64 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.459 -0.792 . . . . 2.0299999999999998 110.519 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB1' ' HG ' ' A' ' 45' ' ' LEU . . . -53.53 -45.9 69.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.536 0.684 . . . . 0.23000000000000001 110.697 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.06 -46.89 72.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.952 -1.022 . . . . 0.20000000000000001 110.404 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 24.4 mmtp -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.874 -0.603 . . . . 2.0099999999999998 111.977 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 80.6 mm-40 -69.7 -26.21 64.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.577 -0.283 . . . . 2.3700000000000001 111.405 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -106.95 8.79 30.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.663 0.268 . . . . 1.49 111.244 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.31 35.2 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.837 -0.619 . . . . 0.33000000000000002 111.705 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.3 mt -84.8 132.82 45.03 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 109.894 -0.41 . . . . 0.17000000000000001 109.894 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.36 141.65 25.88 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.312 2.008 . . . . 0.20999999999999999 112.015 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 35.2 p90 -157.93 161.95 38.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.835 -0.62 . . . . 0.17999999999999999 110.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.61 141.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.25 -0.886 . . . . 0.23999999999999999 109.561 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.8 mm? -88.1 109.63 20.02 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.20999999999999999 109.669 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.512 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 15.4 t-160 -101.35 77.62 1.8 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.816 0.817 . . . . 0.59999999999999998 109.188 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.596 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 10.2 t -115.0 158.28 22.29 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.501 -1.227 . . . . 0.60999999999999999 110.127 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.74 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -108.34 -3.26 33.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.22 -0.752 . . . . 0.93999999999999995 111.22 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 11.0 m-20 -126.22 66.6 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.304 0.573 . . . . 2.3300000000000001 110.075 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.04 -54.72 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.367 -0.833 . . . . 1.6100000000000001 111.129 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.52 -20.42 64.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.322 -0.399 . . . . 2.6299999999999999 111.401 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 1.1 mmp_? -74.16 -26.27 60.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.16 -0.473 . . . . 4.4199999999999999 110.927 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.443 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.6 m-70 -123.17 35.28 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 1.05 111.174 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -59.67 -41.42 97.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.031 -0.604 . . . . 0.97999999999999998 113.01 -175.707 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.25 -37.8 81.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.656 0.265 . . . . 2.5 110.609 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.564 HD23 ' CG1' ' A' ' 57' ' ' VAL . 34.8 tp -68.43 -39.98 81.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.70999999999999996 110.412 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.6 mt -58.96 -42.08 89.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 1.5800000000000001 110.729 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.91 -27.42 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 4.3799999999999999 110.964 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.75 -42.29 50.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.012 -0.54 . . . . 2.4500000000000002 110.614 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.44 HG21 HD21 ' A' ' 81' ' ' LEU . 78.7 mt -67.76 -52.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.45000000000000001 111.18 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 t70 61.26 77.49 0.33 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0900000000000001 111.037 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -163.89 163.42 15.78 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.717 . . . . 0.28999999999999998 109.896 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.532 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.8 Cg_exo -56.97 149.82 59.45 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.804 2.336 . . . . 0.26000000000000001 112.847 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.74 132.4 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.64000000000000001 111.076 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.8 mmm -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.121 -0.696 . . . . 0.82999999999999996 109.121 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.15 132.15 48.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.54000000000000004 111.884 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.74 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 14.4 ptpt -97.2 150.33 36.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.67000000000000004 110.051 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.638 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 32.8 Cg_exo -60.05 127.96 3.93 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.952 -1.27 . . . . 0.75 113.268 2.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -129.74 134.25 47.51 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.34999999999999998 109.253 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.1 t70 -67.21 121.96 16.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.904 -0.776 . . . . 0.51000000000000001 108.904 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.5 p -62.13 -24.37 67.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.26 -0.882 . . . . 0.26000000000000001 112.474 -170.759 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.798 -0.445 . . . . 1.3200000000000001 109.798 177.446 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 25.6 m-20 -69.17 -37.79 78.38 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.937 -0.574 . . . . 0.62 109.972 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 106' ' ' ASP . 34.0 t -64.31 -46.07 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.676 -0.693 . . . . 0.13 110.253 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -60.37 -48.69 80.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.584 -0.735 . . . . 0.13 111.571 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 59.6 mtpt -59.12 -55.03 40.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 1.95 110.989 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.561 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 5.9 mpt_? -51.63 -43.14 62.49 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.028 0.381 . . . . 2.23 112.028 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.69 -50.33 69.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.14000000000000001 110.725 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.486 HD23 HG11 ' A' ' 52' ' ' VAL . 81.1 mt -65.91 -26.3 67.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.509 . . . . 0.27000000000000002 111.572 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 24.2 mm-40 -60.75 -43.43 97.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.678 0.275 . . . . 2.79 110.965 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.532 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 48.9 mtm -71.14 -29.78 65.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.962 0.411 . . . . 0.42999999999999999 110.5 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 35.6 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.787 -0.642 . . . . 1.46 110.691 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.5 mtp . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.57 -0.53 . . . . 1.6499999999999999 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.42 136.26 66.6 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.939 2.426 . . . . 0.33000000000000002 111.989 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -82.86 104.54 13.16 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.312 -0.625 . . . . 0.89000000000000001 109.312 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 49.9 t -100.02 135.1 37.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.514 -0.766 . . . . 0.20000000000000001 110.559 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 50' ' ' ILE . 46.4 tp -111.99 111.84 23.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 0.75 110.644 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -93.65 121.78 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.369 0.604 . . . . 0.13 111.332 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.38 106.79 17.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.20999999999999999 108.857 172.618 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -165.36 125.15 1.8 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 109.663 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.9 -26.5 34.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.863 -0.608 . . . . 1.27 109.607 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -78.71 108.65 8.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.68 -0.691 . . . . 2.5600000000000001 110.59 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.19 -35.09 98.26 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 112.949 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.88 -48.81 75.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.35 . . . . 1.51 110.278 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.5 -45.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 1.01 110.541 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.93 78.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.848 -0.614 . . . . 0.20999999999999999 110.902 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.21 -40.2 93.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.959 -0.564 . . . . 0.60999999999999999 111.08 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.5 m-20 -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 1.22 110.797 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.72 -44.91 96.0 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.806 0.336 . . . . 0.17999999999999999 110.368 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.501 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 46.0 tt0 -53.32 -49.88 66.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.526 -0.761 . . . . 1.04 110.43 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -58.86 -37.85 77.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.318 -0.401 . . . . 0.78000000000000003 111.466 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.39 -46.09 70.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.14000000000000001 110.889 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 66.1 m-85 -67.55 -43.8 79.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 0.13 110.938 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -59.78 -35.12 73.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.68999999999999995 110.675 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.14 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.51000000000000001 110.767 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.12 -10.54 59.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.65000000000000002 110.979 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.4 49.34 2.21 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.837 -0.697 . . . . 0.28999999999999998 112.279 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.09 163.69 29.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.357 -0.238 . . . . 0.23000000000000001 110.357 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -110.0 123.69 50.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.605 -0.517 . . . . 2.1400000000000001 109.605 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.2 t -106.65 138.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.526 0.565 . . . . 0.19 112.526 -168.19 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.61 133.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.377 -0.971 . . . . 0.23000000000000001 108.377 170.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.18 130.79 58.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.77 0.319 . . . . 0.94999999999999996 111.025 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.76 144.36 35.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.16 110.367 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.79 16.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.572 -0.285 . . . . 0.23999999999999999 111.432 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -134.18 176.6 8.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.086 -0.246 . . . . 0.25 110.677 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 1.5 p -68.37 -48.08 65.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.755 -0.461 . . . . 1.6000000000000001 109.755 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.25 -50.2 74.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.439 -0.801 . . . . 0.69999999999999996 111.779 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.69 -37.81 76.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.893 0.378 . . . . 1.4099999999999999 111.582 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -70.93 -49.46 45.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.259 -0.428 . . . . 0.17999999999999999 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 73.7 mt -61.63 -26.27 67.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.619 -0.718 . . . . 0.82999999999999996 110.502 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -62.74 -56.7 15.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 2.4100000000000001 110.309 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 28.8 t -70.32 -17.8 63.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.462 -0.336 . . . . 1.1299999999999999 111.094 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -68.32 -41.48 80.79 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.259 -0.645 . . . . 1.23 109.259 175.918 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.22 12.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.48 . . . . 0.42999999999999999 111.209 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.86 -37.19 73.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.037 -0.528 . . . . 0.62 111.619 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' SER . 91.1 m-20 -114.57 150.04 43.24 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.41999999999999998 110.863 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 73.0 Cg_endo -86.21 81.14 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.322 2.682 . . . . 0.23999999999999999 111.767 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 9' ' ' LEU . 44.1 mm -62.72 123.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.38 -0.827 . . . . 0.22 111.51 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.4 m-20 -90.66 -37.79 13.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.633 -0.712 . . . . 0.28999999999999998 110.063 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 11.3 p -157.35 155.66 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.761 -0.654 . . . . 0.12 109.619 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.78 162.62 35.0 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.431 0.634 . . . . 0.14000000000000001 112.063 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -134.72 111.69 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.092 -0.958 . . . . 0.95999999999999996 109.053 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.778 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.6 mp -112.96 114.99 27.71 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.238 0.458 . . . . 0.16 112.238 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 27.5 t70 -77.46 123.38 26.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.576 -0.898 . . . . 1.77 108.576 168.143 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.53 ' CG1' HD23 ' A' ' 92' ' ' LEU . 20.2 t -88.3 -10.8 10.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.363 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.7 56.28 0.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.824 -0.625 . . . . 2.3700000000000001 109.967 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.15 -26.82 67.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.744 -0.662 . . . . 0.84999999999999998 109.917 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.29 -168.43 31.27 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.57 -1.012 . . . . 0.81999999999999995 110.57 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.62 -43.1 62.15 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.662 2.241 . . . . 1.1799999999999999 111.737 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -115.26 -33.28 5.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 3.5299999999999998 110.755 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -58.05 123.52 16.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.265 0.555 . . . . 0.95999999999999996 111.253 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -144.59 149.97 36.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.513 -0.767 . . . . 0.48999999999999999 110.268 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -73.38 86.03 1.49 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.208 -0.664 . . . . 1.3 109.208 171.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.82 -71.57 0.81 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.396 -0.907 . . . . 0.23000000000000001 112.264 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -54.1 -25.77 38.71 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.54 2.16 . . . . 0.23999999999999999 111.926 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.6 t -69.17 -48.25 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.12 110.165 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.47 86.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.242 -0.89 . . . . 0.16 109.906 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 35.2 t70 -61.87 -42.94 99.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.207 -0.906 . . . . 2.0299999999999998 110.44 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB1' ' HG ' ' A' ' 45' ' ' LEU . . . -56.33 -46.63 79.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.448 0.642 . . . . 0.23000000000000001 110.903 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.48 -46.38 83.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.20000000000000001 110.188 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 73' ' ' LYS . 11.1 mmmm -58.85 -33.85 70.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.612 -0.722 . . . . 2.0099999999999998 111.486 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 99.0 mt-30 -57.84 -47.85 81.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 2.3700000000000001 110.979 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -92.15 6.41 46.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.196 -0.456 . . . . 1.49 110.939 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.15 31.84 21.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.33000000000000002 111.343 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -75.63 135.24 71.86 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.685 -0.487 . . . . 0.17000000000000001 109.685 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 118' ' ' CYS . 30.2 Cg_endo -75.56 138.65 21.97 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.132 1.888 . . . . 0.20999999999999999 111.687 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -157.19 159.32 37.6 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 110.285 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mt -122.91 139.25 50.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.67 -0.695 . . . . 0.23999999999999999 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 96' ' ' ILE . 2.4 mm? -88.84 108.37 19.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.611 -0.514 . . . . 0.20999999999999999 109.611 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.648 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.4 t-160 -103.0 71.8 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.775 -0.824 . . . . 0.59999999999999998 108.775 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.547 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 4.9 t -100.87 153.99 19.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.693 -1.14 . . . . 0.60999999999999999 111.99 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -91.95 -6.58 65.12 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.93999999999999995 112.348 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 2.3300000000000001 110.762 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.17 -4.35 11.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.894 -0.594 . . . . 1.6100000000000001 109.852 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.39 -59.82 2.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 2.6299999999999999 111.19 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -70.96 -41.55 70.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.389 0.614 . . . . 4.4199999999999999 110.781 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.539 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.2 m-70 -87.58 14.57 8.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.46 -0.791 . . . . 1.05 110.732 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -57.56 -49.92 69.53 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.441 -0.409 . . . . 0.97999999999999998 113.332 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.29 -40.04 96.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 2.5 110.332 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.53 HD23 ' CG1' ' A' ' 57' ' ' VAL . 33.1 tp -59.67 -42.61 93.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.70999999999999996 110.303 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.4 mt -60.39 -35.45 75.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.5800000000000001 111.336 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 19.1 mmm180 -71.44 -27.42 63.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.095 0.474 . . . . 4.3799999999999999 110.904 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.22 -33.44 63.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.831 -0.622 . . . . 2.4500000000000002 109.955 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 92' ' ' LEU . 81.3 mt -71.42 -56.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.324 -0.853 . . . . 0.45000000000000001 110.999 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 59.97 78.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.536 0.684 . . . . 1.0900000000000001 110.879 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -161.11 163.14 21.06 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 0.28999999999999998 109.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.23 141.44 96.68 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.589 2.193 . . . . 0.26000000000000001 112.437 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -119.7 133.66 65.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.14 0.495 . . . . 0.64000000000000001 111.274 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.8 mmm -118.94 91.28 3.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.712 -0.847 . . . . 0.82999999999999996 108.712 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.31 154.1 36.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.895 -0.593 . . . . 0.54000000000000004 111.735 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 96.4 mttt -90.75 143.84 29.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.67000000000000004 109.747 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 140.4 66.03 Favored 'Cis proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.561 -1.433 . . . . 0.75 112.607 2.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.648 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -137.16 129.46 29.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.807 -0.633 . . . . 0.34999999999999998 110.273 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 110' ' ' VAL . 10.3 t70 -72.28 129.69 39.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.966 -0.753 . . . . 0.51000000000000001 108.966 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.541 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.3 p -63.46 -22.67 67.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.271 -0.877 . . . . 0.26000000000000001 112.542 -171.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.6 p -68.77 -42.9 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 1.3200000000000001 109.927 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.563 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 45.4 m-20 -68.18 -41.26 81.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.62 109.548 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 106' ' ' ASP . 24.7 t -61.86 -44.59 99.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.556 -0.747 . . . . 0.13 110.519 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.15 -50.59 65.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.13 111.637 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 108' ' ' SER . 30.6 mtpp -64.25 -40.67 96.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 1.95 111.61 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.563 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 10.2 mpt_? -63.55 -32.1 73.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.886 0.374 . . . . 2.23 111.77 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.55 -51.33 10.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 0.14000000000000001 111.053 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.521 HD23 HG11 ' A' ' 52' ' ' VAL . 64.4 mt -63.5 -26.01 68.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.107 0.78 . . . . 0.27000000000000002 113.107 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -25.78 62.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.62 -0.432 . . . . 2.79 110.914 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.6 mtm -71.61 -25.68 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.42999999999999999 111.161 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.423 ' HB2' ' CG ' ' A' ' 78' ' ' PRO . 45.2 t . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 1.46 110.974 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.451 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 80.2 mtp . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.183 -0.673 . . . . 1.6499999999999999 109.183 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 33.6 Cg_exo -59.53 134.79 60.38 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.479 2.119 . . . . 0.33000000000000002 111.823 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 14.4 tptp -83.64 103.81 13.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.326 -0.62 . . . . 0.89000000000000001 109.326 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.3 t -99.5 130.47 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.815 -0.63 . . . . 0.20000000000000001 110.779 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.434 ' HB2' HD12 ' A' ' 50' ' ' ILE . 49.9 tp -106.04 112.46 25.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.852 -0.613 . . . . 0.75 110.295 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -92.97 122.8 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.077 0.465 . . . . 0.13 111.613 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.44 101.04 10.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.284 -0.871 . . . . 0.20999999999999999 109.284 173.274 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.24 127.18 5.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.448 -0.796 . . . . 1.4099999999999999 109.8 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -89.41 -16.56 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.78 -0.645 . . . . 1.27 110.125 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -88.36 108.39 21.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 2.5600000000000001 110.301 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.93 -34.94 99.33 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.748 2.299 . . . . 0.32000000000000001 112.982 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 59.8 tp -62.94 -49.7 73.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 1.51 110.513 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.95 -45.32 97.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 1.01 110.624 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 34' ' ' VAL . . . -57.54 -52.21 66.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.20999999999999999 110.784 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.449 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 36.7 ttp -62.55 -37.29 85.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.60999999999999999 111.008 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 107' ' ' THR . 8.0 t-20 -65.69 -47.8 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.22 110.501 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 53.1 mt -60.26 -45.56 92.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.936 -0.575 . . . . 0.17999999999999999 109.888 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 57.7 tt0 -51.8 -50.42 60.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.131 -0.941 . . . . 1.04 111.063 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.449 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 17.5 m-85 -67.17 -32.38 73.43 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.139 -0.224 . . . . 0.78000000000000003 111.249 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.85 85.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.84 0.353 . . . . 0.14000000000000001 110.827 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -68.08 -45.76 72.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.46 . . . . 0.13 110.644 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 45.8 mt-10 -61.9 -30.19 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.474 -0.33 . . . . 0.68999999999999995 110.765 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.01 -41.56 95.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.149 -0.478 . . . . 0.51000000000000001 110.549 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -74.71 -15.62 60.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 0.65000000000000002 110.84 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.76 44.92 1.46 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.833 -0.699 . . . . 0.28999999999999998 112.559 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -134.21 153.62 51.74 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.771 -0.253 . . . . 0.23000000000000001 110.437 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.28 142.49 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.558 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 44.4 t -123.72 143.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.48 0.548 . . . . 0.19 112.48 -170.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.501 HG11 ' OG ' ' A' ' 44' ' ' SER . 14.9 t -118.44 132.28 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.758 . . . . 0.23000000000000001 108.955 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.431 HG23 ' HB1' ' A' ' 18' ' ' ALA . 12.7 p -96.56 130.39 45.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.028 0.442 . . . . 0.94999999999999996 111.601 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.23 134.63 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.16 110.701 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.14 17.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.23999999999999999 111.003 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.0 p -124.79 162.05 25.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.114 -0.494 . . . . 0.25 110.648 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 67.1 m -66.32 -33.67 76.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.56 -0.533 . . . . 1.6000000000000001 109.56 175.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.27 -48.4 78.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.513 -0.767 . . . . 0.69999999999999996 111.045 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -58.28 -42.09 85.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.243 0.544 . . . . 1.4099999999999999 110.574 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.3 -53.01 62.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.142 -0.935 . . . . 0.17999999999999999 111.522 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 86.9 mt -61.54 -28.68 69.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.071 0.462 . . . . 0.82999999999999996 110.96 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.55 -53.47 22.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 2.4100000000000001 109.748 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.501 ' OG ' HG11 ' A' ' 33' ' ' VAL . 22.7 t -65.95 -34.77 78.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 110.372 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.51 -35.56 78.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 1.23 110.776 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.52 -33.84 28.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.378 -0.374 . . . . 0.42999999999999999 111.118 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.43 -38.12 35.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.62 111.611 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -114.94 163.55 19.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.46 . . . . 0.41999999999999998 110.753 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.65 83.03 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.434 2.756 . . . . 0.23999999999999999 111.309 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 37.1 mm -65.74 122.21 16.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.562 -0.745 . . . . 0.22 111.754 -174.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.766 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 32.5 m-20 -91.09 -32.47 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.115 -0.948 . . . . 0.28999999999999998 110.771 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.571 HG11 HD23 ' A' ' 115' ' ' LEU . 14.4 p -160.2 158.3 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.12 109.836 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.19 161.09 39.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.156 0.503 . . . . 0.14000000000000001 111.907 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.56 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -132.09 112.41 19.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.7 . . . . 0.95999999999999996 109.682 174.453 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.792 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -112.47 121.8 45.86 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.23 -0.441 . . . . 0.16 112.083 -170.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.671 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.8 t0 -81.66 114.98 20.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.86 -0.792 . . . . 1.77 108.86 168.94 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.528 ' H ' ' HB ' ' A' ' 83' ' ' THR . 17.2 t -76.53 -7.91 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.038 -0.983 . . . . 0.80000000000000004 110.43 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.13 65.93 1.21 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 2.3700000000000001 109.778 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.08 -29.5 70.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.581 -0.736 . . . . 0.84999999999999998 109.621 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 -162.54 12.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.151 -0.931 . . . . 0.81999999999999995 111.09 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.0 -38.76 93.19 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.89 2.393 . . . . 1.1799999999999999 112.676 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' NZ ' ' HB2' ' A' ' 62' ' ' LYS . 4.5 ttmp? -126.35 -34.43 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.468 -0.333 . . . . 3.5299999999999998 110.792 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 p -60.48 127.61 32.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.476 0.655 . . . . 0.95999999999999996 111.054 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -144.29 156.02 44.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.412 -0.813 . . . . 0.48999999999999999 110.8 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.8 p -70.49 86.79 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.894 -0.78 . . . . 1.3 108.894 168.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.16 -74.82 1.04 Allowed Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 120.191 -1.004 . . . . 0.23000000000000001 112.374 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.68 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.9 Cg_exo -53.37 -26.19 34.22 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.488 2.125 . . . . 0.23999999999999999 111.981 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 10.7 t -69.33 -44.79 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.12 110.381 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -52.69 64.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.828 . . . . 0.16 109.956 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 33.3 t70 -60.99 -38.18 85.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.107 -0.951 . . . . 2.0299999999999998 110.495 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.1 78.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.355 0.597 . . . . 0.23000000000000001 111.03 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.38 -39.7 85.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.402 -0.817 . . . . 0.20000000000000001 110.095 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -59.55 -39.03 82.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.622 -0.717 . . . . 2.0099999999999998 111.171 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 55.0 mt-30 -65.56 -43.18 90.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 2.3700000000000001 111.216 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -87.85 2.18 52.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.828 0.347 . . . . 1.49 110.813 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.01 31.22 19.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.538 -0.756 . . . . 0.33000000000000002 111.454 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.99 131.9 49.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.17000000000000001 109.775 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 25.6 Cg_endo -73.7 138.47 26.51 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.166 1.911 . . . . 0.20999999999999999 111.62 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.02 157.39 34.59 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.609 -0.723 . . . . 0.17999999999999999 110.387 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.7 mt -122.31 141.06 44.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.609 -0.723 . . . . 0.23999999999999999 109.888 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 96' ' ' ILE . 2.2 mm? -89.33 108.23 19.51 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.78 -0.452 . . . . 0.20999999999999999 109.78 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.634 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.6 t-160 -103.02 72.28 1.17 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.512 -0.921 . . . . 0.59999999999999998 108.512 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.671 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 10.2 t -99.77 155.01 17.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.276 -1.329 . . . . 0.60999999999999999 111.784 -170.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 0.9 59.39 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.734 -0.666 . . . . 0.93999999999999995 112.898 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -154.78 121.08 5.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 2.3300000000000001 110.258 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.3 mp -106.47 -22.89 12.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.183 -0.462 . . . . 1.6100000000000001 111.606 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -83.87 -30.65 26.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.9 -0.32 . . . . 2.6299999999999999 111.213 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -79.85 -10.08 59.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.348 0.594 . . . . 4.4199999999999999 110.348 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.538 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 99.5 m-70 -131.35 24.11 4.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 1.05 111.225 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -63.73 -42.01 98.75 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.851 -0.69 . . . . 0.97999999999999998 112.879 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 33.1 mt-10 -71.66 -25.37 62.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 2.5 110.369 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 57' ' ' VAL . 55.5 tp -74.53 -43.59 55.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.207 -0.451 . . . . 0.70999999999999996 110.224 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.1 mt -58.38 -37.7 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 1.5800000000000001 111.834 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 36.5 ptt180 -65.24 -26.57 68.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 4.3799999999999999 110.912 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -76.12 -35.27 59.36 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.157 0.503 . . . . 2.4500000000000002 110.136 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 81' ' ' LEU . 55.8 mt -69.9 -52.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.228 -0.897 . . . . 0.45000000000000001 110.445 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 55.51 70.37 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.465 0.65 . . . . 1.0900000000000001 110.579 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -155.96 162.38 27.54 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.368 -0.833 . . . . 0.28999999999999998 109.349 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.24 141.22 94.53 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.666 2.244 . . . . 0.26000000000000001 112.62 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.7 t -118.62 134.68 61.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.64000000000000001 111.289 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 78.6 mmm -119.44 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.656 -0.868 . . . . 0.82999999999999996 108.656 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.69 152.53 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.018 -0.537 . . . . 0.54000000000000004 111.691 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 95.8 mttt -90.29 144.81 31.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.723 -0.671 . . . . 0.67000000000000004 109.844 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.6 Cg_exo -71.12 142.15 71.92 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.561 -1.433 . . . . 0.75 112.433 0.697 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.634 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -139.83 130.18 25.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.83 -0.623 . . . . 0.34999999999999998 110.266 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.8 t70 -66.11 124.31 22.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.51000000000000001 109.404 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.4 p -62.56 -27.63 69.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.432 -0.803 . . . . 0.26000000000000001 112.238 -172.277 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 t -70.02 -40.1 75.41 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.615 -0.513 . . . . 1.3200000000000001 109.615 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -65.27 -43.98 89.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.086 0.469 . . . . 0.62 109.803 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 106' ' ' ASP . 23.4 t -60.75 -43.7 95.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.307 -0.86 . . . . 0.13 110.428 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.46 -50.53 67.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.13 111.171 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.618 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 54.9 mtpt -56.33 -55.53 32.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 1.95 111.341 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 35.5 mmt180 -60.03 -35.46 75.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 2.23 111.374 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.31 47.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.509 . . . . 0.14000000000000001 110.541 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.571 HD23 HG11 ' A' ' 52' ' ' VAL . 80.7 mt -63.52 -25.5 68.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.631 . . . . 0.27000000000000002 111.848 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 35.0 mm-40 -60.42 -26.53 66.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.694 0.283 . . . . 2.79 111.236 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 67.9 mtm -85.81 -1.67 57.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.49 -0.323 . . . . 0.42999999999999999 111.369 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 49.2 t . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.167 0.508 . . . . 1.46 110.044 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 90.8 mtp . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 110.032 -0.359 . . . . 1.6499999999999999 110.032 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.24 137.73 44.66 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.165 2.577 . . . . 0.33000000000000002 111.928 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.97 107.3 17.04 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.342 -0.614 . . . . 0.89000000000000001 109.342 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' CG1' ' A' ' 52' ' ' VAL . 47.1 t -100.09 138.86 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 0.20000000000000001 110.809 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 48.3 tp -111.23 115.66 29.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.398 -0.365 . . . . 0.75 110.276 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.17 123.47 51.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.231 0.539 . . . . 0.13 111.024 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.78 106.01 16.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.214 -0.903 . . . . 0.20999999999999999 109.326 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -168.34 123.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.044 -0.526 . . . . 1.4099999999999999 109.761 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.5 t70 -87.1 -19.99 27.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.661 . . . . 1.27 110.1 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB3' HD13 ' A' ' 17' ' ' ILE . 44.5 mm-40 -81.22 104.86 3.25 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 115.878 -0.601 . . . . 2.5600000000000001 109.963 175.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.0 Cg_exo -58.07 -29.5 87.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.919 2.413 . . . . 0.32000000000000001 113.427 -172.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt -69.61 -50.74 41.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.879 -0.415 . . . . 1.51 109.879 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -63.3 -44.08 98.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.01 109.736 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.64 -49.17 78.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.359 -0.837 . . . . 0.20999999999999999 110.557 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.0 ttp -59.33 -42.27 91.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.60999999999999999 111.068 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.512 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.7 m-20 -64.38 -47.55 78.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 1.22 111.083 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.9 mt -60.11 -46.1 90.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.39 -0.368 . . . . 0.17999999999999999 110.449 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 49.3 tt0 -54.47 -51.03 66.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.818 -0.628 . . . . 1.04 110.917 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.857 -0.337 . . . . 0.78000000000000003 110.887 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.68 -46.32 72.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.941 0.401 . . . . 0.14000000000000001 110.277 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 m-85 -66.9 -44.03 81.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.13 110.803 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.02 -28.04 67.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.537 -0.301 . . . . 0.68999999999999995 111.015 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.32 -27.81 65.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.314 0.578 . . . . 0.51000000000000001 109.983 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -84.71 2.45 41.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.67 . . . . 0.65000000000000002 111.05 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 5' ' ' MET . . . 81.92 47.15 6.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.922 -0.656 . . . . 0.28999999999999998 112.632 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.98 8.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.633 0.254 . . . . 0.23000000000000001 110.363 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.82 134.29 55.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.514 -0.55 . . . . 2.1400000000000001 109.514 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -116.07 135.79 55.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.319 0.489 . . . . 0.19 112.319 -168.816 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.46 122.74 63.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.23000000000000001 107.925 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.57 124.73 55.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.721 -0.392 . . . . 0.94999999999999996 110.697 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.11 139.31 50.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.934 -0.576 . . . . 0.16 110.702 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.83 -11.35 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.23999999999999999 111.252 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -130.68 170.53 14.19 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.954 -0.298 . . . . 0.25 111.492 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.559 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.2 p -60.84 -49.47 77.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.6000000000000001 109.646 171.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -52.24 -50.01 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.667 -1.151 . . . . 0.69999999999999996 111.764 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -59.81 -37.02 77.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 1.4099999999999999 111.187 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -71.38 -49.46 41.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.67 -0.695 . . . . 0.17999999999999999 111.225 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 72.8 mt -63.5 -28.98 70.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.731 -0.668 . . . . 0.82999999999999996 110.158 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 7.5 tmtm? -63.93 -50.69 67.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.385 -0.598 . . . . 2.4100000000000001 109.385 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 t -64.65 -32.02 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.219 -0.446 . . . . 1.1299999999999999 110.878 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 -41.81 89.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.123 0.487 . . . . 1.23 110.376 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.19 -38.26 20.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.42999999999999999 111.54 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.33 -36.47 58.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.065 -0.516 . . . . 0.62 111.408 -174.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -122.16 162.11 39.23 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.345 -0.389 . . . . 0.41999999999999998 110.428 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -92.82 88.24 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.303 2.669 . . . . 0.23999999999999999 111.149 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 47.1 mm -67.4 119.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.715 -0.675 . . . . 0.22 111.52 -174.592 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -91.06 -30.75 16.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.924 -0.58 . . . . 0.28999999999999998 110.197 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 115' ' ' LEU . 12.0 p -160.88 157.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.731 . . . . 0.12 109.409 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.84 166.02 25.92 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.456 0.646 . . . . 0.14000000000000001 111.239 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -137.9 120.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.747 -1.205 . . . . 0.95999999999999996 107.747 174.301 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.9 mp -116.36 109.17 16.99 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.729 -0.388 . . . . 0.16 111.301 -170.272 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.79 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -80.67 97.78 7.41 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.8 -0.815 . . . . 1.77 108.8 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 64' ' ' HIS . 46.8 t -50.71 -31.18 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.212 -0.904 . . . . 0.80000000000000004 112.44 -170.815 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -95.75 80.08 3.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.934 0.397 . . . . 2.3700000000000001 110.392 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.83 -14.45 59.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.563 0.697 . . . . 0.84999999999999998 110.09 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.88 -166.27 35.82 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.754 -0.938 . . . . 0.81999999999999995 110.754 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.71 -45.36 41.64 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.916 2.411 . . . . 1.1799999999999999 112.311 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -120.85 -22.14 6.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.371 -0.377 . . . . 3.5299999999999998 110.812 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.7 m -63.4 129.12 38.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.112 0.482 . . . . 0.95999999999999996 111.147 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 15.5 p80 -144.0 153.27 42.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.48999999999999999 110.282 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.5 m -79.1 86.44 4.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.827 -0.805 . . . . 1.3 108.827 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.55 -66.47 0.7 Allowed Glycine 0 C--N 1.328 0.132 0 C-N-CA 120.62 -0.8 . . . . 0.23000000000000001 112.392 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.67 -23.76 50.87 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.396 2.064 . . . . 0.23999999999999999 111.621 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.508 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.5 t -68.17 -47.74 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.96 -0.564 . . . . 0.12 109.774 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.06 -47.73 80.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.99 -1.005 . . . . 0.16 110.087 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 19.3 t70 -64.09 -36.41 83.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 2.0299999999999998 110.571 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -62.93 -40.48 97.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.409 0.623 . . . . 0.23000000000000001 110.888 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.69 -43.87 62.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.20000000000000001 110.529 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 28.2 mmmt -57.33 -39.58 76.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.565 -0.743 . . . . 2.0099999999999998 111.166 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.667 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 6.8 pt20 -64.88 -37.76 88.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.533 -0.758 . . . . 2.3700000000000001 110.957 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG3' ' CG ' ' A' ' 74' ' ' GLN . 96.3 mtt180 -99.47 7.57 45.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 1.49 111.899 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.94 23.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.133 -0.485 . . . . 0.33000000000000002 111.734 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.429 HG21 HG22 ' A' ' 50' ' ' ILE . 81.8 mt -83.54 132.7 48.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.17000000000000001 109.744 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -72.62 140.67 33.07 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.354 2.036 . . . . 0.20999999999999999 112.302 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 12.2 p90 -161.25 156.9 24.78 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.17999999999999999 110.417 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 mt -119.6 138.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.591 -0.731 . . . . 0.23999999999999999 109.869 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 96' ' ' ILE . 2.5 mm? -89.19 109.71 20.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.17 -0.678 . . . . 0.20999999999999999 109.17 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.79 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 19.3 t-160 -102.05 117.54 35.01 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.638 -0.875 . . . . 0.59999999999999998 108.638 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.736 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 8.9 t -171.33 154.21 3.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.733 0.301 . . . . 0.60999999999999999 110.586 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.2 33.13 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.465 -0.654 . . . . 0.93999999999999995 111.465 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -111.21 60.44 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.353 0.597 . . . . 2.3300000000000001 109.928 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.69 -48.78 58.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.408 -0.815 . . . . 1.6100000000000001 110.871 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -63.55 -33.62 76.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 2.6299999999999999 110.783 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 4.9 mmp_? -71.82 -15.4 62.14 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 4.4199999999999999 111.9 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 87.3 m-70 -134.25 31.59 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.745 0.276 . . . . 1.05 111.745 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.01 -28.48 71.69 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.835 -0.698 . . . . 0.97999999999999998 112.469 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.579 ' HA ' ' HE ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -76.45 -26.1 55.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 2.5 110.34 178.996 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 tp -76.95 -47.51 20.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.85 -0.614 . . . . 0.70999999999999996 109.864 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 79.2 mt -57.3 -39.59 76.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.861 -0.608 . . . . 1.5800000000000001 112.082 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 91' ' ' GLU . 11.1 ptp180 -66.17 -25.28 66.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.668 0.27 . . . . 4.3799999999999999 111.343 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -73.38 -30.16 63.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.398 0.618 . . . . 2.4500000000000002 110.14 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.504 HG21 HD21 ' A' ' 81' ' ' LEU . 55.4 mt -82.72 -53.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.18 -0.918 . . . . 0.45000000000000001 110.877 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.02 74.22 0.34 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.718 0.77 . . . . 1.0900000000000001 110.831 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.31 168.56 11.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 114.789 -1.096 . . . . 0.28999999999999998 108.503 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.83 135.85 71.67 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.097 1.865 . . . . 0.26000000000000001 112.338 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 t -123.75 117.47 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.64000000000000001 110.726 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.613 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.4 mtp -103.05 116.75 33.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.82999999999999996 109.941 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.736 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.97 148.87 37.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.814 -0.63 . . . . 0.54000000000000004 111.594 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 76.8 mttt -90.68 143.18 28.61 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 0.67000000000000004 109.779 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -74.04 144.55 81.33 Favored 'Cis proline' 0 C--O 1.234 0.299 0 C-N-CA 123.282 -1.549 . . . . 0.75 112.925 1.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.663 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -138.66 131.88 30.01 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.347 -0.842 . . . . 0.34999999999999998 108.936 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 110' ' ' VAL . 11.3 t70 -73.08 129.42 38.04 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.964 -0.754 . . . . 0.51000000000000001 108.964 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.3 p -62.18 -21.05 64.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.375 -0.829 . . . . 0.26000000000000001 112.758 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.7 p -69.02 -43.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.874 -0.417 . . . . 1.3200000000000001 109.874 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.82 -39.9 87.84 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.134 -0.484 . . . . 0.62 110.166 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.613 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.8 t -61.87 -47.76 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.754 -0.657 . . . . 0.13 110.333 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.16 -48.37 78.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 0.13 111.21 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.28 -41.18 98.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 1.95 111.271 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -68.1 -27.38 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.745 0.307 . . . . 2.23 111.66 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -49.89 12.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.921 0.391 . . . . 0.14000000000000001 110.233 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.539 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 71.1 mt -65.08 -27.09 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.85 0.685 . . . . 0.27000000000000002 112.85 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.56 -26.92 66.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.732 -0.387 . . . . 2.79 110.946 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 69.8 mtm -73.84 -33.04 63.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.416 -0.356 . . . . 0.42999999999999999 111.06 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.539 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.5 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.32 0.581 . . . . 1.46 110.522 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 54.6 mtt . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.8 0.333 . . . . 1.6499999999999999 110.963 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HG2' HD22 ' A' ' 115' ' ' LEU . 1.5 Cg_endo -70.84 142.91 44.27 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.846 2.364 . . . . 0.33000000000000002 112.428 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -90.05 105.63 17.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.89000000000000001 109.004 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.3 t -99.73 136.27 31.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.987 -0.551 . . . . 0.20000000000000001 111.27 -173.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HB2' HD12 ' A' ' 50' ' ' ILE . 42.5 tp -109.31 112.0 23.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.134 -0.485 . . . . 0.75 110.273 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.62 122.86 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.298 0.57 . . . . 0.13 111.641 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -103.76 111.94 24.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.7 -1.136 . . . . 0.20999999999999999 108.704 172.686 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -170.16 127.23 0.84 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.38 -0.6 . . . . 1.4099999999999999 109.38 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.6 t70 -85.24 -25.58 27.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.27 110.324 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -75.55 106.57 3.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 2.5600000000000001 110.555 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 33.1 Cg_exo -59.64 -31.7 94.74 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.771 2.314 . . . . 0.32000000000000001 112.982 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.47 -49.59 68.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.329 -0.619 . . . . 1.51 109.329 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.2 mt -66.24 -47.08 85.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.374 -0.83 . . . . 1.01 111.27 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.56 82.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 0.20999999999999999 110.654 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -58.96 -44.74 91.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.727 -0.67 . . . . 0.60999999999999999 110.924 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.509 ' HB3' HG21 ' A' ' 107' ' ' THR . 1.3 m120 -68.2 -37.35 80.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.751 -0.659 . . . . 1.22 111.394 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.65 -45.04 88.48 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.506 -0.315 . . . . 0.17999999999999999 110.379 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 62.4 tt0 -55.25 -53.05 61.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 1.04 110.311 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -64.16 -27.72 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.78000000000000003 111.563 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.66 -46.36 63.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.766 0.317 . . . . 0.14000000000000001 110.73 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.701 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 54.0 m-85 -67.26 -42.3 84.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.367 -0.379 . . . . 0.13 110.526 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.58 -31.79 71.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.68999999999999995 110.039 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -35.52 76.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.756 -0.656 . . . . 0.51000000000000001 110.694 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -75.76 -20.55 58.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.142 0.496 . . . . 0.65000000000000002 110.305 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 56.27 0.7 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.705 -0.679 . . . . 0.28999999999999998 111.748 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.16 171.37 15.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.728 0.299 . . . . 0.23000000000000001 110.803 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.99 150.25 25.09 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 47.1 t -134.27 138.49 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.389 0.514 . . . . 0.19 112.389 -172.615 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG11 ' OG ' ' A' ' 44' ' ' SER . 12.0 t -115.58 126.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.058 -0.719 . . . . 0.23000000000000001 109.058 168.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.46 130.64 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.076 0.465 . . . . 0.94999999999999996 111.278 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -141.25 134.48 29.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.16 110.662 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.11 -10.73 20.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.451 . . . . 0.23999999999999999 111.078 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.636 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 38.3 p -127.34 168.4 14.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.395 . . . . 0.25 110.757 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.551 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.6 m -70.95 -35.33 72.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.292 -0.413 . . . . 1.6000000000000001 110.047 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.69999999999999996 111.219 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.636 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 55.4 mt-30 -61.87 -37.99 86.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.255 0.55 . . . . 1.4099999999999999 110.57 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.65 -51.44 65.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.328 -0.851 . . . . 0.17999999999999999 111.388 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.7 mt -62.53 -30.2 71.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.82999999999999996 111.021 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -49.16 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 2.4100000000000001 109.776 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.405 ' OG ' HG11 ' A' ' 33' ' ' VAL . 43.7 t -64.57 -38.12 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.037 -0.529 . . . . 1.1299999999999999 110.7 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.25 -32.27 72.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.284 0.564 . . . . 1.23 110.688 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.33 -41.43 16.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 0.42999999999999999 111.348 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.93 -34.49 59.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.0 -0.545 . . . . 0.62 111.629 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -118.32 161.49 34.88 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.41999999999999998 110.503 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.61 84.28 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.388 2.726 . . . . 0.23999999999999999 111.495 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.7 mm -64.62 123.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.651 -0.704 . . . . 0.22 111.736 -174.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 37.7 m-20 -92.58 -30.63 15.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.483 -0.781 . . . . 0.28999999999999998 110.277 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.5 p -159.81 155.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.111 -0.495 . . . . 0.12 109.807 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 164.06 29.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.359 0.6 . . . . 0.14000000000000001 111.49 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -135.33 112.39 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.512 -0.767 . . . . 0.95999999999999996 108.944 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.655 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -109.05 108.36 19.03 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.667 -0.413 . . . . 0.16 111.723 -170.637 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.0 t70 -78.82 126.21 30.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.598 -0.89 . . . . 1.77 108.598 172.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.509 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 21.3 t -73.96 -16.44 16.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.596 -0.729 . . . . 0.80000000000000004 110.862 -173.532 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -99.03 85.23 3.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.278 0.561 . . . . 2.3700000000000001 110.566 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.7 mt -99.88 -4.52 30.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.513 0.673 . . . . 0.84999999999999998 109.503 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.07 -174.47 40.99 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.895 -1.048 . . . . 0.81999999999999995 110.731 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.09 -45.41 31.97 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.696 2.264 . . . . 1.1799999999999999 111.98 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -107.29 -32.8 7.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.859 -0.61 . . . . 3.5299999999999998 110.129 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.7 m -65.56 126.91 29.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 0.95999999999999996 111.96 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -144.5 152.72 41.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.29 -0.868 . . . . 0.48999999999999999 109.413 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 28.5 p -67.44 87.67 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.296 0.569 . . . . 1.3 109.876 173.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.4 -69.78 0.43 Allowed Glycine 0 C--O 1.224 -0.496 0 C-N-CA 120.669 -0.777 . . . . 0.23000000000000001 112.119 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.9 Cg_exo -51.91 -30.56 39.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.594 2.196 . . . . 0.23999999999999999 112.134 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 11' ' ' LEU . 22.6 t -66.33 -39.15 83.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.451 0.643 . . . . 0.12 110.068 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.83 -47.18 75.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.091 -0.959 . . . . 0.16 110.093 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 2.7 m-20 -60.45 -42.77 96.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 2.0299999999999998 109.968 176.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.53 63.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 111.249 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.55 -40.77 89.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.417 -0.81 . . . . 0.20000000000000001 110.579 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 62.8 mmtt -59.67 -35.21 74.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.0099999999999998 111.079 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 53.7 mt-30 -70.39 -37.32 74.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 2.3700000000000001 111.171 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -93.04 4.67 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.681 0.277 . . . . 1.49 111.231 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.59 33.73 22.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.33000000000000002 111.617 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.18 133.87 32.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.144 -0.48 . . . . 0.17000000000000001 110.063 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.98 143.95 29.74 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.525 2.15 . . . . 0.20999999999999999 112.32 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 41.7 p90 -158.53 160.24 36.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.552 -0.749 . . . . 0.17999999999999999 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 mt -125.07 139.53 50.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 109.639 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.94 113.62 24.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.302 0.572 . . . . 0.20999999999999999 109.465 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.814 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 17.2 t-160 -101.63 130.03 47.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.386 -0.968 . . . . 0.59999999999999998 108.386 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 11.1 t -178.72 162.14 1.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.9 -0.32 . . . . 0.60999999999999999 110.703 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.74 13.8 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.335 -1.106 . . . . 0.93999999999999995 110.335 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -114.29 49.56 1.0 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.136 -0.532 . . . . 2.3300000000000001 110.137 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.85 -30.6 65.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.6100000000000001 111.944 -173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.77 -34.48 24.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.292 0.568 . . . . 2.6299999999999999 109.867 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.512 ' HD3' ' OD2' ' A' ' 85' ' ' ASP . 44.6 ttt180 -67.32 -34.91 78.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.313 -0.858 . . . . 4.4199999999999999 111.128 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.441 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.0 m-70 -118.62 28.66 8.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 1.05 111.473 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.65 95.88 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.001 -0.618 . . . . 0.97999999999999998 112.756 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 29.5 mt-10 -61.37 -45.57 93.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 2.5 110.154 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.84 -44.94 95.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.70999999999999996 110.572 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 73.5 mt -59.6 -38.62 81.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 1.5800000000000001 111.372 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -71.26 -27.03 63.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.399 -0.364 . . . . 4.3799999999999999 111.18 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 66.9 mttm -74.21 -43.74 55.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.333 0.587 . . . . 2.4500000000000002 110.032 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.563 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 83.5 mt -62.45 -51.34 73.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.189 -0.914 . . . . 0.45000000000000001 110.581 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.7 t70 62.47 75.58 0.4 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.425 0.631 . . . . 1.0900000000000001 110.828 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' HB3' ' CD2' ' A' ' 81' ' ' LEU . . . -161.12 167.41 13.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.28999999999999998 109.339 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.24 142.69 97.51 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.399 2.066 . . . . 0.26000000000000001 112.667 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -124.24 124.36 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.64000000000000001 111.054 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.14 110.5 22.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.28 -0.637 . . . . 0.82999999999999996 109.28 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.21 146.66 41.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.015 -0.539 . . . . 0.54000000000000004 111.91 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 86.8 mttt -91.19 142.52 27.28 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.67000000000000004 109.709 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.5 Cg_exo -71.14 139.59 59.39 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.505 -1.456 . . . . 0.75 112.992 3.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.596 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -132.79 136.44 46.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.34999999999999998 109.619 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 110' ' ' VAL . 10.5 t70 -79.38 131.58 36.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.472 -0.936 . . . . 0.51000000000000001 108.472 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.3 p -64.84 -23.56 67.27 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.672 -0.695 . . . . 0.26000000000000001 112.24 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -72.68 -33.31 66.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.551 -0.537 . . . . 1.3200000000000001 109.551 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -70.49 -45.8 64.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.809 -0.632 . . . . 0.62 109.36 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 106' ' ' ASP . 30.6 t -60.12 -43.44 92.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.264 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.701 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -61.89 -50.06 73.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.702 -0.681 . . . . 0.13 111.369 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.5 mttp -59.79 -49.95 75.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 1.95 111.167 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -59.7 -38.36 81.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 2.23 111.475 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.67 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 0.14000000000000001 110.603 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.522 HD22 ' HG2' ' A' ' 6' ' ' PRO . 63.0 mt -65.26 -25.44 67.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.27000000000000002 112.167 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 20.5 mm-40 -59.16 -30.23 68.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 2.79 111.208 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.5 mtm -88.81 1.94 54.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.42999999999999999 110.992 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 51.1 t . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 116.146 -0.479 . . . . 1.46 111.573 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 91.2 mtp . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.98 0.419 . . . . 1.6499999999999999 110.811 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.66 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -63.94 142.22 80.83 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.413 2.742 . . . . 0.33000000000000002 112.224 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -87.93 103.04 15.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.904 -0.776 . . . . 0.89000000000000001 108.904 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.458 HG22 ' CG1' ' A' ' 52' ' ' VAL . 54.9 t -99.23 135.49 34.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.003 -0.544 . . . . 0.20000000000000001 110.859 -173.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.497 ' HB2' HD12 ' A' ' 50' ' ' ILE . 40.4 tp -110.96 111.21 22.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.184 -0.462 . . . . 0.75 110.573 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -92.6 125.65 45.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.13 111.324 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -107.33 104.17 13.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.023 -0.989 . . . . 0.20999999999999999 109.231 173.69 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -165.16 123.23 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.88 -0.6 . . . . 1.4099999999999999 110.075 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.5 t70 -83.42 -22.06 32.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.798 -0.637 . . . . 1.27 110.781 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.81 107.0 9.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.119 -0.326 . . . . 2.5600000000000001 110.119 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.2 Cg_exo -58.5 -28.86 86.95 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 113.484 -174.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 tp -64.64 -49.96 68.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.998 0.428 . . . . 1.51 110.115 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.18 -41.37 89.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.834 -0.621 . . . . 1.01 110.559 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.17 82.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.20999999999999999 110.854 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.3 ttp -62.08 -42.8 99.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.60999999999999999 110.862 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.406 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.8 m-20 -64.21 -40.9 97.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.848 -0.615 . . . . 1.22 111.432 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 38.8 mt -64.56 -45.02 88.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.612 0.244 . . . . 0.17999999999999999 110.525 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.561 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 47.1 tt0 -55.6 -50.28 70.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.974 -0.557 . . . . 1.04 110.466 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -65.04 -27.17 68.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.78000000000000003 111.508 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.18 -45.02 58.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.14000000000000001 110.643 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -70.45 -42.16 71.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.112 -0.495 . . . . 0.13 110.917 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.46 -35.92 78.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.916 0.389 . . . . 0.68999999999999995 110.032 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.92 -31.86 73.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.633 -0.712 . . . . 0.51000000000000001 110.732 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -86.19 5.66 33.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.65000000000000002 111.159 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.76 52.7 5.31 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.948 -0.644 . . . . 0.28999999999999998 112.46 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' CB ' ' HD2' ' A' ' 6' ' ' PRO . . . -138.4 163.54 31.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 110.658 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -101.91 144.26 30.76 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.985 -0.746 . . . . 2.1400000000000001 108.985 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.561 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -127.58 143.75 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.027 0.441 . . . . 0.19 111.843 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.472 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.7 t -117.7 128.61 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.805 -0.813 . . . . 0.23000000000000001 108.805 168.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -97.23 122.75 49.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.548 -0.461 . . . . 0.94999999999999996 110.986 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -134.14 135.41 43.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.626 -0.716 . . . . 0.16 109.819 176.533 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.42 -21.61 14.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.331 -0.395 . . . . 0.23999999999999999 110.922 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 17.1 p -115.39 170.99 7.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.991 0.424 . . . . 0.25 111.125 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 22.3 p -65.06 -47.62 76.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.477 0.656 . . . . 1.6000000000000001 109.367 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -55.91 -45.72 78.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.279 -1.328 . . . . 0.69999999999999996 111.997 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.476 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 55.6 mt-30 -59.54 -45.31 92.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.426 0.631 . . . . 1.4099999999999999 110.304 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.12 -50.84 71.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.062 -0.972 . . . . 0.17999999999999999 111.141 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 57.7 mt -63.14 -31.34 72.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.761 -0.654 . . . . 0.82999999999999996 110.83 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -68.59 -53.44 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 2.4100000000000001 109.841 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.472 ' OG ' HG11 ' A' ' 33' ' ' VAL . 33.3 t -65.45 -32.91 74.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.894 0.378 . . . . 1.1299999999999999 110.621 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.446 HD23 ' HB1' ' A' ' 71' ' ' ALA . 16.3 tp -65.4 -33.51 76.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.23 110.797 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.32 -35.95 30.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.896 -0.593 . . . . 0.42999999999999999 111.258 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.98 -38.07 32.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.62 111.524 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -112.62 164.69 14.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.984 -0.553 . . . . 0.41999999999999998 110.89 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -94.78 78.29 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.571 2.847 . . . . 0.23999999999999999 111.594 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -64.04 119.29 7.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.751 -0.659 . . . . 0.22 111.236 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.4 m-20 -87.75 -29.67 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.726 -0.67 . . . . 0.28999999999999998 110.457 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.466 HG11 HD23 ' A' ' 115' ' ' LEU . 14.3 p -160.53 156.49 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 0.12 110.349 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.05 165.56 27.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.281 0.562 . . . . 0.14000000000000001 112.059 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.66 112.11 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.95999999999999996 109.583 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 9.7 mp -112.52 116.93 31.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.296 0.48 . . . . 0.16 112.296 -168.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.11 107.1 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 1.77 109.637 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' CG1' HD23 ' A' ' 92' ' ' LEU . 12.9 t -68.82 -9.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.041 -0.527 . . . . 0.80000000000000004 111.964 -172.087 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -114.96 63.27 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 2.3700000000000001 110.981 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD11 ' SG ' ' A' ' 65' ' ' CYS . 97.5 mt -64.52 -27.85 69.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.265 0.555 . . . . 0.84999999999999998 110.874 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.22 32.22 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.192 -0.763 . . . . 0.81999999999999995 111.192 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.54 -40.66 82.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.931 2.421 . . . . 1.1799999999999999 112.513 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -123.83 -31.55 3.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.655 0.264 . . . . 3.5299999999999998 110.783 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -65.95 127.03 30.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.058 0.456 . . . . 0.95999999999999996 111.706 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -144.57 153.38 41.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.707 -0.678 . . . . 0.48999999999999999 110.061 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 2.6 m -73.7 85.94 1.65 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.984 -0.747 . . . . 1.3 108.984 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.47 -63.93 0.54 Allowed Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.841 -0.695 . . . . 0.23000000000000001 111.842 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.45 -24.91 37.68 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.348 2.032 . . . . 0.23999999999999999 111.381 173.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 11' ' ' LEU . 20.9 t -68.45 -45.01 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.748 -0.66 . . . . 0.12 109.995 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.49 -49.41 77.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 0.16 110.165 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 50.7 m-20 -61.95 -41.6 98.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 2.0299999999999998 110.238 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.446 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -56.63 -44.16 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.019 -0.537 . . . . 0.23000000000000001 111.256 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.11 -42.19 76.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.56 -0.745 . . . . 0.20000000000000001 110.268 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.9 mmtt -59.88 -36.74 77.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.681 -0.691 . . . . 2.0099999999999998 111.447 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 71.2 mt-30 -63.29 -39.07 93.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 2.3700000000000001 111.237 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -96.02 6.14 49.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.29 -0.414 . . . . 1.49 111.235 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 35.57 22.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.797 -0.638 . . . . 0.33000000000000002 111.754 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.0 mt -89.12 133.79 34.5 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 116.501 -0.318 . . . . 0.17000000000000001 110.441 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 26.7 Cg_endo -74.2 141.46 29.21 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.49 2.127 . . . . 0.20999999999999999 111.765 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 16.9 p90 -159.16 160.58 35.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.675 -0.693 . . . . 0.17999999999999999 110.225 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.462 HG21 ' HG2' ' A' ' 101' ' ' MET . 16.0 mt -125.52 141.42 45.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.482 -0.781 . . . . 0.23999999999999999 109.987 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.84 108.71 19.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.309 -0.626 . . . . 0.20999999999999999 109.309 177.752 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.669 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.9 t-160 -103.66 74.01 1.22 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.481 0.658 . . . . 0.59999999999999998 109.261 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.429 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 4.5 t -105.86 163.56 12.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.646 -1.161 . . . . 0.60999999999999999 111.048 -172.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 -4.99 57.7 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.901 -0.59 . . . . 0.93999999999999995 112.31 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -137.95 132.72 32.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.108 0.48 . . . . 2.3300000000000001 109.826 172.728 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.1 mp -111.83 -25.85 9.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 1.6100000000000001 110.856 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.18 -45.97 12.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.126 0.489 . . . . 2.6299999999999999 110.898 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.34 -40.15 95.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.513 -0.767 . . . . 4.4199999999999999 110.938 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.526 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 49.7 m-70 -102.31 25.19 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.565 -0.288 . . . . 1.05 111.163 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.74 -37.88 95.56 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.967 -0.635 . . . . 0.97999999999999998 112.975 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 11.7 tt0 -66.94 -39.8 87.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 2.5 110.258 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.465 HD23 ' CG1' ' A' ' 57' ' ' VAL . 41.4 tp -68.12 -40.01 82.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.227 -0.442 . . . . 0.70999999999999996 109.863 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 89.0 mt -59.15 -39.6 82.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.453 -0.34 . . . . 1.5800000000000001 111.189 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 24.4 ptt180 -73.95 -26.05 60.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 4.3799999999999999 110.584 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -70.34 -34.15 72.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.295 0.569 . . . . 2.4500000000000002 110.163 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.596 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 95.8 mt -77.36 -53.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.366 -0.834 . . . . 0.45000000000000001 110.677 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.0 t70 64.47 75.26 0.38 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.764 0.792 . . . . 1.0900000000000001 110.917 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.87 162.11 25.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.902 -1.044 . . . . 0.28999999999999998 109.383 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.75 147.19 89.48 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.658 2.239 . . . . 0.26000000000000001 112.539 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.1 t -124.25 134.97 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.202 -0.454 . . . . 0.64000000000000001 110.971 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.462 ' HG2' HG21 ' A' ' 80' ' ' ILE . 92.2 mmm -114.77 107.47 15.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.286 -0.635 . . . . 0.82999999999999996 109.286 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -73.04 143.86 47.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.944 -0.571 . . . . 0.54000000000000004 111.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 94.0 mttt -91.45 146.74 33.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.046 -0.525 . . . . 0.67000000000000004 110.186 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.19 127.31 13.8 Favored 'Cis proline' 0 C--O 1.234 0.278 0 C-N-CA 123.619 -1.409 . . . . 0.75 112.699 2.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.669 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -119.35 130.04 55.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.728 -0.669 . . . . 0.34999999999999998 110.297 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.15 129.97 38.87 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.04 -1.096 . . . . 0.51000000000000001 108.04 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 39.9 p -64.28 -20.47 66.09 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.875 0.695 . . . . 0.26000000000000001 112.875 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 76.1 p -65.87 -42.32 90.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.995 0.426 . . . . 1.3200000000000001 110.176 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 -39.79 84.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.159 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.44 -45.14 98.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 0.13 110.327 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.31 -48.81 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.554 -0.748 . . . . 0.13 111.479 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 1.95 111.269 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.8 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 2.23 111.402 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.2 -46.81 17.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.49 . . . . 0.14000000000000001 110.392 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD23 HG11 ' A' ' 52' ' ' VAL . 77.1 mt -70.59 -26.08 63.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.634 0.605 . . . . 0.27000000000000002 112.634 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -63.07 -33.19 74.92 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.815 -0.354 . . . . 2.79 110.415 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.3 mtm -76.08 -30.69 58.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.193 0.52 . . . . 0.42999999999999999 110.139 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.5 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 1.46 111.033 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.461 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.793 0.33 . . . . 1.6499999999999999 111.662 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 17.3 Cg_exo -70.45 136.06 30.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.045 2.496 . . . . 0.33000000000000002 110.984 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -85.98 109.48 18.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.431 -0.581 . . . . 0.89000000000000001 109.431 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG22 ' CG1' ' A' ' 52' ' ' VAL . 38.0 t -100.14 130.79 48.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.9 -0.591 . . . . 0.20000000000000001 110.916 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.499 ' HB2' HD12 ' A' ' 50' ' ' ILE . 54.1 tp -105.04 112.14 25.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.83 0.348 . . . . 0.75 110.306 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 54' ' ' VAL . 25.3 t -93.12 121.03 43.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.118 0.485 . . . . 0.13 111.507 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm? -102.45 101.11 11.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.297 -0.865 . . . . 0.20999999999999999 108.889 171.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -159.51 120.98 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.479 -0.782 . . . . 1.4099999999999999 109.921 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 19.0 t70 -87.49 -19.03 28.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.9 -0.591 . . . . 1.27 109.941 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -83.51 105.65 5.89 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 2.5600000000000001 109.835 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.1 Cg_exo -59.03 -32.97 98.49 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.736 2.291 . . . . 0.32000000000000001 113.063 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.37 -49.19 78.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.621 -0.511 . . . . 1.51 109.621 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.23 -46.04 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 1.01 110.88 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.59 72.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.069 0.461 . . . . 0.20999999999999999 110.783 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.0 ttp -63.27 -44.92 93.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.553 -0.749 . . . . 0.60999999999999999 111.231 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HG21 ' A' ' 107' ' ' THR . 10.9 m-20 -67.68 -36.78 81.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.098 -0.501 . . . . 1.22 111.497 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.4 mt -65.54 -46.14 80.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.739 0.304 . . . . 0.17999999999999999 110.188 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 48.2 tt0 -55.17 -48.38 73.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 1.04 110.406 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -63.48 -37.88 89.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.441 -0.345 . . . . 0.78000000000000003 111.199 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.54 -49.36 69.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.435 -0.348 . . . . 0.14000000000000001 111.275 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -63.96 -45.73 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.247 -0.433 . . . . 0.13 110.86 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.66 -28.42 69.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.366 -0.379 . . . . 0.68999999999999995 111.164 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.8 -33.33 66.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.51000000000000001 110.229 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.78 -14.73 59.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.65000000000000002 110.817 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 53.11 0.8 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 112.373 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.4 175.95 9.13 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.872 -0.193 . . . . 0.23000000000000001 110.683 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.45 129.91 49.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.064 -0.717 . . . . 2.1400000000000001 109.064 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.3 t -118.25 142.15 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 112.664 0.616 . . . . 0.19 112.664 -164.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 44' ' ' SER . 10.4 t -114.38 136.38 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.867 -0.79 . . . . 0.23000000000000001 108.867 169.544 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.02 125.09 58.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 0.94999999999999996 111.191 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.78 139.53 45.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.109 -0.496 . . . . 0.16 110.424 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.94 -13.16 15.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.347 -0.388 . . . . 0.23999999999999999 111.2 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.0 p -127.79 167.44 16.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.485 -0.325 . . . . 0.25 110.555 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 74.6 m -68.73 -34.19 75.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.845 -0.428 . . . . 1.6000000000000001 109.845 175.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.37 -48.01 81.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.69999999999999996 110.613 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -59.08 -41.03 87.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.353 0.596 . . . . 1.4099999999999999 110.621 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.658 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -62.0 -54.75 37.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.15 -0.932 . . . . 0.17999999999999999 111.419 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 62.7 mt -64.46 -30.7 71.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.013 -0.54 . . . . 0.82999999999999996 110.767 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -64.43 -47.43 79.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.292 -0.633 . . . . 2.4100000000000001 109.292 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.468 ' HB3' HG11 ' A' ' 33' ' ' VAL . 11.0 m -72.28 -30.46 64.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.922 -0.581 . . . . 1.1299999999999999 110.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.428 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 21.6 tp -67.1 -35.93 80.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 1.23 110.637 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.24 -35.15 48.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.055 -0.52 . . . . 0.42999999999999999 110.814 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.53 -36.28 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.745 -0.661 . . . . 0.62 111.17 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.59 148.56 48.24 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.358 0.599 . . . . 0.41999999999999998 111.284 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.65 88.59 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.321 2.681 . . . . 0.23999999999999999 111.498 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 9' ' ' LEU . 42.6 mm -68.56 127.95 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.663 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -98.89 -27.03 14.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.28999999999999998 110.414 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' HG22 ' A' ' 8' ' ' VAL . 11.7 p -159.48 159.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.12 109.49 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -145.71 165.84 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.376 0.607 . . . . 0.14000000000000001 112.128 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -138.14 111.76 7.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.221 -0.899 . . . . 0.95999999999999996 109.192 175.899 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.625 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -114.43 124.08 51.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.329 0.492 . . . . 0.16 112.329 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.5 t0 -85.1 115.1 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.815 0.817 . . . . 1.77 109.336 169.231 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.753 HG13 HD23 ' A' ' 92' ' ' LEU . 65.8 t -59.97 -24.17 29.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.588 -1.187 . . . . 0.80000000000000004 110.96 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 7.7 t30 -113.01 75.53 0.92 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 2.3700000000000001 110.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.3 -29.57 67.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.809 0.814 . . . . 0.84999999999999998 109.052 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.37 -172.22 34.28 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.567 -1.197 . . . . 0.81999999999999995 110.241 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HB2' ' HD2' ' A' ' 62' ' ' LYS . 86.1 Cg_exo -52.92 -44.52 47.9 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.905 2.403 . . . . 1.1799999999999999 112.399 176.683 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -109.59 -34.1 6.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 3.5299999999999998 110.563 177.572 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.8 m -65.89 127.46 32.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.351 0.596 . . . . 0.95999999999999996 111.146 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -144.23 149.89 37.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 0.48999999999999999 110.34 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -71.74 86.57 0.94 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.514 0.674 . . . . 1.3 109.431 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.65 -73.06 0.7 Allowed Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.355 -0.926 . . . . 0.23000000000000001 112.164 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.8 Cg_exo -53.29 -25.3 30.08 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.583 2.189 . . . . 0.23999999999999999 112.221 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 11' ' ' LEU . 12.6 t -72.12 -46.72 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.228 0.537 . . . . 0.12 110.365 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.42 -51.81 67.93 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.314 -0.857 . . . . 0.16 109.802 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.28 -37.34 85.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 110.49 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -56.96 -48.23 78.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.409 0.623 . . . . 0.23000000000000001 110.969 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.04 -41.61 77.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.399 -0.818 . . . . 0.20000000000000001 110.402 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 29.9 mmmt -57.89 -39.39 77.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.585 -0.734 . . . . 2.0099999999999998 110.807 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -62.64 -46.68 87.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.688 . . . . 2.3700000000000001 111.462 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -86.41 2.8 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 1.49 111.086 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.0 33.16 21.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.763 -0.653 . . . . 0.33000000000000002 111.308 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.74 131.39 47.45 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 116.085 -0.507 . . . . 0.17000000000000001 109.845 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.2 Cg_endo -72.72 139.39 30.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.17 1.913 . . . . 0.20999999999999999 111.616 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 12.5 p90 -156.44 155.28 31.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.902 -0.59 . . . . 0.17999999999999999 110.719 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.34 139.61 44.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.538 -0.756 . . . . 0.23999999999999999 109.505 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 96' ' ' ILE . 2.5 mm? -88.69 107.45 18.94 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.281 -0.637 . . . . 0.20999999999999999 109.281 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 101' ' ' MET . 14.7 t-160 -103.46 72.52 1.15 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.275 -1.009 . . . . 0.59999999999999998 108.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.631 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 9.7 t -103.52 159.63 15.42 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 113.989 -1.46 . . . . 0.60999999999999999 111.401 -171.609 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.689 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -106.24 9.42 42.41 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.623 -0.799 . . . . 0.93999999999999995 111.42 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 17.7 t70 -137.06 141.31 42.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.877 0.37 . . . . 2.3300000000000001 110.861 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.6 mt -130.08 -31.88 1.87 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.079 -0.51 . . . . 1.6100000000000001 110.71 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.54 -39.39 16.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.478 0.548 . . . . 2.6299999999999999 112.478 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -70.16 -52.58 22.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.692 0.282 . . . . 4.4199999999999999 111.141 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -97.21 29.1 3.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.426 -0.352 . . . . 1.05 110.304 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.18 -34.08 62.1 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.448 -0.406 . . . . 0.97999999999999998 113.796 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.88 -26.04 68.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 2.5 111.259 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.753 HD23 HG13 ' A' ' 57' ' ' VAL . 15.3 tp -74.96 -47.87 27.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.22 -0.445 . . . . 0.70999999999999996 110.954 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -60.48 -36.37 78.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.911 0.386 . . . . 1.5800000000000001 110.955 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.43 -34.12 73.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.311 -0.859 . . . . 4.3799999999999999 111.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -81.34 -29.36 34.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 2.4500000000000002 111.063 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 92' ' ' LEU . 70.7 mt -67.71 -50.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.798 -0.637 . . . . 0.45000000000000001 111.327 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.21 75.96 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.413 0.625 . . . . 1.0900000000000001 110.617 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -162.71 161.99 19.07 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.437 -0.802 . . . . 0.28999999999999998 109.44 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 31.8 Cg_exo -59.99 137.3 75.07 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.79 2.327 . . . . 0.26000000000000001 112.465 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.9 135.33 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.891 -0.595 . . . . 0.64000000000000001 110.904 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.6 mtp -127.24 90.91 3.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.294 -0.632 . . . . 0.82999999999999996 109.294 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.62 139.78 57.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.54000000000000004 111.62 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.689 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 15.3 ptpt -91.56 149.84 40.06 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.594 -0.73 . . . . 0.67000000000000004 109.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.564 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 16.7 Cg_exo -66.54 138.43 39.56 Favored 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 123.534 -1.444 . . . . 0.75 113.118 3.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -142.07 133.93 27.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.253 -0.885 . . . . 0.34999999999999998 108.778 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 110' ' ' VAL . 12.9 t70 -65.09 123.36 19.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.585 -0.524 . . . . 0.51000000000000001 109.585 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.9 p -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.495 -0.775 . . . . 0.26000000000000001 112.555 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -70.81 -39.74 72.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.455 -0.572 . . . . 1.3200000000000001 109.455 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -67.01 -44.26 80.76 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.62 109.84 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.59 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 25.4 t -59.95 -42.11 88.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.197 -0.911 . . . . 0.13 110.378 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.85 -50.47 66.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.598 -0.728 . . . . 0.13 111.558 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.85 -41.1 99.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 1.95 111.538 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 31.1 mmt180 -71.82 -24.91 61.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.7 0.285 . . . . 2.23 111.492 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 -48.98 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 0.14000000000000001 110.279 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.627 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 69.0 mt -64.55 -26.82 68.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.931 0.715 . . . . 0.27000000000000002 112.931 -175.562 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.69 -28.98 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.779 -0.368 . . . . 2.79 110.969 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.448 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 57.7 mtm -75.21 -21.81 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.42999999999999999 111.03 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 25.4 p . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.06 0.457 . . . . 1.46 110.529 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 12.1 ptp . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.811 0.815 . . . . 1.6499999999999999 112.554 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 1.1 Cg_endo -69.53 141.13 45.3 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.153 1.902 . . . . 0.33000000000000002 112.743 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -89.56 105.92 18.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.635 -0.711 . . . . 0.89000000000000001 109.087 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.6 t -100.66 134.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.20000000000000001 111.228 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 50' ' ' ILE . 50.5 tp -110.55 113.31 25.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.008 -0.542 . . . . 0.75 110.564 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -95.05 129.11 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.962 0.411 . . . . 0.13 111.113 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -110.0 101.54 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.20999999999999999 109.982 176.349 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -165.14 133.25 3.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.658 -0.497 . . . . 1.4099999999999999 109.658 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -87.47 -31.95 19.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.884 -0.598 . . . . 1.27 110.497 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.1 111.46 13.7 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.22 -0.289 . . . . 2.5600000000000001 110.22 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.48 -31.92 95.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.998 2.465 . . . . 0.32000000000000001 113.027 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.81 -49.64 69.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.891 -0.411 . . . . 1.51 109.891 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.08 -47.69 86.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 1.01 110.415 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.76 -49.43 77.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.49 -0.777 . . . . 0.20999999999999999 111.477 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.5 ttp -66.22 -34.12 77.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.382 -0.372 . . . . 0.60999999999999999 111.093 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.539 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.2 m-20 -66.77 -43.88 82.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.311 -0.404 . . . . 1.22 110.609 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.39 -44.06 97.35 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.184 -0.462 . . . . 0.17999999999999999 110.021 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.481 ' HA ' HG11 ' A' ' 32' ' ' VAL . 56.6 tt0 -52.18 -53.83 38.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 1.04 110.684 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -63.76 -33.35 75.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.777 0.323 . . . . 0.78000000000000003 111.138 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.87 71.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.215 -0.448 . . . . 0.14000000000000001 111.046 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.3 m-85 -66.95 -40.41 87.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.13 110.849 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.6 mt-10 -61.6 -35.66 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.68999999999999995 110.539 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.73 -29.25 67.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.52 . . . . 0.51000000000000001 110.761 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -82.78 -2.0 53.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.65000000000000002 110.923 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.16 50.54 3.62 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.878 -0.677 . . . . 0.28999999999999998 112.404 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.87 162.32 35.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.204 -0.295 . . . . 0.23000000000000001 110.204 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.78 132.98 51.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.572 -0.529 . . . . 2.1400000000000001 109.572 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 22' ' ' GLN . 21.8 t -113.78 139.95 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.014 0.375 . . . . 0.19 112.014 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.485 HG11 ' OG ' ' A' ' 44' ' ' SER . 10.2 t -114.45 127.29 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.588 -0.893 . . . . 0.23000000000000001 108.588 167.281 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.61 123.4 50.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.727 -0.389 . . . . 0.94999999999999996 110.769 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.36 134.32 47.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.064 -0.516 . . . . 0.16 109.994 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.02 -18.95 19.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.833 -0.621 . . . . 0.23999999999999999 110.909 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.2 p -125.12 164.89 19.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.705 -0.398 . . . . 0.25 111.163 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 76.5 m -65.16 -35.46 81.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 109.681 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.6 -46.91 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.984 -0.553 . . . . 0.69999999999999996 110.641 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -61.42 -41.65 97.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.955 -0.566 . . . . 1.4099999999999999 110.822 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.619 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.46 -49.65 72.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.559 -0.746 . . . . 0.17999999999999999 111.484 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 81.7 mt -60.58 -33.42 72.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.82999999999999996 110.885 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 6.8 tmtm? -66.73 -52.58 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.814 -0.63 . . . . 2.4100000000000001 109.945 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.485 ' OG ' HG11 ' A' ' 33' ' ' VAL . 14.1 t -65.4 -34.42 78.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.367 -0.379 . . . . 1.1299999999999999 110.44 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.406 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 17.7 tp -62.05 -36.44 81.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 1.23 110.852 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.05 -39.84 22.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 0.42999999999999999 111.194 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.58 -37.79 65.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.62 111.397 -176.551 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -115.29 163.14 21.14 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.41999999999999998 110.411 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.84 82.54 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.446 2.764 . . . . 0.23999999999999999 111.531 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.7 mm -63.96 122.43 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.463 -0.79 . . . . 0.22 111.526 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -90.22 -34.71 15.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.56 -0.746 . . . . 0.28999999999999998 110.32 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -154.7 154.27 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.12 109.987 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -137.21 162.89 32.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.374 0.606 . . . . 0.14000000000000001 111.657 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -135.17 112.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.411 -0.813 . . . . 0.95999999999999996 109.185 176.774 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mp -107.54 97.95 7.62 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.442 0.639 . . . . 0.16 110.975 -172.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.734 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -74.22 82.98 1.85 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.929 -1.032 . . . . 1.77 109.35 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 60.5 t -42.46 -42.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 114.541 -1.208 . . . . 0.80000000000000004 113.71 -169.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -78.35 74.43 4.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.014 0.435 . . . . 2.3700000000000001 110.755 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.7 mt -78.52 -22.85 46.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.55 0.691 . . . . 0.84999999999999998 109.444 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.8 -174.39 45.95 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.904 -1.044 . . . . 0.81999999999999995 110.503 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.49 -40.13 87.2 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.598 2.199 . . . . 1.1799999999999999 112.339 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -118.06 -23.69 7.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.088 -0.506 . . . . 3.5299999999999998 110.723 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.9 m -70.32 124.74 24.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.214 0.53 . . . . 0.95999999999999996 110.973 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -144.97 148.31 33.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.726 -0.67 . . . . 0.48999999999999999 110.353 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.501 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -76.44 87.32 3.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.857 -0.794 . . . . 1.3 108.857 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -110.71 -67.52 0.56 Allowed Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.47 -0.871 . . . . 0.23000000000000001 112.541 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 38.9 Cg_exo -53.96 -21.35 20.86 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.354 2.036 . . . . 0.23999999999999999 111.902 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' A' ' 11' ' ' LEU . 38.5 t -70.17 -42.67 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.889 -0.596 . . . . 0.12 110.071 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.99 -45.68 91.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.564 -0.744 . . . . 0.16 109.905 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.0 m-20 -61.74 -43.78 98.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.0299999999999998 109.804 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -56.4 -48.71 76.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.23000000000000001 111.165 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.11 -41.44 97.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.514 -0.766 . . . . 0.20000000000000001 110.297 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -60.94 -34.47 74.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.829 -0.623 . . . . 2.0099999999999998 111.757 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 15.8 mm100 -65.47 -35.5 81.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.457 -0.338 . . . . 2.3700000000000001 110.929 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -100.24 7.93 44.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 1.49 111.421 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.89 36.31 27.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.33000000000000002 111.694 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.82 133.41 35.82 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.413 -0.358 . . . . 0.17000000000000001 110.152 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.9 141.35 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.607 2.205 . . . . 0.20999999999999999 112.113 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 21.8 p90 -156.7 157.9 35.98 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.378 -0.828 . . . . 0.17999999999999999 110.453 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 mt -120.05 139.05 48.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.246 -0.888 . . . . 0.23999999999999999 109.646 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 96' ' ' ILE . 1.6 mm? -89.23 108.01 19.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.905 -0.776 . . . . 0.20999999999999999 108.905 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.743 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 12.0 t-160 -101.77 102.59 13.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.359 0.599 . . . . 0.59999999999999998 110.111 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 7.9 t -164.21 149.96 10.74 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.964 -0.46 . . . . 0.60999999999999999 110.423 -173.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.3 -13.32 36.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.483 -1.047 . . . . 0.93999999999999995 110.483 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 33.0 t70 -94.36 103.81 15.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.815 -0.809 . . . . 2.3300000000000001 108.815 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.41 -62.14 1.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.216 -0.447 . . . . 1.6100000000000001 112.036 -171.098 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.13 -29.86 68.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.051 0.453 . . . . 2.6299999999999999 111.17 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 65.6 ttt180 -67.81 -18.73 64.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 4.4199999999999999 110.944 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -131.25 33.18 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.511 . . . . 1.05 110.289 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.43 -41.8 98.72 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.97999999999999998 113.012 -175.203 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.89 -37.08 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.695 0.284 . . . . 2.5 111.108 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' HG13 ' A' ' 96' ' ' ILE . 24.2 tp -64.08 -49.53 71.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.264 0.554 . . . . 0.70999999999999996 110.052 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.7 mt -61.47 -31.32 71.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.133 -0.939 . . . . 1.5800000000000001 111.252 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 95.9 mtt180 -63.97 -37.98 89.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 4.3799999999999999 110.866 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -66.33 -47.4 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.53 0.681 . . . . 2.4500000000000002 110.273 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 81' ' ' LEU . 41.2 mt -66.31 -56.33 14.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.519 -1.219 . . . . 0.45000000000000001 111.215 -175.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.9 t70 47.99 59.55 4.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.882 0.848 . . . . 1.0900000000000001 110.715 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . -132.66 168.98 15.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.077 -0.965 . . . . 0.28999999999999998 109.336 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 78.3 Cg_exo -51.67 136.64 50.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.238 1.959 . . . . 0.26000000000000001 112.756 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.1 t -123.14 136.26 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.352 -0.84 . . . . 0.64000000000000001 110.146 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 94.5 mtp -118.35 106.06 12.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.343 -0.614 . . . . 0.82999999999999996 109.343 173.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.67 153.04 44.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.474 -0.785 . . . . 0.54000000000000004 110.842 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -91.04 146.32 33.42 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 0.67000000000000004 109.838 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.52 148.65 89.58 Favored 'Cis proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.548 -1.438 . . . . 0.75 112.858 0.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.743 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -140.61 135.97 32.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.695 -0.684 . . . . 0.34999999999999998 109.615 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.9 t0 -75.93 132.55 40.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.8 -0.815 . . . . 0.51000000000000001 108.8 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.7 p -67.7 -21.17 65.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.707 -0.679 . . . . 0.26000000000000001 112.189 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.9 p -76.0 -29.08 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.154 0.502 . . . . 1.3200000000000001 109.672 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.97 -45.5 49.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.62 109.57 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.686 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 23.2 t -59.03 -44.59 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.13 110.428 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -59.11 -52.68 64.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.13 111.346 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 37.3 mtmm -62.96 -47.03 84.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.033 -0.53 . . . . 1.95 111.039 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -56.49 -37.65 70.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.325 . . . . 2.23 111.513 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.46 48.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.14000000000000001 110.794 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.495 HD23 HG11 ' A' ' 52' ' ' VAL . 74.6 mt -64.02 -25.29 68.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.27000000000000002 112.0 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 42.5 mm-40 -59.31 -31.09 68.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.642 0.258 . . . . 2.79 111.066 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.491 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 62.0 mtm -84.96 -23.07 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 0.42999999999999999 111.402 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.152 0.501 . . . . 1.46 110.119 178.901 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.465 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.7 mtt . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 110.184 -0.302 . . . . 1.6499999999999999 110.184 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.5 Cg_exo -66.36 136.93 45.33 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.643 2.229 . . . . 0.33000000000000002 111.741 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.477 ' HB3' HD13 ' A' ' 50' ' ' ILE . 9.3 mttp -84.22 109.67 17.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 0.89000000000000001 110.839 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 39.1 t -101.66 117.83 47.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 0.20000000000000001 110.515 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.442 HD21 ' HB1' ' A' ' 41' ' ' ALA . 58.2 tp -97.66 109.9 22.56 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.698 -0.683 . . . . 0.75 110.432 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.08 123.86 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.199 0.523 . . . . 0.13 111.479 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.705 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.2 mm? -101.72 106.2 17.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.095 -0.957 . . . . 0.20999999999999999 108.897 172.44 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -165.5 131.28 2.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.889 -0.596 . . . . 1.4099999999999999 109.873 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 24.4 t70 -94.13 -21.25 19.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.418 -0.81 . . . . 1.27 109.722 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 17' ' ' ILE . 9.6 mm-40 -81.81 105.58 4.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 2.5600000000000001 110.193 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 34.5 Cg_exo -59.81 -25.19 78.57 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.771 2.314 . . . . 0.32000000000000001 113.366 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.32 -52.04 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.312 -0.625 . . . . 1.51 109.312 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.9 mp -63.85 -43.8 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.55 . . . . 1.01 110.069 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.27 66.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.20999999999999999 110.715 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 42.2 ttp -62.96 -38.77 92.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 111.257 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . 7.3 m-20 -65.11 -42.56 93.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.21 -0.45 . . . . 1.22 111.289 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 52.8 mt -65.21 -43.8 90.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.17999999999999999 109.967 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HA ' HG21 ' A' ' 32' ' ' VAL . 38.6 tt0 -52.86 -50.93 62.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.163 -0.926 . . . . 1.04 110.662 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -64.5 -33.37 75.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.78000000000000003 111.629 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.17 -49.29 61.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.14000000000000001 111.061 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 73.2 m-85 -66.93 -42.09 85.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.13 110.967 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -64.84 -26.96 68.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.576 -0.284 . . . . 0.68999999999999995 110.703 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.51000000000000001 110.951 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.06 -12.15 59.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.65000000000000002 111.223 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.89 51.74 1.35 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.785 -0.722 . . . . 0.28999999999999998 112.135 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.7 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.209 -0.293 . . . . 0.23000000000000001 110.209 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.08 130.58 55.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.654 -0.499 . . . . 2.1400000000000001 109.654 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 22' ' ' GLN . 40.7 t -109.01 138.37 36.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.173 -0.467 . . . . 0.19 111.71 -171.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.63 123.39 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.771 -0.826 . . . . 0.23000000000000001 108.771 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.5 p -92.85 128.68 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.94999999999999996 111.17 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.8 135.05 34.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.16 110.605 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.08 -10.91 20.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.292 -0.413 . . . . 0.23999999999999999 111.37 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -130.26 166.1 21.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 0.25 111.075 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.657 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 85.9 m -66.36 -34.92 79.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 1.6000000000000001 110.301 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -61.08 -51.57 68.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.69999999999999996 110.578 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -55.93 -37.07 68.45 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.999 -0.546 . . . . 1.4099999999999999 111.245 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.705 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -69.28 -52.74 24.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.542 -0.753 . . . . 0.17999999999999999 111.133 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.73 -34.96 70.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.87 -0.604 . . . . 0.82999999999999996 110.873 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -52.74 63.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.469 . . . . 2.4100000000000001 110.557 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 -36.74 84.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.88 -0.6 . . . . 1.1299999999999999 110.481 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.9 -36.09 80.29 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.074 0.464 . . . . 1.23 110.939 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.47 -35.91 45.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.426 . . . . 0.42999999999999999 111.442 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -85.88 -31.47 22.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.059 0.457 . . . . 0.62 111.106 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -123.25 162.8 37.71 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.614 . . . . 0.41999999999999998 111.415 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.454 ' HD2' ' HD2' ' A' ' 7' ' ' LYS . 89.2 Cg_endo -95.47 90.55 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.68 2.92 . . . . 0.23999999999999999 111.383 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 7' ' ' LYS . 40.4 mm -73.94 123.85 30.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.784 -0.644 . . . . 0.22 111.329 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.532 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 24.8 m-20 -88.75 -28.48 20.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.552 -0.749 . . . . 0.28999999999999998 110.884 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -164.05 158.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.979 -0.378 . . . . 0.12 109.979 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -139.8 167.13 22.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.14000000000000001 111.806 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.58 112.26 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 0.95999999999999996 109.028 176.351 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.7 mp -111.22 119.59 39.45 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.43 0.53 . . . . 0.16 112.43 -167.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -85.02 141.67 30.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.861 -0.792 . . . . 1.77 108.861 167.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 93' ' ' LEU . 13.1 t -100.89 2.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.584 0.707 . . . . 0.80000000000000004 111.148 -170.477 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -124.37 62.7 1.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.682 -0.69 . . . . 2.3700000000000001 109.862 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.54 -15.84 60.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.833 -0.621 . . . . 0.84999999999999998 110.24 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.31 -171.5 41.7 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.105 -0.798 . . . . 0.81999999999999995 111.105 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -50.83 -45.55 35.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.061 2.507 . . . . 1.1799999999999999 112.148 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -117.95 -26.67 6.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 3.5299999999999998 110.106 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -62.47 125.16 22.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.95999999999999996 111.402 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -143.97 157.0 44.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.439 -0.8 . . . . 0.48999999999999999 109.647 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -71.4 87.48 0.86 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.388 0.613 . . . . 1.3 109.493 171.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.24 -72.68 0.63 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.468 -0.872 . . . . 0.23000000000000001 112.19 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.657 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 44.0 Cg_exo -53.62 -26.39 37.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.565 2.176 . . . . 0.23999999999999999 112.212 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.3 t -68.66 -43.35 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.12 110.201 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.77 -48.05 82.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.344 -0.844 . . . . 0.16 109.823 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 29.4 t70 -65.35 -40.5 93.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.47 -0.786 . . . . 2.0299999999999998 110.484 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.22 -47.98 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.398 0.618 . . . . 0.23000000000000001 110.955 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.65 -42.26 71.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.215 -0.902 . . . . 0.20000000000000001 110.733 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -59.22 -36.56 75.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.599 . . . . 2.0099999999999998 111.225 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 77.5 mm-40 -64.82 -37.4 87.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 2.3700000000000001 111.574 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -97.56 5.31 49.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.397 -0.365 . . . . 1.49 111.397 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 31.09 20.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.971 -0.558 . . . . 0.33000000000000002 111.399 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.8 mt -83.36 130.08 57.93 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 109.595 -0.52 . . . . 0.17000000000000001 109.595 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.28 142.95 38.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.309 2.006 . . . . 0.20999999999999999 111.362 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 25.6 p90 -159.3 157.16 30.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.124 0.487 . . . . 0.17999999999999999 110.621 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.424 HG21 ' HG2' ' A' ' 101' ' ' MET . 34.8 mt -121.39 138.59 51.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.311 -0.859 . . . . 0.23999999999999999 109.853 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.34 108.68 19.46 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.758 -0.83 . . . . 0.20999999999999999 108.758 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.609 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 17.4 t-160 -105.82 85.33 2.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.369 0.604 . . . . 0.59999999999999998 109.476 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 57' ' ' VAL . 9.6 t -134.05 160.49 37.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.841 -1.072 . . . . 0.60999999999999999 110.212 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.08 2.27 38.05 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.569 -1.013 . . . . 0.93999999999999995 110.569 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.29 51.09 1.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.545 . . . . 2.3300000000000001 110.692 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.66 -41.45 96.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.702 -0.681 . . . . 1.6100000000000001 111.145 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.01 -40.81 17.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.562 -0.29 . . . . 2.6299999999999999 110.793 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -43.59 80.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.102 -0.499 . . . . 4.4199999999999999 111.521 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -119.46 32.04 6.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 1.05 111.149 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -59.13 -41.09 96.44 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.999 -0.619 . . . . 0.97999999999999998 112.809 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.61 -47.17 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.134 0.493 . . . . 2.5 110.624 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.3 tp -60.29 -45.69 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.602 -0.727 . . . . 0.70999999999999996 110.32 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 57' ' ' VAL . 74.2 mt -58.64 -39.93 81.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 1.5800000000000001 111.368 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 4.7 mmp_? -64.26 -33.46 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 4.3799999999999999 111.361 178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.8 -34.12 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 2.4500000000000002 111.069 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 92' ' ' LEU . 80.8 mt -64.76 -52.82 49.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.089 -0.505 . . . . 0.45000000000000001 110.314 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.51 76.0 0.36 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.815 0.697 . . . . 1.0900000000000001 110.787 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -157.6 162.3 27.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.403 -0.817 . . . . 0.28999999999999998 108.95 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.706 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -57.26 136.19 74.82 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.448 2.098 . . . . 0.26000000000000001 112.429 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.91 132.6 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.64000000000000001 110.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.9 mmm -113.04 105.54 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.895 -0.78 . . . . 0.82999999999999996 108.895 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 146.14 55.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.003 -0.544 . . . . 0.54000000000000004 111.475 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.3 mttt -91.05 141.61 26.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.67000000000000004 109.473 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.57 156.41 99.23 Favored 'Cis proline' 0 CA--C 1.528 0.217 0 C-N-CA 123.413 -1.494 . . . . 0.75 113.339 2.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.609 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.76 135.1 15.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.34999999999999998 109.915 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -70.94 130.23 41.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.897 -1.149 . . . . 0.51000000000000001 107.897 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 33.5 p -65.05 -18.35 65.22 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.737 0.643 . . . . 0.26000000000000001 112.737 -171.084 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.3 p -71.15 -38.81 72.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.459 -0.496 . . . . 1.3200000000000001 109.689 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.38 -46.76 87.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.412 0.625 . . . . 0.62 109.575 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.72 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.853 -1.067 . . . . 0.13 110.394 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.64 -50.03 72.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.13 111.518 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -59.59 -43.32 93.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 1.95 111.349 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 117' ' ' MET . 23.9 mmt180 -68.16 -31.79 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.965 0.412 . . . . 2.23 111.321 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.67 -48.53 25.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.14000000000000001 110.473 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.471 HD23 HG11 ' A' ' 52' ' ' VAL . 70.1 mt -66.42 -32.09 73.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.489 0.551 . . . . 0.27000000000000002 112.489 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -70.2 -22.16 62.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.599 -0.441 . . . . 2.79 110.978 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.706 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 56.5 mtm -77.55 -16.35 58.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 0.42999999999999999 110.613 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 43.2 t . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 121.265 0.555 . . . . 1.46 109.64 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 CA--C 1.531 0.25 0 N-CA-C 112.595 0.591 . . . . 1.6499999999999999 112.595 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.86 138.8 65.05 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.917 2.411 . . . . 0.33000000000000002 112.04 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -87.17 105.09 16.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.48 -0.563 . . . . 0.89000000000000001 109.48 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG22 ' CG1' ' A' ' 52' ' ' VAL . 50.2 t -99.88 135.34 35.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.903 -0.59 . . . . 0.20000000000000001 110.939 -174.037 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 52.1 tp -110.54 111.94 23.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.198 -0.455 . . . . 0.75 110.709 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.97 122.43 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.215 0.531 . . . . 0.13 111.467 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.19 101.27 11.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.20999999999999999 108.642 172.129 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -159.03 120.0 3.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.866 -0.606 . . . . 1.4099999999999999 109.956 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 36.8 t70 -88.41 -16.9 31.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.307 -0.406 . . . . 1.27 110.332 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.9 mt-10 -82.95 103.16 2.23 Favored Pre-proline 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 2.5600000000000001 109.421 173.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.9 Cg_exo -58.48 -29.04 87.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.667 2.244 . . . . 0.32000000000000001 113.07 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -51.28 57.21 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.682 -0.488 . . . . 1.51 109.682 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.8 mp -64.25 -43.4 97.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 1.01 110.182 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.42 -47.53 81.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.678 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.7 ttp -64.28 -39.32 93.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.516 -0.765 . . . . 0.60999999999999999 110.874 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.415 ' HB3' HG21 ' A' ' 107' ' ' THR . 60.7 m-20 -66.32 -47.04 74.82 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.969 -0.56 . . . . 1.22 111.207 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.3 mt -60.01 -45.32 93.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.039 -0.356 . . . . 0.17999999999999999 110.039 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.486 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 21.0 tt0 -52.19 -50.6 61.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 1.04 110.535 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -68.82 -31.21 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.78000000000000003 111.522 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.8 -43.09 76.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.833 0.349 . . . . 0.14000000000000001 110.838 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 50.1 m-85 -69.37 -42.68 74.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 0.13 110.881 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 43.3 mt-10 -62.51 -32.02 72.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.68999999999999995 110.24 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.31 -35.13 79.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.51000000000000001 110.818 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -83.98 6.52 21.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.65000000000000002 110.625 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 57.38 2.85 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.28999999999999998 112.485 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.27 170.48 15.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.23000000000000001 111.051 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -115.92 132.54 56.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.186 -0.672 . . . . 2.1400000000000001 109.186 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.486 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.5 t -117.12 137.29 51.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.749 0.648 . . . . 0.19 112.749 -166.833 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -110.91 135.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.464 -0.939 . . . . 0.23000000000000001 108.464 169.668 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.28 128.74 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.911 0.386 . . . . 0.94999999999999996 110.754 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.577 . . . . 0.16 110.41 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.17 -6.54 22.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.492 . . . . 0.23999999999999999 110.769 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -132.31 163.95 27.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.876 -0.602 . . . . 0.25 110.315 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.578 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 79.6 m -68.46 -33.05 73.5 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.744 -0.382 . . . . 1.6000000000000001 110.139 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.66 -39.38 84.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.69999999999999996 111.176 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -62.45 -36.67 83.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.258 0.552 . . . . 1.4099999999999999 110.473 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.75 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -67.88 -53.22 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.405 -0.816 . . . . 0.17999999999999999 111.267 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 79.0 mt -59.45 -33.2 70.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.82999999999999996 110.663 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -63.97 -49.71 71.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.936 -0.394 . . . . 2.4100000000000001 109.936 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 m -67.21 -27.04 66.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.958 -0.565 . . . . 1.1299999999999999 111.319 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.2 -35.79 69.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 1.23 111.052 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.12 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.42999999999999999 111.06 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -83.01 -28.24 29.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.86 -0.609 . . . . 0.62 111.464 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -131.66 160.2 68.5 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 110.109 -0.33 . . . . 0.41999999999999998 110.109 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -94.47 89.3 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.484 2.789 . . . . 0.23999999999999999 111.552 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.2 mm -67.78 123.29 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.655 -0.702 . . . . 0.22 111.801 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.32 -34.81 18.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 110.296 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.543 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -159.13 158.74 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.12 110.082 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.78 166.01 25.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.203 0.525 . . . . 0.14000000000000001 112.069 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.75 112.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.334 -0.848 . . . . 0.95999999999999996 109.302 176.359 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.737 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -113.58 121.86 45.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.432 0.53 . . . . 0.16 112.432 -167.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -80.49 109.96 15.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.809 0.814 . . . . 1.77 108.959 169.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.673 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 17.3 t -59.05 -19.65 16.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.353 -1.294 . . . . 0.80000000000000004 112.253 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -123.88 80.41 1.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 2.3700000000000001 110.573 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.28 -32.3 62.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.751 -0.659 . . . . 0.84999999999999998 110.01 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -169.66 28.71 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.233 -0.747 . . . . 0.81999999999999995 111.233 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.47 -37.76 96.29 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.165 2.577 . . . . 1.1799999999999999 112.599 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 62' ' ' LYS . 13.8 tmtt? -113.57 -34.31 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.695 -0.483 . . . . 3.5299999999999998 109.695 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -63.52 124.52 21.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.95999999999999996 111.65 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.94 149.8 35.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.34 -0.845 . . . . 0.48999999999999999 109.598 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.1 p -71.47 87.15 0.87 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.491 0.663 . . . . 1.3 109.257 171.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.94 -71.6 0.55 Allowed Glycine 0 CA--C 1.509 -0.303 0 C-N-CA 120.451 -0.88 . . . . 0.23000000000000001 112.045 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 52.4 Cg_exo -52.34 -25.14 23.3 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.625 2.217 . . . . 0.23999999999999999 112.064 174.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.4 t -71.74 -44.7 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.12 110.24 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.78 -49.43 77.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.281 -0.872 . . . . 0.16 110.118 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 17.5 m-20 -62.08 -40.18 94.96 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.678 -0.692 . . . . 2.0299999999999998 110.28 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.24 -50.01 74.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.279 0.562 . . . . 0.23000000000000001 111.073 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.22 -42.74 96.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.492 -0.776 . . . . 0.20000000000000001 110.312 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 64.0 mmtt -61.41 -33.48 73.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.588 -0.733 . . . . 2.0099999999999998 111.498 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 79.4 mm-40 -71.62 -37.44 70.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.16 -0.473 . . . . 2.3700000000000001 111.358 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -90.1 2.14 55.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 1.49 111.256 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 36.47 17.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.489 -0.778 . . . . 0.33000000000000002 111.205 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.06 134.06 30.78 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.072 -0.513 . . . . 0.17000000000000001 110.274 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.38 140.85 24.9 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.351 2.034 . . . . 0.20999999999999999 111.728 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 31.6 p90 -156.74 161.92 39.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 0.17999999999999999 110.662 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -125.62 140.77 47.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.364 -0.835 . . . . 0.23999999999999999 109.913 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.413 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.91 109.07 19.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.03 0.443 . . . . 0.20999999999999999 110.027 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.61 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.2 t-160 -109.43 86.11 2.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.223 0.535 . . . . 0.59999999999999998 109.798 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.597 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -126.75 160.15 31.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.341 -0.845 . . . . 0.60999999999999999 111.217 -172.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.55 16.19 52.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.082 -0.58 . . . . 0.93999999999999995 112.541 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -149.99 113.53 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.876 0.37 . . . . 2.3300000000000001 110.785 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.7 -5.03 15.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.25 -0.432 . . . . 1.6100000000000001 110.677 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ASP . . . . . 0.44 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 14.2 t70 -83.18 -53.59 5.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.126 -0.488 . . . . 2.6299999999999999 111.082 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 5.2 mpt_? -80.35 -3.4 49.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.174 0.511 . . . . 4.4199999999999999 110.852 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.546 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 96.9 m-70 -119.17 16.57 13.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.94 -0.573 . . . . 1.05 111.226 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -55.49 -44.84 85.49 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.852 -0.69 . . . . 0.97999999999999998 112.474 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 43.8 tt0 -63.28 -42.68 99.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.956 0.408 . . . . 2.5 110.669 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 57' ' ' VAL . 32.8 tp -64.09 -40.19 95.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.796 -0.638 . . . . 0.70999999999999996 110.462 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 76.6 mt -61.06 -34.88 75.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 111.338 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 65.1 mtm-85 -72.5 -26.19 61.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 4.3799999999999999 110.414 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.79 -26.47 54.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 2.4500000000000002 110.284 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.426 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 77.9 mt -83.28 -63.26 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.74 -0.664 . . . . 0.45000000000000001 110.746 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.2 t70 61.4 83.11 0.15 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.734 -0.666 . . . . 1.0900000000000001 110.622 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.38 165.11 13.28 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.694 -0.685 . . . . 0.28999999999999998 109.735 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.58 140.36 93.13 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.841 2.361 . . . . 0.26000000000000001 112.85 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.96 133.68 65.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.64000000000000001 111.357 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 83.5 mmm -121.08 92.37 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.418 -0.956 . . . . 0.82999999999999996 108.418 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.48 154.84 40.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.104 -0.498 . . . . 0.54000000000000004 111.786 -173.967 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 94.8 mttt -89.96 142.85 29.21 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.67000000000000004 109.475 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 10.8 Cg_exo -71.71 145.61 83.35 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.487 -1.464 . . . . 0.75 112.909 0.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.61 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 134.32 25.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.34999999999999998 109.965 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.572 ' O ' HG23 ' A' ' 110' ' ' VAL . 16.7 t70 -73.44 128.25 34.98 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.417 -0.586 . . . . 0.51000000000000001 109.417 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -65.64 -21.52 66.57 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 112.823 -170.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.8 t -72.9 -41.09 64.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.527 -0.545 . . . . 1.3200000000000001 109.527 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.93 -40.7 91.63 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.118 0.485 . . . . 0.62 110.056 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 106' ' ' ASP . 24.8 t -63.82 -42.5 96.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.443 -0.799 . . . . 0.13 110.375 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.64 -48.65 68.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.798 -0.637 . . . . 0.13 111.58 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -60.46 -45.56 93.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.183 -0.462 . . . . 1.95 111.453 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 34.1 mmt180 -67.49 -25.4 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 2.23 111.391 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.23 -51.47 9.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.002 0.429 . . . . 0.14000000000000001 110.43 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 HG11 ' A' ' 52' ' ' VAL . 75.4 mt -64.54 -27.54 69.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.869 0.692 . . . . 0.27000000000000002 112.869 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 9.3 pt-20 -67.44 -32.06 72.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.442 -0.503 . . . . 2.79 110.719 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.8 mtm -72.6 -29.53 63.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.42999999999999999 111.285 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 17.8 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.954 0.407 . . . . 1.46 110.757 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 109.037 -0.727 . . . . 1.6499999999999999 109.037 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 26.0 Cg_exo -62.6 134.47 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.678 2.252 . . . . 0.33000000000000002 111.799 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -87.12 107.1 18.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.388 0.614 . . . . 0.89000000000000001 109.405 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 58.7 t -99.93 130.83 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.216 -0.902 . . . . 0.20000000000000001 111.033 -172.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 50' ' ' ILE . 49.4 tp -105.61 111.24 23.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 0.75 110.357 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.37 123.36 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.13 111.422 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -103.48 106.04 16.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.21 -0.905 . . . . 0.20999999999999999 108.57 171.489 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.21 125.61 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.195 0.522 . . . . 1.4099999999999999 110.444 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 t70 -90.72 -13.8 33.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.564 -0.744 . . . . 1.27 109.895 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -89.74 104.02 7.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 2.5600000000000001 109.89 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.7 Cg_exo -59.44 -31.53 94.91 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.919 2.412 . . . . 0.32000000000000001 113.045 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.59 -49.88 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.593 -0.521 . . . . 1.51 109.593 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -67.24 -44.07 87.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 1.01 110.888 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -51.28 68.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 0.20999999999999999 110.737 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.2 ttp -61.46 -43.33 99.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.358 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.507 ' HB3' HG21 ' A' ' 107' ' ' THR . 7.1 m-20 -67.47 -39.02 85.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.341 -0.39 . . . . 1.22 111.227 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 51.4 mt -62.91 -45.78 90.92 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 110.071 -0.344 . . . . 0.17999999999999999 110.071 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.597 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 36.4 tt0 -54.31 -52.68 60.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.547 -0.752 . . . . 1.04 110.314 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -64.77 -30.34 71.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.467 -0.333 . . . . 0.78000000000000003 111.416 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.47 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.14000000000000001 110.82 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 63.7 m-85 -68.46 -41.48 80.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.13 110.682 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.11 -32.52 73.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 0.68999999999999995 110.525 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.49 -32.71 73.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.089 0.471 . . . . 0.51000000000000001 110.231 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -84.03 1.25 44.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.65000000000000002 111.167 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 50.73 3.95 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.28999999999999998 112.539 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.37 167.16 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.246 -0.279 . . . . 0.23000000000000001 110.246 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -113.44 132.3 55.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.297 -0.631 . . . . 2.1400000000000001 109.297 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.597 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 4.8 t -121.79 147.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.852 0.686 . . . . 0.19 112.852 -167.111 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 t -120.44 143.34 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.348 -0.842 . . . . 0.23000000000000001 108.793 168.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -111.85 126.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.94999999999999996 111.123 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.53 142.98 45.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.702 -0.681 . . . . 0.16 110.139 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.86 -2.92 15.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.682 0.277 . . . . 0.23999999999999999 111.402 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -136.9 169.95 16.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.52 -0.309 . . . . 0.25 111.046 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.531 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 18.6 p -59.99 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.579 . . . . 1.6000000000000001 109.536 172.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.77 -49.91 69.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.597 -1.183 . . . . 0.69999999999999996 111.813 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -59.31 -38.57 80.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.107 0.48 . . . . 1.4099999999999999 111.092 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.661 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -68.75 -51.35 42.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.694 . . . . 0.17999999999999999 111.18 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 67.3 mt -63.97 -28.19 69.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.642 -0.708 . . . . 0.82999999999999996 110.733 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -66.77 -51.28 57.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.521 . . . . 2.4100000000000001 110.123 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.3 t -65.48 -34.11 77.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 1.1299999999999999 110.907 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.411 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 14.6 tp -61.94 -33.16 73.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.232 0.539 . . . . 1.23 110.211 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.56 22.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.42999999999999999 111.065 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.35 -37.97 56.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.546 . . . . 0.62 111.108 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -123.5 159.44 55.21 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.096 -0.502 . . . . 0.41999999999999998 110.091 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -93.22 86.67 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.358 2.705 . . . . 0.23999999999999999 111.075 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.6 mm -63.94 122.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.537 -0.756 . . . . 0.22 111.485 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 43.2 m-20 -92.57 -29.97 15.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.558 -0.746 . . . . 0.28999999999999998 110.142 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.0 p -158.41 156.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.12 109.716 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.39 168.99 18.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.355 0.597 . . . . 0.14000000000000001 112.146 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.38 112.61 4.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.206 -0.906 . . . . 0.95999999999999996 109.207 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.614 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -112.81 116.91 30.81 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.531 0.567 . . . . 0.16 112.531 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.91 133.7 38.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.217 -0.66 . . . . 1.77 109.217 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.467 ' H ' ' HB ' ' A' ' 83' ' ' THR . 19.8 t -93.8 -10.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.771 -0.649 . . . . 0.80000000000000004 111.249 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -116.32 53.82 0.86 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 2.3700000000000001 110.551 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.66 -41.26 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.262 0.553 . . . . 0.84999999999999998 110.473 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.82 -172.99 29.92 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.96 -0.856 . . . . 0.81999999999999995 110.96 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.59 -43.76 52.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.827 2.351 . . . . 1.1799999999999999 112.263 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -113.42 -27.96 7.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.24 -0.436 . . . . 3.5299999999999998 110.879 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.7 m -68.54 123.95 22.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.95999999999999996 111.3 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.3 152.26 40.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.099 -0.955 . . . . 0.48999999999999999 109.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.2 p -68.76 86.31 0.33 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.406 0.622 . . . . 1.3 109.521 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.3 -66.47 0.3 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.791 -0.718 . . . . 0.23000000000000001 112.023 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.47 -28.14 53.06 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.234 1.956 . . . . 0.23999999999999999 111.541 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -71.11 -44.37 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.12 110.195 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.99 87.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.29 -0.868 . . . . 0.16 110.092 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 21.7 t70 -61.52 -43.67 98.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.359 -0.837 . . . . 2.0299999999999998 110.395 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -55.19 -49.34 72.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.836 -0.62 . . . . 0.23000000000000001 111.036 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.66 -43.39 89.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.421 -0.808 . . . . 0.20000000000000001 110.656 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 56.2 mmtt -60.65 -32.98 72.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.675 -0.693 . . . . 2.0099999999999998 111.397 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 14.4 mm100 -71.55 -33.48 69.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 2.3700000000000001 111.526 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -93.23 1.07 57.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.678 -0.237 . . . . 1.49 111.131 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.16 34.5 13.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.7 -0.682 . . . . 0.33000000000000002 111.307 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.4 mt -87.55 133.9 37.12 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.439 . . . . 0.17000000000000001 110.223 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 27.5 Cg_endo -75.36 143.37 27.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.373 2.049 . . . . 0.20999999999999999 112.051 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 28.7 p90 -159.65 159.29 32.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.748 -0.66 . . . . 0.17999999999999999 110.462 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -124.0 139.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.408 -0.815 . . . . 0.23999999999999999 109.728 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mm? -88.43 109.69 20.22 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.451 -0.574 . . . . 0.20999999999999999 109.451 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.618 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 19.7 t-160 -102.25 90.88 4.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.987 -0.552 . . . . 0.59999999999999998 109.732 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 9.3 t -139.63 160.98 38.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.364 -0.835 . . . . 0.60999999999999999 110.409 -174.109 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.07 9.47 20.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.89 -0.671 . . . . 0.93999999999999995 111.82 175.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.62 60.26 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.195 0.521 . . . . 2.3300000000000001 110.822 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.68 -41.39 79.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.566 -0.743 . . . . 1.6100000000000001 110.08 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.3 -20.14 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.603 -0.726 . . . . 2.6299999999999999 111.371 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 3.6 tpm_? -90.56 -22.07 21.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 4.4199999999999999 110.761 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.499 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.1 m-70 -126.01 28.86 6.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 1.05 111.637 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -58.17 -37.99 88.32 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.119 -0.562 . . . . 0.97999999999999998 112.602 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.0 -46.01 75.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.855 0.36 . . . . 2.5 110.699 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD23 ' CG1' ' A' ' 57' ' ' VAL . 56.8 tp -60.89 -39.66 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.70999999999999996 110.501 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.9 mt -61.78 -32.77 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.5800000000000001 111.067 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -72.53 -38.54 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.88 0.372 . . . . 4.3799999999999999 110.297 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.91 -42.26 89.22 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.532 0.682 . . . . 2.4500000000000002 110.233 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.497 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 84.7 mt -72.07 -58.79 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.892 -1.049 . . . . 0.45000000000000001 111.067 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.3 t70 62.54 82.07 0.19 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.618 0.723 . . . . 1.0900000000000001 111.093 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.413 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -163.45 162.09 17.48 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.28999999999999998 108.986 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -58.27 146.25 89.88 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.57 2.18 . . . . 0.26000000000000001 112.528 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.7 t -123.05 132.4 71.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.64000000000000001 111.028 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.6 mmm -113.87 106.25 14.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.82999999999999996 109.129 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.03 146.35 53.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.984 -0.553 . . . . 0.54000000000000004 111.938 -174.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.6 mttt -91.59 145.11 30.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.827 -0.624 . . . . 0.67000000000000004 110.204 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.22 142.61 75.04 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 123.572 -1.428 . . . . 0.75 112.422 -0.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.618 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -133.08 135.44 45.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.867 -0.606 . . . . 0.34999999999999998 109.806 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.4 t0 -70.38 127.31 32.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.287 -1.005 . . . . 0.51000000000000001 108.287 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.507 HG21 ' HB3' ' A' ' 20' ' ' ASN . 22.9 p -63.22 -20.5 65.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.348 -0.842 . . . . 0.26000000000000001 112.646 -172.272 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -70.53 -40.29 73.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.3200000000000001 109.943 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.34 -39.56 81.85 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.62 109.903 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.6 t -65.15 -45.31 94.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.13 110.09 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.14 -50.42 71.95 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.685 -0.689 . . . . 0.13 111.374 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 67.9 mttm -57.42 -51.5 69.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 1.95 111.304 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -61.26 -39.46 90.44 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.112 0.257 . . . . 2.23 111.686 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.94 79.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.14000000000000001 110.172 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 HG11 ' A' ' 52' ' ' VAL . 85.1 mt -67.02 -25.34 66.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.27000000000000002 111.768 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 36.7 mm-40 -60.79 -38.47 85.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.986 0.422 . . . . 2.79 110.692 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.518 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.4 mtm -79.59 -10.66 59.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.42999999999999999 110.717 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 36.7 t . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 1.46 110.202 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 16.7 mmt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.807 -0.442 . . . . 1.6499999999999999 109.807 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.4 Cg_endo -68.06 135.68 35.54 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.609 1.539 . . . . 0.33000000000000002 110.635 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 34.1 tptt -84.63 104.53 14.69 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.724 -0.472 . . . . 0.89000000000000001 109.724 -178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 52' ' ' VAL . 46.7 t -100.14 128.97 51.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.84 -0.618 . . . . 0.20000000000000001 110.978 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.436 ' HB2' HD12 ' A' ' 50' ' ' ILE . 50.5 tp -107.43 119.01 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.451 -0.34 . . . . 0.75 110.462 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 54' ' ' VAL . 44.5 t -100.17 124.93 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.149 0.5 . . . . 0.13 111.43 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -104.51 106.41 16.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.284 -0.871 . . . . 0.20999999999999999 109.013 172.841 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -167.3 128.95 1.59 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.975 -0.557 . . . . 1.4099999999999999 109.687 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.5 t70 -84.58 -28.88 26.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 1.27 109.661 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HB3' HD13 ' A' ' 17' ' ' ILE . 1.2 mp0 -74.07 109.55 7.15 Favored Pre-proline 0 N--CA 1.462 0.147 0 CA-C-N 116.249 -0.432 . . . . 2.5600000000000001 110.583 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.6 Cg_exo -60.39 -29.59 89.11 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.527 2.151 . . . . 0.32000000000000001 112.733 -178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -52.47 42.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.059 -0.349 . . . . 1.51 110.059 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.5 mp -62.69 -42.6 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 1.01 109.927 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.09 71.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.502 -0.772 . . . . 0.20999999999999999 110.832 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.497 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 47.6 ttp -65.05 -38.37 90.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.60999999999999999 111.202 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.447 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.3 m-20 -64.82 -44.07 91.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.047 -0.524 . . . . 1.22 110.982 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 39.3 mt -61.91 -44.99 95.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.437 -0.347 . . . . 0.17999999999999999 110.253 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.623 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 43.4 tt0 -53.44 -51.18 63.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.633 -0.712 . . . . 1.04 110.815 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -63.43 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.78000000000000003 111.33 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.19 78.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.306 -0.406 . . . . 0.14000000000000001 110.95 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 57.0 m-85 -71.19 -42.09 69.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.422 . . . . 0.13 110.874 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 46.0 mt-10 -65.4 -28.24 69.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.996 0.427 . . . . 0.68999999999999995 110.079 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.8 -32.18 70.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.51000000000000001 110.616 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -83.97 -2.5 56.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.227 0.537 . . . . 0.65000000000000002 110.461 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 62.76 1.61 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.601 -0.727 . . . . 0.28999999999999998 111.998 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -145.32 172.16 13.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 0.23000000000000001 111.359 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -114.57 137.24 52.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.938 -0.573 . . . . 2.1400000000000001 109.612 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 5.1 t -120.19 146.91 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 0.19 111.913 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.438 HG11 ' OG ' ' A' ' 44' ' ' SER . 24.1 t -119.6 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.23000000000000001 108.919 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t -97.24 124.72 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.94999999999999996 110.885 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.59 134.64 41.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.007 -0.542 . . . . 0.16 110.415 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.48 -11.02 20.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.97 0.414 . . . . 0.23999999999999999 110.792 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.3 p -129.87 160.77 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 0.25 110.732 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.594 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.1 m -63.92 -35.5 80.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.736 -0.468 . . . . 1.6000000000000001 109.736 174.366 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.0 -47.87 84.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.69999999999999996 111.19 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -59.01 -41.24 87.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.642 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.675 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.36 -51.77 64.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.274 -0.875 . . . . 0.17999999999999999 111.444 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.9 mt -62.24 -32.23 72.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.067 -0.515 . . . . 0.82999999999999996 110.894 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.27 -50.64 69.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 2.4100000000000001 110.219 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.438 ' OG ' HG11 ' A' ' 33' ' ' VAL . 23.2 t -68.5 -35.07 76.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 1.1299999999999999 110.551 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -57.3 -39.67 76.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.23 109.817 177.613 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.82 30.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.42999999999999999 111.408 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.84 -38.34 58.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.998 0.428 . . . . 0.62 111.777 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -114.48 163.94 17.83 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.41999999999999998 110.758 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -96.0 76.01 0.13 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.494 2.796 . . . . 0.23999999999999999 111.341 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.2 mm -56.78 120.24 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.228 -0.896 . . . . 0.22 111.725 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.793 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 16.8 m-20 -90.09 -31.19 17.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.372 -0.831 . . . . 0.28999999999999998 110.629 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -160.34 156.7 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.12 109.914 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.81 160.92 39.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.46 0.648 . . . . 0.14000000000000001 112.168 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -133.07 112.04 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.95999999999999996 109.243 174.782 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.689 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -111.78 117.73 33.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.986 0.422 . . . . 0.16 112.039 -170.026 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.87 129.96 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.839 -0.8 . . . . 1.77 108.839 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' H ' ' HB ' ' A' ' 83' ' ' THR . 61.8 t -88.97 -35.72 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.139 -0.482 . . . . 0.80000000000000004 111.475 -171.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.68 60.66 4.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.072 0.463 . . . . 2.3700000000000001 111.382 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.362 0.601 . . . . 0.84999999999999998 110.148 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.69 -171.58 32.05 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.65 -0.98 . . . . 0.81999999999999995 110.65 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.11 -36.83 96.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.856 2.371 . . . . 1.1799999999999999 113.104 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -127.24 -21.76 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 3.5299999999999998 111.557 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 p -73.54 126.41 30.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.483 0.658 . . . . 0.95999999999999996 110.709 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -144.93 155.09 43.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 110.301 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.5 p -69.49 87.27 0.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.488 -0.56 . . . . 1.3 109.488 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.78 -69.88 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.504 -0.855 . . . . 0.23000000000000001 112.499 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.522 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 50.9 Cg_exo -51.47 -27.51 24.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.8 2.333 . . . . 0.23999999999999999 111.979 175.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.502 HG11 ' CD2' ' A' ' 11' ' ' LEU . 14.3 t -69.28 -44.75 80.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 0.12 110.042 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.55 93.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.143 -0.935 . . . . 0.16 110.156 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 37.8 m-20 -64.12 -42.07 96.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.447 . . . . 2.0299999999999998 110.345 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.54 -46.81 70.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.389 0.614 . . . . 0.23000000000000001 110.881 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.66 -46.72 71.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.023 -0.989 . . . . 0.20000000000000001 110.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -56.53 -36.02 68.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.515 -0.766 . . . . 2.0099999999999998 111.849 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.1 mt-30 -61.42 -44.39 97.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 2.3700000000000001 111.696 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -94.59 7.14 46.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.569 -0.287 . . . . 1.49 111.214 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.14 34.79 21.18 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.626 . . . . 0.33000000000000002 111.264 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.79 133.38 55.35 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.17000000000000001 109.984 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 13.3 Cg_endo -73.81 137.02 23.97 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.117 1.878 . . . . 0.20999999999999999 111.423 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -156.49 158.85 37.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.937 -0.574 . . . . 0.17999999999999999 110.617 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.0 mt -124.24 140.9 46.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.21 -0.904 . . . . 0.23999999999999999 109.795 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.97 107.94 19.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.041 -0.725 . . . . 0.20999999999999999 109.041 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.7 t-160 -101.61 78.95 1.89 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.995 -0.742 . . . . 0.59999999999999998 108.995 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.485 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 4.7 t -118.32 158.76 24.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.788 -1.096 . . . . 0.60999999999999999 110.915 -171.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.36 -1.35 55.66 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.012 -0.613 . . . . 0.93999999999999995 111.883 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.95 120.45 26.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.771 0.32 . . . . 2.3300000000000001 110.783 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HA ' HD11 ' A' ' 93' ' ' LEU . 7.1 mp -114.38 -6.85 12.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 1.6100000000000001 109.904 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -84.39 -60.92 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 2.6299999999999999 111.387 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -40.24 78.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.092 0.472 . . . . 4.4199999999999999 110.421 -174.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.407 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 97.3 m-70 -92.27 22.4 4.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.211 -0.449 . . . . 1.05 111.256 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.55 -41.83 98.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.121 -0.561 . . . . 0.97999999999999998 112.698 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.06 -45.8 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 2.5 110.678 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.26 -44.24 92.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.70999999999999996 110.472 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 86' ' ' LEU . 63.2 mt -61.97 -31.48 71.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.838 -0.619 . . . . 1.5800000000000001 111.239 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 25.4 mtm180 -70.55 -32.6 70.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.4 -0.364 . . . . 4.3799999999999999 110.622 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.05 -39.4 50.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.997 -0.547 . . . . 2.4500000000000002 110.375 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.92 -52.89 43.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.612 -0.722 . . . . 0.45000000000000001 110.014 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.74 74.36 0.41 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.593 -0.73 . . . . 1.0900000000000001 110.952 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -153.13 163.79 22.44 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.152 -0.931 . . . . 0.28999999999999998 109.22 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.697 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 66.3 Cg_exo -54.96 141.08 79.27 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.491 2.127 . . . . 0.26000000000000001 112.768 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.56 140.26 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.806 -0.633 . . . . 0.64000000000000001 110.621 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.3 mmm -121.32 95.32 4.64 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 0.82999999999999996 108.887 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.3 147.07 52.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.953 -0.567 . . . . 0.54000000000000004 111.466 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 85.9 mttt -91.17 147.0 34.64 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.708 . . . . 0.67000000000000004 110.434 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.6 Cg_exo -73.05 152.25 98.06 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.483 -1.466 . . . . 0.75 112.459 1.565 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.617 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -148.57 129.34 14.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.34999999999999998 110.511 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 110' ' ' VAL . 16.4 t70 -66.28 128.96 38.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.51000000000000001 109.143 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.447 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.4 p -64.83 -24.7 67.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.59 -0.732 . . . . 0.26000000000000001 112.581 -170.498 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 32.3 t -68.13 -40.91 82.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.651 -0.5 . . . . 1.3200000000000001 109.651 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -40.76 92.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.076 0.465 . . . . 0.62 110.097 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 106' ' ' ASP . 22.0 t -64.36 -42.57 95.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.579 -0.737 . . . . 0.13 110.475 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.34 -48.5 72.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.727 -0.67 . . . . 0.13 111.349 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 108' ' ' SER . 99.0 mttt -60.39 -46.48 89.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 1.95 110.887 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.3 mmt180 -62.4 -28.55 69.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.126 -0.488 . . . . 2.23 111.309 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.37 -51.65 9.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.14000000000000001 110.576 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 52' ' ' VAL . 88.3 mt -65.41 -29.35 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.493 0.553 . . . . 0.27000000000000002 112.493 -176.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.511 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.3 pt-20 -67.44 -25.8 66.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.8 0.333 . . . . 2.79 111.255 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.697 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 43.5 mtm -81.53 -14.54 56.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.019 0.438 . . . . 0.42999999999999999 110.711 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 46.9 t . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 115.897 -0.592 . . . . 1.46 111.609 -174.148 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 7.2 ptm . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 109.737 -0.468 . . . . 1.6499999999999999 109.737 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 1.6 Cg_endo -73.01 143.96 37.22 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.271 1.981 . . . . 0.33000000000000002 112.426 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 34.5 tptt -90.23 105.54 17.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.738 -0.665 . . . . 0.89000000000000001 109.271 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.7 t -100.61 137.61 27.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.138 -0.483 . . . . 0.20000000000000001 111.153 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.637 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.2 tm? -115.66 110.76 19.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.75 109.906 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.04 128.83 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.235 0.54 . . . . 0.13 111.039 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -108.12 100.8 10.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.197 -0.91 . . . . 0.20999999999999999 108.884 175.852 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -164.17 134.77 4.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.172 0.51 . . . . 1.4099999999999999 110.101 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -97.16 -23.83 16.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.468 -0.787 . . . . 1.27 109.993 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.0 mt-10 -76.03 108.15 5.61 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.658 -0.497 . . . . 2.5600000000000001 109.658 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 14' ' ' GLU . 32.2 Cg_exo -57.48 -35.84 98.8 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 123.073 2.515 . . . . 0.32000000000000001 113.537 -171.774 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 16' ' ' LEU . 4.7 tt -65.0 -50.85 64.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.813 -0.44 . . . . 1.51 109.813 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -62.02 -46.97 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.498 . . . . 1.01 109.814 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.239 -0.891 . . . . 0.20999999999999999 110.824 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.429 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 38.2 ttp -63.41 -44.86 93.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.60999999999999999 111.083 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.57 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.7 t-20 -65.28 -42.56 93.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 1.22 110.425 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.5 mt -64.39 -43.48 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.17999999999999999 110.227 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 48.4 tt0 -53.22 -50.57 64.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.663 -0.699 . . . . 1.04 110.318 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 14.4 m-85 -63.18 -34.96 78.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.78000000000000003 111.206 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.53 71.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.919 0.39 . . . . 0.14000000000000001 110.656 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 55.0 m-85 -66.96 -41.9 86.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.123 -0.49 . . . . 0.13 110.613 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.75 -36.8 79.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.68999999999999995 110.632 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.73 -33.22 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.51000000000000001 110.835 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -80.41 -1.41 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.65000000000000002 110.531 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.15 50.48 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 116.004 -0.544 . . . . 0.28999999999999998 112.414 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.74 158.99 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.323 . . . . 0.23000000000000001 110.783 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.46 138.81 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.988 -0.745 . . . . 2.1400000000000001 108.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.497 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.4 t -120.86 132.14 71.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.482 . . . . 0.19 111.988 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.38 136.1 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.23000000000000001 108.338 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.1 t -111.02 123.97 67.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.631 -0.428 . . . . 0.94999999999999996 111.002 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.26 134.92 50.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.867 -0.606 . . . . 0.16 110.338 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.48 -11.85 18.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.998 0.428 . . . . 0.23999999999999999 111.147 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.9 p -128.83 173.39 10.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.169 -0.468 . . . . 0.25 110.227 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 75.5 m -73.63 -32.08 63.86 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.598 . . . . 1.6000000000000001 109.387 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.13 -51.04 70.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.913 -0.585 . . . . 0.69999999999999996 110.912 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -55.89 -42.13 75.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.864 -0.607 . . . . 1.4099999999999999 110.7 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -62.66 -52.93 61.38 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.434 -0.803 . . . . 0.17999999999999999 111.278 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.6 mt -59.43 -29.16 67.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.961 -0.563 . . . . 0.82999999999999996 110.942 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.1 tmtp? -65.6 -55.7 16.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.773 -0.454 . . . . 2.4100000000000001 109.773 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.9 t -64.55 -35.26 80.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 1.1299999999999999 110.55 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.446 HD11 HD23 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.937 -0.574 . . . . 1.23 110.984 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.55 -38.17 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.42999999999999999 111.237 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.19 -37.65 61.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.883 -0.598 . . . . 0.62 111.598 -175.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.44 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 43.9 m-80 -120.09 165.22 18.64 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 111.214 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -95.45 86.15 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.625 2.883 . . . . 0.23999999999999999 111.466 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -65.07 118.37 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.329 -0.85 . . . . 0.22 111.258 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -84.27 -32.38 24.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.28999999999999998 110.23 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 115' ' ' LEU . 14.3 p -158.65 154.02 5.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.928 -0.578 . . . . 0.12 110.2 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 162.57 33.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.515 0.674 . . . . 0.14000000000000001 111.61 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.445 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -135.14 111.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.739 -0.837 . . . . 0.95999999999999996 108.739 176.012 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.42 ' HA ' ' CB ' ' A' ' 11' ' ' LEU . 10.5 mp -106.42 98.42 8.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.268 0.556 . . . . 0.16 111.084 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.871 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -76.14 93.35 3.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.079 -0.964 . . . . 1.77 109.448 174.077 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.1 t -54.29 -25.94 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.971 -1.013 . . . . 0.80000000000000004 111.945 -172.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -79.01 68.9 5.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.076 -0.511 . . . . 2.3700000000000001 111.456 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 -32.65 22.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.176 0.513 . . . . 0.84999999999999998 110.311 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.39 -174.02 40.1 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.678 -0.692 . . . . 0.81999999999999995 111.599 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.51 -35.13 96.51 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.076 2.517 . . . . 1.1799999999999999 112.741 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -123.4 -29.42 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.933 -0.576 . . . . 3.5299999999999998 110.253 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.7 m -64.97 125.67 25.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.95999999999999996 111.656 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -144.57 154.78 43.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 0.48999999999999999 110.079 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.459 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -78.7 87.85 4.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.297 -0.631 . . . . 1.3 109.297 174.737 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.21 -72.66 0.87 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.689 -0.767 . . . . 0.23000000000000001 112.363 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.3 Cg_exo -52.82 -24.58 24.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.83 2.353 . . . . 0.23999999999999999 112.331 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 11' ' ' LEU . 30.3 t -64.42 -40.08 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.542 0.687 . . . . 0.12 110.014 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.58 -41.93 98.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.854 -1.067 . . . . 0.16 110.159 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.12 -47.18 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.81 -0.632 . . . . 2.0299999999999998 109.972 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -50.3 -49.93 52.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.605 0.716 . . . . 0.23000000000000001 110.848 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.446 HD23 HD11 ' A' ' 45' ' ' LEU . 97.6 mt -66.12 -47.83 72.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.045 -0.98 . . . . 0.20000000000000001 111.015 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -59.13 -34.52 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.583 . . . . 2.0099999999999998 111.787 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -69.43 -34.68 74.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.316 -0.402 . . . . 2.3700000000000001 111.347 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 75' ' ' ARG . 55.5 mtt180 -95.71 7.53 46.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 1.49 111.077 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.06 34.11 23.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.694 -0.685 . . . . 0.33000000000000002 111.563 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.41 132.67 38.43 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.489 -0.323 . . . . 0.17000000000000001 110.295 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.16 139.77 24.26 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.59 2.193 . . . . 0.20999999999999999 112.2 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 39.2 p90 -155.42 156.91 36.18 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.726 -0.67 . . . . 0.17999999999999999 110.402 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -117.84 138.39 48.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.404 -0.816 . . . . 0.23999999999999999 109.401 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 98' ' ' ALA . 2.1 mm? -88.78 107.96 19.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.492 -0.929 . . . . 0.20999999999999999 108.492 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.871 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 11.7 t-160 -101.34 123.16 44.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.41 -0.959 . . . . 0.59999999999999998 108.41 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 5.4 t -163.12 144.0 9.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.073 -0.651 . . . . 0.60999999999999999 111.947 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 103' ' ' LYS . . . -89.68 -6.77 69.77 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.93999999999999995 111.398 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 88' ' ' ARG . 9.7 t70 -112.57 114.72 27.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.564 -0.532 . . . . 2.3300000000000001 109.564 177.165 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 102' ' ' ALA . 80.7 mt -115.53 -17.93 11.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.343 -0.39 . . . . 1.6100000000000001 111.268 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -85.76 -52.01 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.88 -0.328 . . . . 2.6299999999999999 111.464 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -67.69 -33.2 74.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.03 0.443 . . . . 4.4199999999999999 110.382 -177.761 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.569 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 93.0 m-70 -102.11 16.51 25.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.273 -0.421 . . . . 1.05 111.347 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -60.52 -49.94 73.11 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.943 -0.646 . . . . 0.97999999999999998 113.056 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 3.1 mp0 -60.55 -40.59 92.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.078 -0.341 . . . . 2.5 110.078 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 tp -60.17 -43.35 95.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.931 -0.577 . . . . 0.70999999999999996 110.892 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 67.6 mt -57.87 -37.39 73.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.5800000000000001 110.893 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.412 ' NH2' ' HG3' ' A' ' 91' ' ' GLU . 48.3 mtm105 -78.43 -26.9 46.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 4.3799999999999999 111.225 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 96.7 mttt -69.11 -39.21 79.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.448 0.642 . . . . 2.4500000000000002 109.826 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.431 HG23 ' HB1' ' A' ' 69' ' ' ALA . 95.8 mt -69.09 -54.12 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.008 -0.997 . . . . 0.45000000000000001 110.621 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 64.74 78.8 0.27 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.686 0.755 . . . . 1.0900000000000001 111.206 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.427 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -162.01 169.29 9.64 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.942 -1.026 . . . . 0.28999999999999998 108.721 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.468 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 32.3 Cg_exo -58.45 137.27 79.45 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.164 1.91 . . . . 0.26000000000000001 112.331 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.5 t -119.78 130.71 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.64000000000000001 110.757 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 91.9 mtp -115.89 124.2 50.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.574 . . . . 0.82999999999999996 109.449 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -82.5 152.88 25.86 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.238 -0.437 . . . . 0.54000000000000004 111.201 -175.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.742 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 89.7 mttt -91.27 141.8 26.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.704 -0.48 . . . . 0.67000000000000004 109.704 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.27 153.5 97.25 Favored 'Cis proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.074 -1.636 . . . . 0.75 112.788 1.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.6 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -145.45 130.73 18.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.34999999999999998 109.461 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 110' ' ' VAL . 15.5 t70 -67.11 127.62 33.31 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.974 -0.75 . . . . 0.51000000000000001 108.974 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.57 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.0 p -63.57 -25.12 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.777 . . . . 0.26000000000000001 112.269 -170.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.4 t -70.95 -36.53 72.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.565 -0.532 . . . . 1.3200000000000001 109.565 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 106' ' ' ASP . 15.4 m-20 -66.54 -46.2 76.89 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.512 -0.551 . . . . 0.62 109.512 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.509 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.3 t -60.14 -41.22 85.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 0.13 110.472 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.669 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.29 -51.4 60.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.566 -0.743 . . . . 0.13 111.446 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.67 -38.72 90.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.244 -0.434 . . . . 1.95 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.9 mmt180 -66.83 -28.64 68.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.43 . . . . 2.23 111.432 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -47.17 16.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.08 0.467 . . . . 0.14000000000000001 110.108 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.583 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 78.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.935 0.717 . . . . 0.27000000000000002 112.935 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.52 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.4 pt-20 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 2.79 110.677 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.468 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 63.5 mtm -76.09 -29.48 57.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.277 -0.42 . . . . 0.42999999999999999 111.352 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 10.7 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 121.027 0.441 . . . . 1.46 110.192 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.447 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 18.3 mmt . . . . . 0 C--O 1.234 0.281 0 N-CA-C 110.541 -0.17 . . . . 1.6499999999999999 110.541 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 27.4 Cg_exo -62.64 132.22 36.83 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.306 2.004 . . . . 0.33000000000000002 110.881 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -86.68 103.31 15.03 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.399 -0.593 . . . . 0.89000000000000001 109.399 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.6 t -99.49 128.31 51.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.549 -0.75 . . . . 0.20000000000000001 110.616 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.568 ' HB2' HD12 ' A' ' 50' ' ' ILE . 55.2 tp -104.33 115.39 30.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.802 0.335 . . . . 0.75 111.034 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.43 122.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.294 0.569 . . . . 0.13 111.324 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.648 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 1.5 mm? -101.65 118.98 38.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.549 -1.278 . . . . 0.20999999999999999 107.549 169.429 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.746 ' CD ' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -161.43 158.43 26.7 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.952 -0.299 . . . . 1.4099999999999999 110.368 -174.328 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.44 -5.36 8.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.904 0.383 . . . . 1.27 110.635 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 42.2 mm-40 -109.82 103.18 52.7 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 2.5600000000000001 110.574 175.444 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.29 -26.85 72.42 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.058 2.506 . . . . 0.32000000000000001 113.235 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.58 -47.59 72.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.968 -0.753 . . . . 1.51 108.968 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.59 -46.22 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.371 -0.831 . . . . 1.01 111.005 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . 0.746 ' HB2' ' CD ' ' A' ' 12' ' ' GLU . . . -56.17 -49.84 72.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.285 -0.416 . . . . 0.20999999999999999 111.053 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.6 ttp -55.96 -42.4 76.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.588 -0.733 . . . . 0.60999999999999999 110.695 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.537 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.8 m-80 -68.95 -42.54 76.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 1.22 111.412 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.68 -44.96 88.65 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.611 0.243 . . . . 0.17999999999999999 110.538 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.487 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -55.65 -50.73 69.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.941 -0.572 . . . . 1.04 109.991 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.4 -27.75 66.49 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.78000000000000003 111.363 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.08 -49.12 60.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.869 0.366 . . . . 0.14000000000000001 110.527 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -66.26 -43.45 86.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.13 110.867 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 30.9 mt-10 -65.38 -28.6 69.39 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.936 -0.306 . . . . 0.68999999999999995 110.635 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.58 -32.96 66.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.51000000000000001 110.593 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -77.78 -20.16 53.8 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.042 0.449 . . . . 0.65000000000000002 110.417 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.46 62.24 0.63 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.575 -0.739 . . . . 0.28999999999999998 112.377 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -148.71 177.28 9.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.799 0.333 . . . . 0.23000000000000001 111.255 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 129.36 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.388 -0.597 . . . . 2.1400000000000001 109.388 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.487 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 15.1 t -115.04 135.55 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.584 0.587 . . . . 0.19 112.584 -167.31 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' OG ' ' A' ' 44' ' ' SER . 41.6 t -105.44 141.92 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.825 -0.806 . . . . 0.23000000000000001 108.825 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.2 t -112.74 126.01 70.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.537 0.208 . . . . 0.94999999999999996 110.709 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.49 134.77 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.16 111.047 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' GLU . . . -97.64 -22.67 16.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.282 0.563 . . . . 0.23999999999999999 111.082 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.3 p -117.31 159.76 22.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.856 -0.611 . . . . 0.25 110.668 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 m -64.36 -31.27 72.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.293 -0.632 . . . . 1.6000000000000001 109.293 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.52 -52.88 63.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 0.69999999999999996 110.96 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -57.79 -39.87 78.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.263 0.554 . . . . 1.4099999999999999 110.954 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -65.59 -50.49 64.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.374 -0.83 . . . . 0.17999999999999999 111.333 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.2 mt -63.47 -30.4 71.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.137 -0.483 . . . . 0.82999999999999996 111.08 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -66.76 -48.21 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.124 0.488 . . . . 2.4100000000000001 109.686 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.412 ' OG ' HG11 ' A' ' 33' ' ' VAL . 8.3 t -66.09 -33.48 75.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 1.1299999999999999 110.452 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -39.08 78.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.272 0.558 . . . . 1.23 110.135 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.65 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.831 -0.622 . . . . 0.42999999999999999 111.563 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.55 -36.51 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.62 111.355 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -118.12 163.65 23.84 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.218 -0.447 . . . . 0.41999999999999998 110.615 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -96.88 85.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 123.6 2.866 . . . . 0.23999999999999999 111.302 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.3 mm -62.32 119.95 7.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 0.22 111.552 -175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 23.2 m-20 -89.2 -30.52 18.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.675 -0.693 . . . . 0.28999999999999998 110.629 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.5 p -163.83 156.34 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.693 -0.685 . . . . 0.12 109.285 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.29 160.17 40.56 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.557 0.694 . . . . 0.14000000000000001 112.291 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -132.0 112.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.838 -1.074 . . . . 0.95999999999999996 109.124 175.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.814 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.7 mp -109.72 104.63 13.65 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.095 0.474 . . . . 0.16 111.943 -170.403 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.832 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -71.64 93.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.39 -0.823 . . . . 1.77 109.232 172.271 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 40.9 t -58.63 -27.41 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.552 . . . . 0.80000000000000004 111.499 -175.521 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.406 HD22 ' C ' ' A' ' 58' ' ' ASN . 0.3 OUTLIER -80.43 51.97 1.54 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.761 -0.654 . . . . 2.3700000000000001 112.397 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt -70.11 -24.48 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.84999999999999998 110.475 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.07 -178.12 46.05 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.97 -0.852 . . . . 0.81999999999999995 110.97 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.64 -36.13 97.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.613 2.209 . . . . 1.1799999999999999 112.015 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -114.51 -34.39 5.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 3.5299999999999998 110.122 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.0 m -65.64 125.81 26.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.899 -0.591 . . . . 0.95999999999999996 111.163 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -146.54 151.18 36.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.886 -0.597 . . . . 0.48999999999999999 110.812 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -74.89 87.34 2.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.916 -0.772 . . . . 1.3 108.916 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.83 -70.34 0.61 Allowed Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.369 -0.919 . . . . 0.23000000000000001 112.472 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.2 Cg_exo -52.62 -23.53 20.04 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.604 2.203 . . . . 0.23999999999999999 112.049 175.153 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 11' ' ' LEU . 24.5 t -70.3 -45.22 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.12 110.123 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.67 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.162 -0.926 . . . . 0.16 110.104 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 31.1 m-20 -63.53 -40.17 96.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.667 . . . . 2.0299999999999998 110.175 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.39 -49.17 75.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.512 0.672 . . . . 0.23000000000000001 110.601 176.59 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.58 -40.59 92.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.105 -0.952 . . . . 0.20000000000000001 110.526 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 73' ' ' LYS . 16.3 mmmt -59.29 -38.56 80.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.572 -0.74 . . . . 2.0099999999999998 111.157 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 80.5 mm-40 -62.3 -45.6 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 2.3700000000000001 111.487 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -92.95 7.51 43.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 1.49 111.391 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.79 24.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.33000000000000002 111.427 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.64 134.43 50.83 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.552 -0.536 . . . . 0.17000000000000001 109.552 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 15.2 Cg_endo -73.25 139.52 29.37 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.076 1.851 . . . . 0.20999999999999999 111.406 177.846 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -160.82 156.66 25.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.054 -0.521 . . . . 0.17999999999999999 110.385 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -123.42 141.05 45.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.403 -0.817 . . . . 0.23999999999999999 109.881 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 96' ' ' ILE . 2.0 mm? -88.79 108.78 19.69 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.097 -0.705 . . . . 0.20999999999999999 109.097 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.832 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 15.1 t-160 -101.27 104.66 15.69 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.128 -0.693 . . . . 0.59999999999999998 109.128 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 4.3 t -151.85 151.86 31.86 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.32 -0.552 . . . . 0.60999999999999999 111.679 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.17 9.13 63.16 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.551 -0.75 . . . . 0.93999999999999995 111.471 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -149.89 122.33 8.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.853 0.358 . . . . 2.3300000000000001 111.429 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.615 HD12 HD21 ' A' ' 93' ' ' LEU . 3.2 mm? -118.68 7.66 11.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.386 -0.598 . . . . 1.6100000000000001 109.386 172.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -85.04 -54.62 4.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 111.566 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 8.0 mpt_? -77.47 -11.83 59.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.4199999999999999 111.113 -173.745 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -125.26 26.03 6.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 1.05 109.794 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.492 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -60.96 -38.61 95.74 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.97999999999999998 113.447 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.8 -25.87 68.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 2.5 110.709 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.68 -42.48 86.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.908 -0.587 . . . . 0.70999999999999996 110.85 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.615 HD21 HD12 ' A' ' 86' ' ' LEU . 2.3 mm? -60.41 -26.92 67.05 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.441 -0.345 . . . . 1.5800000000000001 111.108 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -66.66 -33.2 75.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 4.3799999999999999 111.026 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.42 -27.45 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 2.4500000000000002 110.287 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 81' ' ' LEU . 62.2 mt -79.74 -63.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.447 -0.797 . . . . 0.45000000000000001 111.115 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.0 t70 55.87 74.15 0.4 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.743 0.782 . . . . 1.0900000000000001 110.788 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.77 165.82 16.68 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.141 -0.936 . . . . 0.28999999999999998 109.225 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.52 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 43.4 Cg_exo -59.16 141.25 97.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.535 2.156 . . . . 0.26000000000000001 112.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.13 121.01 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.039 -0.528 . . . . 0.64000000000000001 111.16 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.444 ' O ' ' HD2' ' A' ' 82' ' ' HIS . 73.9 mmm -102.41 99.02 9.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.151 -0.685 . . . . 0.82999999999999996 109.151 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -74.97 159.5 31.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.169 -0.468 . . . . 0.54000000000000004 111.04 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 98.3 mttt -93.1 153.35 41.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.782 -0.644 . . . . 0.67000000000000004 110.469 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 15.5 Cg_exo -69.18 136.07 35.77 Favored 'Cis proline' 0 C--N 1.343 0.237 0 C-N-CA 123.648 -1.397 . . . . 0.75 112.328 -1.666 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.668 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -128.69 133.53 48.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.34999999999999998 110.038 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 110' ' ' VAL . 17.1 t70 -78.54 129.67 35.1 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 0.51000000000000001 108.616 176.628 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.537 HG21 ' HB3' ' A' ' 20' ' ' ASN . 19.9 p -64.11 -22.39 66.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.696 -0.683 . . . . 0.26000000000000001 112.236 -172.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 t -70.98 -40.68 71.77 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.452 -0.573 . . . . 1.3200000000000001 109.452 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.56 -44.27 91.27 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.149 -0.478 . . . . 0.62 109.967 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.7 t -61.62 -44.32 98.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.355 -0.839 . . . . 0.13 110.396 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.67 -51.43 67.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.749 -0.66 . . . . 0.13 111.215 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.7 mtpt -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 1.95 110.735 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -55.38 -40.03 70.84 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.314 0.384 . . . . 2.23 111.452 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.4 63.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.14000000000000001 110.845 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.41 -25.87 66.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.27000000000000002 111.988 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 mm-40 -57.18 -47.72 80.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.958 0.409 . . . . 2.79 110.395 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.52 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 52.8 mtm -72.34 -28.5 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.42999999999999999 110.718 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 50.5 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.809 -0.632 . . . . 1.46 110.493 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 56.6 mtt . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.506 0.193 . . . . 1.6499999999999999 110.798 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.545 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.0 Cg_exo -63.25 138.26 65.57 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.801 2.334 . . . . 0.33000000000000002 111.411 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -88.53 105.43 17.63 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.754 -0.461 . . . . 0.89000000000000001 109.754 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.8 t -100.18 135.72 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.695 -0.684 . . . . 0.20000000000000001 110.905 -175.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.494 ' HB2' HD12 ' A' ' 50' ' ' ILE . 41.1 tp -110.4 113.22 25.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.903 0.383 . . . . 0.75 110.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.83 120.04 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.342 0.592 . . . . 0.13 111.589 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm? -102.33 101.12 11.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.872 -1.058 . . . . 0.20999999999999999 108.89 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.55 118.43 3.2 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.389 -0.823 . . . . 1.4099999999999999 109.732 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 25.8 t70 -83.76 -19.76 34.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.068 -0.515 . . . . 1.27 110.068 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -84.2 102.87 2.37 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.537 -0.542 . . . . 2.5600000000000001 109.537 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 36.6 Cg_exo -58.9 -31.15 94.88 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.878 2.385 . . . . 0.32000000000000001 113.026 -173.076 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.39 -49.26 78.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 1.51 109.77 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.12 -43.49 78.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.653 -0.703 . . . . 1.01 110.67 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.84 74.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.506 . . . . 0.20999999999999999 110.732 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.4 ttp -64.6 -41.65 96.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.315 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.539 ' HB3' HG21 ' A' ' 107' ' ' THR . 16.9 m-20 -65.12 -46.44 80.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.297 -0.411 . . . . 1.22 110.977 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 45.7 mt -59.78 -46.43 89.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.464 -0.335 . . . . 0.17999999999999999 110.267 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.574 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 64.0 tt0 -52.29 -48.49 65.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.673 -0.694 . . . . 1.04 110.356 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -69.32 -31.89 70.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.78000000000000003 111.761 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.942 0.401 . . . . 0.14000000000000001 110.535 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.614 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 49.5 m-85 -67.4 -44.49 78.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.001 -0.545 . . . . 0.13 110.849 177.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 28.2 mt-10 -62.98 -32.62 74.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.618 0.247 . . . . 0.68999999999999995 110.602 177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.32 -35.19 80.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 110.163 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -81.08 -0.07 38.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 110.886 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 50.0 4.2 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.991 -0.623 . . . . 0.28999999999999998 112.322 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.22 167.34 21.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.829 0.347 . . . . 0.23000000000000001 110.903 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -108.01 144.68 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.156 -0.683 . . . . 2.1400000000000001 109.156 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.574 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 31.3 t -128.8 139.95 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.19 112.24 -170.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 44' ' ' SER . 14.2 t -111.71 136.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.665 -0.865 . . . . 0.23000000000000001 108.665 169.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.62 124.41 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 110.71 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.56 138.05 37.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.09 -0.504 . . . . 0.16 110.342 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.43 -5.55 16.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.395 -0.366 . . . . 0.23999999999999999 111.193 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.3 p -133.78 166.26 23.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.537 -0.302 . . . . 0.25 111.309 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.612 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 19.6 p -59.21 -49.28 78.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.334 -0.617 . . . . 1.6000000000000001 109.334 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -49.83 -55.36 14.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.42 -1.264 . . . . 0.69999999999999996 111.944 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -55.17 -46.44 75.79 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 110.876 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.11 -46.18 88.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.279 -0.873 . . . . 0.17999999999999999 111.838 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -66.0 -30.46 71.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.209 -0.451 . . . . 0.82999999999999996 110.451 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -67.32 -54.88 16.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 2.4100000000000001 109.48 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.405 ' HB3' HG11 ' A' ' 33' ' ' VAL . 15.1 m -62.29 -30.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.492 -0.322 . . . . 1.1299999999999999 111.373 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -62.12 -42.22 99.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 1.23 110.201 178.221 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.54 -32.03 22.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.265 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.18 -35.57 61.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.62 111.062 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -120.48 162.95 31.6 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.41999999999999998 110.427 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -95.39 82.96 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.34 2.693 . . . . 0.23999999999999999 111.363 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.9 mm -66.25 127.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.815 -0.63 . . . . 0.22 111.452 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.493 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.0 m-20 -99.25 -28.41 13.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 0.28999999999999998 110.703 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -162.11 157.09 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.587 -0.523 . . . . 0.12 109.587 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -144.03 165.63 27.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.14000000000000001 112.32 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.531 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.49 112.19 9.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.95999999999999996 109.533 176.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.1 mp -116.0 120.06 37.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.189 0.441 . . . . 0.16 112.189 -167.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -83.24 130.54 35.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.097 -0.705 . . . . 1.77 109.097 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.583 ' H ' ' HB ' ' A' ' 83' ' ' THR . 12.7 t -87.47 -6.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.16 -0.927 . . . . 0.80000000000000004 110.365 -173.055 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . 0.404 HD22 ' CG ' ' A' ' 85' ' ' ASP . 53.3 t-20 -121.87 73.47 1.08 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.088 0.47 . . . . 2.3700000000000001 109.966 174.714 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.65 -24.09 59.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.506 0.669 . . . . 0.84999999999999998 109.468 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.42 -175.3 41.07 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.681 -0.967 . . . . 0.81999999999999995 110.681 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -52.6 -38.81 76.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.119 2.546 . . . . 1.1799999999999999 112.715 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -117.97 -34.57 4.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.486 -0.325 . . . . 3.5299999999999998 111.361 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -68.61 128.0 35.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.95999999999999996 111.488 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -144.32 157.15 44.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.71 -0.677 . . . . 0.48999999999999999 110.104 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 27.6 p -70.89 86.62 0.7 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.686 0.755 . . . . 1.3 109.549 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.38 -63.94 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.559 -0.829 . . . . 0.23000000000000001 112.009 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.24 -26.87 72.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.246 1.964 . . . . 0.23999999999999999 111.254 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.9 t -69.75 -45.92 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.627 -0.715 . . . . 0.12 110.171 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.34 90.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.162 -0.926 . . . . 0.16 110.29 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.603 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.5 t70 -69.05 -41.7 77.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 2.0299999999999998 110.205 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.7 77.99 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.297 0.57 . . . . 0.23000000000000001 110.715 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD23 HD21 ' A' ' 45' ' ' LEU . 91.4 mt -66.02 -46.33 78.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.3 -0.863 . . . . 0.20000000000000001 110.51 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -59.26 -28.7 66.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.065 -0.516 . . . . 2.0099999999999998 112.011 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 76.2 mt-30 -63.63 -48.06 78.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.768 0.318 . . . . 2.3700000000000001 110.974 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.05 7.66 39.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.34 -0.391 . . . . 1.49 111.361 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.54 42.69 20.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.33000000000000002 111.031 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 HG22 ' A' ' 50' ' ' ILE . 70.6 mt -88.33 132.34 39.61 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.148 -0.478 . . . . 0.17000000000000001 110.142 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.3 Cg_endo -74.85 140.05 25.42 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.477 2.118 . . . . 0.20999999999999999 111.759 177.402 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 25.7 p90 -157.22 160.86 39.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.969 -0.56 . . . . 0.17999999999999999 110.695 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -124.33 138.88 52.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.23999999999999999 110.013 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 96' ' ' ILE . 2.0 mm? -89.15 108.7 19.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.367 -0.605 . . . . 0.20999999999999999 109.367 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 14.7 t-160 -103.08 84.39 2.34 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.558 0.694 . . . . 0.59999999999999998 109.51 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.583 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 13.3 t -129.81 165.12 22.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.563 -1.199 . . . . 0.60999999999999999 110.329 -172.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.53 6.82 28.18 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.149 -0.78 . . . . 0.93999999999999995 111.149 173.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 2.2 m-20 -114.87 71.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 2.3300000000000001 110.48 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.0 mp -84.7 -33.27 23.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 1.6100000000000001 110.354 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.38 -34.51 36.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 2.6299999999999999 110.655 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -75.64 -23.05 56.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 4.4199999999999999 110.589 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.513 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 11.3 m170 -124.46 24.12 8.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.503 0.557 . . . . 1.05 112.503 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.4 -36.72 90.25 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.792 -0.718 . . . . 0.97999999999999998 112.486 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 44.2 mt-10 -63.18 -51.7 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 2.5 110.501 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.9 tp -60.46 -42.79 96.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.061 -0.518 . . . . 0.70999999999999996 110.472 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 77.1 mt -60.27 -38.3 83.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 1.5800000000000001 111.692 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 7.8 ptm180 -72.45 -26.9 62.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.815 0.34 . . . . 4.3799999999999999 110.463 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -78.3 -41.05 34.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.248 0.547 . . . . 2.4500000000000002 110.001 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.503 HG21 HD21 ' A' ' 81' ' ' LEU . 76.9 mt -60.61 -44.52 97.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.177 -0.92 . . . . 0.45000000000000001 110.529 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 39.0 t70 55.43 77.09 0.24 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.443 0.639 . . . . 1.0900000000000001 111.161 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.56 160.7 15.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.979 -1.01 . . . . 0.28999999999999998 109.113 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 36.4 Cg_exo -60.17 147.33 93.79 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.675 2.25 . . . . 0.26000000000000001 112.451 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.97 130.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 0.64000000000000001 110.915 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 82.5 mmm -114.3 107.54 15.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.782 -0.822 . . . . 0.82999999999999996 108.782 174.286 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.43 150.17 48.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.822 0.344 . . . . 0.54000000000000004 111.613 -176.482 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.07 139.96 25.85 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.586 -0.524 . . . . 0.67000000000000004 109.586 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.17 158.54 96.15 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.665 -1.39 . . . . 0.75 112.515 1.966 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.75 132.62 13.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.34999999999999998 110.097 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.2 t70 -65.49 127.91 33.77 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.89 -0.781 . . . . 0.51000000000000001 108.89 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 20' ' ' ASN . 19.3 p -64.67 -21.05 66.64 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 112.444 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.53 -37.79 65.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.339 -0.615 . . . . 1.3200000000000001 109.339 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.02 -44.81 91.45 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.62 109.53 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.531 HG12 HG11 ' A' ' 54' ' ' VAL . 21.3 t -63.24 -42.4 96.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 0.13 110.629 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.43 -50.53 67.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 0.13 111.454 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.63 -42.64 98.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.977 -0.556 . . . . 1.95 111.212 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.42 -31.07 71.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 2.23 111.247 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.57 -49.38 12.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.233 -0.44 . . . . 0.14000000000000001 111.016 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.461 HD23 HG11 ' A' ' 52' ' ' VAL . 67.4 mt -66.58 -26.16 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.884 0.698 . . . . 0.27000000000000002 112.884 -175.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 117' ' ' MET . 4.1 pt-20 -62.39 -33.47 74.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.12 0.486 . . . . 2.79 109.927 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.434 ' N ' ' HG3' ' A' ' 116' ' ' GLU . 47.6 mtm -77.47 -14.17 59.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.925 -0.58 . . . . 0.42999999999999999 110.893 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.1 t . . . . . 0 C--N 1.321 -0.653 0 CA-C-O 121.283 0.563 . . . . 1.46 109.799 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.467 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.546 0.212 . . . . 1.6499999999999999 111.21 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.8 Cg_exo -67.03 135.45 37.58 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.792 2.328 . . . . 0.33000000000000002 111.222 175.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 39.8 tptt -85.92 106.14 16.9 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.513 -0.551 . . . . 0.89000000000000001 109.513 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.3 t -99.92 134.82 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.935 -0.575 . . . . 0.20000000000000001 110.979 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.7 tp -109.57 111.94 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.11 -0.496 . . . . 0.75 110.471 176.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.7 t -94.44 122.55 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.275 0.56 . . . . 0.13 111.736 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.75 102.93 13.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.921 -1.036 . . . . 0.20999999999999999 109.022 173.317 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -160.57 121.74 3.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.043 -0.526 . . . . 1.4099999999999999 110.289 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 38.3 t70 -92.85 -11.75 32.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 1.27 110.169 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.0 mt-10 -85.73 101.71 2.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.075 -0.713 . . . . 2.5600000000000001 109.075 171.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.0 Cg_exo -59.74 -28.87 88.3 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.752 2.301 . . . . 0.32000000000000001 113.459 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 3.5 tm? -65.76 -51.02 62.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.344 -0.613 . . . . 1.51 109.344 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -64.18 -43.78 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.91 -0.586 . . . . 1.01 110.055 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.82 63.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.672 -0.695 . . . . 0.20999999999999999 111.035 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 41.7 ttp -64.07 -39.28 93.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.597 -0.729 . . . . 0.60999999999999999 110.947 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.64 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.5 t-20 -65.28 -41.19 94.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.377 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.8 mt -62.6 -43.84 97.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.056 -0.52 . . . . 0.17999999999999999 110.407 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.532 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 42.7 tt0 -53.64 -51.43 63.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 1.04 110.062 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 29.4 m-85 -58.18 -39.35 78.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.78000000000000003 111.437 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.87 58.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.475 -0.329 . . . . 0.14000000000000001 110.994 -174.071 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 43.7 m-85 -63.27 -43.94 96.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.37 -0.377 . . . . 0.13 110.385 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.21 -39.23 82.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.005 0.431 . . . . 0.68999999999999995 110.575 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.83 -28.6 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.51000000000000001 110.812 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -84.04 4.43 30.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.99 0.424 . . . . 0.65000000000000002 110.513 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . 82.87 48.63 5.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.905 -0.665 . . . . 0.28999999999999998 112.432 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -135.75 175.8 9.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.705 0.288 . . . . 0.23000000000000001 111.135 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -113.23 145.64 40.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.77 -0.826 . . . . 2.1400000000000001 108.77 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.532 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.3 t -131.72 135.97 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.618 0.599 . . . . 0.19 112.618 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.54 136.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.549 -0.908 . . . . 0.23000000000000001 108.549 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.79 126.96 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.938 0.399 . . . . 0.94999999999999996 110.863 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -133.48 134.53 43.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.908 -0.587 . . . . 0.16 110.285 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.62 -10.24 21.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.126 0.488 . . . . 0.23999999999999999 110.806 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.508 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 70.7 p -127.64 165.53 19.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.853 -0.612 . . . . 0.25 110.185 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.578 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 78.1 m -72.1 -30.89 65.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.2 -44.17 84.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.69999999999999996 111.031 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.508 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 56.2 mt-30 -62.99 -35.8 81.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.308 0.575 . . . . 1.4099999999999999 110.31 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.668 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -64.74 -54.66 27.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.433 -0.803 . . . . 0.17999999999999999 111.401 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.9 mt -59.33 -33.42 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.82999999999999996 110.263 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -61.88 -53.85 50.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.454 -0.794 . . . . 2.4100000000000001 110.433 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.0 t -63.85 -38.72 92.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.934 -0.575 . . . . 1.1299999999999999 110.616 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.25 -36.28 81.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.126 0.489 . . . . 1.23 110.692 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.5 37.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.219 -0.446 . . . . 0.42999999999999999 111.319 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -80.46 -37.94 30.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.898 0.38 . . . . 0.62 111.637 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 24.0 m-80 -110.75 160.07 30.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.302 -0.408 . . . . 0.41999999999999998 110.448 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -94.85 84.32 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 123.5 2.8 . . . . 0.23999999999999999 111.695 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mm -67.81 128.29 30.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.698 -0.683 . . . . 0.22 111.499 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -95.4 -32.9 12.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.28999999999999998 110.362 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 12.4 p -158.08 158.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.12 109.382 -178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -140.26 168.03 20.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.421 0.629 . . . . 0.14000000000000001 111.476 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.526 HG21 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -140.69 121.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.853 -1.166 . . . . 0.95999999999999996 107.853 176.155 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.616 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -123.78 122.61 38.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.1 0.407 . . . . 0.16 112.1 -167.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.641 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 53.4 t0 -85.18 119.17 25.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 1.77 109.553 170.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.797 HG13 HD23 ' A' ' 92' ' ' LEU . 95.8 t -69.49 -28.84 39.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.052 -0.976 . . . . 0.80000000000000004 110.391 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -99.72 62.05 1.17 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.846 -0.616 . . . . 2.3700000000000001 110.393 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.81 -28.31 68.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.318 0.58 . . . . 0.84999999999999998 109.626 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.43 -171.94 41.44 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.559 -1.016 . . . . 0.81999999999999995 110.559 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.1 -45.37 41.18 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.556 2.17 . . . . 1.1799999999999999 111.858 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -107.18 -34.32 7.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 3.5299999999999998 110.454 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -68.55 125.27 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.227 0.537 . . . . 0.95999999999999996 111.364 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.491 ' HB2' HD22 ' A' ' 92' ' ' LEU . 16.8 p80 -146.6 148.52 32.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.778 -0.646 . . . . 0.48999999999999999 110.309 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.8 p -71.43 86.64 0.85 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.395 0.617 . . . . 1.3 109.734 172.1 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.85 -72.15 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.364 -0.922 . . . . 0.23000000000000001 112.407 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.9 Cg_exo -53.31 -26.38 34.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.731 2.287 . . . . 0.23999999999999999 112.023 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 11' ' ' LEU . 13.9 t -69.2 -48.32 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.113 0.483 . . . . 0.12 110.158 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.21 80.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.256 -0.884 . . . . 0.16 110.173 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.3 t70 -63.3 -39.05 93.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 2.0299999999999998 110.81 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.23000000000000001 110.905 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.87 -41.18 95.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.20000000000000001 110.162 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 2.7 mmpt? -59.37 -33.75 71.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.477 -0.783 . . . . 2.0099999999999998 111.195 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 73.1 mt-30 -64.09 -47.51 79.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 2.3700000000000001 110.964 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.88 5.58 39.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 1.49 111.089 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.01 32.6 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.689 -0.687 . . . . 0.33000000000000002 111.392 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.7 mt -82.11 133.07 51.74 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.925 -0.579 . . . . 0.17000000000000001 109.798 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -72.9 142.04 34.4 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.229 1.953 . . . . 0.20999999999999999 111.884 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 35.0 p90 -157.23 153.25 27.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 110.449 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -117.39 138.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.565 -0.743 . . . . 0.23999999999999999 109.526 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.5 mm? -88.48 108.09 19.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.113 -0.699 . . . . 0.20999999999999999 109.113 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.592 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.2 t-160 -101.47 76.87 1.72 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.804 -0.813 . . . . 0.59999999999999998 108.804 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.641 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 6.5 t -111.7 155.02 24.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.683 -1.144 . . . . 0.60999999999999999 111.795 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.56 2.16 58.78 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.543 -0.753 . . . . 0.93999999999999995 111.355 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 127.68 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.915 0.388 . . . . 2.3300000000000001 111.779 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.585 HD21 HG11 ' A' ' 100' ' ' VAL . 4.3 mp -117.72 0.63 12.06 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.083 -0.71 . . . . 1.6100000000000001 109.083 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.54 -61.47 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 2.6299999999999999 111.51 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -66.33 -37.77 86.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.546 . . . . 4.4199999999999999 110.213 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -104.22 33.02 3.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.125 -0.489 . . . . 1.05 110.355 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.462 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -62.53 -31.5 79.93 Favored Glycine 0 CA--C 1.511 -0.179 0 C-N-CA 121.15 -0.547 . . . . 0.97999999999999998 113.282 -176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.45 -27.84 69.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.127 0.489 . . . . 2.5 110.021 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.797 HD23 HG13 ' A' ' 57' ' ' VAL . 15.8 tp -71.32 -42.87 68.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.70999999999999996 110.419 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.462 HD23 ' HA2' ' A' ' 90' ' ' GLY . 3.1 mm? -55.61 -40.34 71.97 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.068 0.461 . . . . 1.5800000000000001 110.241 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.94 -26.63 66.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 4.3799999999999999 111.821 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.65 -37.03 36.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.256 0.55 . . . . 2.4500000000000002 110.239 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 92' ' ' LEU . 69.5 mt -75.98 -62.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.293 -0.867 . . . . 0.45000000000000001 111.876 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.23 81.56 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.676 -173.821 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.8 169.09 10.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.28999999999999998 109.341 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 33.7 Cg_exo -61.57 136.26 61.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.286 1.991 . . . . 0.26000000000000001 112.118 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.585 HG11 HD21 ' A' ' 86' ' ' LEU . 40.0 t -124.17 130.09 73.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.325 -0.398 . . . . 0.64000000000000001 110.994 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 98.1 mtp -117.05 106.43 13.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.445 -0.576 . . . . 0.82999999999999996 109.445 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.16 152.98 43.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.54000000000000004 111.507 -176.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.549 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.7 mttt -90.98 142.82 27.78 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.868 -0.605 . . . . 0.67000000000000004 110.032 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.15 158.66 93.6 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.457 -1.476 . . . . 0.75 112.711 1.654 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.592 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.62 131.16 12.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.34999999999999998 109.184 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 110' ' ' VAL . 36.6 t70 -68.05 128.23 35.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.42 -0.585 . . . . 0.51000000000000001 109.42 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.64 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.1 p -59.01 -27.99 65.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.815 -1.084 . . . . 0.26000000000000001 112.544 -172.052 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -64.9 -45.62 85.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.634 -0.506 . . . . 1.3200000000000001 109.634 176.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -61.68 -45.57 93.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.721 -0.474 . . . . 0.62 109.721 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.536 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 20.2 t -59.27 -43.09 89.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.13 110.423 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.62 -50.35 65.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.626 -0.716 . . . . 0.13 111.354 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 108' ' ' SER . 19.7 mtpp -60.19 -42.2 94.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 1.95 111.073 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 32.0 mmt180 -71.81 -28.11 63.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 2.23 111.403 -177.248 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.31 -48.49 17.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.368 . . . . 0.14000000000000001 110.119 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.527 HD23 HG11 ' A' ' 52' ' ' VAL . 82.1 mt -65.1 -26.29 68.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.862 0.69 . . . . 0.27000000000000002 112.862 -176.994 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -25.02 59.54 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.31 -0.556 . . . . 2.79 110.982 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.476 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 70.2 mtm -69.55 -36.08 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.42999999999999999 110.75 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.7 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.147 0.498 . . . . 1.46 110.397 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.6 ptp . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.937 0.399 . . . . 1.6499999999999999 110.753 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.65 148.01 28.64 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.659 2.239 . . . . 0.33000000000000002 113.1 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -95.78 107.82 20.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.437 -0.801 . . . . 0.89000000000000001 109.243 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 52' ' ' VAL . 57.1 t -100.6 133.56 43.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.096 -0.502 . . . . 0.20000000000000001 111.057 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HB2' HD12 ' A' ' 50' ' ' ILE . 43.5 tp -108.76 114.68 28.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.927 0.394 . . . . 0.75 110.402 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.3 t -95.82 120.76 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.34 0.59 . . . . 0.13 111.433 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.05 100.68 10.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.828 -1.078 . . . . 0.20999999999999999 108.873 172.383 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -157.4 117.48 3.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.408 -0.815 . . . . 1.4099999999999999 109.668 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.2 t70 -81.37 -20.91 39.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.062 -0.517 . . . . 1.27 110.225 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -82.31 105.44 4.72 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.573 -0.529 . . . . 2.5600000000000001 109.573 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.7 Cg_exo -58.32 -30.76 92.09 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.619 2.213 . . . . 0.32000000000000001 112.455 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.38 -49.89 73.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.048 0.451 . . . . 1.51 109.869 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.1 mt -69.39 -43.68 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 1.01 111.169 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.92 -45.23 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.47 . . . . 0.20999999999999999 110.303 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -61.95 -46.71 88.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.384 -0.826 . . . . 0.60999999999999999 111.214 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.4 m-80 -65.27 -40.99 94.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.136 -0.484 . . . . 1.22 111.372 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.88 -44.57 95.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.357 -0.383 . . . . 0.17999999999999999 110.266 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -56.36 -49.59 73.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 1.04 110.2 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -62.76 -34.37 77.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.204 -0.453 . . . . 0.78000000000000003 111.201 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -69.02 -51.03 43.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.14000000000000001 110.82 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 53.7 m-85 -63.54 -42.08 98.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.344 -0.389 . . . . 0.13 110.834 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.92 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.96 -0.296 . . . . 0.68999999999999995 110.626 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.8 -26.94 61.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.51000000000000001 110.818 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 69.6 mm-40 -82.51 -10.22 59.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.65000000000000002 110.356 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.32 51.36 1.59 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.28999999999999998 112.421 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.04 167.9 21.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.23000000000000001 110.958 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -106.35 141.89 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.943 -0.762 . . . . 2.1400000000000001 108.943 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -125.83 136.88 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.191 0.441 . . . . 0.19 112.191 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.406 HG11 ' OG ' ' A' ' 44' ' ' SER . 26.2 t -108.27 132.42 56.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.917 -0.771 . . . . 0.23000000000000001 108.917 168.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.14 124.0 56.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.964 0.412 . . . . 0.94999999999999996 111.088 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.89 143.61 43.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.029 -0.532 . . . . 0.16 110.344 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.09 -8.59 14.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.461 -0.336 . . . . 0.23999999999999999 111.308 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 p -131.18 168.11 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.472 -0.331 . . . . 0.25 111.33 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.5 p -59.22 -50.08 75.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.379 0.609 . . . . 1.6000000000000001 109.434 172.554 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.05 -54.12 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.423 -1.262 . . . . 0.69999999999999996 112.215 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.91 -41.18 77.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.25 0.547 . . . . 1.4099999999999999 111.173 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -68.23 -45.9 72.0 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.43 -0.805 . . . . 0.17999999999999999 111.496 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.4 mt -66.52 -28.13 68.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.82999999999999996 110.481 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -66.76 -51.65 53.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 2.4100000000000001 109.831 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.406 ' OG ' HG11 ' A' ' 33' ' ' VAL . 17.3 t -63.56 -37.89 89.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.1299999999999999 110.792 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD21 ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -57.51 -39.88 77.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 1.23 110.366 178.048 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.82 -34.87 30.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.801 -0.636 . . . . 0.42999999999999999 111.39 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -80.21 -38.44 31.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.62 111.568 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -116.13 161.29 31.87 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.188 -0.46 . . . . 0.41999999999999998 110.679 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -93.6 82.29 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.59 2.86 . . . . 0.23999999999999999 110.839 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' A' ' 9' ' ' LEU . 43.6 mm -64.84 116.1 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.348 -0.842 . . . . 0.22 111.563 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.73 -32.53 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.28999999999999998 110.375 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 115' ' ' LEU . 15.0 p -160.59 155.53 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.12 109.77 -176.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.11 167.8 21.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.325 0.583 . . . . 0.14000000000000001 111.677 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.4 111.18 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.447 -0.797 . . . . 0.95999999999999996 109.285 177.735 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.2 mp -115.09 123.41 48.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.141 0.423 . . . . 0.16 112.141 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.99 107.94 15.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.781 0.801 . . . . 1.77 109.816 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG13 HD23 ' A' ' 92' ' ' LEU . 38.2 t -59.17 -19.56 16.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.803 -1.09 . . . . 0.80000000000000004 111.868 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -122.0 70.03 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.531 . . . . 2.3700000000000001 110.72 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.437 HD11 ' SG ' ' A' ' 65' ' ' CYS . 94.9 mt -67.37 -27.85 67.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.84999999999999998 110.295 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.24 -160.7 16.54 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.763 -0.653 . . . . 0.81999999999999995 111.684 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.62 -46.03 36.47 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.897 2.398 . . . . 1.1799999999999999 112.203 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -126.22 -19.75 4.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.137 -0.483 . . . . 3.5299999999999998 110.271 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.6 m -63.47 125.89 25.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.95999999999999996 110.988 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -145.71 153.51 41.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.959 -0.564 . . . . 0.48999999999999999 110.643 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 15.3 m -77.47 85.81 3.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.637 -0.875 . . . . 1.3 108.637 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.76 -65.47 0.62 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.837 -0.697 . . . . 0.23000000000000001 112.689 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -54.77 -25.18 41.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.361 2.041 . . . . 0.23999999999999999 111.247 174.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -69.03 -46.91 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.723 -0.671 . . . . 0.12 109.998 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -58.2 -47.72 82.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.099 -0.955 . . . . 0.16 109.862 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.24 -39.26 94.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.786 -0.643 . . . . 2.0299999999999998 110.555 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -58.61 -44.62 89.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.23000000000000001 111.05 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' CD2' HD21 ' A' ' 45' ' ' LEU . 90.7 mt -69.58 -46.24 66.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.631 -0.713 . . . . 0.20000000000000001 110.293 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 30.1 mmmt -56.06 -35.83 67.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 2.0099999999999998 111.582 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 3.0 pt20 -63.97 -41.46 97.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.908 -0.587 . . . . 2.3700000000000001 110.76 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 96.5 mtt180 -95.51 4.69 52.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.883 -0.598 . . . . 1.49 111.027 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.05 32.95 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.628 -0.715 . . . . 0.33000000000000002 111.266 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.0 mt -80.17 131.65 62.03 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 109.396 -0.594 . . . . 0.17000000000000001 109.396 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 43.2 Cg_endo -76.09 142.19 24.42 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.287 1.992 . . . . 0.20999999999999999 112.014 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 9.3 p90 -158.38 154.67 27.36 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.369 -0.832 . . . . 0.17999999999999999 110.185 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 mt -117.07 138.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.463 -0.79 . . . . 0.23999999999999999 109.781 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.463 HD21 HG21 ' A' ' 96' ' ' ILE . 2.6 mm? -88.5 109.86 20.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.987 -0.551 . . . . 0.20999999999999999 109.702 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.9 t-160 -104.88 86.52 2.47 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.387 0.613 . . . . 0.59999999999999998 109.756 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.537 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -135.85 161.7 34.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.001 -1.0 . . . . 0.60999999999999999 110.577 -172.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.34 22.16 9.01 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.604 -0.808 . . . . 0.93999999999999995 112.409 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.631 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 19.8 t70 -141.69 74.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.337 0.589 . . . . 2.3300000000000001 109.484 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 86' ' ' LEU . 3.3 mp -92.42 -22.94 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.823 -0.626 . . . . 1.6100000000000001 110.887 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -73.86 -48.29 32.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.93 0.395 . . . . 2.6299999999999999 110.625 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.631 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -75.88 -38.64 57.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.169 -0.469 . . . . 4.4199999999999999 110.74 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.493 ' O ' HD13 ' A' ' 93' ' ' LEU . 73.6 m-70 -89.48 17.29 6.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.978 -0.289 . . . . 1.05 110.984 177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.619 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -52.56 -42.51 58.03 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.39 -0.434 . . . . 0.97999999999999998 113.478 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.94 -34.71 65.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.939 0.4 . . . . 2.5 110.693 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.758 HD23 HG13 ' A' ' 57' ' ' VAL . 35.3 tp -72.64 -54.18 9.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.042 -0.526 . . . . 0.70999999999999996 111.514 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.674 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.66 -27.65 68.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.973 -0.691 . . . . 1.5800000000000001 111.823 -176.095 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 27.2 mmm180 -64.17 -46.35 84.37 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.849 -0.614 . . . . 4.3799999999999999 110.961 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.68 -36.14 83.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 2.4500000000000002 110.755 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 92' ' ' LEU . 79.0 mt -64.08 -49.42 81.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 0.45000000000000001 110.503 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.5 t70 58.76 74.52 0.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.607 0.718 . . . . 1.0900000000000001 110.897 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.94 21.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.916 -1.038 . . . . 0.28999999999999998 109.165 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 39.3 Cg_exo -58.74 143.83 98.55 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.455 2.103 . . . . 0.26000000000000001 112.452 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.61 132.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.238 -0.437 . . . . 0.64000000000000001 111.226 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.4 mmm -114.51 106.7 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.857 -0.794 . . . . 0.82999999999999996 108.857 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -67.9 147.61 52.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.023 0.439 . . . . 0.54000000000000004 112.161 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -90.85 141.98 27.23 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.848 -0.614 . . . . 0.67000000000000004 110.116 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.16 155.82 99.76 Favored 'Cis proline' 0 C--O 1.231 0.142 0 C-N-CA 123.137 -1.61 . . . . 0.75 112.389 -0.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.608 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -146.14 139.97 26.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 0.34999999999999998 109.969 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 110' ' ' VAL . 18.7 t70 -70.51 128.24 35.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.251 -0.648 . . . . 0.51000000000000001 109.251 174.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.457 HG21 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -68.86 -19.39 64.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.718 -0.674 . . . . 0.26000000000000001 112.756 -170.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 t -73.94 -37.49 64.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.206 -0.664 . . . . 1.3200000000000001 109.206 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -65.66 -46.48 79.0 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.112 -0.495 . . . . 0.62 109.779 175.779 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.5 t -58.88 -43.52 88.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.377 -0.829 . . . . 0.13 110.647 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.688 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.23 -54.03 39.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.853 -0.612 . . . . 0.13 111.454 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 61.7 mttp -57.5 -48.06 80.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 1.95 111.289 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 26.2 mmt180 -63.82 -34.71 78.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 2.23 111.415 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -46.71 70.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.058 0.456 . . . . 0.14000000000000001 110.27 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.547 HD23 HG11 ' A' ' 52' ' ' VAL . 86.8 mt -66.12 -25.6 67.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 0.27000000000000002 111.877 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 32.8 mm-40 -54.48 -41.04 69.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.537 -0.302 . . . . 2.79 111.388 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 77.6 mtm -70.89 -29.41 65.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.105 0.409 . . . . 0.42999999999999999 112.105 -176.365 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.031 0.443 . . . . 1.46 110.433 -176.18 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.439 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 54.5 mtt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.568 0.223 . . . . 1.6499999999999999 111.365 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -61.99 140.59 85.46 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.104 2.536 . . . . 0.33000000000000002 111.714 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -86.62 103.51 15.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.001 0.429 . . . . 0.89000000000000001 109.899 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' CG1' ' A' ' 52' ' ' VAL . 46.9 t -100.26 136.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.773 -0.649 . . . . 0.20000000000000001 110.977 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 53.7 tp -112.02 113.49 25.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.59 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.3 t -94.34 122.53 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.39 0.614 . . . . 0.13 111.164 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.677 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -101.79 107.42 18.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.812 -1.085 . . . . 0.20999999999999999 108.341 172.94 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -166.38 134.47 2.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 109.956 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.6 t70 -99.55 -23.58 15.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.383 -0.826 . . . . 1.27 110.069 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLU . . . . . 0.481 ' CB ' HD13 ' A' ' 17' ' ' ILE . 33.9 mt-10 -80.31 104.81 2.85 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 109.345 -0.613 . . . . 2.5600000000000001 109.345 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.2 Cg_exo -58.0 -32.68 95.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.014 2.476 . . . . 0.32000000000000001 113.435 -171.416 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.66 -49.68 74.17 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.697 -0.483 . . . . 1.51 109.697 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ILE . . . . . 0.481 HD13 ' CB ' ' A' ' 14' ' ' GLU . 3.3 mp -66.32 -47.59 83.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.544 -0.753 . . . . 1.01 110.126 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.83 74.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.20999999999999999 111.228 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.4 ttp -64.46 -37.08 86.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.013 -0.539 . . . . 0.60999999999999999 110.949 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.524 ' HB3' HG21 ' A' ' 107' ' ' THR . 2.6 m-80 -69.16 -37.0 78.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.25 -0.432 . . . . 1.22 110.915 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.11 -45.89 83.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.42 -0.354 . . . . 0.17999999999999999 110.058 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.475 ' HA ' HG11 ' A' ' 32' ' ' VAL . 23.4 tt0 -51.86 -56.8 11.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.765 -0.652 . . . . 1.04 110.205 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -63.55 -27.65 69.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.859 -0.61 . . . . 0.78000000000000003 111.894 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.9 54.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.834 0.35 . . . . 0.14000000000000001 110.314 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.706 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 47.0 m-85 -66.08 -41.1 91.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 0.13 111.031 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.3 mt-10 -61.29 -37.04 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.68999999999999995 110.582 178.283 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.44 -29.78 68.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 0.51000000000000001 110.338 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -79.48 -13.48 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.65000000000000002 110.66 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.49 50.19 1.58 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.092 -0.575 . . . . 0.28999999999999998 112.399 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.81 165.52 26.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.591 0.234 . . . . 0.23000000000000001 110.898 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -109.27 128.2 54.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.261 -0.644 . . . . 2.1400000000000001 109.261 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 22' ' ' GLN . 37.8 t -113.23 133.98 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.787 0.662 . . . . 0.19 112.787 -167.821 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.97 139.91 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.169 -1.049 . . . . 0.23000000000000001 108.169 167.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.1 t -114.67 125.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.626 -0.43 . . . . 0.94999999999999996 110.879 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -133.54 136.39 44.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.878 -0.601 . . . . 0.16 110.174 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.16 -10.8 21.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.869 0.366 . . . . 0.23999999999999999 111.287 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.2 p -131.23 163.37 27.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.199 -0.455 . . . . 0.25 110.751 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.6 m -63.41 -33.76 76.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.757 -0.46 . . . . 1.6000000000000001 109.757 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.43 -51.61 67.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 110.618 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 51.4 mt-30 -58.98 -39.12 80.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.122 0.487 . . . . 1.4099999999999999 110.805 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -64.74 -49.83 69.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 0.17999999999999999 111.718 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.4 mt -63.25 -27.86 69.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 0.82999999999999996 110.497 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -67.42 -50.29 60.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.787 -0.642 . . . . 2.4100000000000001 109.769 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -65.47 -33.45 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 1.1299999999999999 110.586 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -37.51 77.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 1.23 110.656 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.8 -41.8 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 111.212 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.16 -37.19 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 0.62 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -122.72 162.5 38.28 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.166 -0.47 . . . . 0.41999999999999998 110.724 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -93.28 86.05 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.255 2.637 . . . . 0.23999999999999999 111.018 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 42.4 mm -64.01 119.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 0.22 111.523 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.42 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 41.5 m-20 -87.24 -35.7 18.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.28999999999999998 110.28 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.485 ' CG1' HG22 ' A' ' 8' ' ' VAL . 14.5 p -156.31 155.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.753 -0.658 . . . . 0.12 109.581 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -138.24 163.51 31.57 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.451 0.643 . . . . 0.14000000000000001 111.519 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.488 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -134.84 111.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.511 -0.922 . . . . 0.95999999999999996 108.511 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.71 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -108.01 107.31 17.94 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.711 -0.396 . . . . 0.16 111.802 -169.673 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . 0.843 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.1 t70 -84.97 139.04 32.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.098 -0.704 . . . . 1.77 109.098 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 ' SG ' ' A' ' 65' ' ' CYS . 14.4 t -93.93 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.731 -0.668 . . . . 0.80000000000000004 110.287 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -89.96 60.18 4.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.715 0.769 . . . . 2.3700000000000001 110.164 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.3 mt -89.77 -23.85 21.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.87 -0.605 . . . . 0.84999999999999998 110.067 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.68 -173.13 44.49 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.029 -0.828 . . . . 0.81999999999999995 111.029 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.58 -43.52 57.08 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.565 2.177 . . . . 1.1799999999999999 111.91 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.11 -23.55 6.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.918 -0.583 . . . . 3.5299999999999998 110.404 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -61.91 122.35 15.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.95999999999999996 111.068 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' HIS . . . . . 0.467 ' HB2' HG13 ' A' ' 57' ' ' VAL . 20.0 p80 -144.39 154.22 42.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.495 -0.775 . . . . 0.48999999999999999 109.993 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -70.05 87.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 1.3 109.866 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.57 -74.71 0.74 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.525 -0.845 . . . . 0.23000000000000001 112.523 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 46.5 Cg_exo -53.35 -24.76 28.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.695 2.264 . . . . 0.23999999999999999 112.302 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.2 t -66.33 -44.54 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.375 0.607 . . . . 0.12 109.918 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.43 92.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.918 -1.037 . . . . 0.16 109.966 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.88 -45.59 93.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.514 -0.766 . . . . 2.0299999999999998 110.458 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.05 -41.65 68.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.459 0.647 . . . . 0.23000000000000001 111.366 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.58 -44.84 56.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.375 -0.83 . . . . 0.20000000000000001 110.561 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -54.29 -41.37 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.455 -0.793 . . . . 2.0099999999999998 110.861 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -59.89 -46.44 89.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.708 -0.678 . . . . 2.3700000000000001 111.483 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -92.93 12.06 25.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 1.49 111.451 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.43 37.44 27.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.692 -0.685 . . . . 0.33000000000000002 111.66 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.25 133.53 38.49 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.282 -0.417 . . . . 0.17000000000000001 109.944 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 22.2 Cg_endo -74.99 142.11 27.47 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.298 1.999 . . . . 0.20999999999999999 112.04 177.473 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.479 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 18.7 p90 -159.34 154.94 25.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 110.562 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.4 mt -117.74 137.03 52.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.358 -0.837 . . . . 0.23999999999999999 109.624 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 98' ' ' ALA . 1.8 mm? -89.03 109.4 20.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.238 -0.653 . . . . 0.20999999999999999 109.238 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.843 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 t-160 -97.87 126.85 43.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.904 -1.147 . . . . 0.59999999999999998 107.904 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -169.39 151.23 4.44 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.753 -0.592 . . . . 0.60999999999999999 111.529 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.83 -8.78 59.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.896 -0.669 . . . . 0.93999999999999995 111.565 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -116.32 112.39 21.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.725 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.04 -10.31 15.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.807 -0.633 . . . . 1.6100000000000001 110.057 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -84.03 -60.33 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 2.6299999999999999 111.457 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -71.78 -40.67 69.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 4.4199999999999999 110.778 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' HIS . . . . . 0.486 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 89.8 m-70 -92.48 21.78 5.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.334 -0.394 . . . . 1.05 111.676 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.41 -39.12 97.4 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.924 -0.655 . . . . 0.97999999999999998 112.475 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.42 -41.61 97.43 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.936 0.398 . . . . 2.5 110.346 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 96' ' ' ILE . 63.8 tp -59.77 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.70999999999999996 110.502 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 40.6 mt -60.32 -40.84 92.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.819 -0.628 . . . . 1.5800000000000001 111.122 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -69.78 -25.53 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 4.3799999999999999 111.21 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.15 -32.01 56.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.445 0.641 . . . . 2.4500000000000002 110.232 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 92' ' ' LEU . 93.6 mt -77.35 -54.44 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.45000000000000001 110.912 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.95 76.58 0.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.839 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -158.93 168.16 12.97 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.157 -0.929 . . . . 0.28999999999999998 108.941 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.574 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 47.8 Cg_exo -58.74 140.57 95.55 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.425 2.083 . . . . 0.26000000000000001 112.625 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.85 142.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.64000000000000001 110.873 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.9 mmm -125.57 110.01 13.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.389 -0.597 . . . . 0.82999999999999996 109.389 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.67 150.2 37.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.54000000000000004 111.849 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HE3' ' OD2' ' A' ' 56' ' ' ASP . 77.8 mttt -91.18 140.97 25.9 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.67000000000000004 110.154 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 2.9 Cg_exo -75.35 146.93 87.5 Favored 'Cis proline' 0 C--O 1.233 0.247 0 C-N-CA 123.472 -1.47 . . . . 0.75 112.641 3.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.506 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -136.41 132.58 35.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 0.34999999999999998 110.275 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.7 t70 -73.32 128.07 34.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.51000000000000001 108.486 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.524 HG21 ' HB3' ' A' ' 20' ' ' ASN . 35.9 p -65.96 -17.77 64.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.876 -0.602 . . . . 0.26000000000000001 112.294 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.5 p -71.92 -41.78 67.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.947 -0.39 . . . . 1.3200000000000001 109.947 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.5 -42.16 87.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.139 0.495 . . . . 0.62 110.01 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 106' ' ' ASP . 20.5 t -62.62 -44.11 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.383 -0.826 . . . . 0.13 110.182 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.706 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.63 -51.33 57.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.619 -0.719 . . . . 0.13 111.854 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 52.8 mtpt -60.03 -48.16 82.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 1.95 111.244 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -62.46 -35.82 80.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.68 0.276 . . . . 2.23 111.399 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 52' ' ' VAL . . . -66.32 -46.84 75.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.94 0.4 . . . . 0.14000000000000001 110.041 177.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.64 -26.36 65.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.132 -0.486 . . . . 0.27000000000000002 111.887 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 50.7 mm-40 -56.78 -46.94 81.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.116 0.484 . . . . 2.79 110.375 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.574 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.1 mtm -76.06 -26.69 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 0.42999999999999999 110.76 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 53.4 t . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 1.46 111.146 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' MET . . . . . 0.429 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 86.3 mtp . . . . . 0 CA--C 1.514 -0.418 0 N-CA-C 108.708 -0.849 . . . . 1.6499999999999999 108.708 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 8.8 Cg_exo -63.52 131.42 31.62 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.854 1.703 . . . . 0.33000000000000002 111.372 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -86.01 102.94 14.25 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.507 -0.923 . . . . 0.89000000000000001 108.507 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.8 t -99.69 126.81 53.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.037 -0.529 . . . . 0.20000000000000001 111.087 -172.326 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.5 tm? -102.2 112.24 24.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.578 -0.737 . . . . 0.75 109.476 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.4 t -96.83 125.82 49.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.113 0.482 . . . . 0.13 111.409 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . 0.642 HD23 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.96 100.53 10.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.694 -0.854 . . . . 0.20999999999999999 108.694 173.002 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -157.5 118.17 3.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.907 -0.588 . . . . 1.4099999999999999 109.626 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 32.9 t70 -77.27 -21.2 53.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.848 -0.615 . . . . 1.27 110.223 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -88.05 106.88 13.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.905 -0.589 . . . . 2.5600000000000001 111.117 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 39.2 Cg_exo -58.53 -28.89 87.2 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.86 2.374 . . . . 0.32000000000000001 112.914 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -49.67 68.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.516 -0.55 . . . . 1.51 109.516 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.5 mt -66.37 -45.47 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.733 -0.667 . . . . 1.01 110.514 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.35 73.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 0.20999999999999999 110.82 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.6 ttp -59.37 -43.84 92.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.60999999999999999 111.238 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.9 m-80 -67.86 -38.71 83.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.926 -0.579 . . . . 1.22 111.34 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 mt -65.31 -44.83 86.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.17999999999999999 110.297 172.243 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLN . . . . . 0.615 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 52.2 tt0 -54.49 -51.89 63.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.466 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.09 -34.38 74.83 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.612 -0.267 . . . . 0.78000000000000003 111.116 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.9 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.504 -0.317 . . . . 0.14000000000000001 110.699 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.9 m-85 -68.64 -42.5 77.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.242 -0.435 . . . . 0.13 110.994 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 44.1 mt-10 -61.79 -35.54 78.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.586 -0.279 . . . . 0.68999999999999995 110.461 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.49 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.51000000000000001 110.657 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.81 -10.0 59.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.65000000000000002 110.455 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.63 50.56 1.81 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.28999999999999998 112.399 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -139.79 165.14 28.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.23000000000000001 110.833 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.86 134.97 53.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.422 -0.584 . . . . 2.1400000000000001 109.422 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.615 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.4 t -117.39 140.74 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.41 0.522 . . . . 0.19 112.41 -167.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.43 131.53 64.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.544 -0.91 . . . . 0.23000000000000001 108.544 168.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.6 t -105.43 121.15 57.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.94999999999999996 111.609 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.39 142.66 51.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.819 -0.628 . . . . 0.16 110.471 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.76 -12.6 15.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.899 -0.591 . . . . 0.23999999999999999 110.54 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' THR . . . . . 0.409 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 32.8 p -124.89 174.96 7.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.25 110.955 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' CYS . . . . . 0.611 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.9 m -75.11 -37.0 61.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.033 0.444 . . . . 1.6000000000000001 110.263 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.15 -41.19 90.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.69999999999999996 111.161 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 86.5 mt-30 -59.83 -37.29 78.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.078 0.466 . . . . 1.4099999999999999 110.857 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.57 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -71.46 -48.43 49.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.995 -0.548 . . . . 0.17999999999999999 110.879 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mp -56.02 -37.34 69.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.82999999999999996 110.68 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -63.1 -54.07 43.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 2.4100000000000001 110.444 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -63.99 -29.18 70.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.713 -0.676 . . . . 1.1299999999999999 111.711 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.4 -30.64 69.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.342 0.591 . . . . 1.23 110.513 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.53 -28.57 24.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.4 0.619 . . . . 0.42999999999999999 111.07 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -87.04 -21.68 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 0.62 111.52 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -137.68 163.67 46.69 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 0.41999999999999998 111.115 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -96.32 87.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.767 2.978 . . . . 0.23999999999999999 111.388 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 9' ' ' LEU . 37.9 mm -66.08 124.36 20.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.594 -0.73 . . . . 0.22 111.631 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.701 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 14.3 m-20 -89.48 -34.67 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.542 -0.754 . . . . 0.28999999999999998 110.421 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 115' ' ' LEU . 13.6 p -159.67 157.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.805 -0.634 . . . . 0.12 109.871 -176.306 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.8 164.53 29.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.359 0.599 . . . . 0.14000000000000001 112.008 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.65 110.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.353 -0.84 . . . . 0.95999999999999996 109.301 175.635 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.5 mp -112.7 121.86 45.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.415 -0.357 . . . . 0.16 111.631 -169.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.88 116.49 22.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 1.77 109.645 171.25 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' VAL . . . . . 0.579 HG13 HD23 ' A' ' 92' ' ' LEU . 92.9 t -67.37 -23.74 30.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.061 -0.972 . . . . 0.80000000000000004 110.463 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -103.38 56.94 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.544 -0.753 . . . . 2.3700000000000001 110.695 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.35 -37.32 85.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.939 -0.763 . . . . 0.84999999999999998 108.939 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.85 -171.61 29.29 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.149 -1.18 . . . . 0.81999999999999995 110.149 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.0 -46.26 34.92 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.498 2.132 . . . . 1.1799999999999999 111.862 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.99 -34.93 6.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.409 -0.36 . . . . 3.5299999999999998 110.874 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -62.33 123.56 18.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.325 0.584 . . . . 0.95999999999999996 110.92 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -144.79 152.27 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.551 -0.75 . . . . 0.48999999999999999 110.616 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -73.82 87.5 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.283 0.564 . . . . 1.3 109.811 173.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -106.51 -73.52 0.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.278 -0.963 . . . . 0.23000000000000001 112.598 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.4 Cg_exo -52.19 -27.1 28.68 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.23999999999999999 112.082 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' VAL . . . . . 0.642 HG11 HD23 ' A' ' 11' ' ' LEU . 17.0 t -68.23 -44.07 84.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.12 110.195 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.79 82.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.28 -0.873 . . . . 0.16 110.268 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.52 -42.47 98.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 110.253 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.37 69.34 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.51 0.672 . . . . 0.23000000000000001 110.92 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.6 -42.7 70.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.22 -0.9 . . . . 0.20000000000000001 110.642 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' LYS . . . . . 0.59 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.8 mmtt -60.47 -37.95 82.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.809 -0.632 . . . . 2.0099999999999998 111.11 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.52 -39.06 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 2.3700000000000001 111.441 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -97.46 10.98 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.257 -0.429 . . . . 1.49 111.159 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.82 33.18 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.33000000000000002 112.02 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.73 132.67 39.75 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.228 -0.442 . . . . 0.17000000000000001 110.071 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 18.6 Cg_endo -74.41 140.06 26.74 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.391 2.06 . . . . 0.20999999999999999 111.421 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 23.6 p90 -157.34 161.16 39.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.831 -0.622 . . . . 0.17999999999999999 110.493 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' A' ' 101' ' ' MET . 41.0 mt -124.21 140.95 46.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.288 -0.869 . . . . 0.23999999999999999 109.784 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.4 mm? -88.69 108.01 19.24 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.91 -0.774 . . . . 0.20999999999999999 108.91 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' HIS . . . . . 0.604 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 17.7 t-160 -99.49 82.42 2.65 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.593 0.711 . . . . 0.59999999999999998 109.722 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -137.98 157.97 45.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.426 -1.261 . . . . 0.60999999999999999 109.257 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.23 4.61 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.362 -0.923 . . . . 0.93999999999999995 111.955 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 12.9 m-20 -137.09 69.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 2.3300000000000001 111.458 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.46 HD11 HG11 ' A' ' 100' ' ' VAL . 82.2 mt -63.04 -34.77 78.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 1.6100000000000001 110.254 174.378 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -63.81 -29.17 70.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 2.6299999999999999 111.745 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -72.34 -21.6 61.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.232 0.539 . . . . 4.4199999999999999 110.508 -177.801 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -137.45 45.65 2.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 1.05 110.072 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLY . . . . . 0.763 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . -59.67 -27.06 63.35 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.97999999999999998 113.263 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.68 -25.16 63.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 2.5 110.642 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' LEU . . . . . 0.579 HD23 HG13 ' A' ' 57' ' ' VAL . 27.5 tp -77.22 -52.74 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.70999999999999996 111.884 -174.499 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -63.78 -23.94 67.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.178 0.513 . . . . 1.5800000000000001 111.545 -177.041 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' ARG . . . . . 0.543 ' N ' HD22 ' A' ' 93' ' ' LEU . 99.6 mtt180 -62.57 -34.26 76.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.186 -0.915 . . . . 4.3799999999999999 110.762 173.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -81.93 -33.68 30.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 2.4500000000000002 110.447 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ILE . . . . . 0.59 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 59.4 mt -74.34 -62.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.485 -0.78 . . . . 0.45000000000000001 111.606 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.13 76.81 0.21 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.408 0.623 . . . . 1.0900000000000001 111.471 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.42 164.83 19.37 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.28999999999999998 109.238 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.677 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.7 Cg_exo -56.52 144.26 85.14 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.668 2.245 . . . . 0.26000000000000001 113.003 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 86' ' ' LEU . 46.5 t -121.99 137.74 54.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.64000000000000001 110.751 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' MET . . . . . 0.471 ' HG2' HG21 ' A' ' 80' ' ' ILE . 86.6 mmm -117.56 105.55 12.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.702 -0.851 . . . . 0.82999999999999996 108.702 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.13 145.3 56.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.98 -0.554 . . . . 0.54000000000000004 111.861 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 87.4 mttt -91.34 140.89 25.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 0.67000000000000004 109.897 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.6 154.11 97.21 Favored 'Cis proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.567 -1.431 . . . . 0.75 112.472 2.024 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' ALA . . . . . 0.604 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 137.29 29.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.033 -0.531 . . . . 0.34999999999999998 110.216 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 110' ' ' VAL . 11.4 t70 -71.43 129.71 39.48 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.51000000000000001 108.468 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.9 p -67.18 -22.37 65.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.554 -0.748 . . . . 0.26000000000000001 112.542 -170.244 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 91.6 p -71.19 -37.42 72.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.653 -0.499 . . . . 1.3200000000000001 109.653 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -63.4 -46.68 85.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.323 0.583 . . . . 0.62 109.556 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG12 HG11 ' A' ' 54' ' ' VAL . 21.1 t -62.0 -44.88 99.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.991 -1.004 . . . . 0.13 110.62 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.46 -47.79 80.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.13 111.461 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 108' ' ' SER . 95.2 mttt -62.75 -44.76 95.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 1.95 111.403 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 33.4 mmt180 -64.1 -32.72 74.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.104 0.478 . . . . 2.23 111.091 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.57 -47.9 44.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.088 0.47 . . . . 0.14000000000000001 110.463 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LEU . . . . . 0.56 HD23 HG11 ' A' ' 52' ' ' VAL . 80.8 mt -69.75 -30.03 67.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.785 0.661 . . . . 0.27000000000000002 112.785 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.96 -31.61 72.62 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.763 -0.375 . . . . 2.79 110.715 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 117' ' ' MET . . . . . 0.677 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 55.7 mtm -70.79 -32.3 69.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.42999999999999999 110.802 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 42.0 t . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 1.46 110.486 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 112.388 -0.285 . . . . 8.8000000000000007 112.388 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.97 -9.55 15.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.409 . . . . 6.7800000000000002 110.408 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.5 mtp -85.0 -17.2 38.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.076 -0.511 . . . . 7.21 110.32 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.07 -142.52 4.95 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.915 -0.874 . . . . 1.8500000000000001 110.915 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.16 123.3 71.88 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.637 0.256 . . . . 1.6499999999999999 111.063 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.57 145.83 59.45 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.455 2.77 . . . . 0.33000000000000002 111.689 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -89.73 106.73 18.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.94 0.4 . . . . 0.89000000000000001 109.931 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 60.1 t -100.49 137.36 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.91 -0.586 . . . . 0.20000000000000001 111.062 -175.435 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB2' HD12 ' A' ' 50' ' ' ILE . 47.3 tp -111.11 116.92 31.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.305 -0.407 . . . . 0.75 110.323 174.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 t -100.77 121.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.261 0.553 . . . . 0.13 111.362 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -101.89 104.11 14.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.937 -1.029 . . . . 0.20999999999999999 108.658 172.915 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -161.21 113.47 1.87 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.903 -0.589 . . . . 1.4099999999999999 109.862 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 33.6 t70 -84.08 -12.56 54.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.086 -0.506 . . . . 1.27 109.865 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.28 100.37 1.38 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.347 -0.612 . . . . 2.5600000000000001 109.347 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.9 Cg_exo -60.18 -30.58 91.61 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.839 2.36 . . . . 0.32000000000000001 113.676 -171.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.62 -49.44 73.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.276 -0.638 . . . . 1.51 109.276 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.97 -44.74 92.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.686 -0.688 . . . . 1.01 111.059 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.72 75.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.20999999999999999 110.905 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.5 ttp -60.6 -42.66 97.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.923 -0.581 . . . . 0.60999999999999999 110.871 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.475 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.0 m-80 -66.43 -40.3 89.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.027 -0.533 . . . . 1.22 111.164 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.2 mt -62.98 -42.62 99.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.17999999999999999 110.443 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' CG ' ' HB ' ' A' ' 32' ' ' VAL . 1.5 tt0 -58.07 -50.95 71.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.166 -0.47 . . . . 1.04 109.809 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -56.07 -36.26 67.9 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.024 -0.535 . . . . 0.78000000000000003 111.109 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.6 45.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.14000000000000001 111.105 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 45.9 m-85 -64.81 -43.4 93.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.246 -0.434 . . . . 0.13 110.699 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 47.4 mt-10 -61.89 -35.08 77.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.279 . . . . 0.68999999999999995 110.553 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -32.12 72.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.497 . . . . 0.51000000000000001 110.592 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.978 0.418 . . . . 0.65000000000000002 110.375 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.73 49.74 1.25 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.85 -0.613 . . . . 0.28999999999999998 112.232 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 26' ' ' GLU . . . -139.99 165.93 26.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.646 0.26 . . . . 0.23000000000000001 111.254 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -108.67 142.87 38.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.818 -0.808 . . . . 2.1400000000000001 108.818 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 22' ' ' GLN . 7.0 t -125.9 133.57 68.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.238 0.459 . . . . 0.19 112.238 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.5 t -104.26 124.61 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.844 -0.798 . . . . 0.23000000000000001 108.844 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.49 121.63 49.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.915 0.388 . . . . 0.94999999999999996 110.824 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.57 134.24 46.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.958 -0.565 . . . . 0.16 110.369 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.52 -9.66 21.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.059 -0.519 . . . . 0.23999999999999999 110.8 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 p -128.86 158.85 37.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.25 110.86 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.538 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.6 m -64.27 -32.92 74.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.943 -0.392 . . . . 1.6000000000000001 109.943 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.1 -46.39 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.142 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 35.4 mt-30 -60.31 -42.64 96.0 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.336 0.589 . . . . 1.4099999999999999 110.436 175.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.85 -52.58 63.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.107 -0.951 . . . . 0.17999999999999999 111.732 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -63.87 -29.53 70.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.041 -0.527 . . . . 0.82999999999999996 110.568 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.97 -50.57 61.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.195 -0.668 . . . . 2.4100000000000001 109.195 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.417 ' OG ' HG11 ' A' ' 33' ' ' VAL . 8.7 t -65.45 -31.79 73.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.235 -0.439 . . . . 1.1299999999999999 110.466 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -42.93 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.23 110.544 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.74 20.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.42999999999999999 111.383 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.04 -37.36 58.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.62 111.45 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -123.89 161.07 48.77 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.163 -0.472 . . . . 0.41999999999999998 110.34 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -92.34 85.52 0.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.142 2.562 . . . . 0.23999999999999999 111.363 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 9' ' ' LEU . 40.2 mm -64.62 117.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.79 . . . . 0.22 111.507 -175.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.8 m-20 -83.67 -33.49 25.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.28999999999999998 110.265 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.528 HG11 HD23 ' A' ' 115' ' ' LEU . 14.8 p -160.58 155.38 3.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.12 109.574 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -136.3 166.92 22.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.312 0.577 . . . . 0.14000000000000001 111.266 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.567 HG21 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -141.17 120.75 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.682 -1.229 . . . . 0.95999999999999996 107.682 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.657 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -122.29 118.82 29.43 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.47 0.545 . . . . 0.16 112.47 -166.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.05 128.03 32.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.086 -0.709 . . . . 1.77 109.086 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.584 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 34.6 t -86.19 -22.52 7.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.655 -0.702 . . . . 0.80000000000000004 111.118 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -108.68 62.36 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 110.639 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.0 -34.26 77.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.84999999999999998 110.376 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.4 -173.84 36.63 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.81999999999999995 111.384 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -36.22 91.14 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.038 2.492 . . . . 1.1799999999999999 112.655 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 1.3 tmtp? -119.67 -34.74 3.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.868 0.366 . . . . 3.5299999999999998 110.185 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 p -69.51 127.46 33.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.593 0.711 . . . . 0.95999999999999996 111.472 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -145.36 150.14 36.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.261 -0.881 . . . . 0.48999999999999999 109.847 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 30.7 p -69.7 87.03 0.49 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.18 -0.674 . . . . 1.3 109.18 171.008 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.33 -68.44 0.41 Allowed Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.384 -0.912 . . . . 0.23000000000000001 112.282 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 48.3 Cg_exo -52.95 -28.46 39.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.268 1.978 . . . . 0.23999999999999999 111.532 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.7 t -68.56 -49.12 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.407 0.622 . . . . 0.12 110.05 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.37 88.57 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.887 -1.051 . . . . 0.16 110.292 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 20.8 t70 -66.01 -40.18 90.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.567 -0.742 . . . . 2.0299999999999998 110.516 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.29 74.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.514 0.673 . . . . 0.23000000000000001 110.637 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.28 -44.12 80.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.015 -0.993 . . . . 0.20000000000000001 110.373 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -57.88 -37.13 73.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 2.0099999999999998 111.413 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 77.4 mt-30 -61.8 -47.88 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 2.3700000000000001 111.23 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -90.9 5.62 47.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 1.49 111.582 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 31.29 19.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.33000000000000002 111.544 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.3 mt -81.49 131.48 58.2 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.627 -0.508 . . . . 0.17000000000000001 109.627 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -72.95 143.14 36.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.293 1.996 . . . . 0.20999999999999999 112.208 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 23.9 p90 -160.9 158.5 28.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.761 -0.654 . . . . 0.17999999999999999 110.619 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.43 HG21 ' HG2' ' A' ' 101' ' ' MET . 34.9 mt -123.6 138.23 54.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.329 -0.85 . . . . 0.23999999999999999 109.837 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 2.6 mm? -88.22 108.19 19.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.626 -0.509 . . . . 0.20999999999999999 109.626 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.615 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 22.3 t-160 -102.22 84.22 2.45 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.375 -0.602 . . . . 0.59999999999999998 109.375 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.523 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 7.2 t -125.47 152.34 45.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.445 -0.798 . . . . 0.60999999999999999 111.242 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.04 -8.16 55.63 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.317 -0.713 . . . . 0.93999999999999995 111.317 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 2.7 m-20 -126.98 124.05 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.747 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.13 -51.97 2.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.048 -0.524 . . . . 1.6100000000000001 110.535 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.55 -26.31 68.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 2.6299999999999999 111.388 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 18.1 mmm180 -64.69 -20.03 66.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 4.4199999999999999 111.858 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -144.31 40.01 1.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 1.05 111.319 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.37 -38.67 96.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.095 -0.574 . . . . 0.97999999999999998 112.783 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 6.2 pt-20 -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.449 . . . . 2.5 110.986 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.523 ' O ' HG13 ' A' ' 96' ' ' ILE . 18.9 tp -64.75 -46.97 79.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.70999999999999996 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 57' ' ' VAL . 36.0 mt -59.35 -38.26 79.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.588 -0.733 . . . . 1.5800000000000001 111.673 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 10.9 ptt180 -67.69 -25.84 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 4.3799999999999999 110.626 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 95.7 mttt -81.05 -37.71 28.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.131 0.491 . . . . 2.4500000000000002 110.278 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 92' ' ' LEU . 72.7 mt -65.01 -57.57 10.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.45000000000000001 110.455 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 57.03 76.54 0.31 Allowed 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.874 0.734 . . . . 1.0900000000000001 110.802 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.04 163.22 25.27 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.618 -0.719 . . . . 0.28999999999999998 109.726 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.09 140.85 86.33 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.933 2.422 . . . . 0.26000000000000001 112.151 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 1.1 m -127.64 149.64 32.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.191 0.52 . . . . 0.64000000000000001 110.824 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG2' HG21 ' A' ' 80' ' ' ILE . 74.0 mmm -121.47 107.9 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.82999999999999996 108.373 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -71.69 147.75 47.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.405 -0.361 . . . . 0.54000000000000004 111.446 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.5 mttt -90.92 141.61 26.8 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.05 -0.523 . . . . 0.67000000000000004 109.866 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -73.29 148.19 91.5 Favored 'Cis proline' 0 C--O 1.234 0.28 0 C-N-CA 123.477 -1.468 . . . . 0.75 112.849 2.073 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.615 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -144.78 136.25 25.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.416 -0.811 . . . . 0.34999999999999998 109.328 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.8 t70 -70.69 127.46 32.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.445 -0.946 . . . . 0.51000000000000001 108.445 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.4 p -62.56 -22.32 66.25 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.035 -0.984 . . . . 0.26000000000000001 112.233 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 78.9 p -68.74 -42.26 77.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.82 -0.437 . . . . 1.3200000000000001 109.82 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.75 -38.64 87.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.091 0.472 . . . . 0.62 110.054 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.567 HG12 HG21 ' A' ' 54' ' ' VAL . 33.5 t -64.19 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.283 -0.871 . . . . 0.13 110.106 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -68.47 -47.83 66.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.629 -0.714 . . . . 0.13 111.468 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 7.5 mtmp? -56.35 -55.32 34.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 1.95 111.174 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 35.6 mmt180 -62.1 -31.75 72.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.675 0.274 . . . . 2.23 111.578 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.85 70.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.14000000000000001 110.188 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.528 HD23 HG11 ' A' ' 52' ' ' VAL . 84.3 mt -70.68 -26.29 63.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.141 -0.481 . . . . 0.27000000000000002 111.695 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 8.0 mm-40 -60.64 -34.38 74.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 2.79 110.61 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 47.9 mtm -82.46 -13.62 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.42999999999999999 110.597 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 53.1 t -86.6 -49.32 7.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.748 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.75 158.76 12.26 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.583 -0.818 . . . . 2.5699999999999998 112.044 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -167.17 -79.15 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 111.344 -0.702 . . . . 4.4800000000000004 111.344 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -149.43 108.26 3.86 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.861 -0.422 . . . . 6.4199999999999999 109.861 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt 71.01 115.74 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.841 0.713 . . . . 9.1899999999999995 111.351 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -61.45 129.41 91.06 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.651 -0.704 . . . . 9.5999999999999996 110.413 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.59 62.52 7.13 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.484 2.122 . . . . 11.17 112.11 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.449 -0.786 . . . . 13.279999999999999 110.2 179.455 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.066 -0.414 . . . . 8.8000000000000007 112.066 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.78 141.52 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.262 0.625 . . . . 6.7800000000000002 111.386 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -72.98 128.88 36.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 7.21 110.306 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.52 123.16 5.06 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.765 -0.731 . . . . 1.8500000000000001 111.708 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 64.7 mtt -75.94 134.9 71.09 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 120.539 0.209 . . . . 1.6499999999999999 110.936 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.2 Cg_endo -71.65 141.37 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.236 1.957 . . . . 0.33000000000000002 110.86 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HG3' HD13 ' A' ' 50' ' ' ILE . 48.6 tptt -86.65 103.15 14.85 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.451 -0.574 . . . . 0.89000000000000001 109.451 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.9 t -100.09 134.51 39.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.721 -0.672 . . . . 0.20000000000000001 110.726 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.501 ' HB2' HD12 ' A' ' 50' ' ' ILE . 48.2 tp -111.54 113.44 25.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.863 0.363 . . . . 0.75 110.74 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -93.82 124.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.21 0.529 . . . . 0.13 111.599 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.773 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -105.59 101.37 10.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.057 -0.974 . . . . 0.20999999999999999 108.921 173.673 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -159.5 129.52 5.59 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.805 -0.634 . . . . 1.4099999999999999 109.782 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 28.8 t70 -90.3 -20.4 22.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.325 -0.398 . . . . 1.27 110.499 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -84.86 107.82 12.94 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 109.308 -0.627 . . . . 2.5600000000000001 109.308 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 35.7 Cg_exo -57.96 -29.68 87.41 Favored 'Trans proline' 0 CA--C 1.517 -0.35 0 C-N-CA 122.723 2.282 . . . . 0.32000000000000001 112.264 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.97 -51.33 64.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.456 -0.572 . . . . 1.51 109.456 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.25 -43.38 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 1.01 110.437 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG13 ' A' ' 34' ' ' VAL . . . -58.55 -49.69 76.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.886 -0.597 . . . . 0.20999999999999999 110.925 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.6 -35.93 79.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.93 -0.577 . . . . 0.60999999999999999 111.072 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.6 m-20 -66.02 -41.9 90.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.461 -0.336 . . . . 1.22 110.748 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.43 -44.35 91.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.823 0.344 . . . . 0.17999999999999999 110.145 173.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.518 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 59.6 tt0 -52.71 -53.02 53.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 1.04 110.343 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.79 -29.37 70.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.78000000000000003 111.701 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.19 -46.22 61.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 0.14000000000000001 110.76 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.4 m-85 -67.93 -41.66 82.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.107 -0.497 . . . . 0.13 110.599 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.79 -30.21 71.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.68999999999999995 110.728 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 110.374 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -82.49 8.17 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.65000000000000002 110.746 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.42 51.23 8.63 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.136 -0.554 . . . . 0.28999999999999998 112.448 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -132.64 164.86 25.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.862 0.363 . . . . 0.23000000000000001 111.375 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -108.08 125.97 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.173 -0.677 . . . . 2.1400000000000001 109.173 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.518 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.9 t -114.07 140.72 33.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 112.509 0.559 . . . . 0.19 112.509 -168.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 t -112.41 140.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.637 -0.875 . . . . 0.23000000000000001 108.637 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.431 HG13 ' HB1' ' A' ' 18' ' ' ALA . 84.1 t -111.26 124.7 68.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.773 0.321 . . . . 0.94999999999999996 110.92 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.6 134.09 38.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.146 -0.479 . . . . 0.16 110.725 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.54 -3.23 28.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.019 0.438 . . . . 0.23999999999999999 110.674 177.597 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -137.71 159.83 40.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 0.25 110.719 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 87.6 m -60.32 -34.25 73.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.038 -0.528 . . . . 1.6000000000000001 110.208 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.14 -47.83 81.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.656 . . . . 0.69999999999999996 111.012 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.9 mt-30 -60.56 -37.98 83.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.374 0.607 . . . . 1.4099999999999999 110.696 175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.773 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -65.78 -51.01 62.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.232 -0.894 . . . . 0.17999999999999999 111.708 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.8 mt -60.88 -29.95 69.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.105 0.479 . . . . 0.82999999999999996 110.472 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -64.85 -52.22 57.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.654 -0.703 . . . . 2.4100000000000001 110.158 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 t -67.71 -34.26 76.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.926 -0.579 . . . . 1.1299999999999999 110.304 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -58.68 -42.0 87.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 1.23 110.324 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.51 -33.92 28.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.42999999999999999 111.513 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.75 -37.49 27.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.62 111.623 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.95 164.6 20.18 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.849 0.357 . . . . 0.41999999999999998 110.873 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -95.05 86.96 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.47 2.78 . . . . 0.23999999999999999 111.441 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.2 mm -65.39 123.34 18.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.664 -0.698 . . . . 0.22 111.252 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 45.8 m-20 -93.18 -27.26 16.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.28999999999999998 110.726 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.49 ' CG1' HG22 ' A' ' 8' ' ' VAL . 13.3 p -164.16 157.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.493 -0.558 . . . . 0.12 109.493 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -142.82 165.48 27.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 0.14000000000000001 112.006 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.62 111.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.254 -0.884 . . . . 0.95999999999999996 109.165 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 8.8 mp -113.32 119.25 37.04 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.064 0.394 . . . . 0.16 112.064 -168.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -74.69 132.49 41.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.231 -1.025 . . . . 1.77 108.231 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.596 ' H ' ' HB ' ' A' ' 83' ' ' THR . 22.9 t -86.21 -10.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.386 0.612 . . . . 0.80000000000000004 110.029 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -129.2 73.27 1.51 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.814 -0.63 . . . . 2.3700000000000001 110.056 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 64' ' ' HIS . 4.0 mm? -56.28 -51.43 68.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.864 -0.607 . . . . 0.84999999999999998 109.711 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.61 -157.62 7.87 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.312 -0.858 . . . . 0.81999999999999995 111.184 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -55.12 -45.1 43.21 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.727 2.285 . . . . 1.1799999999999999 112.567 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -119.82 -33.87 3.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 3.5299999999999998 111.208 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 20.1 m -65.5 126.56 28.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.95999999999999996 110.99 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.679 ' HA ' HD23 ' A' ' 59' ' ' LEU . 11.1 p80 -144.86 163.26 34.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.96 -0.564 . . . . 0.48999999999999999 110.253 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 57' ' ' VAL . 26.4 p -75.28 88.32 2.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.315 0.579 . . . . 1.3 109.955 175.619 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 -77.81 1.01 Allowed Glycine 0 C--O 1.228 -0.27 0 C-N-CA 120.091 -1.052 . . . . 0.23000000000000001 111.979 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.6 Cg_exo -51.65 -24.76 18.3 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.024 2.482 . . . . 0.23999999999999999 112.749 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 13.8 t -67.37 -48.58 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 0.12 110.117 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -43.98 84.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.958 -1.019 . . . . 0.16 109.804 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 10.9 m-20 -64.63 -46.66 81.64 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.459 -0.792 . . . . 2.0299999999999998 110.519 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB1' ' HG ' ' A' ' 45' ' ' LEU . . . -53.53 -45.9 69.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.536 0.684 . . . . 0.23000000000000001 110.697 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.06 -46.89 72.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.952 -1.022 . . . . 0.20000000000000001 110.404 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 24.4 mmtp -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.874 -0.603 . . . . 2.0099999999999998 111.977 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 80.6 mm-40 -69.7 -26.21 64.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.577 -0.283 . . . . 2.3700000000000001 111.405 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -106.95 8.79 30.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.663 0.268 . . . . 1.49 111.244 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.31 35.2 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.837 -0.619 . . . . 0.33000000000000002 111.705 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.3 mt -84.8 132.82 45.03 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 109.894 -0.41 . . . . 0.17000000000000001 109.894 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.36 141.65 25.88 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.312 2.008 . . . . 0.20999999999999999 112.015 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 35.2 p90 -157.93 161.95 38.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.835 -0.62 . . . . 0.17999999999999999 110.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.61 141.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.25 -0.886 . . . . 0.23999999999999999 109.561 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.8 mm? -88.1 109.63 20.02 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.20999999999999999 109.669 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.512 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 15.4 t-160 -101.35 77.62 1.8 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.816 0.817 . . . . 0.59999999999999998 109.188 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.596 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 10.2 t -115.0 158.28 22.29 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.501 -1.227 . . . . 0.60999999999999999 110.127 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.74 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -108.34 -3.26 33.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.22 -0.752 . . . . 0.93999999999999995 111.22 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 11.0 m-20 -126.22 66.6 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.304 0.573 . . . . 2.3300000000000001 110.075 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.04 -54.72 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.367 -0.833 . . . . 1.6100000000000001 111.129 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.52 -20.42 64.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.322 -0.399 . . . . 2.6299999999999999 111.401 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 1.1 mmp_? -74.16 -26.27 60.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.16 -0.473 . . . . 4.4199999999999999 110.927 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.443 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.6 m-70 -123.17 35.28 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 1.05 111.174 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -59.67 -41.42 97.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.031 -0.604 . . . . 0.97999999999999998 113.01 -175.707 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.25 -37.8 81.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.656 0.265 . . . . 2.5 110.609 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.564 HD23 ' CG1' ' A' ' 57' ' ' VAL . 34.8 tp -68.43 -39.98 81.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.70999999999999996 110.412 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.6 mt -58.96 -42.08 89.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 1.5800000000000001 110.729 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.91 -27.42 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 4.3799999999999999 110.964 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.75 -42.29 50.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.012 -0.54 . . . . 2.4500000000000002 110.614 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.44 HG21 HD21 ' A' ' 81' ' ' LEU . 78.7 mt -67.76 -52.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.45000000000000001 111.18 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 t70 61.26 77.49 0.33 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0900000000000001 111.037 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -163.89 163.42 15.78 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.717 . . . . 0.28999999999999998 109.896 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.532 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.8 Cg_exo -56.97 149.82 59.45 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.804 2.336 . . . . 0.26000000000000001 112.847 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.74 132.4 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.64000000000000001 111.076 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.8 mmm -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.121 -0.696 . . . . 0.82999999999999996 109.121 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.15 132.15 48.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.54000000000000004 111.884 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.74 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 14.4 ptpt -97.2 150.33 36.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.67000000000000004 110.051 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.638 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 32.8 Cg_exo -60.05 127.96 3.93 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.952 -1.27 . . . . 0.75 113.268 2.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -129.74 134.25 47.51 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.34999999999999998 109.253 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.1 t70 -67.21 121.96 16.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.904 -0.776 . . . . 0.51000000000000001 108.904 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.5 p -62.13 -24.37 67.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.26 -0.882 . . . . 0.26000000000000001 112.474 -170.759 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.798 -0.445 . . . . 1.3200000000000001 109.798 177.446 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 25.6 m-20 -69.17 -37.79 78.38 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.937 -0.574 . . . . 0.62 109.972 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 106' ' ' ASP . 34.0 t -64.31 -46.07 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.676 -0.693 . . . . 0.13 110.253 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -60.37 -48.69 80.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.584 -0.735 . . . . 0.13 111.571 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 59.6 mtpt -59.12 -55.03 40.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 1.95 110.989 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.561 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 5.9 mpt_? -51.63 -43.14 62.49 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.028 0.381 . . . . 2.23 112.028 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.69 -50.33 69.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.14000000000000001 110.725 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.486 HD23 HG11 ' A' ' 52' ' ' VAL . 81.1 mt -65.91 -26.3 67.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.509 . . . . 0.27000000000000002 111.572 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 24.2 mm-40 -60.75 -43.43 97.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.678 0.275 . . . . 2.79 110.965 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.532 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 48.9 mtm -71.14 -29.78 65.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.962 0.411 . . . . 0.42999999999999999 110.5 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 35.6 t -77.42 -54.04 6.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.787 -0.642 . . . . 1.46 110.691 -178.421 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.83 67.05 0.13 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.924 -0.655 . . . . 2.5699999999999998 112.224 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -82.86 -73.34 1.24 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.895 -0.669 . . . . 4.4800000000000004 112.215 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.01 17.44 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.109 0.48 . . . . 6.4199999999999999 110.858 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -143.19 120.87 11.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.767 -0.651 . . . . 9.1899999999999995 110.535 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -79.38 127.85 77.34 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.576 -0.528 . . . . 9.5999999999999996 109.576 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.74 140.17 50.36 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.402 2.068 . . . . 11.17 112.119 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.423 -0.799 . . . . 13.279999999999999 110.753 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.982 -0.447 . . . . 8.8000000000000007 111.982 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.94 45.19 2.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.101 0.477 . . . . 6.7800000000000002 111.042 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.4 ttp -74.11 164.39 26.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.516 . . . . 7.21 109.644 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.43 -70.69 0.8 Allowed Glycine 0 CA--C 1.511 -0.16 0 O-C-N 123.488 0.493 . . . . 1.8500000000000001 112.433 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.5 mtp -102.77 119.98 54.08 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.57 -0.53 . . . . 1.6499999999999999 109.57 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.42 136.26 66.6 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.939 2.426 . . . . 0.33000000000000002 111.989 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -82.86 104.54 13.16 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.312 -0.625 . . . . 0.89000000000000001 109.312 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 49.9 t -100.02 135.1 37.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.514 -0.766 . . . . 0.20000000000000001 110.559 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 50' ' ' ILE . 46.4 tp -111.99 111.84 23.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 0.75 110.644 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -93.65 121.78 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.369 0.604 . . . . 0.13 111.332 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.38 106.79 17.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.20999999999999999 108.857 172.618 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -165.36 125.15 1.8 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 109.663 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.9 -26.5 34.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.863 -0.608 . . . . 1.27 109.607 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -78.71 108.65 8.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.68 -0.691 . . . . 2.5600000000000001 110.59 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.19 -35.09 98.26 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 112.949 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.88 -48.81 75.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.35 . . . . 1.51 110.278 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.5 -45.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 1.01 110.541 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.93 78.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.848 -0.614 . . . . 0.20999999999999999 110.902 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.21 -40.2 93.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.959 -0.564 . . . . 0.60999999999999999 111.08 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.5 m-20 -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 1.22 110.797 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.72 -44.91 96.0 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.806 0.336 . . . . 0.17999999999999999 110.368 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.501 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 46.0 tt0 -53.32 -49.88 66.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.526 -0.761 . . . . 1.04 110.43 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -58.86 -37.85 77.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.318 -0.401 . . . . 0.78000000000000003 111.466 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.39 -46.09 70.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.14000000000000001 110.889 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 66.1 m-85 -67.55 -43.8 79.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 0.13 110.938 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -59.78 -35.12 73.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.68999999999999995 110.675 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.14 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.51000000000000001 110.767 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.12 -10.54 59.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.65000000000000002 110.979 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.4 49.34 2.21 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.837 -0.697 . . . . 0.28999999999999998 112.279 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.09 163.69 29.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.357 -0.238 . . . . 0.23000000000000001 110.357 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -110.0 123.69 50.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.605 -0.517 . . . . 2.1400000000000001 109.605 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.2 t -106.65 138.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.526 0.565 . . . . 0.19 112.526 -168.19 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.61 133.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.377 -0.971 . . . . 0.23000000000000001 108.377 170.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.18 130.79 58.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.77 0.319 . . . . 0.94999999999999996 111.025 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.76 144.36 35.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.16 110.367 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.79 16.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.572 -0.285 . . . . 0.23999999999999999 111.432 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -134.18 176.6 8.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.086 -0.246 . . . . 0.25 110.677 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 1.5 p -68.37 -48.08 65.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.755 -0.461 . . . . 1.6000000000000001 109.755 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.25 -50.2 74.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.439 -0.801 . . . . 0.69999999999999996 111.779 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -58.69 -37.81 76.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.893 0.378 . . . . 1.4099999999999999 111.582 176.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -70.93 -49.46 45.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.259 -0.428 . . . . 0.17999999999999999 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 73.7 mt -61.63 -26.27 67.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.619 -0.718 . . . . 0.82999999999999996 110.502 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -62.74 -56.7 15.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 2.4100000000000001 110.309 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 28.8 t -70.32 -17.8 63.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.462 -0.336 . . . . 1.1299999999999999 111.094 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -68.32 -41.48 80.79 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.259 -0.645 . . . . 1.23 109.259 175.918 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.22 12.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.48 . . . . 0.42999999999999999 111.209 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.86 -37.19 73.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.037 -0.528 . . . . 0.62 111.619 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' SER . 91.1 m-20 -114.57 150.04 43.24 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.41999999999999998 110.863 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 73.0 Cg_endo -86.21 81.14 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.322 2.682 . . . . 0.23999999999999999 111.767 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 9' ' ' LEU . 44.1 mm -62.72 123.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.38 -0.827 . . . . 0.22 111.51 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.4 m-20 -90.66 -37.79 13.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.633 -0.712 . . . . 0.28999999999999998 110.063 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 11.3 p -157.35 155.66 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.761 -0.654 . . . . 0.12 109.619 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.78 162.62 35.0 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.431 0.634 . . . . 0.14000000000000001 112.063 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -134.72 111.69 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.092 -0.958 . . . . 0.95999999999999996 109.053 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.778 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.6 mp -112.96 114.99 27.71 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.238 0.458 . . . . 0.16 112.238 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 27.5 t70 -77.46 123.38 26.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.576 -0.898 . . . . 1.77 108.576 168.143 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' CG1' HD23 ' A' ' 92' ' ' LEU . 20.2 t -88.3 -10.8 10.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.363 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.7 56.28 0.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.824 -0.625 . . . . 2.3700000000000001 109.967 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.15 -26.82 67.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.744 -0.662 . . . . 0.84999999999999998 109.917 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.29 -168.43 31.27 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.57 -1.012 . . . . 0.81999999999999995 110.57 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.62 -43.1 62.15 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.662 2.241 . . . . 1.1799999999999999 111.737 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -115.26 -33.28 5.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 3.5299999999999998 110.755 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -58.05 123.52 16.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.265 0.555 . . . . 0.95999999999999996 111.253 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -144.59 149.97 36.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.513 -0.767 . . . . 0.48999999999999999 110.268 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -73.38 86.03 1.49 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.208 -0.664 . . . . 1.3 109.208 171.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.82 -71.57 0.81 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.396 -0.907 . . . . 0.23000000000000001 112.264 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -54.1 -25.77 38.71 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.54 2.16 . . . . 0.23999999999999999 111.926 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.6 t -69.17 -48.25 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.12 110.165 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.47 86.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.242 -0.89 . . . . 0.16 109.906 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 35.2 t70 -61.87 -42.94 99.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.207 -0.906 . . . . 2.0299999999999998 110.44 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB1' ' HG ' ' A' ' 45' ' ' LEU . . . -56.33 -46.63 79.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.448 0.642 . . . . 0.23000000000000001 110.903 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.48 -46.38 83.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.20000000000000001 110.188 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 73' ' ' LYS . 11.1 mmmm -58.85 -33.85 70.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.612 -0.722 . . . . 2.0099999999999998 111.486 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 99.0 mt-30 -57.84 -47.85 81.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 2.3700000000000001 110.979 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -92.15 6.41 46.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.196 -0.456 . . . . 1.49 110.939 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.15 31.84 21.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.33000000000000002 111.343 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -75.63 135.24 71.86 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.685 -0.487 . . . . 0.17000000000000001 109.685 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 118' ' ' CYS . 30.2 Cg_endo -75.56 138.65 21.97 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.132 1.888 . . . . 0.20999999999999999 111.687 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -157.19 159.32 37.6 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 110.285 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mt -122.91 139.25 50.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.67 -0.695 . . . . 0.23999999999999999 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 96' ' ' ILE . 2.4 mm? -88.84 108.37 19.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.611 -0.514 . . . . 0.20999999999999999 109.611 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.648 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.4 t-160 -103.0 71.8 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.775 -0.824 . . . . 0.59999999999999998 108.775 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.547 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 4.9 t -100.87 153.99 19.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.693 -1.14 . . . . 0.60999999999999999 111.99 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -91.95 -6.58 65.12 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.93999999999999995 112.348 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 2.3300000000000001 110.762 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.17 -4.35 11.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.894 -0.594 . . . . 1.6100000000000001 109.852 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.39 -59.82 2.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 2.6299999999999999 111.19 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -70.96 -41.55 70.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.389 0.614 . . . . 4.4199999999999999 110.781 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.539 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.2 m-70 -87.58 14.57 8.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.46 -0.791 . . . . 1.05 110.732 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -57.56 -49.92 69.53 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.441 -0.409 . . . . 0.97999999999999998 113.332 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.29 -40.04 96.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 2.5 110.332 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.53 HD23 ' CG1' ' A' ' 57' ' ' VAL . 33.1 tp -59.67 -42.61 93.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.70999999999999996 110.303 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.4 mt -60.39 -35.45 75.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.5800000000000001 111.336 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 19.1 mmm180 -71.44 -27.42 63.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.095 0.474 . . . . 4.3799999999999999 110.904 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.22 -33.44 63.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.831 -0.622 . . . . 2.4500000000000002 109.955 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 92' ' ' LEU . 81.3 mt -71.42 -56.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.324 -0.853 . . . . 0.45000000000000001 110.999 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 59.97 78.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.536 0.684 . . . . 1.0900000000000001 110.879 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -161.11 163.14 21.06 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 0.28999999999999998 109.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.23 141.44 96.68 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.589 2.193 . . . . 0.26000000000000001 112.437 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -119.7 133.66 65.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.14 0.495 . . . . 0.64000000000000001 111.274 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.8 mmm -118.94 91.28 3.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.712 -0.847 . . . . 0.82999999999999996 108.712 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.31 154.1 36.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.895 -0.593 . . . . 0.54000000000000004 111.735 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 96.4 mttt -90.75 143.84 29.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.67000000000000004 109.747 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 140.4 66.03 Favored 'Cis proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.561 -1.433 . . . . 0.75 112.607 2.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.648 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -137.16 129.46 29.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.807 -0.633 . . . . 0.34999999999999998 110.273 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 110' ' ' VAL . 10.3 t70 -72.28 129.69 39.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.966 -0.753 . . . . 0.51000000000000001 108.966 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.541 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.3 p -63.46 -22.67 67.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.271 -0.877 . . . . 0.26000000000000001 112.542 -171.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.6 p -68.77 -42.9 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 1.3200000000000001 109.927 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.563 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 45.4 m-20 -68.18 -41.26 81.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.62 109.548 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 106' ' ' ASP . 24.7 t -61.86 -44.59 99.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.556 -0.747 . . . . 0.13 110.519 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.15 -50.59 65.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.13 111.637 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 108' ' ' SER . 30.6 mtpp -64.25 -40.67 96.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 1.95 111.61 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.563 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 10.2 mpt_? -63.55 -32.1 73.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.886 0.374 . . . . 2.23 111.77 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.55 -51.33 10.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 0.14000000000000001 111.053 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.521 HD23 HG11 ' A' ' 52' ' ' VAL . 64.4 mt -63.5 -26.01 68.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.107 0.78 . . . . 0.27000000000000002 113.107 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -25.78 62.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.62 -0.432 . . . . 2.79 110.914 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.6 mtm -71.61 -25.68 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.42999999999999999 111.161 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.423 ' HB2' ' CG ' ' A' ' 78' ' ' PRO . 45.2 t -151.43 67.96 0.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 1.46 110.974 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -112.61 -5.41 24.23 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.035 -0.826 . . . . 2.5699999999999998 111.035 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.69 -33.53 4.24 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.132 -0.556 . . . . 4.4800000000000004 111.726 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.04 103.45 8.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.831 0.348 . . . . 6.4199999999999999 110.542 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -106.18 150.04 26.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.108 -0.496 . . . . 9.1899999999999995 110.321 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.24 115.59 61.9 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.035 -0.529 . . . . 9.5999999999999996 111.021 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.42 171.59 9.85 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.709 2.273 . . . . 11.17 111.782 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.559 -0.734 . . . . 13.279999999999999 110.514 178.494 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 112.053 -0.419 . . . . 8.8000000000000007 112.053 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.38 102.56 3.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.789 0.328 . . . . 6.7800000000000002 111.047 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 ttt -103.02 -21.17 13.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.323 0.583 . . . . 7.21 110.548 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.31 -35.95 5.57 Favored Glycine 0 CA--C 1.509 -0.303 0 N-CA-C 111.362 -0.695 . . . . 1.8500000000000001 111.362 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.451 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 80.2 mtp -92.24 130.98 35.94 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.183 -0.673 . . . . 1.6499999999999999 109.183 175.175 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 33.6 Cg_exo -59.53 134.79 60.38 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.479 2.119 . . . . 0.33000000000000002 111.823 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 14.4 tptp -83.64 103.81 13.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.326 -0.62 . . . . 0.89000000000000001 109.326 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.3 t -99.5 130.47 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.815 -0.63 . . . . 0.20000000000000001 110.779 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.434 ' HB2' HD12 ' A' ' 50' ' ' ILE . 49.9 tp -106.04 112.46 25.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.852 -0.613 . . . . 0.75 110.295 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -92.97 122.8 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.077 0.465 . . . . 0.13 111.613 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.44 101.04 10.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.284 -0.871 . . . . 0.20999999999999999 109.284 173.274 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.24 127.18 5.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.448 -0.796 . . . . 1.4099999999999999 109.8 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -89.41 -16.56 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.78 -0.645 . . . . 1.27 110.125 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -88.36 108.39 21.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 2.5600000000000001 110.301 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.93 -34.94 99.33 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.748 2.299 . . . . 0.32000000000000001 112.982 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 59.8 tp -62.94 -49.7 73.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 1.51 110.513 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.95 -45.32 97.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 1.01 110.624 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 34' ' ' VAL . . . -57.54 -52.21 66.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.20999999999999999 110.784 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.449 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 36.7 ttp -62.55 -37.29 85.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.60999999999999999 111.008 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 107' ' ' THR . 8.0 t-20 -65.69 -47.8 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.22 110.501 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 53.1 mt -60.26 -45.56 92.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.936 -0.575 . . . . 0.17999999999999999 109.888 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 57.7 tt0 -51.8 -50.42 60.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.131 -0.941 . . . . 1.04 111.063 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.449 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 17.5 m-85 -67.17 -32.38 73.43 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.139 -0.224 . . . . 0.78000000000000003 111.249 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.85 85.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.84 0.353 . . . . 0.14000000000000001 110.827 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -68.08 -45.76 72.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.46 . . . . 0.13 110.644 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 45.8 mt-10 -61.9 -30.19 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.474 -0.33 . . . . 0.68999999999999995 110.765 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.01 -41.56 95.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.149 -0.478 . . . . 0.51000000000000001 110.549 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -74.71 -15.62 60.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 0.65000000000000002 110.84 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.76 44.92 1.46 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.833 -0.699 . . . . 0.28999999999999998 112.559 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -134.21 153.62 51.74 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.771 -0.253 . . . . 0.23000000000000001 110.437 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.28 142.49 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.558 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 44.4 t -123.72 143.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.48 0.548 . . . . 0.19 112.48 -170.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.501 HG11 ' OG ' ' A' ' 44' ' ' SER . 14.9 t -118.44 132.28 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.758 . . . . 0.23000000000000001 108.955 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.431 HG23 ' HB1' ' A' ' 18' ' ' ALA . 12.7 p -96.56 130.39 45.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.028 0.442 . . . . 0.94999999999999996 111.601 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.23 134.63 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.16 110.701 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.14 17.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.23999999999999999 111.003 178.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.0 p -124.79 162.05 25.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.114 -0.494 . . . . 0.25 110.648 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 67.1 m -66.32 -33.67 76.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.56 -0.533 . . . . 1.6000000000000001 109.56 175.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.27 -48.4 78.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.513 -0.767 . . . . 0.69999999999999996 111.045 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -58.28 -42.09 85.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.243 0.544 . . . . 1.4099999999999999 110.574 176.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.3 -53.01 62.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.142 -0.935 . . . . 0.17999999999999999 111.522 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 86.9 mt -61.54 -28.68 69.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.071 0.462 . . . . 0.82999999999999996 110.96 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.55 -53.47 22.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 2.4100000000000001 109.748 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.501 ' OG ' HG11 ' A' ' 33' ' ' VAL . 22.7 t -65.95 -34.77 78.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 110.372 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.51 -35.56 78.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 1.23 110.776 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.52 -33.84 28.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.378 -0.374 . . . . 0.42999999999999999 111.118 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.43 -38.12 35.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.62 111.611 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -114.94 163.55 19.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.46 . . . . 0.41999999999999998 110.753 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.65 83.03 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.434 2.756 . . . . 0.23999999999999999 111.309 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 37.1 mm -65.74 122.21 16.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.562 -0.745 . . . . 0.22 111.754 -174.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.766 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 32.5 m-20 -91.09 -32.47 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.115 -0.948 . . . . 0.28999999999999998 110.771 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.571 HG11 HD23 ' A' ' 115' ' ' LEU . 14.4 p -160.2 158.3 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.12 109.836 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.19 161.09 39.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.156 0.503 . . . . 0.14000000000000001 111.907 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.56 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -132.09 112.41 19.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.7 . . . . 0.95999999999999996 109.682 174.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.792 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -112.47 121.8 45.86 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.23 -0.441 . . . . 0.16 112.083 -170.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.671 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.8 t0 -81.66 114.98 20.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.86 -0.792 . . . . 1.77 108.86 168.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.528 ' H ' ' HB ' ' A' ' 83' ' ' THR . 17.2 t -76.53 -7.91 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.038 -0.983 . . . . 0.80000000000000004 110.43 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.13 65.93 1.21 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 2.3700000000000001 109.778 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.08 -29.5 70.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.581 -0.736 . . . . 0.84999999999999998 109.621 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 -162.54 12.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.151 -0.931 . . . . 0.81999999999999995 111.09 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.0 -38.76 93.19 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.89 2.393 . . . . 1.1799999999999999 112.676 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' NZ ' ' HB2' ' A' ' 62' ' ' LYS . 4.5 ttmp? -126.35 -34.43 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.468 -0.333 . . . . 3.5299999999999998 110.792 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 p -60.48 127.61 32.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.476 0.655 . . . . 0.95999999999999996 111.054 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -144.29 156.02 44.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.412 -0.813 . . . . 0.48999999999999999 110.8 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.8 p -70.49 86.79 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.894 -0.78 . . . . 1.3 108.894 168.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.16 -74.82 1.04 Allowed Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 120.191 -1.004 . . . . 0.23000000000000001 112.374 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.68 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.9 Cg_exo -53.37 -26.19 34.22 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.488 2.125 . . . . 0.23999999999999999 111.981 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 10.7 t -69.33 -44.79 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.12 110.381 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -52.69 64.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.828 . . . . 0.16 109.956 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 33.3 t70 -60.99 -38.18 85.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.107 -0.951 . . . . 2.0299999999999998 110.495 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.1 78.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.355 0.597 . . . . 0.23000000000000001 111.03 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.38 -39.7 85.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.402 -0.817 . . . . 0.20000000000000001 110.095 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -59.55 -39.03 82.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.622 -0.717 . . . . 2.0099999999999998 111.171 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 55.0 mt-30 -65.56 -43.18 90.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 2.3700000000000001 111.216 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -87.85 2.18 52.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.828 0.347 . . . . 1.49 110.813 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.01 31.22 19.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.538 -0.756 . . . . 0.33000000000000002 111.454 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.99 131.9 49.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.17000000000000001 109.775 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 25.6 Cg_endo -73.7 138.47 26.51 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.166 1.911 . . . . 0.20999999999999999 111.62 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.02 157.39 34.59 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.609 -0.723 . . . . 0.17999999999999999 110.387 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.7 mt -122.31 141.06 44.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.609 -0.723 . . . . 0.23999999999999999 109.888 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 96' ' ' ILE . 2.2 mm? -89.33 108.23 19.51 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.78 -0.452 . . . . 0.20999999999999999 109.78 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.634 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.6 t-160 -103.02 72.28 1.17 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.512 -0.921 . . . . 0.59999999999999998 108.512 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.671 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 10.2 t -99.77 155.01 17.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.276 -1.329 . . . . 0.60999999999999999 111.784 -170.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 0.9 59.39 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.734 -0.666 . . . . 0.93999999999999995 112.898 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -154.78 121.08 5.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 2.3300000000000001 110.258 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.3 mp -106.47 -22.89 12.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.183 -0.462 . . . . 1.6100000000000001 111.606 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -83.87 -30.65 26.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.9 -0.32 . . . . 2.6299999999999999 111.213 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -79.85 -10.08 59.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.348 0.594 . . . . 4.4199999999999999 110.348 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.538 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 99.5 m-70 -131.35 24.11 4.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 1.05 111.225 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -63.73 -42.01 98.75 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.851 -0.69 . . . . 0.97999999999999998 112.879 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 33.1 mt-10 -71.66 -25.37 62.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 2.5 110.369 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 57' ' ' VAL . 55.5 tp -74.53 -43.59 55.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.207 -0.451 . . . . 0.70999999999999996 110.224 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.1 mt -58.38 -37.7 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 1.5800000000000001 111.834 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 36.5 ptt180 -65.24 -26.57 68.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 4.3799999999999999 110.912 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -76.12 -35.27 59.36 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.157 0.503 . . . . 2.4500000000000002 110.136 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 81' ' ' LEU . 55.8 mt -69.9 -52.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.228 -0.897 . . . . 0.45000000000000001 110.445 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 55.51 70.37 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.465 0.65 . . . . 1.0900000000000001 110.579 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -155.96 162.38 27.54 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.368 -0.833 . . . . 0.28999999999999998 109.349 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.24 141.22 94.53 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.666 2.244 . . . . 0.26000000000000001 112.62 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.7 t -118.62 134.68 61.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.64000000000000001 111.289 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 78.6 mmm -119.44 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.656 -0.868 . . . . 0.82999999999999996 108.656 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.69 152.53 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.018 -0.537 . . . . 0.54000000000000004 111.691 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 95.8 mttt -90.29 144.81 31.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.723 -0.671 . . . . 0.67000000000000004 109.844 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.6 Cg_exo -71.12 142.15 71.92 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.561 -1.433 . . . . 0.75 112.433 0.697 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.634 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -139.83 130.18 25.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.83 -0.623 . . . . 0.34999999999999998 110.266 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.8 t70 -66.11 124.31 22.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.51000000000000001 109.404 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.4 p -62.56 -27.63 69.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.432 -0.803 . . . . 0.26000000000000001 112.238 -172.277 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 t -70.02 -40.1 75.41 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.615 -0.513 . . . . 1.3200000000000001 109.615 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -65.27 -43.98 89.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.086 0.469 . . . . 0.62 109.803 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 106' ' ' ASP . 23.4 t -60.75 -43.7 95.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.307 -0.86 . . . . 0.13 110.428 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.46 -50.53 67.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.13 111.171 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.618 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 54.9 mtpt -56.33 -55.53 32.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 1.95 111.341 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 35.5 mmt180 -60.03 -35.46 75.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 2.23 111.374 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.31 47.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.509 . . . . 0.14000000000000001 110.541 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.571 HD23 HG11 ' A' ' 52' ' ' VAL . 80.7 mt -63.52 -25.5 68.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.631 . . . . 0.27000000000000002 111.848 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 35.0 mm-40 -60.42 -26.53 66.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.694 0.283 . . . . 2.79 111.236 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 67.9 mtm -85.81 -1.67 57.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.49 -0.323 . . . . 0.42999999999999999 111.369 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 49.2 t -135.59 73.63 1.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.167 0.508 . . . . 1.46 110.044 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.26 31.19 7.34 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.702 -0.761 . . . . 2.5699999999999998 112.371 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -107.76 42.79 1.84 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.929 -0.653 . . . . 4.4800000000000004 112.005 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.1 t70 73.3 154.51 0.15 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.471 0.708 . . . . 6.4199999999999999 110.933 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 57.3 tttp 63.45 63.84 0.85 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.326 0.584 . . . . 9.1899999999999995 110.375 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -78.07 122.52 85.49 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.743 -0.662 . . . . 9.5999999999999996 110.359 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.53 159.02 54.24 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.505 2.136 . . . . 11.17 112.136 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.544 -0.741 . . . . 13.279999999999999 110.697 -178.437 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.833 -0.507 . . . . 8.8000000000000007 111.833 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.56 138.6 56.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.835 0.35 . . . . 6.7800000000000002 110.669 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.3 ttt -66.48 -27.37 67.74 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.668 -0.696 . . . . 7.21 110.887 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.72 -139.71 3.49 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.791 -0.923 . . . . 1.8500000000000001 110.791 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 90.8 mtp -114.32 119.79 39.52 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 110.032 -0.359 . . . . 1.6499999999999999 110.032 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.24 137.73 44.66 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.165 2.577 . . . . 0.33000000000000002 111.928 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.97 107.3 17.04 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.342 -0.614 . . . . 0.89000000000000001 109.342 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' CG1' ' A' ' 52' ' ' VAL . 47.1 t -100.09 138.86 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 0.20000000000000001 110.809 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 48.3 tp -111.23 115.66 29.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.398 -0.365 . . . . 0.75 110.276 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.17 123.47 51.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.231 0.539 . . . . 0.13 111.024 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.78 106.01 16.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.214 -0.903 . . . . 0.20999999999999999 109.326 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -168.34 123.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.044 -0.526 . . . . 1.4099999999999999 109.761 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.5 t70 -87.1 -19.99 27.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.661 . . . . 1.27 110.1 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB3' HD13 ' A' ' 17' ' ' ILE . 44.5 mm-40 -81.22 104.86 3.25 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 115.878 -0.601 . . . . 2.5600000000000001 109.963 175.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.0 Cg_exo -58.07 -29.5 87.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.919 2.413 . . . . 0.32000000000000001 113.427 -172.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt -69.61 -50.74 41.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.879 -0.415 . . . . 1.51 109.879 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -63.3 -44.08 98.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.01 109.736 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.64 -49.17 78.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.359 -0.837 . . . . 0.20999999999999999 110.557 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.0 ttp -59.33 -42.27 91.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.60999999999999999 111.068 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.512 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.7 m-20 -64.38 -47.55 78.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 1.22 111.083 -179.443 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.9 mt -60.11 -46.1 90.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.39 -0.368 . . . . 0.17999999999999999 110.449 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 49.3 tt0 -54.47 -51.03 66.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.818 -0.628 . . . . 1.04 110.917 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.857 -0.337 . . . . 0.78000000000000003 110.887 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.68 -46.32 72.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.941 0.401 . . . . 0.14000000000000001 110.277 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 m-85 -66.9 -44.03 81.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.13 110.803 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.02 -28.04 67.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.537 -0.301 . . . . 0.68999999999999995 111.015 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.32 -27.81 65.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.314 0.578 . . . . 0.51000000000000001 109.983 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -84.71 2.45 41.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.67 . . . . 0.65000000000000002 111.05 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 5' ' ' MET . . . 81.92 47.15 6.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.922 -0.656 . . . . 0.28999999999999998 112.632 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.98 8.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.633 0.254 . . . . 0.23000000000000001 110.363 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.82 134.29 55.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.514 -0.55 . . . . 2.1400000000000001 109.514 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -116.07 135.79 55.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.319 0.489 . . . . 0.19 112.319 -168.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.46 122.74 63.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.23000000000000001 107.925 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.57 124.73 55.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.721 -0.392 . . . . 0.94999999999999996 110.697 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.11 139.31 50.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.934 -0.576 . . . . 0.16 110.702 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.83 -11.35 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.23999999999999999 111.252 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -130.68 170.53 14.19 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.954 -0.298 . . . . 0.25 111.492 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.559 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.2 p -60.84 -49.47 77.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.6000000000000001 109.646 171.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -52.24 -50.01 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.667 -1.151 . . . . 0.69999999999999996 111.764 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -59.81 -37.02 77.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 1.4099999999999999 111.187 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -71.38 -49.46 41.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.67 -0.695 . . . . 0.17999999999999999 111.225 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 72.8 mt -63.5 -28.98 70.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.731 -0.668 . . . . 0.82999999999999996 110.158 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 7.5 tmtm? -63.93 -50.69 67.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.385 -0.598 . . . . 2.4100000000000001 109.385 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 t -64.65 -32.02 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.219 -0.446 . . . . 1.1299999999999999 110.878 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 -41.81 89.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.123 0.487 . . . . 1.23 110.376 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.19 -38.26 20.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.42999999999999999 111.54 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.33 -36.47 58.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.065 -0.516 . . . . 0.62 111.408 -174.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -122.16 162.11 39.23 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.345 -0.389 . . . . 0.41999999999999998 110.428 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -92.82 88.24 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.303 2.669 . . . . 0.23999999999999999 111.149 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 47.1 mm -67.4 119.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.715 -0.675 . . . . 0.22 111.52 -174.592 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -91.06 -30.75 16.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.924 -0.58 . . . . 0.28999999999999998 110.197 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 115' ' ' LEU . 12.0 p -160.88 157.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.731 . . . . 0.12 109.409 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.84 166.02 25.92 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.456 0.646 . . . . 0.14000000000000001 111.239 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -137.9 120.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.747 -1.205 . . . . 0.95999999999999996 107.747 174.301 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.9 mp -116.36 109.17 16.99 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.729 -0.388 . . . . 0.16 111.301 -170.272 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.79 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -80.67 97.78 7.41 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.8 -0.815 . . . . 1.77 108.8 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 64' ' ' HIS . 46.8 t -50.71 -31.18 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.212 -0.904 . . . . 0.80000000000000004 112.44 -170.815 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -95.75 80.08 3.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.934 0.397 . . . . 2.3700000000000001 110.392 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.83 -14.45 59.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.563 0.697 . . . . 0.84999999999999998 110.09 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.88 -166.27 35.82 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.754 -0.938 . . . . 0.81999999999999995 110.754 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.71 -45.36 41.64 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.916 2.411 . . . . 1.1799999999999999 112.311 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -120.85 -22.14 6.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.371 -0.377 . . . . 3.5299999999999998 110.812 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.7 m -63.4 129.12 38.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.112 0.482 . . . . 0.95999999999999996 111.147 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 15.5 p80 -144.0 153.27 42.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.48999999999999999 110.282 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.5 m -79.1 86.44 4.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.827 -0.805 . . . . 1.3 108.827 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.55 -66.47 0.7 Allowed Glycine 0 C--N 1.328 0.132 0 C-N-CA 120.62 -0.8 . . . . 0.23000000000000001 112.392 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.67 -23.76 50.87 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.396 2.064 . . . . 0.23999999999999999 111.621 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.508 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.5 t -68.17 -47.74 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.96 -0.564 . . . . 0.12 109.774 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.06 -47.73 80.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.99 -1.005 . . . . 0.16 110.087 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 19.3 t70 -64.09 -36.41 83.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 2.0299999999999998 110.571 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -62.93 -40.48 97.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.409 0.623 . . . . 0.23000000000000001 110.888 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.69 -43.87 62.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.20000000000000001 110.529 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 28.2 mmmt -57.33 -39.58 76.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.565 -0.743 . . . . 2.0099999999999998 111.166 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.667 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 6.8 pt20 -64.88 -37.76 88.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.533 -0.758 . . . . 2.3700000000000001 110.957 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG3' ' CG ' ' A' ' 74' ' ' GLN . 96.3 mtt180 -99.47 7.57 45.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 1.49 111.899 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.94 23.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.133 -0.485 . . . . 0.33000000000000002 111.734 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.429 HG21 HG22 ' A' ' 50' ' ' ILE . 81.8 mt -83.54 132.7 48.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.17000000000000001 109.744 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -72.62 140.67 33.07 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.354 2.036 . . . . 0.20999999999999999 112.302 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 12.2 p90 -161.25 156.9 24.78 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.17999999999999999 110.417 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 mt -119.6 138.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.591 -0.731 . . . . 0.23999999999999999 109.869 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 96' ' ' ILE . 2.5 mm? -89.19 109.71 20.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.17 -0.678 . . . . 0.20999999999999999 109.17 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.79 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 19.3 t-160 -102.05 117.54 35.01 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.638 -0.875 . . . . 0.59999999999999998 108.638 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.736 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 8.9 t -171.33 154.21 3.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.733 0.301 . . . . 0.60999999999999999 110.586 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.2 33.13 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.465 -0.654 . . . . 0.93999999999999995 111.465 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -111.21 60.44 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.353 0.597 . . . . 2.3300000000000001 109.928 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.69 -48.78 58.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.408 -0.815 . . . . 1.6100000000000001 110.871 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -63.55 -33.62 76.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 2.6299999999999999 110.783 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 4.9 mmp_? -71.82 -15.4 62.14 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 4.4199999999999999 111.9 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 87.3 m-70 -134.25 31.59 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.745 0.276 . . . . 1.05 111.745 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.01 -28.48 71.69 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.835 -0.698 . . . . 0.97999999999999998 112.469 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.579 ' HA ' ' HE ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -76.45 -26.1 55.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 2.5 110.34 178.996 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 tp -76.95 -47.51 20.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.85 -0.614 . . . . 0.70999999999999996 109.864 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 79.2 mt -57.3 -39.59 76.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.861 -0.608 . . . . 1.5800000000000001 112.082 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 91' ' ' GLU . 11.1 ptp180 -66.17 -25.28 66.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.668 0.27 . . . . 4.3799999999999999 111.343 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -73.38 -30.16 63.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.398 0.618 . . . . 2.4500000000000002 110.14 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.504 HG21 HD21 ' A' ' 81' ' ' LEU . 55.4 mt -82.72 -53.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.18 -0.918 . . . . 0.45000000000000001 110.877 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.02 74.22 0.34 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.718 0.77 . . . . 1.0900000000000001 110.831 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.31 168.56 11.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 114.789 -1.096 . . . . 0.28999999999999998 108.503 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.83 135.85 71.67 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.097 1.865 . . . . 0.26000000000000001 112.338 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 t -123.75 117.47 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.64000000000000001 110.726 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.613 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.4 mtp -103.05 116.75 33.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.82999999999999996 109.941 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.736 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.97 148.87 37.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.814 -0.63 . . . . 0.54000000000000004 111.594 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 76.8 mttt -90.68 143.18 28.61 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 0.67000000000000004 109.779 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -74.04 144.55 81.33 Favored 'Cis proline' 0 C--O 1.234 0.299 0 C-N-CA 123.282 -1.549 . . . . 0.75 112.925 1.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.663 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -138.66 131.88 30.01 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.347 -0.842 . . . . 0.34999999999999998 108.936 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 110' ' ' VAL . 11.3 t70 -73.08 129.42 38.04 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.964 -0.754 . . . . 0.51000000000000001 108.964 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.3 p -62.18 -21.05 64.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.375 -0.829 . . . . 0.26000000000000001 112.758 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.7 p -69.02 -43.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.874 -0.417 . . . . 1.3200000000000001 109.874 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.82 -39.9 87.84 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.134 -0.484 . . . . 0.62 110.166 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.613 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.8 t -61.87 -47.76 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.754 -0.657 . . . . 0.13 110.333 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.16 -48.37 78.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 0.13 111.21 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.28 -41.18 98.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 1.95 111.271 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -68.1 -27.38 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.745 0.307 . . . . 2.23 111.66 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -49.89 12.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.921 0.391 . . . . 0.14000000000000001 110.233 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.539 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 71.1 mt -65.08 -27.09 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.85 0.685 . . . . 0.27000000000000002 112.85 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.56 -26.92 66.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.732 -0.387 . . . . 2.79 110.946 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 69.8 mtm -73.84 -33.04 63.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.416 -0.356 . . . . 0.42999999999999999 111.06 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.539 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.5 p -91.69 -1.57 57.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.32 0.581 . . . . 1.46 110.522 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -104.18 16.49 49.55 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.83 -0.908 . . . . 2.5699999999999998 110.83 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -163.76 65.16 0.24 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.286 -0.726 . . . . 4.4800000000000004 111.286 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.06 15.57 8.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.236 0.541 . . . . 6.4199999999999999 110.501 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -110.42 144.67 38.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.544 -0.753 . . . . 9.1899999999999995 109.887 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -67.9 134.48 92.03 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.1 -0.5 . . . . 9.5999999999999996 110.549 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.73 49.14 1.46 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.934 2.423 . . . . 11.17 112.307 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.51 -0.757 . . . . 13.279999999999999 109.861 -178.436 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.898 -0.481 . . . . 8.8000000000000007 111.898 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.83 85.83 7.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.94 0.4 . . . . 6.7800000000000002 110.918 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.65 157.59 18.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.073 -0.512 . . . . 7.21 109.704 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.93 100.83 0.84 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.842 -0.694 . . . . 1.8500000000000001 111.945 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 54.6 mtt -74.66 128.64 85.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.8 0.333 . . . . 1.6499999999999999 110.963 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HG2' HD22 ' A' ' 115' ' ' LEU . 1.5 Cg_endo -70.84 142.91 44.27 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.846 2.364 . . . . 0.33000000000000002 112.428 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -90.05 105.63 17.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.89000000000000001 109.004 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.3 t -99.73 136.27 31.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.987 -0.551 . . . . 0.20000000000000001 111.27 -173.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HB2' HD12 ' A' ' 50' ' ' ILE . 42.5 tp -109.31 112.0 23.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.134 -0.485 . . . . 0.75 110.273 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.62 122.86 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.298 0.57 . . . . 0.13 111.641 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -103.76 111.94 24.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.7 -1.136 . . . . 0.20999999999999999 108.704 172.686 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -170.16 127.23 0.84 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.38 -0.6 . . . . 1.4099999999999999 109.38 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.6 t70 -85.24 -25.58 27.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.27 110.324 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -75.55 106.57 3.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 2.5600000000000001 110.555 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 33.1 Cg_exo -59.64 -31.7 94.74 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.771 2.314 . . . . 0.32000000000000001 112.982 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.47 -49.59 68.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.329 -0.619 . . . . 1.51 109.329 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.2 mt -66.24 -47.08 85.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.374 -0.83 . . . . 1.01 111.27 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.56 82.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 0.20999999999999999 110.654 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -58.96 -44.74 91.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.727 -0.67 . . . . 0.60999999999999999 110.924 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' HB3' HG21 ' A' ' 107' ' ' THR . 1.3 m120 -68.2 -37.35 80.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.751 -0.659 . . . . 1.22 111.394 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.65 -45.04 88.48 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.506 -0.315 . . . . 0.17999999999999999 110.379 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 62.4 tt0 -55.25 -53.05 61.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 1.04 110.311 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -64.16 -27.72 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.78000000000000003 111.563 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.66 -46.36 63.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.766 0.317 . . . . 0.14000000000000001 110.73 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.701 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 54.0 m-85 -67.26 -42.3 84.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.367 -0.379 . . . . 0.13 110.526 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.58 -31.79 71.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.68999999999999995 110.039 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -35.52 76.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.756 -0.656 . . . . 0.51000000000000001 110.694 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -75.76 -20.55 58.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.142 0.496 . . . . 0.65000000000000002 110.305 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 56.27 0.7 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.705 -0.679 . . . . 0.28999999999999998 111.748 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.16 171.37 15.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.728 0.299 . . . . 0.23000000000000001 110.803 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.99 150.25 25.09 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 47.1 t -134.27 138.49 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.389 0.514 . . . . 0.19 112.389 -172.615 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG11 ' OG ' ' A' ' 44' ' ' SER . 12.0 t -115.58 126.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.058 -0.719 . . . . 0.23000000000000001 109.058 168.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.46 130.64 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.076 0.465 . . . . 0.94999999999999996 111.278 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -141.25 134.48 29.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.16 110.662 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.11 -10.73 20.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.451 . . . . 0.23999999999999999 111.078 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.636 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 38.3 p -127.34 168.4 14.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.395 . . . . 0.25 110.757 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.551 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.6 m -70.95 -35.33 72.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.292 -0.413 . . . . 1.6000000000000001 110.047 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.69999999999999996 111.219 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.636 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 55.4 mt-30 -61.87 -37.99 86.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.255 0.55 . . . . 1.4099999999999999 110.57 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.65 -51.44 65.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.328 -0.851 . . . . 0.17999999999999999 111.388 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.7 mt -62.53 -30.2 71.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.82999999999999996 111.021 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -49.16 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 2.4100000000000001 109.776 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.405 ' OG ' HG11 ' A' ' 33' ' ' VAL . 43.7 t -64.57 -38.12 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.037 -0.529 . . . . 1.1299999999999999 110.7 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.25 -32.27 72.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.284 0.564 . . . . 1.23 110.688 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.33 -41.43 16.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 0.42999999999999999 111.348 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.93 -34.49 59.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.0 -0.545 . . . . 0.62 111.629 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -118.32 161.49 34.88 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.41999999999999998 110.503 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.61 84.28 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.388 2.726 . . . . 0.23999999999999999 111.495 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.7 mm -64.62 123.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.651 -0.704 . . . . 0.22 111.736 -174.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 37.7 m-20 -92.58 -30.63 15.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.483 -0.781 . . . . 0.28999999999999998 110.277 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.5 p -159.81 155.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.111 -0.495 . . . . 0.12 109.807 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 164.06 29.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.359 0.6 . . . . 0.14000000000000001 111.49 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -135.33 112.39 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.512 -0.767 . . . . 0.95999999999999996 108.944 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.655 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -109.05 108.36 19.03 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.667 -0.413 . . . . 0.16 111.723 -170.637 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.0 t70 -78.82 126.21 30.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.598 -0.89 . . . . 1.77 108.598 172.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.509 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 21.3 t -73.96 -16.44 16.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.596 -0.729 . . . . 0.80000000000000004 110.862 -173.532 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -99.03 85.23 3.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.278 0.561 . . . . 2.3700000000000001 110.566 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.7 mt -99.88 -4.52 30.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.513 0.673 . . . . 0.84999999999999998 109.503 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.07 -174.47 40.99 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.895 -1.048 . . . . 0.81999999999999995 110.731 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.09 -45.41 31.97 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.696 2.264 . . . . 1.1799999999999999 111.98 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -107.29 -32.8 7.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.859 -0.61 . . . . 3.5299999999999998 110.129 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.7 m -65.56 126.91 29.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 0.95999999999999996 111.96 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -144.5 152.72 41.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.29 -0.868 . . . . 0.48999999999999999 109.413 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 28.5 p -67.44 87.67 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.296 0.569 . . . . 1.3 109.876 173.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.4 -69.78 0.43 Allowed Glycine 0 C--O 1.224 -0.496 0 C-N-CA 120.669 -0.777 . . . . 0.23000000000000001 112.119 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.9 Cg_exo -51.91 -30.56 39.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.594 2.196 . . . . 0.23999999999999999 112.134 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 11' ' ' LEU . 22.6 t -66.33 -39.15 83.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.451 0.643 . . . . 0.12 110.068 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.83 -47.18 75.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.091 -0.959 . . . . 0.16 110.093 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 2.7 m-20 -60.45 -42.77 96.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 2.0299999999999998 109.968 176.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.53 63.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 111.249 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.55 -40.77 89.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.417 -0.81 . . . . 0.20000000000000001 110.579 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 62.8 mmtt -59.67 -35.21 74.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.0099999999999998 111.079 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 53.7 mt-30 -70.39 -37.32 74.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 2.3700000000000001 111.171 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -93.04 4.67 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.681 0.277 . . . . 1.49 111.231 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.59 33.73 22.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.33000000000000002 111.617 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.18 133.87 32.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.144 -0.48 . . . . 0.17000000000000001 110.063 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.98 143.95 29.74 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.525 2.15 . . . . 0.20999999999999999 112.32 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 41.7 p90 -158.53 160.24 36.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.552 -0.749 . . . . 0.17999999999999999 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 mt -125.07 139.53 50.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 109.639 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.94 113.62 24.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.302 0.572 . . . . 0.20999999999999999 109.465 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.814 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 17.2 t-160 -101.63 130.03 47.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.386 -0.968 . . . . 0.59999999999999998 108.386 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 11.1 t -178.72 162.14 1.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.9 -0.32 . . . . 0.60999999999999999 110.703 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.74 13.8 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.335 -1.106 . . . . 0.93999999999999995 110.335 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -114.29 49.56 1.0 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.136 -0.532 . . . . 2.3300000000000001 110.137 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.85 -30.6 65.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.6100000000000001 111.944 -173.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.77 -34.48 24.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.292 0.568 . . . . 2.6299999999999999 109.867 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.512 ' HD3' ' OD2' ' A' ' 85' ' ' ASP . 44.6 ttt180 -67.32 -34.91 78.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.313 -0.858 . . . . 4.4199999999999999 111.128 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.441 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.0 m-70 -118.62 28.66 8.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 1.05 111.473 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.65 95.88 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.001 -0.618 . . . . 0.97999999999999998 112.756 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 29.5 mt-10 -61.37 -45.57 93.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 2.5 110.154 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.84 -44.94 95.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.70999999999999996 110.572 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 73.5 mt -59.6 -38.62 81.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 1.5800000000000001 111.372 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -71.26 -27.03 63.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.399 -0.364 . . . . 4.3799999999999999 111.18 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 66.9 mttm -74.21 -43.74 55.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.333 0.587 . . . . 2.4500000000000002 110.032 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.563 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 83.5 mt -62.45 -51.34 73.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.189 -0.914 . . . . 0.45000000000000001 110.581 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.7 t70 62.47 75.58 0.4 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.425 0.631 . . . . 1.0900000000000001 110.828 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' HB3' ' CD2' ' A' ' 81' ' ' LEU . . . -161.12 167.41 13.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.28999999999999998 109.339 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.24 142.69 97.51 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.399 2.066 . . . . 0.26000000000000001 112.667 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -124.24 124.36 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.64000000000000001 111.054 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.14 110.5 22.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.28 -0.637 . . . . 0.82999999999999996 109.28 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.21 146.66 41.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.015 -0.539 . . . . 0.54000000000000004 111.91 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 86.8 mttt -91.19 142.52 27.28 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.67000000000000004 109.709 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.5 Cg_exo -71.14 139.59 59.39 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.505 -1.456 . . . . 0.75 112.992 3.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.596 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -132.79 136.44 46.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.34999999999999998 109.619 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 110' ' ' VAL . 10.5 t70 -79.38 131.58 36.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.472 -0.936 . . . . 0.51000000000000001 108.472 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.3 p -64.84 -23.56 67.27 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.672 -0.695 . . . . 0.26000000000000001 112.24 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -72.68 -33.31 66.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.551 -0.537 . . . . 1.3200000000000001 109.551 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -70.49 -45.8 64.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.809 -0.632 . . . . 0.62 109.36 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 106' ' ' ASP . 30.6 t -60.12 -43.44 92.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.264 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.701 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -61.89 -50.06 73.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.702 -0.681 . . . . 0.13 111.369 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.5 mttp -59.79 -49.95 75.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 1.95 111.167 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -59.7 -38.36 81.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 2.23 111.475 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.67 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 0.14000000000000001 110.603 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD22 ' HG2' ' A' ' 6' ' ' PRO . 63.0 mt -65.26 -25.44 67.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.27000000000000002 112.167 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 20.5 mm-40 -59.16 -30.23 68.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 2.79 111.208 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.5 mtm -88.81 1.94 54.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.42999999999999999 110.992 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 51.1 t -118.69 -50.03 2.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.146 -0.479 . . . . 1.46 111.573 -177.152 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.05 98.24 1.32 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.036 -0.602 . . . . 2.5699999999999998 112.408 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.06 -90.16 1.58 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.819 -0.705 . . . . 4.4800000000000004 111.832 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 122' ' ' LYS . 24.1 t70 56.67 -156.96 0.28 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.647 0.379 . . . . 6.4199999999999999 109.986 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.546 ' H ' ' HD3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -114.5 121.27 43.01 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.989 -0.445 . . . . 9.1899999999999995 110.26 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.69 118.2 68.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.096 -0.502 . . . . 9.5999999999999996 110.699 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.98 173.19 14.87 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.742 2.295 . . . . 11.17 112.346 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.461 -0.781 . . . . 13.279999999999999 110.239 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.98 -0.448 . . . . 8.8000000000000007 111.98 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.78 117.39 22.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.981 -0.377 . . . . 6.7800000000000002 109.981 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.7 mtm -77.96 115.77 17.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.318 -0.401 . . . . 7.21 110.541 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.23 86.2 1.49 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.001 -0.84 . . . . 1.8500000000000001 111.001 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 91.2 mtp -87.0 118.56 70.22 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.98 0.419 . . . . 1.6499999999999999 110.811 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.66 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -63.94 142.22 80.83 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.413 2.742 . . . . 0.33000000000000002 112.224 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -87.93 103.04 15.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.904 -0.776 . . . . 0.89000000000000001 108.904 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.458 HG22 ' CG1' ' A' ' 52' ' ' VAL . 54.9 t -99.23 135.49 34.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.003 -0.544 . . . . 0.20000000000000001 110.859 -173.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.497 ' HB2' HD12 ' A' ' 50' ' ' ILE . 40.4 tp -110.96 111.21 22.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.184 -0.462 . . . . 0.75 110.573 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -92.6 125.65 45.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.13 111.324 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -107.33 104.17 13.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.023 -0.989 . . . . 0.20999999999999999 109.231 173.69 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -165.16 123.23 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.88 -0.6 . . . . 1.4099999999999999 110.075 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.5 t70 -83.42 -22.06 32.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.798 -0.637 . . . . 1.27 110.781 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.81 107.0 9.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.119 -0.326 . . . . 2.5600000000000001 110.119 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.2 Cg_exo -58.5 -28.86 86.95 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 113.484 -174.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 tp -64.64 -49.96 68.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.998 0.428 . . . . 1.51 110.115 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.18 -41.37 89.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.834 -0.621 . . . . 1.01 110.559 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.17 82.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.20999999999999999 110.854 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.3 ttp -62.08 -42.8 99.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.60999999999999999 110.862 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.406 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.8 m-20 -64.21 -40.9 97.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.848 -0.615 . . . . 1.22 111.432 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 38.8 mt -64.56 -45.02 88.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.612 0.244 . . . . 0.17999999999999999 110.525 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.561 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 47.1 tt0 -55.6 -50.28 70.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.974 -0.557 . . . . 1.04 110.466 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -65.04 -27.17 68.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.78000000000000003 111.508 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.18 -45.02 58.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.14000000000000001 110.643 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -70.45 -42.16 71.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.112 -0.495 . . . . 0.13 110.917 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.46 -35.92 78.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.916 0.389 . . . . 0.68999999999999995 110.032 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.92 -31.86 73.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.633 -0.712 . . . . 0.51000000000000001 110.732 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -86.19 5.66 33.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.65000000000000002 111.159 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.76 52.7 5.31 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.948 -0.644 . . . . 0.28999999999999998 112.46 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' CB ' ' HD2' ' A' ' 6' ' ' PRO . . . -138.4 163.54 31.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 110.658 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -101.91 144.26 30.76 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.985 -0.746 . . . . 2.1400000000000001 108.985 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.561 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -127.58 143.75 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.027 0.441 . . . . 0.19 111.843 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.472 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.7 t -117.7 128.61 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.805 -0.813 . . . . 0.23000000000000001 108.805 168.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -97.23 122.75 49.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.548 -0.461 . . . . 0.94999999999999996 110.986 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -134.14 135.41 43.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.626 -0.716 . . . . 0.16 109.819 176.533 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.42 -21.61 14.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.331 -0.395 . . . . 0.23999999999999999 110.922 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 17.1 p -115.39 170.99 7.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.991 0.424 . . . . 0.25 111.125 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 22.3 p -65.06 -47.62 76.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.477 0.656 . . . . 1.6000000000000001 109.367 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -55.91 -45.72 78.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.279 -1.328 . . . . 0.69999999999999996 111.997 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.476 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 55.6 mt-30 -59.54 -45.31 92.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.426 0.631 . . . . 1.4099999999999999 110.304 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.12 -50.84 71.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.062 -0.972 . . . . 0.17999999999999999 111.141 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 57.7 mt -63.14 -31.34 72.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.761 -0.654 . . . . 0.82999999999999996 110.83 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -68.59 -53.44 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 2.4100000000000001 109.841 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.472 ' OG ' HG11 ' A' ' 33' ' ' VAL . 33.3 t -65.45 -32.91 74.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.894 0.378 . . . . 1.1299999999999999 110.621 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.446 HD23 ' HB1' ' A' ' 71' ' ' ALA . 16.3 tp -65.4 -33.51 76.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.23 110.797 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.32 -35.95 30.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.896 -0.593 . . . . 0.42999999999999999 111.258 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.98 -38.07 32.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.62 111.524 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -112.62 164.69 14.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.984 -0.553 . . . . 0.41999999999999998 110.89 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -94.78 78.29 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.571 2.847 . . . . 0.23999999999999999 111.594 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -64.04 119.29 7.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.751 -0.659 . . . . 0.22 111.236 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.4 m-20 -87.75 -29.67 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.726 -0.67 . . . . 0.28999999999999998 110.457 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.466 HG11 HD23 ' A' ' 115' ' ' LEU . 14.3 p -160.53 156.49 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 0.12 110.349 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.05 165.56 27.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.281 0.562 . . . . 0.14000000000000001 112.059 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.66 112.11 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.95999999999999996 109.583 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 9.7 mp -112.52 116.93 31.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.296 0.48 . . . . 0.16 112.296 -168.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.11 107.1 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 1.77 109.637 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' CG1' HD23 ' A' ' 92' ' ' LEU . 12.9 t -68.82 -9.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.041 -0.527 . . . . 0.80000000000000004 111.964 -172.087 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -114.96 63.27 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 2.3700000000000001 110.981 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD11 ' SG ' ' A' ' 65' ' ' CYS . 97.5 mt -64.52 -27.85 69.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.265 0.555 . . . . 0.84999999999999998 110.874 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.22 32.22 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.192 -0.763 . . . . 0.81999999999999995 111.192 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.54 -40.66 82.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.931 2.421 . . . . 1.1799999999999999 112.513 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -123.83 -31.55 3.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.655 0.264 . . . . 3.5299999999999998 110.783 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -65.95 127.03 30.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.058 0.456 . . . . 0.95999999999999996 111.706 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -144.57 153.38 41.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.707 -0.678 . . . . 0.48999999999999999 110.061 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 2.6 m -73.7 85.94 1.65 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.984 -0.747 . . . . 1.3 108.984 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.47 -63.93 0.54 Allowed Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.841 -0.695 . . . . 0.23000000000000001 111.842 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.45 -24.91 37.68 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.348 2.032 . . . . 0.23999999999999999 111.381 173.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 11' ' ' LEU . 20.9 t -68.45 -45.01 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.748 -0.66 . . . . 0.12 109.995 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.49 -49.41 77.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 0.16 110.165 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 50.7 m-20 -61.95 -41.6 98.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 2.0299999999999998 110.238 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.446 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -56.63 -44.16 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.019 -0.537 . . . . 0.23000000000000001 111.256 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.11 -42.19 76.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.56 -0.745 . . . . 0.20000000000000001 110.268 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.9 mmtt -59.88 -36.74 77.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.681 -0.691 . . . . 2.0099999999999998 111.447 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 71.2 mt-30 -63.29 -39.07 93.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 2.3700000000000001 111.237 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -96.02 6.14 49.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.29 -0.414 . . . . 1.49 111.235 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 35.57 22.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.797 -0.638 . . . . 0.33000000000000002 111.754 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.0 mt -89.12 133.79 34.5 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 116.501 -0.318 . . . . 0.17000000000000001 110.441 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 26.7 Cg_endo -74.2 141.46 29.21 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.49 2.127 . . . . 0.20999999999999999 111.765 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 16.9 p90 -159.16 160.58 35.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.675 -0.693 . . . . 0.17999999999999999 110.225 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.462 HG21 ' HG2' ' A' ' 101' ' ' MET . 16.0 mt -125.52 141.42 45.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.482 -0.781 . . . . 0.23999999999999999 109.987 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.84 108.71 19.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.309 -0.626 . . . . 0.20999999999999999 109.309 177.752 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.669 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.9 t-160 -103.66 74.01 1.22 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.481 0.658 . . . . 0.59999999999999998 109.261 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.429 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 4.5 t -105.86 163.56 12.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.646 -1.161 . . . . 0.60999999999999999 111.048 -172.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 -4.99 57.7 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.901 -0.59 . . . . 0.93999999999999995 112.31 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -137.95 132.72 32.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.108 0.48 . . . . 2.3300000000000001 109.826 172.728 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.1 mp -111.83 -25.85 9.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 1.6100000000000001 110.856 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.18 -45.97 12.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.126 0.489 . . . . 2.6299999999999999 110.898 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.34 -40.15 95.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.513 -0.767 . . . . 4.4199999999999999 110.938 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.526 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 49.7 m-70 -102.31 25.19 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.565 -0.288 . . . . 1.05 111.163 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.74 -37.88 95.56 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.967 -0.635 . . . . 0.97999999999999998 112.975 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 11.7 tt0 -66.94 -39.8 87.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 2.5 110.258 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD23 ' CG1' ' A' ' 57' ' ' VAL . 41.4 tp -68.12 -40.01 82.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.227 -0.442 . . . . 0.70999999999999996 109.863 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 89.0 mt -59.15 -39.6 82.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.453 -0.34 . . . . 1.5800000000000001 111.189 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 24.4 ptt180 -73.95 -26.05 60.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 4.3799999999999999 110.584 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -70.34 -34.15 72.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.295 0.569 . . . . 2.4500000000000002 110.163 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.596 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 95.8 mt -77.36 -53.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.366 -0.834 . . . . 0.45000000000000001 110.677 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.0 t70 64.47 75.26 0.38 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.764 0.792 . . . . 1.0900000000000001 110.917 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.87 162.11 25.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.902 -1.044 . . . . 0.28999999999999998 109.383 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.75 147.19 89.48 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.658 2.239 . . . . 0.26000000000000001 112.539 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.1 t -124.25 134.97 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.202 -0.454 . . . . 0.64000000000000001 110.971 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.462 ' HG2' HG21 ' A' ' 80' ' ' ILE . 92.2 mmm -114.77 107.47 15.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.286 -0.635 . . . . 0.82999999999999996 109.286 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -73.04 143.86 47.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.944 -0.571 . . . . 0.54000000000000004 111.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 94.0 mttt -91.45 146.74 33.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.046 -0.525 . . . . 0.67000000000000004 110.186 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.19 127.31 13.8 Favored 'Cis proline' 0 C--O 1.234 0.278 0 C-N-CA 123.619 -1.409 . . . . 0.75 112.699 2.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.669 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -119.35 130.04 55.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.728 -0.669 . . . . 0.34999999999999998 110.297 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.15 129.97 38.87 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.04 -1.096 . . . . 0.51000000000000001 108.04 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 39.9 p -64.28 -20.47 66.09 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.875 0.695 . . . . 0.26000000000000001 112.875 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 76.1 p -65.87 -42.32 90.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.995 0.426 . . . . 1.3200000000000001 110.176 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 -39.79 84.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.159 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.44 -45.14 98.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 0.13 110.327 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.31 -48.81 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.554 -0.748 . . . . 0.13 111.479 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 1.95 111.269 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.8 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 2.23 111.402 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.2 -46.81 17.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.49 . . . . 0.14000000000000001 110.392 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD23 HG11 ' A' ' 52' ' ' VAL . 77.1 mt -70.59 -26.08 63.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.634 0.605 . . . . 0.27000000000000002 112.634 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -63.07 -33.19 74.92 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.815 -0.354 . . . . 2.79 110.415 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.3 mtm -76.08 -30.69 58.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.193 0.52 . . . . 0.42999999999999999 110.139 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.5 t -73.27 -46.73 48.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 1.46 111.033 -178.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.64 11.79 70.64 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.813 -0.708 . . . . 2.5699999999999998 112.31 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.65 72.35 0.21 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.794 -0.717 . . . . 4.4800000000000004 112.239 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.15 117.75 21.96 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.876 -0.416 . . . . 6.4199999999999999 109.876 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.47 163.04 36.94 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.795 -0.639 . . . . 9.1899999999999995 110.82 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -78.69 117.24 65.37 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.76 -0.655 . . . . 9.5999999999999996 109.429 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.41 113.79 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.328 2.685 . . . . 11.17 113.136 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.572 -0.728 . . . . 13.279999999999999 110.044 178.494 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.767 -0.533 . . . . 8.8000000000000007 111.767 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.03 59.88 3.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.228 0.537 . . . . 6.7800000000000002 110.643 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.489 ' HB2' ' SD ' ' A' ' 5' ' ' MET . 17.7 ptp -96.89 125.45 41.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 7.21 111.013 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.54 74.28 0.24 Allowed Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.632 -0.713 . . . . 1.8500000000000001 111.713 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' A' ' 3' ' ' MET . 0.1 OUTLIER -63.45 134.18 95.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.793 0.33 . . . . 1.6499999999999999 111.662 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 17.3 Cg_exo -70.45 136.06 30.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.045 2.496 . . . . 0.33000000000000002 110.984 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -85.98 109.48 18.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.431 -0.581 . . . . 0.89000000000000001 109.431 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG22 ' CG1' ' A' ' 52' ' ' VAL . 38.0 t -100.14 130.79 48.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.9 -0.591 . . . . 0.20000000000000001 110.916 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.499 ' HB2' HD12 ' A' ' 50' ' ' ILE . 54.1 tp -105.04 112.14 25.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.83 0.348 . . . . 0.75 110.306 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 54' ' ' VAL . 25.3 t -93.12 121.03 43.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.118 0.485 . . . . 0.13 111.507 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm? -102.45 101.11 11.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.297 -0.865 . . . . 0.20999999999999999 108.889 171.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -159.51 120.98 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.479 -0.782 . . . . 1.4099999999999999 109.921 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 19.0 t70 -87.49 -19.03 28.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.9 -0.591 . . . . 1.27 109.941 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -83.51 105.65 5.89 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 2.5600000000000001 109.835 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.1 Cg_exo -59.03 -32.97 98.49 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.736 2.291 . . . . 0.32000000000000001 113.063 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.37 -49.19 78.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.621 -0.511 . . . . 1.51 109.621 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.23 -46.04 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 1.01 110.88 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.59 72.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.069 0.461 . . . . 0.20999999999999999 110.783 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.0 ttp -63.27 -44.92 93.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.553 -0.749 . . . . 0.60999999999999999 111.231 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HG21 ' A' ' 107' ' ' THR . 10.9 m-20 -67.68 -36.78 81.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.098 -0.501 . . . . 1.22 111.497 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.4 mt -65.54 -46.14 80.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.739 0.304 . . . . 0.17999999999999999 110.188 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 48.2 tt0 -55.17 -48.38 73.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 1.04 110.406 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -63.48 -37.88 89.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.441 -0.345 . . . . 0.78000000000000003 111.199 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.54 -49.36 69.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.435 -0.348 . . . . 0.14000000000000001 111.275 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -63.96 -45.73 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.247 -0.433 . . . . 0.13 110.86 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.66 -28.42 69.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.366 -0.379 . . . . 0.68999999999999995 111.164 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.8 -33.33 66.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.51000000000000001 110.229 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.78 -14.73 59.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.65000000000000002 110.817 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 53.11 0.8 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 112.373 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.4 175.95 9.13 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.872 -0.193 . . . . 0.23000000000000001 110.683 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.45 129.91 49.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.064 -0.717 . . . . 2.1400000000000001 109.064 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.3 t -118.25 142.15 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 112.664 0.616 . . . . 0.19 112.664 -164.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 44' ' ' SER . 10.4 t -114.38 136.38 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.867 -0.79 . . . . 0.23000000000000001 108.867 169.544 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.02 125.09 58.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 0.94999999999999996 111.191 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.78 139.53 45.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.109 -0.496 . . . . 0.16 110.424 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.94 -13.16 15.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.347 -0.388 . . . . 0.23999999999999999 111.2 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.0 p -127.79 167.44 16.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.485 -0.325 . . . . 0.25 110.555 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 74.6 m -68.73 -34.19 75.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.845 -0.428 . . . . 1.6000000000000001 109.845 175.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.37 -48.01 81.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.69999999999999996 110.613 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -59.08 -41.03 87.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.353 0.596 . . . . 1.4099999999999999 110.621 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.658 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -62.0 -54.75 37.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.15 -0.932 . . . . 0.17999999999999999 111.419 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 62.7 mt -64.46 -30.7 71.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.013 -0.54 . . . . 0.82999999999999996 110.767 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -64.43 -47.43 79.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.292 -0.633 . . . . 2.4100000000000001 109.292 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.468 ' HB3' HG11 ' A' ' 33' ' ' VAL . 11.0 m -72.28 -30.46 64.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.922 -0.581 . . . . 1.1299999999999999 110.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 21.6 tp -67.1 -35.93 80.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 1.23 110.637 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.24 -35.15 48.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.055 -0.52 . . . . 0.42999999999999999 110.814 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.53 -36.28 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.745 -0.661 . . . . 0.62 111.17 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.59 148.56 48.24 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.358 0.599 . . . . 0.41999999999999998 111.284 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.65 88.59 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.321 2.681 . . . . 0.23999999999999999 111.498 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 9' ' ' LEU . 42.6 mm -68.56 127.95 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.663 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -98.89 -27.03 14.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.28999999999999998 110.414 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' HG22 ' A' ' 8' ' ' VAL . 11.7 p -159.48 159.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.12 109.49 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -145.71 165.84 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.376 0.607 . . . . 0.14000000000000001 112.128 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -138.14 111.76 7.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.221 -0.899 . . . . 0.95999999999999996 109.192 175.899 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.625 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -114.43 124.08 51.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.329 0.492 . . . . 0.16 112.329 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.5 t0 -85.1 115.1 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.815 0.817 . . . . 1.77 109.336 169.231 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.753 HG13 HD23 ' A' ' 92' ' ' LEU . 65.8 t -59.97 -24.17 29.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.588 -1.187 . . . . 0.80000000000000004 110.96 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 7.7 t30 -113.01 75.53 0.92 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 2.3700000000000001 110.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.3 -29.57 67.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.809 0.814 . . . . 0.84999999999999998 109.052 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.37 -172.22 34.28 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.567 -1.197 . . . . 0.81999999999999995 110.241 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HB2' ' HD2' ' A' ' 62' ' ' LYS . 86.1 Cg_exo -52.92 -44.52 47.9 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.905 2.403 . . . . 1.1799999999999999 112.399 176.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -109.59 -34.1 6.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 3.5299999999999998 110.563 177.572 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.8 m -65.89 127.46 32.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.351 0.596 . . . . 0.95999999999999996 111.146 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -144.23 149.89 37.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 0.48999999999999999 110.34 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -71.74 86.57 0.94 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.514 0.674 . . . . 1.3 109.431 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.65 -73.06 0.7 Allowed Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.355 -0.926 . . . . 0.23000000000000001 112.164 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.8 Cg_exo -53.29 -25.3 30.08 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.583 2.189 . . . . 0.23999999999999999 112.221 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 11' ' ' LEU . 12.6 t -72.12 -46.72 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.228 0.537 . . . . 0.12 110.365 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.42 -51.81 67.93 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.314 -0.857 . . . . 0.16 109.802 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.28 -37.34 85.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 110.49 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -56.96 -48.23 78.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.409 0.623 . . . . 0.23000000000000001 110.969 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.04 -41.61 77.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.399 -0.818 . . . . 0.20000000000000001 110.402 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 29.9 mmmt -57.89 -39.39 77.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.585 -0.734 . . . . 2.0099999999999998 110.807 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 48.7 mt-30 -62.64 -46.68 87.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.688 . . . . 2.3700000000000001 111.462 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -86.41 2.8 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 1.49 111.086 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.0 33.16 21.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.763 -0.653 . . . . 0.33000000000000002 111.308 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.74 131.39 47.45 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 116.085 -0.507 . . . . 0.17000000000000001 109.845 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.2 Cg_endo -72.72 139.39 30.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.17 1.913 . . . . 0.20999999999999999 111.616 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 12.5 p90 -156.44 155.28 31.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.902 -0.59 . . . . 0.17999999999999999 110.719 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.34 139.61 44.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.538 -0.756 . . . . 0.23999999999999999 109.505 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 96' ' ' ILE . 2.5 mm? -88.69 107.45 18.94 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.281 -0.637 . . . . 0.20999999999999999 109.281 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 101' ' ' MET . 14.7 t-160 -103.46 72.52 1.15 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.275 -1.009 . . . . 0.59999999999999998 108.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.631 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 9.7 t -103.52 159.63 15.42 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 113.989 -1.46 . . . . 0.60999999999999999 111.401 -171.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.689 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -106.24 9.42 42.41 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.623 -0.799 . . . . 0.93999999999999995 111.42 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 17.7 t70 -137.06 141.31 42.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.877 0.37 . . . . 2.3300000000000001 110.861 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.6 mt -130.08 -31.88 1.87 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.079 -0.51 . . . . 1.6100000000000001 110.71 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.54 -39.39 16.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.478 0.548 . . . . 2.6299999999999999 112.478 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -70.16 -52.58 22.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.692 0.282 . . . . 4.4199999999999999 111.141 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -97.21 29.1 3.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.426 -0.352 . . . . 1.05 110.304 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.18 -34.08 62.1 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.448 -0.406 . . . . 0.97999999999999998 113.796 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.88 -26.04 68.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 2.5 111.259 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.753 HD23 HG13 ' A' ' 57' ' ' VAL . 15.3 tp -74.96 -47.87 27.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.22 -0.445 . . . . 0.70999999999999996 110.954 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -60.48 -36.37 78.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.911 0.386 . . . . 1.5800000000000001 110.955 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.43 -34.12 73.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.311 -0.859 . . . . 4.3799999999999999 111.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -81.34 -29.36 34.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 2.4500000000000002 111.063 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 92' ' ' LEU . 70.7 mt -67.71 -50.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.798 -0.637 . . . . 0.45000000000000001 111.327 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.21 75.96 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.413 0.625 . . . . 1.0900000000000001 110.617 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -162.71 161.99 19.07 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.437 -0.802 . . . . 0.28999999999999998 109.44 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 31.8 Cg_exo -59.99 137.3 75.07 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.79 2.327 . . . . 0.26000000000000001 112.465 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.9 135.33 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.891 -0.595 . . . . 0.64000000000000001 110.904 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.6 mtp -127.24 90.91 3.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.294 -0.632 . . . . 0.82999999999999996 109.294 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.62 139.78 57.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.54000000000000004 111.62 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.689 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 15.3 ptpt -91.56 149.84 40.06 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.594 -0.73 . . . . 0.67000000000000004 109.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.564 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 16.7 Cg_exo -66.54 138.43 39.56 Favored 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 123.534 -1.444 . . . . 0.75 113.118 3.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -142.07 133.93 27.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.253 -0.885 . . . . 0.34999999999999998 108.778 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 110' ' ' VAL . 12.9 t70 -65.09 123.36 19.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.585 -0.524 . . . . 0.51000000000000001 109.585 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.9 p -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.495 -0.775 . . . . 0.26000000000000001 112.555 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -70.81 -39.74 72.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.455 -0.572 . . . . 1.3200000000000001 109.455 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -67.01 -44.26 80.76 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.62 109.84 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.59 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 25.4 t -59.95 -42.11 88.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.197 -0.911 . . . . 0.13 110.378 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.85 -50.47 66.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.598 -0.728 . . . . 0.13 111.558 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.85 -41.1 99.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 1.95 111.538 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 31.1 mmt180 -71.82 -24.91 61.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.7 0.285 . . . . 2.23 111.492 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 -48.98 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 0.14000000000000001 110.279 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.627 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 69.0 mt -64.55 -26.82 68.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.931 0.715 . . . . 0.27000000000000002 112.931 -175.562 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.69 -28.98 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.779 -0.368 . . . . 2.79 110.969 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.448 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 57.7 mtm -75.21 -21.81 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.42999999999999999 111.03 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 25.4 p -106.54 25.27 11.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.06 0.457 . . . . 1.46 110.529 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.11 -32.32 83.78 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.699 -0.682 . . . . 2.5699999999999998 112.113 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.36 64.14 0.7 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.731 -0.747 . . . . 4.4800000000000004 112.13 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -88.18 52.81 2.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.529 0.681 . . . . 6.4199999999999999 109.955 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -83.29 70.31 10.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.143 -0.935 . . . . 9.1899999999999995 110.106 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -98.62 127.0 37.08 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.612 -0.722 . . . . 9.5999999999999996 110.223 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.14 118.68 5.71 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.581 2.188 . . . . 11.17 112.079 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.52 -0.753 . . . . 13.279999999999999 110.317 -179.598 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 112.523 -0.231 . . . . 8.8000000000000007 112.523 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.36 25.17 14.52 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.88 0.472 . . . . 6.7800000000000002 111.242 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt -123.45 171.2 9.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.167 -0.469 . . . . 7.21 110.009 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.608 ' O ' ' HG2' ' A' ' 5' ' ' MET . . . 90.91 -37.86 3.31 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.007 -0.616 . . . . 1.8500000000000001 112.314 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 4' ' ' GLY . 12.1 ptp 56.74 141.38 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 125.317 1.447 . . . . 1.6499999999999999 112.554 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 1.1 Cg_endo -69.53 141.13 45.3 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.153 1.902 . . . . 0.33000000000000002 112.743 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -89.56 105.92 18.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.635 -0.711 . . . . 0.89000000000000001 109.087 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.6 t -100.66 134.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.20000000000000001 111.228 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 50' ' ' ILE . 50.5 tp -110.55 113.31 25.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.008 -0.542 . . . . 0.75 110.564 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -95.05 129.11 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.962 0.411 . . . . 0.13 111.113 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -110.0 101.54 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.20999999999999999 109.982 176.349 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -165.14 133.25 3.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.658 -0.497 . . . . 1.4099999999999999 109.658 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -87.47 -31.95 19.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.884 -0.598 . . . . 1.27 110.497 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.1 111.46 13.7 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.22 -0.289 . . . . 2.5600000000000001 110.22 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.48 -31.92 95.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.998 2.465 . . . . 0.32000000000000001 113.027 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.81 -49.64 69.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.891 -0.411 . . . . 1.51 109.891 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.08 -47.69 86.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 1.01 110.415 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.76 -49.43 77.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.49 -0.777 . . . . 0.20999999999999999 111.477 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.5 ttp -66.22 -34.12 77.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.382 -0.372 . . . . 0.60999999999999999 111.093 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.539 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.2 m-20 -66.77 -43.88 82.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.311 -0.404 . . . . 1.22 110.609 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.39 -44.06 97.35 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.184 -0.462 . . . . 0.17999999999999999 110.021 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.481 ' HA ' HG11 ' A' ' 32' ' ' VAL . 56.6 tt0 -52.18 -53.83 38.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 1.04 110.684 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -63.76 -33.35 75.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.777 0.323 . . . . 0.78000000000000003 111.138 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.87 71.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.215 -0.448 . . . . 0.14000000000000001 111.046 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.3 m-85 -66.95 -40.41 87.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.13 110.849 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.6 mt-10 -61.6 -35.66 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.68999999999999995 110.539 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.73 -29.25 67.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.52 . . . . 0.51000000000000001 110.761 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -82.78 -2.0 53.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.65000000000000002 110.923 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.16 50.54 3.62 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.878 -0.677 . . . . 0.28999999999999998 112.404 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.87 162.32 35.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.204 -0.295 . . . . 0.23000000000000001 110.204 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.78 132.98 51.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.572 -0.529 . . . . 2.1400000000000001 109.572 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 22' ' ' GLN . 21.8 t -113.78 139.95 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.014 0.375 . . . . 0.19 112.014 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.485 HG11 ' OG ' ' A' ' 44' ' ' SER . 10.2 t -114.45 127.29 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.588 -0.893 . . . . 0.23000000000000001 108.588 167.281 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.61 123.4 50.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.727 -0.389 . . . . 0.94999999999999996 110.769 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.36 134.32 47.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.064 -0.516 . . . . 0.16 109.994 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.02 -18.95 19.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.833 -0.621 . . . . 0.23999999999999999 110.909 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.2 p -125.12 164.89 19.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.705 -0.398 . . . . 0.25 111.163 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 76.5 m -65.16 -35.46 81.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 109.681 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.6 -46.91 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.984 -0.553 . . . . 0.69999999999999996 110.641 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -61.42 -41.65 97.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.955 -0.566 . . . . 1.4099999999999999 110.822 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.619 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.46 -49.65 72.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.559 -0.746 . . . . 0.17999999999999999 111.484 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 81.7 mt -60.58 -33.42 72.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.82999999999999996 110.885 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 6.8 tmtm? -66.73 -52.58 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.814 -0.63 . . . . 2.4100000000000001 109.945 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.485 ' OG ' HG11 ' A' ' 33' ' ' VAL . 14.1 t -65.4 -34.42 78.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.367 -0.379 . . . . 1.1299999999999999 110.44 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.406 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 17.7 tp -62.05 -36.44 81.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 1.23 110.852 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.05 -39.84 22.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 0.42999999999999999 111.194 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.58 -37.79 65.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.62 111.397 -176.551 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -115.29 163.14 21.14 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.41999999999999998 110.411 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.84 82.54 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.446 2.764 . . . . 0.23999999999999999 111.531 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.7 mm -63.96 122.43 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.463 -0.79 . . . . 0.22 111.526 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -90.22 -34.71 15.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.56 -0.746 . . . . 0.28999999999999998 110.32 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -154.7 154.27 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.12 109.987 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -137.21 162.89 32.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.374 0.606 . . . . 0.14000000000000001 111.657 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -135.17 112.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.411 -0.813 . . . . 0.95999999999999996 109.185 176.774 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mp -107.54 97.95 7.62 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.442 0.639 . . . . 0.16 110.975 -172.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.734 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -74.22 82.98 1.85 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.929 -1.032 . . . . 1.77 109.35 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.401 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 60.5 t -42.46 -42.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 114.541 -1.208 . . . . 0.80000000000000004 113.71 -169.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.0 t30 -78.35 74.43 4.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.014 0.435 . . . . 2.3700000000000001 110.755 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.7 mt -78.52 -22.85 46.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.55 0.691 . . . . 0.84999999999999998 109.444 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.8 -174.39 45.95 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.904 -1.044 . . . . 0.81999999999999995 110.503 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.49 -40.13 87.2 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.598 2.199 . . . . 1.1799999999999999 112.339 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -118.06 -23.69 7.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.088 -0.506 . . . . 3.5299999999999998 110.723 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.9 m -70.32 124.74 24.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.214 0.53 . . . . 0.95999999999999996 110.973 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -144.97 148.31 33.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.726 -0.67 . . . . 0.48999999999999999 110.353 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.501 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -76.44 87.32 3.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.857 -0.794 . . . . 1.3 108.857 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -110.71 -67.52 0.56 Allowed Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.47 -0.871 . . . . 0.23000000000000001 112.541 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 38.9 Cg_exo -53.96 -21.35 20.86 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.354 2.036 . . . . 0.23999999999999999 111.902 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' A' ' 11' ' ' LEU . 38.5 t -70.17 -42.67 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.889 -0.596 . . . . 0.12 110.071 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.99 -45.68 91.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.564 -0.744 . . . . 0.16 109.905 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.0 m-20 -61.74 -43.78 98.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.0299999999999998 109.804 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -56.4 -48.71 76.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.23000000000000001 111.165 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.11 -41.44 97.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.514 -0.766 . . . . 0.20000000000000001 110.297 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -60.94 -34.47 74.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.829 -0.623 . . . . 2.0099999999999998 111.757 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 15.8 mm100 -65.47 -35.5 81.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.457 -0.338 . . . . 2.3700000000000001 110.929 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -100.24 7.93 44.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 1.49 111.421 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.89 36.31 27.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.33000000000000002 111.694 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.82 133.41 35.82 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.413 -0.358 . . . . 0.17000000000000001 110.152 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.9 141.35 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.607 2.205 . . . . 0.20999999999999999 112.113 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 21.8 p90 -156.7 157.9 35.98 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.378 -0.828 . . . . 0.17999999999999999 110.453 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 mt -120.05 139.05 48.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.246 -0.888 . . . . 0.23999999999999999 109.646 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 96' ' ' ILE . 1.6 mm? -89.23 108.01 19.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.905 -0.776 . . . . 0.20999999999999999 108.905 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.743 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 12.0 t-160 -101.77 102.59 13.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.359 0.599 . . . . 0.59999999999999998 110.111 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 7.9 t -164.21 149.96 10.74 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.964 -0.46 . . . . 0.60999999999999999 110.423 -173.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.3 -13.32 36.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.483 -1.047 . . . . 0.93999999999999995 110.483 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 33.0 t70 -94.36 103.81 15.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.815 -0.809 . . . . 2.3300000000000001 108.815 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.41 -62.14 1.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.216 -0.447 . . . . 1.6100000000000001 112.036 -171.098 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.13 -29.86 68.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.051 0.453 . . . . 2.6299999999999999 111.17 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 65.6 ttt180 -67.81 -18.73 64.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 4.4199999999999999 110.944 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -131.25 33.18 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.511 . . . . 1.05 110.289 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.43 -41.8 98.72 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.97999999999999998 113.012 -175.203 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.89 -37.08 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.695 0.284 . . . . 2.5 111.108 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' HG13 ' A' ' 96' ' ' ILE . 24.2 tp -64.08 -49.53 71.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.264 0.554 . . . . 0.70999999999999996 110.052 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.7 mt -61.47 -31.32 71.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.133 -0.939 . . . . 1.5800000000000001 111.252 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 95.9 mtt180 -63.97 -37.98 89.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 4.3799999999999999 110.866 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -66.33 -47.4 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.53 0.681 . . . . 2.4500000000000002 110.273 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 81' ' ' LEU . 41.2 mt -66.31 -56.33 14.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.519 -1.219 . . . . 0.45000000000000001 111.215 -175.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.9 t70 47.99 59.55 4.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.882 0.848 . . . . 1.0900000000000001 110.715 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . -132.66 168.98 15.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.077 -0.965 . . . . 0.28999999999999998 109.336 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 78.3 Cg_exo -51.67 136.64 50.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.238 1.959 . . . . 0.26000000000000001 112.756 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.1 t -123.14 136.26 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.352 -0.84 . . . . 0.64000000000000001 110.146 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 94.5 mtp -118.35 106.06 12.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.343 -0.614 . . . . 0.82999999999999996 109.343 173.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.67 153.04 44.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.474 -0.785 . . . . 0.54000000000000004 110.842 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -91.04 146.32 33.42 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 0.67000000000000004 109.838 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.52 148.65 89.58 Favored 'Cis proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.548 -1.438 . . . . 0.75 112.858 0.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.743 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -140.61 135.97 32.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.695 -0.684 . . . . 0.34999999999999998 109.615 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.9 t0 -75.93 132.55 40.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.8 -0.815 . . . . 0.51000000000000001 108.8 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.7 p -67.7 -21.17 65.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.707 -0.679 . . . . 0.26000000000000001 112.189 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.9 p -76.0 -29.08 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.154 0.502 . . . . 1.3200000000000001 109.672 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.97 -45.5 49.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.62 109.57 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.686 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 23.2 t -59.03 -44.59 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.13 110.428 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -59.11 -52.68 64.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.13 111.346 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 37.3 mtmm -62.96 -47.03 84.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.033 -0.53 . . . . 1.95 111.039 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -56.49 -37.65 70.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.325 . . . . 2.23 111.513 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.46 48.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.14000000000000001 110.794 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.495 HD23 HG11 ' A' ' 52' ' ' VAL . 74.6 mt -64.02 -25.29 68.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.27000000000000002 112.0 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 42.5 mm-40 -59.31 -31.09 68.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.642 0.258 . . . . 2.79 111.066 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.491 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 62.0 mtm -84.96 -23.07 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 0.42999999999999999 111.402 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 49.4 t -175.73 98.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.152 0.501 . . . . 1.46 110.119 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.413 ' CA ' ' HG3' ' A' ' 6' ' ' PRO . . . -179.29 71.67 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.249 -0.741 . . . . 2.5699999999999998 111.249 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.52 -47.27 3.03 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.287 -1.125 . . . . 4.4800000000000004 110.287 -172.936 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 68.76 -177.92 0.22 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.33 0.652 . . . . 6.4199999999999999 111.698 173.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -121.23 53.2 1.16 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.41 -0.814 . . . . 9.1899999999999995 109.676 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -77.9 127.74 81.04 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.365 -0.834 . . . . 9.5999999999999996 110.078 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.42 73.48 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.964 2.443 . . . . 11.17 112.285 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.434 -0.793 . . . . 13.279999999999999 110.538 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.893 -0.483 . . . . 8.8000000000000007 111.893 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 3' ' ' MET . . . -142.74 160.85 39.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.649 0.224 . . . . 6.7800000000000002 110.673 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.424 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 1.8 mpt? 74.26 -23.46 0.23 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.64 0.776 . . . . 7.21 112.274 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.05 -88.58 1.58 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.232 -0.747 . . . . 1.8500000000000001 111.232 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.465 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.7 mtt -103.61 131.17 22.3 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.184 -0.302 . . . . 1.6499999999999999 110.184 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.5 Cg_exo -66.36 136.93 45.33 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.643 2.229 . . . . 0.33000000000000002 111.741 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.477 ' HB3' HD13 ' A' ' 50' ' ' ILE . 9.3 mttp -84.22 109.67 17.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 0.89000000000000001 110.839 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 39.1 t -101.66 117.83 47.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 0.20000000000000001 110.515 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.442 HD21 ' HB1' ' A' ' 41' ' ' ALA . 58.2 tp -97.66 109.9 22.56 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.698 -0.683 . . . . 0.75 110.432 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.08 123.86 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.199 0.523 . . . . 0.13 111.479 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.705 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.2 mm? -101.72 106.2 17.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.095 -0.957 . . . . 0.20999999999999999 108.897 172.44 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -165.5 131.28 2.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.889 -0.596 . . . . 1.4099999999999999 109.873 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 24.4 t70 -94.13 -21.25 19.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.418 -0.81 . . . . 1.27 109.722 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 17' ' ' ILE . 9.6 mm-40 -81.81 105.58 4.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 2.5600000000000001 110.193 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 34.5 Cg_exo -59.81 -25.19 78.57 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.771 2.314 . . . . 0.32000000000000001 113.366 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.32 -52.04 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.312 -0.625 . . . . 1.51 109.312 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.9 mp -63.85 -43.8 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.55 . . . . 1.01 110.069 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.27 66.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.20999999999999999 110.715 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 42.2 ttp -62.96 -38.77 92.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 111.257 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . 7.3 m-20 -65.11 -42.56 93.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.21 -0.45 . . . . 1.22 111.289 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 52.8 mt -65.21 -43.8 90.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.17999999999999999 109.967 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HA ' HG21 ' A' ' 32' ' ' VAL . 38.6 tt0 -52.86 -50.93 62.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.163 -0.926 . . . . 1.04 110.662 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -64.5 -33.37 75.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.78000000000000003 111.629 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.17 -49.29 61.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.14000000000000001 111.061 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 73.2 m-85 -66.93 -42.09 85.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.13 110.967 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -64.84 -26.96 68.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.576 -0.284 . . . . 0.68999999999999995 110.703 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.51000000000000001 110.951 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.06 -12.15 59.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.65000000000000002 111.223 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.89 51.74 1.35 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.785 -0.722 . . . . 0.28999999999999998 112.135 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.7 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.209 -0.293 . . . . 0.23000000000000001 110.209 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.08 130.58 55.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.654 -0.499 . . . . 2.1400000000000001 109.654 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 22' ' ' GLN . 40.7 t -109.01 138.37 36.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.173 -0.467 . . . . 0.19 111.71 -171.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.63 123.39 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.771 -0.826 . . . . 0.23000000000000001 108.771 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.5 p -92.85 128.68 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.94999999999999996 111.17 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.8 135.05 34.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.16 110.605 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.08 -10.91 20.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.292 -0.413 . . . . 0.23999999999999999 111.37 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -130.26 166.1 21.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 0.25 111.075 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.657 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 85.9 m -66.36 -34.92 79.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 1.6000000000000001 110.301 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -61.08 -51.57 68.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.69999999999999996 110.578 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -55.93 -37.07 68.45 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.999 -0.546 . . . . 1.4099999999999999 111.245 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.705 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -69.28 -52.74 24.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.542 -0.753 . . . . 0.17999999999999999 111.133 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.73 -34.96 70.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.87 -0.604 . . . . 0.82999999999999996 110.873 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -52.74 63.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.469 . . . . 2.4100000000000001 110.557 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 -36.74 84.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.88 -0.6 . . . . 1.1299999999999999 110.481 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.9 -36.09 80.29 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.074 0.464 . . . . 1.23 110.939 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.47 -35.91 45.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.426 . . . . 0.42999999999999999 111.442 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -85.88 -31.47 22.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.059 0.457 . . . . 0.62 111.106 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -123.25 162.8 37.71 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.614 . . . . 0.41999999999999998 111.415 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.454 ' HD2' ' HD2' ' A' ' 7' ' ' LYS . 89.2 Cg_endo -95.47 90.55 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.68 2.92 . . . . 0.23999999999999999 111.383 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 7' ' ' LYS . 40.4 mm -73.94 123.85 30.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.784 -0.644 . . . . 0.22 111.329 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.532 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 24.8 m-20 -88.75 -28.48 20.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.552 -0.749 . . . . 0.28999999999999998 110.884 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -164.05 158.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.979 -0.378 . . . . 0.12 109.979 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -139.8 167.13 22.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.14000000000000001 111.806 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.58 112.26 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 0.95999999999999996 109.028 176.351 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.7 mp -111.22 119.59 39.45 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.43 0.53 . . . . 0.16 112.43 -167.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -85.02 141.67 30.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.861 -0.792 . . . . 1.77 108.861 167.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 93' ' ' LEU . 13.1 t -100.89 2.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.584 0.707 . . . . 0.80000000000000004 111.148 -170.477 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -124.37 62.7 1.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.682 -0.69 . . . . 2.3700000000000001 109.862 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.54 -15.84 60.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.833 -0.621 . . . . 0.84999999999999998 110.24 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.31 -171.5 41.7 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.105 -0.798 . . . . 0.81999999999999995 111.105 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -50.83 -45.55 35.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.061 2.507 . . . . 1.1799999999999999 112.148 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -117.95 -26.67 6.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 3.5299999999999998 110.106 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -62.47 125.16 22.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.95999999999999996 111.402 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -143.97 157.0 44.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.439 -0.8 . . . . 0.48999999999999999 109.647 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -71.4 87.48 0.86 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.388 0.613 . . . . 1.3 109.493 171.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.24 -72.68 0.63 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.468 -0.872 . . . . 0.23000000000000001 112.19 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.657 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 44.0 Cg_exo -53.62 -26.39 37.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.565 2.176 . . . . 0.23999999999999999 112.212 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.3 t -68.66 -43.35 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.12 110.201 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.77 -48.05 82.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.344 -0.844 . . . . 0.16 109.823 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 29.4 t70 -65.35 -40.5 93.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.47 -0.786 . . . . 2.0299999999999998 110.484 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.22 -47.98 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.398 0.618 . . . . 0.23000000000000001 110.955 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.65 -42.26 71.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.215 -0.902 . . . . 0.20000000000000001 110.733 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -59.22 -36.56 75.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.599 . . . . 2.0099999999999998 111.225 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 77.5 mm-40 -64.82 -37.4 87.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 2.3700000000000001 111.574 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -97.56 5.31 49.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.397 -0.365 . . . . 1.49 111.397 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 31.09 20.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.971 -0.558 . . . . 0.33000000000000002 111.399 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.8 mt -83.36 130.08 57.93 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 109.595 -0.52 . . . . 0.17000000000000001 109.595 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.28 142.95 38.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.309 2.006 . . . . 0.20999999999999999 111.362 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 25.6 p90 -159.3 157.16 30.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.124 0.487 . . . . 0.17999999999999999 110.621 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.424 HG21 ' HG2' ' A' ' 101' ' ' MET . 34.8 mt -121.39 138.59 51.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.311 -0.859 . . . . 0.23999999999999999 109.853 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.34 108.68 19.46 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.758 -0.83 . . . . 0.20999999999999999 108.758 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.609 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 17.4 t-160 -105.82 85.33 2.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.369 0.604 . . . . 0.59999999999999998 109.476 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 57' ' ' VAL . 9.6 t -134.05 160.49 37.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.841 -1.072 . . . . 0.60999999999999999 110.212 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.08 2.27 38.05 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.569 -1.013 . . . . 0.93999999999999995 110.569 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.29 51.09 1.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.545 . . . . 2.3300000000000001 110.692 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.66 -41.45 96.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.702 -0.681 . . . . 1.6100000000000001 111.145 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.01 -40.81 17.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.562 -0.29 . . . . 2.6299999999999999 110.793 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -43.59 80.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.102 -0.499 . . . . 4.4199999999999999 111.521 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 56.5 m80 -119.46 32.04 6.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 1.05 111.149 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -59.13 -41.09 96.44 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.999 -0.619 . . . . 0.97999999999999998 112.809 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.61 -47.17 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.134 0.493 . . . . 2.5 110.624 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.3 tp -60.29 -45.69 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.602 -0.727 . . . . 0.70999999999999996 110.32 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 57' ' ' VAL . 74.2 mt -58.64 -39.93 81.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 1.5800000000000001 111.368 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 4.7 mmp_? -64.26 -33.46 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 4.3799999999999999 111.361 178.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.8 -34.12 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 2.4500000000000002 111.069 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 92' ' ' LEU . 80.8 mt -64.76 -52.82 49.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.089 -0.505 . . . . 0.45000000000000001 110.314 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.51 76.0 0.36 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.815 0.697 . . . . 1.0900000000000001 110.787 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -157.6 162.3 27.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.403 -0.817 . . . . 0.28999999999999998 108.95 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.706 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -57.26 136.19 74.82 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.448 2.098 . . . . 0.26000000000000001 112.429 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.91 132.6 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.64000000000000001 110.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.9 mmm -113.04 105.54 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.895 -0.78 . . . . 0.82999999999999996 108.895 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 146.14 55.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.003 -0.544 . . . . 0.54000000000000004 111.475 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.3 mttt -91.05 141.61 26.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.67000000000000004 109.473 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.57 156.41 99.23 Favored 'Cis proline' 0 CA--C 1.528 0.217 0 C-N-CA 123.413 -1.494 . . . . 0.75 113.339 2.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.609 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.76 135.1 15.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.34999999999999998 109.915 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -70.94 130.23 41.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.897 -1.149 . . . . 0.51000000000000001 107.897 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 33.5 p -65.05 -18.35 65.22 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.737 0.643 . . . . 0.26000000000000001 112.737 -171.084 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.3 p -71.15 -38.81 72.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.459 -0.496 . . . . 1.3200000000000001 109.689 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.38 -46.76 87.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.412 0.625 . . . . 0.62 109.575 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.72 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.853 -1.067 . . . . 0.13 110.394 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.64 -50.03 72.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.13 111.518 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -59.59 -43.32 93.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 1.95 111.349 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 117' ' ' MET . 23.9 mmt180 -68.16 -31.79 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.965 0.412 . . . . 2.23 111.321 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.67 -48.53 25.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.14000000000000001 110.473 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.471 HD23 HG11 ' A' ' 52' ' ' VAL . 70.1 mt -66.42 -32.09 73.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.489 0.551 . . . . 0.27000000000000002 112.489 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -70.2 -22.16 62.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.599 -0.441 . . . . 2.79 110.978 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.706 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 56.5 mtm -77.55 -16.35 58.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 0.42999999999999999 110.613 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 43.2 t -90.7 -42.74 10.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.265 0.555 . . . . 1.46 109.64 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.64 -104.86 0.93 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.64 -0.709 . . . . 2.5699999999999998 111.331 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.75 -29.47 2.99 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.003 -0.618 . . . . 4.4800000000000004 113.063 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.4 t70 68.71 16.99 8.94 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.573 0.702 . . . . 6.4199999999999999 110.045 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -165.53 135.56 3.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.746 -0.661 . . . . 9.1899999999999995 110.723 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -104.55 137.36 19.2 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.086 -0.506 . . . . 9.5999999999999996 110.028 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.34 129.73 13.27 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.37 2.046 . . . . 11.17 112.13 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.511 -0.757 . . . . 13.279999999999999 110.501 179.483 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.861 -0.496 . . . . 8.8000000000000007 111.861 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.66 34.13 17.74 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.826 0.451 . . . . 6.7800000000000002 111.329 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.6 mtm -95.09 135.15 36.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.135 -0.484 . . . . 7.21 109.974 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 5' ' ' MET . . . -163.07 62.38 0.26 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.846 -0.692 . . . . 1.8500000000000001 112.027 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 56.4 mtt 68.22 131.55 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.483 0.713 . . . . 1.6499999999999999 112.595 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.86 138.8 65.05 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.917 2.411 . . . . 0.33000000000000002 112.04 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -87.17 105.09 16.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.48 -0.563 . . . . 0.89000000000000001 109.48 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG22 ' CG1' ' A' ' 52' ' ' VAL . 50.2 t -99.88 135.34 35.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.903 -0.59 . . . . 0.20000000000000001 110.939 -174.037 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 52.1 tp -110.54 111.94 23.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.198 -0.455 . . . . 0.75 110.709 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.97 122.43 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.215 0.531 . . . . 0.13 111.467 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.19 101.27 11.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.20999999999999999 108.642 172.129 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -159.03 120.0 3.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.866 -0.606 . . . . 1.4099999999999999 109.956 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 36.8 t70 -88.41 -16.9 31.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.307 -0.406 . . . . 1.27 110.332 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.9 mt-10 -82.95 103.16 2.23 Favored Pre-proline 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 2.5600000000000001 109.421 173.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.9 Cg_exo -58.48 -29.04 87.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.667 2.244 . . . . 0.32000000000000001 113.07 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -51.28 57.21 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.682 -0.488 . . . . 1.51 109.682 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.8 mp -64.25 -43.4 97.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 1.01 110.182 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.42 -47.53 81.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.678 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.7 ttp -64.28 -39.32 93.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.516 -0.765 . . . . 0.60999999999999999 110.874 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.415 ' HB3' HG21 ' A' ' 107' ' ' THR . 60.7 m-20 -66.32 -47.04 74.82 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.969 -0.56 . . . . 1.22 111.207 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.3 mt -60.01 -45.32 93.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.039 -0.356 . . . . 0.17999999999999999 110.039 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.486 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 21.0 tt0 -52.19 -50.6 61.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 1.04 110.535 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -68.82 -31.21 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.78000000000000003 111.522 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.8 -43.09 76.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.833 0.349 . . . . 0.14000000000000001 110.838 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 50.1 m-85 -69.37 -42.68 74.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 0.13 110.881 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 43.3 mt-10 -62.51 -32.02 72.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.68999999999999995 110.24 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.31 -35.13 79.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.51000000000000001 110.818 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -83.98 6.52 21.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.65000000000000002 110.625 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 57.38 2.85 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.28999999999999998 112.485 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.27 170.48 15.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.23000000000000001 111.051 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -115.92 132.54 56.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.186 -0.672 . . . . 2.1400000000000001 109.186 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.486 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.5 t -117.12 137.29 51.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.749 0.648 . . . . 0.19 112.749 -166.833 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -110.91 135.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.464 -0.939 . . . . 0.23000000000000001 108.464 169.668 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.28 128.74 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.911 0.386 . . . . 0.94999999999999996 110.754 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.577 . . . . 0.16 110.41 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -103.17 -6.54 22.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.492 . . . . 0.23999999999999999 110.769 178.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -132.31 163.95 27.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.876 -0.602 . . . . 0.25 110.315 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.578 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 79.6 m -68.46 -33.05 73.5 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.744 -0.382 . . . . 1.6000000000000001 110.139 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.66 -39.38 84.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.69999999999999996 111.176 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 37.8 mt-30 -62.45 -36.67 83.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.258 0.552 . . . . 1.4099999999999999 110.473 174.247 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.75 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -67.88 -53.22 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.405 -0.816 . . . . 0.17999999999999999 111.267 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 79.0 mt -59.45 -33.2 70.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.82999999999999996 110.663 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -63.97 -49.71 71.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.936 -0.394 . . . . 2.4100000000000001 109.936 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 m -67.21 -27.04 66.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.958 -0.565 . . . . 1.1299999999999999 111.319 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.2 -35.79 69.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 1.23 111.052 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.12 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.42999999999999999 111.06 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -83.01 -28.24 29.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.86 -0.609 . . . . 0.62 111.464 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -131.66 160.2 68.5 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 110.109 -0.33 . . . . 0.41999999999999998 110.109 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -94.47 89.3 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.484 2.789 . . . . 0.23999999999999999 111.552 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.2 mm -67.78 123.29 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.655 -0.702 . . . . 0.22 111.801 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.32 -34.81 18.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 110.296 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.543 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -159.13 158.74 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.12 110.082 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.78 166.01 25.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.203 0.525 . . . . 0.14000000000000001 112.069 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.75 112.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.334 -0.848 . . . . 0.95999999999999996 109.302 176.359 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.737 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -113.58 121.86 45.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.432 0.53 . . . . 0.16 112.432 -167.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -80.49 109.96 15.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.809 0.814 . . . . 1.77 108.959 169.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.673 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 17.3 t -59.05 -19.65 16.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.353 -1.294 . . . . 0.80000000000000004 112.253 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -123.88 80.41 1.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 2.3700000000000001 110.573 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.28 -32.3 62.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.751 -0.659 . . . . 0.84999999999999998 110.01 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -169.66 28.71 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.233 -0.747 . . . . 0.81999999999999995 111.233 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.47 -37.76 96.29 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.165 2.577 . . . . 1.1799999999999999 112.599 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 62' ' ' LYS . 13.8 tmtt? -113.57 -34.31 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.695 -0.483 . . . . 3.5299999999999998 109.695 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -63.52 124.52 21.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.95999999999999996 111.65 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.94 149.8 35.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.34 -0.845 . . . . 0.48999999999999999 109.598 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.1 p -71.47 87.15 0.87 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.491 0.663 . . . . 1.3 109.257 171.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.94 -71.6 0.55 Allowed Glycine 0 CA--C 1.509 -0.303 0 C-N-CA 120.451 -0.88 . . . . 0.23000000000000001 112.045 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 52.4 Cg_exo -52.34 -25.14 23.3 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.625 2.217 . . . . 0.23999999999999999 112.064 174.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.4 t -71.74 -44.7 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.12 110.24 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.78 -49.43 77.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.281 -0.872 . . . . 0.16 110.118 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 17.5 m-20 -62.08 -40.18 94.96 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.678 -0.692 . . . . 2.0299999999999998 110.28 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.24 -50.01 74.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.279 0.562 . . . . 0.23000000000000001 111.073 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.22 -42.74 96.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.492 -0.776 . . . . 0.20000000000000001 110.312 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 64.0 mmtt -61.41 -33.48 73.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.588 -0.733 . . . . 2.0099999999999998 111.498 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 79.4 mm-40 -71.62 -37.44 70.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.16 -0.473 . . . . 2.3700000000000001 111.358 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -90.1 2.14 55.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 1.49 111.256 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 36.47 17.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.489 -0.778 . . . . 0.33000000000000002 111.205 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.06 134.06 30.78 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.072 -0.513 . . . . 0.17000000000000001 110.274 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.38 140.85 24.9 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.351 2.034 . . . . 0.20999999999999999 111.728 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 31.6 p90 -156.74 161.92 39.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 0.17999999999999999 110.662 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -125.62 140.77 47.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.364 -0.835 . . . . 0.23999999999999999 109.913 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.413 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.91 109.07 19.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.03 0.443 . . . . 0.20999999999999999 110.027 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.61 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.2 t-160 -109.43 86.11 2.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.223 0.535 . . . . 0.59999999999999998 109.798 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.597 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -126.75 160.15 31.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.341 -0.845 . . . . 0.60999999999999999 111.217 -172.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.55 16.19 52.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.082 -0.58 . . . . 0.93999999999999995 112.541 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -149.99 113.53 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.876 0.37 . . . . 2.3300000000000001 110.785 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.7 -5.03 15.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.25 -0.432 . . . . 1.6100000000000001 110.677 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ASP . . . . . 0.44 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 14.2 t70 -83.18 -53.59 5.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.126 -0.488 . . . . 2.6299999999999999 111.082 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 5.2 mpt_? -80.35 -3.4 49.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.174 0.511 . . . . 4.4199999999999999 110.852 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.546 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 96.9 m-70 -119.17 16.57 13.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.94 -0.573 . . . . 1.05 111.226 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -55.49 -44.84 85.49 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.852 -0.69 . . . . 0.97999999999999998 112.474 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 43.8 tt0 -63.28 -42.68 99.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.956 0.408 . . . . 2.5 110.669 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 57' ' ' VAL . 32.8 tp -64.09 -40.19 95.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.796 -0.638 . . . . 0.70999999999999996 110.462 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 76.6 mt -61.06 -34.88 75.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 111.338 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 65.1 mtm-85 -72.5 -26.19 61.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 4.3799999999999999 110.414 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.79 -26.47 54.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 2.4500000000000002 110.284 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.426 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 77.9 mt -83.28 -63.26 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.74 -0.664 . . . . 0.45000000000000001 110.746 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.2 t70 61.4 83.11 0.15 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.734 -0.666 . . . . 1.0900000000000001 110.622 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.38 165.11 13.28 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.694 -0.685 . . . . 0.28999999999999998 109.735 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.58 140.36 93.13 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.841 2.361 . . . . 0.26000000000000001 112.85 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.96 133.68 65.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.64000000000000001 111.357 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 83.5 mmm -121.08 92.37 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.418 -0.956 . . . . 0.82999999999999996 108.418 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.48 154.84 40.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.104 -0.498 . . . . 0.54000000000000004 111.786 -173.967 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 94.8 mttt -89.96 142.85 29.21 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.67000000000000004 109.475 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 10.8 Cg_exo -71.71 145.61 83.35 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.487 -1.464 . . . . 0.75 112.909 0.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.61 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 134.32 25.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.34999999999999998 109.965 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.572 ' O ' HG23 ' A' ' 110' ' ' VAL . 16.7 t70 -73.44 128.25 34.98 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.417 -0.586 . . . . 0.51000000000000001 109.417 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -65.64 -21.52 66.57 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 112.823 -170.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.8 t -72.9 -41.09 64.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.527 -0.545 . . . . 1.3200000000000001 109.527 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.93 -40.7 91.63 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.118 0.485 . . . . 0.62 110.056 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 106' ' ' ASP . 24.8 t -63.82 -42.5 96.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.443 -0.799 . . . . 0.13 110.375 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.64 -48.65 68.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.798 -0.637 . . . . 0.13 111.58 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -60.46 -45.56 93.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.183 -0.462 . . . . 1.95 111.453 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 34.1 mmt180 -67.49 -25.4 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 2.23 111.391 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.23 -51.47 9.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.002 0.429 . . . . 0.14000000000000001 110.43 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 HG11 ' A' ' 52' ' ' VAL . 75.4 mt -64.54 -27.54 69.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.869 0.692 . . . . 0.27000000000000002 112.869 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 9.3 pt-20 -67.44 -32.06 72.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.442 -0.503 . . . . 2.79 110.719 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.8 mtm -72.6 -29.53 63.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.42999999999999999 111.285 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 17.8 p -86.13 0.48 53.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.954 0.407 . . . . 1.46 110.757 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.17 -20.5 75.0 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.997 -0.841 . . . . 2.5699999999999998 110.997 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -136.82 -134.73 3.32 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.879 -0.888 . . . . 4.4800000000000004 110.879 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -156.63 -157.59 0.71 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.541 -0.54 . . . . 6.4199999999999999 109.541 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.09 111.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.107 0.479 . . . . 9.1899999999999995 110.966 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.55 138.17 77.58 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.697 -0.683 . . . . 9.5999999999999996 110.558 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.59 158.07 47.9 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.3 2.0 . . . . 11.17 111.588 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.511 -0.756 . . . . 13.279999999999999 110.181 178.735 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 112.215 -0.354 . . . . 8.8000000000000007 112.215 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.23 54.79 3.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.48 . . . . 6.7800000000000002 110.729 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.0 tpt -146.57 127.44 14.46 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.112 -0.699 . . . . 7.21 109.112 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.8 -56.8 4.94 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.845 -0.902 . . . . 1.8500000000000001 110.845 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp -81.9 124.67 79.01 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.037 -0.727 . . . . 1.6499999999999999 109.037 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 26.0 Cg_exo -62.6 134.47 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.678 2.252 . . . . 0.33000000000000002 111.799 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -87.12 107.1 18.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.388 0.614 . . . . 0.89000000000000001 109.405 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 58.7 t -99.93 130.83 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.216 -0.902 . . . . 0.20000000000000001 111.033 -172.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 50' ' ' ILE . 49.4 tp -105.61 111.24 23.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 0.75 110.357 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.37 123.36 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.13 111.422 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -103.48 106.04 16.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.21 -0.905 . . . . 0.20999999999999999 108.57 171.489 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.21 125.61 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.195 0.522 . . . . 1.4099999999999999 110.444 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 t70 -90.72 -13.8 33.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.564 -0.744 . . . . 1.27 109.895 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -89.74 104.02 7.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 2.5600000000000001 109.89 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.7 Cg_exo -59.44 -31.53 94.91 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.919 2.412 . . . . 0.32000000000000001 113.045 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.59 -49.88 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.593 -0.521 . . . . 1.51 109.593 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -67.24 -44.07 87.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 1.01 110.888 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -51.28 68.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 0.20999999999999999 110.737 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.2 ttp -61.46 -43.33 99.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.358 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.507 ' HB3' HG21 ' A' ' 107' ' ' THR . 7.1 m-20 -67.47 -39.02 85.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.341 -0.39 . . . . 1.22 111.227 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 51.4 mt -62.91 -45.78 90.92 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 110.071 -0.344 . . . . 0.17999999999999999 110.071 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.597 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 36.4 tt0 -54.31 -52.68 60.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.547 -0.752 . . . . 1.04 110.314 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -64.77 -30.34 71.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.467 -0.333 . . . . 0.78000000000000003 111.416 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.47 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.14000000000000001 110.82 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 63.7 m-85 -68.46 -41.48 80.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.13 110.682 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.11 -32.52 73.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 0.68999999999999995 110.525 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.49 -32.71 73.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.089 0.471 . . . . 0.51000000000000001 110.231 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -84.03 1.25 44.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.65000000000000002 111.167 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 50.73 3.95 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.28999999999999998 112.539 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.37 167.16 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.246 -0.279 . . . . 0.23000000000000001 110.246 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -113.44 132.3 55.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.297 -0.631 . . . . 2.1400000000000001 109.297 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.597 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 4.8 t -121.79 147.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.852 0.686 . . . . 0.19 112.852 -167.111 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 t -120.44 143.34 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.348 -0.842 . . . . 0.23000000000000001 108.793 168.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -111.85 126.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.94999999999999996 111.123 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.53 142.98 45.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.702 -0.681 . . . . 0.16 110.139 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.86 -2.92 15.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.682 0.277 . . . . 0.23999999999999999 111.402 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -136.9 169.95 16.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.52 -0.309 . . . . 0.25 111.046 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.531 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 18.6 p -59.99 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.579 . . . . 1.6000000000000001 109.536 172.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.77 -49.91 69.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.597 -1.183 . . . . 0.69999999999999996 111.813 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 42.6 mt-30 -59.31 -38.57 80.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.107 0.48 . . . . 1.4099999999999999 111.092 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.661 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -68.75 -51.35 42.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.694 . . . . 0.17999999999999999 111.18 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 67.3 mt -63.97 -28.19 69.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.642 -0.708 . . . . 0.82999999999999996 110.733 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -66.77 -51.28 57.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.521 . . . . 2.4100000000000001 110.123 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.3 t -65.48 -34.11 77.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 1.1299999999999999 110.907 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.411 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 14.6 tp -61.94 -33.16 73.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.232 0.539 . . . . 1.23 110.211 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.56 22.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.42999999999999999 111.065 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.35 -37.97 56.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.546 . . . . 0.62 111.108 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -123.5 159.44 55.21 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.096 -0.502 . . . . 0.41999999999999998 110.091 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -93.22 86.67 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.358 2.705 . . . . 0.23999999999999999 111.075 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.6 mm -63.94 122.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.537 -0.756 . . . . 0.22 111.485 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 43.2 m-20 -92.57 -29.97 15.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.558 -0.746 . . . . 0.28999999999999998 110.142 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.0 p -158.41 156.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.12 109.716 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.39 168.99 18.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.355 0.597 . . . . 0.14000000000000001 112.146 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.38 112.61 4.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.206 -0.906 . . . . 0.95999999999999996 109.207 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.614 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -112.81 116.91 30.81 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.531 0.567 . . . . 0.16 112.531 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.91 133.7 38.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.217 -0.66 . . . . 1.77 109.217 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.467 ' H ' ' HB ' ' A' ' 83' ' ' THR . 19.8 t -93.8 -10.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.771 -0.649 . . . . 0.80000000000000004 111.249 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -116.32 53.82 0.86 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 2.3700000000000001 110.551 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.66 -41.26 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.262 0.553 . . . . 0.84999999999999998 110.473 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.82 -172.99 29.92 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.96 -0.856 . . . . 0.81999999999999995 110.96 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.59 -43.76 52.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.827 2.351 . . . . 1.1799999999999999 112.263 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -113.42 -27.96 7.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.24 -0.436 . . . . 3.5299999999999998 110.879 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.7 m -68.54 123.95 22.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.95999999999999996 111.3 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.3 152.26 40.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.099 -0.955 . . . . 0.48999999999999999 109.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.2 p -68.76 86.31 0.33 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.406 0.622 . . . . 1.3 109.521 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.3 -66.47 0.3 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.791 -0.718 . . . . 0.23000000000000001 112.023 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.47 -28.14 53.06 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.234 1.956 . . . . 0.23999999999999999 111.541 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -71.11 -44.37 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.12 110.195 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.99 87.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.29 -0.868 . . . . 0.16 110.092 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 21.7 t70 -61.52 -43.67 98.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.359 -0.837 . . . . 2.0299999999999998 110.395 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -55.19 -49.34 72.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.836 -0.62 . . . . 0.23000000000000001 111.036 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.66 -43.39 89.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.421 -0.808 . . . . 0.20000000000000001 110.656 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 56.2 mmtt -60.65 -32.98 72.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.675 -0.693 . . . . 2.0099999999999998 111.397 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 14.4 mm100 -71.55 -33.48 69.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 2.3700000000000001 111.526 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -93.23 1.07 57.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.678 -0.237 . . . . 1.49 111.131 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.16 34.5 13.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.7 -0.682 . . . . 0.33000000000000002 111.307 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.4 mt -87.55 133.9 37.12 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.439 . . . . 0.17000000000000001 110.223 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 27.5 Cg_endo -75.36 143.37 27.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.373 2.049 . . . . 0.20999999999999999 112.051 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 28.7 p90 -159.65 159.29 32.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.748 -0.66 . . . . 0.17999999999999999 110.462 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -124.0 139.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.408 -0.815 . . . . 0.23999999999999999 109.728 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mm? -88.43 109.69 20.22 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.451 -0.574 . . . . 0.20999999999999999 109.451 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.618 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 19.7 t-160 -102.25 90.88 4.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.987 -0.552 . . . . 0.59999999999999998 109.732 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 9.3 t -139.63 160.98 38.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.364 -0.835 . . . . 0.60999999999999999 110.409 -174.109 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.07 9.47 20.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.89 -0.671 . . . . 0.93999999999999995 111.82 175.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.62 60.26 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.195 0.521 . . . . 2.3300000000000001 110.822 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.68 -41.39 79.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.566 -0.743 . . . . 1.6100000000000001 110.08 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.3 -20.14 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.603 -0.726 . . . . 2.6299999999999999 111.371 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 3.6 tpm_? -90.56 -22.07 21.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 4.4199999999999999 110.761 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.499 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.1 m-70 -126.01 28.86 6.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 1.05 111.637 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -58.17 -37.99 88.32 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.119 -0.562 . . . . 0.97999999999999998 112.602 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.0 -46.01 75.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.855 0.36 . . . . 2.5 110.699 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD23 ' CG1' ' A' ' 57' ' ' VAL . 56.8 tp -60.89 -39.66 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.70999999999999996 110.501 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.9 mt -61.78 -32.77 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.5800000000000001 111.067 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -72.53 -38.54 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.88 0.372 . . . . 4.3799999999999999 110.297 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.91 -42.26 89.22 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.532 0.682 . . . . 2.4500000000000002 110.233 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.497 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 84.7 mt -72.07 -58.79 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.892 -1.049 . . . . 0.45000000000000001 111.067 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.3 t70 62.54 82.07 0.19 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.618 0.723 . . . . 1.0900000000000001 111.093 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.413 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -163.45 162.09 17.48 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.28999999999999998 108.986 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -58.27 146.25 89.88 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.57 2.18 . . . . 0.26000000000000001 112.528 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.7 t -123.05 132.4 71.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.64000000000000001 111.028 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.6 mmm -113.87 106.25 14.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.82999999999999996 109.129 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.03 146.35 53.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.984 -0.553 . . . . 0.54000000000000004 111.938 -174.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.6 mttt -91.59 145.11 30.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.827 -0.624 . . . . 0.67000000000000004 110.204 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.22 142.61 75.04 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 123.572 -1.428 . . . . 0.75 112.422 -0.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.618 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -133.08 135.44 45.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.867 -0.606 . . . . 0.34999999999999998 109.806 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.4 t0 -70.38 127.31 32.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.287 -1.005 . . . . 0.51000000000000001 108.287 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.507 HG21 ' HB3' ' A' ' 20' ' ' ASN . 22.9 p -63.22 -20.5 65.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.348 -0.842 . . . . 0.26000000000000001 112.646 -172.272 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -70.53 -40.29 73.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.3200000000000001 109.943 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.34 -39.56 81.85 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.62 109.903 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.6 t -65.15 -45.31 94.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.13 110.09 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.14 -50.42 71.95 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.685 -0.689 . . . . 0.13 111.374 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 67.9 mttm -57.42 -51.5 69.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 1.95 111.304 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -61.26 -39.46 90.44 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.112 0.257 . . . . 2.23 111.686 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.94 79.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.14000000000000001 110.172 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 HG11 ' A' ' 52' ' ' VAL . 85.1 mt -67.02 -25.34 66.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.27000000000000002 111.768 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 36.7 mm-40 -60.79 -38.47 85.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.986 0.422 . . . . 2.79 110.692 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.518 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.4 mtm -79.59 -10.66 59.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.42999999999999999 110.717 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 36.7 t -88.86 18.57 4.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 1.46 110.202 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.62 85.89 0.53 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.436 -0.666 . . . . 2.5699999999999998 111.436 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.48 -90.96 0.84 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.225 -0.75 . . . . 4.4800000000000004 111.225 -176.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -155.67 24.19 0.39 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.362 0.601 . . . . 6.4199999999999999 109.761 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.07 129.71 24.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.924 -0.58 . . . . 9.1899999999999995 111.145 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.43 139.94 92.25 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.619 -0.719 . . . . 9.5999999999999996 109.448 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.93 89.27 0.37 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.585 2.19 . . . . 11.17 112.405 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.573 -0.727 . . . . 13.279999999999999 110.734 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.411 -0.675 . . . . 8.8000000000000007 111.411 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.14 49.34 1.24 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.251 0.548 . . . . 6.7800000000000002 110.255 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.9 mmm -103.4 -4.67 23.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.771 -0.65 . . . . 7.21 110.352 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.16 -53.52 0.79 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.173 -0.771 . . . . 1.8500000000000001 111.173 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 16.7 mmt -123.83 141.29 36.43 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.807 -0.442 . . . . 1.6499999999999999 109.807 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.4 Cg_endo -68.06 135.68 35.54 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.609 1.539 . . . . 0.33000000000000002 110.635 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 34.1 tptt -84.63 104.53 14.69 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.724 -0.472 . . . . 0.89000000000000001 109.724 -178.452 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 52' ' ' VAL . 46.7 t -100.14 128.97 51.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.84 -0.618 . . . . 0.20000000000000001 110.978 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.436 ' HB2' HD12 ' A' ' 50' ' ' ILE . 50.5 tp -107.43 119.01 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.451 -0.34 . . . . 0.75 110.462 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 54' ' ' VAL . 44.5 t -100.17 124.93 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.149 0.5 . . . . 0.13 111.43 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -104.51 106.41 16.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.284 -0.871 . . . . 0.20999999999999999 109.013 172.841 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -167.3 128.95 1.59 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.975 -0.557 . . . . 1.4099999999999999 109.687 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.5 t70 -84.58 -28.88 26.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 1.27 109.661 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HB3' HD13 ' A' ' 17' ' ' ILE . 1.2 mp0 -74.07 109.55 7.15 Favored Pre-proline 0 N--CA 1.462 0.147 0 CA-C-N 116.249 -0.432 . . . . 2.5600000000000001 110.583 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.6 Cg_exo -60.39 -29.59 89.11 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.527 2.151 . . . . 0.32000000000000001 112.733 -178.467 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -52.47 42.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.059 -0.349 . . . . 1.51 110.059 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.5 mp -62.69 -42.6 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 1.01 109.927 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.09 71.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.502 -0.772 . . . . 0.20999999999999999 110.832 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.497 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 47.6 ttp -65.05 -38.37 90.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.60999999999999999 111.202 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.447 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.3 m-20 -64.82 -44.07 91.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.047 -0.524 . . . . 1.22 110.982 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 39.3 mt -61.91 -44.99 95.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.437 -0.347 . . . . 0.17999999999999999 110.253 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.623 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 43.4 tt0 -53.44 -51.18 63.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.633 -0.712 . . . . 1.04 110.815 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -63.43 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.78000000000000003 111.33 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.19 78.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.306 -0.406 . . . . 0.14000000000000001 110.95 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 57.0 m-85 -71.19 -42.09 69.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.422 . . . . 0.13 110.874 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 46.0 mt-10 -65.4 -28.24 69.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.996 0.427 . . . . 0.68999999999999995 110.079 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.8 -32.18 70.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.51000000000000001 110.616 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -83.97 -2.5 56.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.227 0.537 . . . . 0.65000000000000002 110.461 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 62.76 1.61 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.601 -0.727 . . . . 0.28999999999999998 111.998 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -145.32 172.16 13.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 0.23000000000000001 111.359 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -114.57 137.24 52.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.938 -0.573 . . . . 2.1400000000000001 109.612 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 5.1 t -120.19 146.91 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 0.19 111.913 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.438 HG11 ' OG ' ' A' ' 44' ' ' SER . 24.1 t -119.6 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.23000000000000001 108.919 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t -97.24 124.72 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.94999999999999996 110.885 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.59 134.64 41.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.007 -0.542 . . . . 0.16 110.415 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.48 -11.02 20.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.97 0.414 . . . . 0.23999999999999999 110.792 179.527 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.3 p -129.87 160.77 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 0.25 110.732 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.594 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.1 m -63.92 -35.5 80.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.736 -0.468 . . . . 1.6000000000000001 109.736 174.366 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.0 -47.87 84.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.69999999999999996 111.19 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -59.01 -41.24 87.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.642 176.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.675 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.36 -51.77 64.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.274 -0.875 . . . . 0.17999999999999999 111.444 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.9 mt -62.24 -32.23 72.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.067 -0.515 . . . . 0.82999999999999996 110.894 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.27 -50.64 69.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 2.4100000000000001 110.219 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.438 ' OG ' HG11 ' A' ' 33' ' ' VAL . 23.2 t -68.5 -35.07 76.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 1.1299999999999999 110.551 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -57.3 -39.67 76.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.23 109.817 177.613 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.82 30.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.42999999999999999 111.408 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.84 -38.34 58.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.998 0.428 . . . . 0.62 111.777 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 20.2 m120 -114.48 163.94 17.83 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.41999999999999998 110.758 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -96.0 76.01 0.13 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.494 2.796 . . . . 0.23999999999999999 111.341 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.2 mm -56.78 120.24 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.228 -0.896 . . . . 0.22 111.725 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.793 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 16.8 m-20 -90.09 -31.19 17.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.372 -0.831 . . . . 0.28999999999999998 110.629 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -160.34 156.7 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.12 109.914 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.81 160.92 39.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.46 0.648 . . . . 0.14000000000000001 112.168 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -133.07 112.04 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.95999999999999996 109.243 174.782 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.689 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -111.78 117.73 33.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.986 0.422 . . . . 0.16 112.039 -170.026 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.87 129.96 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.839 -0.8 . . . . 1.77 108.839 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' H ' ' HB ' ' A' ' 83' ' ' THR . 61.8 t -88.97 -35.72 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.139 -0.482 . . . . 0.80000000000000004 111.475 -171.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.68 60.66 4.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.072 0.463 . . . . 2.3700000000000001 111.382 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.362 0.601 . . . . 0.84999999999999998 110.148 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.69 -171.58 32.05 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.65 -0.98 . . . . 0.81999999999999995 110.65 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.11 -36.83 96.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.856 2.371 . . . . 1.1799999999999999 113.104 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -127.24 -21.76 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 3.5299999999999998 111.557 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 p -73.54 126.41 30.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.483 0.658 . . . . 0.95999999999999996 110.709 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -144.93 155.09 43.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 110.301 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.5 p -69.49 87.27 0.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.488 -0.56 . . . . 1.3 109.488 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.78 -69.88 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.504 -0.855 . . . . 0.23000000000000001 112.499 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.522 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 50.9 Cg_exo -51.47 -27.51 24.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.8 2.333 . . . . 0.23999999999999999 111.979 175.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.502 HG11 ' CD2' ' A' ' 11' ' ' LEU . 14.3 t -69.28 -44.75 80.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 0.12 110.042 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.55 93.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.143 -0.935 . . . . 0.16 110.156 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 37.8 m-20 -64.12 -42.07 96.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.447 . . . . 2.0299999999999998 110.345 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.54 -46.81 70.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.389 0.614 . . . . 0.23000000000000001 110.881 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.66 -46.72 71.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.023 -0.989 . . . . 0.20000000000000001 110.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -56.53 -36.02 68.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.515 -0.766 . . . . 2.0099999999999998 111.849 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.1 mt-30 -61.42 -44.39 97.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 2.3700000000000001 111.696 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -94.59 7.14 46.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.569 -0.287 . . . . 1.49 111.214 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.14 34.79 21.18 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.626 . . . . 0.33000000000000002 111.264 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.79 133.38 55.35 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.17000000000000001 109.984 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 13.3 Cg_endo -73.81 137.02 23.97 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.117 1.878 . . . . 0.20999999999999999 111.423 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -156.49 158.85 37.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.937 -0.574 . . . . 0.17999999999999999 110.617 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.0 mt -124.24 140.9 46.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.21 -0.904 . . . . 0.23999999999999999 109.795 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.97 107.94 19.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.041 -0.725 . . . . 0.20999999999999999 109.041 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.7 t-160 -101.61 78.95 1.89 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.995 -0.742 . . . . 0.59999999999999998 108.995 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.485 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 4.7 t -118.32 158.76 24.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.788 -1.096 . . . . 0.60999999999999999 110.915 -171.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.36 -1.35 55.66 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.012 -0.613 . . . . 0.93999999999999995 111.883 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.95 120.45 26.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.771 0.32 . . . . 2.3300000000000001 110.783 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HA ' HD11 ' A' ' 93' ' ' LEU . 7.1 mp -114.38 -6.85 12.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 1.6100000000000001 109.904 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -84.39 -60.92 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 2.6299999999999999 111.387 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -40.24 78.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.092 0.472 . . . . 4.4199999999999999 110.421 -174.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.407 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 97.3 m-70 -92.27 22.4 4.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.211 -0.449 . . . . 1.05 111.256 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.55 -41.83 98.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.121 -0.561 . . . . 0.97999999999999998 112.698 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.06 -45.8 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 2.5 110.678 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.26 -44.24 92.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.70999999999999996 110.472 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 86' ' ' LEU . 63.2 mt -61.97 -31.48 71.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.838 -0.619 . . . . 1.5800000000000001 111.239 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 25.4 mtm180 -70.55 -32.6 70.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.4 -0.364 . . . . 4.3799999999999999 110.622 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.05 -39.4 50.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.997 -0.547 . . . . 2.4500000000000002 110.375 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.92 -52.89 43.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.612 -0.722 . . . . 0.45000000000000001 110.014 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.74 74.36 0.41 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.593 -0.73 . . . . 1.0900000000000001 110.952 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -153.13 163.79 22.44 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.152 -0.931 . . . . 0.28999999999999998 109.22 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.697 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 66.3 Cg_exo -54.96 141.08 79.27 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.491 2.127 . . . . 0.26000000000000001 112.768 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.56 140.26 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.806 -0.633 . . . . 0.64000000000000001 110.621 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.3 mmm -121.32 95.32 4.64 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 0.82999999999999996 108.887 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.3 147.07 52.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.953 -0.567 . . . . 0.54000000000000004 111.466 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 85.9 mttt -91.17 147.0 34.64 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.708 . . . . 0.67000000000000004 110.434 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.6 Cg_exo -73.05 152.25 98.06 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.483 -1.466 . . . . 0.75 112.459 1.565 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.617 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -148.57 129.34 14.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.34999999999999998 110.511 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 110' ' ' VAL . 16.4 t70 -66.28 128.96 38.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.51000000000000001 109.143 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.447 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.4 p -64.83 -24.7 67.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.59 -0.732 . . . . 0.26000000000000001 112.581 -170.498 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 32.3 t -68.13 -40.91 82.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.651 -0.5 . . . . 1.3200000000000001 109.651 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -40.76 92.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.076 0.465 . . . . 0.62 110.097 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 106' ' ' ASP . 22.0 t -64.36 -42.57 95.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.579 -0.737 . . . . 0.13 110.475 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.34 -48.5 72.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.727 -0.67 . . . . 0.13 111.349 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 108' ' ' SER . 99.0 mttt -60.39 -46.48 89.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 1.95 110.887 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.3 mmt180 -62.4 -28.55 69.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.126 -0.488 . . . . 2.23 111.309 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.37 -51.65 9.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.14000000000000001 110.576 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 52' ' ' VAL . 88.3 mt -65.41 -29.35 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.493 0.553 . . . . 0.27000000000000002 112.493 -176.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.511 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.3 pt-20 -67.44 -25.8 66.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.8 0.333 . . . . 2.79 111.255 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.697 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 43.5 mtm -81.53 -14.54 56.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.019 0.438 . . . . 0.42999999999999999 110.711 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 46.9 t -102.53 -55.67 2.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.897 -0.592 . . . . 1.46 111.609 -174.148 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -128.74 17.21 5.79 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.544 -0.836 . . . . 2.5699999999999998 112.821 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.95 -25.26 60.29 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.758 -0.734 . . . . 4.4800000000000004 111.682 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.5 101.28 13.17 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.463 -0.569 . . . . 6.4199999999999999 109.463 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -141.18 131.39 24.91 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 9.1899999999999995 110.241 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.57 119.56 77.3 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.235 -0.439 . . . . 9.5999999999999996 109.971 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.87 74.52 1.77 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.796 2.331 . . . . 11.17 112.541 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-N 115.719 -0.673 . . . . 13.279999999999999 109.985 -179.523 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 112.292 -0.323 . . . . 8.8000000000000007 112.292 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.47 -49.48 6.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 6.7800000000000002 111.269 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.1 mtt -79.53 -25.75 41.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.682 0.754 . . . . 7.21 109.722 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.36 -109.74 0.3 Allowed Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.85 -1.068 . . . . 1.8500000000000001 111.243 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 7.2 ptm -151.01 138.03 11.77 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.737 -0.468 . . . . 1.6499999999999999 109.737 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 1.6 Cg_endo -73.01 143.96 37.22 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.271 1.981 . . . . 0.33000000000000002 112.426 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 34.5 tptt -90.23 105.54 17.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.738 -0.665 . . . . 0.89000000000000001 109.271 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.7 t -100.61 137.61 27.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.138 -0.483 . . . . 0.20000000000000001 111.153 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.637 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.2 tm? -115.66 110.76 19.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.75 109.906 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.04 128.83 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.235 0.54 . . . . 0.13 111.039 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -108.12 100.8 10.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.197 -0.91 . . . . 0.20999999999999999 108.884 175.852 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -164.17 134.77 4.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.172 0.51 . . . . 1.4099999999999999 110.101 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -97.16 -23.83 16.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.468 -0.787 . . . . 1.27 109.993 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.0 mt-10 -76.03 108.15 5.61 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.658 -0.497 . . . . 2.5600000000000001 109.658 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 14' ' ' GLU . 32.2 Cg_exo -57.48 -35.84 98.8 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 123.073 2.515 . . . . 0.32000000000000001 113.537 -171.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 16' ' ' LEU . 4.7 tt -65.0 -50.85 64.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.813 -0.44 . . . . 1.51 109.813 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -62.02 -46.97 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.498 . . . . 1.01 109.814 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.239 -0.891 . . . . 0.20999999999999999 110.824 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.429 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 38.2 ttp -63.41 -44.86 93.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.60999999999999999 111.083 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.57 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.7 t-20 -65.28 -42.56 93.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 1.22 110.425 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.5 mt -64.39 -43.48 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.17999999999999999 110.227 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 48.4 tt0 -53.22 -50.57 64.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.663 -0.699 . . . . 1.04 110.318 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 14.4 m-85 -63.18 -34.96 78.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.78000000000000003 111.206 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.53 71.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.919 0.39 . . . . 0.14000000000000001 110.656 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 55.0 m-85 -66.96 -41.9 86.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.123 -0.49 . . . . 0.13 110.613 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.75 -36.8 79.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.68999999999999995 110.632 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.73 -33.22 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.51000000000000001 110.835 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -80.41 -1.41 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.65000000000000002 110.531 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.15 50.48 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 116.004 -0.544 . . . . 0.28999999999999998 112.414 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.74 158.99 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.323 . . . . 0.23000000000000001 110.783 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.46 138.81 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.988 -0.745 . . . . 2.1400000000000001 108.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.497 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.4 t -120.86 132.14 71.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.482 . . . . 0.19 111.988 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.38 136.1 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.23000000000000001 108.338 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.1 t -111.02 123.97 67.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.631 -0.428 . . . . 0.94999999999999996 111.002 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.26 134.92 50.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.867 -0.606 . . . . 0.16 110.338 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.48 -11.85 18.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.998 0.428 . . . . 0.23999999999999999 111.147 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.9 p -128.83 173.39 10.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.169 -0.468 . . . . 0.25 110.227 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 75.5 m -73.63 -32.08 63.86 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.598 . . . . 1.6000000000000001 109.387 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.13 -51.04 70.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.913 -0.585 . . . . 0.69999999999999996 110.912 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 33.1 mt-30 -55.89 -42.13 75.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.864 -0.607 . . . . 1.4099999999999999 110.7 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -62.66 -52.93 61.38 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.434 -0.803 . . . . 0.17999999999999999 111.278 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.6 mt -59.43 -29.16 67.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.961 -0.563 . . . . 0.82999999999999996 110.942 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.1 tmtp? -65.6 -55.7 16.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.773 -0.454 . . . . 2.4100000000000001 109.773 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.9 t -64.55 -35.26 80.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 1.1299999999999999 110.55 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.446 HD11 HD23 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.937 -0.574 . . . . 1.23 110.984 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.55 -38.17 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.42999999999999999 111.237 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.19 -37.65 61.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.883 -0.598 . . . . 0.62 111.598 -175.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.44 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 43.9 m-80 -120.09 165.22 18.64 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 111.214 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -95.45 86.15 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.625 2.883 . . . . 0.23999999999999999 111.466 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -65.07 118.37 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.329 -0.85 . . . . 0.22 111.258 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -84.27 -32.38 24.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.28999999999999998 110.23 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 115' ' ' LEU . 14.3 p -158.65 154.02 5.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.928 -0.578 . . . . 0.12 110.2 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 162.57 33.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.515 0.674 . . . . 0.14000000000000001 111.61 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.445 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -135.14 111.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.739 -0.837 . . . . 0.95999999999999996 108.739 176.012 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.42 ' HA ' ' CB ' ' A' ' 11' ' ' LEU . 10.5 mp -106.42 98.42 8.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.268 0.556 . . . . 0.16 111.084 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.871 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -76.14 93.35 3.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.079 -0.964 . . . . 1.77 109.448 174.077 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.1 t -54.29 -25.94 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.971 -1.013 . . . . 0.80000000000000004 111.945 -172.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -79.01 68.9 5.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.076 -0.511 . . . . 2.3700000000000001 111.456 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 -32.65 22.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.176 0.513 . . . . 0.84999999999999998 110.311 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.39 -174.02 40.1 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.678 -0.692 . . . . 0.81999999999999995 111.599 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.51 -35.13 96.51 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.076 2.517 . . . . 1.1799999999999999 112.741 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -123.4 -29.42 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.933 -0.576 . . . . 3.5299999999999998 110.253 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.7 m -64.97 125.67 25.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.95999999999999996 111.656 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -144.57 154.78 43.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 0.48999999999999999 110.079 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.459 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -78.7 87.85 4.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.297 -0.631 . . . . 1.3 109.297 174.737 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.21 -72.66 0.87 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.689 -0.767 . . . . 0.23000000000000001 112.363 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.3 Cg_exo -52.82 -24.58 24.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.83 2.353 . . . . 0.23999999999999999 112.331 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 11' ' ' LEU . 30.3 t -64.42 -40.08 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.542 0.687 . . . . 0.12 110.014 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.58 -41.93 98.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.854 -1.067 . . . . 0.16 110.159 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.12 -47.18 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.81 -0.632 . . . . 2.0299999999999998 109.972 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -50.3 -49.93 52.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.605 0.716 . . . . 0.23000000000000001 110.848 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.446 HD23 HD11 ' A' ' 45' ' ' LEU . 97.6 mt -66.12 -47.83 72.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.045 -0.98 . . . . 0.20000000000000001 111.015 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -59.13 -34.52 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.583 . . . . 2.0099999999999998 111.787 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -69.43 -34.68 74.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.316 -0.402 . . . . 2.3700000000000001 111.347 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 75' ' ' ARG . 55.5 mtt180 -95.71 7.53 46.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 1.49 111.077 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.06 34.11 23.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.694 -0.685 . . . . 0.33000000000000002 111.563 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.41 132.67 38.43 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.489 -0.323 . . . . 0.17000000000000001 110.295 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.16 139.77 24.26 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.59 2.193 . . . . 0.20999999999999999 112.2 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 39.2 p90 -155.42 156.91 36.18 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.726 -0.67 . . . . 0.17999999999999999 110.402 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -117.84 138.39 48.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.404 -0.816 . . . . 0.23999999999999999 109.401 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 98' ' ' ALA . 2.1 mm? -88.78 107.96 19.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.492 -0.929 . . . . 0.20999999999999999 108.492 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.871 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 11.7 t-160 -101.34 123.16 44.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.41 -0.959 . . . . 0.59999999999999998 108.41 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 5.4 t -163.12 144.0 9.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.073 -0.651 . . . . 0.60999999999999999 111.947 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 103' ' ' LYS . . . -89.68 -6.77 69.77 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.93999999999999995 111.398 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 88' ' ' ARG . 9.7 t70 -112.57 114.72 27.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.564 -0.532 . . . . 2.3300000000000001 109.564 177.165 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 102' ' ' ALA . 80.7 mt -115.53 -17.93 11.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.343 -0.39 . . . . 1.6100000000000001 111.268 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -85.76 -52.01 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.88 -0.328 . . . . 2.6299999999999999 111.464 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -67.69 -33.2 74.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.03 0.443 . . . . 4.4199999999999999 110.382 -177.761 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.569 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 93.0 m-70 -102.11 16.51 25.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.273 -0.421 . . . . 1.05 111.347 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -60.52 -49.94 73.11 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.943 -0.646 . . . . 0.97999999999999998 113.056 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 3.1 mp0 -60.55 -40.59 92.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.078 -0.341 . . . . 2.5 110.078 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 tp -60.17 -43.35 95.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.931 -0.577 . . . . 0.70999999999999996 110.892 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 67.6 mt -57.87 -37.39 73.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.5800000000000001 110.893 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.412 ' NH2' ' HG3' ' A' ' 91' ' ' GLU . 48.3 mtm105 -78.43 -26.9 46.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 4.3799999999999999 111.225 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 96.7 mttt -69.11 -39.21 79.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.448 0.642 . . . . 2.4500000000000002 109.826 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.431 HG23 ' HB1' ' A' ' 69' ' ' ALA . 95.8 mt -69.09 -54.12 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.008 -0.997 . . . . 0.45000000000000001 110.621 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 64.74 78.8 0.27 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.686 0.755 . . . . 1.0900000000000001 111.206 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.427 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -162.01 169.29 9.64 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.942 -1.026 . . . . 0.28999999999999998 108.721 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.468 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 32.3 Cg_exo -58.45 137.27 79.45 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.164 1.91 . . . . 0.26000000000000001 112.331 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.5 t -119.78 130.71 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.64000000000000001 110.757 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 91.9 mtp -115.89 124.2 50.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.574 . . . . 0.82999999999999996 109.449 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -82.5 152.88 25.86 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.238 -0.437 . . . . 0.54000000000000004 111.201 -175.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.742 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 89.7 mttt -91.27 141.8 26.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.704 -0.48 . . . . 0.67000000000000004 109.704 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.27 153.5 97.25 Favored 'Cis proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.074 -1.636 . . . . 0.75 112.788 1.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.6 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -145.45 130.73 18.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.34999999999999998 109.461 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 110' ' ' VAL . 15.5 t70 -67.11 127.62 33.31 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.974 -0.75 . . . . 0.51000000000000001 108.974 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.57 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.0 p -63.57 -25.12 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.777 . . . . 0.26000000000000001 112.269 -170.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.4 t -70.95 -36.53 72.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.565 -0.532 . . . . 1.3200000000000001 109.565 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 106' ' ' ASP . 15.4 m-20 -66.54 -46.2 76.89 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.512 -0.551 . . . . 0.62 109.512 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.509 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.3 t -60.14 -41.22 85.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 0.13 110.472 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.669 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.29 -51.4 60.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.566 -0.743 . . . . 0.13 111.446 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.67 -38.72 90.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.244 -0.434 . . . . 1.95 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.9 mmt180 -66.83 -28.64 68.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.43 . . . . 2.23 111.432 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -47.17 16.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.08 0.467 . . . . 0.14000000000000001 110.108 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.583 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 78.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.935 0.717 . . . . 0.27000000000000002 112.935 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.52 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.4 pt-20 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 2.79 110.677 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.468 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 63.5 mtm -76.09 -29.48 57.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.277 -0.42 . . . . 0.42999999999999999 111.352 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 10.7 p -89.35 -21.03 23.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.027 0.441 . . . . 1.46 110.192 176.576 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -67.53 -15.1 65.71 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 111.464 -0.654 . . . . 2.5699999999999998 111.464 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -145.87 57.47 0.51 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.541 -1.023 . . . . 4.4800000000000004 110.541 174.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.59 145.89 55.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.172 0.51 . . . . 6.4199999999999999 111.334 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -162.94 166.53 23.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.4 -0.818 . . . . 9.1899999999999995 109.007 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 35.9 mt-10 -59.39 129.83 87.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 O-C-N 123.073 0.233 . . . . 9.5999999999999996 110.398 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 123' ' ' GLU . 12.2 Cg_exo -71.42 47.09 0.82 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.962 2.441 . . . . 11.17 112.57 176.448 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.603 -0.713 . . . . 13.279999999999999 110.166 -177.735 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 112.123 -0.391 . . . . 8.8000000000000007 112.123 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.53 56.14 5.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.175 0.512 . . . . 6.7800000000000002 111.192 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.2 ttm -104.49 80.49 1.69 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.037 -0.529 . . . . 7.21 110.903 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.14 -29.83 27.1 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.871 -0.891 . . . . 1.8500000000000001 110.871 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.447 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 18.3 mmt -68.46 144.14 96.13 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.057 -0.572 . . . . 1.6499999999999999 110.541 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 27.4 Cg_exo -62.64 132.22 36.83 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.306 2.004 . . . . 0.33000000000000002 110.881 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -86.68 103.31 15.03 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.399 -0.593 . . . . 0.89000000000000001 109.399 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.6 t -99.49 128.31 51.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.549 -0.75 . . . . 0.20000000000000001 110.616 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.568 ' HB2' HD12 ' A' ' 50' ' ' ILE . 55.2 tp -104.33 115.39 30.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.802 0.335 . . . . 0.75 111.034 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.43 122.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.294 0.569 . . . . 0.13 111.324 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.648 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 1.5 mm? -101.65 118.98 38.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.549 -1.278 . . . . 0.20999999999999999 107.549 169.429 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.746 ' CD ' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -161.43 158.43 26.7 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.952 -0.299 . . . . 1.4099999999999999 110.368 -174.328 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.44 -5.36 8.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.904 0.383 . . . . 1.27 110.635 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 42.2 mm-40 -109.82 103.18 52.7 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 2.5600000000000001 110.574 175.444 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.29 -26.85 72.42 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.058 2.506 . . . . 0.32000000000000001 113.235 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.58 -47.59 72.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.968 -0.753 . . . . 1.51 108.968 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.59 -46.22 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.371 -0.831 . . . . 1.01 111.005 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . 0.746 ' HB2' ' CD ' ' A' ' 12' ' ' GLU . . . -56.17 -49.84 72.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.285 -0.416 . . . . 0.20999999999999999 111.053 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.6 ttp -55.96 -42.4 76.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.588 -0.733 . . . . 0.60999999999999999 110.695 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.537 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.8 m-80 -68.95 -42.54 76.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 1.22 111.412 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.68 -44.96 88.65 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.611 0.243 . . . . 0.17999999999999999 110.538 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.487 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -55.65 -50.73 69.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.941 -0.572 . . . . 1.04 109.991 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.4 -27.75 66.49 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.78000000000000003 111.363 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.08 -49.12 60.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.869 0.366 . . . . 0.14000000000000001 110.527 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -66.26 -43.45 86.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.13 110.867 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 30.9 mt-10 -65.38 -28.6 69.39 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.936 -0.306 . . . . 0.68999999999999995 110.635 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.58 -32.96 66.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.51000000000000001 110.593 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -77.78 -20.16 53.8 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.042 0.449 . . . . 0.65000000000000002 110.417 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.46 62.24 0.63 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.575 -0.739 . . . . 0.28999999999999998 112.377 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -148.71 177.28 9.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.799 0.333 . . . . 0.23000000000000001 111.255 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 129.36 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.388 -0.597 . . . . 2.1400000000000001 109.388 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.487 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 15.1 t -115.04 135.55 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.584 0.587 . . . . 0.19 112.584 -167.31 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' OG ' ' A' ' 44' ' ' SER . 41.6 t -105.44 141.92 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.825 -0.806 . . . . 0.23000000000000001 108.825 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.2 t -112.74 126.01 70.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.537 0.208 . . . . 0.94999999999999996 110.709 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.49 134.77 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.16 111.047 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' GLU . . . -97.64 -22.67 16.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.282 0.563 . . . . 0.23999999999999999 111.082 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.3 p -117.31 159.76 22.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.856 -0.611 . . . . 0.25 110.668 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 m -64.36 -31.27 72.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.293 -0.632 . . . . 1.6000000000000001 109.293 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.52 -52.88 63.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 0.69999999999999996 110.96 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.2 mt-30 -57.79 -39.87 78.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.263 0.554 . . . . 1.4099999999999999 110.954 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -65.59 -50.49 64.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.374 -0.83 . . . . 0.17999999999999999 111.333 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.2 mt -63.47 -30.4 71.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.137 -0.483 . . . . 0.82999999999999996 111.08 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -66.76 -48.21 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.124 0.488 . . . . 2.4100000000000001 109.686 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.412 ' OG ' HG11 ' A' ' 33' ' ' VAL . 8.3 t -66.09 -33.48 75.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 1.1299999999999999 110.452 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -39.08 78.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.272 0.558 . . . . 1.23 110.135 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.65 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.831 -0.622 . . . . 0.42999999999999999 111.563 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.55 -36.51 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.62 111.355 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -118.12 163.65 23.84 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.218 -0.447 . . . . 0.41999999999999998 110.615 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -96.88 85.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 123.6 2.866 . . . . 0.23999999999999999 111.302 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.3 mm -62.32 119.95 7.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 0.22 111.552 -175.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 23.2 m-20 -89.2 -30.52 18.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.675 -0.693 . . . . 0.28999999999999998 110.629 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.5 p -163.83 156.34 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.693 -0.685 . . . . 0.12 109.285 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.29 160.17 40.56 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.557 0.694 . . . . 0.14000000000000001 112.291 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -132.0 112.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.838 -1.074 . . . . 0.95999999999999996 109.124 175.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.814 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.7 mp -109.72 104.63 13.65 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.095 0.474 . . . . 0.16 111.943 -170.403 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.832 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -71.64 93.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.39 -0.823 . . . . 1.77 109.232 172.271 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 40.9 t -58.63 -27.41 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.552 . . . . 0.80000000000000004 111.499 -175.521 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.406 HD22 ' C ' ' A' ' 58' ' ' ASN . 0.3 OUTLIER -80.43 51.97 1.54 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.761 -0.654 . . . . 2.3700000000000001 112.397 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt -70.11 -24.48 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.84999999999999998 110.475 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.07 -178.12 46.05 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.97 -0.852 . . . . 0.81999999999999995 110.97 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.64 -36.13 97.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.613 2.209 . . . . 1.1799999999999999 112.015 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -114.51 -34.39 5.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 3.5299999999999998 110.122 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.0 m -65.64 125.81 26.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.899 -0.591 . . . . 0.95999999999999996 111.163 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -146.54 151.18 36.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.886 -0.597 . . . . 0.48999999999999999 110.812 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -74.89 87.34 2.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.916 -0.772 . . . . 1.3 108.916 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.83 -70.34 0.61 Allowed Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.369 -0.919 . . . . 0.23000000000000001 112.472 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.2 Cg_exo -52.62 -23.53 20.04 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.604 2.203 . . . . 0.23999999999999999 112.049 175.153 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 11' ' ' LEU . 24.5 t -70.3 -45.22 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.12 110.123 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.67 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.162 -0.926 . . . . 0.16 110.104 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 31.1 m-20 -63.53 -40.17 96.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.667 . . . . 2.0299999999999998 110.175 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.39 -49.17 75.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.512 0.672 . . . . 0.23000000000000001 110.601 176.59 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.58 -40.59 92.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.105 -0.952 . . . . 0.20000000000000001 110.526 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 73' ' ' LYS . 16.3 mmmt -59.29 -38.56 80.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.572 -0.74 . . . . 2.0099999999999998 111.157 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 80.5 mm-40 -62.3 -45.6 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 2.3700000000000001 111.487 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -92.95 7.51 43.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 1.49 111.391 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.79 24.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.33000000000000002 111.427 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.64 134.43 50.83 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.552 -0.536 . . . . 0.17000000000000001 109.552 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 15.2 Cg_endo -73.25 139.52 29.37 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.076 1.851 . . . . 0.20999999999999999 111.406 177.846 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -160.82 156.66 25.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.054 -0.521 . . . . 0.17999999999999999 110.385 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -123.42 141.05 45.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.403 -0.817 . . . . 0.23999999999999999 109.881 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 96' ' ' ILE . 2.0 mm? -88.79 108.78 19.69 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.097 -0.705 . . . . 0.20999999999999999 109.097 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.832 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 15.1 t-160 -101.27 104.66 15.69 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.128 -0.693 . . . . 0.59999999999999998 109.128 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 4.3 t -151.85 151.86 31.86 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.32 -0.552 . . . . 0.60999999999999999 111.679 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.17 9.13 63.16 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.551 -0.75 . . . . 0.93999999999999995 111.471 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -149.89 122.33 8.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.853 0.358 . . . . 2.3300000000000001 111.429 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.615 HD12 HD21 ' A' ' 93' ' ' LEU . 3.2 mm? -118.68 7.66 11.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.386 -0.598 . . . . 1.6100000000000001 109.386 172.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -85.04 -54.62 4.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 111.566 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 8.0 mpt_? -77.47 -11.83 59.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.4199999999999999 111.113 -173.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -125.26 26.03 6.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 1.05 109.794 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.492 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -60.96 -38.61 95.74 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.97999999999999998 113.447 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.8 -25.87 68.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 2.5 110.709 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.68 -42.48 86.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.908 -0.587 . . . . 0.70999999999999996 110.85 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.615 HD21 HD12 ' A' ' 86' ' ' LEU . 2.3 mm? -60.41 -26.92 67.05 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.441 -0.345 . . . . 1.5800000000000001 111.108 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -66.66 -33.2 75.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 4.3799999999999999 111.026 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.42 -27.45 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 2.4500000000000002 110.287 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 81' ' ' LEU . 62.2 mt -79.74 -63.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.447 -0.797 . . . . 0.45000000000000001 111.115 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.0 t70 55.87 74.15 0.4 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.743 0.782 . . . . 1.0900000000000001 110.788 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.77 165.82 16.68 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.141 -0.936 . . . . 0.28999999999999998 109.225 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.52 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 43.4 Cg_exo -59.16 141.25 97.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.535 2.156 . . . . 0.26000000000000001 112.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.13 121.01 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.039 -0.528 . . . . 0.64000000000000001 111.16 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.444 ' O ' ' HD2' ' A' ' 82' ' ' HIS . 73.9 mmm -102.41 99.02 9.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.151 -0.685 . . . . 0.82999999999999996 109.151 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -74.97 159.5 31.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.169 -0.468 . . . . 0.54000000000000004 111.04 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 98.3 mttt -93.1 153.35 41.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.782 -0.644 . . . . 0.67000000000000004 110.469 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 15.5 Cg_exo -69.18 136.07 35.77 Favored 'Cis proline' 0 C--N 1.343 0.237 0 C-N-CA 123.648 -1.397 . . . . 0.75 112.328 -1.666 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.668 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -128.69 133.53 48.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.34999999999999998 110.038 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 110' ' ' VAL . 17.1 t70 -78.54 129.67 35.1 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 0.51000000000000001 108.616 176.628 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.537 HG21 ' HB3' ' A' ' 20' ' ' ASN . 19.9 p -64.11 -22.39 66.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.696 -0.683 . . . . 0.26000000000000001 112.236 -172.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 t -70.98 -40.68 71.77 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.452 -0.573 . . . . 1.3200000000000001 109.452 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.56 -44.27 91.27 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.149 -0.478 . . . . 0.62 109.967 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.7 t -61.62 -44.32 98.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.355 -0.839 . . . . 0.13 110.396 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.67 -51.43 67.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.749 -0.66 . . . . 0.13 111.215 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.7 mtpt -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 1.95 110.735 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -55.38 -40.03 70.84 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.314 0.384 . . . . 2.23 111.452 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.4 63.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.14000000000000001 110.845 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.41 -25.87 66.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.27000000000000002 111.988 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 mm-40 -57.18 -47.72 80.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.958 0.409 . . . . 2.79 110.395 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.52 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 52.8 mtm -72.34 -28.5 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.42999999999999999 110.718 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 50.5 t -65.99 -43.76 86.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.809 -0.632 . . . . 1.46 110.493 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.05 71.2 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.776 -0.726 . . . . 2.5699999999999998 111.848 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.71 -150.04 20.81 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.672 -0.775 . . . . 4.4800000000000004 111.859 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.91 98.57 10.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.129 0.49 . . . . 6.4199999999999999 110.524 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -107.45 82.86 1.72 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.783 -0.644 . . . . 9.1899999999999995 109.554 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 40.6 mt-10 -82.35 124.82 77.8 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.727 -0.669 . . . . 9.5999999999999996 110.784 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 123' ' ' GLU . 24.5 Cg_exo -64.23 99.69 0.3 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.751 2.301 . . . . 11.17 111.866 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.528 -0.749 . . . . 13.279999999999999 110.267 179.081 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.868 -0.493 . . . . 8.8000000000000007 111.868 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.22 35.78 18.2 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.895 0.478 . . . . 6.7800000000000002 111.435 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.6 mtt -135.33 10.14 3.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 7.21 110.783 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.4 -70.18 2.66 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.887 -0.673 . . . . 1.8500000000000001 112.276 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 56.6 mtt -97.08 135.82 21.79 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.506 0.193 . . . . 1.6499999999999999 110.798 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.545 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.0 Cg_exo -63.25 138.26 65.57 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.801 2.334 . . . . 0.33000000000000002 111.411 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -88.53 105.43 17.63 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.754 -0.461 . . . . 0.89000000000000001 109.754 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.8 t -100.18 135.72 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.695 -0.684 . . . . 0.20000000000000001 110.905 -175.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.494 ' HB2' HD12 ' A' ' 50' ' ' ILE . 41.1 tp -110.4 113.22 25.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.903 0.383 . . . . 0.75 110.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.83 120.04 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.342 0.592 . . . . 0.13 111.589 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm? -102.33 101.12 11.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.872 -1.058 . . . . 0.20999999999999999 108.89 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.55 118.43 3.2 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.389 -0.823 . . . . 1.4099999999999999 109.732 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 25.8 t70 -83.76 -19.76 34.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.068 -0.515 . . . . 1.27 110.068 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -84.2 102.87 2.37 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.537 -0.542 . . . . 2.5600000000000001 109.537 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 36.6 Cg_exo -58.9 -31.15 94.88 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.878 2.385 . . . . 0.32000000000000001 113.026 -173.076 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.39 -49.26 78.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 1.51 109.77 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.12 -43.49 78.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.653 -0.703 . . . . 1.01 110.67 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.84 74.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.506 . . . . 0.20999999999999999 110.732 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.4 ttp -64.6 -41.65 96.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.315 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.539 ' HB3' HG21 ' A' ' 107' ' ' THR . 16.9 m-20 -65.12 -46.44 80.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.297 -0.411 . . . . 1.22 110.977 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 45.7 mt -59.78 -46.43 89.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.464 -0.335 . . . . 0.17999999999999999 110.267 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.574 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 64.0 tt0 -52.29 -48.49 65.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.673 -0.694 . . . . 1.04 110.356 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -69.32 -31.89 70.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.78000000000000003 111.761 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.942 0.401 . . . . 0.14000000000000001 110.535 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.614 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 49.5 m-85 -67.4 -44.49 78.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.001 -0.545 . . . . 0.13 110.849 177.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 28.2 mt-10 -62.98 -32.62 74.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.618 0.247 . . . . 0.68999999999999995 110.602 177.388 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.32 -35.19 80.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 110.163 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -81.08 -0.07 38.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 110.886 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 50.0 4.2 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.991 -0.623 . . . . 0.28999999999999998 112.322 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.22 167.34 21.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.829 0.347 . . . . 0.23000000000000001 110.903 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -108.01 144.68 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.156 -0.683 . . . . 2.1400000000000001 109.156 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.574 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 31.3 t -128.8 139.95 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.19 112.24 -170.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 44' ' ' SER . 14.2 t -111.71 136.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.665 -0.865 . . . . 0.23000000000000001 108.665 169.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.62 124.41 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 110.71 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.56 138.05 37.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.09 -0.504 . . . . 0.16 110.342 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -108.43 -5.55 16.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.395 -0.366 . . . . 0.23999999999999999 111.193 -179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.3 p -133.78 166.26 23.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.537 -0.302 . . . . 0.25 111.309 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.612 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 19.6 p -59.21 -49.28 78.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.334 -0.617 . . . . 1.6000000000000001 109.334 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -49.83 -55.36 14.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.42 -1.264 . . . . 0.69999999999999996 111.944 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -55.17 -46.44 75.79 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 110.876 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.11 -46.18 88.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.279 -0.873 . . . . 0.17999999999999999 111.838 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -66.0 -30.46 71.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.209 -0.451 . . . . 0.82999999999999996 110.451 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -67.32 -54.88 16.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 2.4100000000000001 109.48 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.405 ' HB3' HG11 ' A' ' 33' ' ' VAL . 15.1 m -62.29 -30.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.492 -0.322 . . . . 1.1299999999999999 111.373 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -62.12 -42.22 99.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 1.23 110.201 178.221 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.54 -32.03 22.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.265 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.18 -35.57 61.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.62 111.062 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -120.48 162.95 31.6 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.41999999999999998 110.427 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -95.39 82.96 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.34 2.693 . . . . 0.23999999999999999 111.363 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.9 mm -66.25 127.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.815 -0.63 . . . . 0.22 111.452 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.493 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.0 m-20 -99.25 -28.41 13.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 0.28999999999999998 110.703 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -162.11 157.09 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.587 -0.523 . . . . 0.12 109.587 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -144.03 165.63 27.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.14000000000000001 112.32 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.531 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.49 112.19 9.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.95999999999999996 109.533 176.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.1 mp -116.0 120.06 37.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.189 0.441 . . . . 0.16 112.189 -167.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -83.24 130.54 35.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.097 -0.705 . . . . 1.77 109.097 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.583 ' H ' ' HB ' ' A' ' 83' ' ' THR . 12.7 t -87.47 -6.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.16 -0.927 . . . . 0.80000000000000004 110.365 -173.055 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . 0.404 HD22 ' CG ' ' A' ' 85' ' ' ASP . 53.3 t-20 -121.87 73.47 1.08 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.088 0.47 . . . . 2.3700000000000001 109.966 174.714 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.65 -24.09 59.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.506 0.669 . . . . 0.84999999999999998 109.468 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.42 -175.3 41.07 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.681 -0.967 . . . . 0.81999999999999995 110.681 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -52.6 -38.81 76.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.119 2.546 . . . . 1.1799999999999999 112.715 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -117.97 -34.57 4.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.486 -0.325 . . . . 3.5299999999999998 111.361 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -68.61 128.0 35.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.95999999999999996 111.488 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -144.32 157.15 44.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.71 -0.677 . . . . 0.48999999999999999 110.104 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 27.6 p -70.89 86.62 0.7 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.686 0.755 . . . . 1.3 109.549 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.38 -63.94 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.559 -0.829 . . . . 0.23000000000000001 112.009 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.24 -26.87 72.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.246 1.964 . . . . 0.23999999999999999 111.254 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.9 t -69.75 -45.92 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.627 -0.715 . . . . 0.12 110.171 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.34 90.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.162 -0.926 . . . . 0.16 110.29 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.603 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.5 t70 -69.05 -41.7 77.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 2.0299999999999998 110.205 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.7 77.99 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.297 0.57 . . . . 0.23000000000000001 110.715 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD23 HD21 ' A' ' 45' ' ' LEU . 91.4 mt -66.02 -46.33 78.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.3 -0.863 . . . . 0.20000000000000001 110.51 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -59.26 -28.7 66.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.065 -0.516 . . . . 2.0099999999999998 112.011 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 76.2 mt-30 -63.63 -48.06 78.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.768 0.318 . . . . 2.3700000000000001 110.974 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.05 7.66 39.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.34 -0.391 . . . . 1.49 111.361 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.54 42.69 20.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.33000000000000002 111.031 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 HG22 ' A' ' 50' ' ' ILE . 70.6 mt -88.33 132.34 39.61 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.148 -0.478 . . . . 0.17000000000000001 110.142 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.3 Cg_endo -74.85 140.05 25.42 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.477 2.118 . . . . 0.20999999999999999 111.759 177.402 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 25.7 p90 -157.22 160.86 39.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.969 -0.56 . . . . 0.17999999999999999 110.695 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -124.33 138.88 52.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.23999999999999999 110.013 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 96' ' ' ILE . 2.0 mm? -89.15 108.7 19.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.367 -0.605 . . . . 0.20999999999999999 109.367 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 14.7 t-160 -103.08 84.39 2.34 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.558 0.694 . . . . 0.59999999999999998 109.51 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.583 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 13.3 t -129.81 165.12 22.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.563 -1.199 . . . . 0.60999999999999999 110.329 -172.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.53 6.82 28.18 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.149 -0.78 . . . . 0.93999999999999995 111.149 173.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 2.2 m-20 -114.87 71.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 2.3300000000000001 110.48 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.0 mp -84.7 -33.27 23.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 1.6100000000000001 110.354 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.38 -34.51 36.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 2.6299999999999999 110.655 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -75.64 -23.05 56.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 4.4199999999999999 110.589 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.513 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 11.3 m170 -124.46 24.12 8.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.503 0.557 . . . . 1.05 112.503 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.4 -36.72 90.25 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.792 -0.718 . . . . 0.97999999999999998 112.486 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 44.2 mt-10 -63.18 -51.7 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 2.5 110.501 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.9 tp -60.46 -42.79 96.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.061 -0.518 . . . . 0.70999999999999996 110.472 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 77.1 mt -60.27 -38.3 83.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 1.5800000000000001 111.692 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 7.8 ptm180 -72.45 -26.9 62.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.815 0.34 . . . . 4.3799999999999999 110.463 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -78.3 -41.05 34.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.248 0.547 . . . . 2.4500000000000002 110.001 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.503 HG21 HD21 ' A' ' 81' ' ' LEU . 76.9 mt -60.61 -44.52 97.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.177 -0.92 . . . . 0.45000000000000001 110.529 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 39.0 t70 55.43 77.09 0.24 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.443 0.639 . . . . 1.0900000000000001 111.161 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.56 160.7 15.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.979 -1.01 . . . . 0.28999999999999998 109.113 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 36.4 Cg_exo -60.17 147.33 93.79 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.675 2.25 . . . . 0.26000000000000001 112.451 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.97 130.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 0.64000000000000001 110.915 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 82.5 mmm -114.3 107.54 15.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.782 -0.822 . . . . 0.82999999999999996 108.782 174.286 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.43 150.17 48.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.822 0.344 . . . . 0.54000000000000004 111.613 -176.482 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.07 139.96 25.85 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.586 -0.524 . . . . 0.67000000000000004 109.586 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.17 158.54 96.15 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.665 -1.39 . . . . 0.75 112.515 1.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.75 132.62 13.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.34999999999999998 110.097 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.2 t70 -65.49 127.91 33.77 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.89 -0.781 . . . . 0.51000000000000001 108.89 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 20' ' ' ASN . 19.3 p -64.67 -21.05 66.64 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 112.444 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.53 -37.79 65.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.339 -0.615 . . . . 1.3200000000000001 109.339 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.02 -44.81 91.45 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.62 109.53 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.531 HG12 HG11 ' A' ' 54' ' ' VAL . 21.3 t -63.24 -42.4 96.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 0.13 110.629 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.43 -50.53 67.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 0.13 111.454 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.63 -42.64 98.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.977 -0.556 . . . . 1.95 111.212 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.42 -31.07 71.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 2.23 111.247 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.57 -49.38 12.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.233 -0.44 . . . . 0.14000000000000001 111.016 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.461 HD23 HG11 ' A' ' 52' ' ' VAL . 67.4 mt -66.58 -26.16 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.884 0.698 . . . . 0.27000000000000002 112.884 -175.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 117' ' ' MET . 4.1 pt-20 -62.39 -33.47 74.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.12 0.486 . . . . 2.79 109.927 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.459 ' HG2' ' HG3' ' A' ' 122' ' ' LYS . 47.6 mtm -77.47 -14.17 59.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.925 -0.58 . . . . 0.42999999999999999 110.893 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.1 t -86.63 -6.98 58.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.283 0.563 . . . . 1.46 109.799 177.087 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -116.31 -165.01 14.02 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.893 -0.67 . . . . 2.5699999999999998 111.959 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.43 8.5 48.1 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.958 -0.639 . . . . 4.4800000000000004 112.608 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -106.07 21.04 18.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.252 0.548 . . . . 6.4199999999999999 110.654 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HG3' ' HG2' ' A' ' 117' ' ' MET . 1.7 tmtp? -76.81 121.52 23.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.531 -0.759 . . . . 9.1899999999999995 111.028 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -88.88 135.63 31.71 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.425 -0.584 . . . . 9.5999999999999996 109.425 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.53 104.4 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.822 2.348 . . . . 11.17 112.539 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.661 -0.685 . . . . 13.279999999999999 110.252 -179.478 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.961 0 N-CA-C 112.035 -0.426 . . . . 8.8000000000000007 112.035 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.2 -42.47 79.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 6.7800000000000002 111.762 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.5 mtp -91.96 -7.3 49.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.156 0.503 . . . . 7.21 110.572 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.33 148.29 4.81 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.998 -0.62 . . . . 1.8500000000000001 111.799 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.467 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -62.75 130.85 94.08 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-O 120.546 0.212 . . . . 1.6499999999999999 111.21 176.573 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.8 Cg_exo -67.03 135.45 37.58 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.792 2.328 . . . . 0.33000000000000002 111.222 175.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 39.8 tptt -85.92 106.14 16.9 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.513 -0.551 . . . . 0.89000000000000001 109.513 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.3 t -99.92 134.82 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.935 -0.575 . . . . 0.20000000000000001 110.979 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.7 tp -109.57 111.94 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.11 -0.496 . . . . 0.75 110.471 176.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.7 t -94.44 122.55 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.275 0.56 . . . . 0.13 111.736 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.75 102.93 13.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.921 -1.036 . . . . 0.20999999999999999 109.022 173.317 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -160.57 121.74 3.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.043 -0.526 . . . . 1.4099999999999999 110.289 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 38.3 t70 -92.85 -11.75 32.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 1.27 110.169 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.0 mt-10 -85.73 101.71 2.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.075 -0.713 . . . . 2.5600000000000001 109.075 171.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.0 Cg_exo -59.74 -28.87 88.3 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.752 2.301 . . . . 0.32000000000000001 113.459 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 3.5 tm? -65.76 -51.02 62.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.344 -0.613 . . . . 1.51 109.344 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -64.18 -43.78 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.91 -0.586 . . . . 1.01 110.055 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.82 63.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.672 -0.695 . . . . 0.20999999999999999 111.035 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 41.7 ttp -64.07 -39.28 93.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.597 -0.729 . . . . 0.60999999999999999 110.947 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.64 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.5 t-20 -65.28 -41.19 94.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.377 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.8 mt -62.6 -43.84 97.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.056 -0.52 . . . . 0.17999999999999999 110.407 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.532 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 42.7 tt0 -53.64 -51.43 63.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 1.04 110.062 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 29.4 m-85 -58.18 -39.35 78.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.78000000000000003 111.437 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.87 58.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.475 -0.329 . . . . 0.14000000000000001 110.994 -174.071 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 43.7 m-85 -63.27 -43.94 96.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.37 -0.377 . . . . 0.13 110.385 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.21 -39.23 82.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.005 0.431 . . . . 0.68999999999999995 110.575 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.83 -28.6 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.51000000000000001 110.812 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -84.04 4.43 30.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.99 0.424 . . . . 0.65000000000000002 110.513 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . 82.87 48.63 5.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.905 -0.665 . . . . 0.28999999999999998 112.432 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -135.75 175.8 9.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.705 0.288 . . . . 0.23000000000000001 111.135 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -113.23 145.64 40.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.77 -0.826 . . . . 2.1400000000000001 108.77 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.532 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.3 t -131.72 135.97 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.618 0.599 . . . . 0.19 112.618 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.54 136.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.549 -0.908 . . . . 0.23000000000000001 108.549 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.79 126.96 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.938 0.399 . . . . 0.94999999999999996 110.863 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -133.48 134.53 43.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.908 -0.587 . . . . 0.16 110.285 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.62 -10.24 21.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.126 0.488 . . . . 0.23999999999999999 110.806 178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.508 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 70.7 p -127.64 165.53 19.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.853 -0.612 . . . . 0.25 110.185 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.578 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 78.1 m -72.1 -30.89 65.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.2 -44.17 84.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.69999999999999996 111.031 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.508 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 56.2 mt-30 -62.99 -35.8 81.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.308 0.575 . . . . 1.4099999999999999 110.31 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.668 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -64.74 -54.66 27.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.433 -0.803 . . . . 0.17999999999999999 111.401 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.9 mt -59.33 -33.42 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.82999999999999996 110.263 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -61.88 -53.85 50.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.454 -0.794 . . . . 2.4100000000000001 110.433 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.0 t -63.85 -38.72 92.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.934 -0.575 . . . . 1.1299999999999999 110.616 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.25 -36.28 81.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.126 0.489 . . . . 1.23 110.692 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.5 37.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.219 -0.446 . . . . 0.42999999999999999 111.319 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -80.46 -37.94 30.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.898 0.38 . . . . 0.62 111.637 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 24.0 m-80 -110.75 160.07 30.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.302 -0.408 . . . . 0.41999999999999998 110.448 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -94.85 84.32 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 123.5 2.8 . . . . 0.23999999999999999 111.695 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mm -67.81 128.29 30.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.698 -0.683 . . . . 0.22 111.499 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -95.4 -32.9 12.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.28999999999999998 110.362 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 12.4 p -158.08 158.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.12 109.382 -178.352 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -140.26 168.03 20.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.421 0.629 . . . . 0.14000000000000001 111.476 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.526 HG21 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -140.69 121.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.853 -1.166 . . . . 0.95999999999999996 107.853 176.155 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.616 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -123.78 122.61 38.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.1 0.407 . . . . 0.16 112.1 -167.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.641 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 53.4 t0 -85.18 119.17 25.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 1.77 109.553 170.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.797 HG13 HD23 ' A' ' 92' ' ' LEU . 95.8 t -69.49 -28.84 39.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.052 -0.976 . . . . 0.80000000000000004 110.391 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.1 t30 -99.72 62.05 1.17 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.846 -0.616 . . . . 2.3700000000000001 110.393 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.81 -28.31 68.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.318 0.58 . . . . 0.84999999999999998 109.626 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.43 -171.94 41.44 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.559 -1.016 . . . . 0.81999999999999995 110.559 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.1 -45.37 41.18 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.556 2.17 . . . . 1.1799999999999999 111.858 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -107.18 -34.32 7.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 3.5299999999999998 110.454 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -68.55 125.27 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.227 0.537 . . . . 0.95999999999999996 111.364 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.491 ' HB2' HD22 ' A' ' 92' ' ' LEU . 16.8 p80 -146.6 148.52 32.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.778 -0.646 . . . . 0.48999999999999999 110.309 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.8 p -71.43 86.64 0.85 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.395 0.617 . . . . 1.3 109.734 172.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.85 -72.15 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.364 -0.922 . . . . 0.23000000000000001 112.407 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.9 Cg_exo -53.31 -26.38 34.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.731 2.287 . . . . 0.23999999999999999 112.023 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 11' ' ' LEU . 13.9 t -69.2 -48.32 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.113 0.483 . . . . 0.12 110.158 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.21 80.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.256 -0.884 . . . . 0.16 110.173 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.3 t70 -63.3 -39.05 93.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 2.0299999999999998 110.81 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.23000000000000001 110.905 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.87 -41.18 95.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.20000000000000001 110.162 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 2.7 mmpt? -59.37 -33.75 71.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.477 -0.783 . . . . 2.0099999999999998 111.195 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 73.1 mt-30 -64.09 -47.51 79.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 2.3700000000000001 110.964 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.88 5.58 39.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 1.49 111.089 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.01 32.6 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.689 -0.687 . . . . 0.33000000000000002 111.392 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.7 mt -82.11 133.07 51.74 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.925 -0.579 . . . . 0.17000000000000001 109.798 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -72.9 142.04 34.4 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.229 1.953 . . . . 0.20999999999999999 111.884 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 35.0 p90 -157.23 153.25 27.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 110.449 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -117.39 138.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.565 -0.743 . . . . 0.23999999999999999 109.526 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.5 mm? -88.48 108.09 19.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.113 -0.699 . . . . 0.20999999999999999 109.113 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.592 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.2 t-160 -101.47 76.87 1.72 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.804 -0.813 . . . . 0.59999999999999998 108.804 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.641 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 6.5 t -111.7 155.02 24.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.683 -1.144 . . . . 0.60999999999999999 111.795 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.56 2.16 58.78 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.543 -0.753 . . . . 0.93999999999999995 111.355 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 127.68 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.915 0.388 . . . . 2.3300000000000001 111.779 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.585 HD21 HG11 ' A' ' 100' ' ' VAL . 4.3 mp -117.72 0.63 12.06 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.083 -0.71 . . . . 1.6100000000000001 109.083 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.54 -61.47 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 2.6299999999999999 111.51 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -66.33 -37.77 86.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.546 . . . . 4.4199999999999999 110.213 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -104.22 33.02 3.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.125 -0.489 . . . . 1.05 110.355 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.462 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -62.53 -31.5 79.93 Favored Glycine 0 CA--C 1.511 -0.179 0 C-N-CA 121.15 -0.547 . . . . 0.97999999999999998 113.282 -176.406 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.45 -27.84 69.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.127 0.489 . . . . 2.5 110.021 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.797 HD23 HG13 ' A' ' 57' ' ' VAL . 15.8 tp -71.32 -42.87 68.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.70999999999999996 110.419 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.462 HD23 ' HA2' ' A' ' 90' ' ' GLY . 3.1 mm? -55.61 -40.34 71.97 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.068 0.461 . . . . 1.5800000000000001 110.241 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.94 -26.63 66.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 4.3799999999999999 111.821 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.65 -37.03 36.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.256 0.55 . . . . 2.4500000000000002 110.239 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 92' ' ' LEU . 69.5 mt -75.98 -62.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.293 -0.867 . . . . 0.45000000000000001 111.876 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.23 81.56 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.676 -173.821 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.8 169.09 10.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.28999999999999998 109.341 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 33.7 Cg_exo -61.57 136.26 61.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.286 1.991 . . . . 0.26000000000000001 112.118 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.585 HG11 HD21 ' A' ' 86' ' ' LEU . 40.0 t -124.17 130.09 73.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.325 -0.398 . . . . 0.64000000000000001 110.994 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 98.1 mtp -117.05 106.43 13.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.445 -0.576 . . . . 0.82999999999999996 109.445 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.16 152.98 43.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.54000000000000004 111.507 -176.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.549 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.7 mttt -90.98 142.82 27.78 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.868 -0.605 . . . . 0.67000000000000004 110.032 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.15 158.66 93.6 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.457 -1.476 . . . . 0.75 112.711 1.654 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.592 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.62 131.16 12.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.34999999999999998 109.184 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 110' ' ' VAL . 36.6 t70 -68.05 128.23 35.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.42 -0.585 . . . . 0.51000000000000001 109.42 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.64 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.1 p -59.01 -27.99 65.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.815 -1.084 . . . . 0.26000000000000001 112.544 -172.052 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -64.9 -45.62 85.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.634 -0.506 . . . . 1.3200000000000001 109.634 176.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -61.68 -45.57 93.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.721 -0.474 . . . . 0.62 109.721 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.536 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 20.2 t -59.27 -43.09 89.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.13 110.423 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.62 -50.35 65.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.626 -0.716 . . . . 0.13 111.354 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 108' ' ' SER . 19.7 mtpp -60.19 -42.2 94.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 1.95 111.073 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 32.0 mmt180 -71.81 -28.11 63.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 2.23 111.403 -177.248 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.31 -48.49 17.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.368 . . . . 0.14000000000000001 110.119 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.527 HD23 HG11 ' A' ' 52' ' ' VAL . 82.1 mt -65.1 -26.29 68.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.862 0.69 . . . . 0.27000000000000002 112.862 -176.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -25.02 59.54 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.31 -0.556 . . . . 2.79 110.982 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.476 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 70.2 mtm -69.55 -36.08 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.42999999999999999 110.75 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.7 p -94.36 12.28 27.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.147 0.498 . . . . 1.46 110.397 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.9 52.86 4.79 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.995 -0.548 . . . . 2.5699999999999998 112.266 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.97 -80.21 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.855 -0.688 . . . . 4.4800000000000004 111.621 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -160.81 160.39 31.11 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.005 -0.369 . . . . 6.4199999999999999 110.005 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.67 111.1 10.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.094 -0.503 . . . . 9.1899999999999995 110.366 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -72.31 124.4 90.76 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.578 -0.527 . . . . 9.5999999999999996 109.578 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.27 95.7 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.8 2.333 . . . . 11.17 112.877 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.375 -0.821 . . . . 13.279999999999999 109.67 176.023 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.897 -0.481 . . . . 8.8000000000000007 111.897 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.76 -25.85 18.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.665 0.269 . . . . 6.7800000000000002 111.589 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -157.0 171.05 21.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.016 0.436 . . . . 7.21 111.259 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.75 46.36 1.0 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.947 -0.861 . . . . 1.8500000000000001 110.947 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.6 ptp -106.06 155.41 38.5 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 1.6499999999999999 110.753 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.65 148.01 28.64 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.659 2.239 . . . . 0.33000000000000002 113.1 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -95.78 107.82 20.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.437 -0.801 . . . . 0.89000000000000001 109.243 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 52' ' ' VAL . 57.1 t -100.6 133.56 43.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.096 -0.502 . . . . 0.20000000000000001 111.057 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HB2' HD12 ' A' ' 50' ' ' ILE . 43.5 tp -108.76 114.68 28.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.927 0.394 . . . . 0.75 110.402 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.3 t -95.82 120.76 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.34 0.59 . . . . 0.13 111.433 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.05 100.68 10.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.828 -1.078 . . . . 0.20999999999999999 108.873 172.383 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -157.4 117.48 3.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.408 -0.815 . . . . 1.4099999999999999 109.668 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.2 t70 -81.37 -20.91 39.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.062 -0.517 . . . . 1.27 110.225 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -82.31 105.44 4.72 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.573 -0.529 . . . . 2.5600000000000001 109.573 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.7 Cg_exo -58.32 -30.76 92.09 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.619 2.213 . . . . 0.32000000000000001 112.455 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.38 -49.89 73.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.048 0.451 . . . . 1.51 109.869 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.1 mt -69.39 -43.68 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 1.01 111.169 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.92 -45.23 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.47 . . . . 0.20999999999999999 110.303 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -61.95 -46.71 88.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.384 -0.826 . . . . 0.60999999999999999 111.214 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.4 m-80 -65.27 -40.99 94.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.136 -0.484 . . . . 1.22 111.372 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.88 -44.57 95.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.357 -0.383 . . . . 0.17999999999999999 110.266 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -56.36 -49.59 73.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 1.04 110.2 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -62.76 -34.37 77.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.204 -0.453 . . . . 0.78000000000000003 111.201 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -69.02 -51.03 43.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.14000000000000001 110.82 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 53.7 m-85 -63.54 -42.08 98.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.344 -0.389 . . . . 0.13 110.834 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.92 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.96 -0.296 . . . . 0.68999999999999995 110.626 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.8 -26.94 61.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.51000000000000001 110.818 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 69.6 mm-40 -82.51 -10.22 59.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.65000000000000002 110.356 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.32 51.36 1.59 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.28999999999999998 112.421 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.04 167.9 21.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.23000000000000001 110.958 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -106.35 141.89 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.943 -0.762 . . . . 2.1400000000000001 108.943 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -125.83 136.88 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.191 0.441 . . . . 0.19 112.191 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.406 HG11 ' OG ' ' A' ' 44' ' ' SER . 26.2 t -108.27 132.42 56.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.917 -0.771 . . . . 0.23000000000000001 108.917 168.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.14 124.0 56.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.964 0.412 . . . . 0.94999999999999996 111.088 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.89 143.61 43.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.029 -0.532 . . . . 0.16 110.344 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -112.09 -8.59 14.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.461 -0.336 . . . . 0.23999999999999999 111.308 -179.93 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 p -131.18 168.11 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.472 -0.331 . . . . 0.25 111.33 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.5 p -59.22 -50.08 75.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.379 0.609 . . . . 1.6000000000000001 109.434 172.554 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.05 -54.12 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.423 -1.262 . . . . 0.69999999999999996 112.215 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 mt-30 -56.91 -41.18 77.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.25 0.547 . . . . 1.4099999999999999 111.173 179.485 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -68.23 -45.9 72.0 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.43 -0.805 . . . . 0.17999999999999999 111.496 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.4 mt -66.52 -28.13 68.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.82999999999999996 110.481 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -66.76 -51.65 53.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 2.4100000000000001 109.831 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.406 ' OG ' HG11 ' A' ' 33' ' ' VAL . 17.3 t -63.56 -37.89 89.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.1299999999999999 110.792 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD21 ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -57.51 -39.88 77.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 1.23 110.366 178.048 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.82 -34.87 30.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.801 -0.636 . . . . 0.42999999999999999 111.39 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -80.21 -38.44 31.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.62 111.568 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.0 m120 -116.13 161.29 31.87 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.188 -0.46 . . . . 0.41999999999999998 110.679 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -93.6 82.29 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.59 2.86 . . . . 0.23999999999999999 110.839 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' A' ' 9' ' ' LEU . 43.6 mm -64.84 116.1 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.348 -0.842 . . . . 0.22 111.563 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.73 -32.53 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.28999999999999998 110.375 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 115' ' ' LEU . 15.0 p -160.59 155.53 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.12 109.77 -176.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.11 167.8 21.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.325 0.583 . . . . 0.14000000000000001 111.677 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.4 111.18 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.447 -0.797 . . . . 0.95999999999999996 109.285 177.735 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.2 mp -115.09 123.41 48.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.141 0.423 . . . . 0.16 112.141 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.99 107.94 15.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.781 0.801 . . . . 1.77 109.816 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG13 HD23 ' A' ' 92' ' ' LEU . 38.2 t -59.17 -19.56 16.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.803 -1.09 . . . . 0.80000000000000004 111.868 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -122.0 70.03 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.531 . . . . 2.3700000000000001 110.72 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.437 HD11 ' SG ' ' A' ' 65' ' ' CYS . 94.9 mt -67.37 -27.85 67.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.84999999999999998 110.295 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.24 -160.7 16.54 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.763 -0.653 . . . . 0.81999999999999995 111.684 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.62 -46.03 36.47 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.897 2.398 . . . . 1.1799999999999999 112.203 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -126.22 -19.75 4.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.137 -0.483 . . . . 3.5299999999999998 110.271 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.6 m -63.47 125.89 25.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.95999999999999996 110.988 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -145.71 153.51 41.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.959 -0.564 . . . . 0.48999999999999999 110.643 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 15.3 m -77.47 85.81 3.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.637 -0.875 . . . . 1.3 108.637 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.76 -65.47 0.62 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.837 -0.697 . . . . 0.23000000000000001 112.689 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -54.77 -25.18 41.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.361 2.041 . . . . 0.23999999999999999 111.247 174.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -69.03 -46.91 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.723 -0.671 . . . . 0.12 109.998 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -58.2 -47.72 82.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.099 -0.955 . . . . 0.16 109.862 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.24 -39.26 94.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.786 -0.643 . . . . 2.0299999999999998 110.555 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -58.61 -44.62 89.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.23000000000000001 111.05 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' CD2' HD21 ' A' ' 45' ' ' LEU . 90.7 mt -69.58 -46.24 66.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.631 -0.713 . . . . 0.20000000000000001 110.293 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 30.1 mmmt -56.06 -35.83 67.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 2.0099999999999998 111.582 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 3.0 pt20 -63.97 -41.46 97.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.908 -0.587 . . . . 2.3700000000000001 110.76 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 96.5 mtt180 -95.51 4.69 52.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.883 -0.598 . . . . 1.49 111.027 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.05 32.95 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.628 -0.715 . . . . 0.33000000000000002 111.266 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.0 mt -80.17 131.65 62.03 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 109.396 -0.594 . . . . 0.17000000000000001 109.396 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 43.2 Cg_endo -76.09 142.19 24.42 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.287 1.992 . . . . 0.20999999999999999 112.014 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 9.3 p90 -158.38 154.67 27.36 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.369 -0.832 . . . . 0.17999999999999999 110.185 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 mt -117.07 138.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.463 -0.79 . . . . 0.23999999999999999 109.781 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.463 HD21 HG21 ' A' ' 96' ' ' ILE . 2.6 mm? -88.5 109.86 20.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.987 -0.551 . . . . 0.20999999999999999 109.702 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.9 t-160 -104.88 86.52 2.47 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.387 0.613 . . . . 0.59999999999999998 109.756 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.537 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -135.85 161.7 34.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.001 -1.0 . . . . 0.60999999999999999 110.577 -172.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.34 22.16 9.01 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.604 -0.808 . . . . 0.93999999999999995 112.409 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.631 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 19.8 t70 -141.69 74.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.337 0.589 . . . . 2.3300000000000001 109.484 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 86' ' ' LEU . 3.3 mp -92.42 -22.94 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.823 -0.626 . . . . 1.6100000000000001 110.887 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -73.86 -48.29 32.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.93 0.395 . . . . 2.6299999999999999 110.625 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.631 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -75.88 -38.64 57.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.169 -0.469 . . . . 4.4199999999999999 110.74 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.493 ' O ' HD13 ' A' ' 93' ' ' LEU . 73.6 m-70 -89.48 17.29 6.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.978 -0.289 . . . . 1.05 110.984 177.371 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.619 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -52.56 -42.51 58.03 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.39 -0.434 . . . . 0.97999999999999998 113.478 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.94 -34.71 65.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.939 0.4 . . . . 2.5 110.693 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.758 HD23 HG13 ' A' ' 57' ' ' VAL . 35.3 tp -72.64 -54.18 9.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.042 -0.526 . . . . 0.70999999999999996 111.514 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.674 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.66 -27.65 68.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.973 -0.691 . . . . 1.5800000000000001 111.823 -176.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 27.2 mmm180 -64.17 -46.35 84.37 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.849 -0.614 . . . . 4.3799999999999999 110.961 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.68 -36.14 83.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 2.4500000000000002 110.755 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 92' ' ' LEU . 79.0 mt -64.08 -49.42 81.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 0.45000000000000001 110.503 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.5 t70 58.76 74.52 0.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.607 0.718 . . . . 1.0900000000000001 110.897 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.94 21.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.916 -1.038 . . . . 0.28999999999999998 109.165 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 39.3 Cg_exo -58.74 143.83 98.55 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.455 2.103 . . . . 0.26000000000000001 112.452 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.61 132.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.238 -0.437 . . . . 0.64000000000000001 111.226 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.4 mmm -114.51 106.7 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.857 -0.794 . . . . 0.82999999999999996 108.857 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -67.9 147.61 52.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.023 0.439 . . . . 0.54000000000000004 112.161 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -90.85 141.98 27.23 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.848 -0.614 . . . . 0.67000000000000004 110.116 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.16 155.82 99.76 Favored 'Cis proline' 0 C--O 1.231 0.142 0 C-N-CA 123.137 -1.61 . . . . 0.75 112.389 -0.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.608 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -146.14 139.97 26.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 0.34999999999999998 109.969 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 110' ' ' VAL . 18.7 t70 -70.51 128.24 35.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.251 -0.648 . . . . 0.51000000000000001 109.251 174.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.457 HG21 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -68.86 -19.39 64.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.718 -0.674 . . . . 0.26000000000000001 112.756 -170.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 t -73.94 -37.49 64.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.206 -0.664 . . . . 1.3200000000000001 109.206 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -65.66 -46.48 79.0 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.112 -0.495 . . . . 0.62 109.779 175.779 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.5 t -58.88 -43.52 88.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.377 -0.829 . . . . 0.13 110.647 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.688 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.23 -54.03 39.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.853 -0.612 . . . . 0.13 111.454 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 61.7 mttp -57.5 -48.06 80.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 1.95 111.289 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 26.2 mmt180 -63.82 -34.71 78.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 2.23 111.415 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -46.71 70.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.058 0.456 . . . . 0.14000000000000001 110.27 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.547 HD23 HG11 ' A' ' 52' ' ' VAL . 86.8 mt -66.12 -25.6 67.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 0.27000000000000002 111.877 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 32.8 mm-40 -54.48 -41.04 69.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.537 -0.302 . . . . 2.79 111.388 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 77.6 mtm -70.89 -29.41 65.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.105 0.409 . . . . 0.42999999999999999 112.105 -176.365 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.7 t -179.92 104.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.031 0.443 . . . . 1.46 110.433 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 141.21 -39.86 1.39 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.517 -0.849 . . . . 2.5699999999999998 112.156 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.6 -59.33 9.99 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.809 -0.71 . . . . 4.4800000000000004 111.427 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.6 t70 54.8 36.8 27.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.685 0.755 . . . . 6.4199999999999999 110.403 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -93.98 129.32 40.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 9.1899999999999995 110.548 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -63.02 126.09 88.22 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.579 -0.737 . . . . 9.5999999999999996 110.018 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.6 72.74 4.9 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.616 2.21 . . . . 11.17 112.256 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.5 -0.762 . . . . 13.279999999999999 110.282 179.859 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.423 -0.271 . . . . 8.8000000000000007 112.423 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' ALA . . . . . 0.585 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . 49.2 71.82 0.35 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.268 0.556 . . . . 6.7800000000000002 111.569 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -72.81 -19.92 61.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.27 0.557 . . . . 7.21 110.34 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.05 59.0 0.47 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.57 -0.741 . . . . 1.8500000000000001 111.478 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.585 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 54.5 mtt -62.05 130.41 92.74 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.568 0.223 . . . . 1.6499999999999999 111.365 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -61.99 140.59 85.46 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.104 2.536 . . . . 0.33000000000000002 111.714 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -86.62 103.51 15.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.001 0.429 . . . . 0.89000000000000001 109.899 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' CG1' ' A' ' 52' ' ' VAL . 46.9 t -100.26 136.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.773 -0.649 . . . . 0.20000000000000001 110.977 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 53.7 tp -112.02 113.49 25.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.59 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.3 t -94.34 122.53 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.39 0.614 . . . . 0.13 111.164 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.677 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -101.79 107.42 18.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.812 -1.085 . . . . 0.20999999999999999 108.341 172.94 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -166.38 134.47 2.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 109.956 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.6 t70 -99.55 -23.58 15.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.383 -0.826 . . . . 1.27 110.069 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLU . . . . . 0.481 ' CB ' HD13 ' A' ' 17' ' ' ILE . 33.9 mt-10 -80.31 104.81 2.85 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 109.345 -0.613 . . . . 2.5600000000000001 109.345 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.2 Cg_exo -58.0 -32.68 95.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.014 2.476 . . . . 0.32000000000000001 113.435 -171.416 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.66 -49.68 74.17 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.697 -0.483 . . . . 1.51 109.697 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.481 HD13 ' CB ' ' A' ' 14' ' ' GLU . 3.3 mp -66.32 -47.59 83.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.544 -0.753 . . . . 1.01 110.126 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.83 74.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.20999999999999999 111.228 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.4 ttp -64.46 -37.08 86.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.013 -0.539 . . . . 0.60999999999999999 110.949 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' HB3' HG21 ' A' ' 107' ' ' THR . 2.6 m-80 -69.16 -37.0 78.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.25 -0.432 . . . . 1.22 110.915 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.11 -45.89 83.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.42 -0.354 . . . . 0.17999999999999999 110.058 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' HA ' HG11 ' A' ' 32' ' ' VAL . 23.4 tt0 -51.86 -56.8 11.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.765 -0.652 . . . . 1.04 110.205 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -63.55 -27.65 69.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.859 -0.61 . . . . 0.78000000000000003 111.894 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.9 54.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.834 0.35 . . . . 0.14000000000000001 110.314 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.706 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 47.0 m-85 -66.08 -41.1 91.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 0.13 111.031 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.3 mt-10 -61.29 -37.04 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.68999999999999995 110.582 178.283 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.44 -29.78 68.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 0.51000000000000001 110.338 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -79.48 -13.48 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.65000000000000002 110.66 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.49 50.19 1.58 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.092 -0.575 . . . . 0.28999999999999998 112.399 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.81 165.52 26.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.591 0.234 . . . . 0.23000000000000001 110.898 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -109.27 128.2 54.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.261 -0.644 . . . . 2.1400000000000001 109.261 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 22' ' ' GLN . 37.8 t -113.23 133.98 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.787 0.662 . . . . 0.19 112.787 -167.821 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.97 139.91 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.169 -1.049 . . . . 0.23000000000000001 108.169 167.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.1 t -114.67 125.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.626 -0.43 . . . . 0.94999999999999996 110.879 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -133.54 136.39 44.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.878 -0.601 . . . . 0.16 110.174 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.16 -10.8 21.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.869 0.366 . . . . 0.23999999999999999 111.287 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.2 p -131.23 163.37 27.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.199 -0.455 . . . . 0.25 110.751 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.6 m -63.41 -33.76 76.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.757 -0.46 . . . . 1.6000000000000001 109.757 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.43 -51.61 67.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 110.618 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 51.4 mt-30 -58.98 -39.12 80.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.122 0.487 . . . . 1.4099999999999999 110.805 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -64.74 -49.83 69.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 0.17999999999999999 111.718 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.4 mt -63.25 -27.86 69.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 0.82999999999999996 110.497 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -67.42 -50.29 60.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.787 -0.642 . . . . 2.4100000000000001 109.769 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -65.47 -33.45 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 1.1299999999999999 110.586 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -37.51 77.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 1.23 110.656 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.8 -41.8 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 111.212 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.16 -37.19 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 0.62 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 11.9 m120 -122.72 162.5 38.28 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.166 -0.47 . . . . 0.41999999999999998 110.724 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -93.28 86.05 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.255 2.637 . . . . 0.23999999999999999 111.018 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 42.4 mm -64.01 119.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 0.22 111.523 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.42 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 41.5 m-20 -87.24 -35.7 18.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.28999999999999998 110.28 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.485 ' CG1' HG22 ' A' ' 8' ' ' VAL . 14.5 p -156.31 155.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.753 -0.658 . . . . 0.12 109.581 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -138.24 163.51 31.57 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.451 0.643 . . . . 0.14000000000000001 111.519 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -134.84 111.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.511 -0.922 . . . . 0.95999999999999996 108.511 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.71 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -108.01 107.31 17.94 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.711 -0.396 . . . . 0.16 111.802 -169.673 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . 0.843 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.1 t70 -84.97 139.04 32.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.098 -0.704 . . . . 1.77 109.098 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 ' SG ' ' A' ' 65' ' ' CYS . 14.4 t -93.93 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.731 -0.668 . . . . 0.80000000000000004 110.287 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -89.96 60.18 4.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.715 0.769 . . . . 2.3700000000000001 110.164 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.3 mt -89.77 -23.85 21.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.87 -0.605 . . . . 0.84999999999999998 110.067 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.68 -173.13 44.49 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.029 -0.828 . . . . 0.81999999999999995 111.029 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.58 -43.52 57.08 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.565 2.177 . . . . 1.1799999999999999 111.91 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.11 -23.55 6.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.918 -0.583 . . . . 3.5299999999999998 110.404 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -61.91 122.35 15.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.95999999999999996 111.068 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' HIS . . . . . 0.467 ' HB2' HG13 ' A' ' 57' ' ' VAL . 20.0 p80 -144.39 154.22 42.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.495 -0.775 . . . . 0.48999999999999999 109.993 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -70.05 87.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 1.3 109.866 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.57 -74.71 0.74 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.525 -0.845 . . . . 0.23000000000000001 112.523 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 46.5 Cg_exo -53.35 -24.76 28.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.695 2.264 . . . . 0.23999999999999999 112.302 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.2 t -66.33 -44.54 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.375 0.607 . . . . 0.12 109.918 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.43 92.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.918 -1.037 . . . . 0.16 109.966 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.88 -45.59 93.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.514 -0.766 . . . . 2.0299999999999998 110.458 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.05 -41.65 68.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.459 0.647 . . . . 0.23000000000000001 111.366 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.58 -44.84 56.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.375 -0.83 . . . . 0.20000000000000001 110.561 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -54.29 -41.37 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.455 -0.793 . . . . 2.0099999999999998 110.861 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 21.7 mm-40 -59.89 -46.44 89.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.708 -0.678 . . . . 2.3700000000000001 111.483 179.121 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -92.93 12.06 25.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 1.49 111.451 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.43 37.44 27.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.692 -0.685 . . . . 0.33000000000000002 111.66 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.25 133.53 38.49 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.282 -0.417 . . . . 0.17000000000000001 109.944 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 22.2 Cg_endo -74.99 142.11 27.47 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.298 1.999 . . . . 0.20999999999999999 112.04 177.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 18.7 p90 -159.34 154.94 25.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 110.562 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.4 mt -117.74 137.03 52.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.358 -0.837 . . . . 0.23999999999999999 109.624 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 98' ' ' ALA . 1.8 mm? -89.03 109.4 20.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.238 -0.653 . . . . 0.20999999999999999 109.238 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.843 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 t-160 -97.87 126.85 43.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.904 -1.147 . . . . 0.59999999999999998 107.904 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -169.39 151.23 4.44 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.753 -0.592 . . . . 0.60999999999999999 111.529 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.83 -8.78 59.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.896 -0.669 . . . . 0.93999999999999995 111.565 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -116.32 112.39 21.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.725 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.04 -10.31 15.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.807 -0.633 . . . . 1.6100000000000001 110.057 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -84.03 -60.33 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 2.6299999999999999 111.457 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -71.78 -40.67 69.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 4.4199999999999999 110.778 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' HIS . . . . . 0.486 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 89.8 m-70 -92.48 21.78 5.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.334 -0.394 . . . . 1.05 111.676 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.41 -39.12 97.4 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.924 -0.655 . . . . 0.97999999999999998 112.475 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.42 -41.61 97.43 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.936 0.398 . . . . 2.5 110.346 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 96' ' ' ILE . 63.8 tp -59.77 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.70999999999999996 110.502 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 40.6 mt -60.32 -40.84 92.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.819 -0.628 . . . . 1.5800000000000001 111.122 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -69.78 -25.53 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 4.3799999999999999 111.21 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.15 -32.01 56.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.445 0.641 . . . . 2.4500000000000002 110.232 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 92' ' ' LEU . 93.6 mt -77.35 -54.44 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.45000000000000001 110.912 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.95 76.58 0.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.839 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -158.93 168.16 12.97 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.157 -0.929 . . . . 0.28999999999999998 108.941 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.574 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 47.8 Cg_exo -58.74 140.57 95.55 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.425 2.083 . . . . 0.26000000000000001 112.625 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.85 142.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.64000000000000001 110.873 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.9 mmm -125.57 110.01 13.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.389 -0.597 . . . . 0.82999999999999996 109.389 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.67 150.2 37.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.54000000000000004 111.849 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HE3' ' OD2' ' A' ' 56' ' ' ASP . 77.8 mttt -91.18 140.97 25.9 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.67000000000000004 110.154 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 2.9 Cg_exo -75.35 146.93 87.5 Favored 'Cis proline' 0 C--O 1.233 0.247 0 C-N-CA 123.472 -1.47 . . . . 0.75 112.641 3.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.506 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -136.41 132.58 35.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 0.34999999999999998 110.275 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.7 t70 -73.32 128.07 34.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.51000000000000001 108.486 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.524 HG21 ' HB3' ' A' ' 20' ' ' ASN . 35.9 p -65.96 -17.77 64.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.876 -0.602 . . . . 0.26000000000000001 112.294 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.5 p -71.92 -41.78 67.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.947 -0.39 . . . . 1.3200000000000001 109.947 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.5 -42.16 87.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.139 0.495 . . . . 0.62 110.01 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 106' ' ' ASP . 20.5 t -62.62 -44.11 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.383 -0.826 . . . . 0.13 110.182 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.706 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.63 -51.33 57.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.619 -0.719 . . . . 0.13 111.854 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 52.8 mtpt -60.03 -48.16 82.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 1.95 111.244 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -62.46 -35.82 80.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.68 0.276 . . . . 2.23 111.399 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 52' ' ' VAL . . . -66.32 -46.84 75.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.94 0.4 . . . . 0.14000000000000001 110.041 177.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.64 -26.36 65.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.132 -0.486 . . . . 0.27000000000000002 111.887 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 50.7 mm-40 -56.78 -46.94 81.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.116 0.484 . . . . 2.79 110.375 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.574 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.1 mtm -76.06 -26.69 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 0.42999999999999999 110.76 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 53.4 t -58.64 -52.73 64.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 1.46 111.146 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -146.26 129.91 3.52 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.47 -0.871 . . . . 2.5699999999999998 112.055 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.88 -28.97 74.11 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.158 -0.777 . . . . 4.4800000000000004 111.158 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.41 128.75 38.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.915 -0.402 . . . . 6.4199999999999999 109.915 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -83.85 155.94 22.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.484 -0.325 . . . . 9.1899999999999995 110.27 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -72.5 115.41 39.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 9.5999999999999996 110.109 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.7 37.64 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.978 2.452 . . . . 11.17 112.772 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.726 0 CA-C-O 118.568 -0.73 . . . . 13.279999999999999 110.483 -178.287 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.681 -0.568 . . . . 8.8000000000000007 111.681 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.39 -43.37 71.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.517 0.562 . . . . 6.7800000000000002 112.517 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -102.09 27.23 6.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.741 0.305 . . . . 7.21 111.289 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.47 20.34 78.28 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 121.005 -0.617 . . . . 1.8500000000000001 111.948 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' MET . . . . . 0.429 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 86.3 mtp -143.2 139.41 16.63 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 108.708 -0.849 . . . . 1.6499999999999999 108.708 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 8.8 Cg_exo -63.52 131.42 31.62 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.854 1.703 . . . . 0.33000000000000002 111.372 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -86.01 102.94 14.25 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.507 -0.923 . . . . 0.89000000000000001 108.507 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.8 t -99.69 126.81 53.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.037 -0.529 . . . . 0.20000000000000001 111.087 -172.326 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.5 tm? -102.2 112.24 24.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.578 -0.737 . . . . 0.75 109.476 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.4 t -96.83 125.82 49.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.113 0.482 . . . . 0.13 111.409 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . 0.642 HD23 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.96 100.53 10.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.694 -0.854 . . . . 0.20999999999999999 108.694 173.002 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -157.5 118.17 3.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.907 -0.588 . . . . 1.4099999999999999 109.626 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 32.9 t70 -77.27 -21.2 53.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.848 -0.615 . . . . 1.27 110.223 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -88.05 106.88 13.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.905 -0.589 . . . . 2.5600000000000001 111.117 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 39.2 Cg_exo -58.53 -28.89 87.2 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.86 2.374 . . . . 0.32000000000000001 112.914 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -49.67 68.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.516 -0.55 . . . . 1.51 109.516 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.5 mt -66.37 -45.47 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.733 -0.667 . . . . 1.01 110.514 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.35 73.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 0.20999999999999999 110.82 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.6 ttp -59.37 -43.84 92.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.60999999999999999 111.238 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.9 m-80 -67.86 -38.71 83.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.926 -0.579 . . . . 1.22 111.34 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 mt -65.31 -44.83 86.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.17999999999999999 110.297 172.243 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLN . . . . . 0.615 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 52.2 tt0 -54.49 -51.89 63.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.466 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.09 -34.38 74.83 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.612 -0.267 . . . . 0.78000000000000003 111.116 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.9 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.504 -0.317 . . . . 0.14000000000000001 110.699 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.9 m-85 -68.64 -42.5 77.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.242 -0.435 . . . . 0.13 110.994 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 44.1 mt-10 -61.79 -35.54 78.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.586 -0.279 . . . . 0.68999999999999995 110.461 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.49 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.51000000000000001 110.657 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.81 -10.0 59.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.65000000000000002 110.455 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.63 50.56 1.81 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.28999999999999998 112.399 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -139.79 165.14 28.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.23000000000000001 110.833 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.86 134.97 53.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.422 -0.584 . . . . 2.1400000000000001 109.422 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.615 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.4 t -117.39 140.74 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.41 0.522 . . . . 0.19 112.41 -167.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.43 131.53 64.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.544 -0.91 . . . . 0.23000000000000001 108.544 168.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.6 t -105.43 121.15 57.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.94999999999999996 111.609 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.39 142.66 51.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.819 -0.628 . . . . 0.16 110.471 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.76 -12.6 15.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.899 -0.591 . . . . 0.23999999999999999 110.54 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' THR . . . . . 0.409 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 32.8 p -124.89 174.96 7.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.25 110.955 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' CYS . . . . . 0.611 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.9 m -75.11 -37.0 61.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.033 0.444 . . . . 1.6000000000000001 110.263 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.15 -41.19 90.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.69999999999999996 111.161 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 86.5 mt-30 -59.83 -37.29 78.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.078 0.466 . . . . 1.4099999999999999 110.857 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.57 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -71.46 -48.43 49.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.995 -0.548 . . . . 0.17999999999999999 110.879 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mp -56.02 -37.34 69.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.82999999999999996 110.68 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -63.1 -54.07 43.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 2.4100000000000001 110.444 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -63.99 -29.18 70.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.713 -0.676 . . . . 1.1299999999999999 111.711 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.4 -30.64 69.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.342 0.591 . . . . 1.23 110.513 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.53 -28.57 24.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.4 0.619 . . . . 0.42999999999999999 111.07 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -87.04 -21.68 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 0.62 111.52 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -137.68 163.67 46.69 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 0.41999999999999998 111.115 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -96.32 87.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.767 2.978 . . . . 0.23999999999999999 111.388 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 9' ' ' LEU . 37.9 mm -66.08 124.36 20.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.594 -0.73 . . . . 0.22 111.631 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.701 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 14.3 m-20 -89.48 -34.67 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.542 -0.754 . . . . 0.28999999999999998 110.421 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 115' ' ' LEU . 13.6 p -159.67 157.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.805 -0.634 . . . . 0.12 109.871 -176.306 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.8 164.53 29.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.359 0.599 . . . . 0.14000000000000001 112.008 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.65 110.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.353 -0.84 . . . . 0.95999999999999996 109.301 175.635 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.5 mp -112.7 121.86 45.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.415 -0.357 . . . . 0.16 111.631 -169.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.88 116.49 22.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 1.77 109.645 171.25 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' VAL . . . . . 0.579 HG13 HD23 ' A' ' 92' ' ' LEU . 92.9 t -67.37 -23.74 30.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.061 -0.972 . . . . 0.80000000000000004 110.463 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 56.6 t30 -103.38 56.94 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.544 -0.753 . . . . 2.3700000000000001 110.695 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.35 -37.32 85.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.939 -0.763 . . . . 0.84999999999999998 108.939 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.85 -171.61 29.29 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.149 -1.18 . . . . 0.81999999999999995 110.149 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.0 -46.26 34.92 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.498 2.132 . . . . 1.1799999999999999 111.862 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.99 -34.93 6.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.409 -0.36 . . . . 3.5299999999999998 110.874 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -62.33 123.56 18.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.325 0.584 . . . . 0.95999999999999996 110.92 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -144.79 152.27 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.551 -0.75 . . . . 0.48999999999999999 110.616 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -73.82 87.5 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.283 0.564 . . . . 1.3 109.811 173.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -106.51 -73.52 0.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.278 -0.963 . . . . 0.23000000000000001 112.598 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.4 Cg_exo -52.19 -27.1 28.68 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.23999999999999999 112.082 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.642 HG11 HD23 ' A' ' 11' ' ' LEU . 17.0 t -68.23 -44.07 84.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.12 110.195 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.79 82.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.28 -0.873 . . . . 0.16 110.268 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.52 -42.47 98.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 110.253 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.37 69.34 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.51 0.672 . . . . 0.23000000000000001 110.92 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.6 -42.7 70.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.22 -0.9 . . . . 0.20000000000000001 110.642 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' LYS . . . . . 0.59 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.8 mmtt -60.47 -37.95 82.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.809 -0.632 . . . . 2.0099999999999998 111.11 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.52 -39.06 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 2.3700000000000001 111.441 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -97.46 10.98 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.257 -0.429 . . . . 1.49 111.159 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.82 33.18 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.33000000000000002 112.02 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.73 132.67 39.75 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.228 -0.442 . . . . 0.17000000000000001 110.071 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 18.6 Cg_endo -74.41 140.06 26.74 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.391 2.06 . . . . 0.20999999999999999 111.421 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 23.6 p90 -157.34 161.16 39.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.831 -0.622 . . . . 0.17999999999999999 110.493 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' A' ' 101' ' ' MET . 41.0 mt -124.21 140.95 46.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.288 -0.869 . . . . 0.23999999999999999 109.784 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.4 mm? -88.69 108.01 19.24 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.91 -0.774 . . . . 0.20999999999999999 108.91 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' HIS . . . . . 0.604 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 17.7 t-160 -99.49 82.42 2.65 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.593 0.711 . . . . 0.59999999999999998 109.722 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -137.98 157.97 45.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.426 -1.261 . . . . 0.60999999999999999 109.257 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.23 4.61 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.362 -0.923 . . . . 0.93999999999999995 111.955 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 12.9 m-20 -137.09 69.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 2.3300000000000001 111.458 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.46 HD11 HG11 ' A' ' 100' ' ' VAL . 82.2 mt -63.04 -34.77 78.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 1.6100000000000001 110.254 174.378 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -63.81 -29.17 70.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 2.6299999999999999 111.745 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -72.34 -21.6 61.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.232 0.539 . . . . 4.4199999999999999 110.508 -177.801 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -137.45 45.65 2.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 1.05 110.072 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLY . . . . . 0.763 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . -59.67 -27.06 63.35 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.97999999999999998 113.263 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.68 -25.16 63.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 2.5 110.642 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' LEU . . . . . 0.579 HD23 HG13 ' A' ' 57' ' ' VAL . 27.5 tp -77.22 -52.74 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.70999999999999996 111.884 -174.499 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -63.78 -23.94 67.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.178 0.513 . . . . 1.5800000000000001 111.545 -177.041 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' ARG . . . . . 0.543 ' N ' HD22 ' A' ' 93' ' ' LEU . 99.6 mtt180 -62.57 -34.26 76.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.186 -0.915 . . . . 4.3799999999999999 110.762 173.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -81.93 -33.68 30.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 2.4500000000000002 110.447 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ILE . . . . . 0.59 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 59.4 mt -74.34 -62.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.485 -0.78 . . . . 0.45000000000000001 111.606 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.13 76.81 0.21 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.408 0.623 . . . . 1.0900000000000001 111.471 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.42 164.83 19.37 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.28999999999999998 109.238 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.677 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.7 Cg_exo -56.52 144.26 85.14 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.668 2.245 . . . . 0.26000000000000001 113.003 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 86' ' ' LEU . 46.5 t -121.99 137.74 54.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.64000000000000001 110.751 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' MET . . . . . 0.471 ' HG2' HG21 ' A' ' 80' ' ' ILE . 86.6 mmm -117.56 105.55 12.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.702 -0.851 . . . . 0.82999999999999996 108.702 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.13 145.3 56.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.98 -0.554 . . . . 0.54000000000000004 111.861 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 87.4 mttt -91.34 140.89 25.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 0.67000000000000004 109.897 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.6 154.11 97.21 Favored 'Cis proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.567 -1.431 . . . . 0.75 112.472 2.024 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' ALA . . . . . 0.604 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 137.29 29.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.033 -0.531 . . . . 0.34999999999999998 110.216 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 110' ' ' VAL . 11.4 t70 -71.43 129.71 39.48 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.51000000000000001 108.468 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.9 p -67.18 -22.37 65.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.554 -0.748 . . . . 0.26000000000000001 112.542 -170.244 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 91.6 p -71.19 -37.42 72.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.653 -0.499 . . . . 1.3200000000000001 109.653 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -63.4 -46.68 85.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.323 0.583 . . . . 0.62 109.556 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG12 HG11 ' A' ' 54' ' ' VAL . 21.1 t -62.0 -44.88 99.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.991 -1.004 . . . . 0.13 110.62 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.46 -47.79 80.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.13 111.461 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 108' ' ' SER . 95.2 mttt -62.75 -44.76 95.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 1.95 111.403 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 33.4 mmt180 -64.1 -32.72 74.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.104 0.478 . . . . 2.23 111.091 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.57 -47.9 44.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.088 0.47 . . . . 0.14000000000000001 110.463 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LEU . . . . . 0.56 HD23 HG11 ' A' ' 52' ' ' VAL . 80.8 mt -69.75 -30.03 67.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.785 0.661 . . . . 0.27000000000000002 112.785 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.96 -31.61 72.62 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.763 -0.375 . . . . 2.79 110.715 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 117' ' ' MET . . . . . 0.677 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 55.7 mtm -70.79 -32.3 69.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.42999999999999999 110.802 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 42.0 t -76.45 -42.09 45.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 1.46 110.486 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.81 -73.27 2.64 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.044 -0.598 . . . . 2.5699999999999998 112.704 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 155.85 71.39 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.07 -0.586 . . . . 4.4800000000000004 111.645 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -84.71 133.12 34.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.87 0.367 . . . . 6.4199999999999999 110.423 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -124.39 126.77 46.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.155 -0.475 . . . . 9.1899999999999995 110.057 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -96.6 109.87 50.28 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.851 -0.426 . . . . 9.5999999999999996 109.851 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.78 52.59 4.28 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.957 2.438 . . . . 11.17 112.267 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.667 -0.683 . . . . 13.279999999999999 110.15 -179.917 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.447 -0.593 0 CA-C-O 120.637 0.256 . . . . 1.6499999999999999 111.063 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.57 145.83 59.45 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.455 2.77 . . . . 0.33000000000000002 111.689 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -89.73 106.73 18.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.94 0.4 . . . . 0.89000000000000001 109.931 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 60.1 t -100.49 137.36 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.91 -0.586 . . . . 0.20000000000000001 111.062 -175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB2' HD12 ' A' ' 50' ' ' ILE . 47.3 tp -111.11 116.92 31.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.305 -0.407 . . . . 0.75 110.323 174.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 t -100.77 121.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.261 0.553 . . . . 0.13 111.362 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -101.89 104.11 14.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.937 -1.029 . . . . 0.20999999999999999 108.658 172.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -161.21 113.47 1.87 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.903 -0.589 . . . . 1.4099999999999999 109.862 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 33.6 t70 -84.08 -12.56 54.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.086 -0.506 . . . . 1.27 109.865 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.28 100.37 1.38 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.347 -0.612 . . . . 2.5600000000000001 109.347 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.9 Cg_exo -60.18 -30.58 91.61 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.839 2.36 . . . . 0.32000000000000001 113.676 -171.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.62 -49.44 73.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.276 -0.638 . . . . 1.51 109.276 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.97 -44.74 92.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.686 -0.688 . . . . 1.01 111.059 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.72 75.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.20999999999999999 110.905 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.5 ttp -60.6 -42.66 97.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.923 -0.581 . . . . 0.60999999999999999 110.871 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.475 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.0 m-80 -66.43 -40.3 89.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.027 -0.533 . . . . 1.22 111.164 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.2 mt -62.98 -42.62 99.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.17999999999999999 110.443 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.465 ' CG ' ' HB ' ' A' ' 32' ' ' VAL . 1.5 tt0 -58.07 -50.95 71.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.166 -0.47 . . . . 1.04 109.809 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -56.07 -36.26 67.9 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.024 -0.535 . . . . 0.78000000000000003 111.109 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.6 45.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.14000000000000001 111.105 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 45.9 m-85 -64.81 -43.4 93.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.246 -0.434 . . . . 0.13 110.699 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 47.4 mt-10 -61.89 -35.08 77.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.279 . . . . 0.68999999999999995 110.553 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -32.12 72.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.497 . . . . 0.51000000000000001 110.592 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.978 0.418 . . . . 0.65000000000000002 110.375 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.73 49.74 1.25 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.85 -0.613 . . . . 0.28999999999999998 112.232 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 26' ' ' GLU . . . -139.99 165.93 26.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.646 0.26 . . . . 0.23000000000000001 111.254 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -108.67 142.87 38.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.818 -0.808 . . . . 2.1400000000000001 108.818 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 22' ' ' GLN . 7.0 t -125.9 133.57 68.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.238 0.459 . . . . 0.19 112.238 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.417 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.5 t -104.26 124.61 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.844 -0.798 . . . . 0.23000000000000001 108.844 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.49 121.63 49.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.915 0.388 . . . . 0.94999999999999996 110.824 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.57 134.24 46.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.958 -0.565 . . . . 0.16 110.369 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.423 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -100.52 -9.66 21.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.059 -0.519 . . . . 0.23999999999999999 110.8 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 p -128.86 158.85 37.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.25 110.86 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.538 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.6 m -64.27 -32.92 74.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.943 -0.392 . . . . 1.6000000000000001 109.943 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.1 -46.39 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.142 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.423 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 36.0 mt-30 -60.31 -42.64 96.0 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.336 0.589 . . . . 1.4099999999999999 110.436 175.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.85 -52.58 63.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.107 -0.951 . . . . 0.17999999999999999 111.732 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -63.87 -29.53 70.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.041 -0.527 . . . . 0.82999999999999996 110.568 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.97 -50.57 61.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.195 -0.668 . . . . 2.4100000000000001 109.195 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.417 ' OG ' HG11 ' A' ' 33' ' ' VAL . 8.7 t -65.45 -31.79 73.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.235 -0.439 . . . . 1.1299999999999999 110.466 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -42.93 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.23 110.544 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.74 20.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.42999999999999999 111.383 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.04 -37.36 58.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.62 111.45 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -123.89 161.07 48.77 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.163 -0.472 . . . . 0.41999999999999998 110.34 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -92.34 85.52 0.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.142 2.562 . . . . 0.23999999999999999 111.363 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 9' ' ' LEU . 40.2 mm -64.62 117.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.79 . . . . 0.22 111.507 -175.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.8 m-20 -83.67 -33.49 25.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.28999999999999998 110.265 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.528 HG11 HD23 ' A' ' 115' ' ' LEU . 14.8 p -160.58 155.38 3.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.12 109.574 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -136.3 166.92 22.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.312 0.577 . . . . 0.14000000000000001 111.266 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.567 HG21 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -141.17 120.75 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.682 -1.229 . . . . 0.95999999999999996 107.682 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.657 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -122.29 118.82 29.43 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.47 0.545 . . . . 0.16 112.47 -166.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.05 128.03 32.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.086 -0.709 . . . . 1.77 109.086 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.584 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 34.6 t -86.19 -22.52 7.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.655 -0.702 . . . . 0.80000000000000004 111.118 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -108.68 62.36 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 110.639 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.0 -34.26 77.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.84999999999999998 110.376 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.4 -173.84 36.63 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.81999999999999995 111.384 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -36.22 91.14 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.038 2.492 . . . . 1.1799999999999999 112.655 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 1.3 tmtp? -119.67 -34.74 3.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.868 0.366 . . . . 3.5299999999999998 110.185 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 p -69.51 127.46 33.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.593 0.711 . . . . 0.95999999999999996 111.472 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -145.36 150.14 36.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.261 -0.881 . . . . 0.48999999999999999 109.847 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 30.7 p -69.7 87.03 0.49 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.18 -0.674 . . . . 1.3 109.18 171.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.33 -68.44 0.41 Allowed Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.384 -0.912 . . . . 0.23000000000000001 112.282 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 48.3 Cg_exo -52.95 -28.46 39.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.268 1.978 . . . . 0.23999999999999999 111.532 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.7 t -68.56 -49.12 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.407 0.622 . . . . 0.12 110.05 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.37 88.57 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.887 -1.051 . . . . 0.16 110.292 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 20.8 t70 -66.01 -40.18 90.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.567 -0.742 . . . . 2.0299999999999998 110.516 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.29 74.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.514 0.673 . . . . 0.23000000000000001 110.637 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.28 -44.12 80.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.015 -0.993 . . . . 0.20000000000000001 110.373 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -57.88 -37.13 73.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 2.0099999999999998 111.413 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 77.4 mt-30 -61.8 -47.88 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 2.3700000000000001 111.23 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -90.9 5.62 47.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 1.49 111.582 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 31.29 19.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.33000000000000002 111.544 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.3 mt -81.49 131.48 58.2 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.627 -0.508 . . . . 0.17000000000000001 109.627 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -72.95 143.14 36.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.293 1.996 . . . . 0.20999999999999999 112.208 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 23.9 p90 -160.9 158.5 28.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.761 -0.654 . . . . 0.17999999999999999 110.619 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.43 HG21 ' HG2' ' A' ' 101' ' ' MET . 34.9 mt -123.6 138.23 54.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.329 -0.85 . . . . 0.23999999999999999 109.837 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 2.6 mm? -88.22 108.19 19.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.626 -0.509 . . . . 0.20999999999999999 109.626 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.615 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 22.3 t-160 -102.22 84.22 2.45 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.375 -0.602 . . . . 0.59999999999999998 109.375 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.523 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 7.2 t -125.47 152.34 45.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.445 -0.798 . . . . 0.60999999999999999 111.242 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.04 -8.16 55.63 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.317 -0.713 . . . . 0.93999999999999995 111.317 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 2.7 m-20 -126.98 124.05 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.747 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.13 -51.97 2.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.048 -0.524 . . . . 1.6100000000000001 110.535 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.55 -26.31 68.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 2.6299999999999999 111.388 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 18.1 mmm180 -64.69 -20.03 66.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 4.4199999999999999 111.858 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -144.31 40.01 1.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 1.05 111.319 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.37 -38.67 96.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.095 -0.574 . . . . 0.97999999999999998 112.783 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 6.2 pt-20 -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.449 . . . . 2.5 110.986 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.523 ' O ' HG13 ' A' ' 96' ' ' ILE . 18.9 tp -64.75 -46.97 79.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.70999999999999996 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 57' ' ' VAL . 36.0 mt -59.35 -38.26 79.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.588 -0.733 . . . . 1.5800000000000001 111.673 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 10.9 ptt180 -67.69 -25.84 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 4.3799999999999999 110.626 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 95.7 mttt -81.05 -37.71 28.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.131 0.491 . . . . 2.4500000000000002 110.278 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 92' ' ' LEU . 72.7 mt -65.01 -57.57 10.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.45000000000000001 110.455 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 57.03 76.54 0.31 Allowed 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.874 0.734 . . . . 1.0900000000000001 110.802 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.04 163.22 25.27 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.618 -0.719 . . . . 0.28999999999999998 109.726 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.09 140.85 86.33 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.933 2.422 . . . . 0.26000000000000001 112.151 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 1.1 m -127.64 149.64 32.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.191 0.52 . . . . 0.64000000000000001 110.824 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG2' HG21 ' A' ' 80' ' ' ILE . 74.0 mmm -121.47 107.9 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.82999999999999996 108.373 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -71.69 147.75 47.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.405 -0.361 . . . . 0.54000000000000004 111.446 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.5 mttt -90.92 141.61 26.8 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.05 -0.523 . . . . 0.67000000000000004 109.866 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -73.29 148.19 91.5 Favored 'Cis proline' 0 C--O 1.234 0.28 0 C-N-CA 123.477 -1.468 . . . . 0.75 112.849 2.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.615 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -144.78 136.25 25.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.416 -0.811 . . . . 0.34999999999999998 109.328 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.8 t70 -70.69 127.46 32.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.445 -0.946 . . . . 0.51000000000000001 108.445 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.4 p -62.56 -22.32 66.25 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.035 -0.984 . . . . 0.26000000000000001 112.233 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 78.9 p -68.74 -42.26 77.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.82 -0.437 . . . . 1.3200000000000001 109.82 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.75 -38.64 87.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.091 0.472 . . . . 0.62 110.054 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.567 HG12 HG21 ' A' ' 54' ' ' VAL . 33.5 t -64.19 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.283 -0.871 . . . . 0.13 110.106 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -68.47 -47.83 66.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.629 -0.714 . . . . 0.13 111.468 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 7.5 mtmp? -56.35 -55.32 34.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 1.95 111.174 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 35.6 mmt180 -62.1 -31.75 72.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.675 0.274 . . . . 2.23 111.578 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.85 70.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.14000000000000001 110.188 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.528 HD23 HG11 ' A' ' 52' ' ' VAL . 84.3 mt -70.68 -26.29 63.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.141 -0.481 . . . . 0.27000000000000002 111.695 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 8.0 mm-40 -60.64 -34.38 74.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 2.79 110.61 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 47.9 mtm -82.46 -13.62 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.42999999999999999 110.597 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 53.1 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.748 -178.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 64.7 mtt . . . . . 0 N--CA 1.453 -0.303 0 CA-C-O 120.539 0.209 . . . . 1.6499999999999999 110.936 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.2 Cg_endo -71.65 141.37 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.236 1.957 . . . . 0.33000000000000002 110.86 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HG3' HD13 ' A' ' 50' ' ' ILE . 48.6 tptt -86.65 103.15 14.85 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.451 -0.574 . . . . 0.89000000000000001 109.451 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.49 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.9 t -100.09 134.51 39.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.721 -0.672 . . . . 0.20000000000000001 110.726 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.501 ' HB2' HD12 ' A' ' 50' ' ' ILE . 48.2 tp -111.54 113.44 25.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.863 0.363 . . . . 0.75 110.74 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -93.82 124.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.21 0.529 . . . . 0.13 111.599 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.773 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -105.59 101.37 10.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.057 -0.974 . . . . 0.20999999999999999 108.921 173.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -159.5 129.52 5.59 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.805 -0.634 . . . . 1.4099999999999999 109.782 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 28.8 t70 -90.3 -20.4 22.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.325 -0.398 . . . . 1.27 110.499 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -84.86 107.82 12.94 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 109.308 -0.627 . . . . 2.5600000000000001 109.308 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 35.7 Cg_exo -57.96 -29.68 87.41 Favored 'Trans proline' 0 CA--C 1.517 -0.35 0 C-N-CA 122.723 2.282 . . . . 0.32000000000000001 112.264 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.97 -51.33 64.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.456 -0.572 . . . . 1.51 109.456 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.25 -43.38 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 1.01 110.437 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG13 ' A' ' 34' ' ' VAL . . . -58.55 -49.69 76.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.886 -0.597 . . . . 0.20999999999999999 110.925 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.6 -35.93 79.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.93 -0.577 . . . . 0.60999999999999999 111.072 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.6 m-20 -66.02 -41.9 90.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.461 -0.336 . . . . 1.22 110.748 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.43 -44.35 91.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.823 0.344 . . . . 0.17999999999999999 110.145 173.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.518 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 59.6 tt0 -52.71 -53.02 53.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 1.04 110.343 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.79 -29.37 70.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.78000000000000003 111.701 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.19 -46.22 61.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 0.14000000000000001 110.76 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.4 m-85 -67.93 -41.66 82.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.107 -0.497 . . . . 0.13 110.599 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.79 -30.21 71.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.68999999999999995 110.728 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 110.374 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -82.49 8.17 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.65000000000000002 110.746 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.42 51.23 8.63 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.136 -0.554 . . . . 0.28999999999999998 112.448 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -132.64 164.86 25.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.862 0.363 . . . . 0.23000000000000001 111.375 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -108.08 125.97 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.173 -0.677 . . . . 2.1400000000000001 109.173 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.518 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.9 t -114.07 140.72 33.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 112.509 0.559 . . . . 0.19 112.509 -168.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 t -112.41 140.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.637 -0.875 . . . . 0.23000000000000001 108.637 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.431 HG13 ' HB1' ' A' ' 18' ' ' ALA . 84.1 t -111.26 124.7 68.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.773 0.321 . . . . 0.94999999999999996 110.92 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.6 134.09 38.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.146 -0.479 . . . . 0.16 110.725 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.584 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.54 -3.23 28.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.019 0.438 . . . . 0.23999999999999999 110.674 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -137.71 159.83 40.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 0.25 110.719 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 87.6 m -60.32 -34.25 73.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.038 -0.528 . . . . 1.6000000000000001 110.208 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.14 -47.83 81.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.656 . . . . 0.69999999999999996 111.012 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.584 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 38.5 mt-30 -60.56 -37.98 83.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.374 0.607 . . . . 1.4099999999999999 110.696 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.773 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -65.78 -51.01 62.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.232 -0.894 . . . . 0.17999999999999999 111.708 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.8 mt -60.88 -29.95 69.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.105 0.479 . . . . 0.82999999999999996 110.472 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -64.85 -52.22 57.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.654 -0.703 . . . . 2.4100000000000001 110.158 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 t -67.71 -34.26 76.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.926 -0.579 . . . . 1.1299999999999999 110.304 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -58.68 -42.0 87.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 1.23 110.324 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.51 -33.92 28.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.42999999999999999 111.513 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.75 -37.49 27.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.62 111.623 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.95 164.6 20.18 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.849 0.357 . . . . 0.41999999999999998 110.873 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -95.05 86.96 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.47 2.78 . . . . 0.23999999999999999 111.441 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.2 mm -65.39 123.34 18.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.664 -0.698 . . . . 0.22 111.252 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 45.8 m-20 -93.18 -27.26 16.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.28999999999999998 110.726 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.49 ' CG1' HG22 ' A' ' 8' ' ' VAL . 13.3 p -164.16 157.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.493 -0.558 . . . . 0.12 109.493 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -142.82 165.48 27.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 0.14000000000000001 112.006 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.403 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.62 111.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.254 -0.884 . . . . 0.95999999999999996 109.165 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 8.8 mp -113.32 119.25 37.04 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.064 0.394 . . . . 0.16 112.064 -168.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -74.69 132.49 41.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.231 -1.025 . . . . 1.77 108.231 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.596 ' H ' ' HB ' ' A' ' 83' ' ' THR . 22.9 t -86.21 -10.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.386 0.612 . . . . 0.80000000000000004 110.029 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -129.2 73.27 1.51 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.814 -0.63 . . . . 2.3700000000000001 110.056 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 64' ' ' HIS . 4.0 mm? -56.28 -51.43 68.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.864 -0.607 . . . . 0.84999999999999998 109.711 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.61 -157.62 7.87 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.312 -0.858 . . . . 0.81999999999999995 111.184 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -55.12 -45.1 43.21 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.727 2.285 . . . . 1.1799999999999999 112.567 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -119.82 -33.87 3.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 3.5299999999999998 111.208 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 20.1 m -65.5 126.56 28.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.95999999999999996 110.99 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.679 ' HA ' HD23 ' A' ' 59' ' ' LEU . 11.1 p80 -144.86 163.26 34.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.96 -0.564 . . . . 0.48999999999999999 110.253 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 57' ' ' VAL . 26.4 p -75.28 88.32 2.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.315 0.579 . . . . 1.3 109.955 175.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 -77.81 1.01 Allowed Glycine 0 C--O 1.228 -0.27 0 C-N-CA 120.091 -1.052 . . . . 0.23000000000000001 111.979 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.6 Cg_exo -51.65 -24.76 18.3 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.024 2.482 . . . . 0.23999999999999999 112.749 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 13.8 t -67.37 -48.58 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 0.12 110.117 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -43.98 84.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.958 -1.019 . . . . 0.16 109.804 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 10.9 m-20 -64.63 -46.66 81.64 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.459 -0.792 . . . . 2.0299999999999998 110.519 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB1' ' HG ' ' A' ' 45' ' ' LEU . . . -53.53 -45.9 69.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.536 0.684 . . . . 0.23000000000000001 110.697 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.06 -46.89 72.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.952 -1.022 . . . . 0.20000000000000001 110.404 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 24.4 mmtp -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.874 -0.603 . . . . 2.0099999999999998 111.977 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 80.6 mm-40 -69.7 -26.21 64.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.577 -0.283 . . . . 2.3700000000000001 111.405 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -106.95 8.79 30.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.663 0.268 . . . . 1.49 111.244 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.31 35.2 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.837 -0.619 . . . . 0.33000000000000002 111.705 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.3 mt -84.8 132.82 45.03 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 109.894 -0.41 . . . . 0.17000000000000001 109.894 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.36 141.65 25.88 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.312 2.008 . . . . 0.20999999999999999 112.015 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 35.2 p90 -157.93 161.95 38.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.835 -0.62 . . . . 0.17999999999999999 110.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.61 141.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.25 -0.886 . . . . 0.23999999999999999 109.561 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.8 mm? -88.1 109.63 20.02 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.20999999999999999 109.669 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.512 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 15.4 t-160 -101.35 77.62 1.8 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.816 0.817 . . . . 0.59999999999999998 109.188 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.596 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 10.2 t -115.0 158.28 22.29 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.501 -1.227 . . . . 0.60999999999999999 110.127 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.74 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -108.34 -3.26 33.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.22 -0.752 . . . . 0.93999999999999995 111.22 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 11.0 m-20 -126.22 66.6 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.304 0.573 . . . . 2.3300000000000001 110.075 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.04 -54.72 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.367 -0.833 . . . . 1.6100000000000001 111.129 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.52 -20.42 64.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.322 -0.399 . . . . 2.6299999999999999 111.401 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 1.1 mmp_? -74.16 -26.27 60.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.16 -0.473 . . . . 4.4199999999999999 110.927 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.443 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.6 m-70 -123.17 35.28 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 1.05 111.174 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -59.67 -41.42 97.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.031 -0.604 . . . . 0.97999999999999998 113.01 -175.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.25 -37.8 81.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.656 0.265 . . . . 2.5 110.609 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.564 HD23 ' CG1' ' A' ' 57' ' ' VAL . 34.8 tp -68.43 -39.98 81.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.70999999999999996 110.412 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.6 mt -58.96 -42.08 89.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 1.5800000000000001 110.729 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.91 -27.42 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 4.3799999999999999 110.964 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.75 -42.29 50.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.012 -0.54 . . . . 2.4500000000000002 110.614 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.44 HG21 HD21 ' A' ' 81' ' ' LEU . 78.7 mt -67.76 -52.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.45000000000000001 111.18 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 t70 61.26 77.49 0.33 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0900000000000001 111.037 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -163.89 163.42 15.78 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.717 . . . . 0.28999999999999998 109.896 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.532 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.8 Cg_exo -56.97 149.82 59.45 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.804 2.336 . . . . 0.26000000000000001 112.847 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.74 132.4 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.64000000000000001 111.076 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.8 mmm -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.121 -0.696 . . . . 0.82999999999999996 109.121 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.15 132.15 48.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.54000000000000004 111.884 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.74 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 14.4 ptpt -97.2 150.33 36.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.67000000000000004 110.051 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.638 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 32.8 Cg_exo -60.05 127.96 3.93 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.952 -1.27 . . . . 0.75 113.268 2.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -129.74 134.25 47.51 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.34999999999999998 109.253 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.1 t70 -67.21 121.96 16.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.904 -0.776 . . . . 0.51000000000000001 108.904 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.5 p -62.13 -24.37 67.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.26 -0.882 . . . . 0.26000000000000001 112.474 -170.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.798 -0.445 . . . . 1.3200000000000001 109.798 177.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 25.6 m-20 -69.17 -37.79 78.38 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.937 -0.574 . . . . 0.62 109.972 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 106' ' ' ASP . 34.0 t -64.31 -46.07 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.676 -0.693 . . . . 0.13 110.253 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -60.37 -48.69 80.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.584 -0.735 . . . . 0.13 111.571 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 59.6 mtpt -59.12 -55.03 40.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 1.95 110.989 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.561 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 5.9 mpt_? -51.63 -43.14 62.49 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.028 0.381 . . . . 2.23 112.028 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.69 -50.33 69.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.14000000000000001 110.725 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.486 HD23 HG11 ' A' ' 52' ' ' VAL . 81.1 mt -65.91 -26.3 67.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.509 . . . . 0.27000000000000002 111.572 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 24.2 mm-40 -60.75 -43.43 97.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.678 0.275 . . . . 2.79 110.965 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.532 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 48.9 mtm -71.14 -29.78 65.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.962 0.411 . . . . 0.42999999999999999 110.5 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 35.6 t . . . . . 0 C--N 1.324 -0.535 0 CA-C-N 115.787 -0.642 . . . . 1.46 110.691 -178.421 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.5 mtp . . . . . 0 N--CA 1.449 -0.483 0 N-CA-C 109.57 -0.53 . . . . 1.6499999999999999 109.57 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.42 136.26 66.6 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.939 2.426 . . . . 0.33000000000000002 111.989 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -82.86 104.54 13.16 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.312 -0.625 . . . . 0.89000000000000001 109.312 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 49.9 t -100.02 135.1 37.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.514 -0.766 . . . . 0.20000000000000001 110.559 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 50' ' ' ILE . 46.4 tp -111.99 111.84 23.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 0.75 110.644 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -93.65 121.78 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.369 0.604 . . . . 0.13 111.332 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.38 106.79 17.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.20999999999999999 108.857 172.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -165.36 125.15 1.8 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 109.663 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.9 -26.5 34.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.863 -0.608 . . . . 1.27 109.607 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -78.71 108.65 8.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.68 -0.691 . . . . 2.5600000000000001 110.59 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.19 -35.09 98.26 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 112.949 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.88 -48.81 75.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.35 . . . . 1.51 110.278 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.5 -45.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 1.01 110.541 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.93 78.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.848 -0.614 . . . . 0.20999999999999999 110.902 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.21 -40.2 93.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.959 -0.564 . . . . 0.60999999999999999 111.08 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.541 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.5 m-20 -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 1.22 110.797 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.72 -44.91 96.0 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.806 0.336 . . . . 0.17999999999999999 110.368 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.501 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.4 tt0 -53.32 -49.88 66.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.526 -0.761 . . . . 1.04 110.43 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -58.86 -37.85 77.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.318 -0.401 . . . . 0.78000000000000003 111.466 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.39 -46.09 70.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.14000000000000001 110.889 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 66.1 m-85 -67.55 -43.8 79.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 0.13 110.938 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -59.78 -35.12 73.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.68999999999999995 110.675 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.14 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.51000000000000001 110.767 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.12 -10.54 59.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.65000000000000002 110.979 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.4 49.34 2.21 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.837 -0.697 . . . . 0.28999999999999998 112.279 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.09 163.69 29.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.357 -0.238 . . . . 0.23000000000000001 110.357 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -110.0 123.69 50.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.605 -0.517 . . . . 2.1400000000000001 109.605 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.2 t -106.65 138.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.526 0.565 . . . . 0.19 112.526 -168.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.61 133.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.377 -0.971 . . . . 0.23000000000000001 108.377 170.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.18 130.79 58.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.77 0.319 . . . . 0.94999999999999996 111.025 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.76 144.36 35.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.16 110.367 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.79 16.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.572 -0.285 . . . . 0.23999999999999999 111.432 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -134.18 176.6 8.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.086 -0.246 . . . . 0.25 110.677 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 1.5 p -68.37 -48.08 65.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.755 -0.461 . . . . 1.6000000000000001 109.755 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.25 -50.2 74.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.439 -0.801 . . . . 0.69999999999999996 111.779 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -58.69 -37.81 76.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.893 0.378 . . . . 1.4099999999999999 111.582 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -70.93 -49.46 45.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.259 -0.428 . . . . 0.17999999999999999 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 73.7 mt -61.63 -26.27 67.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.619 -0.718 . . . . 0.82999999999999996 110.502 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -62.74 -56.7 15.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 2.4100000000000001 110.309 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 28.8 t -70.32 -17.8 63.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.462 -0.336 . . . . 1.1299999999999999 111.094 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -68.32 -41.48 80.79 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.259 -0.645 . . . . 1.23 109.259 175.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.22 12.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.48 . . . . 0.42999999999999999 111.209 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.86 -37.19 73.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.037 -0.528 . . . . 0.62 111.619 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' SER . 91.1 m-20 -114.57 150.04 43.24 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.41999999999999998 110.863 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 73.0 Cg_endo -86.21 81.14 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.322 2.682 . . . . 0.23999999999999999 111.767 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 9' ' ' LEU . 44.1 mm -62.72 123.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.38 -0.827 . . . . 0.22 111.51 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.4 m-20 -90.66 -37.79 13.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.633 -0.712 . . . . 0.28999999999999998 110.063 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 11.3 p -157.35 155.66 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.761 -0.654 . . . . 0.12 109.619 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.78 162.62 35.0 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.431 0.634 . . . . 0.14000000000000001 112.063 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.469 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -134.72 111.69 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.092 -0.958 . . . . 0.95999999999999996 109.053 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.778 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.6 mp -112.96 114.99 27.71 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.238 0.458 . . . . 0.16 112.238 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 27.5 t70 -77.46 123.38 26.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.576 -0.898 . . . . 1.77 108.576 168.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.53 ' CG1' HD23 ' A' ' 92' ' ' LEU . 20.2 t -88.3 -10.8 10.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.363 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.7 56.28 0.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.824 -0.625 . . . . 2.3700000000000001 109.967 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.15 -26.82 67.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.744 -0.662 . . . . 0.84999999999999998 109.917 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.29 -168.43 31.27 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.57 -1.012 . . . . 0.81999999999999995 110.57 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.62 -43.1 62.15 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.662 2.241 . . . . 1.1799999999999999 111.737 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -115.26 -33.28 5.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 3.5299999999999998 110.755 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -58.05 123.52 16.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.265 0.555 . . . . 0.95999999999999996 111.253 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -144.59 149.97 36.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.513 -0.767 . . . . 0.48999999999999999 110.268 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -73.38 86.03 1.49 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.208 -0.664 . . . . 1.3 109.208 171.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.82 -71.57 0.81 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.396 -0.907 . . . . 0.23000000000000001 112.264 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -54.1 -25.77 38.71 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.54 2.16 . . . . 0.23999999999999999 111.926 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.6 t -69.17 -48.25 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.12 110.165 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.47 86.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.242 -0.89 . . . . 0.16 109.906 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 35.2 t70 -61.87 -42.94 99.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.207 -0.906 . . . . 2.0299999999999998 110.44 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB1' ' HG ' ' A' ' 45' ' ' LEU . . . -56.33 -46.63 79.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.448 0.642 . . . . 0.23000000000000001 110.903 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.48 -46.38 83.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.20000000000000001 110.188 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 73' ' ' LYS . 11.1 mmmm -58.85 -33.85 70.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.612 -0.722 . . . . 2.0099999999999998 111.486 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 99.0 mt-30 -57.84 -47.85 81.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 2.3700000000000001 110.979 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -92.15 6.41 46.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.196 -0.456 . . . . 1.49 110.939 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.15 31.84 21.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.33000000000000002 111.343 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -75.63 135.24 71.86 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.685 -0.487 . . . . 0.17000000000000001 109.685 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 118' ' ' CYS . 30.2 Cg_endo -75.56 138.65 21.97 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.132 1.888 . . . . 0.20999999999999999 111.687 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -157.19 159.32 37.6 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 110.285 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mt -122.91 139.25 50.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.67 -0.695 . . . . 0.23999999999999999 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 96' ' ' ILE . 2.4 mm? -88.84 108.37 19.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.611 -0.514 . . . . 0.20999999999999999 109.611 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.648 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.4 t-160 -103.0 71.8 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.775 -0.824 . . . . 0.59999999999999998 108.775 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.547 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 4.9 t -100.87 153.99 19.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.693 -1.14 . . . . 0.60999999999999999 111.99 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -91.95 -6.58 65.12 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.93999999999999995 112.348 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 2.3300000000000001 110.762 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.17 -4.35 11.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.894 -0.594 . . . . 1.6100000000000001 109.852 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.39 -59.82 2.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 2.6299999999999999 111.19 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -70.96 -41.55 70.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.389 0.614 . . . . 4.4199999999999999 110.781 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.539 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.2 m-70 -87.58 14.57 8.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.46 -0.791 . . . . 1.05 110.732 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -57.56 -49.92 69.53 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.441 -0.409 . . . . 0.97999999999999998 113.332 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.29 -40.04 96.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 2.5 110.332 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.53 HD23 ' CG1' ' A' ' 57' ' ' VAL . 33.1 tp -59.67 -42.61 93.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.70999999999999996 110.303 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.4 mt -60.39 -35.45 75.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.5800000000000001 111.336 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 19.1 mmm180 -71.44 -27.42 63.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.095 0.474 . . . . 4.3799999999999999 110.904 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.22 -33.44 63.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.831 -0.622 . . . . 2.4500000000000002 109.955 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 92' ' ' LEU . 81.3 mt -71.42 -56.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.324 -0.853 . . . . 0.45000000000000001 110.999 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 59.97 78.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.536 0.684 . . . . 1.0900000000000001 110.879 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -161.11 163.14 21.06 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 0.28999999999999998 109.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.23 141.44 96.68 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.589 2.193 . . . . 0.26000000000000001 112.437 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -119.7 133.66 65.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.14 0.495 . . . . 0.64000000000000001 111.274 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.8 mmm -118.94 91.28 3.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.712 -0.847 . . . . 0.82999999999999996 108.712 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.31 154.1 36.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.895 -0.593 . . . . 0.54000000000000004 111.735 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 96.4 mttt -90.75 143.84 29.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.67000000000000004 109.747 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 140.4 66.03 Favored 'Cis proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.561 -1.433 . . . . 0.75 112.607 2.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.648 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -137.16 129.46 29.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.807 -0.633 . . . . 0.34999999999999998 110.273 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 110' ' ' VAL . 10.3 t70 -72.28 129.69 39.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.966 -0.753 . . . . 0.51000000000000001 108.966 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.541 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.3 p -63.46 -22.67 67.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.271 -0.877 . . . . 0.26000000000000001 112.542 -171.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.6 p -68.77 -42.9 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 1.3200000000000001 109.927 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.563 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 45.4 m-20 -68.18 -41.26 81.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.62 109.548 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 106' ' ' ASP . 24.7 t -61.86 -44.59 99.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.556 -0.747 . . . . 0.13 110.519 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.15 -50.59 65.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.13 111.637 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 108' ' ' SER . 30.6 mtpp -64.25 -40.67 96.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 1.95 111.61 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.563 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 10.2 mpt_? -63.55 -32.1 73.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.886 0.374 . . . . 2.23 111.77 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.55 -51.33 10.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 0.14000000000000001 111.053 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.521 HD23 HG11 ' A' ' 52' ' ' VAL . 64.4 mt -63.5 -26.01 68.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.107 0.78 . . . . 0.27000000000000002 113.107 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -25.78 62.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.62 -0.432 . . . . 2.79 110.914 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.6 mtm -71.61 -25.68 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.42999999999999999 111.161 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.423 ' HB2' ' CG ' ' A' ' 78' ' ' PRO . 45.2 t . . . . . 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 1.46 110.974 177.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.451 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 80.2 mtp . . . . . 0 N--CA 1.45 -0.451 0 N-CA-C 109.183 -0.673 . . . . 1.6499999999999999 109.183 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 33.6 Cg_exo -59.53 134.79 60.38 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.479 2.119 . . . . 0.33000000000000002 111.823 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 14.4 tptp -83.64 103.81 13.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.326 -0.62 . . . . 0.89000000000000001 109.326 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.3 t -99.5 130.47 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.815 -0.63 . . . . 0.20000000000000001 110.779 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.434 ' HB2' HD12 ' A' ' 50' ' ' ILE . 49.9 tp -106.04 112.46 25.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.852 -0.613 . . . . 0.75 110.295 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -92.97 122.8 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.077 0.465 . . . . 0.13 111.613 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.44 101.04 10.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.284 -0.871 . . . . 0.20999999999999999 109.284 173.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.24 127.18 5.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.448 -0.796 . . . . 1.4099999999999999 109.8 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -89.41 -16.56 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.78 -0.645 . . . . 1.27 110.125 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -88.36 108.39 21.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 2.5600000000000001 110.301 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.93 -34.94 99.33 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.748 2.299 . . . . 0.32000000000000001 112.982 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 59.8 tp -62.94 -49.7 73.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 1.51 110.513 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.95 -45.32 97.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 1.01 110.624 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 34' ' ' VAL . . . -57.54 -52.21 66.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.20999999999999999 110.784 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.449 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 36.7 ttp -62.55 -37.29 85.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.60999999999999999 111.008 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 107' ' ' THR . 8.0 t-20 -65.69 -47.8 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.22 110.501 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.426 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 53.1 mt -60.26 -45.56 92.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.936 -0.575 . . . . 0.17999999999999999 109.888 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.558 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 57.7 tt0 -51.8 -50.42 60.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.131 -0.941 . . . . 1.04 111.063 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.449 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 17.5 m-85 -67.17 -32.38 73.43 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.139 -0.224 . . . . 0.78000000000000003 111.249 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.85 85.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.84 0.353 . . . . 0.14000000000000001 110.827 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -68.08 -45.76 72.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.46 . . . . 0.13 110.644 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 45.8 mt-10 -61.9 -30.19 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.474 -0.33 . . . . 0.68999999999999995 110.765 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.01 -41.56 95.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.149 -0.478 . . . . 0.51000000000000001 110.549 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -74.71 -15.62 60.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 0.65000000000000002 110.84 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.76 44.92 1.46 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.833 -0.699 . . . . 0.28999999999999998 112.559 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -134.21 153.62 51.74 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.771 -0.253 . . . . 0.23000000000000001 110.437 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.28 142.49 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.558 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 44.4 t -123.72 143.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.48 0.548 . . . . 0.19 112.48 -170.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.501 HG11 ' OG ' ' A' ' 44' ' ' SER . 14.9 t -118.44 132.28 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.758 . . . . 0.23000000000000001 108.955 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.431 HG23 ' HB1' ' A' ' 18' ' ' ALA . 12.7 p -96.56 130.39 45.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.028 0.442 . . . . 0.94999999999999996 111.601 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.23 134.63 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.16 110.701 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.433 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.79 -13.14 17.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.23999999999999999 111.003 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.0 p -124.79 162.05 25.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.114 -0.494 . . . . 0.25 110.648 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 67.1 m -66.32 -33.67 76.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.56 -0.533 . . . . 1.6000000000000001 109.56 175.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.27 -48.4 78.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.513 -0.767 . . . . 0.69999999999999996 111.045 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.433 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 38.9 mt-30 -58.28 -42.09 85.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.243 0.544 . . . . 1.4099999999999999 110.574 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.3 -53.01 62.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.142 -0.935 . . . . 0.17999999999999999 111.522 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 86.9 mt -61.54 -28.68 69.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.071 0.462 . . . . 0.82999999999999996 110.96 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.55 -53.47 22.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 2.4100000000000001 109.748 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.501 ' OG ' HG11 ' A' ' 33' ' ' VAL . 22.7 t -65.95 -34.77 78.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 110.372 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.51 -35.56 78.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 1.23 110.776 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.52 -33.84 28.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.378 -0.374 . . . . 0.42999999999999999 111.118 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.43 -38.12 35.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.62 111.611 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -114.94 163.55 19.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.46 . . . . 0.41999999999999998 110.753 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.65 83.03 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.434 2.756 . . . . 0.23999999999999999 111.309 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 37.1 mm -65.74 122.21 16.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.562 -0.745 . . . . 0.22 111.754 -174.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.766 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 32.5 m-20 -91.09 -32.47 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.115 -0.948 . . . . 0.28999999999999998 110.771 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.571 HG11 HD23 ' A' ' 115' ' ' LEU . 14.4 p -160.2 158.3 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.12 109.836 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.19 161.09 39.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.156 0.503 . . . . 0.14000000000000001 111.907 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.56 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -132.09 112.41 19.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.7 . . . . 0.95999999999999996 109.682 174.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.792 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -112.47 121.8 45.86 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.23 -0.441 . . . . 0.16 112.083 -170.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.671 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.8 t0 -81.66 114.98 20.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.86 -0.792 . . . . 1.77 108.86 168.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.528 ' H ' ' HB ' ' A' ' 83' ' ' THR . 17.2 t -76.53 -7.91 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.038 -0.983 . . . . 0.80000000000000004 110.43 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.13 65.93 1.21 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 2.3700000000000001 109.778 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.08 -29.5 70.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.581 -0.736 . . . . 0.84999999999999998 109.621 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 -162.54 12.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.151 -0.931 . . . . 0.81999999999999995 111.09 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.0 -38.76 93.19 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.89 2.393 . . . . 1.1799999999999999 112.676 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.439 ' NZ ' ' HB2' ' A' ' 62' ' ' LYS . 4.5 ttmp? -126.35 -34.43 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.468 -0.333 . . . . 3.5299999999999998 110.792 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 p -60.48 127.61 32.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.476 0.655 . . . . 0.95999999999999996 111.054 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -144.29 156.02 44.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.412 -0.813 . . . . 0.48999999999999999 110.8 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.8 p -70.49 86.79 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.894 -0.78 . . . . 1.3 108.894 168.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.16 -74.82 1.04 Allowed Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 120.191 -1.004 . . . . 0.23000000000000001 112.374 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.68 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.9 Cg_exo -53.37 -26.19 34.22 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.488 2.125 . . . . 0.23999999999999999 111.981 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 10.7 t -69.33 -44.79 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.12 110.381 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -52.69 64.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.828 . . . . 0.16 109.956 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 33.3 t70 -60.99 -38.18 85.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.107 -0.951 . . . . 2.0299999999999998 110.495 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.1 78.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.355 0.597 . . . . 0.23000000000000001 111.03 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.38 -39.7 85.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.402 -0.817 . . . . 0.20000000000000001 110.095 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -59.55 -39.03 82.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.622 -0.717 . . . . 2.0099999999999998 111.171 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 55.0 mt-30 -65.56 -43.18 90.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 2.3700000000000001 111.216 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -87.85 2.18 52.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.828 0.347 . . . . 1.49 110.813 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.01 31.22 19.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.538 -0.756 . . . . 0.33000000000000002 111.454 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.99 131.9 49.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.17000000000000001 109.775 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 25.6 Cg_endo -73.7 138.47 26.51 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.166 1.911 . . . . 0.20999999999999999 111.62 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.02 157.39 34.59 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.609 -0.723 . . . . 0.17999999999999999 110.387 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.7 mt -122.31 141.06 44.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.609 -0.723 . . . . 0.23999999999999999 109.888 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 96' ' ' ILE . 2.2 mm? -89.33 108.23 19.51 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.78 -0.452 . . . . 0.20999999999999999 109.78 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.634 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.6 t-160 -103.02 72.28 1.17 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.512 -0.921 . . . . 0.59999999999999998 108.512 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.671 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 10.2 t -99.77 155.01 17.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.276 -1.329 . . . . 0.60999999999999999 111.784 -170.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 0.9 59.39 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.734 -0.666 . . . . 0.93999999999999995 112.898 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -154.78 121.08 5.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 2.3300000000000001 110.258 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.3 mp -106.47 -22.89 12.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.183 -0.462 . . . . 1.6100000000000001 111.606 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -83.87 -30.65 26.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.9 -0.32 . . . . 2.6299999999999999 111.213 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -79.85 -10.08 59.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.348 0.594 . . . . 4.4199999999999999 110.348 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.538 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 99.5 m-70 -131.35 24.11 4.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 1.05 111.225 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -63.73 -42.01 98.75 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.851 -0.69 . . . . 0.97999999999999998 112.879 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 33.1 mt-10 -71.66 -25.37 62.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 2.5 110.369 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 57' ' ' VAL . 55.5 tp -74.53 -43.59 55.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.207 -0.451 . . . . 0.70999999999999996 110.224 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.1 mt -58.38 -37.7 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 1.5800000000000001 111.834 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 36.5 ptt180 -65.24 -26.57 68.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 4.3799999999999999 110.912 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -76.12 -35.27 59.36 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.157 0.503 . . . . 2.4500000000000002 110.136 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 81' ' ' LEU . 55.8 mt -69.9 -52.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.228 -0.897 . . . . 0.45000000000000001 110.445 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 55.51 70.37 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.465 0.65 . . . . 1.0900000000000001 110.579 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -155.96 162.38 27.54 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.368 -0.833 . . . . 0.28999999999999998 109.349 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.24 141.22 94.53 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.666 2.244 . . . . 0.26000000000000001 112.62 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.7 t -118.62 134.68 61.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.64000000000000001 111.289 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 78.6 mmm -119.44 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.656 -0.868 . . . . 0.82999999999999996 108.656 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.69 152.53 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.018 -0.537 . . . . 0.54000000000000004 111.691 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 95.8 mttt -90.29 144.81 31.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.723 -0.671 . . . . 0.67000000000000004 109.844 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.6 Cg_exo -71.12 142.15 71.92 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.561 -1.433 . . . . 0.75 112.433 0.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.634 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -139.83 130.18 25.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.83 -0.623 . . . . 0.34999999999999998 110.266 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.8 t70 -66.11 124.31 22.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.51000000000000001 109.404 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.4 p -62.56 -27.63 69.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.432 -0.803 . . . . 0.26000000000000001 112.238 -172.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 t -70.02 -40.1 75.41 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.615 -0.513 . . . . 1.3200000000000001 109.615 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -65.27 -43.98 89.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.086 0.469 . . . . 0.62 109.803 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 106' ' ' ASP . 23.4 t -60.75 -43.7 95.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.307 -0.86 . . . . 0.13 110.428 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.46 -50.53 67.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.13 111.171 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.618 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 54.9 mtpt -56.33 -55.53 32.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 1.95 111.341 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 35.5 mmt180 -60.03 -35.46 75.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 2.23 111.374 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.31 47.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.509 . . . . 0.14000000000000001 110.541 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.571 HD23 HG11 ' A' ' 52' ' ' VAL . 80.7 mt -63.52 -25.5 68.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.631 . . . . 0.27000000000000002 111.848 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 35.0 mm-40 -60.42 -26.53 66.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.694 0.283 . . . . 2.79 111.236 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 67.9 mtm -85.81 -1.67 57.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.49 -0.323 . . . . 0.42999999999999999 111.369 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 49.2 t . . . . . 0 C--N 1.323 -0.544 0 CA-C-O 121.167 0.508 . . . . 1.46 110.044 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 90.8 mtp . . . . . 0 N--CA 1.45 -0.426 0 N-CA-C 110.032 -0.359 . . . . 1.6499999999999999 110.032 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.24 137.73 44.66 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.165 2.577 . . . . 0.33000000000000002 111.928 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.97 107.3 17.04 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.342 -0.614 . . . . 0.89000000000000001 109.342 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' CG1' ' A' ' 52' ' ' VAL . 47.1 t -100.09 138.86 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 0.20000000000000001 110.809 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 48.3 tp -111.23 115.66 29.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.398 -0.365 . . . . 0.75 110.276 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.17 123.47 51.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.231 0.539 . . . . 0.13 111.024 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.78 106.01 16.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.214 -0.903 . . . . 0.20999999999999999 109.326 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -168.34 123.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.044 -0.526 . . . . 1.4099999999999999 109.761 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.5 t70 -87.1 -19.99 27.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.661 . . . . 1.27 110.1 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB3' HD13 ' A' ' 17' ' ' ILE . 44.5 mm-40 -81.22 104.86 3.25 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 115.878 -0.601 . . . . 2.5600000000000001 109.963 175.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.0 Cg_exo -58.07 -29.5 87.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.919 2.413 . . . . 0.32000000000000001 113.427 -172.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt -69.61 -50.74 41.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.879 -0.415 . . . . 1.51 109.879 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -63.3 -44.08 98.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.01 109.736 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.64 -49.17 78.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.359 -0.837 . . . . 0.20999999999999999 110.557 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.0 ttp -59.33 -42.27 91.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.60999999999999999 111.068 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.512 ' HB3' HG21 ' A' ' 107' ' ' THR . 0.7 OUTLIER -64.38 -47.55 78.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 1.22 111.083 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.9 mt -60.11 -46.1 90.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.39 -0.368 . . . . 0.17999999999999999 110.449 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 49.3 tt0 -54.47 -51.03 66.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.818 -0.628 . . . . 1.04 110.917 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.857 -0.337 . . . . 0.78000000000000003 110.887 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.68 -46.32 72.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.941 0.401 . . . . 0.14000000000000001 110.277 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 m-85 -66.9 -44.03 81.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.13 110.803 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.02 -28.04 67.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.537 -0.301 . . . . 0.68999999999999995 111.015 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.32 -27.81 65.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.314 0.578 . . . . 0.51000000000000001 109.983 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -84.71 2.45 41.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.67 . . . . 0.65000000000000002 111.05 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 5' ' ' MET . . . 81.92 47.15 6.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.922 -0.656 . . . . 0.28999999999999998 112.632 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.98 8.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.633 0.254 . . . . 0.23000000000000001 110.363 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.82 134.29 55.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.514 -0.55 . . . . 2.1400000000000001 109.514 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -116.07 135.79 55.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.319 0.489 . . . . 0.19 112.319 -168.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.46 122.74 63.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.23000000000000001 107.925 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.57 124.73 55.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.721 -0.392 . . . . 0.94999999999999996 110.697 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.11 139.31 50.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.934 -0.576 . . . . 0.16 110.702 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.83 -11.35 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.23999999999999999 111.252 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -130.68 170.53 14.19 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.954 -0.298 . . . . 0.25 111.492 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.559 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.2 p -60.84 -49.47 77.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.6000000000000001 109.646 171.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -52.24 -50.01 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.667 -1.151 . . . . 0.69999999999999996 111.764 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -59.81 -37.02 77.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 1.4099999999999999 111.187 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -71.38 -49.46 41.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.67 -0.695 . . . . 0.17999999999999999 111.225 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 72.8 mt -63.5 -28.98 70.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.731 -0.668 . . . . 0.82999999999999996 110.158 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 7.5 tmtm? -63.93 -50.69 67.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.385 -0.598 . . . . 2.4100000000000001 109.385 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 t -64.65 -32.02 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.219 -0.446 . . . . 1.1299999999999999 110.878 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 -41.81 89.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.123 0.487 . . . . 1.23 110.376 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.19 -38.26 20.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.42999999999999999 111.54 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.33 -36.47 58.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.065 -0.516 . . . . 0.62 111.408 -174.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -122.16 162.11 39.23 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.345 -0.389 . . . . 0.41999999999999998 110.428 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -92.82 88.24 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.303 2.669 . . . . 0.23999999999999999 111.149 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 47.1 mm -67.4 119.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.715 -0.675 . . . . 0.22 111.52 -174.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -91.06 -30.75 16.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.924 -0.58 . . . . 0.28999999999999998 110.197 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 115' ' ' LEU . 12.0 p -160.88 157.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.731 . . . . 0.12 109.409 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.84 166.02 25.92 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.456 0.646 . . . . 0.14000000000000001 111.239 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -137.9 120.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.747 -1.205 . . . . 0.95999999999999996 107.747 174.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.9 mp -116.36 109.17 16.99 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.729 -0.388 . . . . 0.16 111.301 -170.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.79 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -80.67 97.78 7.41 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.8 -0.815 . . . . 1.77 108.8 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 64' ' ' HIS . 46.8 t -50.71 -31.18 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.212 -0.904 . . . . 0.80000000000000004 112.44 -170.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -95.75 80.08 3.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.934 0.397 . . . . 2.3700000000000001 110.392 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.83 -14.45 59.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.563 0.697 . . . . 0.84999999999999998 110.09 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.88 -166.27 35.82 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.754 -0.938 . . . . 0.81999999999999995 110.754 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.71 -45.36 41.64 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.916 2.411 . . . . 1.1799999999999999 112.311 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -120.85 -22.14 6.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.371 -0.377 . . . . 3.5299999999999998 110.812 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.7 m -63.4 129.12 38.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.112 0.482 . . . . 0.95999999999999996 111.147 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 15.5 p80 -144.0 153.27 42.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.48999999999999999 110.282 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.5 m -79.1 86.44 4.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.827 -0.805 . . . . 1.3 108.827 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.55 -66.47 0.7 Allowed Glycine 0 C--N 1.328 0.132 0 C-N-CA 120.62 -0.8 . . . . 0.23000000000000001 112.392 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.67 -23.76 50.87 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.396 2.064 . . . . 0.23999999999999999 111.621 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.508 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.5 t -68.17 -47.74 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.96 -0.564 . . . . 0.12 109.774 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.06 -47.73 80.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.99 -1.005 . . . . 0.16 110.087 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 19.3 t70 -64.09 -36.41 83.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 2.0299999999999998 110.571 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -62.93 -40.48 97.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.409 0.623 . . . . 0.23000000000000001 110.888 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.69 -43.87 62.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.20000000000000001 110.529 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 28.2 mmmt -57.33 -39.58 76.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.565 -0.743 . . . . 2.0099999999999998 111.166 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.667 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 6.8 pt20 -64.88 -37.76 88.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.533 -0.758 . . . . 2.3700000000000001 110.957 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG3' ' CG ' ' A' ' 74' ' ' GLN . 96.3 mtt180 -99.47 7.57 45.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 1.49 111.899 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.94 23.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.133 -0.485 . . . . 0.33000000000000002 111.734 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.429 HG21 HG22 ' A' ' 50' ' ' ILE . 81.8 mt -83.54 132.7 48.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.17000000000000001 109.744 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -72.62 140.67 33.07 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.354 2.036 . . . . 0.20999999999999999 112.302 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 12.2 p90 -161.25 156.9 24.78 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.17999999999999999 110.417 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 mt -119.6 138.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.591 -0.731 . . . . 0.23999999999999999 109.869 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 96' ' ' ILE . 2.5 mm? -89.19 109.71 20.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.17 -0.678 . . . . 0.20999999999999999 109.17 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.79 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 19.3 t-160 -102.05 117.54 35.01 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.638 -0.875 . . . . 0.59999999999999998 108.638 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.736 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 8.9 t -171.33 154.21 3.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.733 0.301 . . . . 0.60999999999999999 110.586 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.2 33.13 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.465 -0.654 . . . . 0.93999999999999995 111.465 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -111.21 60.44 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.353 0.597 . . . . 2.3300000000000001 109.928 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.69 -48.78 58.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.408 -0.815 . . . . 1.6100000000000001 110.871 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -63.55 -33.62 76.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 2.6299999999999999 110.783 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 4.9 mmp_? -71.82 -15.4 62.14 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 4.4199999999999999 111.9 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 87.3 m-70 -134.25 31.59 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.745 0.276 . . . . 1.05 111.745 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.01 -28.48 71.69 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.835 -0.698 . . . . 0.97999999999999998 112.469 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.579 ' HA ' ' HE ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -76.45 -26.1 55.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 2.5 110.34 178.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 tp -76.95 -47.51 20.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.85 -0.614 . . . . 0.70999999999999996 109.864 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 79.2 mt -57.3 -39.59 76.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.861 -0.608 . . . . 1.5800000000000001 112.082 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 91' ' ' GLU . 11.1 ptp180 -66.17 -25.28 66.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.668 0.27 . . . . 4.3799999999999999 111.343 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -73.38 -30.16 63.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.398 0.618 . . . . 2.4500000000000002 110.14 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.504 HG21 HD21 ' A' ' 81' ' ' LEU . 55.4 mt -82.72 -53.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.18 -0.918 . . . . 0.45000000000000001 110.877 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.02 74.22 0.34 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.718 0.77 . . . . 1.0900000000000001 110.831 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.31 168.56 11.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 114.789 -1.096 . . . . 0.28999999999999998 108.503 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.83 135.85 71.67 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.097 1.865 . . . . 0.26000000000000001 112.338 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 t -123.75 117.47 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.64000000000000001 110.726 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.613 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.4 mtp -103.05 116.75 33.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.82999999999999996 109.941 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.736 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.97 148.87 37.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.814 -0.63 . . . . 0.54000000000000004 111.594 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 76.8 mttt -90.68 143.18 28.61 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 0.67000000000000004 109.779 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -74.04 144.55 81.33 Favored 'Cis proline' 0 C--O 1.234 0.299 0 C-N-CA 123.282 -1.549 . . . . 0.75 112.925 1.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.663 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -138.66 131.88 30.01 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.347 -0.842 . . . . 0.34999999999999998 108.936 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 110' ' ' VAL . 11.3 t70 -73.08 129.42 38.04 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.964 -0.754 . . . . 0.51000000000000001 108.964 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.3 p -62.18 -21.05 64.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.375 -0.829 . . . . 0.26000000000000001 112.758 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.7 p -69.02 -43.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.874 -0.417 . . . . 1.3200000000000001 109.874 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.82 -39.9 87.84 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.134 -0.484 . . . . 0.62 110.166 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.613 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.8 t -61.87 -47.76 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.754 -0.657 . . . . 0.13 110.333 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.16 -48.37 78.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 0.13 111.21 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.28 -41.18 98.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 1.95 111.271 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -68.1 -27.38 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.745 0.307 . . . . 2.23 111.66 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -49.89 12.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.921 0.391 . . . . 0.14000000000000001 110.233 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.539 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 71.1 mt -65.08 -27.09 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.85 0.685 . . . . 0.27000000000000002 112.85 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.56 -26.92 66.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.732 -0.387 . . . . 2.79 110.946 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 69.8 mtm -73.84 -33.04 63.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.416 -0.356 . . . . 0.42999999999999999 111.06 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.539 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.5 p . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 121.32 0.581 . . . . 1.46 110.522 177.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 54.6 mtt . . . . . 0 N--CA 1.453 -0.324 0 CA-C-O 120.8 0.333 . . . . 1.6499999999999999 110.963 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HG2' HD22 ' A' ' 115' ' ' LEU . 1.5 Cg_endo -70.84 142.91 44.27 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.846 2.364 . . . . 0.33000000000000002 112.428 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -90.05 105.63 17.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.89000000000000001 109.004 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.3 t -99.73 136.27 31.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.987 -0.551 . . . . 0.20000000000000001 111.27 -173.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HB2' HD12 ' A' ' 50' ' ' ILE . 42.5 tp -109.31 112.0 23.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.134 -0.485 . . . . 0.75 110.273 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.62 122.86 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.298 0.57 . . . . 0.13 111.641 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -103.76 111.94 24.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.7 -1.136 . . . . 0.20999999999999999 108.704 172.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -170.16 127.23 0.84 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.38 -0.6 . . . . 1.4099999999999999 109.38 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.6 t70 -85.24 -25.58 27.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.27 110.324 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -75.55 106.57 3.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 2.5600000000000001 110.555 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 33.1 Cg_exo -59.64 -31.7 94.74 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.771 2.314 . . . . 0.32000000000000001 112.982 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.47 -49.59 68.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.329 -0.619 . . . . 1.51 109.329 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.2 mt -66.24 -47.08 85.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.374 -0.83 . . . . 1.01 111.27 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.56 82.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 0.20999999999999999 110.654 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -58.96 -44.74 91.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.727 -0.67 . . . . 0.60999999999999999 110.924 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.509 ' HB3' HG21 ' A' ' 107' ' ' THR . 2.1 m-80 -68.2 -37.35 80.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.751 -0.659 . . . . 1.22 111.394 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.65 -45.04 88.48 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.506 -0.315 . . . . 0.17999999999999999 110.379 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 62.4 tt0 -55.25 -53.05 61.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 1.04 110.311 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -64.16 -27.72 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.78000000000000003 111.563 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.66 -46.36 63.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.766 0.317 . . . . 0.14000000000000001 110.73 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.701 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 54.0 m-85 -67.26 -42.3 84.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.367 -0.379 . . . . 0.13 110.526 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.58 -31.79 71.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.68999999999999995 110.039 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -35.52 76.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.756 -0.656 . . . . 0.51000000000000001 110.694 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -75.76 -20.55 58.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.142 0.496 . . . . 0.65000000000000002 110.305 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 56.27 0.7 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.705 -0.679 . . . . 0.28999999999999998 111.748 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.16 171.37 15.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.728 0.299 . . . . 0.23000000000000001 110.803 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.99 150.25 25.09 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 47.1 t -134.27 138.49 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.389 0.514 . . . . 0.19 112.389 -172.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG11 ' OG ' ' A' ' 44' ' ' SER . 12.0 t -115.58 126.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.058 -0.719 . . . . 0.23000000000000001 109.058 168.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.46 130.64 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.076 0.465 . . . . 0.94999999999999996 111.278 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -141.25 134.48 29.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.16 110.662 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.458 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.11 -10.73 20.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.451 . . . . 0.23999999999999999 111.078 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.636 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 38.3 p -127.34 168.4 14.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.395 . . . . 0.25 110.757 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.551 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.6 m -70.95 -35.33 72.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.292 -0.413 . . . . 1.6000000000000001 110.047 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.69999999999999996 111.219 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.636 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 17.2 mt-30 -61.87 -37.99 86.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.255 0.55 . . . . 1.4099999999999999 110.57 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.65 -51.44 65.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.328 -0.851 . . . . 0.17999999999999999 111.388 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.7 mt -62.53 -30.2 71.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.82999999999999996 111.021 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -49.16 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 2.4100000000000001 109.776 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.405 ' OG ' HG11 ' A' ' 33' ' ' VAL . 43.7 t -64.57 -38.12 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.037 -0.529 . . . . 1.1299999999999999 110.7 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.25 -32.27 72.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.284 0.564 . . . . 1.23 110.688 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.33 -41.43 16.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 0.42999999999999999 111.348 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.93 -34.49 59.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.0 -0.545 . . . . 0.62 111.629 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -118.32 161.49 34.88 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.41999999999999998 110.503 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.61 84.28 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.388 2.726 . . . . 0.23999999999999999 111.495 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.7 mm -64.62 123.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.651 -0.704 . . . . 0.22 111.736 -174.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 37.7 m-20 -92.58 -30.63 15.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.483 -0.781 . . . . 0.28999999999999998 110.277 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.5 p -159.81 155.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.111 -0.495 . . . . 0.12 109.807 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 164.06 29.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.359 0.6 . . . . 0.14000000000000001 111.49 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -135.33 112.39 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.512 -0.767 . . . . 0.95999999999999996 108.944 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.655 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -109.05 108.36 19.03 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.667 -0.413 . . . . 0.16 111.723 -170.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.0 t70 -78.82 126.21 30.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.598 -0.89 . . . . 1.77 108.598 172.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.509 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 21.3 t -73.96 -16.44 16.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.596 -0.729 . . . . 0.80000000000000004 110.862 -173.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -99.03 85.23 3.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.278 0.561 . . . . 2.3700000000000001 110.566 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.7 mt -99.88 -4.52 30.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.513 0.673 . . . . 0.84999999999999998 109.503 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.07 -174.47 40.99 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.895 -1.048 . . . . 0.81999999999999995 110.731 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.09 -45.41 31.97 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.696 2.264 . . . . 1.1799999999999999 111.98 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -107.29 -32.8 7.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.859 -0.61 . . . . 3.5299999999999998 110.129 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.7 m -65.56 126.91 29.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 0.95999999999999996 111.96 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -144.5 152.72 41.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.29 -0.868 . . . . 0.48999999999999999 109.413 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 28.5 p -67.44 87.67 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.296 0.569 . . . . 1.3 109.876 173.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.4 -69.78 0.43 Allowed Glycine 0 C--O 1.224 -0.496 0 C-N-CA 120.669 -0.777 . . . . 0.23000000000000001 112.119 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.9 Cg_exo -51.91 -30.56 39.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.594 2.196 . . . . 0.23999999999999999 112.134 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 11' ' ' LEU . 22.6 t -66.33 -39.15 83.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.451 0.643 . . . . 0.12 110.068 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.83 -47.18 75.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.091 -0.959 . . . . 0.16 110.093 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 2.7 m-20 -60.45 -42.77 96.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 2.0299999999999998 109.968 176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.53 63.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 111.249 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.55 -40.77 89.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.417 -0.81 . . . . 0.20000000000000001 110.579 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 62.8 mmtt -59.67 -35.21 74.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.0099999999999998 111.079 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 46.4 mt-30 -70.39 -37.32 74.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 2.3700000000000001 111.171 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -93.04 4.67 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.681 0.277 . . . . 1.49 111.231 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.59 33.73 22.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.33000000000000002 111.617 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.18 133.87 32.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.144 -0.48 . . . . 0.17000000000000001 110.063 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.98 143.95 29.74 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.525 2.15 . . . . 0.20999999999999999 112.32 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 41.7 p90 -158.53 160.24 36.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.552 -0.749 . . . . 0.17999999999999999 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 mt -125.07 139.53 50.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 109.639 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.94 113.62 24.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.302 0.572 . . . . 0.20999999999999999 109.465 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.814 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 17.2 t-160 -101.63 130.03 47.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.386 -0.968 . . . . 0.59999999999999998 108.386 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 11.1 t -178.72 162.14 1.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.9 -0.32 . . . . 0.60999999999999999 110.703 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.74 13.8 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.335 -1.106 . . . . 0.93999999999999995 110.335 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -114.29 49.56 1.0 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.136 -0.532 . . . . 2.3300000000000001 110.137 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.85 -30.6 65.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.6100000000000001 111.944 -173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.77 -34.48 24.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.292 0.568 . . . . 2.6299999999999999 109.867 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.512 ' HD3' ' OD2' ' A' ' 85' ' ' ASP . 44.6 ttt180 -67.32 -34.91 78.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.313 -0.858 . . . . 4.4199999999999999 111.128 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.441 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.0 m-70 -118.62 28.66 8.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 1.05 111.473 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.65 95.88 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.001 -0.618 . . . . 0.97999999999999998 112.756 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 29.5 mt-10 -61.37 -45.57 93.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 2.5 110.154 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.84 -44.94 95.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.70999999999999996 110.572 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 73.5 mt -59.6 -38.62 81.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 1.5800000000000001 111.372 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -71.26 -27.03 63.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.399 -0.364 . . . . 4.3799999999999999 111.18 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 66.9 mttm -74.21 -43.74 55.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.333 0.587 . . . . 2.4500000000000002 110.032 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.563 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 83.5 mt -62.45 -51.34 73.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.189 -0.914 . . . . 0.45000000000000001 110.581 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.7 t70 62.47 75.58 0.4 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.425 0.631 . . . . 1.0900000000000001 110.828 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.409 ' HB3' ' CD2' ' A' ' 81' ' ' LEU . . . -161.12 167.41 13.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.28999999999999998 109.339 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.24 142.69 97.51 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.399 2.066 . . . . 0.26000000000000001 112.667 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -124.24 124.36 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.64000000000000001 111.054 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.14 110.5 22.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.28 -0.637 . . . . 0.82999999999999996 109.28 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.21 146.66 41.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.015 -0.539 . . . . 0.54000000000000004 111.91 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 86.8 mttt -91.19 142.52 27.28 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.67000000000000004 109.709 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.5 Cg_exo -71.14 139.59 59.39 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.505 -1.456 . . . . 0.75 112.992 3.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.596 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -132.79 136.44 46.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.34999999999999998 109.619 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 110' ' ' VAL . 10.5 t70 -79.38 131.58 36.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.472 -0.936 . . . . 0.51000000000000001 108.472 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.3 p -64.84 -23.56 67.27 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.672 -0.695 . . . . 0.26000000000000001 112.24 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -72.68 -33.31 66.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.551 -0.537 . . . . 1.3200000000000001 109.551 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -70.49 -45.8 64.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.809 -0.632 . . . . 0.62 109.36 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 106' ' ' ASP . 30.6 t -60.12 -43.44 92.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.264 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.701 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -61.89 -50.06 73.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.702 -0.681 . . . . 0.13 111.369 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.5 mttp -59.79 -49.95 75.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 1.95 111.167 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -59.7 -38.36 81.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 2.23 111.475 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.67 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 0.14000000000000001 110.603 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.522 HD22 ' HG2' ' A' ' 6' ' ' PRO . 63.0 mt -65.26 -25.44 67.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.27000000000000002 112.167 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 20.5 mm-40 -59.16 -30.23 68.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 2.79 111.208 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.5 mtm -88.81 1.94 54.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.42999999999999999 110.992 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 51.1 t . . . . . 0 C--N 1.323 -0.554 0 CA-C-N 116.146 -0.479 . . . . 1.46 111.573 -177.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 91.2 mtp . . . . . 0 N--CA 1.449 -0.483 0 CA-C-O 120.98 0.419 . . . . 1.6499999999999999 110.811 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.66 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -63.94 142.22 80.83 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.413 2.742 . . . . 0.33000000000000002 112.224 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -87.93 103.04 15.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.904 -0.776 . . . . 0.89000000000000001 108.904 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.458 HG22 ' CG1' ' A' ' 52' ' ' VAL . 54.9 t -99.23 135.49 34.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.003 -0.544 . . . . 0.20000000000000001 110.859 -173.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.497 ' HB2' HD12 ' A' ' 50' ' ' ILE . 40.4 tp -110.96 111.21 22.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.184 -0.462 . . . . 0.75 110.573 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -92.6 125.65 45.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.13 111.324 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -107.33 104.17 13.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.023 -0.989 . . . . 0.20999999999999999 109.231 173.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -165.16 123.23 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.88 -0.6 . . . . 1.4099999999999999 110.075 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.5 t70 -83.42 -22.06 32.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.798 -0.637 . . . . 1.27 110.781 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.81 107.0 9.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.119 -0.326 . . . . 2.5600000000000001 110.119 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.2 Cg_exo -58.5 -28.86 86.95 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 113.484 -174.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 tp -64.64 -49.96 68.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.998 0.428 . . . . 1.51 110.115 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.18 -41.37 89.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.834 -0.621 . . . . 1.01 110.559 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.17 82.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.20999999999999999 110.854 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.3 ttp -62.08 -42.8 99.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.60999999999999999 110.862 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.406 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.8 m-20 -64.21 -40.9 97.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.848 -0.615 . . . . 1.22 111.432 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 38.8 mt -64.56 -45.02 88.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.612 0.244 . . . . 0.17999999999999999 110.525 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.561 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.2 tt0 -55.6 -50.28 70.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.974 -0.557 . . . . 1.04 110.466 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -65.04 -27.17 68.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.78000000000000003 111.508 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.18 -45.02 58.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.14000000000000001 110.643 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -70.45 -42.16 71.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.112 -0.495 . . . . 0.13 110.917 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.46 -35.92 78.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.916 0.389 . . . . 0.68999999999999995 110.032 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.92 -31.86 73.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.633 -0.712 . . . . 0.51000000000000001 110.732 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -86.19 5.66 33.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.65000000000000002 111.159 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.76 52.7 5.31 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.948 -0.644 . . . . 0.28999999999999998 112.46 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.4 ' CB ' ' HD2' ' A' ' 6' ' ' PRO . . . -138.4 163.54 31.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 110.658 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -101.91 144.26 30.76 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.985 -0.746 . . . . 2.1400000000000001 108.985 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.561 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -127.58 143.75 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.027 0.441 . . . . 0.19 111.843 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.472 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.7 t -117.7 128.61 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.805 -0.813 . . . . 0.23000000000000001 108.805 168.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -97.23 122.75 49.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.548 -0.461 . . . . 0.94999999999999996 110.986 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -134.14 135.41 43.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.626 -0.716 . . . . 0.16 109.819 176.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.42 -21.61 14.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.331 -0.395 . . . . 0.23999999999999999 110.922 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 17.1 p -115.39 170.99 7.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.991 0.424 . . . . 0.25 111.125 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.593 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 22.3 p -65.06 -47.62 76.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.477 0.656 . . . . 1.6000000000000001 109.367 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -55.91 -45.72 78.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.279 -1.328 . . . . 0.69999999999999996 111.997 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.476 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 55.6 mt-30 -59.54 -45.31 92.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.426 0.631 . . . . 1.4099999999999999 110.304 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.12 -50.84 71.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.062 -0.972 . . . . 0.17999999999999999 111.141 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 57.7 mt -63.14 -31.34 72.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.761 -0.654 . . . . 0.82999999999999996 110.83 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -68.59 -53.44 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 2.4100000000000001 109.841 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.472 ' OG ' HG11 ' A' ' 33' ' ' VAL . 33.3 t -65.45 -32.91 74.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.894 0.378 . . . . 1.1299999999999999 110.621 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.446 HD23 ' HB1' ' A' ' 71' ' ' ALA . 16.3 tp -65.4 -33.51 76.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.23 110.797 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.32 -35.95 30.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.896 -0.593 . . . . 0.42999999999999999 111.258 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.98 -38.07 32.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.62 111.524 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -112.62 164.69 14.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.984 -0.553 . . . . 0.41999999999999998 110.89 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -94.78 78.29 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.571 2.847 . . . . 0.23999999999999999 111.594 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -64.04 119.29 7.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.751 -0.659 . . . . 0.22 111.236 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.4 m-20 -87.75 -29.67 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.726 -0.67 . . . . 0.28999999999999998 110.457 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.466 HG11 HD23 ' A' ' 115' ' ' LEU . 14.3 p -160.53 156.49 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 0.12 110.349 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.05 165.56 27.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.281 0.562 . . . . 0.14000000000000001 112.059 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.66 112.11 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.95999999999999996 109.583 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 9.7 mp -112.52 116.93 31.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.296 0.48 . . . . 0.16 112.296 -168.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.11 107.1 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 1.77 109.637 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.465 ' CG1' HD23 ' A' ' 92' ' ' LEU . 12.9 t -68.82 -9.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.041 -0.527 . . . . 0.80000000000000004 111.964 -172.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -114.96 63.27 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 2.3700000000000001 110.981 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.41 HD11 ' SG ' ' A' ' 65' ' ' CYS . 97.5 mt -64.52 -27.85 69.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.265 0.555 . . . . 0.84999999999999998 110.874 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.22 32.22 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.192 -0.763 . . . . 0.81999999999999995 111.192 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.54 -40.66 82.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.931 2.421 . . . . 1.1799999999999999 112.513 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -123.83 -31.55 3.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.655 0.264 . . . . 3.5299999999999998 110.783 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -65.95 127.03 30.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.058 0.456 . . . . 0.95999999999999996 111.706 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -144.57 153.38 41.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.707 -0.678 . . . . 0.48999999999999999 110.061 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 2.6 m -73.7 85.94 1.65 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.984 -0.747 . . . . 1.3 108.984 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.47 -63.93 0.54 Allowed Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.841 -0.695 . . . . 0.23000000000000001 111.842 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.45 -24.91 37.68 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.348 2.032 . . . . 0.23999999999999999 111.381 173.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 11' ' ' LEU . 20.9 t -68.45 -45.01 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.748 -0.66 . . . . 0.12 109.995 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.49 -49.41 77.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 0.16 110.165 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 50.7 m-20 -61.95 -41.6 98.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 2.0299999999999998 110.238 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.446 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -56.63 -44.16 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.019 -0.537 . . . . 0.23000000000000001 111.256 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.11 -42.19 76.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.56 -0.745 . . . . 0.20000000000000001 110.268 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.9 mmtt -59.88 -36.74 77.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.681 -0.691 . . . . 2.0099999999999998 111.447 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 71.2 mt-30 -63.29 -39.07 93.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 2.3700000000000001 111.237 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -96.02 6.14 49.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.29 -0.414 . . . . 1.49 111.235 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 35.57 22.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.797 -0.638 . . . . 0.33000000000000002 111.754 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.0 mt -89.12 133.79 34.5 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 116.501 -0.318 . . . . 0.17000000000000001 110.441 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 26.7 Cg_endo -74.2 141.46 29.21 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.49 2.127 . . . . 0.20999999999999999 111.765 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 16.9 p90 -159.16 160.58 35.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.675 -0.693 . . . . 0.17999999999999999 110.225 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.462 HG21 ' HG2' ' A' ' 101' ' ' MET . 16.0 mt -125.52 141.42 45.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.482 -0.781 . . . . 0.23999999999999999 109.987 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.84 108.71 19.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.309 -0.626 . . . . 0.20999999999999999 109.309 177.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.669 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.9 t-160 -103.66 74.01 1.22 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.481 0.658 . . . . 0.59999999999999998 109.261 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.429 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 4.5 t -105.86 163.56 12.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.646 -1.161 . . . . 0.60999999999999999 111.048 -172.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 -4.99 57.7 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.901 -0.59 . . . . 0.93999999999999995 112.31 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -137.95 132.72 32.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.108 0.48 . . . . 2.3300000000000001 109.826 172.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.1 mp -111.83 -25.85 9.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 1.6100000000000001 110.856 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.18 -45.97 12.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.126 0.489 . . . . 2.6299999999999999 110.898 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.34 -40.15 95.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.513 -0.767 . . . . 4.4199999999999999 110.938 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.526 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 49.7 m-70 -102.31 25.19 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.565 -0.288 . . . . 1.05 111.163 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.74 -37.88 95.56 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.967 -0.635 . . . . 0.97999999999999998 112.975 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 11.7 tt0 -66.94 -39.8 87.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 2.5 110.258 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.465 HD23 ' CG1' ' A' ' 57' ' ' VAL . 41.4 tp -68.12 -40.01 82.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.227 -0.442 . . . . 0.70999999999999996 109.863 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 89.0 mt -59.15 -39.6 82.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.453 -0.34 . . . . 1.5800000000000001 111.189 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 24.4 ptt180 -73.95 -26.05 60.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 4.3799999999999999 110.584 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -70.34 -34.15 72.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.295 0.569 . . . . 2.4500000000000002 110.163 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.596 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 95.8 mt -77.36 -53.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.366 -0.834 . . . . 0.45000000000000001 110.677 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.0 t70 64.47 75.26 0.38 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.764 0.792 . . . . 1.0900000000000001 110.917 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.87 162.11 25.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.902 -1.044 . . . . 0.28999999999999998 109.383 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.75 147.19 89.48 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.658 2.239 . . . . 0.26000000000000001 112.539 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.1 t -124.25 134.97 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.202 -0.454 . . . . 0.64000000000000001 110.971 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.462 ' HG2' HG21 ' A' ' 80' ' ' ILE . 92.2 mmm -114.77 107.47 15.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.286 -0.635 . . . . 0.82999999999999996 109.286 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -73.04 143.86 47.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.944 -0.571 . . . . 0.54000000000000004 111.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 94.0 mttt -91.45 146.74 33.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.046 -0.525 . . . . 0.67000000000000004 110.186 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.19 127.31 13.8 Favored 'Cis proline' 0 C--O 1.234 0.278 0 C-N-CA 123.619 -1.409 . . . . 0.75 112.699 2.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.669 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -119.35 130.04 55.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.728 -0.669 . . . . 0.34999999999999998 110.297 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.15 129.97 38.87 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.04 -1.096 . . . . 0.51000000000000001 108.04 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 39.9 p -64.28 -20.47 66.09 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.875 0.695 . . . . 0.26000000000000001 112.875 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 76.1 p -65.87 -42.32 90.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.995 0.426 . . . . 1.3200000000000001 110.176 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 -39.79 84.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.159 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.44 -45.14 98.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 0.13 110.327 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.31 -48.81 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.554 -0.748 . . . . 0.13 111.479 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 1.95 111.269 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.8 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 2.23 111.402 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.2 -46.81 17.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.49 . . . . 0.14000000000000001 110.392 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.466 HD23 HG11 ' A' ' 52' ' ' VAL . 77.1 mt -70.59 -26.08 63.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.634 0.605 . . . . 0.27000000000000002 112.634 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -63.07 -33.19 74.92 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.815 -0.354 . . . . 2.79 110.415 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.3 mtm -76.08 -30.69 58.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.193 0.52 . . . . 0.42999999999999999 110.139 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.5 t . . . . . 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 1.46 111.033 -178.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.461 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.1 OUTLIER . . . . . 0 N--CA 1.45 -0.448 0 CA-C-O 120.793 0.33 . . . . 1.6499999999999999 111.662 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 17.3 Cg_exo -70.45 136.06 30.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.045 2.496 . . . . 0.33000000000000002 110.984 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -85.98 109.48 18.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.431 -0.581 . . . . 0.89000000000000001 109.431 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.515 HG22 ' CG1' ' A' ' 52' ' ' VAL . 38.0 t -100.14 130.79 48.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.9 -0.591 . . . . 0.20000000000000001 110.916 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.499 ' HB2' HD12 ' A' ' 50' ' ' ILE . 54.1 tp -105.04 112.14 25.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.83 0.348 . . . . 0.75 110.306 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 54' ' ' VAL . 25.3 t -93.12 121.03 43.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.118 0.485 . . . . 0.13 111.507 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm? -102.45 101.11 11.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.297 -0.865 . . . . 0.20999999999999999 108.889 171.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -159.51 120.98 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.479 -0.782 . . . . 1.4099999999999999 109.921 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 19.0 t70 -87.49 -19.03 28.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.9 -0.591 . . . . 1.27 109.941 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -83.51 105.65 5.89 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 2.5600000000000001 109.835 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.1 Cg_exo -59.03 -32.97 98.49 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.736 2.291 . . . . 0.32000000000000001 113.063 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.37 -49.19 78.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.621 -0.511 . . . . 1.51 109.621 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.23 -46.04 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 1.01 110.88 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.59 72.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.069 0.461 . . . . 0.20999999999999999 110.783 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.0 ttp -63.27 -44.92 93.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.553 -0.749 . . . . 0.60999999999999999 111.231 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HG21 ' A' ' 107' ' ' THR . 10.9 m-20 -67.68 -36.78 81.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.098 -0.501 . . . . 1.22 111.497 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.4 mt -65.54 -46.14 80.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.739 0.304 . . . . 0.17999999999999999 110.188 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 48.2 tt0 -55.17 -48.38 73.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 1.04 110.406 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -63.48 -37.88 89.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.441 -0.345 . . . . 0.78000000000000003 111.199 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.54 -49.36 69.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.435 -0.348 . . . . 0.14000000000000001 111.275 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -63.96 -45.73 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.247 -0.433 . . . . 0.13 110.86 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.66 -28.42 69.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.366 -0.379 . . . . 0.68999999999999995 111.164 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.8 -33.33 66.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.51000000000000001 110.229 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.78 -14.73 59.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.65000000000000002 110.817 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 53.11 0.8 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 112.373 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.4 175.95 9.13 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.872 -0.193 . . . . 0.23000000000000001 110.683 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.45 129.91 49.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.064 -0.717 . . . . 2.1400000000000001 109.064 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.3 t -118.25 142.15 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 112.664 0.616 . . . . 0.19 112.664 -164.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 44' ' ' SER . 10.4 t -114.38 136.38 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.867 -0.79 . . . . 0.23000000000000001 108.867 169.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.02 125.09 58.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 0.94999999999999996 111.191 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.78 139.53 45.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.109 -0.496 . . . . 0.16 110.424 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.94 -13.16 15.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.347 -0.388 . . . . 0.23999999999999999 111.2 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.0 p -127.79 167.44 16.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.485 -0.325 . . . . 0.25 110.555 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 74.6 m -68.73 -34.19 75.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.845 -0.428 . . . . 1.6000000000000001 109.845 175.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.37 -48.01 81.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.69999999999999996 110.613 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -59.08 -41.03 87.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.353 0.596 . . . . 1.4099999999999999 110.621 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.658 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -62.0 -54.75 37.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.15 -0.932 . . . . 0.17999999999999999 111.419 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 62.7 mt -64.46 -30.7 71.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.013 -0.54 . . . . 0.82999999999999996 110.767 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -64.43 -47.43 79.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.292 -0.633 . . . . 2.4100000000000001 109.292 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.468 ' HB3' HG11 ' A' ' 33' ' ' VAL . 11.0 m -72.28 -30.46 64.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.922 -0.581 . . . . 1.1299999999999999 110.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.428 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 21.6 tp -67.1 -35.93 80.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 1.23 110.637 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.24 -35.15 48.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.055 -0.52 . . . . 0.42999999999999999 110.814 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.53 -36.28 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.745 -0.661 . . . . 0.62 111.17 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.59 148.56 48.24 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.358 0.599 . . . . 0.41999999999999998 111.284 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.65 88.59 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.321 2.681 . . . . 0.23999999999999999 111.498 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 9' ' ' LEU . 42.6 mm -68.56 127.95 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.663 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -98.89 -27.03 14.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.28999999999999998 110.414 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' HG22 ' A' ' 8' ' ' VAL . 11.7 p -159.48 159.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.12 109.49 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -145.71 165.84 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.376 0.607 . . . . 0.14000000000000001 112.128 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -138.14 111.76 7.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.221 -0.899 . . . . 0.95999999999999996 109.192 175.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.625 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -114.43 124.08 51.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.329 0.492 . . . . 0.16 112.329 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.5 t0 -85.1 115.1 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.815 0.817 . . . . 1.77 109.336 169.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.753 HG13 HD23 ' A' ' 92' ' ' LEU . 65.8 t -59.97 -24.17 29.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.588 -1.187 . . . . 0.80000000000000004 110.96 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 7.7 t30 -113.01 75.53 0.92 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 2.3700000000000001 110.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.3 -29.57 67.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.809 0.814 . . . . 0.84999999999999998 109.052 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.37 -172.22 34.28 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.567 -1.197 . . . . 0.81999999999999995 110.241 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HB2' ' HD2' ' A' ' 62' ' ' LYS . 86.1 Cg_exo -52.92 -44.52 47.9 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.905 2.403 . . . . 1.1799999999999999 112.399 176.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -109.59 -34.1 6.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 3.5299999999999998 110.563 177.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.8 m -65.89 127.46 32.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.351 0.596 . . . . 0.95999999999999996 111.146 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -144.23 149.89 37.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 0.48999999999999999 110.34 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -71.74 86.57 0.94 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.514 0.674 . . . . 1.3 109.431 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.65 -73.06 0.7 Allowed Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.355 -0.926 . . . . 0.23000000000000001 112.164 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.8 Cg_exo -53.29 -25.3 30.08 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.583 2.189 . . . . 0.23999999999999999 112.221 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 11' ' ' LEU . 12.6 t -72.12 -46.72 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.228 0.537 . . . . 0.12 110.365 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.42 -51.81 67.93 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.314 -0.857 . . . . 0.16 109.802 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.28 -37.34 85.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 110.49 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -56.96 -48.23 78.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.409 0.623 . . . . 0.23000000000000001 110.969 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.04 -41.61 77.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.399 -0.818 . . . . 0.20000000000000001 110.402 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 29.9 mmmt -57.89 -39.39 77.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.585 -0.734 . . . . 2.0099999999999998 110.807 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -62.64 -46.68 87.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.688 . . . . 2.3700000000000001 111.462 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -86.41 2.8 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 1.49 111.086 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.0 33.16 21.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.763 -0.653 . . . . 0.33000000000000002 111.308 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.74 131.39 47.45 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 116.085 -0.507 . . . . 0.17000000000000001 109.845 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.2 Cg_endo -72.72 139.39 30.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.17 1.913 . . . . 0.20999999999999999 111.616 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 12.5 p90 -156.44 155.28 31.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.902 -0.59 . . . . 0.17999999999999999 110.719 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.34 139.61 44.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.538 -0.756 . . . . 0.23999999999999999 109.505 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 96' ' ' ILE . 2.5 mm? -88.69 107.45 18.94 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.281 -0.637 . . . . 0.20999999999999999 109.281 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 101' ' ' MET . 14.7 t-160 -103.46 72.52 1.15 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.275 -1.009 . . . . 0.59999999999999998 108.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.631 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 9.7 t -103.52 159.63 15.42 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 113.989 -1.46 . . . . 0.60999999999999999 111.401 -171.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.689 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -106.24 9.42 42.41 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.623 -0.799 . . . . 0.93999999999999995 111.42 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 17.7 t70 -137.06 141.31 42.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.877 0.37 . . . . 2.3300000000000001 110.861 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.6 mt -130.08 -31.88 1.87 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.079 -0.51 . . . . 1.6100000000000001 110.71 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.54 -39.39 16.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.478 0.548 . . . . 2.6299999999999999 112.478 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -70.16 -52.58 22.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.692 0.282 . . . . 4.4199999999999999 111.141 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -97.21 29.1 3.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.426 -0.352 . . . . 1.05 110.304 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.18 -34.08 62.1 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.448 -0.406 . . . . 0.97999999999999998 113.796 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.88 -26.04 68.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 2.5 111.259 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.753 HD23 HG13 ' A' ' 57' ' ' VAL . 15.3 tp -74.96 -47.87 27.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.22 -0.445 . . . . 0.70999999999999996 110.954 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -60.48 -36.37 78.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.911 0.386 . . . . 1.5800000000000001 110.955 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.43 -34.12 73.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.311 -0.859 . . . . 4.3799999999999999 111.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -81.34 -29.36 34.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 2.4500000000000002 111.063 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 92' ' ' LEU . 70.7 mt -67.71 -50.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.798 -0.637 . . . . 0.45000000000000001 111.327 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.21 75.96 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.413 0.625 . . . . 1.0900000000000001 110.617 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -162.71 161.99 19.07 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.437 -0.802 . . . . 0.28999999999999998 109.44 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 31.8 Cg_exo -59.99 137.3 75.07 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.79 2.327 . . . . 0.26000000000000001 112.465 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.9 135.33 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.891 -0.595 . . . . 0.64000000000000001 110.904 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.6 mtp -127.24 90.91 3.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.294 -0.632 . . . . 0.82999999999999996 109.294 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.62 139.78 57.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.54000000000000004 111.62 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.689 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 15.3 ptpt -91.56 149.84 40.06 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.594 -0.73 . . . . 0.67000000000000004 109.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.564 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 16.7 Cg_exo -66.54 138.43 39.56 Favored 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 123.534 -1.444 . . . . 0.75 113.118 3.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -142.07 133.93 27.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.253 -0.885 . . . . 0.34999999999999998 108.778 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 110' ' ' VAL . 12.9 t70 -65.09 123.36 19.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.585 -0.524 . . . . 0.51000000000000001 109.585 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.9 p -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.495 -0.775 . . . . 0.26000000000000001 112.555 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -70.81 -39.74 72.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.455 -0.572 . . . . 1.3200000000000001 109.455 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -67.01 -44.26 80.76 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.62 109.84 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.59 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 25.4 t -59.95 -42.11 88.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.197 -0.911 . . . . 0.13 110.378 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.85 -50.47 66.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.598 -0.728 . . . . 0.13 111.558 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.85 -41.1 99.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 1.95 111.538 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 31.1 mmt180 -71.82 -24.91 61.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.7 0.285 . . . . 2.23 111.492 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 -48.98 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 0.14000000000000001 110.279 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.627 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 69.0 mt -64.55 -26.82 68.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.931 0.715 . . . . 0.27000000000000002 112.931 -175.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.69 -28.98 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.779 -0.368 . . . . 2.79 110.969 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.448 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 57.7 mtm -75.21 -21.81 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.42999999999999999 111.03 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 25.4 p . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 121.06 0.457 . . . . 1.46 110.529 176.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.425 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 12.1 ptp . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 121.811 0.815 . . . . 1.6499999999999999 112.554 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 1.1 Cg_endo -69.53 141.13 45.3 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.153 1.902 . . . . 0.33000000000000002 112.743 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -89.56 105.92 18.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.635 -0.711 . . . . 0.89000000000000001 109.087 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.6 t -100.66 134.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.20000000000000001 111.228 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 50' ' ' ILE . 50.5 tp -110.55 113.31 25.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.008 -0.542 . . . . 0.75 110.564 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -95.05 129.11 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.962 0.411 . . . . 0.13 111.113 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -110.0 101.54 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.20999999999999999 109.982 176.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -165.14 133.25 3.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.658 -0.497 . . . . 1.4099999999999999 109.658 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -87.47 -31.95 19.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.884 -0.598 . . . . 1.27 110.497 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.1 111.46 13.7 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.22 -0.289 . . . . 2.5600000000000001 110.22 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.48 -31.92 95.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.998 2.465 . . . . 0.32000000000000001 113.027 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.81 -49.64 69.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.891 -0.411 . . . . 1.51 109.891 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.08 -47.69 86.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 1.01 110.415 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.76 -49.43 77.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.49 -0.777 . . . . 0.20999999999999999 111.477 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.5 ttp -66.22 -34.12 77.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.382 -0.372 . . . . 0.60999999999999999 111.093 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.539 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.2 m-20 -66.77 -43.88 82.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.311 -0.404 . . . . 1.22 110.609 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.39 -44.06 97.35 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.184 -0.462 . . . . 0.17999999999999999 110.021 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.481 ' HA ' HG11 ' A' ' 32' ' ' VAL . 56.6 tt0 -52.18 -53.83 38.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 1.04 110.684 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -63.76 -33.35 75.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.777 0.323 . . . . 0.78000000000000003 111.138 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.87 71.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.215 -0.448 . . . . 0.14000000000000001 111.046 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.3 m-85 -66.95 -40.41 87.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.13 110.849 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.6 mt-10 -61.6 -35.66 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.68999999999999995 110.539 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.73 -29.25 67.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.52 . . . . 0.51000000000000001 110.761 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -82.78 -2.0 53.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.65000000000000002 110.923 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.16 50.54 3.62 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.878 -0.677 . . . . 0.28999999999999998 112.404 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.87 162.32 35.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.204 -0.295 . . . . 0.23000000000000001 110.204 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.78 132.98 51.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.572 -0.529 . . . . 2.1400000000000001 109.572 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 22' ' ' GLN . 21.8 t -113.78 139.95 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.014 0.375 . . . . 0.19 112.014 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.485 HG11 ' OG ' ' A' ' 44' ' ' SER . 10.2 t -114.45 127.29 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.588 -0.893 . . . . 0.23000000000000001 108.588 167.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.61 123.4 50.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.727 -0.389 . . . . 0.94999999999999996 110.769 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.36 134.32 47.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.064 -0.516 . . . . 0.16 109.994 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.02 -18.95 19.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.833 -0.621 . . . . 0.23999999999999999 110.909 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.2 p -125.12 164.89 19.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.705 -0.398 . . . . 0.25 111.163 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.646 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 76.5 m -65.16 -35.46 81.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 109.681 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.6 -46.91 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.984 -0.553 . . . . 0.69999999999999996 110.641 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -61.42 -41.65 97.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.955 -0.566 . . . . 1.4099999999999999 110.822 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.619 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.46 -49.65 72.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.559 -0.746 . . . . 0.17999999999999999 111.484 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 81.7 mt -60.58 -33.42 72.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.82999999999999996 110.885 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 6.8 tmtm? -66.73 -52.58 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.814 -0.63 . . . . 2.4100000000000001 109.945 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.485 ' OG ' HG11 ' A' ' 33' ' ' VAL . 14.1 t -65.4 -34.42 78.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.367 -0.379 . . . . 1.1299999999999999 110.44 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.406 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 17.7 tp -62.05 -36.44 81.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 1.23 110.852 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.05 -39.84 22.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 0.42999999999999999 111.194 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.58 -37.79 65.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.62 111.397 -176.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -115.29 163.14 21.14 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.41999999999999998 110.411 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.84 82.54 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.446 2.764 . . . . 0.23999999999999999 111.531 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.7 mm -63.96 122.43 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.463 -0.79 . . . . 0.22 111.526 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -90.22 -34.71 15.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.56 -0.746 . . . . 0.28999999999999998 110.32 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -154.7 154.27 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.12 109.987 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -137.21 162.89 32.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.374 0.606 . . . . 0.14000000000000001 111.657 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -135.17 112.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.411 -0.813 . . . . 0.95999999999999996 109.185 176.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mp -107.54 97.95 7.62 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.442 0.639 . . . . 0.16 110.975 -172.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.734 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -74.22 82.98 1.85 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.929 -1.032 . . . . 1.77 109.35 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.401 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 60.5 t -42.46 -42.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 114.541 -1.208 . . . . 0.80000000000000004 113.71 -169.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.35 74.43 4.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.014 0.435 . . . . 2.3700000000000001 110.755 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.7 mt -78.52 -22.85 46.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.55 0.691 . . . . 0.84999999999999998 109.444 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.8 -174.39 45.95 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.904 -1.044 . . . . 0.81999999999999995 110.503 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.49 -40.13 87.2 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.598 2.199 . . . . 1.1799999999999999 112.339 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -118.06 -23.69 7.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.088 -0.506 . . . . 3.5299999999999998 110.723 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.9 m -70.32 124.74 24.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.214 0.53 . . . . 0.95999999999999996 110.973 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -144.97 148.31 33.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.726 -0.67 . . . . 0.48999999999999999 110.353 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.501 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -76.44 87.32 3.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.857 -0.794 . . . . 1.3 108.857 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.417 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -110.71 -67.52 0.56 Allowed Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.47 -0.871 . . . . 0.23000000000000001 112.541 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 38.9 Cg_exo -53.96 -21.35 20.86 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.354 2.036 . . . . 0.23999999999999999 111.902 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' A' ' 11' ' ' LEU . 38.5 t -70.17 -42.67 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.889 -0.596 . . . . 0.12 110.071 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.99 -45.68 91.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.564 -0.744 . . . . 0.16 109.905 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.0 m-20 -61.74 -43.78 98.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.0299999999999998 109.804 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -56.4 -48.71 76.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.23000000000000001 111.165 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.11 -41.44 97.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.514 -0.766 . . . . 0.20000000000000001 110.297 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -60.94 -34.47 74.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.829 -0.623 . . . . 2.0099999999999998 111.757 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 15.8 mm100 -65.47 -35.5 81.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.457 -0.338 . . . . 2.3700000000000001 110.929 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -100.24 7.93 44.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 1.49 111.421 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.89 36.31 27.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.33000000000000002 111.694 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.82 133.41 35.82 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.413 -0.358 . . . . 0.17000000000000001 110.152 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.9 141.35 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.607 2.205 . . . . 0.20999999999999999 112.113 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 21.8 p90 -156.7 157.9 35.98 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.378 -0.828 . . . . 0.17999999999999999 110.453 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 mt -120.05 139.05 48.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.246 -0.888 . . . . 0.23999999999999999 109.646 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 96' ' ' ILE . 1.6 mm? -89.23 108.01 19.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.905 -0.776 . . . . 0.20999999999999999 108.905 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.743 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 12.0 t-160 -101.77 102.59 13.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.359 0.599 . . . . 0.59999999999999998 110.111 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 7.9 t -164.21 149.96 10.74 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.964 -0.46 . . . . 0.60999999999999999 110.423 -173.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.3 -13.32 36.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.483 -1.047 . . . . 0.93999999999999995 110.483 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 33.0 t70 -94.36 103.81 15.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.815 -0.809 . . . . 2.3300000000000001 108.815 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.41 -62.14 1.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.216 -0.447 . . . . 1.6100000000000001 112.036 -171.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.13 -29.86 68.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.051 0.453 . . . . 2.6299999999999999 111.17 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 65.6 ttt180 -67.81 -18.73 64.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 4.4199999999999999 110.944 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -131.25 33.18 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.511 . . . . 1.05 110.289 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.43 -41.8 98.72 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.97999999999999998 113.012 -175.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.89 -37.08 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.695 0.284 . . . . 2.5 111.108 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' HG13 ' A' ' 96' ' ' ILE . 24.2 tp -64.08 -49.53 71.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.264 0.554 . . . . 0.70999999999999996 110.052 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.7 mt -61.47 -31.32 71.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.133 -0.939 . . . . 1.5800000000000001 111.252 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 95.9 mtt180 -63.97 -37.98 89.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 4.3799999999999999 110.866 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -66.33 -47.4 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.53 0.681 . . . . 2.4500000000000002 110.273 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 81' ' ' LEU . 41.2 mt -66.31 -56.33 14.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.519 -1.219 . . . . 0.45000000000000001 111.215 -175.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.9 t70 47.99 59.55 4.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.882 0.848 . . . . 1.0900000000000001 110.715 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . -132.66 168.98 15.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.077 -0.965 . . . . 0.28999999999999998 109.336 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 78.3 Cg_exo -51.67 136.64 50.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.238 1.959 . . . . 0.26000000000000001 112.756 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.1 t -123.14 136.26 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.352 -0.84 . . . . 0.64000000000000001 110.146 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 94.5 mtp -118.35 106.06 12.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.343 -0.614 . . . . 0.82999999999999996 109.343 173.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.67 153.04 44.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.474 -0.785 . . . . 0.54000000000000004 110.842 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -91.04 146.32 33.42 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 0.67000000000000004 109.838 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.52 148.65 89.58 Favored 'Cis proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.548 -1.438 . . . . 0.75 112.858 0.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.743 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -140.61 135.97 32.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.695 -0.684 . . . . 0.34999999999999998 109.615 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.9 t0 -75.93 132.55 40.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.8 -0.815 . . . . 0.51000000000000001 108.8 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.7 p -67.7 -21.17 65.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.707 -0.679 . . . . 0.26000000000000001 112.189 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.9 p -76.0 -29.08 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.154 0.502 . . . . 1.3200000000000001 109.672 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.97 -45.5 49.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.62 109.57 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.686 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 23.2 t -59.03 -44.59 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.13 110.428 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -59.11 -52.68 64.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.13 111.346 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 37.3 mtmm -62.96 -47.03 84.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.033 -0.53 . . . . 1.95 111.039 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -56.49 -37.65 70.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.325 . . . . 2.23 111.513 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.46 48.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.14000000000000001 110.794 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.495 HD23 HG11 ' A' ' 52' ' ' VAL . 74.6 mt -64.02 -25.29 68.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.27000000000000002 112.0 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 42.5 mm-40 -59.31 -31.09 68.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.642 0.258 . . . . 2.79 111.066 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.491 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 62.0 mtm -84.96 -23.07 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 0.42999999999999999 111.402 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 49.4 t . . . . . 0 C--N 1.331 -0.225 0 CA-C-O 121.152 0.501 . . . . 1.46 110.119 178.901 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.465 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.7 mtt . . . . . 0 N--CA 1.454 -0.251 0 N-CA-C 110.184 -0.302 . . . . 1.6499999999999999 110.184 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.5 Cg_exo -66.36 136.93 45.33 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.643 2.229 . . . . 0.33000000000000002 111.741 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.477 ' HB3' HD13 ' A' ' 50' ' ' ILE . 9.3 mttp -84.22 109.67 17.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 0.89000000000000001 110.839 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 39.1 t -101.66 117.83 47.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 0.20000000000000001 110.515 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.442 HD21 ' HB1' ' A' ' 41' ' ' ALA . 58.2 tp -97.66 109.9 22.56 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.698 -0.683 . . . . 0.75 110.432 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.08 123.86 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.199 0.523 . . . . 0.13 111.479 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.705 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.2 mm? -101.72 106.2 17.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.095 -0.957 . . . . 0.20999999999999999 108.897 172.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -165.5 131.28 2.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.889 -0.596 . . . . 1.4099999999999999 109.873 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 24.4 t70 -94.13 -21.25 19.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.418 -0.81 . . . . 1.27 109.722 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 17' ' ' ILE . 9.6 mm-40 -81.81 105.58 4.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 2.5600000000000001 110.193 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 34.5 Cg_exo -59.81 -25.19 78.57 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.771 2.314 . . . . 0.32000000000000001 113.366 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.32 -52.04 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.312 -0.625 . . . . 1.51 109.312 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.9 mp -63.85 -43.8 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.55 . . . . 1.01 110.069 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.27 66.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.20999999999999999 110.715 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 42.2 ttp -62.96 -38.77 92.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 111.257 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . 7.3 m-20 -65.11 -42.56 93.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.21 -0.45 . . . . 1.22 111.289 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 52.8 mt -65.21 -43.8 90.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.17999999999999999 109.967 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HA ' HG21 ' A' ' 32' ' ' VAL . 38.6 tt0 -52.86 -50.93 62.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.163 -0.926 . . . . 1.04 110.662 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -64.5 -33.37 75.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.78000000000000003 111.629 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.17 -49.29 61.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.14000000000000001 111.061 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 73.2 m-85 -66.93 -42.09 85.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.13 110.967 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -64.84 -26.96 68.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.576 -0.284 . . . . 0.68999999999999995 110.703 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.51000000000000001 110.951 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.06 -12.15 59.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.65000000000000002 111.223 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.89 51.74 1.35 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.785 -0.722 . . . . 0.28999999999999998 112.135 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.7 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.209 -0.293 . . . . 0.23000000000000001 110.209 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.08 130.58 55.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.654 -0.499 . . . . 2.1400000000000001 109.654 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 22' ' ' GLN . 40.7 t -109.01 138.37 36.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.173 -0.467 . . . . 0.19 111.71 -171.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.63 123.39 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.771 -0.826 . . . . 0.23000000000000001 108.771 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.5 p -92.85 128.68 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.94999999999999996 111.17 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.8 135.05 34.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.16 110.605 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.08 -10.91 20.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.292 -0.413 . . . . 0.23999999999999999 111.37 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -130.26 166.1 21.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 0.25 111.075 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.657 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 85.9 m -66.36 -34.92 79.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 1.6000000000000001 110.301 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -61.08 -51.57 68.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.69999999999999996 110.578 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -55.93 -37.07 68.45 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.999 -0.546 . . . . 1.4099999999999999 111.245 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.705 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -69.28 -52.74 24.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.542 -0.753 . . . . 0.17999999999999999 111.133 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.73 -34.96 70.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.87 -0.604 . . . . 0.82999999999999996 110.873 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -52.74 63.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.469 . . . . 2.4100000000000001 110.557 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 -36.74 84.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.88 -0.6 . . . . 1.1299999999999999 110.481 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.9 -36.09 80.29 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.074 0.464 . . . . 1.23 110.939 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.47 -35.91 45.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.426 . . . . 0.42999999999999999 111.442 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -85.88 -31.47 22.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.059 0.457 . . . . 0.62 111.106 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -123.25 162.8 37.71 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.614 . . . . 0.41999999999999998 111.415 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.454 ' HD2' ' HD2' ' A' ' 7' ' ' LYS . 89.2 Cg_endo -95.47 90.55 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.68 2.92 . . . . 0.23999999999999999 111.383 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 7' ' ' LYS . 40.4 mm -73.94 123.85 30.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.784 -0.644 . . . . 0.22 111.329 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.532 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 24.8 m-20 -88.75 -28.48 20.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.552 -0.749 . . . . 0.28999999999999998 110.884 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -164.05 158.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.979 -0.378 . . . . 0.12 109.979 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -139.8 167.13 22.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.14000000000000001 111.806 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.58 112.26 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 0.95999999999999996 109.028 176.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.7 mp -111.22 119.59 39.45 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.43 0.53 . . . . 0.16 112.43 -167.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -85.02 141.67 30.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.861 -0.792 . . . . 1.77 108.861 167.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 93' ' ' LEU . 13.1 t -100.89 2.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.584 0.707 . . . . 0.80000000000000004 111.148 -170.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -124.37 62.7 1.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.682 -0.69 . . . . 2.3700000000000001 109.862 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.54 -15.84 60.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.833 -0.621 . . . . 0.84999999999999998 110.24 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.31 -171.5 41.7 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.105 -0.798 . . . . 0.81999999999999995 111.105 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -50.83 -45.55 35.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.061 2.507 . . . . 1.1799999999999999 112.148 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -117.95 -26.67 6.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 3.5299999999999998 110.106 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -62.47 125.16 22.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.95999999999999996 111.402 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -143.97 157.0 44.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.439 -0.8 . . . . 0.48999999999999999 109.647 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -71.4 87.48 0.86 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.388 0.613 . . . . 1.3 109.493 171.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.24 -72.68 0.63 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.468 -0.872 . . . . 0.23000000000000001 112.19 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.657 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 44.0 Cg_exo -53.62 -26.39 37.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.565 2.176 . . . . 0.23999999999999999 112.212 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.3 t -68.66 -43.35 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.12 110.201 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.77 -48.05 82.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.344 -0.844 . . . . 0.16 109.823 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 29.4 t70 -65.35 -40.5 93.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.47 -0.786 . . . . 2.0299999999999998 110.484 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.22 -47.98 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.398 0.618 . . . . 0.23000000000000001 110.955 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.65 -42.26 71.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.215 -0.902 . . . . 0.20000000000000001 110.733 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -59.22 -36.56 75.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.599 . . . . 2.0099999999999998 111.225 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 13.4 mm100 -64.82 -37.4 87.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 2.3700000000000001 111.574 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -97.56 5.31 49.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.397 -0.365 . . . . 1.49 111.397 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 31.09 20.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.971 -0.558 . . . . 0.33000000000000002 111.399 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.8 mt -83.36 130.08 57.93 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 109.595 -0.52 . . . . 0.17000000000000001 109.595 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.28 142.95 38.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.309 2.006 . . . . 0.20999999999999999 111.362 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 25.6 p90 -159.3 157.16 30.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.124 0.487 . . . . 0.17999999999999999 110.621 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.424 HG21 ' HG2' ' A' ' 101' ' ' MET . 34.8 mt -121.39 138.59 51.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.311 -0.859 . . . . 0.23999999999999999 109.853 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.34 108.68 19.46 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.758 -0.83 . . . . 0.20999999999999999 108.758 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.609 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 17.4 t-160 -105.82 85.33 2.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.369 0.604 . . . . 0.59999999999999998 109.476 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 57' ' ' VAL . 9.6 t -134.05 160.49 37.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.841 -1.072 . . . . 0.60999999999999999 110.212 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.08 2.27 38.05 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.569 -1.013 . . . . 0.93999999999999995 110.569 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.29 51.09 1.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.545 . . . . 2.3300000000000001 110.692 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.66 -41.45 96.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.702 -0.681 . . . . 1.6100000000000001 111.145 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.01 -40.81 17.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.562 -0.29 . . . . 2.6299999999999999 110.793 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -43.59 80.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.102 -0.499 . . . . 4.4199999999999999 111.521 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -119.46 32.04 6.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 1.05 111.149 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -59.13 -41.09 96.44 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.999 -0.619 . . . . 0.97999999999999998 112.809 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.61 -47.17 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.134 0.493 . . . . 2.5 110.624 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.3 tp -60.29 -45.69 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.602 -0.727 . . . . 0.70999999999999996 110.32 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 57' ' ' VAL . 74.2 mt -58.64 -39.93 81.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 1.5800000000000001 111.368 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 4.7 mmp_? -64.26 -33.46 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 4.3799999999999999 111.361 178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.8 -34.12 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 2.4500000000000002 111.069 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 92' ' ' LEU . 80.8 mt -64.76 -52.82 49.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.089 -0.505 . . . . 0.45000000000000001 110.314 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.51 76.0 0.36 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.815 0.697 . . . . 1.0900000000000001 110.787 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -157.6 162.3 27.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.403 -0.817 . . . . 0.28999999999999998 108.95 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.706 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -57.26 136.19 74.82 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.448 2.098 . . . . 0.26000000000000001 112.429 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.91 132.6 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.64000000000000001 110.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.9 mmm -113.04 105.54 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.895 -0.78 . . . . 0.82999999999999996 108.895 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 146.14 55.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.003 -0.544 . . . . 0.54000000000000004 111.475 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.3 mttt -91.05 141.61 26.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.67000000000000004 109.473 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.57 156.41 99.23 Favored 'Cis proline' 0 CA--C 1.528 0.217 0 C-N-CA 123.413 -1.494 . . . . 0.75 113.339 2.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.609 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.76 135.1 15.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.34999999999999998 109.915 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -70.94 130.23 41.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.897 -1.149 . . . . 0.51000000000000001 107.897 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 33.5 p -65.05 -18.35 65.22 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.737 0.643 . . . . 0.26000000000000001 112.737 -171.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.3 p -71.15 -38.81 72.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.459 -0.496 . . . . 1.3200000000000001 109.689 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.38 -46.76 87.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.412 0.625 . . . . 0.62 109.575 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.72 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.853 -1.067 . . . . 0.13 110.394 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.64 -50.03 72.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.13 111.518 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -59.59 -43.32 93.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 1.95 111.349 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 117' ' ' MET . 23.9 mmt180 -68.16 -31.79 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.965 0.412 . . . . 2.23 111.321 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.67 -48.53 25.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.14000000000000001 110.473 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.471 HD23 HG11 ' A' ' 52' ' ' VAL . 70.1 mt -66.42 -32.09 73.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.489 0.551 . . . . 0.27000000000000002 112.489 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -70.2 -22.16 62.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.599 -0.441 . . . . 2.79 110.978 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.706 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 56.5 mtm -77.55 -16.35 58.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 0.42999999999999999 110.613 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 43.2 t . . . . . 0 C--N 1.327 -0.373 0 CA-C-O 121.265 0.555 . . . . 1.46 109.64 175.079 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 56.4 mtt . . . . . 0 CA--C 1.531 0.25 0 N-CA-C 112.595 0.591 . . . . 1.6499999999999999 112.595 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.86 138.8 65.05 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.917 2.411 . . . . 0.33000000000000002 112.04 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -87.17 105.09 16.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.48 -0.563 . . . . 0.89000000000000001 109.48 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.497 HG22 ' CG1' ' A' ' 52' ' ' VAL . 50.2 t -99.88 135.34 35.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.903 -0.59 . . . . 0.20000000000000001 110.939 -174.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 52.1 tp -110.54 111.94 23.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.198 -0.455 . . . . 0.75 110.709 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.97 122.43 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.215 0.531 . . . . 0.13 111.467 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.19 101.27 11.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.20999999999999999 108.642 172.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -159.03 120.0 3.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.866 -0.606 . . . . 1.4099999999999999 109.956 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 36.8 t70 -88.41 -16.9 31.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.307 -0.406 . . . . 1.27 110.332 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.9 mt-10 -82.95 103.16 2.23 Favored Pre-proline 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 2.5600000000000001 109.421 173.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.9 Cg_exo -58.48 -29.04 87.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.667 2.244 . . . . 0.32000000000000001 113.07 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -51.28 57.21 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.682 -0.488 . . . . 1.51 109.682 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.8 mp -64.25 -43.4 97.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 1.01 110.182 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.42 -47.53 81.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.678 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.7 ttp -64.28 -39.32 93.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.516 -0.765 . . . . 0.60999999999999999 110.874 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.415 ' HB3' HG21 ' A' ' 107' ' ' THR . 60.7 m-20 -66.32 -47.04 74.82 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.969 -0.56 . . . . 1.22 111.207 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.3 mt -60.01 -45.32 93.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.039 -0.356 . . . . 0.17999999999999999 110.039 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.486 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -52.19 -50.6 61.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 1.04 110.535 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -68.82 -31.21 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.78000000000000003 111.522 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.8 -43.09 76.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.833 0.349 . . . . 0.14000000000000001 110.838 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 50.1 m-85 -69.37 -42.68 74.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 0.13 110.881 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 43.3 mt-10 -62.51 -32.02 72.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.68999999999999995 110.24 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.31 -35.13 79.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.51000000000000001 110.818 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -83.98 6.52 21.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.65000000000000002 110.625 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 57.38 2.85 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.28999999999999998 112.485 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.27 170.48 15.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.23000000000000001 111.051 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -115.92 132.54 56.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.186 -0.672 . . . . 2.1400000000000001 109.186 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.486 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.5 t -117.12 137.29 51.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.749 0.648 . . . . 0.19 112.749 -166.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -110.91 135.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.464 -0.939 . . . . 0.23000000000000001 108.464 169.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.28 128.74 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.911 0.386 . . . . 0.94999999999999996 110.754 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.577 . . . . 0.16 110.41 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.471 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -103.17 -6.54 22.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.492 . . . . 0.23999999999999999 110.769 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -132.31 163.95 27.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.876 -0.602 . . . . 0.25 110.315 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.578 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 79.6 m -68.46 -33.05 73.5 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.744 -0.382 . . . . 1.6000000000000001 110.139 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.66 -39.38 84.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.69999999999999996 111.176 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.471 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 36.7 mt-30 -62.45 -36.67 83.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.258 0.552 . . . . 1.4099999999999999 110.473 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.75 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -67.88 -53.22 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.405 -0.816 . . . . 0.17999999999999999 111.267 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 79.0 mt -59.45 -33.2 70.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.82999999999999996 110.663 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -63.97 -49.71 71.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.936 -0.394 . . . . 2.4100000000000001 109.936 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 m -67.21 -27.04 66.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.958 -0.565 . . . . 1.1299999999999999 111.319 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.2 -35.79 69.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 1.23 111.052 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.12 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.42999999999999999 111.06 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -83.01 -28.24 29.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.86 -0.609 . . . . 0.62 111.464 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -131.66 160.2 68.5 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 110.109 -0.33 . . . . 0.41999999999999998 110.109 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -94.47 89.3 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.484 2.789 . . . . 0.23999999999999999 111.552 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.2 mm -67.78 123.29 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.655 -0.702 . . . . 0.22 111.801 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.32 -34.81 18.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 110.296 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.543 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -159.13 158.74 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.12 110.082 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.78 166.01 25.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.203 0.525 . . . . 0.14000000000000001 112.069 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.75 112.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.334 -0.848 . . . . 0.95999999999999996 109.302 176.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.737 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -113.58 121.86 45.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.432 0.53 . . . . 0.16 112.432 -167.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -80.49 109.96 15.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.809 0.814 . . . . 1.77 108.959 169.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.673 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 17.3 t -59.05 -19.65 16.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.353 -1.294 . . . . 0.80000000000000004 112.253 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -123.88 80.41 1.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 2.3700000000000001 110.573 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.28 -32.3 62.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.751 -0.659 . . . . 0.84999999999999998 110.01 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -169.66 28.71 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.233 -0.747 . . . . 0.81999999999999995 111.233 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.47 -37.76 96.29 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.165 2.577 . . . . 1.1799999999999999 112.599 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 62' ' ' LYS . 13.8 tmtt? -113.57 -34.31 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.695 -0.483 . . . . 3.5299999999999998 109.695 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -63.52 124.52 21.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.95999999999999996 111.65 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.94 149.8 35.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.34 -0.845 . . . . 0.48999999999999999 109.598 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.1 p -71.47 87.15 0.87 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.491 0.663 . . . . 1.3 109.257 171.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.94 -71.6 0.55 Allowed Glycine 0 CA--C 1.509 -0.303 0 C-N-CA 120.451 -0.88 . . . . 0.23000000000000001 112.045 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 52.4 Cg_exo -52.34 -25.14 23.3 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.625 2.217 . . . . 0.23999999999999999 112.064 174.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.4 t -71.74 -44.7 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.12 110.24 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.78 -49.43 77.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.281 -0.872 . . . . 0.16 110.118 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 17.5 m-20 -62.08 -40.18 94.96 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.678 -0.692 . . . . 2.0299999999999998 110.28 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.24 -50.01 74.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.279 0.562 . . . . 0.23000000000000001 111.073 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.22 -42.74 96.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.492 -0.776 . . . . 0.20000000000000001 110.312 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 64.0 mmtt -61.41 -33.48 73.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.588 -0.733 . . . . 2.0099999999999998 111.498 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 79.4 mm-40 -71.62 -37.44 70.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.16 -0.473 . . . . 2.3700000000000001 111.358 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -90.1 2.14 55.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 1.49 111.256 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 36.47 17.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.489 -0.778 . . . . 0.33000000000000002 111.205 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.06 134.06 30.78 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.072 -0.513 . . . . 0.17000000000000001 110.274 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.38 140.85 24.9 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.351 2.034 . . . . 0.20999999999999999 111.728 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 31.6 p90 -156.74 161.92 39.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 0.17999999999999999 110.662 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -125.62 140.77 47.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.364 -0.835 . . . . 0.23999999999999999 109.913 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.413 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.91 109.07 19.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.03 0.443 . . . . 0.20999999999999999 110.027 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.61 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.2 t-160 -109.43 86.11 2.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.223 0.535 . . . . 0.59999999999999998 109.798 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.597 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -126.75 160.15 31.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.341 -0.845 . . . . 0.60999999999999999 111.217 -172.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.55 16.19 52.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.082 -0.58 . . . . 0.93999999999999995 112.541 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -149.99 113.53 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.876 0.37 . . . . 2.3300000000000001 110.785 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.7 -5.03 15.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.25 -0.432 . . . . 1.6100000000000001 110.677 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . 0.44 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 14.2 t70 -83.18 -53.59 5.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.126 -0.488 . . . . 2.6299999999999999 111.082 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 5.2 mpt_? -80.35 -3.4 49.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.174 0.511 . . . . 4.4199999999999999 110.852 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.546 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 96.9 m-70 -119.17 16.57 13.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.94 -0.573 . . . . 1.05 111.226 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -55.49 -44.84 85.49 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.852 -0.69 . . . . 0.97999999999999998 112.474 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 43.8 tt0 -63.28 -42.68 99.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.956 0.408 . . . . 2.5 110.669 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 57' ' ' VAL . 32.8 tp -64.09 -40.19 95.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.796 -0.638 . . . . 0.70999999999999996 110.462 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 76.6 mt -61.06 -34.88 75.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 111.338 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 65.1 mtm-85 -72.5 -26.19 61.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 4.3799999999999999 110.414 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.79 -26.47 54.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 2.4500000000000002 110.284 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.426 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 77.9 mt -83.28 -63.26 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.74 -0.664 . . . . 0.45000000000000001 110.746 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.2 t70 61.4 83.11 0.15 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.734 -0.666 . . . . 1.0900000000000001 110.622 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.38 165.11 13.28 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.694 -0.685 . . . . 0.28999999999999998 109.735 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.58 140.36 93.13 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.841 2.361 . . . . 0.26000000000000001 112.85 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.96 133.68 65.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.64000000000000001 111.357 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 83.5 mmm -121.08 92.37 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.418 -0.956 . . . . 0.82999999999999996 108.418 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.48 154.84 40.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.104 -0.498 . . . . 0.54000000000000004 111.786 -173.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 94.8 mttt -89.96 142.85 29.21 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.67000000000000004 109.475 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 10.8 Cg_exo -71.71 145.61 83.35 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.487 -1.464 . . . . 0.75 112.909 0.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.61 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 134.32 25.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.34999999999999998 109.965 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.572 ' O ' HG23 ' A' ' 110' ' ' VAL . 16.7 t70 -73.44 128.25 34.98 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.417 -0.586 . . . . 0.51000000000000001 109.417 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -65.64 -21.52 66.57 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 112.823 -170.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.8 t -72.9 -41.09 64.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.527 -0.545 . . . . 1.3200000000000001 109.527 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.93 -40.7 91.63 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.118 0.485 . . . . 0.62 110.056 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 106' ' ' ASP . 24.8 t -63.82 -42.5 96.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.443 -0.799 . . . . 0.13 110.375 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.64 -48.65 68.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.798 -0.637 . . . . 0.13 111.58 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -60.46 -45.56 93.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.183 -0.462 . . . . 1.95 111.453 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 34.1 mmt180 -67.49 -25.4 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 2.23 111.391 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.23 -51.47 9.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.002 0.429 . . . . 0.14000000000000001 110.43 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 HG11 ' A' ' 52' ' ' VAL . 75.4 mt -64.54 -27.54 69.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.869 0.692 . . . . 0.27000000000000002 112.869 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 9.3 pt-20 -67.44 -32.06 72.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.442 -0.503 . . . . 2.79 110.719 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.8 mtm -72.6 -29.53 63.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.42999999999999999 111.285 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 17.8 p . . . . . 0 C--N 1.331 -0.234 0 CA-C-O 120.954 0.407 . . . . 1.46 110.757 177.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp . . . . . 0 N--CA 1.448 -0.539 0 N-CA-C 109.037 -0.727 . . . . 1.6499999999999999 109.037 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 26.0 Cg_exo -62.6 134.47 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.678 2.252 . . . . 0.33000000000000002 111.799 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -87.12 107.1 18.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.388 0.614 . . . . 0.89000000000000001 109.405 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 58.7 t -99.93 130.83 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.216 -0.902 . . . . 0.20000000000000001 111.033 -172.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 50' ' ' ILE . 49.4 tp -105.61 111.24 23.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 0.75 110.357 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.37 123.36 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.13 111.422 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -103.48 106.04 16.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.21 -0.905 . . . . 0.20999999999999999 108.57 171.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.21 125.61 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.195 0.522 . . . . 1.4099999999999999 110.444 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 t70 -90.72 -13.8 33.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.564 -0.744 . . . . 1.27 109.895 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -89.74 104.02 7.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 2.5600000000000001 109.89 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.7 Cg_exo -59.44 -31.53 94.91 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.919 2.412 . . . . 0.32000000000000001 113.045 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.59 -49.88 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.593 -0.521 . . . . 1.51 109.593 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -67.24 -44.07 87.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 1.01 110.888 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -51.28 68.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 0.20999999999999999 110.737 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.2 ttp -61.46 -43.33 99.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.358 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.507 ' HB3' HG21 ' A' ' 107' ' ' THR . 7.1 m-20 -67.47 -39.02 85.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.341 -0.39 . . . . 1.22 111.227 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 51.4 mt -62.91 -45.78 90.92 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 110.071 -0.344 . . . . 0.17999999999999999 110.071 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.597 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 36.4 tt0 -54.31 -52.68 60.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.547 -0.752 . . . . 1.04 110.314 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -64.77 -30.34 71.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.467 -0.333 . . . . 0.78000000000000003 111.416 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.47 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.14000000000000001 110.82 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 63.7 m-85 -68.46 -41.48 80.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.13 110.682 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.11 -32.52 73.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 0.68999999999999995 110.525 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.49 -32.71 73.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.089 0.471 . . . . 0.51000000000000001 110.231 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -84.03 1.25 44.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.65000000000000002 111.167 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 50.73 3.95 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.28999999999999998 112.539 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.37 167.16 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.246 -0.279 . . . . 0.23000000000000001 110.246 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -113.44 132.3 55.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.297 -0.631 . . . . 2.1400000000000001 109.297 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.597 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 4.8 t -121.79 147.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.852 0.686 . . . . 0.19 112.852 -167.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 t -120.44 143.34 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.348 -0.842 . . . . 0.23000000000000001 108.793 168.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -111.85 126.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.94999999999999996 111.123 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.53 142.98 45.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.702 -0.681 . . . . 0.16 110.139 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.86 -2.92 15.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.682 0.277 . . . . 0.23999999999999999 111.402 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -136.9 169.95 16.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.52 -0.309 . . . . 0.25 111.046 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.531 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 18.6 p -59.99 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.579 . . . . 1.6000000000000001 109.536 172.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.77 -49.91 69.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.597 -1.183 . . . . 0.69999999999999996 111.813 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -59.31 -38.57 80.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.107 0.48 . . . . 1.4099999999999999 111.092 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.661 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -68.75 -51.35 42.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.694 . . . . 0.17999999999999999 111.18 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 67.3 mt -63.97 -28.19 69.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.642 -0.708 . . . . 0.82999999999999996 110.733 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -66.77 -51.28 57.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.521 . . . . 2.4100000000000001 110.123 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.3 t -65.48 -34.11 77.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 1.1299999999999999 110.907 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.411 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 14.6 tp -61.94 -33.16 73.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.232 0.539 . . . . 1.23 110.211 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.56 22.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.42999999999999999 111.065 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.35 -37.97 56.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.546 . . . . 0.62 111.108 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -123.5 159.44 55.21 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.096 -0.502 . . . . 0.41999999999999998 110.091 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -93.22 86.67 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.358 2.705 . . . . 0.23999999999999999 111.075 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.6 mm -63.94 122.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.537 -0.756 . . . . 0.22 111.485 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 43.2 m-20 -92.57 -29.97 15.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.558 -0.746 . . . . 0.28999999999999998 110.142 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.0 p -158.41 156.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.12 109.716 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.39 168.99 18.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.355 0.597 . . . . 0.14000000000000001 112.146 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.43 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.38 112.61 4.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.206 -0.906 . . . . 0.95999999999999996 109.207 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.614 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -112.81 116.91 30.81 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.531 0.567 . . . . 0.16 112.531 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.91 133.7 38.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.217 -0.66 . . . . 1.77 109.217 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.467 ' H ' ' HB ' ' A' ' 83' ' ' THR . 19.8 t -93.8 -10.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.771 -0.649 . . . . 0.80000000000000004 111.249 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -116.32 53.82 0.86 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 2.3700000000000001 110.551 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.66 -41.26 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.262 0.553 . . . . 0.84999999999999998 110.473 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.82 -172.99 29.92 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.96 -0.856 . . . . 0.81999999999999995 110.96 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.59 -43.76 52.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.827 2.351 . . . . 1.1799999999999999 112.263 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -113.42 -27.96 7.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.24 -0.436 . . . . 3.5299999999999998 110.879 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.7 m -68.54 123.95 22.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.95999999999999996 111.3 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.3 152.26 40.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.099 -0.955 . . . . 0.48999999999999999 109.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.2 p -68.76 86.31 0.33 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.406 0.622 . . . . 1.3 109.521 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.3 -66.47 0.3 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.791 -0.718 . . . . 0.23000000000000001 112.023 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.47 -28.14 53.06 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.234 1.956 . . . . 0.23999999999999999 111.541 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -71.11 -44.37 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.12 110.195 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.99 87.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.29 -0.868 . . . . 0.16 110.092 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 21.7 t70 -61.52 -43.67 98.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.359 -0.837 . . . . 2.0299999999999998 110.395 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -55.19 -49.34 72.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.836 -0.62 . . . . 0.23000000000000001 111.036 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.66 -43.39 89.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.421 -0.808 . . . . 0.20000000000000001 110.656 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 56.2 mmtt -60.65 -32.98 72.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.675 -0.693 . . . . 2.0099999999999998 111.397 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 14.4 mm100 -71.55 -33.48 69.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 2.3700000000000001 111.526 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -93.23 1.07 57.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.678 -0.237 . . . . 1.49 111.131 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.16 34.5 13.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.7 -0.682 . . . . 0.33000000000000002 111.307 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.4 mt -87.55 133.9 37.12 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.439 . . . . 0.17000000000000001 110.223 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 27.5 Cg_endo -75.36 143.37 27.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.373 2.049 . . . . 0.20999999999999999 112.051 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 28.7 p90 -159.65 159.29 32.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.748 -0.66 . . . . 0.17999999999999999 110.462 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -124.0 139.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.408 -0.815 . . . . 0.23999999999999999 109.728 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mm? -88.43 109.69 20.22 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.451 -0.574 . . . . 0.20999999999999999 109.451 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.618 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 19.7 t-160 -102.25 90.88 4.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.987 -0.552 . . . . 0.59999999999999998 109.732 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 9.3 t -139.63 160.98 38.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.364 -0.835 . . . . 0.60999999999999999 110.409 -174.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.07 9.47 20.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.89 -0.671 . . . . 0.93999999999999995 111.82 175.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.62 60.26 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.195 0.521 . . . . 2.3300000000000001 110.822 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.68 -41.39 79.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.566 -0.743 . . . . 1.6100000000000001 110.08 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.3 -20.14 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.603 -0.726 . . . . 2.6299999999999999 111.371 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 3.6 tpm_? -90.56 -22.07 21.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 4.4199999999999999 110.761 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.499 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.1 m-70 -126.01 28.86 6.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 1.05 111.637 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -58.17 -37.99 88.32 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.119 -0.562 . . . . 0.97999999999999998 112.602 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.0 -46.01 75.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.855 0.36 . . . . 2.5 110.699 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.43 HD23 ' CG1' ' A' ' 57' ' ' VAL . 56.8 tp -60.89 -39.66 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.70999999999999996 110.501 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.9 mt -61.78 -32.77 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.5800000000000001 111.067 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -72.53 -38.54 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.88 0.372 . . . . 4.3799999999999999 110.297 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.91 -42.26 89.22 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.532 0.682 . . . . 2.4500000000000002 110.233 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.497 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 84.7 mt -72.07 -58.79 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.892 -1.049 . . . . 0.45000000000000001 111.067 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.3 t70 62.54 82.07 0.19 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.618 0.723 . . . . 1.0900000000000001 111.093 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.413 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -163.45 162.09 17.48 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.28999999999999998 108.986 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -58.27 146.25 89.88 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.57 2.18 . . . . 0.26000000000000001 112.528 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.7 t -123.05 132.4 71.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.64000000000000001 111.028 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.6 mmm -113.87 106.25 14.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.82999999999999996 109.129 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.03 146.35 53.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.984 -0.553 . . . . 0.54000000000000004 111.938 -174.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.6 mttt -91.59 145.11 30.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.827 -0.624 . . . . 0.67000000000000004 110.204 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.22 142.61 75.04 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 123.572 -1.428 . . . . 0.75 112.422 -0.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.618 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -133.08 135.44 45.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.867 -0.606 . . . . 0.34999999999999998 109.806 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.4 t0 -70.38 127.31 32.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.287 -1.005 . . . . 0.51000000000000001 108.287 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.507 HG21 ' HB3' ' A' ' 20' ' ' ASN . 22.9 p -63.22 -20.5 65.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.348 -0.842 . . . . 0.26000000000000001 112.646 -172.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -70.53 -40.29 73.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.3200000000000001 109.943 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.34 -39.56 81.85 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.62 109.903 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.6 t -65.15 -45.31 94.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.13 110.09 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.14 -50.42 71.95 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.685 -0.689 . . . . 0.13 111.374 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 67.9 mttm -57.42 -51.5 69.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 1.95 111.304 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -61.26 -39.46 90.44 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.112 0.257 . . . . 2.23 111.686 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.94 79.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.14000000000000001 110.172 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 HG11 ' A' ' 52' ' ' VAL . 85.1 mt -67.02 -25.34 66.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.27000000000000002 111.768 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 36.7 mm-40 -60.79 -38.47 85.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.986 0.422 . . . . 2.79 110.692 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.518 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.4 mtm -79.59 -10.66 59.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.42999999999999999 110.717 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 36.7 t . . . . . 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 1.46 110.202 179.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 16.7 mmt . . . . . 0 C--O 1.233 0.214 0 N-CA-C 109.807 -0.442 . . . . 1.6499999999999999 109.807 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.4 Cg_endo -68.06 135.68 35.54 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.609 1.539 . . . . 0.33000000000000002 110.635 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 34.1 tptt -84.63 104.53 14.69 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.724 -0.472 . . . . 0.89000000000000001 109.724 -178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 52' ' ' VAL . 46.7 t -100.14 128.97 51.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.84 -0.618 . . . . 0.20000000000000001 110.978 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.436 ' HB2' HD12 ' A' ' 50' ' ' ILE . 50.5 tp -107.43 119.01 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.451 -0.34 . . . . 0.75 110.462 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 54' ' ' VAL . 44.5 t -100.17 124.93 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.149 0.5 . . . . 0.13 111.43 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -104.51 106.41 16.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.284 -0.871 . . . . 0.20999999999999999 109.013 172.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -167.3 128.95 1.59 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.975 -0.557 . . . . 1.4099999999999999 109.687 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.5 t70 -84.58 -28.88 26.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 1.27 109.661 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HB3' HD13 ' A' ' 17' ' ' ILE . 1.2 mp0 -74.07 109.55 7.15 Favored Pre-proline 0 N--CA 1.462 0.147 0 CA-C-N 116.249 -0.432 . . . . 2.5600000000000001 110.583 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.6 Cg_exo -60.39 -29.59 89.11 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.527 2.151 . . . . 0.32000000000000001 112.733 -178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -52.47 42.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.059 -0.349 . . . . 1.51 110.059 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.5 mp -62.69 -42.6 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 1.01 109.927 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.09 71.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.502 -0.772 . . . . 0.20999999999999999 110.832 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.497 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 47.6 ttp -65.05 -38.37 90.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.60999999999999999 111.202 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.447 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.3 m-20 -64.82 -44.07 91.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.047 -0.524 . . . . 1.22 110.982 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 39.3 mt -61.91 -44.99 95.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.437 -0.347 . . . . 0.17999999999999999 110.253 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.623 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 43.4 tt0 -53.44 -51.18 63.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.633 -0.712 . . . . 1.04 110.815 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -63.43 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.78000000000000003 111.33 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.19 78.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.306 -0.406 . . . . 0.14000000000000001 110.95 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 57.0 m-85 -71.19 -42.09 69.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.422 . . . . 0.13 110.874 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 46.0 mt-10 -65.4 -28.24 69.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.996 0.427 . . . . 0.68999999999999995 110.079 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.8 -32.18 70.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.51000000000000001 110.616 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -83.97 -2.5 56.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.227 0.537 . . . . 0.65000000000000002 110.461 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 62.76 1.61 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.601 -0.727 . . . . 0.28999999999999998 111.998 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -145.32 172.16 13.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 0.23000000000000001 111.359 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -114.57 137.24 52.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.938 -0.573 . . . . 2.1400000000000001 109.612 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 5.1 t -120.19 146.91 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 0.19 111.913 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.438 HG11 ' OG ' ' A' ' 44' ' ' SER . 24.1 t -119.6 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.23000000000000001 108.919 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t -97.24 124.72 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.94999999999999996 110.885 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.59 134.64 41.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.007 -0.542 . . . . 0.16 110.415 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.432 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -100.48 -11.02 20.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.97 0.414 . . . . 0.23999999999999999 110.792 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.3 p -129.87 160.77 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 0.25 110.732 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.594 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.1 m -63.92 -35.5 80.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.736 -0.468 . . . . 1.6000000000000001 109.736 174.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.0 -47.87 84.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.69999999999999996 111.19 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 39.4 mt-30 -59.01 -41.24 87.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.642 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.675 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.36 -51.77 64.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.274 -0.875 . . . . 0.17999999999999999 111.444 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.9 mt -62.24 -32.23 72.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.067 -0.515 . . . . 0.82999999999999996 110.894 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.27 -50.64 69.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 2.4100000000000001 110.219 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.438 ' OG ' HG11 ' A' ' 33' ' ' VAL . 23.2 t -68.5 -35.07 76.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 1.1299999999999999 110.551 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -57.3 -39.67 76.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.23 109.817 177.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.82 30.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.42999999999999999 111.408 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.84 -38.34 58.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.998 0.428 . . . . 0.62 111.777 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -114.48 163.94 17.83 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.41999999999999998 110.758 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -96.0 76.01 0.13 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.494 2.796 . . . . 0.23999999999999999 111.341 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.2 mm -56.78 120.24 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.228 -0.896 . . . . 0.22 111.725 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.793 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 16.8 m-20 -90.09 -31.19 17.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.372 -0.831 . . . . 0.28999999999999998 110.629 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -160.34 156.7 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.12 109.914 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.81 160.92 39.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.46 0.648 . . . . 0.14000000000000001 112.168 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -133.07 112.04 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.95999999999999996 109.243 174.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.689 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -111.78 117.73 33.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.986 0.422 . . . . 0.16 112.039 -170.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.87 129.96 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.839 -0.8 . . . . 1.77 108.839 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.485 ' H ' ' HB ' ' A' ' 83' ' ' THR . 61.8 t -88.97 -35.72 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.139 -0.482 . . . . 0.80000000000000004 111.475 -171.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.68 60.66 4.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.072 0.463 . . . . 2.3700000000000001 111.382 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.362 0.601 . . . . 0.84999999999999998 110.148 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.69 -171.58 32.05 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.65 -0.98 . . . . 0.81999999999999995 110.65 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.11 -36.83 96.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.856 2.371 . . . . 1.1799999999999999 113.104 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -127.24 -21.76 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 3.5299999999999998 111.557 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 p -73.54 126.41 30.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.483 0.658 . . . . 0.95999999999999996 110.709 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -144.93 155.09 43.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 110.301 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.5 p -69.49 87.27 0.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.488 -0.56 . . . . 1.3 109.488 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.78 -69.88 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.504 -0.855 . . . . 0.23000000000000001 112.499 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.522 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 50.9 Cg_exo -51.47 -27.51 24.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.8 2.333 . . . . 0.23999999999999999 111.979 175.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.502 HG11 ' CD2' ' A' ' 11' ' ' LEU . 14.3 t -69.28 -44.75 80.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 0.12 110.042 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.55 93.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.143 -0.935 . . . . 0.16 110.156 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 37.8 m-20 -64.12 -42.07 96.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.447 . . . . 2.0299999999999998 110.345 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.54 -46.81 70.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.389 0.614 . . . . 0.23000000000000001 110.881 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.66 -46.72 71.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.023 -0.989 . . . . 0.20000000000000001 110.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -56.53 -36.02 68.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.515 -0.766 . . . . 2.0099999999999998 111.849 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.1 mt-30 -61.42 -44.39 97.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 2.3700000000000001 111.696 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -94.59 7.14 46.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.569 -0.287 . . . . 1.49 111.214 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.14 34.79 21.18 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.626 . . . . 0.33000000000000002 111.264 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.79 133.38 55.35 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.17000000000000001 109.984 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 13.3 Cg_endo -73.81 137.02 23.97 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.117 1.878 . . . . 0.20999999999999999 111.423 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -156.49 158.85 37.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.937 -0.574 . . . . 0.17999999999999999 110.617 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.0 mt -124.24 140.9 46.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.21 -0.904 . . . . 0.23999999999999999 109.795 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.97 107.94 19.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.041 -0.725 . . . . 0.20999999999999999 109.041 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.7 t-160 -101.61 78.95 1.89 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.995 -0.742 . . . . 0.59999999999999998 108.995 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.485 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 4.7 t -118.32 158.76 24.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.788 -1.096 . . . . 0.60999999999999999 110.915 -171.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.36 -1.35 55.66 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.012 -0.613 . . . . 0.93999999999999995 111.883 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.95 120.45 26.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.771 0.32 . . . . 2.3300000000000001 110.783 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HA ' HD11 ' A' ' 93' ' ' LEU . 7.1 mp -114.38 -6.85 12.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 1.6100000000000001 109.904 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -84.39 -60.92 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 2.6299999999999999 111.387 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -40.24 78.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.092 0.472 . . . . 4.4199999999999999 110.421 -174.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.407 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 97.3 m-70 -92.27 22.4 4.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.211 -0.449 . . . . 1.05 111.256 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.55 -41.83 98.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.121 -0.561 . . . . 0.97999999999999998 112.698 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.06 -45.8 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 2.5 110.678 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.26 -44.24 92.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.70999999999999996 110.472 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 86' ' ' LEU . 63.2 mt -61.97 -31.48 71.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.838 -0.619 . . . . 1.5800000000000001 111.239 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 25.4 mtm180 -70.55 -32.6 70.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.4 -0.364 . . . . 4.3799999999999999 110.622 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.05 -39.4 50.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.997 -0.547 . . . . 2.4500000000000002 110.375 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.92 -52.89 43.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.612 -0.722 . . . . 0.45000000000000001 110.014 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.74 74.36 0.41 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.593 -0.73 . . . . 1.0900000000000001 110.952 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -153.13 163.79 22.44 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.152 -0.931 . . . . 0.28999999999999998 109.22 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.697 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 66.3 Cg_exo -54.96 141.08 79.27 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.491 2.127 . . . . 0.26000000000000001 112.768 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.56 140.26 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.806 -0.633 . . . . 0.64000000000000001 110.621 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.3 mmm -121.32 95.32 4.64 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 0.82999999999999996 108.887 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.3 147.07 52.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.953 -0.567 . . . . 0.54000000000000004 111.466 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 85.9 mttt -91.17 147.0 34.64 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.708 . . . . 0.67000000000000004 110.434 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.6 Cg_exo -73.05 152.25 98.06 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.483 -1.466 . . . . 0.75 112.459 1.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.617 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -148.57 129.34 14.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.34999999999999998 110.511 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 110' ' ' VAL . 16.4 t70 -66.28 128.96 38.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.51000000000000001 109.143 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.447 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.4 p -64.83 -24.7 67.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.59 -0.732 . . . . 0.26000000000000001 112.581 -170.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 32.3 t -68.13 -40.91 82.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.651 -0.5 . . . . 1.3200000000000001 109.651 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -40.76 92.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.076 0.465 . . . . 0.62 110.097 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 106' ' ' ASP . 22.0 t -64.36 -42.57 95.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.579 -0.737 . . . . 0.13 110.475 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.34 -48.5 72.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.727 -0.67 . . . . 0.13 111.349 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 108' ' ' SER . 99.0 mttt -60.39 -46.48 89.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 1.95 110.887 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.511 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.3 mmt180 -62.4 -28.55 69.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.126 -0.488 . . . . 2.23 111.309 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.37 -51.65 9.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.14000000000000001 110.576 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 52' ' ' VAL . 88.3 mt -65.41 -29.35 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.493 0.553 . . . . 0.27000000000000002 112.493 -176.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.511 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.3 pt-20 -67.44 -25.8 66.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.8 0.333 . . . . 2.79 111.255 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.697 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 43.5 mtm -81.53 -14.54 56.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.019 0.438 . . . . 0.42999999999999999 110.711 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 46.9 t . . . . . 0 C--N 1.321 -0.648 0 CA-C-N 115.897 -0.592 . . . . 1.46 111.609 -174.148 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 7.2 ptm . . . . . 0 N--CA 1.447 -0.597 0 N-CA-C 109.737 -0.468 . . . . 1.6499999999999999 109.737 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 1.6 Cg_endo -73.01 143.96 37.22 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.271 1.981 . . . . 0.33000000000000002 112.426 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 34.5 tptt -90.23 105.54 17.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.738 -0.665 . . . . 0.89000000000000001 109.271 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.415 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.7 t -100.61 137.61 27.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.138 -0.483 . . . . 0.20000000000000001 111.153 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.637 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.2 tm? -115.66 110.76 19.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.75 109.906 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.04 128.83 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.235 0.54 . . . . 0.13 111.039 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -108.12 100.8 10.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.197 -0.91 . . . . 0.20999999999999999 108.884 175.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -164.17 134.77 4.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.172 0.51 . . . . 1.4099999999999999 110.101 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -97.16 -23.83 16.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.468 -0.787 . . . . 1.27 109.993 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.0 mt-10 -76.03 108.15 5.61 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.658 -0.497 . . . . 2.5600000000000001 109.658 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 14' ' ' GLU . 32.2 Cg_exo -57.48 -35.84 98.8 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 123.073 2.515 . . . . 0.32000000000000001 113.537 -171.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 16' ' ' LEU . 4.7 tt -65.0 -50.85 64.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.813 -0.44 . . . . 1.51 109.813 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -62.02 -46.97 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.498 . . . . 1.01 109.814 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.239 -0.891 . . . . 0.20999999999999999 110.824 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.429 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 38.2 ttp -63.41 -44.86 93.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.60999999999999999 111.083 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.57 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.7 t-20 -65.28 -42.56 93.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 1.22 110.425 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.5 mt -64.39 -43.48 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.17999999999999999 110.227 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.6 tt0 -53.22 -50.57 64.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.663 -0.699 . . . . 1.04 110.318 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 14.4 m-85 -63.18 -34.96 78.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.78000000000000003 111.206 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.53 71.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.919 0.39 . . . . 0.14000000000000001 110.656 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 55.0 m-85 -66.96 -41.9 86.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.123 -0.49 . . . . 0.13 110.613 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.75 -36.8 79.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.68999999999999995 110.632 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.73 -33.22 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.51000000000000001 110.835 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -80.41 -1.41 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.65000000000000002 110.531 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.15 50.48 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 116.004 -0.544 . . . . 0.28999999999999998 112.414 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.74 158.99 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.323 . . . . 0.23000000000000001 110.783 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.46 138.81 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.988 -0.745 . . . . 2.1400000000000001 108.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.497 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.4 t -120.86 132.14 71.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.482 . . . . 0.19 111.988 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.38 136.1 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.23000000000000001 108.338 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.1 t -111.02 123.97 67.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.631 -0.428 . . . . 0.94999999999999996 111.002 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.26 134.92 50.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.867 -0.606 . . . . 0.16 110.338 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.48 -11.85 18.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.998 0.428 . . . . 0.23999999999999999 111.147 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.9 p -128.83 173.39 10.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.169 -0.468 . . . . 0.25 110.227 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 75.5 m -73.63 -32.08 63.86 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.598 . . . . 1.6000000000000001 109.387 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.13 -51.04 70.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.913 -0.585 . . . . 0.69999999999999996 110.912 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -55.89 -42.13 75.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.864 -0.607 . . . . 1.4099999999999999 110.7 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -62.66 -52.93 61.38 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.434 -0.803 . . . . 0.17999999999999999 111.278 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.6 mt -59.43 -29.16 67.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.961 -0.563 . . . . 0.82999999999999996 110.942 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.1 tmtp? -65.6 -55.7 16.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.773 -0.454 . . . . 2.4100000000000001 109.773 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.9 t -64.55 -35.26 80.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 1.1299999999999999 110.55 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.446 HD11 HD23 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.937 -0.574 . . . . 1.23 110.984 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.55 -38.17 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.42999999999999999 111.237 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.19 -37.65 61.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.883 -0.598 . . . . 0.62 111.598 -175.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.44 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 43.9 m-80 -120.09 165.22 18.64 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 111.214 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -95.45 86.15 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.625 2.883 . . . . 0.23999999999999999 111.466 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -65.07 118.37 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.329 -0.85 . . . . 0.22 111.258 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -84.27 -32.38 24.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.28999999999999998 110.23 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 115' ' ' LEU . 14.3 p -158.65 154.02 5.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.928 -0.578 . . . . 0.12 110.2 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 162.57 33.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.515 0.674 . . . . 0.14000000000000001 111.61 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.445 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -135.14 111.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.739 -0.837 . . . . 0.95999999999999996 108.739 176.012 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.42 ' HA ' ' CB ' ' A' ' 11' ' ' LEU . 10.5 mp -106.42 98.42 8.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.268 0.556 . . . . 0.16 111.084 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.871 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -76.14 93.35 3.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.079 -0.964 . . . . 1.77 109.448 174.077 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.1 t -54.29 -25.94 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.971 -1.013 . . . . 0.80000000000000004 111.945 -172.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -79.01 68.9 5.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.076 -0.511 . . . . 2.3700000000000001 111.456 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 -32.65 22.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.176 0.513 . . . . 0.84999999999999998 110.311 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.39 -174.02 40.1 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.678 -0.692 . . . . 0.81999999999999995 111.599 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.51 -35.13 96.51 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.076 2.517 . . . . 1.1799999999999999 112.741 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -123.4 -29.42 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.933 -0.576 . . . . 3.5299999999999998 110.253 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.7 m -64.97 125.67 25.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.95999999999999996 111.656 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -144.57 154.78 43.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 0.48999999999999999 110.079 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.459 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -78.7 87.85 4.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.297 -0.631 . . . . 1.3 109.297 174.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.21 -72.66 0.87 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.689 -0.767 . . . . 0.23000000000000001 112.363 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.3 Cg_exo -52.82 -24.58 24.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.83 2.353 . . . . 0.23999999999999999 112.331 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 11' ' ' LEU . 30.3 t -64.42 -40.08 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.542 0.687 . . . . 0.12 110.014 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.58 -41.93 98.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.854 -1.067 . . . . 0.16 110.159 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.12 -47.18 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.81 -0.632 . . . . 2.0299999999999998 109.972 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -50.3 -49.93 52.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.605 0.716 . . . . 0.23000000000000001 110.848 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.446 HD23 HD11 ' A' ' 45' ' ' LEU . 97.6 mt -66.12 -47.83 72.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.045 -0.98 . . . . 0.20000000000000001 111.015 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -59.13 -34.52 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.583 . . . . 2.0099999999999998 111.787 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -69.43 -34.68 74.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.316 -0.402 . . . . 2.3700000000000001 111.347 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 75' ' ' ARG . 55.5 mtt180 -95.71 7.53 46.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 1.49 111.077 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.06 34.11 23.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.694 -0.685 . . . . 0.33000000000000002 111.563 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.41 132.67 38.43 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.489 -0.323 . . . . 0.17000000000000001 110.295 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.16 139.77 24.26 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.59 2.193 . . . . 0.20999999999999999 112.2 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 39.2 p90 -155.42 156.91 36.18 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.726 -0.67 . . . . 0.17999999999999999 110.402 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -117.84 138.39 48.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.404 -0.816 . . . . 0.23999999999999999 109.401 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 98' ' ' ALA . 2.1 mm? -88.78 107.96 19.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.492 -0.929 . . . . 0.20999999999999999 108.492 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.871 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 11.7 t-160 -101.34 123.16 44.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.41 -0.959 . . . . 0.59999999999999998 108.41 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 5.4 t -163.12 144.0 9.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.073 -0.651 . . . . 0.60999999999999999 111.947 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 103' ' ' LYS . . . -89.68 -6.77 69.77 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.93999999999999995 111.398 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 88' ' ' ARG . 9.7 t70 -112.57 114.72 27.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.564 -0.532 . . . . 2.3300000000000001 109.564 177.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 102' ' ' ALA . 80.7 mt -115.53 -17.93 11.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.343 -0.39 . . . . 1.6100000000000001 111.268 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -85.76 -52.01 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.88 -0.328 . . . . 2.6299999999999999 111.464 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -67.69 -33.2 74.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.03 0.443 . . . . 4.4199999999999999 110.382 -177.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.569 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 93.0 m-70 -102.11 16.51 25.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.273 -0.421 . . . . 1.05 111.347 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -60.52 -49.94 73.11 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.943 -0.646 . . . . 0.97999999999999998 113.056 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 3.1 mp0 -60.55 -40.59 92.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.078 -0.341 . . . . 2.5 110.078 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 tp -60.17 -43.35 95.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.931 -0.577 . . . . 0.70999999999999996 110.892 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 67.6 mt -57.87 -37.39 73.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.5800000000000001 110.893 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.412 ' NH2' ' HG3' ' A' ' 91' ' ' GLU . 48.3 mtm105 -78.43 -26.9 46.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 4.3799999999999999 111.225 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 96.7 mttt -69.11 -39.21 79.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.448 0.642 . . . . 2.4500000000000002 109.826 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.431 HG23 ' HB1' ' A' ' 69' ' ' ALA . 95.8 mt -69.09 -54.12 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.008 -0.997 . . . . 0.45000000000000001 110.621 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 64.74 78.8 0.27 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.686 0.755 . . . . 1.0900000000000001 111.206 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.427 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -162.01 169.29 9.64 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.942 -1.026 . . . . 0.28999999999999998 108.721 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.468 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 32.3 Cg_exo -58.45 137.27 79.45 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.164 1.91 . . . . 0.26000000000000001 112.331 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.5 t -119.78 130.71 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.64000000000000001 110.757 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 91.9 mtp -115.89 124.2 50.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.574 . . . . 0.82999999999999996 109.449 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -82.5 152.88 25.86 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.238 -0.437 . . . . 0.54000000000000004 111.201 -175.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.742 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 89.7 mttt -91.27 141.8 26.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.704 -0.48 . . . . 0.67000000000000004 109.704 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.27 153.5 97.25 Favored 'Cis proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.074 -1.636 . . . . 0.75 112.788 1.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.6 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -145.45 130.73 18.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.34999999999999998 109.461 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 110' ' ' VAL . 15.5 t70 -67.11 127.62 33.31 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.974 -0.75 . . . . 0.51000000000000001 108.974 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.57 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.0 p -63.57 -25.12 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.777 . . . . 0.26000000000000001 112.269 -170.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.4 t -70.95 -36.53 72.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.565 -0.532 . . . . 1.3200000000000001 109.565 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 106' ' ' ASP . 15.4 m-20 -66.54 -46.2 76.89 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.512 -0.551 . . . . 0.62 109.512 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.509 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.3 t -60.14 -41.22 85.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 0.13 110.472 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.669 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.29 -51.4 60.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.566 -0.743 . . . . 0.13 111.446 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.67 -38.72 90.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.244 -0.434 . . . . 1.95 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.9 mmt180 -66.83 -28.64 68.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.43 . . . . 2.23 111.432 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -47.17 16.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.08 0.467 . . . . 0.14000000000000001 110.108 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.583 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 78.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.935 0.717 . . . . 0.27000000000000002 112.935 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.52 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.4 pt-20 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 2.79 110.677 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.468 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 63.5 mtm -76.09 -29.48 57.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.277 -0.42 . . . . 0.42999999999999999 111.352 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 10.7 p . . . . . 0 C--N 1.328 -0.335 0 CA-C-O 121.027 0.441 . . . . 1.46 110.192 176.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.447 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 18.3 mmt . . . . . 0 C--O 1.234 0.281 0 N-CA-C 110.541 -0.17 . . . . 1.6499999999999999 110.541 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 27.4 Cg_exo -62.64 132.22 36.83 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.306 2.004 . . . . 0.33000000000000002 110.881 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -86.68 103.31 15.03 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.399 -0.593 . . . . 0.89000000000000001 109.399 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.6 t -99.49 128.31 51.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.549 -0.75 . . . . 0.20000000000000001 110.616 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.568 ' HB2' HD12 ' A' ' 50' ' ' ILE . 55.2 tp -104.33 115.39 30.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.802 0.335 . . . . 0.75 111.034 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.43 122.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.294 0.569 . . . . 0.13 111.324 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.648 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 1.5 mm? -101.65 118.98 38.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.549 -1.278 . . . . 0.20999999999999999 107.549 169.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.746 ' CD ' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -161.43 158.43 26.7 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.952 -0.299 . . . . 1.4099999999999999 110.368 -174.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.44 -5.36 8.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.904 0.383 . . . . 1.27 110.635 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 42.2 mm-40 -109.82 103.18 52.7 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 2.5600000000000001 110.574 175.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.29 -26.85 72.42 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.058 2.506 . . . . 0.32000000000000001 113.235 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.58 -47.59 72.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.968 -0.753 . . . . 1.51 108.968 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.59 -46.22 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.371 -0.831 . . . . 1.01 111.005 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . 0.746 ' HB2' ' CD ' ' A' ' 12' ' ' GLU . . . -56.17 -49.84 72.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.285 -0.416 . . . . 0.20999999999999999 111.053 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.6 ttp -55.96 -42.4 76.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.588 -0.733 . . . . 0.60999999999999999 110.695 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.537 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.8 m-80 -68.95 -42.54 76.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 1.22 111.412 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.68 -44.96 88.65 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.611 0.243 . . . . 0.17999999999999999 110.538 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.487 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -55.65 -50.73 69.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.941 -0.572 . . . . 1.04 109.991 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.4 -27.75 66.49 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.78000000000000003 111.363 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.08 -49.12 60.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.869 0.366 . . . . 0.14000000000000001 110.527 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -66.26 -43.45 86.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.13 110.867 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 30.9 mt-10 -65.38 -28.6 69.39 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.936 -0.306 . . . . 0.68999999999999995 110.635 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.58 -32.96 66.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.51000000000000001 110.593 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -77.78 -20.16 53.8 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.042 0.449 . . . . 0.65000000000000002 110.417 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.46 62.24 0.63 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.575 -0.739 . . . . 0.28999999999999998 112.377 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -148.71 177.28 9.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.799 0.333 . . . . 0.23000000000000001 111.255 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 129.36 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.388 -0.597 . . . . 2.1400000000000001 109.388 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.487 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 15.1 t -115.04 135.55 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.584 0.587 . . . . 0.19 112.584 -167.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' OG ' ' A' ' 44' ' ' SER . 41.6 t -105.44 141.92 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.825 -0.806 . . . . 0.23000000000000001 108.825 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.2 t -112.74 126.01 70.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.537 0.208 . . . . 0.94999999999999996 110.709 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.49 134.77 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.16 111.047 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' GLU . . . -97.64 -22.67 16.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.282 0.563 . . . . 0.23999999999999999 111.082 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.3 p -117.31 159.76 22.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.856 -0.611 . . . . 0.25 110.668 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 m -64.36 -31.27 72.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.293 -0.632 . . . . 1.6000000000000001 109.293 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.52 -52.88 63.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 0.69999999999999996 110.96 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -57.79 -39.87 78.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.263 0.554 . . . . 1.4099999999999999 110.954 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -65.59 -50.49 64.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.374 -0.83 . . . . 0.17999999999999999 111.333 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.2 mt -63.47 -30.4 71.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.137 -0.483 . . . . 0.82999999999999996 111.08 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -66.76 -48.21 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.124 0.488 . . . . 2.4100000000000001 109.686 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.412 ' OG ' HG11 ' A' ' 33' ' ' VAL . 8.3 t -66.09 -33.48 75.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 1.1299999999999999 110.452 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -39.08 78.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.272 0.558 . . . . 1.23 110.135 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.65 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.831 -0.622 . . . . 0.42999999999999999 111.563 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.55 -36.51 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.62 111.355 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -118.12 163.65 23.84 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.218 -0.447 . . . . 0.41999999999999998 110.615 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -96.88 85.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 123.6 2.866 . . . . 0.23999999999999999 111.302 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.3 mm -62.32 119.95 7.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 0.22 111.552 -175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 23.2 m-20 -89.2 -30.52 18.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.675 -0.693 . . . . 0.28999999999999998 110.629 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.5 p -163.83 156.34 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.693 -0.685 . . . . 0.12 109.285 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.29 160.17 40.56 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.557 0.694 . . . . 0.14000000000000001 112.291 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -132.0 112.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.838 -1.074 . . . . 0.95999999999999996 109.124 175.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.814 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.7 mp -109.72 104.63 13.65 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.095 0.474 . . . . 0.16 111.943 -170.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.832 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -71.64 93.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.39 -0.823 . . . . 1.77 109.232 172.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 40.9 t -58.63 -27.41 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.552 . . . . 0.80000000000000004 111.499 -175.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.406 HD22 ' C ' ' A' ' 58' ' ' ASN . 0.3 OUTLIER -80.43 51.97 1.54 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.761 -0.654 . . . . 2.3700000000000001 112.397 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt -70.11 -24.48 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.84999999999999998 110.475 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.07 -178.12 46.05 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.97 -0.852 . . . . 0.81999999999999995 110.97 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.64 -36.13 97.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.613 2.209 . . . . 1.1799999999999999 112.015 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -114.51 -34.39 5.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 3.5299999999999998 110.122 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.0 m -65.64 125.81 26.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.899 -0.591 . . . . 0.95999999999999996 111.163 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -146.54 151.18 36.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.886 -0.597 . . . . 0.48999999999999999 110.812 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -74.89 87.34 2.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.916 -0.772 . . . . 1.3 108.916 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.83 -70.34 0.61 Allowed Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.369 -0.919 . . . . 0.23000000000000001 112.472 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.2 Cg_exo -52.62 -23.53 20.04 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.604 2.203 . . . . 0.23999999999999999 112.049 175.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 11' ' ' LEU . 24.5 t -70.3 -45.22 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.12 110.123 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.67 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.162 -0.926 . . . . 0.16 110.104 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 31.1 m-20 -63.53 -40.17 96.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.667 . . . . 2.0299999999999998 110.175 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.39 -49.17 75.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.512 0.672 . . . . 0.23000000000000001 110.601 176.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.58 -40.59 92.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.105 -0.952 . . . . 0.20000000000000001 110.526 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 73' ' ' LYS . 16.3 mmmt -59.29 -38.56 80.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.572 -0.74 . . . . 2.0099999999999998 111.157 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 13.0 mm100 -62.3 -45.6 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 2.3700000000000001 111.487 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -92.95 7.51 43.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 1.49 111.391 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.79 24.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.33000000000000002 111.427 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.64 134.43 50.83 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.552 -0.536 . . . . 0.17000000000000001 109.552 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 15.2 Cg_endo -73.25 139.52 29.37 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.076 1.851 . . . . 0.20999999999999999 111.406 177.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -160.82 156.66 25.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.054 -0.521 . . . . 0.17999999999999999 110.385 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -123.42 141.05 45.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.403 -0.817 . . . . 0.23999999999999999 109.881 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 96' ' ' ILE . 2.0 mm? -88.79 108.78 19.69 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.097 -0.705 . . . . 0.20999999999999999 109.097 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.832 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 15.1 t-160 -101.27 104.66 15.69 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.128 -0.693 . . . . 0.59999999999999998 109.128 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 4.3 t -151.85 151.86 31.86 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.32 -0.552 . . . . 0.60999999999999999 111.679 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.17 9.13 63.16 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.551 -0.75 . . . . 0.93999999999999995 111.471 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -149.89 122.33 8.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.853 0.358 . . . . 2.3300000000000001 111.429 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.615 HD12 HD21 ' A' ' 93' ' ' LEU . 3.2 mm? -118.68 7.66 11.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.386 -0.598 . . . . 1.6100000000000001 109.386 172.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -85.04 -54.62 4.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 111.566 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 8.0 mpt_? -77.47 -11.83 59.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.4199999999999999 111.113 -173.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -125.26 26.03 6.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 1.05 109.794 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.492 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -60.96 -38.61 95.74 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.97999999999999998 113.447 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.8 -25.87 68.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 2.5 110.709 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.68 -42.48 86.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.908 -0.587 . . . . 0.70999999999999996 110.85 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.615 HD21 HD12 ' A' ' 86' ' ' LEU . 2.3 mm? -60.41 -26.92 67.05 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.441 -0.345 . . . . 1.5800000000000001 111.108 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -66.66 -33.2 75.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 4.3799999999999999 111.026 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.42 -27.45 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 2.4500000000000002 110.287 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 81' ' ' LEU . 62.2 mt -79.74 -63.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.447 -0.797 . . . . 0.45000000000000001 111.115 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.0 t70 55.87 74.15 0.4 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.743 0.782 . . . . 1.0900000000000001 110.788 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.77 165.82 16.68 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.141 -0.936 . . . . 0.28999999999999998 109.225 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.52 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 43.4 Cg_exo -59.16 141.25 97.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.535 2.156 . . . . 0.26000000000000001 112.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.13 121.01 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.039 -0.528 . . . . 0.64000000000000001 111.16 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.444 ' O ' ' HD2' ' A' ' 82' ' ' HIS . 73.9 mmm -102.41 99.02 9.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.151 -0.685 . . . . 0.82999999999999996 109.151 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -74.97 159.5 31.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.169 -0.468 . . . . 0.54000000000000004 111.04 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 98.3 mttt -93.1 153.35 41.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.782 -0.644 . . . . 0.67000000000000004 110.469 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 15.5 Cg_exo -69.18 136.07 35.77 Favored 'Cis proline' 0 C--N 1.343 0.237 0 C-N-CA 123.648 -1.397 . . . . 0.75 112.328 -1.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.668 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -128.69 133.53 48.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.34999999999999998 110.038 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 110' ' ' VAL . 17.1 t70 -78.54 129.67 35.1 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 0.51000000000000001 108.616 176.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.537 HG21 ' HB3' ' A' ' 20' ' ' ASN . 19.9 p -64.11 -22.39 66.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.696 -0.683 . . . . 0.26000000000000001 112.236 -172.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 t -70.98 -40.68 71.77 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.452 -0.573 . . . . 1.3200000000000001 109.452 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.56 -44.27 91.27 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.149 -0.478 . . . . 0.62 109.967 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.7 t -61.62 -44.32 98.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.355 -0.839 . . . . 0.13 110.396 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.67 -51.43 67.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.749 -0.66 . . . . 0.13 111.215 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.7 mtpt -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 1.95 110.735 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -55.38 -40.03 70.84 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.314 0.384 . . . . 2.23 111.452 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.4 63.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.14000000000000001 110.845 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.41 -25.87 66.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.27000000000000002 111.988 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 mm-40 -57.18 -47.72 80.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.958 0.409 . . . . 2.79 110.395 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.52 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 52.8 mtm -72.34 -28.5 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.42999999999999999 110.718 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 50.5 t . . . . . 0 C--N 1.327 -0.39 0 CA-C-N 115.809 -0.632 . . . . 1.46 110.493 -179.128 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 56.6 mtt . . . . . 0 N--CA 1.454 -0.257 0 CA-C-O 120.506 0.193 . . . . 1.6499999999999999 110.798 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.545 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.0 Cg_exo -63.25 138.26 65.57 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.801 2.334 . . . . 0.33000000000000002 111.411 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -88.53 105.43 17.63 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.754 -0.461 . . . . 0.89000000000000001 109.754 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.8 t -100.18 135.72 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.695 -0.684 . . . . 0.20000000000000001 110.905 -175.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.494 ' HB2' HD12 ' A' ' 50' ' ' ILE . 41.1 tp -110.4 113.22 25.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.903 0.383 . . . . 0.75 110.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.83 120.04 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.342 0.592 . . . . 0.13 111.589 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm? -102.33 101.12 11.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.872 -1.058 . . . . 0.20999999999999999 108.89 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.55 118.43 3.2 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.389 -0.823 . . . . 1.4099999999999999 109.732 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 25.8 t70 -83.76 -19.76 34.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.068 -0.515 . . . . 1.27 110.068 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -84.2 102.87 2.37 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.537 -0.542 . . . . 2.5600000000000001 109.537 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 36.6 Cg_exo -58.9 -31.15 94.88 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.878 2.385 . . . . 0.32000000000000001 113.026 -173.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.39 -49.26 78.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 1.51 109.77 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.12 -43.49 78.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.653 -0.703 . . . . 1.01 110.67 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.84 74.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.506 . . . . 0.20999999999999999 110.732 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.4 ttp -64.6 -41.65 96.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.315 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.539 ' HB3' HG21 ' A' ' 107' ' ' THR . 16.9 m-20 -65.12 -46.44 80.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.297 -0.411 . . . . 1.22 110.977 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 45.7 mt -59.78 -46.43 89.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.464 -0.335 . . . . 0.17999999999999999 110.267 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.574 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 64.0 tt0 -52.29 -48.49 65.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.673 -0.694 . . . . 1.04 110.356 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -69.32 -31.89 70.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.78000000000000003 111.761 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.942 0.401 . . . . 0.14000000000000001 110.535 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.614 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 49.5 m-85 -67.4 -44.49 78.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.001 -0.545 . . . . 0.13 110.849 177.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 28.2 mt-10 -62.98 -32.62 74.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.618 0.247 . . . . 0.68999999999999995 110.602 177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.32 -35.19 80.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 110.163 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -81.08 -0.07 38.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 110.886 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 50.0 4.2 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.991 -0.623 . . . . 0.28999999999999998 112.322 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.22 167.34 21.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.829 0.347 . . . . 0.23000000000000001 110.903 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -108.01 144.68 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.156 -0.683 . . . . 2.1400000000000001 109.156 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.574 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 31.3 t -128.8 139.95 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.19 112.24 -170.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 44' ' ' SER . 14.2 t -111.71 136.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.665 -0.865 . . . . 0.23000000000000001 108.665 169.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.62 124.41 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 110.71 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.56 138.05 37.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.09 -0.504 . . . . 0.16 110.342 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.428 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -108.43 -5.55 16.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.395 -0.366 . . . . 0.23999999999999999 111.193 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.3 p -133.78 166.26 23.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.537 -0.302 . . . . 0.25 111.309 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.612 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 19.6 p -59.21 -49.28 78.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.334 -0.617 . . . . 1.6000000000000001 109.334 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -49.83 -55.36 14.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.42 -1.264 . . . . 0.69999999999999996 111.944 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.428 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 44.7 mt-30 -55.17 -46.44 75.79 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 110.876 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.11 -46.18 88.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.279 -0.873 . . . . 0.17999999999999999 111.838 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -66.0 -30.46 71.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.209 -0.451 . . . . 0.82999999999999996 110.451 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -67.32 -54.88 16.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 2.4100000000000001 109.48 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.405 ' HB3' HG11 ' A' ' 33' ' ' VAL . 15.1 m -62.29 -30.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.492 -0.322 . . . . 1.1299999999999999 111.373 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -62.12 -42.22 99.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 1.23 110.201 178.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.54 -32.03 22.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.265 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.18 -35.57 61.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.62 111.062 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -120.48 162.95 31.6 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.41999999999999998 110.427 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -95.39 82.96 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.34 2.693 . . . . 0.23999999999999999 111.363 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.9 mm -66.25 127.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.815 -0.63 . . . . 0.22 111.452 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.493 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.0 m-20 -99.25 -28.41 13.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 0.28999999999999998 110.703 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -162.11 157.09 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.587 -0.523 . . . . 0.12 109.587 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -144.03 165.63 27.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.14000000000000001 112.32 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.531 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.49 112.19 9.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.95999999999999996 109.533 176.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.1 mp -116.0 120.06 37.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.189 0.441 . . . . 0.16 112.189 -167.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -83.24 130.54 35.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.097 -0.705 . . . . 1.77 109.097 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.583 ' H ' ' HB ' ' A' ' 83' ' ' THR . 12.7 t -87.47 -6.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.16 -0.927 . . . . 0.80000000000000004 110.365 -173.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.404 HD22 ' CG ' ' A' ' 85' ' ' ASP . 53.3 t-20 -121.87 73.47 1.08 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.088 0.47 . . . . 2.3700000000000001 109.966 174.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.65 -24.09 59.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.506 0.669 . . . . 0.84999999999999998 109.468 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.42 -175.3 41.07 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.681 -0.967 . . . . 0.81999999999999995 110.681 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -52.6 -38.81 76.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.119 2.546 . . . . 1.1799999999999999 112.715 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -117.97 -34.57 4.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.486 -0.325 . . . . 3.5299999999999998 111.361 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -68.61 128.0 35.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.95999999999999996 111.488 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -144.32 157.15 44.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.71 -0.677 . . . . 0.48999999999999999 110.104 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 27.6 p -70.89 86.62 0.7 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.686 0.755 . . . . 1.3 109.549 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.38 -63.94 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.559 -0.829 . . . . 0.23000000000000001 112.009 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.24 -26.87 72.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.246 1.964 . . . . 0.23999999999999999 111.254 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.9 t -69.75 -45.92 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.627 -0.715 . . . . 0.12 110.171 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.34 90.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.162 -0.926 . . . . 0.16 110.29 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.603 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.5 t70 -69.05 -41.7 77.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 2.0299999999999998 110.205 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.7 77.99 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.297 0.57 . . . . 0.23000000000000001 110.715 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.418 HD23 HD21 ' A' ' 45' ' ' LEU . 91.4 mt -66.02 -46.33 78.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.3 -0.863 . . . . 0.20000000000000001 110.51 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -59.26 -28.7 66.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.065 -0.516 . . . . 2.0099999999999998 112.011 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 76.2 mt-30 -63.63 -48.06 78.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.768 0.318 . . . . 2.3700000000000001 110.974 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.05 7.66 39.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.34 -0.391 . . . . 1.49 111.361 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.54 42.69 20.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.33000000000000002 111.031 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 HG22 ' A' ' 50' ' ' ILE . 70.6 mt -88.33 132.34 39.61 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.148 -0.478 . . . . 0.17000000000000001 110.142 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.3 Cg_endo -74.85 140.05 25.42 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.477 2.118 . . . . 0.20999999999999999 111.759 177.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 25.7 p90 -157.22 160.86 39.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.969 -0.56 . . . . 0.17999999999999999 110.695 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -124.33 138.88 52.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.23999999999999999 110.013 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 96' ' ' ILE . 2.0 mm? -89.15 108.7 19.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.367 -0.605 . . . . 0.20999999999999999 109.367 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 14.7 t-160 -103.08 84.39 2.34 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.558 0.694 . . . . 0.59999999999999998 109.51 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.583 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 13.3 t -129.81 165.12 22.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.563 -1.199 . . . . 0.60999999999999999 110.329 -172.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.53 6.82 28.18 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.149 -0.78 . . . . 0.93999999999999995 111.149 173.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 2.2 m-20 -114.87 71.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 2.3300000000000001 110.48 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.0 mp -84.7 -33.27 23.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 1.6100000000000001 110.354 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.38 -34.51 36.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 2.6299999999999999 110.655 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -75.64 -23.05 56.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 4.4199999999999999 110.589 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.513 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 11.3 m170 -124.46 24.12 8.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.503 0.557 . . . . 1.05 112.503 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.4 -36.72 90.25 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.792 -0.718 . . . . 0.97999999999999998 112.486 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 44.2 mt-10 -63.18 -51.7 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 2.5 110.501 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.9 tp -60.46 -42.79 96.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.061 -0.518 . . . . 0.70999999999999996 110.472 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 77.1 mt -60.27 -38.3 83.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 1.5800000000000001 111.692 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 7.8 ptm180 -72.45 -26.9 62.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.815 0.34 . . . . 4.3799999999999999 110.463 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -78.3 -41.05 34.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.248 0.547 . . . . 2.4500000000000002 110.001 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.503 HG21 HD21 ' A' ' 81' ' ' LEU . 76.9 mt -60.61 -44.52 97.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.177 -0.92 . . . . 0.45000000000000001 110.529 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 39.0 t70 55.43 77.09 0.24 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.443 0.639 . . . . 1.0900000000000001 111.161 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.56 160.7 15.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.979 -1.01 . . . . 0.28999999999999998 109.113 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 36.4 Cg_exo -60.17 147.33 93.79 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.675 2.25 . . . . 0.26000000000000001 112.451 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.97 130.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 0.64000000000000001 110.915 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 82.5 mmm -114.3 107.54 15.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.782 -0.822 . . . . 0.82999999999999996 108.782 174.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.43 150.17 48.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.822 0.344 . . . . 0.54000000000000004 111.613 -176.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.07 139.96 25.85 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.586 -0.524 . . . . 0.67000000000000004 109.586 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.17 158.54 96.15 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.665 -1.39 . . . . 0.75 112.515 1.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.75 132.62 13.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.34999999999999998 110.097 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.2 t70 -65.49 127.91 33.77 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.89 -0.781 . . . . 0.51000000000000001 108.89 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 20' ' ' ASN . 19.3 p -64.67 -21.05 66.64 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 112.444 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.53 -37.79 65.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.339 -0.615 . . . . 1.3200000000000001 109.339 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.02 -44.81 91.45 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.62 109.53 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.531 HG12 HG11 ' A' ' 54' ' ' VAL . 21.3 t -63.24 -42.4 96.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 0.13 110.629 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.43 -50.53 67.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 0.13 111.454 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.63 -42.64 98.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.977 -0.556 . . . . 1.95 111.212 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.42 -31.07 71.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 2.23 111.247 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.57 -49.38 12.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.233 -0.44 . . . . 0.14000000000000001 111.016 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.461 HD23 HG11 ' A' ' 52' ' ' VAL . 67.4 mt -66.58 -26.16 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.884 0.698 . . . . 0.27000000000000002 112.884 -175.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 117' ' ' MET . 4.1 pt-20 -62.39 -33.47 74.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.12 0.486 . . . . 2.79 109.927 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.434 ' N ' ' HG3' ' A' ' 116' ' ' GLU . 47.6 mtm -77.47 -14.17 59.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.925 -0.58 . . . . 0.42999999999999999 110.893 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.1 t . . . . . 0 C--N 1.321 -0.653 0 CA-C-O 121.283 0.563 . . . . 1.46 109.799 177.087 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.467 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER . . . . . 0 N--CA 1.453 -0.298 0 CA-C-O 120.546 0.212 . . . . 1.6499999999999999 111.21 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.8 Cg_exo -67.03 135.45 37.58 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.792 2.328 . . . . 0.33000000000000002 111.222 175.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 39.8 tptt -85.92 106.14 16.9 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.513 -0.551 . . . . 0.89000000000000001 109.513 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.3 t -99.92 134.82 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.935 -0.575 . . . . 0.20000000000000001 110.979 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.7 tp -109.57 111.94 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.11 -0.496 . . . . 0.75 110.471 176.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.7 t -94.44 122.55 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.275 0.56 . . . . 0.13 111.736 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.75 102.93 13.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.921 -1.036 . . . . 0.20999999999999999 109.022 173.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -160.57 121.74 3.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.043 -0.526 . . . . 1.4099999999999999 110.289 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 38.3 t70 -92.85 -11.75 32.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 1.27 110.169 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.0 mt-10 -85.73 101.71 2.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.075 -0.713 . . . . 2.5600000000000001 109.075 171.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.0 Cg_exo -59.74 -28.87 88.3 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.752 2.301 . . . . 0.32000000000000001 113.459 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 3.5 tm? -65.76 -51.02 62.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.344 -0.613 . . . . 1.51 109.344 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -64.18 -43.78 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.91 -0.586 . . . . 1.01 110.055 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.82 63.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.672 -0.695 . . . . 0.20999999999999999 111.035 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 41.7 ttp -64.07 -39.28 93.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.597 -0.729 . . . . 0.60999999999999999 110.947 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.64 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.5 t-20 -65.28 -41.19 94.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.377 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.8 mt -62.6 -43.84 97.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.056 -0.52 . . . . 0.17999999999999999 110.407 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.532 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.1 tt0 -53.64 -51.43 63.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 1.04 110.062 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 29.4 m-85 -58.18 -39.35 78.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.78000000000000003 111.437 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.87 58.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.475 -0.329 . . . . 0.14000000000000001 110.994 -174.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 43.7 m-85 -63.27 -43.94 96.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.37 -0.377 . . . . 0.13 110.385 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.21 -39.23 82.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.005 0.431 . . . . 0.68999999999999995 110.575 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.83 -28.6 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.51000000000000001 110.812 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -84.04 4.43 30.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.99 0.424 . . . . 0.65000000000000002 110.513 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . 82.87 48.63 5.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.905 -0.665 . . . . 0.28999999999999998 112.432 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -135.75 175.8 9.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.705 0.288 . . . . 0.23000000000000001 111.135 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -113.23 145.64 40.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.77 -0.826 . . . . 2.1400000000000001 108.77 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.532 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.3 t -131.72 135.97 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.618 0.599 . . . . 0.19 112.618 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.54 136.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.549 -0.908 . . . . 0.23000000000000001 108.549 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.79 126.96 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.938 0.399 . . . . 0.94999999999999996 110.863 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' HE21 ' A' ' 40' ' ' GLN . . . -133.48 134.53 43.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.908 -0.587 . . . . 0.16 110.285 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.423 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -100.62 -10.24 21.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.126 0.488 . . . . 0.23999999999999999 110.806 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.508 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 70.7 p -127.64 165.53 19.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.853 -0.612 . . . . 0.25 110.185 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.578 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 78.1 m -72.1 -30.89 65.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.2 -44.17 84.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.69999999999999996 111.031 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.508 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 18.4 mt-30 -62.99 -35.8 81.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.308 0.575 . . . . 1.4099999999999999 110.31 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.668 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -64.74 -54.66 27.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.433 -0.803 . . . . 0.17999999999999999 111.401 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.9 mt -59.33 -33.42 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.82999999999999996 110.263 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -61.88 -53.85 50.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.454 -0.794 . . . . 2.4100000000000001 110.433 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.0 t -63.85 -38.72 92.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.934 -0.575 . . . . 1.1299999999999999 110.616 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.25 -36.28 81.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.126 0.489 . . . . 1.23 110.692 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.5 37.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.219 -0.446 . . . . 0.42999999999999999 111.319 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -80.46 -37.94 30.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.898 0.38 . . . . 0.62 111.637 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 24.0 m-80 -110.75 160.07 30.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.302 -0.408 . . . . 0.41999999999999998 110.448 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -94.85 84.32 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 123.5 2.8 . . . . 0.23999999999999999 111.695 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mm -67.81 128.29 30.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.698 -0.683 . . . . 0.22 111.499 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -95.4 -32.9 12.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.28999999999999998 110.362 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 12.4 p -158.08 158.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.12 109.382 -178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -140.26 168.03 20.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.421 0.629 . . . . 0.14000000000000001 111.476 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.526 HG21 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -140.69 121.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.853 -1.166 . . . . 0.95999999999999996 107.853 176.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.616 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -123.78 122.61 38.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.1 0.407 . . . . 0.16 112.1 -167.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.641 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 53.4 t0 -85.18 119.17 25.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 1.77 109.553 170.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.797 HG13 HD23 ' A' ' 92' ' ' LEU . 95.8 t -69.49 -28.84 39.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.052 -0.976 . . . . 0.80000000000000004 110.391 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -99.72 62.05 1.17 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.846 -0.616 . . . . 2.3700000000000001 110.393 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.81 -28.31 68.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.318 0.58 . . . . 0.84999999999999998 109.626 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.43 -171.94 41.44 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.559 -1.016 . . . . 0.81999999999999995 110.559 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.1 -45.37 41.18 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.556 2.17 . . . . 1.1799999999999999 111.858 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -107.18 -34.32 7.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 3.5299999999999998 110.454 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -68.55 125.27 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.227 0.537 . . . . 0.95999999999999996 111.364 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.491 ' HB2' HD22 ' A' ' 92' ' ' LEU . 16.8 p80 -146.6 148.52 32.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.778 -0.646 . . . . 0.48999999999999999 110.309 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.8 p -71.43 86.64 0.85 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.395 0.617 . . . . 1.3 109.734 172.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.85 -72.15 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.364 -0.922 . . . . 0.23000000000000001 112.407 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.9 Cg_exo -53.31 -26.38 34.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.731 2.287 . . . . 0.23999999999999999 112.023 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 11' ' ' LEU . 13.9 t -69.2 -48.32 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.113 0.483 . . . . 0.12 110.158 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.21 80.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.256 -0.884 . . . . 0.16 110.173 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.3 t70 -63.3 -39.05 93.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 2.0299999999999998 110.81 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.23000000000000001 110.905 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.87 -41.18 95.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.20000000000000001 110.162 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 2.7 mmpt? -59.37 -33.75 71.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.477 -0.783 . . . . 2.0099999999999998 111.195 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 24.1 mt-30 -64.09 -47.51 79.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 2.3700000000000001 110.964 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.88 5.58 39.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 1.49 111.089 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.01 32.6 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.689 -0.687 . . . . 0.33000000000000002 111.392 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.7 mt -82.11 133.07 51.74 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.925 -0.579 . . . . 0.17000000000000001 109.798 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -72.9 142.04 34.4 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.229 1.953 . . . . 0.20999999999999999 111.884 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 35.0 p90 -157.23 153.25 27.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 110.449 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -117.39 138.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.565 -0.743 . . . . 0.23999999999999999 109.526 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.5 mm? -88.48 108.09 19.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.113 -0.699 . . . . 0.20999999999999999 109.113 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.592 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.2 t-160 -101.47 76.87 1.72 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.804 -0.813 . . . . 0.59999999999999998 108.804 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.641 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 6.5 t -111.7 155.02 24.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.683 -1.144 . . . . 0.60999999999999999 111.795 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.56 2.16 58.78 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.543 -0.753 . . . . 0.93999999999999995 111.355 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 127.68 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.915 0.388 . . . . 2.3300000000000001 111.779 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.585 HD21 HG11 ' A' ' 100' ' ' VAL . 4.3 mp -117.72 0.63 12.06 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.083 -0.71 . . . . 1.6100000000000001 109.083 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.54 -61.47 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 2.6299999999999999 111.51 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -66.33 -37.77 86.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.546 . . . . 4.4199999999999999 110.213 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -104.22 33.02 3.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.125 -0.489 . . . . 1.05 110.355 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.462 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -62.53 -31.5 79.93 Favored Glycine 0 CA--C 1.511 -0.179 0 C-N-CA 121.15 -0.547 . . . . 0.97999999999999998 113.282 -176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.45 -27.84 69.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.127 0.489 . . . . 2.5 110.021 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.797 HD23 HG13 ' A' ' 57' ' ' VAL . 15.8 tp -71.32 -42.87 68.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.70999999999999996 110.419 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.462 HD23 ' HA2' ' A' ' 90' ' ' GLY . 3.1 mm? -55.61 -40.34 71.97 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.068 0.461 . . . . 1.5800000000000001 110.241 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.94 -26.63 66.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 4.3799999999999999 111.821 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.65 -37.03 36.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.256 0.55 . . . . 2.4500000000000002 110.239 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 92' ' ' LEU . 69.5 mt -75.98 -62.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.293 -0.867 . . . . 0.45000000000000001 111.876 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.23 81.56 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.676 -173.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.8 169.09 10.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.28999999999999998 109.341 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 33.7 Cg_exo -61.57 136.26 61.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.286 1.991 . . . . 0.26000000000000001 112.118 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.585 HG11 HD21 ' A' ' 86' ' ' LEU . 40.0 t -124.17 130.09 73.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.325 -0.398 . . . . 0.64000000000000001 110.994 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 98.1 mtp -117.05 106.43 13.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.445 -0.576 . . . . 0.82999999999999996 109.445 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.16 152.98 43.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.54000000000000004 111.507 -176.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.549 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.7 mttt -90.98 142.82 27.78 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.868 -0.605 . . . . 0.67000000000000004 110.032 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.15 158.66 93.6 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.457 -1.476 . . . . 0.75 112.711 1.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.592 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.62 131.16 12.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.34999999999999998 109.184 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 110' ' ' VAL . 36.6 t70 -68.05 128.23 35.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.42 -0.585 . . . . 0.51000000000000001 109.42 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.64 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.1 p -59.01 -27.99 65.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.815 -1.084 . . . . 0.26000000000000001 112.544 -172.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -64.9 -45.62 85.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.634 -0.506 . . . . 1.3200000000000001 109.634 176.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -61.68 -45.57 93.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.721 -0.474 . . . . 0.62 109.721 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.536 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 20.2 t -59.27 -43.09 89.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.13 110.423 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.62 -50.35 65.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.626 -0.716 . . . . 0.13 111.354 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 108' ' ' SER . 19.7 mtpp -60.19 -42.2 94.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 1.95 111.073 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 32.0 mmt180 -71.81 -28.11 63.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 2.23 111.403 -177.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.31 -48.49 17.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.368 . . . . 0.14000000000000001 110.119 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.527 HD23 HG11 ' A' ' 52' ' ' VAL . 82.1 mt -65.1 -26.29 68.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.862 0.69 . . . . 0.27000000000000002 112.862 -176.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -25.02 59.54 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.31 -0.556 . . . . 2.79 110.982 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.476 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 70.2 mtm -69.55 -36.08 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.42999999999999999 110.75 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.7 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-O 121.147 0.498 . . . . 1.46 110.397 176.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.6 ptp . . . . . 0 C--O 1.235 0.298 0 CA-C-O 120.937 0.399 . . . . 1.6499999999999999 110.753 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.65 148.01 28.64 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.659 2.239 . . . . 0.33000000000000002 113.1 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -95.78 107.82 20.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.437 -0.801 . . . . 0.89000000000000001 109.243 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 52' ' ' VAL . 57.1 t -100.6 133.56 43.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.096 -0.502 . . . . 0.20000000000000001 111.057 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HB2' HD12 ' A' ' 50' ' ' ILE . 43.5 tp -108.76 114.68 28.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.927 0.394 . . . . 0.75 110.402 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.3 t -95.82 120.76 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.34 0.59 . . . . 0.13 111.433 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.05 100.68 10.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.828 -1.078 . . . . 0.20999999999999999 108.873 172.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -157.4 117.48 3.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.408 -0.815 . . . . 1.4099999999999999 109.668 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.2 t70 -81.37 -20.91 39.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.062 -0.517 . . . . 1.27 110.225 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -82.31 105.44 4.72 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.573 -0.529 . . . . 2.5600000000000001 109.573 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.7 Cg_exo -58.32 -30.76 92.09 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.619 2.213 . . . . 0.32000000000000001 112.455 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.38 -49.89 73.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.048 0.451 . . . . 1.51 109.869 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.1 mt -69.39 -43.68 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 1.01 111.169 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.92 -45.23 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.47 . . . . 0.20999999999999999 110.303 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -61.95 -46.71 88.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.384 -0.826 . . . . 0.60999999999999999 111.214 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.457 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.4 m-80 -65.27 -40.99 94.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.136 -0.484 . . . . 1.22 111.372 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.88 -44.57 95.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.357 -0.383 . . . . 0.17999999999999999 110.266 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -56.36 -49.59 73.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 1.04 110.2 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -62.76 -34.37 77.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.204 -0.453 . . . . 0.78000000000000003 111.201 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -69.02 -51.03 43.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.14000000000000001 110.82 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 53.7 m-85 -63.54 -42.08 98.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.344 -0.389 . . . . 0.13 110.834 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.92 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.96 -0.296 . . . . 0.68999999999999995 110.626 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.8 -26.94 61.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.51000000000000001 110.818 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 69.6 mm-40 -82.51 -10.22 59.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.65000000000000002 110.356 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.32 51.36 1.59 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.28999999999999998 112.421 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.04 167.9 21.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.23000000000000001 110.958 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -106.35 141.89 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.943 -0.762 . . . . 2.1400000000000001 108.943 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -125.83 136.88 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.191 0.441 . . . . 0.19 112.191 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.406 HG11 ' OG ' ' A' ' 44' ' ' SER . 26.2 t -108.27 132.42 56.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.917 -0.771 . . . . 0.23000000000000001 108.917 168.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.14 124.0 56.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.964 0.412 . . . . 0.94999999999999996 111.088 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.89 143.61 43.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.029 -0.532 . . . . 0.16 110.344 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . 0.507 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -112.09 -8.59 14.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.461 -0.336 . . . . 0.23999999999999999 111.308 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 p -131.18 168.11 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.472 -0.331 . . . . 0.25 111.33 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.5 p -59.22 -50.08 75.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.379 0.609 . . . . 1.6000000000000001 109.434 172.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.05 -54.12 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.423 -1.262 . . . . 0.69999999999999996 112.215 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.507 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 44.0 mt-30 -56.91 -41.18 77.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.25 0.547 . . . . 1.4099999999999999 111.173 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -68.23 -45.9 72.0 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.43 -0.805 . . . . 0.17999999999999999 111.496 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.4 mt -66.52 -28.13 68.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.82999999999999996 110.481 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -66.76 -51.65 53.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 2.4100000000000001 109.831 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.406 ' OG ' HG11 ' A' ' 33' ' ' VAL . 17.3 t -63.56 -37.89 89.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.1299999999999999 110.792 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . 0.402 HD21 ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -57.51 -39.88 77.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 1.23 110.366 178.048 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.82 -34.87 30.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.801 -0.636 . . . . 0.42999999999999999 111.39 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -80.21 -38.44 31.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.62 111.568 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -116.13 161.29 31.87 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.188 -0.46 . . . . 0.41999999999999998 110.679 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -93.6 82.29 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.59 2.86 . . . . 0.23999999999999999 110.839 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' A' ' 9' ' ' LEU . 43.6 mm -64.84 116.1 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.348 -0.842 . . . . 0.22 111.563 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.73 -32.53 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.28999999999999998 110.375 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 115' ' ' LEU . 15.0 p -160.59 155.53 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.12 109.77 -176.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.11 167.8 21.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.325 0.583 . . . . 0.14000000000000001 111.677 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.463 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.4 111.18 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.447 -0.797 . . . . 0.95999999999999996 109.285 177.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.2 mp -115.09 123.41 48.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.141 0.423 . . . . 0.16 112.141 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.99 107.94 15.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.781 0.801 . . . . 1.77 109.816 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.758 HG13 HD23 ' A' ' 92' ' ' LEU . 38.2 t -59.17 -19.56 16.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.803 -1.09 . . . . 0.80000000000000004 111.868 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -122.0 70.03 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.531 . . . . 2.3700000000000001 110.72 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.437 HD11 ' SG ' ' A' ' 65' ' ' CYS . 94.9 mt -67.37 -27.85 67.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.84999999999999998 110.295 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.24 -160.7 16.54 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.763 -0.653 . . . . 0.81999999999999995 111.684 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.62 -46.03 36.47 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.897 2.398 . . . . 1.1799999999999999 112.203 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -126.22 -19.75 4.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.137 -0.483 . . . . 3.5299999999999998 110.271 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.6 m -63.47 125.89 25.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.95999999999999996 110.988 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -145.71 153.51 41.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.959 -0.564 . . . . 0.48999999999999999 110.643 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 15.3 m -77.47 85.81 3.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.637 -0.875 . . . . 1.3 108.637 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.76 -65.47 0.62 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.837 -0.697 . . . . 0.23000000000000001 112.689 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -54.77 -25.18 41.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.361 2.041 . . . . 0.23999999999999999 111.247 174.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -69.03 -46.91 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.723 -0.671 . . . . 0.12 109.998 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -58.2 -47.72 82.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.099 -0.955 . . . . 0.16 109.862 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.24 -39.26 94.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.786 -0.643 . . . . 2.0299999999999998 110.555 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -58.61 -44.62 89.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.23000000000000001 111.05 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . 0.402 ' CD2' HD21 ' A' ' 45' ' ' LEU . 90.7 mt -69.58 -46.24 66.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.631 -0.713 . . . . 0.20000000000000001 110.293 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 30.1 mmmt -56.06 -35.83 67.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 2.0099999999999998 111.582 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 1.5 pt20 -63.97 -41.46 97.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.908 -0.587 . . . . 2.3700000000000001 110.76 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 96.5 mtt180 -95.51 4.69 52.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.883 -0.598 . . . . 1.49 111.027 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.05 32.95 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.628 -0.715 . . . . 0.33000000000000002 111.266 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.0 mt -80.17 131.65 62.03 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 109.396 -0.594 . . . . 0.17000000000000001 109.396 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 43.2 Cg_endo -76.09 142.19 24.42 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.287 1.992 . . . . 0.20999999999999999 112.014 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 9.3 p90 -158.38 154.67 27.36 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.369 -0.832 . . . . 0.17999999999999999 110.185 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 mt -117.07 138.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.463 -0.79 . . . . 0.23999999999999999 109.781 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.463 HD21 HG21 ' A' ' 96' ' ' ILE . 2.6 mm? -88.5 109.86 20.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.987 -0.551 . . . . 0.20999999999999999 109.702 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.9 t-160 -104.88 86.52 2.47 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.387 0.613 . . . . 0.59999999999999998 109.756 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.537 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -135.85 161.7 34.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.001 -1.0 . . . . 0.60999999999999999 110.577 -172.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.34 22.16 9.01 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.604 -0.808 . . . . 0.93999999999999995 112.409 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.631 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 19.8 t70 -141.69 74.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.337 0.589 . . . . 2.3300000000000001 109.484 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 86' ' ' LEU . 3.3 mp -92.42 -22.94 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.823 -0.626 . . . . 1.6100000000000001 110.887 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -73.86 -48.29 32.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.93 0.395 . . . . 2.6299999999999999 110.625 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.631 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -75.88 -38.64 57.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.169 -0.469 . . . . 4.4199999999999999 110.74 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.493 ' O ' HD13 ' A' ' 93' ' ' LEU . 73.6 m-70 -89.48 17.29 6.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.978 -0.289 . . . . 1.05 110.984 177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.619 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -52.56 -42.51 58.03 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.39 -0.434 . . . . 0.97999999999999998 113.478 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.94 -34.71 65.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.939 0.4 . . . . 2.5 110.693 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.758 HD23 HG13 ' A' ' 57' ' ' VAL . 35.3 tp -72.64 -54.18 9.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.042 -0.526 . . . . 0.70999999999999996 111.514 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.674 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.66 -27.65 68.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.973 -0.691 . . . . 1.5800000000000001 111.823 -176.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 27.2 mmm180 -64.17 -46.35 84.37 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.849 -0.614 . . . . 4.3799999999999999 110.961 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.68 -36.14 83.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 2.4500000000000002 110.755 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 92' ' ' LEU . 79.0 mt -64.08 -49.42 81.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 0.45000000000000001 110.503 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.5 t70 58.76 74.52 0.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.607 0.718 . . . . 1.0900000000000001 110.897 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.94 21.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.916 -1.038 . . . . 0.28999999999999998 109.165 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 39.3 Cg_exo -58.74 143.83 98.55 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.455 2.103 . . . . 0.26000000000000001 112.452 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.61 132.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.238 -0.437 . . . . 0.64000000000000001 111.226 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.4 mmm -114.51 106.7 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.857 -0.794 . . . . 0.82999999999999996 108.857 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -67.9 147.61 52.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.023 0.439 . . . . 0.54000000000000004 112.161 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -90.85 141.98 27.23 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.848 -0.614 . . . . 0.67000000000000004 110.116 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.16 155.82 99.76 Favored 'Cis proline' 0 C--O 1.231 0.142 0 C-N-CA 123.137 -1.61 . . . . 0.75 112.389 -0.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.608 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -146.14 139.97 26.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 0.34999999999999998 109.969 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 110' ' ' VAL . 18.7 t70 -70.51 128.24 35.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.251 -0.648 . . . . 0.51000000000000001 109.251 174.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.457 HG21 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -68.86 -19.39 64.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.718 -0.674 . . . . 0.26000000000000001 112.756 -170.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 t -73.94 -37.49 64.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.206 -0.664 . . . . 1.3200000000000001 109.206 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -65.66 -46.48 79.0 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.112 -0.495 . . . . 0.62 109.779 175.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.5 t -58.88 -43.52 88.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.377 -0.829 . . . . 0.13 110.647 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.688 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.23 -54.03 39.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.853 -0.612 . . . . 0.13 111.454 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 61.7 mttp -57.5 -48.06 80.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 1.95 111.289 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 26.2 mmt180 -63.82 -34.71 78.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 2.23 111.415 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -46.71 70.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.058 0.456 . . . . 0.14000000000000001 110.27 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.547 HD23 HG11 ' A' ' 52' ' ' VAL . 86.8 mt -66.12 -25.6 67.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 0.27000000000000002 111.877 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 32.8 mm-40 -54.48 -41.04 69.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.537 -0.302 . . . . 2.79 111.388 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 77.6 mtm -70.89 -29.41 65.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.105 0.409 . . . . 0.42999999999999999 112.105 -176.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.7 t . . . . . 0 C--N 1.329 -0.288 0 CA-C-O 121.031 0.443 . . . . 1.46 110.433 -176.18 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.439 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 54.5 mtt . . . . . 0 C--O 1.233 0.202 0 CA-C-O 120.568 0.223 . . . . 1.6499999999999999 111.365 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -61.99 140.59 85.46 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.104 2.536 . . . . 0.33000000000000002 111.714 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -86.62 103.51 15.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.001 0.429 . . . . 0.89000000000000001 109.899 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' CG1' ' A' ' 52' ' ' VAL . 46.9 t -100.26 136.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.773 -0.649 . . . . 0.20000000000000001 110.977 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 53.7 tp -112.02 113.49 25.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.59 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.3 t -94.34 122.53 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.39 0.614 . . . . 0.13 111.164 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.677 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -101.79 107.42 18.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.812 -1.085 . . . . 0.20999999999999999 108.341 172.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -166.38 134.47 2.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 109.956 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.6 t70 -99.55 -23.58 15.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.383 -0.826 . . . . 1.27 110.069 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . 0.481 ' CB ' HD13 ' A' ' 17' ' ' ILE . 33.9 mt-10 -80.31 104.81 2.85 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 109.345 -0.613 . . . . 2.5600000000000001 109.345 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.2 Cg_exo -58.0 -32.68 95.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.014 2.476 . . . . 0.32000000000000001 113.435 -171.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.66 -49.68 74.17 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.697 -0.483 . . . . 1.51 109.697 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . 0.481 HD13 ' CB ' ' A' ' 14' ' ' GLU . 3.3 mp -66.32 -47.59 83.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.544 -0.753 . . . . 1.01 110.126 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.83 74.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.20999999999999999 111.228 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.4 ttp -64.46 -37.08 86.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.013 -0.539 . . . . 0.60999999999999999 110.949 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.524 ' HB3' HG21 ' A' ' 107' ' ' THR . 2.6 m-80 -69.16 -37.0 78.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.25 -0.432 . . . . 1.22 110.915 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.11 -45.89 83.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.42 -0.354 . . . . 0.17999999999999999 110.058 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.475 ' HA ' HG11 ' A' ' 32' ' ' VAL . 35.9 tt0 -51.86 -56.8 11.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.765 -0.652 . . . . 1.04 110.205 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -63.55 -27.65 69.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.859 -0.61 . . . . 0.78000000000000003 111.894 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.9 54.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.834 0.35 . . . . 0.14000000000000001 110.314 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.706 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 47.0 m-85 -66.08 -41.1 91.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 0.13 111.031 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.3 mt-10 -61.29 -37.04 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.68999999999999995 110.582 178.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.44 -29.78 68.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 0.51000000000000001 110.338 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -79.48 -13.48 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.65000000000000002 110.66 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.49 50.19 1.58 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.092 -0.575 . . . . 0.28999999999999998 112.399 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.81 165.52 26.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.591 0.234 . . . . 0.23000000000000001 110.898 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -109.27 128.2 54.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.261 -0.644 . . . . 2.1400000000000001 109.261 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 22' ' ' GLN . 37.8 t -113.23 133.98 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.787 0.662 . . . . 0.19 112.787 -167.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.97 139.91 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.169 -1.049 . . . . 0.23000000000000001 108.169 167.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.1 t -114.67 125.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.626 -0.43 . . . . 0.94999999999999996 110.879 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -133.54 136.39 44.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.878 -0.601 . . . . 0.16 110.174 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.16 -10.8 21.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.869 0.366 . . . . 0.23999999999999999 111.287 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.2 p -131.23 163.37 27.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.199 -0.455 . . . . 0.25 110.751 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.6 m -63.41 -33.76 76.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.757 -0.46 . . . . 1.6000000000000001 109.757 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.43 -51.61 67.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 110.618 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 46.8 mt-30 -58.98 -39.12 80.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.122 0.487 . . . . 1.4099999999999999 110.805 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -64.74 -49.83 69.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 0.17999999999999999 111.718 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.4 mt -63.25 -27.86 69.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 0.82999999999999996 110.497 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -67.42 -50.29 60.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.787 -0.642 . . . . 2.4100000000000001 109.769 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -65.47 -33.45 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 1.1299999999999999 110.586 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -37.51 77.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 1.23 110.656 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.8 -41.8 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 111.212 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.16 -37.19 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 0.62 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -122.72 162.5 38.28 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.166 -0.47 . . . . 0.41999999999999998 110.724 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -93.28 86.05 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.255 2.637 . . . . 0.23999999999999999 111.018 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 42.4 mm -64.01 119.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 0.22 111.523 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.42 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 41.5 m-20 -87.24 -35.7 18.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.28999999999999998 110.28 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.485 ' CG1' HG22 ' A' ' 8' ' ' VAL . 14.5 p -156.31 155.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.753 -0.658 . . . . 0.12 109.581 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -138.24 163.51 31.57 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.451 0.643 . . . . 0.14000000000000001 111.519 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.488 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -134.84 111.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.511 -0.922 . . . . 0.95999999999999996 108.511 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.71 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -108.01 107.31 17.94 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.711 -0.396 . . . . 0.16 111.802 -169.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . 0.843 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.1 t70 -84.97 139.04 32.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.098 -0.704 . . . . 1.77 109.098 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 ' SG ' ' A' ' 65' ' ' CYS . 14.4 t -93.93 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.731 -0.668 . . . . 0.80000000000000004 110.287 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -89.96 60.18 4.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.715 0.769 . . . . 2.3700000000000001 110.164 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.3 mt -89.77 -23.85 21.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.87 -0.605 . . . . 0.84999999999999998 110.067 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.68 -173.13 44.49 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.029 -0.828 . . . . 0.81999999999999995 111.029 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.58 -43.52 57.08 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.565 2.177 . . . . 1.1799999999999999 111.91 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.11 -23.55 6.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.918 -0.583 . . . . 3.5299999999999998 110.404 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -61.91 122.35 15.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.95999999999999996 111.068 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . 0.467 ' HB2' HG13 ' A' ' 57' ' ' VAL . 20.0 p80 -144.39 154.22 42.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.495 -0.775 . . . . 0.48999999999999999 109.993 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -70.05 87.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 1.3 109.866 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.57 -74.71 0.74 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.525 -0.845 . . . . 0.23000000000000001 112.523 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 46.5 Cg_exo -53.35 -24.76 28.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.695 2.264 . . . . 0.23999999999999999 112.302 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.2 t -66.33 -44.54 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.375 0.607 . . . . 0.12 109.918 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.43 92.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.918 -1.037 . . . . 0.16 109.966 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.88 -45.59 93.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.514 -0.766 . . . . 2.0299999999999998 110.458 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.05 -41.65 68.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.459 0.647 . . . . 0.23000000000000001 111.366 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.58 -44.84 56.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.375 -0.83 . . . . 0.20000000000000001 110.561 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -54.29 -41.37 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.455 -0.793 . . . . 2.0099999999999998 110.861 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -59.89 -46.44 89.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.708 -0.678 . . . . 2.3700000000000001 111.483 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -92.93 12.06 25.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 1.49 111.451 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.43 37.44 27.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.692 -0.685 . . . . 0.33000000000000002 111.66 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.25 133.53 38.49 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.282 -0.417 . . . . 0.17000000000000001 109.944 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 22.2 Cg_endo -74.99 142.11 27.47 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.298 1.999 . . . . 0.20999999999999999 112.04 177.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.479 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 18.7 p90 -159.34 154.94 25.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 110.562 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.4 mt -117.74 137.03 52.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.358 -0.837 . . . . 0.23999999999999999 109.624 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 98' ' ' ALA . 1.8 mm? -89.03 109.4 20.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.238 -0.653 . . . . 0.20999999999999999 109.238 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.843 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 t-160 -97.87 126.85 43.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.904 -1.147 . . . . 0.59999999999999998 107.904 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -169.39 151.23 4.44 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.753 -0.592 . . . . 0.60999999999999999 111.529 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.83 -8.78 59.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.896 -0.669 . . . . 0.93999999999999995 111.565 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -116.32 112.39 21.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.725 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.04 -10.31 15.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.807 -0.633 . . . . 1.6100000000000001 110.057 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -84.03 -60.33 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 2.6299999999999999 111.457 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -71.78 -40.67 69.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 4.4199999999999999 110.778 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . 0.486 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 89.8 m-70 -92.48 21.78 5.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.334 -0.394 . . . . 1.05 111.676 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.41 -39.12 97.4 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.924 -0.655 . . . . 0.97999999999999998 112.475 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.42 -41.61 97.43 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.936 0.398 . . . . 2.5 110.346 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 96' ' ' ILE . 63.8 tp -59.77 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.70999999999999996 110.502 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 40.6 mt -60.32 -40.84 92.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.819 -0.628 . . . . 1.5800000000000001 111.122 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -69.78 -25.53 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 4.3799999999999999 111.21 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.15 -32.01 56.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.445 0.641 . . . . 2.4500000000000002 110.232 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 92' ' ' LEU . 93.6 mt -77.35 -54.44 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.45000000000000001 110.912 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.95 76.58 0.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.839 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -158.93 168.16 12.97 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.157 -0.929 . . . . 0.28999999999999998 108.941 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.574 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 47.8 Cg_exo -58.74 140.57 95.55 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.425 2.083 . . . . 0.26000000000000001 112.625 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.85 142.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.64000000000000001 110.873 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.9 mmm -125.57 110.01 13.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.389 -0.597 . . . . 0.82999999999999996 109.389 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.67 150.2 37.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.54000000000000004 111.849 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HE3' ' OD2' ' A' ' 56' ' ' ASP . 77.8 mttt -91.18 140.97 25.9 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.67000000000000004 110.154 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 2.9 Cg_exo -75.35 146.93 87.5 Favored 'Cis proline' 0 C--O 1.233 0.247 0 C-N-CA 123.472 -1.47 . . . . 0.75 112.641 3.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.506 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -136.41 132.58 35.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 0.34999999999999998 110.275 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.7 t70 -73.32 128.07 34.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.51000000000000001 108.486 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.524 HG21 ' HB3' ' A' ' 20' ' ' ASN . 35.9 p -65.96 -17.77 64.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.876 -0.602 . . . . 0.26000000000000001 112.294 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.5 p -71.92 -41.78 67.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.947 -0.39 . . . . 1.3200000000000001 109.947 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.5 -42.16 87.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.139 0.495 . . . . 0.62 110.01 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 106' ' ' ASP . 20.5 t -62.62 -44.11 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.383 -0.826 . . . . 0.13 110.182 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.706 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.63 -51.33 57.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.619 -0.719 . . . . 0.13 111.854 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 52.8 mtpt -60.03 -48.16 82.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 1.95 111.244 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -62.46 -35.82 80.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.68 0.276 . . . . 2.23 111.399 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 52' ' ' VAL . . . -66.32 -46.84 75.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.94 0.4 . . . . 0.14000000000000001 110.041 177.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.64 -26.36 65.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.132 -0.486 . . . . 0.27000000000000002 111.887 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 50.7 mm-40 -56.78 -46.94 81.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.116 0.484 . . . . 2.79 110.375 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.574 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.1 mtm -76.06 -26.69 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 0.42999999999999999 110.76 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 53.4 t . . . . . 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 1.46 111.146 -177.454 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' MET . . . . . 0.429 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 86.3 mtp . . . . . 0 CA--C 1.514 -0.418 0 N-CA-C 108.708 -0.849 . . . . 1.6499999999999999 108.708 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 8.8 Cg_exo -63.52 131.42 31.62 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.854 1.703 . . . . 0.33000000000000002 111.372 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -86.01 102.94 14.25 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.507 -0.923 . . . . 0.89000000000000001 108.507 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.8 t -99.69 126.81 53.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.037 -0.529 . . . . 0.20000000000000001 111.087 -172.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.5 tm? -102.2 112.24 24.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.578 -0.737 . . . . 0.75 109.476 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.4 t -96.83 125.82 49.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.113 0.482 . . . . 0.13 111.409 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . 0.642 HD23 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.96 100.53 10.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.694 -0.854 . . . . 0.20999999999999999 108.694 173.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -157.5 118.17 3.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.907 -0.588 . . . . 1.4099999999999999 109.626 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 32.9 t70 -77.27 -21.2 53.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.848 -0.615 . . . . 1.27 110.223 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -88.05 106.88 13.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.905 -0.589 . . . . 2.5600000000000001 111.117 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 39.2 Cg_exo -58.53 -28.89 87.2 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.86 2.374 . . . . 0.32000000000000001 112.914 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -49.67 68.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.516 -0.55 . . . . 1.51 109.516 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.5 mt -66.37 -45.47 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.733 -0.667 . . . . 1.01 110.514 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.35 73.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 0.20999999999999999 110.82 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.6 ttp -59.37 -43.84 92.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.60999999999999999 111.238 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.9 m-80 -67.86 -38.71 83.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.926 -0.579 . . . . 1.22 111.34 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 mt -65.31 -44.83 86.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.17999999999999999 110.297 172.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLN . . . . . 0.615 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 52.2 tt0 -54.49 -51.89 63.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.466 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.09 -34.38 74.83 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.612 -0.267 . . . . 0.78000000000000003 111.116 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.9 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.504 -0.317 . . . . 0.14000000000000001 110.699 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.9 m-85 -68.64 -42.5 77.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.242 -0.435 . . . . 0.13 110.994 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 44.1 mt-10 -61.79 -35.54 78.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.586 -0.279 . . . . 0.68999999999999995 110.461 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.49 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.51000000000000001 110.657 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.81 -10.0 59.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.65000000000000002 110.455 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.63 50.56 1.81 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.28999999999999998 112.399 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -139.79 165.14 28.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.23000000000000001 110.833 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.86 134.97 53.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.422 -0.584 . . . . 2.1400000000000001 109.422 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.615 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.4 t -117.39 140.74 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.41 0.522 . . . . 0.19 112.41 -167.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.43 131.53 64.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.544 -0.91 . . . . 0.23000000000000001 108.544 168.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.6 t -105.43 121.15 57.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.94999999999999996 111.609 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.39 142.66 51.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.819 -0.628 . . . . 0.16 110.471 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.76 -12.6 15.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.899 -0.591 . . . . 0.23999999999999999 110.54 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' THR . . . . . 0.409 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 32.8 p -124.89 174.96 7.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.25 110.955 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' CYS . . . . . 0.611 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.9 m -75.11 -37.0 61.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.033 0.444 . . . . 1.6000000000000001 110.263 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.15 -41.19 90.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.69999999999999996 111.161 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 86.5 mt-30 -59.83 -37.29 78.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.078 0.466 . . . . 1.4099999999999999 110.857 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.57 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -71.46 -48.43 49.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.995 -0.548 . . . . 0.17999999999999999 110.879 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mp -56.02 -37.34 69.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.82999999999999996 110.68 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -63.1 -54.07 43.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 2.4100000000000001 110.444 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -63.99 -29.18 70.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.713 -0.676 . . . . 1.1299999999999999 111.711 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.4 -30.64 69.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.342 0.591 . . . . 1.23 110.513 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.53 -28.57 24.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.4 0.619 . . . . 0.42999999999999999 111.07 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -87.04 -21.68 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 0.62 111.52 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -137.68 163.67 46.69 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 0.41999999999999998 111.115 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -96.32 87.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.767 2.978 . . . . 0.23999999999999999 111.388 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 9' ' ' LEU . 37.9 mm -66.08 124.36 20.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.594 -0.73 . . . . 0.22 111.631 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.701 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 14.3 m-20 -89.48 -34.67 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.542 -0.754 . . . . 0.28999999999999998 110.421 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 115' ' ' LEU . 13.6 p -159.67 157.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.805 -0.634 . . . . 0.12 109.871 -176.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.8 164.53 29.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.359 0.599 . . . . 0.14000000000000001 112.008 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.492 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.65 110.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.353 -0.84 . . . . 0.95999999999999996 109.301 175.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.5 mp -112.7 121.86 45.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.415 -0.357 . . . . 0.16 111.631 -169.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.88 116.49 22.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 1.77 109.645 171.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' VAL . . . . . 0.579 HG13 HD23 ' A' ' 92' ' ' LEU . 92.9 t -67.37 -23.74 30.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.061 -0.972 . . . . 0.80000000000000004 110.463 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.38 56.94 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.544 -0.753 . . . . 2.3700000000000001 110.695 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.35 -37.32 85.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.939 -0.763 . . . . 0.84999999999999998 108.939 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.85 -171.61 29.29 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.149 -1.18 . . . . 0.81999999999999995 110.149 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.0 -46.26 34.92 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.498 2.132 . . . . 1.1799999999999999 111.862 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.99 -34.93 6.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.409 -0.36 . . . . 3.5299999999999998 110.874 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -62.33 123.56 18.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.325 0.584 . . . . 0.95999999999999996 110.92 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -144.79 152.27 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.551 -0.75 . . . . 0.48999999999999999 110.616 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -73.82 87.5 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.283 0.564 . . . . 1.3 109.811 173.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -106.51 -73.52 0.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.278 -0.963 . . . . 0.23000000000000001 112.598 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.4 Cg_exo -52.19 -27.1 28.68 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.23999999999999999 112.082 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' VAL . . . . . 0.642 HG11 HD23 ' A' ' 11' ' ' LEU . 17.0 t -68.23 -44.07 84.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.12 110.195 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.79 82.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.28 -0.873 . . . . 0.16 110.268 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.52 -42.47 98.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 110.253 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.37 69.34 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.51 0.672 . . . . 0.23000000000000001 110.92 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.6 -42.7 70.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.22 -0.9 . . . . 0.20000000000000001 110.642 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' LYS . . . . . 0.59 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.8 mmtt -60.47 -37.95 82.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.809 -0.632 . . . . 2.0099999999999998 111.11 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.52 -39.06 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 2.3700000000000001 111.441 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -97.46 10.98 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.257 -0.429 . . . . 1.49 111.159 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.82 33.18 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.33000000000000002 112.02 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.73 132.67 39.75 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.228 -0.442 . . . . 0.17000000000000001 110.071 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 18.6 Cg_endo -74.41 140.06 26.74 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.391 2.06 . . . . 0.20999999999999999 111.421 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 23.6 p90 -157.34 161.16 39.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.831 -0.622 . . . . 0.17999999999999999 110.493 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' A' ' 101' ' ' MET . 41.0 mt -124.21 140.95 46.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.288 -0.869 . . . . 0.23999999999999999 109.784 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.4 mm? -88.69 108.01 19.24 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.91 -0.774 . . . . 0.20999999999999999 108.91 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' HIS . . . . . 0.604 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 17.7 t-160 -99.49 82.42 2.65 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.593 0.711 . . . . 0.59999999999999998 109.722 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -137.98 157.97 45.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.426 -1.261 . . . . 0.60999999999999999 109.257 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.23 4.61 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.362 -0.923 . . . . 0.93999999999999995 111.955 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 12.9 m-20 -137.09 69.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 2.3300000000000001 111.458 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.46 HD11 HG11 ' A' ' 100' ' ' VAL . 82.2 mt -63.04 -34.77 78.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 1.6100000000000001 110.254 174.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -63.81 -29.17 70.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 2.6299999999999999 111.745 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -72.34 -21.6 61.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.232 0.539 . . . . 4.4199999999999999 110.508 -177.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -137.45 45.65 2.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 1.05 110.072 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLY . . . . . 0.763 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . -59.67 -27.06 63.35 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.97999999999999998 113.263 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.68 -25.16 63.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 2.5 110.642 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' LEU . . . . . 0.579 HD23 HG13 ' A' ' 57' ' ' VAL . 27.5 tp -77.22 -52.74 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.70999999999999996 111.884 -174.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -63.78 -23.94 67.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.178 0.513 . . . . 1.5800000000000001 111.545 -177.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' ARG . . . . . 0.543 ' N ' HD22 ' A' ' 93' ' ' LEU . 99.6 mtt180 -62.57 -34.26 76.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.186 -0.915 . . . . 4.3799999999999999 110.762 173.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -81.93 -33.68 30.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 2.4500000000000002 110.447 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ILE . . . . . 0.59 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 59.4 mt -74.34 -62.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.485 -0.78 . . . . 0.45000000000000001 111.606 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.13 76.81 0.21 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.408 0.623 . . . . 1.0900000000000001 111.471 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.42 164.83 19.37 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.28999999999999998 109.238 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.677 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.7 Cg_exo -56.52 144.26 85.14 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.668 2.245 . . . . 0.26000000000000001 113.003 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 86' ' ' LEU . 46.5 t -121.99 137.74 54.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.64000000000000001 110.751 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' MET . . . . . 0.471 ' HG2' HG21 ' A' ' 80' ' ' ILE . 86.6 mmm -117.56 105.55 12.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.702 -0.851 . . . . 0.82999999999999996 108.702 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.13 145.3 56.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.98 -0.554 . . . . 0.54000000000000004 111.861 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 87.4 mttt -91.34 140.89 25.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 0.67000000000000004 109.897 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.6 154.11 97.21 Favored 'Cis proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.567 -1.431 . . . . 0.75 112.472 2.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' ALA . . . . . 0.604 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 137.29 29.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.033 -0.531 . . . . 0.34999999999999998 110.216 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 110' ' ' VAL . 11.4 t70 -71.43 129.71 39.48 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.51000000000000001 108.468 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.9 p -67.18 -22.37 65.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.554 -0.748 . . . . 0.26000000000000001 112.542 -170.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 91.6 p -71.19 -37.42 72.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.653 -0.499 . . . . 1.3200000000000001 109.653 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -63.4 -46.68 85.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.323 0.583 . . . . 0.62 109.556 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.492 HG12 HG11 ' A' ' 54' ' ' VAL . 21.1 t -62.0 -44.88 99.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.991 -1.004 . . . . 0.13 110.62 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.46 -47.79 80.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.13 111.461 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 108' ' ' SER . 95.2 mttt -62.75 -44.76 95.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 1.95 111.403 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 33.4 mmt180 -64.1 -32.72 74.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.104 0.478 . . . . 2.23 111.091 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.57 -47.9 44.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.088 0.47 . . . . 0.14000000000000001 110.463 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LEU . . . . . 0.56 HD23 HG11 ' A' ' 52' ' ' VAL . 80.8 mt -69.75 -30.03 67.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.785 0.661 . . . . 0.27000000000000002 112.785 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.96 -31.61 72.62 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.763 -0.375 . . . . 2.79 110.715 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' MET . . . . . 0.677 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 55.7 mtm -70.79 -32.3 69.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.42999999999999999 110.802 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 42.0 t . . . . . 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 1.46 110.486 -179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.615 0 N-CA-C 112.388 -0.285 . . . . 8.8000000000000007 112.388 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -108.97 -9.55 15.1 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.96 0.409 . . . . 6.7800000000000002 110.408 178.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 94.5 mtp -85.0 -17.2 38.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.076 -0.511 . . . . 7.21 110.32 178.668 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -132.07 -142.52 4.95 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 110.915 -0.874 . . . . 1.8500000000000001 110.915 175.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -86.16 123.3 71.88 Favored Pre-proline 0 C--N 1.321 -0.635 0 CA-C-O 120.637 0.256 . . . . 1.6499999999999999 111.063 178.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 20.9 Cg_exo -69.57 145.83 59.45 Favored 'Trans proline' 0 C--O 1.235 0.354 0 C-N-CA 123.455 2.77 . . . . 0.33000000000000002 111.689 175.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 47.6 tptt -89.73 106.73 18.65 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.94 0.4 . . . . 0.89000000000000001 109.931 178.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.495 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 60.1 t -100.49 137.36 28.25 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 115.91 -0.586 . . . . 0.20000000000000001 111.062 -175.435 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.456 ' HB2' HD12 ' A' ' 50' ' ' ILE . 47.3 tp -111.11 116.92 31.94 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 116.305 -0.407 . . . . 0.75 110.323 174.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.4 t -100.77 121.75 51.94 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.56 0 CA-C-O 121.261 0.553 . . . . 0.13 111.362 179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.709 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -101.89 104.11 14.82 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 114.937 -1.029 . . . . 0.20999999999999999 108.658 172.915 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -161.21 113.47 1.87 Allowed 'General case' 0 C--N 1.315 -0.93 0 CA-C-N 115.903 -0.589 . . . . 1.4099999999999999 109.862 -175.967 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.524 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 33.6 t70 -84.08 -12.56 54.88 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 116.086 -0.506 . . . . 1.27 109.865 179.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -86.28 100.37 1.38 Allowed Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.347 -0.612 . . . . 2.5600000000000001 109.347 174.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.524 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.9 Cg_exo -60.18 -30.58 91.61 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 122.839 2.36 . . . . 0.32000000000000001 113.676 -171.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -63.62 -49.44 73.29 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.276 -0.638 . . . . 1.51 109.276 177.773 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 60.1 mt -65.97 -44.74 92.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.686 -0.688 . . . . 1.01 111.059 177.219 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.17 -49.72 75.06 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.849 0.356 . . . . 0.20999999999999999 110.905 179.495 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 50.5 ttp -60.6 -42.66 97.24 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.923 -0.581 . . . . 0.60999999999999999 110.871 177.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.475 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.0 m-80 -66.43 -40.3 89.42 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.027 -0.533 . . . . 1.22 111.164 -178.807 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.2 mt -62.98 -42.62 99.89 Favored 'General case' 0 N--CA 1.45 -0.464 0 CA-C-N 116.399 -0.364 . . . . 0.17999999999999999 110.443 174.422 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.465 ' CG ' ' HB ' ' A' ' 32' ' ' VAL . 1.5 tt0 -58.07 -50.95 71.69 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 116.166 -0.47 . . . . 1.04 109.809 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.2 m-85 -56.07 -36.26 67.9 Favored 'General case' 0 N--CA 1.461 0.097 0 CA-C-N 116.024 -0.535 . . . . 0.78000000000000003 111.109 175.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.32 -50.6 45.04 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.051 -0.522 . . . . 0.14000000000000001 111.105 -176.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.532 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 45.9 m-85 -64.81 -43.4 93.26 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.246 -0.434 . . . . 0.13 110.699 179.72 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.441 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 47.4 mt-10 -61.89 -35.08 77.29 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.685 0.279 . . . . 0.68999999999999995 110.553 177.625 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -67.89 -32.12 72.4 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.108 -0.497 . . . . 0.51000000000000001 110.592 179.276 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.3 mm-40 -78.49 -13.01 60.04 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.978 0.418 . . . . 0.65000000000000002 110.375 178.141 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 101.73 49.74 1.25 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.85 -0.613 . . . . 0.28999999999999998 112.232 179.86 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.441 ' O ' ' HA ' ' A' ' 26' ' ' GLU . . . -139.99 165.93 26.0 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.646 0.26 . . . . 0.23000000000000001 111.254 -179.311 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -108.67 142.87 38.53 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.818 -0.808 . . . . 2.1400000000000001 108.818 176.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.465 ' HB ' ' CG ' ' A' ' 22' ' ' GLN . 7.0 t -125.9 133.57 68.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 N-CA-C 112.238 0.459 . . . . 0.19 112.238 -169.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.417 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.5 t -104.26 124.61 58.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 108.844 -0.798 . . . . 0.23000000000000001 108.844 169.417 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 74.5 t -98.49 121.63 49.27 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.809 0 CA-C-O 120.915 0.388 . . . . 0.94999999999999996 110.824 -179.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.57 134.24 46.86 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.958 -0.565 . . . . 0.16 110.369 178.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.423 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -100.52 -9.66 21.84 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 116.059 -0.519 . . . . 0.23999999999999999 110.8 178.594 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 61.3 p -128.86 158.85 37.59 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.005 -0.543 . . . . 0.25 110.86 -176.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.538 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.6 m -64.27 -32.92 74.7 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.943 -0.392 . . . . 1.6000000000000001 109.943 173.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 48.0 mt-10 -64.1 -46.39 84.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.073 -0.512 . . . . 0.69999999999999996 111.142 -179.766 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.423 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 36.0 mt-30 -60.31 -42.64 96.0 Favored 'General case' 0 CA--C 1.519 -0.212 0 CA-C-O 121.336 0.589 . . . . 1.4099999999999999 110.436 175.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.709 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.85 -52.58 63.55 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.107 -0.951 . . . . 0.17999999999999999 111.732 -178.431 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -63.87 -29.53 70.71 Favored 'General case' 0 N--CA 1.45 -0.461 0 CA-C-N 116.041 -0.527 . . . . 0.82999999999999996 110.568 -178.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -66.97 -50.57 61.87 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.195 -0.668 . . . . 2.4100000000000001 109.195 176.225 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.417 ' OG ' HG11 ' A' ' 33' ' ' VAL . 8.7 t -65.45 -31.79 73.07 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.235 -0.439 . . . . 1.1299999999999999 110.466 179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -58.56 -42.93 89.05 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.018 -0.537 . . . . 1.23 110.544 177.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.23 -32.74 20.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 115.949 -0.569 . . . . 0.42999999999999999 111.383 -178.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 24.8 t0 -76.04 -37.36 58.42 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.647 -0.706 . . . . 0.62 111.45 -176.446 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -123.89 161.07 48.77 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-N 116.163 -0.472 . . . . 0.41999999999999998 110.34 -178.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -92.34 85.52 0.23 Allowed 'Trans proline' 0 N--CA 1.449 -1.146 0 C-N-CA 123.142 2.562 . . . . 0.23999999999999999 111.363 179.224 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.456 HD12 ' HB2' ' A' ' 9' ' ' LEU . 40.2 mm -64.62 117.64 5.57 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.766 0 CA-C-N 115.463 -0.79 . . . . 0.22 111.507 -175.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.577 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.8 m-20 -83.67 -33.49 25.2 Favored 'General case' 0 CA--C 1.515 -0.38 0 CA-C-N 115.649 -0.705 . . . . 0.28999999999999998 110.265 178.076 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.528 HG11 HD23 ' A' ' 115' ' ' LEU . 14.8 p -160.58 155.38 3.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 CA-C-N 115.647 -0.706 . . . . 0.12 109.574 -177.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.475 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -136.3 166.92 22.31 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.312 0.577 . . . . 0.14000000000000001 111.266 -179.756 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.567 HG21 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -141.17 120.75 11.67 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.078 0 N-CA-C 107.682 -1.229 . . . . 0.95999999999999996 107.682 175.624 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.657 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -122.29 118.82 29.43 Favored 'General case' 0 C--N 1.32 -0.686 0 N-CA-C 112.47 0.545 . . . . 0.16 112.47 -166.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -79.05 128.03 32.75 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.086 -0.709 . . . . 1.77 109.086 169.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.584 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 34.6 t -86.19 -22.52 7.19 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.031 0 CA-C-N 115.655 -0.702 . . . . 0.80000000000000004 111.118 -170.42 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -108.68 62.36 0.6 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 116.189 -0.46 . . . . 2.3700000000000001 110.639 -176.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 85.7 mt -63.0 -34.26 77.18 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.388 0.613 . . . . 0.84999999999999998 110.376 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.4 -173.84 36.63 Favored Glycine 0 N--CA 1.444 -0.802 0 CA-C-N 115.571 -0.74 . . . . 0.81999999999999995 111.384 177.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -54.89 -36.22 91.14 Favored 'Trans proline' 0 CA--C 1.528 0.208 0 C-N-CA 123.038 2.492 . . . . 1.1799999999999999 112.655 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' LYS . 1.3 tmtp? -119.67 -34.74 3.69 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.868 0.366 . . . . 3.5299999999999998 110.185 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.1 p -69.51 127.46 33.09 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.593 0.711 . . . . 0.95999999999999996 111.472 -177.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.0 p80 -145.36 150.14 36.04 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.261 -0.881 . . . . 0.48999999999999999 109.847 -176.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.657 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 30.7 p -69.7 87.03 0.49 Allowed 'General case' 0 CA--C 1.539 0.541 0 N-CA-C 109.18 -0.674 . . . . 1.3 109.18 171.008 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.33 -68.44 0.41 Allowed Glycine 0 CA--C 1.508 -0.365 0 C-N-CA 120.384 -0.912 . . . . 0.23000000000000001 112.282 -178.346 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.454 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 48.3 Cg_exo -52.95 -28.46 39.73 Favored 'Trans proline' 0 C--N 1.347 0.475 0 C-N-CA 122.268 1.978 . . . . 0.23999999999999999 111.532 174.134 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.487 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.7 t -68.56 -49.12 68.17 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.314 0 CA-C-O 121.407 0.622 . . . . 0.12 110.05 177.121 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.17 -46.37 88.57 Favored 'General case' 0 N--CA 1.45 -0.462 0 CA-C-N 114.887 -1.051 . . . . 0.16 110.292 179.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.509 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 20.8 t70 -66.01 -40.18 90.88 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.567 -0.742 . . . . 2.0299999999999998 110.516 179.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.69 -46.29 74.08 Favored 'General case' 0 C--O 1.233 0.226 0 CA-C-O 121.514 0.673 . . . . 0.23000000000000001 110.637 175.87 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.3 mt -67.28 -44.12 80.1 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.015 -0.993 . . . . 0.20000000000000001 110.373 178.467 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 30.6 mmmt -57.88 -37.13 73.4 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.519 -0.764 . . . . 2.0099999999999998 111.413 176.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.509 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 77.4 mt-30 -61.8 -47.88 83.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.113 -0.494 . . . . 2.3700000000000001 111.23 178.844 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 31.1 mtp180 -90.9 5.62 47.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.215 -0.448 . . . . 1.49 111.582 -176.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 31.29 19.27 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.891 -0.595 . . . . 0.33000000000000002 111.544 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.3 mt -81.49 131.48 58.2 Favored Pre-proline 0 N--CA 1.451 -0.418 0 N-CA-C 109.627 -0.508 . . . . 0.17000000000000001 109.627 178.491 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -72.95 143.14 36.03 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 122.293 1.996 . . . . 0.20999999999999999 112.208 -179.671 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 23.9 p90 -160.9 158.5 28.31 Favored 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.761 -0.654 . . . . 0.17999999999999999 110.619 179.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.43 HG21 ' HG2' ' A' ' 101' ' ' MET . 34.9 mt -123.6 138.23 54.13 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.89 0 CA-C-N 115.329 -0.85 . . . . 0.23999999999999999 109.837 179.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.55 ' HB2' ' HB ' ' A' ' 100' ' ' VAL . 2.6 mm? -88.22 108.19 19.17 Favored 'General case' 0 C--N 1.318 -0.764 0 N-CA-C 109.626 -0.509 . . . . 0.20999999999999999 109.626 179.022 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.615 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 22.3 t-160 -102.22 84.22 2.45 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 109.375 -0.602 . . . . 0.59999999999999998 109.375 -178.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.523 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 7.2 t -125.47 152.34 45.06 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.445 -0.798 . . . . 0.60999999999999999 111.242 -172.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.04 -8.16 55.63 Favored Glycine 0 N--CA 1.448 -0.507 0 N-CA-C 111.317 -0.713 . . . . 0.93999999999999995 111.317 175.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.455 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 2.7 m-20 -126.98 124.05 38.54 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 120.786 0.327 . . . . 2.3300000000000001 110.747 179.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 84.3 mt -107.13 -51.97 2.84 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-N 116.048 -0.524 . . . . 1.6100000000000001 110.535 179.596 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.6 t70 -63.55 -26.31 68.64 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.061 -0.518 . . . . 2.6299999999999999 111.388 -176.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.455 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 18.1 mmm180 -64.69 -20.03 66.09 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.998 -0.546 . . . . 4.4199999999999999 111.858 177.325 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 81.8 m-70 -144.31 40.01 1.32 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.654 0.264 . . . . 1.05 111.319 -176.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.37 -38.67 96.11 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 121.095 -0.574 . . . . 0.97999999999999998 112.783 -177.086 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 6.2 pt-20 -62.09 -41.6 98.36 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.044 0.449 . . . . 2.5 110.986 178.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.523 ' O ' HG13 ' A' ' 96' ' ' ILE . 18.9 tp -64.75 -46.97 79.95 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.70999999999999996 110.176 -179.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.409 HD21 HG21 ' A' ' 57' ' ' VAL . 36.0 mt -59.35 -38.26 79.94 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.588 -0.733 . . . . 1.5800000000000001 111.673 -178.115 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.612 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 10.9 ptt180 -67.69 -25.84 65.88 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.822 0.344 . . . . 4.3799999999999999 110.626 179.91 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.429 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 95.7 mttt -81.05 -37.71 28.62 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.131 0.491 . . . . 2.4500000000000002 110.278 177.393 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.523 HG13 ' O ' ' A' ' 92' ' ' LEU . 72.7 mt -65.01 -57.57 10.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.288 -0.869 . . . . 0.45000000000000001 110.455 179.509 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 17.9 t70 57.03 76.54 0.31 Allowed 'General case' 0 C--O 1.234 0.237 0 O-C-N 123.874 0.734 . . . . 1.0900000000000001 110.802 -178.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -158.04 163.22 25.27 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.618 -0.719 . . . . 0.28999999999999998 109.726 -178.179 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -62.09 140.85 86.33 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.933 2.422 . . . . 0.26000000000000001 112.151 178.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.55 ' HB ' ' HB2' ' A' ' 81' ' ' LEU . 1.1 m -127.64 149.64 32.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.191 0.52 . . . . 0.64000000000000001 110.824 179.464 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.43 ' HG2' HG21 ' A' ' 80' ' ' ILE . 74.0 mmm -121.47 107.9 13.01 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.373 -0.973 . . . . 0.82999999999999996 108.373 175.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.47 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -71.69 147.75 47.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 116.405 -0.361 . . . . 0.54000000000000004 111.446 -174.003 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.51 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.5 mttt -90.92 141.61 26.8 Favored Pre-proline 0 C--N 1.325 -0.481 0 CA-C-N 116.05 -0.523 . . . . 0.67000000000000004 109.866 177.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.41 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -73.29 148.19 91.5 Favored 'Cis proline' 0 C--O 1.234 0.28 0 C-N-CA 123.477 -1.468 . . . . 0.75 112.849 2.073 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.615 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -144.78 136.25 25.4 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.416 -0.811 . . . . 0.34999999999999998 109.328 178.487 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.8 t70 -70.69 127.46 32.73 Favored 'General case' 0 C--N 1.319 -0.752 0 N-CA-C 108.445 -0.946 . . . . 0.51000000000000001 108.445 175.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.475 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.4 p -62.56 -22.32 66.25 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.035 -0.984 . . . . 0.26000000000000001 112.233 -172.798 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.449 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 78.9 p -68.74 -42.26 77.81 Favored 'General case' 0 N--CA 1.454 -0.263 0 N-CA-C 109.82 -0.437 . . . . 1.3200000000000001 109.82 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -66.75 -38.64 87.05 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.091 0.472 . . . . 0.62 110.054 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.567 HG12 HG21 ' A' ' 54' ' ' VAL . 33.5 t -64.19 -43.62 97.36 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.283 -0.871 . . . . 0.13 110.106 177.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.532 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -68.47 -47.83 66.06 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.629 -0.714 . . . . 0.13 111.468 -179.057 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.579 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 7.5 mtmp? -56.35 -55.32 34.96 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.085 -0.507 . . . . 1.95 111.174 -178.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.428 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 35.6 mmt180 -62.1 -31.75 72.23 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.675 0.274 . . . . 2.23 111.578 -177.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -66.87 -47.85 70.59 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.923 0.392 . . . . 0.14000000000000001 110.188 177.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.528 HD23 HG11 ' A' ' 52' ' ' VAL . 84.3 mt -70.68 -26.29 63.36 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.141 -0.481 . . . . 0.27000000000000002 111.695 -179.556 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.579 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 8.0 mm-40 -60.64 -34.38 74.19 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.082 0.468 . . . . 2.79 110.61 174.778 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 47.9 mtm -82.46 -13.62 56.43 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.158 -0.474 . . . . 0.42999999999999999 110.597 177.288 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.577 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 53.1 t -86.6 -49.32 7.61 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.002 -0.544 . . . . 1.46 110.748 -178.38 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 167.75 158.76 12.26 Favored Glycine 0 N--CA 1.441 -0.982 0 C-N-CA 120.583 -0.818 . . . . 2.5699999999999998 112.044 179.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -167.17 -79.15 0.04 OUTLIER Glycine 0 N--CA 1.445 -0.765 0 N-CA-C 111.344 -0.702 . . . . 4.4800000000000004 111.344 179.017 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -149.43 108.26 3.86 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.861 -0.422 . . . . 6.4199999999999999 109.861 178.644 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 40.4 ttpt 71.01 115.74 0.05 OUTLIER 'General case' 0 N--CA 1.464 0.268 0 O-C-N 123.841 0.713 . . . . 9.1899999999999995 111.351 -177.849 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 13.5 mm-40 -61.45 129.41 91.06 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 115.651 -0.704 . . . . 9.5999999999999996 110.413 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -76.59 62.52 7.13 Favored 'Trans proline' 0 N--CA 1.464 -0.244 0 C-N-CA 122.484 2.122 . . . . 11.17 112.11 178.519 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.962 0 CA-C-O 118.449 -0.786 . . . . 13.279999999999999 110.2 179.455 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.763 0 N-CA-C 112.066 -0.414 . . . . 8.8000000000000007 112.066 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 70.78 141.52 0.05 OUTLIER 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 123.262 0.625 . . . . 6.7800000000000002 111.386 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -72.98 128.88 36.78 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.021 -0.536 . . . . 7.21 110.306 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 106.52 123.16 5.06 Favored Glycine 0 N--CA 1.444 -0.808 0 C-N-CA 120.765 -0.731 . . . . 1.8500000000000001 111.708 -179.228 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 64.7 mtt -75.94 134.9 71.09 Favored Pre-proline 0 C--N 1.321 -0.669 0 CA-C-O 120.539 0.209 . . . . 1.6499999999999999 110.936 -178.466 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.53 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.2 Cg_endo -71.65 141.37 37.74 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 122.236 1.957 . . . . 0.33000000000000002 110.86 174.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.402 ' HG3' HD13 ' A' ' 50' ' ' ILE . 48.6 tptt -86.65 103.15 14.85 Favored 'General case' 0 C--N 1.317 -0.838 0 N-CA-C 109.451 -0.574 . . . . 0.89000000000000001 109.451 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.49 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.9 t -100.09 134.51 39.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 CA-C-N 115.721 -0.672 . . . . 0.20000000000000001 110.726 -173.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.501 ' HB2' HD12 ' A' ' 50' ' ' ILE . 48.2 tp -111.54 113.44 25.85 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 120.863 0.363 . . . . 0.75 110.74 177.397 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 44.3 t -93.82 124.84 46.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-O 121.21 0.529 . . . . 0.13 111.599 178.477 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.773 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -105.59 101.37 10.9 Favored 'General case' 0 C--N 1.319 -0.726 0 CA-C-N 115.057 -0.974 . . . . 0.20999999999999999 108.921 173.673 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -159.5 129.52 5.59 Favored 'General case' 0 C--N 1.317 -0.831 0 CA-C-N 115.805 -0.634 . . . . 1.4099999999999999 109.782 -174.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.489 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 28.8 t70 -90.3 -20.4 22.96 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.325 -0.398 . . . . 1.27 110.499 -177.06 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -84.86 107.82 12.94 Favored Pre-proline 0 N--CA 1.438 -1.045 0 N-CA-C 109.308 -0.627 . . . . 2.5600000000000001 109.308 176.028 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.489 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 35.7 Cg_exo -57.96 -29.68 87.41 Favored 'Trans proline' 0 CA--C 1.517 -0.35 0 C-N-CA 122.723 2.282 . . . . 0.32000000000000001 112.264 -176.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -63.97 -51.33 64.81 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.456 -0.572 . . . . 1.51 109.456 176.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 61.6 mt -66.25 -43.38 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.114 -0.494 . . . . 1.01 110.437 179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG13 ' A' ' 34' ' ' VAL . . . -58.55 -49.69 76.49 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.886 -0.597 . . . . 0.20999999999999999 110.925 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.7 ttp -67.6 -35.93 79.9 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.93 -0.577 . . . . 0.60999999999999999 111.072 179.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.463 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.6 m-20 -66.02 -41.9 90.34 Favored 'General case' 0 N--CA 1.45 -0.442 0 CA-C-N 116.461 -0.336 . . . . 1.22 110.748 178.451 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 55.1 mt -64.43 -44.35 91.46 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 120.823 0.344 . . . . 0.17999999999999999 110.145 173.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.518 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 59.6 tt0 -52.71 -53.02 53.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.557 -0.747 . . . . 1.04 110.343 177.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -64.79 -29.37 70.34 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.142 -0.481 . . . . 0.78000000000000003 111.701 178.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -71.19 -46.22 61.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.971 0.415 . . . . 0.14000000000000001 110.76 -179.275 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.643 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.4 m-85 -67.93 -41.66 82.22 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.107 -0.497 . . . . 0.13 110.599 177.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 26.9 mt-10 -63.79 -30.21 71.33 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.711 0.291 . . . . 0.68999999999999995 110.728 177.583 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -68.52 -32.23 72.05 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.27 -0.423 . . . . 0.51000000000000001 110.374 175.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -82.49 8.17 12.37 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.171 -0.468 . . . . 0.65000000000000002 110.746 175.277 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 74.42 51.23 8.63 Favored Glycine 0 N--CA 1.447 -0.576 0 C-N-CA 121.136 -0.554 . . . . 0.28999999999999998 112.448 178.91 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.53 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -132.64 164.86 25.76 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-O 120.862 0.363 . . . . 0.23000000000000001 111.375 179.351 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.1 tt0 -108.08 125.97 52.2 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 109.173 -0.677 . . . . 2.1400000000000001 109.173 -178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.518 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.9 t -114.07 140.72 33.23 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 N-CA-C 112.509 0.559 . . . . 0.19 112.509 -168.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 32.4 t -112.41 140.34 32.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.507 0 N-CA-C 108.637 -0.875 . . . . 0.23000000000000001 108.637 169.281 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.431 HG13 ' HB1' ' A' ' 18' ' ' ALA . 84.1 t -111.26 124.7 68.29 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-O 120.773 0.321 . . . . 0.94999999999999996 110.92 -178.049 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.6 134.09 38.96 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.146 -0.479 . . . . 0.16 110.725 177.589 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.584 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.54 -3.23 28.85 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-O 121.019 0.438 . . . . 0.23999999999999999 110.674 177.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 77.4 p -137.71 159.83 40.91 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 116.01 -0.541 . . . . 0.25 110.719 -177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.632 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 87.6 m -60.32 -34.25 73.55 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.038 -0.528 . . . . 1.6000000000000001 110.208 170.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -63.14 -47.83 81.05 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.758 -0.656 . . . . 0.69999999999999996 111.012 -178.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.584 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 38.5 mt-30 -60.56 -37.98 83.05 Favored 'General case' 0 N--CA 1.456 -0.17 0 CA-C-O 121.374 0.607 . . . . 1.4099999999999999 110.696 175.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.773 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -65.78 -51.01 62.62 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.232 -0.894 . . . . 0.17999999999999999 111.708 -178.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.8 mt -60.88 -29.95 69.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.105 0.479 . . . . 0.82999999999999996 110.472 -179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.3 tttp -64.85 -52.22 57.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.654 -0.703 . . . . 2.4100000000000001 110.158 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 19.0 t -67.71 -34.26 76.51 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.926 -0.579 . . . . 1.1299999999999999 110.304 179.006 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.482 HD22 HG13 ' A' ' 50' ' ' ILE . 0.1 OUTLIER -58.68 -42.0 87.47 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.748 -0.66 . . . . 1.23 110.324 177.941 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.51 -33.92 28.13 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.245 -0.434 . . . . 0.42999999999999999 111.513 -177.344 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 29.3 t70 -81.75 -37.49 27.16 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.213 -0.448 . . . . 0.62 111.623 -175.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 43.3 m-80 -118.95 164.6 20.18 Favored Pre-proline 0 C--N 1.323 -0.55 0 CA-C-O 120.849 0.357 . . . . 0.41999999999999998 110.873 -176.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -95.05 86.96 0.11 Allowed 'Trans proline' 0 N--CA 1.447 -1.252 0 C-N-CA 123.47 2.78 . . . . 0.23999999999999999 111.441 177.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.2 mm -65.39 123.34 18.06 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.814 0 CA-C-N 115.664 -0.698 . . . . 0.22 111.252 -176.853 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.513 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 45.8 m-20 -93.18 -27.26 16.99 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.86 -0.609 . . . . 0.28999999999999998 110.726 -179.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.49 ' CG1' HG22 ' A' ' 8' ' ' VAL . 13.3 p -164.16 157.13 1.73 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 109.493 -0.558 . . . . 0.12 109.493 -178.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.447 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -142.82 165.48 27.26 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.279 0.561 . . . . 0.14000000000000001 112.006 -177.965 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.403 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.62 111.11 8.14 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 115.254 -0.884 . . . . 0.95999999999999996 109.165 176.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.587 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 8.8 mp -113.32 119.25 37.04 Favored 'General case' 0 C--N 1.317 -0.847 0 N-CA-C 112.064 0.394 . . . . 0.16 112.064 -168.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.8 t0 -74.69 132.49 41.72 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 108.231 -1.025 . . . . 1.77 108.231 167.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.596 ' H ' ' HB ' ' A' ' 83' ' ' THR . 22.9 t -86.21 -10.67 11.24 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.261 0 CA-C-O 121.386 0.612 . . . . 0.80000000000000004 110.029 -176.056 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -129.2 73.27 1.51 Allowed 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 115.814 -0.63 . . . . 2.3700000000000001 110.056 178.109 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.679 HD23 ' HA ' ' A' ' 64' ' ' HIS . 4.0 mm? -56.28 -51.43 68.19 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 115.864 -0.607 . . . . 0.84999999999999998 109.711 175.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -150.61 -157.62 7.87 Favored Glycine 0 N--CA 1.443 -0.873 0 CA-C-N 115.312 -0.858 . . . . 0.81999999999999995 111.184 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.5 Cg_exo -55.12 -45.1 43.21 Favored 'Trans proline' 0 C--O 1.233 0.232 0 C-N-CA 122.727 2.285 . . . . 1.1799999999999999 112.567 178.631 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.0 tptp -119.82 -33.87 3.89 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.26 -0.427 . . . . 3.5299999999999998 111.208 -178.635 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . 0.476 ' O ' ' HB2' ' A' ' 59' ' ' LEU . 20.1 m -65.5 126.56 28.68 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.997 0.427 . . . . 0.95999999999999996 110.99 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.679 ' HA ' HD23 ' A' ' 59' ' ' LEU . 11.1 p80 -144.86 163.26 34.64 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.96 -0.564 . . . . 0.48999999999999999 110.253 178.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.529 ' SG ' ' HA ' ' A' ' 57' ' ' VAL . 26.4 p -75.28 88.32 2.53 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 121.315 0.579 . . . . 1.3 109.955 175.619 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.05 -77.81 1.01 Allowed Glycine 0 C--O 1.228 -0.27 0 C-N-CA 120.091 -1.052 . . . . 0.23000000000000001 111.979 178.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.632 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.6 Cg_exo -51.65 -24.76 18.3 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 123.024 2.482 . . . . 0.23999999999999999 112.749 176.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.531 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 13.8 t -67.37 -48.58 77.2 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.439 0 CA-C-O 121.33 0.586 . . . . 0.12 110.117 177.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -57.53 -43.98 84.77 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 114.958 -1.019 . . . . 0.16 109.804 178.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.504 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 10.9 m-20 -64.63 -46.66 81.64 Favored 'General case' 0 C--O 1.221 -0.445 0 CA-C-N 115.459 -0.792 . . . . 2.0299999999999998 110.519 177.392 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.429 ' HB1' ' HG ' ' A' ' 45' ' ' LEU . . . -53.53 -45.9 69.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.536 0.684 . . . . 0.23000000000000001 110.697 179.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 98.6 mt -67.06 -46.89 72.98 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 114.952 -1.022 . . . . 0.20000000000000001 110.404 178.075 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.448 ' HD3' ' HA ' ' A' ' 73' ' ' LYS . 24.4 mmtp -61.17 -33.77 73.97 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 115.874 -0.603 . . . . 2.0099999999999998 111.977 179.359 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.504 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 80.6 mm-40 -69.7 -26.21 64.24 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.577 -0.283 . . . . 2.3700000000000001 111.405 -179.539 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -106.95 8.79 30.71 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.663 0.268 . . . . 1.49 111.244 177.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.31 35.2 24.7 Favored 'General case' 0 N--CA 1.464 0.256 0 CA-C-N 115.837 -0.619 . . . . 0.33000000000000002 111.705 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.3 mt -84.8 132.82 45.03 Favored Pre-proline 0 N--CA 1.45 -0.427 0 N-CA-C 109.894 -0.41 . . . . 0.17000000000000001 109.894 178.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_endo -75.36 141.65 25.88 Favored 'Trans proline' 0 N--CA 1.452 -0.931 0 C-N-CA 122.312 2.008 . . . . 0.20999999999999999 112.015 179.357 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.447 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 35.2 p90 -157.93 161.95 38.23 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.835 -0.62 . . . . 0.17999999999999999 110.735 179.45 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 39.5 mt -127.61 141.52 46.15 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.934 0 CA-C-N 115.25 -0.886 . . . . 0.23999999999999999 109.561 179.214 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.548 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 1.8 mm? -88.1 109.63 20.02 Favored 'General case' 0 C--N 1.318 -0.773 0 CA-C-O 121.156 0.503 . . . . 0.20999999999999999 109.669 178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.512 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 15.4 t-160 -101.35 77.62 1.8 Allowed 'General case' 0 C--N 1.314 -0.937 0 CA-C-O 121.816 0.817 . . . . 0.59999999999999998 109.188 179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.596 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 10.2 t -115.0 158.28 22.29 Favored 'General case' 0 C--N 1.316 -0.856 0 CA-C-N 114.501 -1.227 . . . . 0.60999999999999999 110.127 -175.718 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.74 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -108.34 -3.26 33.24 Favored Glycine 0 N--CA 1.444 -0.831 0 N-CA-C 111.22 -0.752 . . . . 0.93999999999999995 111.22 176.15 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.52 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 11.0 m-20 -126.22 66.6 1.21 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.304 0.573 . . . . 2.3300000000000001 110.075 -174.175 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.9 mp -68.04 -54.72 16.28 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.367 -0.833 . . . . 1.6100000000000001 111.129 -175.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -68.52 -20.42 64.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.322 -0.399 . . . . 2.6299999999999999 111.401 -175.419 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.52 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 1.1 mmp_? -74.16 -26.27 60.21 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.16 -0.473 . . . . 4.4199999999999999 110.927 174.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.443 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.6 m-70 -123.17 35.28 4.91 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.127 -0.488 . . . . 1.05 111.174 -176.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -59.67 -41.42 97.41 Favored Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 121.031 -0.604 . . . . 0.97999999999999998 113.01 -175.707 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -68.25 -37.8 81.13 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.656 0.265 . . . . 2.5 110.609 -179.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.564 HD23 ' CG1' ' A' ' 57' ' ' VAL . 34.8 tp -68.43 -39.98 81.36 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.317 -0.401 . . . . 0.70999999999999996 110.412 179.292 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.443 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.6 mt -58.96 -42.08 89.03 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.33 -0.395 . . . . 1.5800000000000001 110.729 176.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 78.6 mtp180 -64.91 -27.42 68.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.852 -0.613 . . . . 4.3799999999999999 110.964 178.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.3 mttm -75.75 -42.29 50.91 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.012 -0.54 . . . . 2.4500000000000002 110.614 176.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.44 HG21 HD21 ' A' ' 81' ' ' LEU . 78.7 mt -67.76 -52.44 40.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 115.506 -0.77 . . . . 0.45000000000000001 111.18 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 27.2 t70 61.26 77.49 0.33 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.123 0.487 . . . . 1.0900000000000001 111.037 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -163.89 163.42 15.78 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.624 -0.717 . . . . 0.28999999999999998 109.896 178.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.532 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.8 Cg_exo -56.97 149.82 59.45 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.804 2.336 . . . . 0.26000000000000001 112.847 178.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 40.9 t -127.74 132.4 69.0 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 116.248 -0.433 . . . . 0.64000000000000001 111.076 -177.34 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.8 mmm -113.99 100.42 8.4 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.121 -0.696 . . . . 0.82999999999999996 109.121 173.707 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.476 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.15 132.15 48.4 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.123 -0.489 . . . . 0.54000000000000004 111.884 -174.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.74 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 14.4 ptpt -97.2 150.33 36.7 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.148 -0.478 . . . . 0.67000000000000004 110.051 178.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.638 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 32.8 Cg_exo -60.05 127.96 3.93 Favored 'Cis proline' 0 C--N 1.347 0.484 0 C-N-CA 123.952 -1.27 . . . . 0.75 113.268 2.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.512 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -129.74 134.25 47.51 Favored 'General case' 0 CA--C 1.509 -0.617 0 CA-C-N 115.356 -0.838 . . . . 0.34999999999999998 109.253 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.483 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.1 t70 -67.21 121.96 16.79 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.904 -0.776 . . . . 0.51000000000000001 108.904 179.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.463 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.5 p -62.13 -24.37 67.12 Favored 'General case' 0 C--N 1.316 -0.876 0 CA-C-N 115.26 -0.882 . . . . 0.26000000000000001 112.474 -170.759 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.401 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -70.05 -40.72 74.93 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.798 -0.445 . . . . 1.3200000000000001 109.798 177.446 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.561 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 25.6 m-20 -69.17 -37.79 78.38 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 115.937 -0.574 . . . . 0.62 109.972 179.016 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.483 HG23 ' O ' ' A' ' 106' ' ' ASP . 34.0 t -64.31 -46.07 94.25 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 115.676 -0.693 . . . . 0.13 110.253 177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.643 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -60.37 -48.69 80.68 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 115.584 -0.735 . . . . 0.13 111.571 -178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.697 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 59.6 mtpt -59.12 -55.03 40.24 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.122 -0.49 . . . . 1.95 110.989 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.561 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 5.9 mpt_? -51.63 -43.14 62.49 Favored 'General case' 0 CA--C 1.529 0.17 0 N-CA-C 112.028 0.381 . . . . 2.23 112.028 179.839 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.69 -50.33 69.61 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.329 -0.396 . . . . 0.14000000000000001 110.725 -179.803 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.486 HD23 HG11 ' A' ' 52' ' ' VAL . 81.1 mt -65.91 -26.3 67.54 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.081 -0.509 . . . . 0.27000000000000002 111.572 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.697 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 24.2 mm-40 -60.75 -43.43 97.96 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.678 0.275 . . . . 2.79 110.965 177.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.532 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 48.9 mtm -71.14 -29.78 65.65 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 120.962 0.411 . . . . 0.42999999999999999 110.5 -179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.513 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 35.6 t -77.42 -54.04 6.93 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.787 -0.642 . . . . 1.46 110.691 -178.421 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -171.83 67.05 0.13 Allowed Glycine 0 N--CA 1.444 -0.8 0 C-N-CA 120.924 -0.655 . . . . 2.5699999999999998 112.224 -179.208 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -82.86 -73.34 1.24 Allowed Glycine 0 N--CA 1.447 -0.62 0 C-N-CA 120.895 -0.669 . . . . 4.4800000000000004 112.215 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -144.01 17.44 1.76 Allowed 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.109 0.48 . . . . 6.4199999999999999 110.858 -179.231 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -143.19 120.87 11.84 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.767 -0.651 . . . . 9.1899999999999995 110.535 179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -79.38 127.85 77.34 Favored Pre-proline 0 C--N 1.324 -0.513 0 N-CA-C 109.576 -0.528 . . . . 9.5999999999999996 109.576 175.162 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 40.9 Cg_endo -67.74 140.17 50.36 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.402 2.068 . . . . 11.17 112.119 -178.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.035 0 CA-C-O 118.423 -0.799 . . . . 13.279999999999999 110.753 179.847 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.772 0 N-CA-C 111.982 -0.447 . . . . 8.8000000000000007 111.982 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -128.94 45.19 2.84 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.101 0.477 . . . . 6.7800000000000002 111.042 -178.434 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 38.4 ttp -74.11 164.39 26.68 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.066 -0.516 . . . . 7.21 109.644 176.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -51.43 -70.69 0.8 Allowed Glycine 0 CA--C 1.511 -0.16 0 O-C-N 123.488 0.493 . . . . 1.8500000000000001 112.433 -178.608 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 79.5 mtp -102.77 119.98 54.08 Favored Pre-proline 0 C--N 1.319 -0.729 0 N-CA-C 109.57 -0.53 . . . . 1.6499999999999999 109.57 174.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -60.42 136.26 66.6 Favored 'Trans proline' 0 N--CA 1.462 -0.382 0 C-N-CA 122.939 2.426 . . . . 0.33000000000000002 111.989 -177.063 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.7 tptt -82.86 104.54 13.16 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 109.312 -0.625 . . . . 0.89000000000000001 109.312 179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.551 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 49.9 t -100.02 135.1 37.17 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.514 -0.766 . . . . 0.20000000000000001 110.559 -174.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.537 ' HB2' HD12 ' A' ' 50' ' ' ILE . 46.4 tp -111.99 111.84 23.05 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 120.94 0.4 . . . . 0.75 110.644 177.297 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 49.4 t -93.65 121.78 44.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 121.369 0.604 . . . . 0.13 111.332 177.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.581 ' HB2' ' HA ' ' A' ' 55' ' ' LEU . 1.0 OUTLIER -102.38 106.79 17.61 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 114.843 -1.071 . . . . 0.20999999999999999 108.857 172.618 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -165.36 125.15 1.8 Allowed 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.896 -0.593 . . . . 1.4099999999999999 109.663 -176.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -81.9 -26.5 34.06 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.863 -0.608 . . . . 1.27 109.607 -179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 20.2 mm-40 -78.71 108.65 8.49 Favored Pre-proline 0 C--N 1.329 -0.314 0 CA-C-N 115.68 -0.691 . . . . 2.5600000000000001 110.59 178.606 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -59.19 -35.09 98.26 Favored 'Trans proline' 0 CA--C 1.518 -0.29 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 112.949 -175.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 50.2 tp -63.88 -48.81 75.22 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-O 120.836 0.35 . . . . 1.51 110.278 179.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 67.6 mt -65.5 -45.59 92.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.979 -0.555 . . . . 1.01 110.541 178.314 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.31 -48.93 78.94 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.848 -0.614 . . . . 0.20999999999999999 110.902 178.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 32.6 ttp -65.21 -40.2 93.82 Favored 'General case' 0 N--CA 1.449 -0.499 0 CA-C-N 115.959 -0.564 . . . . 0.60999999999999999 111.08 179.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.541 ' HB3' HG21 ' A' ' 107' ' ' THR . 5.5 m-20 -64.27 -43.51 94.6 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.389 -0.369 . . . . 1.22 110.797 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 39.0 mt -61.72 -44.91 96.0 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 120.806 0.336 . . . . 0.17999999999999999 110.368 173.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.501 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.4 tt0 -53.32 -49.88 66.14 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 115.526 -0.761 . . . . 1.04 110.43 178.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -58.86 -37.85 77.43 Favored 'General case' 0 N--CA 1.462 0.146 0 CA-C-N 116.318 -0.401 . . . . 0.78000000000000003 111.466 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.39 -46.09 70.95 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.956 0.407 . . . . 0.14000000000000001 110.889 -176.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 66.1 m-85 -67.55 -43.8 79.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 116.286 -0.416 . . . . 0.13 110.938 178.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -59.78 -35.12 73.99 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.693 0.282 . . . . 0.68999999999999995 110.675 178.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -68.14 -34.75 76.92 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.974 0.416 . . . . 0.51000000000000001 110.767 179.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 18.7 mm-40 -77.12 -10.54 59.46 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.995 -0.548 . . . . 0.65000000000000002 110.979 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 95.4 49.34 2.21 Favored Glycine 0 N--CA 1.445 -0.749 0 C-N-CA 120.837 -0.697 . . . . 0.28999999999999998 112.279 179.29 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.09 163.69 29.74 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 110.357 -0.238 . . . . 0.23000000000000001 110.357 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -110.0 123.69 50.1 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.605 -0.517 . . . . 2.1400000000000001 109.605 -177.812 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.501 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.2 t -106.65 138.46 32.18 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.699 0 N-CA-C 112.526 0.565 . . . . 0.19 112.526 -168.19 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.0 t -114.61 133.22 61.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 108.377 -0.971 . . . . 0.23000000000000001 108.377 170.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.9 t -107.18 130.79 58.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.675 0 CA-C-O 120.77 0.319 . . . . 0.94999999999999996 111.025 -178.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.76 144.36 35.44 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.005 -0.543 . . . . 0.16 110.367 176.041 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -109.94 -3.79 16.34 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.572 -0.285 . . . . 0.23999999999999999 111.432 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 29.9 p -134.18 176.6 8.45 Favored 'General case' 0 C--N 1.326 -0.456 0 C-N-CA 121.086 -0.246 . . . . 0.25 110.677 -176.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.66 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 1.5 p -68.37 -48.08 65.7 Favored 'General case' 0 C--N 1.32 -0.716 0 N-CA-C 109.755 -0.461 . . . . 1.6000000000000001 109.755 172.419 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -58.25 -50.2 74.43 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.439 -0.801 . . . . 0.69999999999999996 111.779 -174.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 1.3 mp0 -58.69 -37.81 76.88 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 120.893 0.378 . . . . 1.4099999999999999 111.582 176.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.573 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -70.93 -49.46 45.47 Favored 'General case' 0 C--N 1.32 -0.683 0 CA-C-N 116.259 -0.428 . . . . 0.17999999999999999 111.084 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.66 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 73.7 mt -61.63 -26.27 67.89 Favored 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.619 -0.718 . . . . 0.82999999999999996 110.502 -179.152 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttpp -62.74 -56.7 15.18 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 2.4100000000000001 110.309 174.051 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.411 ' O ' ' HB2' ' A' ' 48' ' ' ASN . 28.8 t -70.32 -17.8 63.08 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.462 -0.336 . . . . 1.1299999999999999 111.094 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.418 ' HG ' ' HB1' ' A' ' 71' ' ' ALA . 0.2 OUTLIER -68.32 -41.48 80.79 Favored 'General case' 0 C--N 1.319 -0.737 0 N-CA-C 109.259 -0.645 . . . . 1.23 109.259 175.918 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.6 -44.22 12.06 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.143 -0.48 . . . . 0.42999999999999999 111.209 179.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 28.7 t70 -70.86 -37.19 73.09 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.037 -0.528 . . . . 0.62 111.619 -176.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.411 ' HB2' ' O ' ' A' ' 44' ' ' SER . 91.1 m-20 -114.57 150.04 43.24 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-O 121.322 0.582 . . . . 0.41999999999999998 110.863 -177.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.411 ' HD3' ' HA ' ' A' ' 48' ' ' ASN . 73.0 Cg_endo -86.21 81.14 1.62 Allowed 'Trans proline' 0 N--CA 1.455 -0.786 0 C-N-CA 123.322 2.682 . . . . 0.23999999999999999 111.767 177.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.537 HD12 ' HB2' ' A' ' 9' ' ' LEU . 44.1 mm -62.72 123.53 15.64 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.38 -0.827 . . . . 0.22 111.51 -176.102 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.407 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.4 m-20 -90.66 -37.79 13.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.633 -0.712 . . . . 0.28999999999999998 110.063 177.537 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.551 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 11.3 p -157.35 155.66 4.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 115.761 -0.654 . . . . 0.12 109.619 -176.317 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.78 162.62 35.0 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-O 121.431 0.634 . . . . 0.14000000000000001 112.063 -176.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.469 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -134.72 111.69 14.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.781 0 CA-C-N 115.092 -0.958 . . . . 0.95999999999999996 109.053 175.36 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.778 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.6 mp -112.96 114.99 27.71 Favored 'General case' 0 C--N 1.313 -0.998 0 N-CA-C 112.238 0.458 . . . . 0.16 112.238 -169.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.547 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 27.5 t70 -77.46 123.38 26.49 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.576 -0.898 . . . . 1.77 108.576 168.143 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.53 ' CG1' HD23 ' A' ' 92' ' ' LEU . 20.2 t -88.3 -10.8 10.71 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.042 0 CA-C-N 115.876 -0.602 . . . . 0.80000000000000004 110.363 -174.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 6.2 t30 -111.7 56.28 0.65 Allowed 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.824 -0.625 . . . . 2.3700000000000001 109.967 -179.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 79.7 mt -61.15 -26.82 67.96 Favored 'General case' 0 C--O 1.233 0.222 0 CA-C-N 115.744 -0.662 . . . . 0.84999999999999998 109.917 179.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -169.29 -168.43 31.27 Favored Glycine 0 N--CA 1.442 -0.944 0 N-CA-C 110.57 -1.012 . . . . 0.81999999999999995 110.57 175.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 52.2 Cg_exo -54.62 -43.1 62.15 Favored 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.662 2.241 . . . . 1.1799999999999999 111.737 176.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.2 mttp -115.26 -33.28 5.37 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.982 -0.554 . . . . 3.5299999999999998 110.755 178.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 19.9 m -58.05 123.52 16.2 Favored 'General case' 0 N--CA 1.454 -0.273 0 CA-C-O 121.265 0.555 . . . . 0.95999999999999996 111.253 -179.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 23.6 p80 -144.59 149.97 36.67 Favored 'General case' 0 C--N 1.318 -0.761 0 CA-C-N 115.513 -0.767 . . . . 0.48999999999999999 110.268 -178.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.778 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -73.38 86.03 1.49 Allowed 'General case' 0 N--CA 1.447 -0.624 0 N-CA-C 109.208 -0.664 . . . . 1.3 109.208 171.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.82 -71.57 0.81 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.396 -0.907 . . . . 0.23000000000000001 112.264 -178.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 43.9 Cg_exo -54.1 -25.77 38.71 Favored 'Trans proline' 0 N--CA 1.461 -0.399 0 C-N-CA 122.54 2.16 . . . . 0.23999999999999999 111.926 176.105 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.523 HG11 ' CD2' ' A' ' 11' ' ' LEU . 15.6 t -69.17 -48.25 69.82 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.291 0 CA-C-N 116.061 -0.518 . . . . 0.12 110.165 178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.53 -46.47 86.71 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.242 -0.89 . . . . 0.16 109.906 178.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.623 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 35.2 t70 -61.87 -42.94 99.66 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.207 -0.906 . . . . 2.0299999999999998 110.44 177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.418 ' HB1' ' HG ' ' A' ' 45' ' ' LEU . . . -56.33 -46.63 79.83 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.448 0.642 . . . . 0.23000000000000001 110.903 178.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.4 mt -64.48 -46.38 83.29 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.209 -0.905 . . . . 0.20000000000000001 110.188 177.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.418 ' HD2' ' HA ' ' A' ' 73' ' ' LYS . 11.1 mmmm -58.85 -33.85 70.91 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.612 -0.722 . . . . 2.0099999999999998 111.486 177.663 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.623 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 99.0 mt-30 -57.84 -47.85 81.48 Favored 'General case' 0 N--CA 1.466 0.356 0 CA-C-O 120.99 0.424 . . . . 2.3700000000000001 110.979 176.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -92.15 6.41 46.72 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.196 -0.456 . . . . 1.49 110.939 -178.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.15 31.84 21.6 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 115.729 -0.669 . . . . 0.33000000000000002 111.343 -179.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 91.4 mt -75.63 135.24 71.86 Favored Pre-proline 0 N--CA 1.449 -0.499 0 N-CA-C 109.685 -0.487 . . . . 0.17000000000000001 109.685 179.205 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' CG ' ' HB2' ' A' ' 118' ' ' CYS . 30.2 Cg_endo -75.56 138.65 21.97 Favored 'Trans proline' 0 N--CA 1.45 -1.068 0 C-N-CA 122.132 1.888 . . . . 0.20999999999999999 111.687 177.088 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 33.2 p90 -157.19 159.32 37.6 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 115.573 -0.739 . . . . 0.17999999999999999 110.285 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.1 mt -122.91 139.25 50.28 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-N 115.67 -0.695 . . . . 0.23999999999999999 109.825 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.411 HD21 HG21 ' A' ' 96' ' ' ILE . 2.4 mm? -88.84 108.37 19.49 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 109.611 -0.514 . . . . 0.20999999999999999 109.611 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.648 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.4 t-160 -103.0 71.8 1.15 Allowed 'General case' 0 C--N 1.315 -0.916 0 N-CA-C 108.775 -0.824 . . . . 0.59999999999999998 108.775 178.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.547 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 4.9 t -100.87 153.99 19.03 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 114.693 -1.14 . . . . 0.60999999999999999 111.99 -170.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.418 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -91.95 -6.58 65.12 Favored Glycine 0 N--CA 1.45 -0.423 0 CA-C-N 115.59 -0.732 . . . . 0.93999999999999995 112.348 176.582 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -138.34 129.89 27.75 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 120.865 0.364 . . . . 2.3300000000000001 110.762 177.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.1 mp -117.17 -4.35 11.43 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.894 -0.594 . . . . 1.6100000000000001 109.852 174.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 23.6 t70 -84.39 -59.82 2.27 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.877 -0.601 . . . . 2.6299999999999999 111.19 -177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 81.8 mtt180 -70.96 -41.55 70.91 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-O 121.389 0.614 . . . . 4.4199999999999999 110.781 -177.419 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.539 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 83.2 m-70 -87.58 14.57 8.08 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 115.46 -0.791 . . . . 1.05 110.732 -179.681 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.493 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -57.56 -49.92 69.53 Favored Glycine 0 C--N 1.331 0.278 0 C-N-CA 121.441 -0.409 . . . . 0.97999999999999998 113.332 -175.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -63.29 -40.04 96.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.999 0.428 . . . . 2.5 110.332 179.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.53 HD23 ' CG1' ' A' ' 57' ' ' VAL . 33.1 tp -59.67 -42.61 93.26 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.753 -0.658 . . . . 0.70999999999999996 110.303 178.132 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.539 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.4 mt -60.39 -35.45 75.77 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.939 -0.573 . . . . 1.5800000000000001 111.336 178.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.493 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 19.1 mmm180 -71.44 -27.42 63.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.095 0.474 . . . . 4.3799999999999999 110.904 -179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.0 mttt -74.22 -33.44 63.37 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.831 -0.622 . . . . 2.4500000000000002 109.955 175.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.435 HG13 ' O ' ' A' ' 92' ' ' LEU . 81.3 mt -71.42 -56.32 10.8 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.324 -0.853 . . . . 0.45000000000000001 110.999 178.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.0 t70 59.97 78.4 0.27 Allowed 'General case' 0 N--CA 1.466 0.34 0 CA-C-O 121.536 0.684 . . . . 1.0900000000000001 110.879 -178.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -161.11 163.14 21.06 Favored Pre-proline 0 C--N 1.326 -0.418 0 CA-C-N 115.267 -0.879 . . . . 0.28999999999999998 109.366 179.85 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -58.23 141.44 96.68 Favored 'Trans proline' 0 C--N 1.345 0.371 0 C-N-CA 122.589 2.193 . . . . 0.26000000000000001 112.437 -178.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 41.7 t -119.7 133.66 65.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.14 0.495 . . . . 0.64000000000000001 111.274 -177.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.476 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.8 mmm -118.94 91.28 3.52 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 108.712 -0.847 . . . . 0.82999999999999996 108.712 173.302 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.467 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.31 154.1 36.32 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.895 -0.593 . . . . 0.54000000000000004 111.735 -175.331 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 96.4 mttt -90.75 143.84 29.48 Favored Pre-proline 0 C--N 1.327 -0.386 0 CA-C-N 115.836 -0.62 . . . . 0.67000000000000004 109.747 177.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -75.9 140.4 66.03 Favored 'Cis proline' 0 N--CA 1.463 -0.299 0 C-N-CA 123.561 -1.433 . . . . 0.75 112.607 2.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.648 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -137.16 129.46 29.67 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 115.807 -0.633 . . . . 0.34999999999999998 110.273 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.516 ' O ' HG23 ' A' ' 110' ' ' VAL . 10.3 t70 -72.28 129.69 39.01 Favored 'General case' 0 C--N 1.318 -0.794 0 N-CA-C 108.966 -0.753 . . . . 0.51000000000000001 108.966 179.442 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.541 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.3 p -63.46 -22.67 67.02 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 115.271 -0.877 . . . . 0.26000000000000001 112.542 -171.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.433 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.6 p -68.77 -42.9 76.82 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.969 0.414 . . . . 1.3200000000000001 109.927 176.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.563 ' O ' ' HD3' ' A' ' 113' ' ' ARG . 45.4 m-20 -68.18 -41.26 81.72 Favored 'General case' 0 CA--C 1.512 -0.497 0 N-CA-C 109.548 -0.538 . . . . 0.62 109.548 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.516 HG23 ' O ' ' A' ' 106' ' ' ASP . 24.7 t -61.86 -44.59 99.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.556 -0.747 . . . . 0.13 110.519 178.82 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.15 -50.59 65.41 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.13 111.637 -178.508 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 108' ' ' SER . 30.6 mtpp -64.25 -40.67 96.48 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 116.091 -0.504 . . . . 1.95 111.61 -175.507 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.563 ' HD3' ' O ' ' A' ' 109' ' ' ASP . 10.2 mpt_? -63.55 -32.1 73.46 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-O 120.886 0.374 . . . . 2.23 111.77 175.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.55 -51.33 10.09 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.253 -0.43 . . . . 0.14000000000000001 111.053 -178.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.521 HD23 HG11 ' A' ' 52' ' ' VAL . 64.4 mt -63.5 -26.01 68.52 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 113.107 0.78 . . . . 0.27000000000000002 113.107 -174.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -71.14 -25.78 62.72 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 120.62 -0.432 . . . . 2.79 110.914 -179.635 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 65.6 mtm -71.61 -25.68 62.26 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.018 -0.537 . . . . 0.42999999999999999 111.161 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.423 ' HB2' ' CG ' ' A' ' 78' ' ' PRO . 45.2 t -151.43 67.96 0.91 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.283 0.563 . . . . 1.46 110.974 177.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -112.61 -5.41 24.23 Favored Glycine 0 N--CA 1.445 -0.708 0 N-CA-C 111.035 -0.826 . . . . 2.5699999999999998 111.035 174.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 121.69 -33.53 4.24 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 121.132 -0.556 . . . . 4.4800000000000004 111.726 -179.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 20.8 t70 -79.04 103.45 8.99 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.831 0.348 . . . . 6.4199999999999999 110.542 -177.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 33.2 mmtm -106.18 150.04 26.24 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.108 -0.496 . . . . 9.1899999999999995 110.321 178.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.5 mp0 -85.24 115.59 61.9 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.035 -0.529 . . . . 9.5999999999999996 111.021 -174.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -84.42 171.59 9.85 Favored 'Trans proline' 0 N--CA 1.458 -0.613 0 C-N-CA 122.709 2.273 . . . . 11.17 111.782 175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.034 0 CA-C-O 118.559 -0.734 . . . . 13.279999999999999 110.514 178.494 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.77 0 N-CA-C 112.053 -0.419 . . . . 8.8000000000000007 112.053 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -149.38 102.56 3.21 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.789 0.328 . . . . 6.7800000000000002 111.047 -179.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 ttt -103.02 -21.17 13.97 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.323 0.583 . . . . 7.21 110.548 178.546 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.31 -35.95 5.57 Favored Glycine 0 CA--C 1.509 -0.303 0 N-CA-C 111.362 -0.695 . . . . 1.8500000000000001 111.362 177.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.451 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 80.2 mtp -92.24 130.98 35.94 Favored Pre-proline 0 C--N 1.319 -0.725 0 N-CA-C 109.183 -0.673 . . . . 1.6499999999999999 109.183 175.175 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.431 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 33.6 Cg_exo -59.53 134.79 60.38 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.479 2.119 . . . . 0.33000000000000002 111.823 -179.381 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 14.4 tptp -83.64 103.81 13.25 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.326 -0.62 . . . . 0.89000000000000001 109.326 179.894 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 41.3 t -99.5 130.47 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.775 0 CA-C-N 115.815 -0.63 . . . . 0.20000000000000001 110.779 -174.769 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.434 ' HB2' HD12 ' A' ' 50' ' ' ILE . 49.9 tp -106.04 112.46 25.51 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.852 -0.613 . . . . 0.75 110.295 178.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 53.8 t -92.97 122.8 44.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 121.077 0.465 . . . . 0.13 111.613 179.577 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.44 101.04 10.93 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.284 -0.871 . . . . 0.20999999999999999 109.284 173.274 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -158.24 127.18 5.6 Favored 'General case' 0 C--N 1.314 -0.953 0 CA-C-N 115.448 -0.796 . . . . 1.4099999999999999 109.8 -175.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 35.5 t70 -89.41 -16.56 30.66 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.78 -0.645 . . . . 1.27 110.125 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 14.5 mm-40 -88.36 108.39 21.93 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.812 -0.631 . . . . 2.5600000000000001 110.301 173.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_exo -58.93 -34.94 99.33 Favored 'Trans proline' 0 C--N 1.343 0.284 0 C-N-CA 122.748 2.299 . . . . 0.32000000000000001 112.982 -174.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.478 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 59.8 tp -62.94 -49.7 73.71 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.736 0.303 . . . . 1.51 110.513 177.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 66.7 mt -63.95 -45.32 97.18 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.065 -0.516 . . . . 1.01 110.624 177.767 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 34' ' ' VAL . . . -57.54 -52.21 66.31 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.905 -0.589 . . . . 0.20999999999999999 110.784 178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.449 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 36.7 ttp -62.55 -37.29 85.55 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 115.556 -0.747 . . . . 0.60999999999999999 111.008 178.713 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.558 ' HB3' HG21 ' A' ' 107' ' ' THR . 8.0 t-20 -65.69 -47.8 74.19 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.115 -0.493 . . . . 1.22 110.501 -178.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.426 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 53.1 mt -60.26 -45.56 92.87 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-N 115.936 -0.575 . . . . 0.17999999999999999 109.888 174.522 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.558 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 57.7 tt0 -51.8 -50.42 60.82 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 115.131 -0.941 . . . . 1.04 111.063 178.168 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.449 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 17.5 m-85 -67.17 -32.38 73.43 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 121.139 -0.224 . . . . 0.78000000000000003 111.249 178.343 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -66.26 -43.85 85.29 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.84 0.353 . . . . 0.14000000000000001 110.827 -179.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.6 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -68.08 -45.76 72.89 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.189 -0.46 . . . . 0.13 110.644 177.679 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.43 ' HA ' ' O ' ' A' ' 30' ' ' ALA . 45.8 mt-10 -61.9 -30.19 70.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.474 -0.33 . . . . 0.68999999999999995 110.765 178.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.2 t70 -65.01 -41.56 95.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.149 -0.478 . . . . 0.51000000000000001 110.549 175.274 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.7 mm-40 -74.71 -15.62 60.78 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.37 -0.377 . . . . 0.65000000000000002 110.84 179.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 104.76 44.92 1.46 Allowed Glycine 0 N--CA 1.447 -0.592 0 C-N-CA 120.833 -0.699 . . . . 0.28999999999999998 112.559 178.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.451 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -134.21 153.62 51.74 Favored 'General case' 0 C--N 1.323 -0.586 0 O-C-N 122.771 -0.253 . . . . 0.23000000000000001 110.437 178.694 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -95.28 142.49 27.62 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 179.265 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.558 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 44.4 t -123.72 143.34 37.24 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 N-CA-C 112.48 0.548 . . . . 0.19 112.48 -170.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.501 HG11 ' OG ' ' A' ' 44' ' ' SER . 14.9 t -118.44 132.28 68.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.334 0 N-CA-C 108.955 -0.758 . . . . 0.23000000000000001 108.955 170.201 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.431 HG23 ' HB1' ' A' ' 18' ' ' ALA . 12.7 p -96.56 130.39 45.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.643 0 CA-C-O 121.028 0.442 . . . . 0.94999999999999996 111.601 179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -142.23 134.63 27.91 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.156 -0.475 . . . . 0.16 110.701 174.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.433 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.79 -13.14 17.83 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.267 -0.424 . . . . 0.23999999999999999 111.003 178.613 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.0 p -124.79 162.05 25.13 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 116.114 -0.494 . . . . 0.25 110.648 -176.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.68 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 67.1 m -66.32 -33.67 76.26 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 109.56 -0.533 . . . . 1.6000000000000001 109.56 175.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -63.27 -48.4 78.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.513 -0.767 . . . . 0.69999999999999996 111.045 179.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.433 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 38.9 mt-30 -58.28 -42.09 85.77 Favored 'General case' 0 C--O 1.233 0.197 0 CA-C-O 121.243 0.544 . . . . 1.4099999999999999 110.574 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.681 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.3 -53.01 62.23 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.142 -0.935 . . . . 0.17999999999999999 111.522 -179.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.599 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 86.9 mt -61.54 -28.68 69.5 Favored 'General case' 0 N--CA 1.452 -0.351 0 CA-C-O 121.071 0.462 . . . . 0.82999999999999996 110.96 -178.723 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -68.55 -53.47 22.78 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.915 -0.584 . . . . 2.4100000000000001 109.748 178.049 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.501 ' OG ' HG11 ' A' ' 33' ' ' VAL . 22.7 t -65.95 -34.77 78.87 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.252 -0.431 . . . . 1.1299999999999999 110.372 -179.77 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.7 tp -61.51 -35.56 78.04 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.69 -0.686 . . . . 1.23 110.776 179.268 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.52 -33.84 28.11 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.378 -0.374 . . . . 0.42999999999999999 111.118 179.848 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 31.5 t70 -79.43 -38.12 35.45 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 116.08 -0.509 . . . . 0.62 111.611 -176.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.9 m-80 -114.94 163.55 19.37 Favored Pre-proline 0 C--N 1.322 -0.599 0 CA-C-N 116.187 -0.46 . . . . 0.41999999999999998 110.753 -176.205 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -93.65 83.03 0.17 Allowed 'Trans proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.434 2.756 . . . . 0.23999999999999999 111.309 176.747 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.487 ' HA ' ' HB3' ' A' ' 7' ' ' LYS . 37.1 mm -65.74 122.21 16.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.712 0 CA-C-N 115.562 -0.745 . . . . 0.22 111.754 -174.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.766 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 32.5 m-20 -91.09 -32.47 15.86 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.115 -0.948 . . . . 0.28999999999999998 110.771 -178.759 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.571 HG11 HD23 ' A' ' 115' ' ' LEU . 14.4 p -160.2 158.3 2.45 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.597 0 CA-C-N 116.12 -0.491 . . . . 0.12 109.836 -178.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -143.19 161.09 39.17 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.156 0.503 . . . . 0.14000000000000001 111.907 -178.065 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.56 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -132.09 112.41 19.87 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.659 -0.7 . . . . 0.95999999999999996 109.682 174.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.792 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -112.47 121.8 45.86 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 116.23 -0.441 . . . . 0.16 112.083 -170.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.671 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.8 t0 -81.66 114.98 20.71 Favored 'General case' 0 C--N 1.328 -0.348 0 N-CA-C 108.86 -0.792 . . . . 1.77 108.86 168.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.528 ' H ' ' HB ' ' A' ' 83' ' ' THR . 17.2 t -76.53 -7.91 10.88 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.032 0 CA-C-N 115.038 -0.983 . . . . 0.80000000000000004 110.43 -178.217 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -126.13 65.93 1.21 Allowed 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.908 -0.587 . . . . 2.3700000000000001 109.778 179.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.08 -29.5 70.63 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.581 -0.736 . . . . 0.84999999999999998 109.621 178.227 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.09 -162.54 12.8 Favored Glycine 0 N--CA 1.444 -0.831 0 CA-C-N 115.151 -0.931 . . . . 0.81999999999999995 111.09 175.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -55.0 -38.76 93.19 Favored 'Trans proline' 0 CA--C 1.529 0.256 0 C-N-CA 122.89 2.393 . . . . 1.1799999999999999 112.676 177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.439 ' NZ ' ' HB2' ' A' ' 62' ' ' LYS . 4.5 ttmp? -126.35 -34.43 2.49 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.468 -0.333 . . . . 3.5299999999999998 110.792 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.3 p -60.48 127.61 32.56 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-O 121.476 0.655 . . . . 0.95999999999999996 111.054 -178.052 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 10.0 p80 -144.29 156.02 44.09 Favored 'General case' 0 C--N 1.319 -0.751 0 CA-C-N 115.412 -0.813 . . . . 0.48999999999999999 110.8 -174.165 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.792 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.8 p -70.49 86.79 0.63 Allowed 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.894 -0.78 . . . . 1.3 108.894 168.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -103.16 -74.82 1.04 Allowed Glycine 0 CA--C 1.507 -0.448 0 C-N-CA 120.191 -1.004 . . . . 0.23000000000000001 112.374 -176.751 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.68 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.9 Cg_exo -53.37 -26.19 34.22 Favored 'Trans proline' 0 N--CA 1.459 -0.554 0 C-N-CA 122.488 2.125 . . . . 0.23999999999999999 111.981 176.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.516 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 10.7 t -69.33 -44.79 80.08 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.264 0 CA-C-O 121.134 0.492 . . . . 0.12 110.381 179.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.43 -52.69 64.5 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.377 -0.828 . . . . 0.16 109.956 179.585 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 33.3 t70 -60.99 -38.18 85.11 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.107 -0.951 . . . . 2.0299999999999998 110.495 178.797 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -58.45 -49.1 78.53 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 121.355 0.597 . . . . 0.23000000000000001 111.03 178.307 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 90.1 mt -67.38 -39.7 85.66 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.402 -0.817 . . . . 0.20000000000000001 110.095 179.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 31.0 mmmt -59.55 -39.03 82.66 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.622 -0.717 . . . . 2.0099999999999998 111.171 175.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.502 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 55.0 mt-30 -65.56 -43.18 90.64 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.074 -0.512 . . . . 2.3700000000000001 111.216 178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 45.6 mtt180 -87.85 2.18 52.09 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.828 0.347 . . . . 1.49 110.813 -177.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.01 31.22 19.9 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-N 115.538 -0.756 . . . . 0.33000000000000002 111.454 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.4 mt -83.99 131.9 49.97 Favored Pre-proline 0 C--N 1.32 -0.684 0 CA-C-N 116.06 -0.518 . . . . 0.17000000000000001 109.775 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.459 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 25.6 Cg_endo -73.7 138.47 26.51 Favored 'Trans proline' 0 N--CA 1.45 -1.049 0 C-N-CA 122.166 1.911 . . . . 0.20999999999999999 111.62 178.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 8.9 p90 -157.02 157.39 34.59 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.609 -0.723 . . . . 0.17999999999999999 110.387 -178.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.7 mt -122.31 141.06 44.21 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.896 0 CA-C-N 115.609 -0.723 . . . . 0.23999999999999999 109.888 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD21 HG21 ' A' ' 96' ' ' ILE . 2.2 mm? -89.33 108.23 19.51 Favored 'General case' 0 C--N 1.318 -0.781 0 N-CA-C 109.78 -0.452 . . . . 0.20999999999999999 109.78 179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.634 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.6 t-160 -103.02 72.28 1.17 Allowed 'General case' 0 C--N 1.314 -0.942 0 N-CA-C 108.512 -0.921 . . . . 0.59999999999999998 108.512 177.44 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.671 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 10.2 t -99.77 155.01 17.87 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 114.276 -1.329 . . . . 0.60999999999999999 111.784 -170.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.424 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 0.9 59.39 Favored Glycine 0 N--CA 1.448 -0.536 0 CA-C-N 115.734 -0.666 . . . . 0.93999999999999995 112.898 178.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -154.78 121.08 5.3 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.835 0.35 . . . . 2.3300000000000001 110.258 178.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.3 mp -106.47 -22.89 12.65 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.183 -0.462 . . . . 1.6100000000000001 111.606 -175.047 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 4.6 p30 -83.87 -30.65 26.25 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 120.9 -0.32 . . . . 2.6299999999999999 111.213 -175.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 43.8 ttp180 -79.85 -10.08 59.74 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.348 0.594 . . . . 4.4199999999999999 110.348 177.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.538 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 99.5 m-70 -131.35 24.11 4.81 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.028 -0.533 . . . . 1.05 111.225 -176.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.419 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -63.73 -42.01 98.75 Favored Glycine 0 N--CA 1.453 -0.183 0 C-N-CA 120.851 -0.69 . . . . 0.97999999999999998 112.879 -175.396 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.643 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 33.1 mt-10 -71.66 -25.37 62.09 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 121.122 0.487 . . . . 2.5 110.369 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 57' ' ' VAL . 55.5 tp -74.53 -43.59 55.11 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.207 -0.451 . . . . 0.70999999999999996 110.224 174.861 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.538 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 74.1 mt -58.38 -37.7 75.81 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.038 -0.528 . . . . 1.5800000000000001 111.834 -179.286 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.643 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 36.5 ptt180 -65.24 -26.57 68.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.421 -0.354 . . . . 4.3799999999999999 110.912 179.813 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 60.3 mtpt -76.12 -35.27 59.36 Favored 'General case' 0 CA--C 1.517 -0.318 0 CA-C-O 121.157 0.503 . . . . 2.4500000000000002 110.136 177.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.486 HG21 HD21 ' A' ' 81' ' ' LEU . 55.8 mt -69.9 -52.15 33.77 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.731 0 CA-C-N 115.228 -0.897 . . . . 0.45000000000000001 110.445 -179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 14.0 t70 55.51 70.37 0.64 Allowed 'General case' 0 N--CA 1.465 0.295 0 CA-C-O 121.465 0.65 . . . . 1.0900000000000001 110.579 179.386 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -155.96 162.38 27.54 Favored Pre-proline 0 C--N 1.323 -0.545 0 CA-C-N 115.368 -0.833 . . . . 0.28999999999999998 109.349 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -57.24 141.22 94.53 Favored 'Trans proline' 0 C--N 1.345 0.35 0 C-N-CA 122.666 2.244 . . . . 0.26000000000000001 112.62 -178.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.7 t -118.62 134.68 61.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.146 -0.479 . . . . 0.64000000000000001 111.289 -178.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.479 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 78.6 mmm -119.44 90.57 3.36 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.656 -0.868 . . . . 0.82999999999999996 108.656 173.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.486 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -64.69 152.53 42.18 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.018 -0.537 . . . . 0.54000000000000004 111.691 -175.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.424 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 95.8 mttt -90.29 144.81 31.55 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-N 115.723 -0.671 . . . . 0.67000000000000004 109.844 177.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.6 Cg_exo -71.12 142.15 71.92 Favored 'Cis proline' 0 C--N 1.343 0.287 0 C-N-CA 123.561 -1.433 . . . . 0.75 112.433 0.697 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.634 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -139.83 130.18 25.38 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.83 -0.623 . . . . 0.34999999999999998 110.266 179.339 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.602 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.8 t70 -66.11 124.31 22.25 Favored 'General case' 0 C--N 1.318 -0.788 0 CA-C-N 115.711 -0.677 . . . . 0.51000000000000001 109.404 178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.558 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.4 p -62.56 -27.63 69.31 Favored 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 115.432 -0.803 . . . . 0.26000000000000001 112.238 -172.277 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.4 t -70.02 -40.1 75.41 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.615 -0.513 . . . . 1.3200000000000001 109.615 176.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.498 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -65.27 -43.98 89.49 Favored 'General case' 0 CA--C 1.513 -0.459 0 CA-C-O 121.086 0.469 . . . . 0.62 109.803 177.226 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.602 HG23 ' O ' ' A' ' 106' ' ' ASP . 23.4 t -60.75 -43.7 95.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.307 -0.86 . . . . 0.13 110.428 178.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.6 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.46 -50.53 67.14 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.797 -0.638 . . . . 0.13 111.171 179.192 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.618 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 54.9 mtpt -56.33 -55.53 32.27 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.939 -0.573 . . . . 1.95 111.341 -179.213 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.498 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 35.5 mmt180 -60.03 -35.46 75.16 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 120.877 0.37 . . . . 2.23 111.374 -175.036 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.08 -51.31 47.94 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.081 -0.509 . . . . 0.14000000000000001 110.541 178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.571 HD23 HG11 ' A' ' 52' ' ' VAL . 80.7 mt -63.52 -25.5 68.28 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.811 -0.631 . . . . 0.27000000000000002 111.848 -179.24 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 35.0 mm-40 -60.42 -26.53 66.78 Favored 'General case' 0 N--CA 1.462 0.167 0 CA-C-O 120.694 0.283 . . . . 2.79 111.236 176.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 67.9 mtm -85.81 -1.67 57.47 Favored 'General case' 0 C--O 1.234 0.289 0 CA-C-N 116.49 -0.323 . . . . 0.42999999999999999 111.369 -179.64 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.766 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 49.2 t -135.59 73.63 1.48 Allowed 'General case' 0 C--N 1.323 -0.544 0 CA-C-O 121.167 0.508 . . . . 1.46 110.044 178.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 96.26 31.19 7.34 Favored Glycine 0 N--CA 1.446 -0.684 0 C-N-CA 120.702 -0.761 . . . . 2.5699999999999998 112.371 178.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -107.76 42.79 1.84 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.929 -0.653 . . . . 4.4800000000000004 112.005 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 37.1 t70 73.3 154.51 0.15 Allowed 'General case' 0 N--CA 1.467 0.405 0 C-N-CA 123.471 0.708 . . . . 6.4199999999999999 110.933 -179.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 57.3 tttp 63.45 63.84 0.85 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 121.326 0.584 . . . . 9.1899999999999995 110.375 -179.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -78.07 122.52 85.49 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 115.743 -0.662 . . . . 9.5999999999999996 110.359 -179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -70.53 159.02 54.24 Favored 'Trans proline' 0 C--O 1.235 0.345 0 C-N-CA 122.505 2.136 . . . . 11.17 112.136 179.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.245 0.833 0 CA-C-O 118.544 -0.741 . . . . 13.279999999999999 110.697 -178.437 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.648 0 N-CA-C 111.833 -0.507 . . . . 8.8000000000000007 111.833 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -67.56 138.6 56.61 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-O 120.835 0.35 . . . . 6.7800000000000002 110.669 178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 22.3 ttt -66.48 -27.37 67.74 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-N 115.668 -0.696 . . . . 7.21 110.887 -177.29 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.72 -139.71 3.49 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 110.791 -0.923 . . . . 1.8500000000000001 110.791 176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.403 ' HG2' ' O ' ' A' ' 29' ' ' GLY . 90.8 mtp -114.32 119.79 39.52 Favored Pre-proline 0 C--N 1.318 -0.804 0 N-CA-C 110.032 -0.359 . . . . 1.6499999999999999 110.032 176.663 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_exo -67.24 137.73 44.66 Favored 'Trans proline' 0 C--O 1.235 0.346 0 C-N-CA 123.165 2.577 . . . . 0.33000000000000002 111.928 179.8 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -84.97 107.3 17.04 Favored 'General case' 0 C--N 1.321 -0.639 0 N-CA-C 109.342 -0.614 . . . . 0.89000000000000001 109.342 176.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' CG1' ' A' ' 52' ' ' VAL . 47.1 t -100.09 138.86 23.07 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.54 -0.754 . . . . 0.20000000000000001 110.809 -175.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 48.3 tp -111.23 115.66 29.73 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 116.398 -0.365 . . . . 0.75 110.276 174.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.2 t -99.17 123.47 51.85 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 121.231 0.539 . . . . 0.13 111.024 179.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.643 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.8 OUTLIER -103.78 106.01 16.39 Favored 'General case' 0 C--N 1.316 -0.865 0 CA-C-N 115.214 -0.903 . . . . 0.20999999999999999 109.326 174.782 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 7.6 tp10 -168.34 123.69 0.97 Allowed 'General case' 0 C--N 1.319 -0.76 0 CA-C-N 116.044 -0.526 . . . . 1.4099999999999999 109.761 -177.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.5 t70 -87.1 -19.99 27.75 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.745 -0.661 . . . . 1.27 110.1 -178.239 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.422 ' HB3' HD13 ' A' ' 17' ' ' ILE . 44.5 mm-40 -81.22 104.86 3.25 Favored Pre-proline 0 C--O 1.234 0.254 0 CA-C-N 115.878 -0.601 . . . . 2.5600000000000001 109.963 175.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.0 Cg_exo -58.07 -29.5 87.22 Favored 'Trans proline' 0 C--N 1.345 0.386 0 C-N-CA 122.919 2.413 . . . . 0.32000000000000001 113.427 -172.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tt -69.61 -50.74 41.56 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.879 -0.415 . . . . 1.51 109.879 -179.403 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.431 HD12 ' N ' ' A' ' 17' ' ' ILE . 2.6 mp -63.3 -44.08 98.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 116.108 -0.496 . . . . 1.01 109.736 177.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.64 -49.17 78.51 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 115.359 -0.837 . . . . 0.20999999999999999 110.557 178.208 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 41.0 ttp -59.33 -42.27 91.1 Favored 'General case' 0 N--CA 1.452 -0.367 0 CA-C-N 115.797 -0.638 . . . . 0.60999999999999999 111.068 176.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.512 ' HB3' HG21 ' A' ' 107' ' ' THR . 0.7 OUTLIER -64.38 -47.55 78.8 Favored 'General case' 0 N--CA 1.447 -0.589 0 CA-C-N 115.757 -0.656 . . . . 1.22 111.083 -179.443 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 35.9 mt -60.11 -46.1 90.74 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 116.39 -0.368 . . . . 0.17999999999999999 110.449 174.286 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.522 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 49.3 tt0 -54.47 -51.03 66.32 Favored 'General case' 0 N--CA 1.448 -0.529 0 CA-C-N 115.818 -0.628 . . . . 1.04 110.917 -179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -69.0 -27.29 65.56 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 120.857 -0.337 . . . . 0.78000000000000003 110.887 -178.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.68 -46.32 72.66 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 120.941 0.401 . . . . 0.14000000000000001 110.277 177.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.518 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 40.0 m-85 -66.9 -44.03 81.85 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.959 -0.564 . . . . 0.13 110.803 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 29.8 mt-10 -68.02 -28.04 67.07 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.537 -0.301 . . . . 0.68999999999999995 111.015 178.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -69.32 -27.81 65.7 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 121.314 0.578 . . . . 0.51000000000000001 109.983 176.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 27.8 mm-40 -84.71 2.45 41.86 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.727 -0.67 . . . . 0.65000000000000002 111.05 175.197 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.403 ' O ' ' HG2' ' A' ' 5' ' ' MET . . . 81.92 47.15 6.36 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.922 -0.656 . . . . 0.28999999999999998 112.632 178.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -129.15 175.98 8.27 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-O 120.633 0.254 . . . . 0.23000000000000001 110.363 177.033 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -120.82 134.29 55.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 109.514 -0.55 . . . . 2.1400000000000001 109.514 179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.522 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -116.07 135.79 55.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.71 0 N-CA-C 112.319 0.489 . . . . 0.19 112.319 -168.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -108.46 122.74 63.44 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 107.925 -1.139 . . . . 0.23000000000000001 107.925 166.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 46.1 t -101.57 124.73 55.52 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.955 0 C-N-CA 120.721 -0.392 . . . . 0.94999999999999996 110.697 -176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -130.11 139.31 50.93 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.934 -0.576 . . . . 0.16 110.702 -179.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.83 -11.35 18.36 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.966 -0.561 . . . . 0.23999999999999999 111.252 179.497 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 73.9 p -130.68 170.53 14.19 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.954 -0.298 . . . . 0.25 111.492 -177.575 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.559 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.2 p -60.84 -49.47 77.36 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.925 -0.579 . . . . 1.6000000000000001 109.646 171.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 47.8 mt-10 -52.24 -50.01 62.87 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 114.667 -1.151 . . . . 0.69999999999999996 111.764 -179.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 75.6 mt-30 -59.81 -37.02 77.97 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.192 0.52 . . . . 1.4099999999999999 111.187 178.504 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -71.38 -49.46 41.86 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.67 -0.695 . . . . 0.17999999999999999 111.225 -179.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.559 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 72.8 mt -63.5 -28.98 70.33 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.731 -0.668 . . . . 0.82999999999999996 110.158 -179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.42 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 7.5 tmtm? -63.93 -50.69 67.68 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 109.385 -0.598 . . . . 2.4100000000000001 109.385 173.51 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 30.2 t -64.65 -32.02 73.49 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.219 -0.446 . . . . 1.1299999999999999 110.878 -179.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -59.14 -41.81 89.16 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-O 121.123 0.487 . . . . 1.23 110.376 176.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.19 -38.26 20.82 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.058 -0.519 . . . . 0.42999999999999999 111.54 -178.698 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.33 -36.47 58.24 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.065 -0.516 . . . . 0.62 111.408 -174.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -122.16 162.11 39.23 Favored Pre-proline 0 C--N 1.324 -0.506 0 CA-C-N 116.345 -0.389 . . . . 0.41999999999999998 110.428 -176.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -92.82 88.24 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.303 2.669 . . . . 0.23999999999999999 111.149 176.02 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 47.1 mm -67.4 119.19 12.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.727 0 CA-C-N 115.715 -0.675 . . . . 0.22 111.52 -174.592 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.6 m-20 -91.06 -30.75 16.59 Favored 'General case' 0 CA--C 1.513 -0.466 0 CA-C-N 115.924 -0.58 . . . . 0.28999999999999998 110.197 178.45 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.515 HG11 HD23 ' A' ' 115' ' ' LEU . 12.0 p -160.88 157.31 2.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.593 -0.731 . . . . 0.12 109.409 -177.391 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.84 166.02 25.92 Favored 'General case' 0 C--N 1.314 -0.941 0 CA-C-O 121.456 0.646 . . . . 0.14000000000000001 111.239 179.406 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.501 HG21 HG12 ' A' ' 110' ' ' VAL . 0.3 OUTLIER -137.9 120.43 19.33 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.289 0 N-CA-C 107.747 -1.205 . . . . 0.95999999999999996 107.747 174.301 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.9 mp -116.36 109.17 16.99 Favored 'General case' 0 C--N 1.315 -0.93 0 C-N-CA 120.729 -0.388 . . . . 0.16 111.301 -170.272 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.79 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -80.67 97.78 7.41 Favored 'General case' 0 N--CA 1.447 -0.603 0 N-CA-C 108.8 -0.815 . . . . 1.77 108.8 174.39 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.418 ' O ' ' HA ' ' A' ' 64' ' ' HIS . 46.8 t -50.71 -31.18 9.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 115.212 -0.904 . . . . 0.80000000000000004 112.44 -170.815 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.8 t30 -95.75 80.08 3.37 Favored 'General case' 0 C--N 1.318 -0.772 0 CA-C-O 120.934 0.397 . . . . 2.3700000000000001 110.392 -179.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 94.1 mt -76.83 -14.45 59.9 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.563 0.697 . . . . 0.84999999999999998 110.09 177.01 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 178.88 -166.27 35.82 Favored Glycine 0 N--CA 1.439 -1.117 0 N-CA-C 110.754 -0.938 . . . . 0.81999999999999995 110.754 177.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_exo -53.71 -45.36 41.64 Favored 'Trans proline' 0 CA--C 1.53 0.294 0 C-N-CA 122.916 2.411 . . . . 1.1799999999999999 112.311 178.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 12.4 mptt -120.85 -22.14 6.35 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.371 -0.377 . . . . 3.5299999999999998 110.812 176.903 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 47.7 m -63.4 129.12 38.9 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 121.112 0.482 . . . . 0.95999999999999996 111.147 -178.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.418 ' HA ' ' O ' ' A' ' 57' ' ' VAL . 15.5 p80 -144.0 153.27 42.06 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.778 -0.646 . . . . 0.48999999999999999 110.282 -179.014 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.53 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 1.5 m -79.1 86.44 4.92 Favored 'General case' 0 C--N 1.324 -0.539 0 N-CA-C 108.827 -0.805 . . . . 1.3 108.827 172.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -104.55 -66.47 0.7 Allowed Glycine 0 C--N 1.328 0.132 0 C-N-CA 120.62 -0.8 . . . . 0.23000000000000001 112.392 -176.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -56.67 -23.76 50.87 Favored 'Trans proline' 0 N--CA 1.461 -0.396 0 C-N-CA 122.396 2.064 . . . . 0.23999999999999999 111.621 174.343 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.508 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.5 t -68.17 -47.74 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.363 0 CA-C-N 115.96 -0.564 . . . . 0.12 109.774 177.037 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.421 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.06 -47.73 80.27 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.99 -1.005 . . . . 0.16 110.087 178.381 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.411 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 19.3 t70 -64.09 -36.41 83.94 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.002 -0.545 . . . . 2.0299999999999998 110.571 179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.667 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -62.93 -40.48 97.76 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 121.409 0.623 . . . . 0.23000000000000001 110.888 178.408 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -72.69 -43.87 62.51 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.595 -0.73 . . . . 0.20000000000000001 110.529 176.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.421 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 28.2 mmmt -57.33 -39.58 76.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.565 -0.743 . . . . 2.0099999999999998 111.166 176.699 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.667 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 6.8 pt20 -64.88 -37.76 88.71 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.533 -0.758 . . . . 2.3700000000000001 110.957 -177.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG3' ' CG ' ' A' ' 74' ' ' GLN . 96.3 mtt180 -99.47 7.57 45.3 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.825 -0.625 . . . . 1.49 111.899 -179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.19 33.94 23.64 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 116.133 -0.485 . . . . 0.33000000000000002 111.734 179.755 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.429 HG21 HG22 ' A' ' 50' ' ' ILE . 81.8 mt -83.54 132.7 48.68 Favored Pre-proline 0 N--CA 1.449 -0.494 0 N-CA-C 109.744 -0.465 . . . . 0.17000000000000001 109.744 178.29 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_endo -72.62 140.67 33.07 Favored 'Trans proline' 0 N--CA 1.456 -0.735 0 C-N-CA 122.354 2.036 . . . . 0.20999999999999999 112.302 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 12.2 p90 -161.25 156.9 24.78 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.653 -0.703 . . . . 0.17999999999999999 110.417 179.704 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 43.1 mt -119.6 138.28 50.74 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.884 0 CA-C-N 115.591 -0.731 . . . . 0.23999999999999999 109.869 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.504 HD21 HG21 ' A' ' 96' ' ' ILE . 2.5 mm? -89.19 109.71 20.54 Favored 'General case' 0 C--N 1.317 -0.814 0 N-CA-C 109.17 -0.678 . . . . 0.20999999999999999 109.17 177.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.79 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 19.3 t-160 -102.05 117.54 35.01 Favored 'General case' 0 C--N 1.304 -1.383 0 N-CA-C 108.638 -0.875 . . . . 0.59999999999999998 108.638 -179.4 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.736 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 8.9 t -171.33 154.21 3.84 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.733 0.301 . . . . 0.60999999999999999 110.586 -176.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -108.31 -0.2 33.13 Favored Glycine 0 N--CA 1.446 -0.658 0 N-CA-C 111.465 -0.654 . . . . 0.93999999999999995 111.465 175.925 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -111.21 60.44 0.61 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 121.353 0.597 . . . . 2.3300000000000001 109.928 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.3 mp -69.69 -48.78 58.43 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.408 -0.815 . . . . 1.6100000000000001 110.871 -175.523 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -63.55 -33.62 76.0 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.971 0.415 . . . . 2.6299999999999999 110.783 -177.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.43 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 4.9 mmp_? -71.82 -15.4 62.14 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.036 -0.529 . . . . 4.4199999999999999 111.9 178.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.45 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 87.3 m-70 -134.25 31.59 3.49 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 111.745 0.276 . . . . 1.05 111.745 -178.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -70.01 -28.48 71.69 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.835 -0.698 . . . . 0.97999999999999998 112.469 -176.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.579 ' HA ' ' HE ' ' A' ' 94' ' ' ARG . 1.0 OUTLIER -76.45 -26.1 55.09 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.003 0.43 . . . . 2.5 110.34 178.996 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 53.6 tp -76.95 -47.51 20.71 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.85 -0.614 . . . . 0.70999999999999996 109.864 172.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.45 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 79.2 mt -57.3 -39.59 76.08 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.861 -0.608 . . . . 1.5800000000000001 112.082 -179.552 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.579 ' HE ' ' HA ' ' A' ' 91' ' ' GLU . 11.1 ptp180 -66.17 -25.28 66.88 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-O 120.668 0.27 . . . . 4.3799999999999999 111.343 -179.08 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -73.38 -30.16 63.1 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.398 0.618 . . . . 2.4500000000000002 110.14 175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.504 HG21 HD21 ' A' ' 81' ' ' LEU . 55.4 mt -82.72 -53.82 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.723 0 CA-C-N 115.18 -0.918 . . . . 0.45000000000000001 110.877 -177.25 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.5 t70 54.02 74.22 0.34 Allowed 'General case' 0 C--O 1.234 0.286 0 CA-C-O 121.718 0.77 . . . . 1.0900000000000001 110.831 -178.237 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -154.31 168.56 11.62 Favored Pre-proline 0 C--N 1.322 -0.628 0 CA-C-N 114.789 -1.096 . . . . 0.28999999999999998 108.503 179.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_exo -57.83 135.85 71.67 Favored 'Trans proline' 0 C--N 1.346 0.414 0 C-N-CA 122.097 1.865 . . . . 0.26000000000000001 112.338 -177.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 27.5 t -123.75 117.47 51.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.126 -0.488 . . . . 0.64000000000000001 110.726 -177.334 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.613 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.4 mtp -103.05 116.75 33.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 116.334 -0.394 . . . . 0.82999999999999996 109.941 178.033 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.736 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.97 148.87 37.8 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.814 -0.63 . . . . 0.54000000000000004 111.594 -175.232 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 76.8 mttt -90.68 143.18 28.61 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.807 -0.633 . . . . 0.67000000000000004 109.779 175.711 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.405 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.4 Cg_exo -74.04 144.55 81.33 Favored 'Cis proline' 0 C--O 1.234 0.299 0 C-N-CA 123.282 -1.549 . . . . 0.75 112.925 1.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.663 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -138.66 131.88 30.01 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 115.347 -0.842 . . . . 0.34999999999999998 108.936 176.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.484 ' O ' HG23 ' A' ' 110' ' ' VAL . 11.3 t70 -73.08 129.42 38.04 Favored 'General case' 0 C--N 1.318 -0.789 0 N-CA-C 108.964 -0.754 . . . . 0.51000000000000001 108.964 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.512 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.3 p -62.18 -21.05 64.78 Favored 'General case' 0 C--N 1.32 -0.717 0 CA-C-N 115.375 -0.829 . . . . 0.26000000000000001 112.758 -171.731 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 75.7 p -69.02 -43.61 74.42 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.874 -0.417 . . . . 1.3200000000000001 109.874 177.182 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -66.82 -39.9 87.84 Favored 'General case' 0 CA--C 1.512 -0.483 0 CA-C-N 116.134 -0.484 . . . . 0.62 110.166 178.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.613 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.8 t -61.87 -47.76 91.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 115.754 -0.657 . . . . 0.13 110.333 179.3 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.518 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.16 -48.37 78.71 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.663 -0.699 . . . . 0.13 111.21 -179.095 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -63.28 -41.18 98.97 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.068 -0.515 . . . . 1.95 111.271 -177.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.5 mmt180 -68.1 -27.38 66.43 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.745 0.307 . . . . 2.23 111.66 178.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -49.89 12.02 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 120.921 0.391 . . . . 0.14000000000000001 110.233 177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.539 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 71.1 mt -65.08 -27.09 68.53 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.85 0.685 . . . . 0.27000000000000002 112.85 -176.436 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -67.56 -26.92 66.53 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.732 -0.387 . . . . 2.79 110.946 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 69.8 mtm -73.84 -33.04 63.96 Favored 'General case' 0 N--CA 1.451 -0.391 0 CA-C-N 116.416 -0.356 . . . . 0.42999999999999999 111.06 178.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.539 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.5 p -91.69 -1.57 57.37 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.32 0.581 . . . . 1.46 110.522 177.538 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -104.18 16.49 49.55 Favored Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 110.83 -0.908 . . . . 2.5699999999999998 110.83 175.006 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -163.76 65.16 0.24 Allowed Glycine 0 N--CA 1.445 -0.73 0 N-CA-C 111.286 -0.726 . . . . 4.4800000000000004 111.286 -179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.06 15.57 8.48 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.236 0.541 . . . . 6.4199999999999999 110.501 -177.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -110.42 144.67 38.84 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.544 -0.753 . . . . 9.1899999999999995 109.887 178.765 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 23.8 mm-40 -67.9 134.48 92.03 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.1 -0.5 . . . . 9.5999999999999996 110.549 177.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.73 49.14 1.46 Allowed 'Trans proline' 0 CA--C 1.531 0.366 0 C-N-CA 122.934 2.423 . . . . 11.17 112.307 177.122 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.0 0 CA-C-O 118.51 -0.757 . . . . 13.279999999999999 109.861 -178.436 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 111.898 -0.481 . . . . 8.8000000000000007 111.898 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -83.83 85.83 7.24 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.94 0.4 . . . . 6.7800000000000002 110.918 -179.416 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -88.65 157.59 18.51 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.073 -0.512 . . . . 7.21 109.704 177.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.93 100.83 0.84 Allowed Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.842 -0.694 . . . . 1.8500000000000001 111.945 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.414 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 54.6 mtt -74.66 128.64 85.19 Favored Pre-proline 0 C--N 1.322 -0.625 0 CA-C-O 120.8 0.333 . . . . 1.6499999999999999 110.963 178.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.522 ' HG2' HD22 ' A' ' 115' ' ' LEU . 1.5 Cg_endo -70.84 142.91 44.27 Favored 'Trans proline' 0 N--CA 1.459 -0.531 0 C-N-CA 122.846 2.364 . . . . 0.33000000000000002 112.428 -179.26 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 51.6 tptt -90.05 105.63 17.93 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.004 -0.739 . . . . 0.89000000000000001 109.004 175.206 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.522 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.3 t -99.73 136.27 31.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 115.987 -0.551 . . . . 0.20000000000000001 111.27 -173.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.457 ' HB2' HD12 ' A' ' 50' ' ' ILE . 42.5 tp -109.31 112.0 23.9 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 116.134 -0.485 . . . . 0.75 110.273 176.498 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.9 t -94.62 122.86 46.44 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.298 0.57 . . . . 0.13 111.641 -179.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.632 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -103.76 111.94 24.66 Favored 'General case' 0 C--N 1.317 -0.816 0 CA-C-N 114.7 -1.136 . . . . 0.20999999999999999 108.704 172.686 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -170.16 127.23 0.84 Allowed 'General case' 0 C--N 1.319 -0.745 0 N-CA-C 109.38 -0.6 . . . . 1.4099999999999999 109.38 -179.487 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.452 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.6 t70 -85.24 -25.58 27.2 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 116.106 -0.497 . . . . 1.27 110.324 -177.966 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 66.4 mm-40 -75.55 106.57 3.09 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-N 116.197 -0.456 . . . . 2.5600000000000001 110.555 176.032 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.452 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 33.1 Cg_exo -59.64 -31.7 94.74 Favored 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 122.771 2.314 . . . . 0.32000000000000001 112.982 -175.326 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.9 tt -65.47 -49.59 68.49 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.329 -0.619 . . . . 1.51 109.329 179.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 64.2 mt -66.24 -47.08 85.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.374 -0.83 . . . . 1.01 111.27 178.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.14 -46.56 82.6 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.855 0.36 . . . . 0.20999999999999999 110.654 179.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -58.96 -44.74 91.52 Favored 'General case' 0 N--CA 1.449 -0.478 0 CA-C-N 115.727 -0.67 . . . . 0.60999999999999999 110.924 176.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.509 ' HB3' HG21 ' A' ' 107' ' ' THR . 2.1 m-80 -68.2 -37.35 80.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.751 -0.659 . . . . 1.22 111.394 -176.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 46.5 mt -64.65 -45.04 88.48 Favored 'General case' 0 N--CA 1.449 -0.485 0 CA-C-N 116.506 -0.315 . . . . 0.17999999999999999 110.379 173.557 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 62.4 tt0 -55.25 -53.05 61.01 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.116 -0.493 . . . . 1.04 110.311 178.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 35.2 m-85 -64.16 -27.72 69.27 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.244 -0.435 . . . . 0.78000000000000003 111.563 178.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.66 -46.36 63.39 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 120.766 0.317 . . . . 0.14000000000000001 110.73 -179.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.701 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 54.0 m-85 -67.26 -42.3 84.12 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.367 -0.379 . . . . 0.13 110.526 177.862 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -61.58 -31.79 71.86 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.972 0.415 . . . . 0.68999999999999995 110.039 175.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -69.13 -35.52 76.47 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.756 -0.656 . . . . 0.51000000000000001 110.694 177.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 -75.76 -20.55 58.19 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.142 0.496 . . . . 0.65000000000000002 110.305 178.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 56.27 0.7 Allowed Glycine 0 N--CA 1.445 -0.718 0 CA-C-N 115.705 -0.679 . . . . 0.28999999999999998 111.748 -178.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -146.16 171.37 15.03 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.728 0.299 . . . . 0.23000000000000001 110.803 179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -104.99 150.25 25.09 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.117 -0.697 . . . . 2.1400000000000001 109.117 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 47.1 t -134.27 138.49 49.89 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 112.389 0.514 . . . . 0.19 112.389 -172.615 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG11 ' OG ' ' A' ' 44' ' ' SER . 12.0 t -115.58 126.19 73.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 N-CA-C 109.058 -0.719 . . . . 0.23000000000000001 109.058 168.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 14.9 p -92.46 130.64 41.26 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 CA-C-O 121.076 0.465 . . . . 0.94999999999999996 111.278 -179.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.509 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -141.25 134.48 29.49 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.225 -0.443 . . . . 0.16 110.662 174.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.458 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -101.11 -10.73 20.19 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 116.209 -0.451 . . . . 0.23999999999999999 111.078 179.231 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.636 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 38.3 p -127.34 168.4 14.86 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.332 -0.395 . . . . 0.25 110.757 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.551 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.6 m -70.95 -35.33 72.15 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 116.292 -0.413 . . . . 1.6000000000000001 110.047 175.842 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -61.85 -46.6 88.74 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.124 -0.489 . . . . 0.69999999999999996 111.219 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.636 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 17.2 mt-30 -61.87 -37.99 86.62 Favored 'General case' 0 C--O 1.233 0.206 0 CA-C-O 121.255 0.55 . . . . 1.4099999999999999 110.57 178.027 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.632 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.65 -51.44 65.14 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.328 -0.851 . . . . 0.17999999999999999 111.388 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.551 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.7 mt -62.53 -30.2 71.12 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.015 -0.538 . . . . 0.82999999999999996 111.021 -178.855 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -67.72 -49.16 64.09 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.905 -0.589 . . . . 2.4100000000000001 109.776 176.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.405 ' OG ' HG11 ' A' ' 33' ' ' VAL . 43.7 t -64.57 -38.12 89.92 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.037 -0.529 . . . . 1.1299999999999999 110.7 178.726 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.3 tp -61.25 -32.27 72.08 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.284 0.564 . . . . 1.23 110.688 179.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.33 -41.43 16.79 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.66 -0.7 . . . . 0.42999999999999999 111.348 179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -75.93 -34.49 59.88 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.0 -0.545 . . . . 0.62 111.629 -176.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 22.5 m-80 -118.32 161.49 34.88 Favored Pre-proline 0 C--N 1.322 -0.63 0 CA-C-N 116.128 -0.487 . . . . 0.41999999999999998 110.503 -178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.4 Cg_endo -94.61 84.28 0.13 Allowed 'Trans proline' 0 N--CA 1.449 -1.123 0 C-N-CA 123.388 2.726 . . . . 0.23999999999999999 111.495 177.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.457 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.7 mm -64.62 123.74 18.05 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.651 -0.704 . . . . 0.22 111.736 -174.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.543 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 37.7 m-20 -92.58 -30.63 15.54 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.483 -0.781 . . . . 0.28999999999999998 110.277 179.339 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.522 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.5 p -159.81 155.99 3.67 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-N 116.111 -0.495 . . . . 0.12 109.807 179.394 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.456 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 164.06 29.88 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-O 121.359 0.6 . . . . 0.14000000000000001 111.49 -179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.46 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -135.33 112.39 14.16 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.789 0 CA-C-N 115.512 -0.767 . . . . 0.95999999999999996 108.944 176.692 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.655 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.8 mp -109.05 108.36 19.03 Favored 'General case' 0 C--N 1.309 -1.174 0 C-N-CA 120.667 -0.413 . . . . 0.16 111.723 -170.637 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.814 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.0 t70 -78.82 126.21 30.41 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 108.598 -0.89 . . . . 1.77 108.598 172.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.509 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 21.3 t -73.96 -16.44 16.93 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.999 0 CA-C-N 115.596 -0.729 . . . . 0.80000000000000004 110.862 -173.532 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.7 t30 -99.03 85.23 3.2 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-O 121.278 0.561 . . . . 2.3700000000000001 110.566 179.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.7 mt -99.88 -4.52 30.16 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.513 0.673 . . . . 0.84999999999999998 109.503 176.284 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 165.07 -174.47 40.99 Favored Glycine 0 N--CA 1.444 -0.809 0 CA-C-N 114.895 -1.048 . . . . 0.81999999999999995 110.731 177.619 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_exo -58.09 -45.41 31.97 Favored 'Trans proline' 0 C--O 1.233 0.265 0 C-N-CA 122.696 2.264 . . . . 1.1799999999999999 111.98 176.558 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 63.0 tttp -107.29 -32.8 7.62 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.859 -0.61 . . . . 3.5299999999999998 110.129 178.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.7 m -65.56 126.91 29.82 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.631 -0.713 . . . . 0.95999999999999996 111.96 -178.417 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.5 p80 -144.5 152.72 41.01 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-N 115.29 -0.868 . . . . 0.48999999999999999 109.413 177.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.655 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 28.5 p -67.44 87.67 0.2 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.296 0.569 . . . . 1.3 109.876 173.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -116.4 -69.78 0.43 Allowed Glycine 0 C--O 1.224 -0.496 0 C-N-CA 120.669 -0.777 . . . . 0.23000000000000001 112.119 178.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.401 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.9 Cg_exo -51.91 -30.56 39.55 Favored 'Trans proline' 0 C--N 1.345 0.351 0 C-N-CA 122.594 2.196 . . . . 0.23999999999999999 112.134 176.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.414 HG11 ' CD2' ' A' ' 11' ' ' LEU . 22.6 t -66.33 -39.15 83.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 121.451 0.643 . . . . 0.12 110.068 177.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -65.83 -47.18 75.87 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 115.091 -0.959 . . . . 0.16 110.093 -179.427 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.434 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 2.7 m-20 -60.45 -42.77 96.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.025 -0.534 . . . . 2.0299999999999998 109.968 176.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.87 -51.53 63.35 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.919 -0.582 . . . . 0.23000000000000001 111.249 177.613 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.0 mt -66.55 -40.77 89.2 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.417 -0.81 . . . . 0.20000000000000001 110.579 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.563 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 62.8 mmtt -59.67 -35.21 74.0 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.708 -0.678 . . . . 2.0099999999999998 111.079 176.535 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.434 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 46.4 mt-30 -70.39 -37.32 74.48 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.148 -0.478 . . . . 2.3700000000000001 111.171 179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 62.4 mtt180 -93.04 4.67 53.61 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.681 0.277 . . . . 1.49 111.231 -179.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.59 33.73 22.14 Favored 'General case' 0 N--CA 1.465 0.324 0 CA-C-N 115.833 -0.621 . . . . 0.33000000000000002 111.617 179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.6 mt -90.18 133.87 32.58 Favored Pre-proline 0 C--N 1.325 -0.496 0 CA-C-N 116.144 -0.48 . . . . 0.17000000000000001 110.063 179.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -74.98 143.95 29.74 Favored 'Trans proline' 0 N--CA 1.452 -0.951 0 C-N-CA 122.525 2.15 . . . . 0.20999999999999999 112.32 179.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.456 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 41.7 p90 -158.53 160.24 36.45 Favored 'General case' 0 C--N 1.316 -0.86 0 CA-C-N 115.552 -0.749 . . . . 0.17999999999999999 110.289 178.894 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 27.2 mt -125.07 139.53 50.87 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.097 0 CA-C-N 115.161 -0.927 . . . . 0.23999999999999999 109.639 178.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.94 113.62 24.67 Favored 'General case' 0 C--N 1.317 -0.811 0 CA-C-O 121.302 0.572 . . . . 0.20999999999999999 109.465 178.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.814 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 17.2 t-160 -101.63 130.03 47.88 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.386 -0.968 . . . . 0.59999999999999998 108.386 177.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.461 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 11.1 t -178.72 162.14 1.33 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.9 -0.32 . . . . 0.60999999999999999 110.703 -178.522 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -114.74 13.8 20.11 Favored Glycine 0 N--CA 1.449 -0.484 0 N-CA-C 110.335 -1.106 . . . . 0.93999999999999995 110.335 172.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.512 ' OD2' ' HD3' ' A' ' 88' ' ' ARG . 1.0 OUTLIER -114.29 49.56 1.0 Allowed 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.136 -0.532 . . . . 2.3300000000000001 110.137 -178.653 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.6 mp -71.85 -30.6 65.61 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.205 -0.452 . . . . 1.6100000000000001 111.944 -173.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 54.2 m-20 -83.77 -34.48 24.78 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.292 0.568 . . . . 2.6299999999999999 109.867 178.544 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.512 ' HD3' ' OD2' ' A' ' 85' ' ' ASP . 44.6 ttt180 -67.32 -34.91 78.35 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.313 -0.858 . . . . 4.4199999999999999 111.128 178.427 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.441 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.0 m-70 -118.62 28.66 8.18 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.182 -0.463 . . . . 1.05 111.473 -177.247 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -61.01 -38.65 95.88 Favored Glycine 0 N--CA 1.454 -0.158 0 C-N-CA 121.001 -0.618 . . . . 0.97999999999999998 112.756 -177.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.455 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 29.5 mt-10 -61.37 -45.57 93.82 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.032 0.444 . . . . 2.5 110.154 177.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 39.3 tp -61.84 -44.94 95.83 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.699 -0.682 . . . . 0.70999999999999996 110.572 179.424 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.441 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 73.5 mt -59.6 -38.62 81.76 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.937 -0.574 . . . . 1.5800000000000001 111.372 -178.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -71.26 -27.03 63.16 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.399 -0.364 . . . . 4.3799999999999999 111.18 178.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.455 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 66.9 mttm -74.21 -43.74 55.96 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.333 0.587 . . . . 2.4500000000000002 110.032 175.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.563 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 83.5 mt -62.45 -51.34 73.43 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 115.189 -0.914 . . . . 0.45000000000000001 110.581 177.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.7 t70 62.47 75.58 0.4 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.425 0.631 . . . . 1.0900000000000001 110.828 178.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.409 ' HB3' ' CD2' ' A' ' 81' ' ' LEU . . . -161.12 167.41 13.45 Favored Pre-proline 0 C--N 1.325 -0.466 0 CA-C-N 115.29 -0.868 . . . . 0.28999999999999998 109.339 177.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 39.2 Cg_exo -58.24 142.69 97.51 Favored 'Trans proline' 0 C--N 1.351 0.7 0 C-N-CA 122.399 2.066 . . . . 0.26000000000000001 112.667 178.7 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.1 t -124.24 124.36 68.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.335 -0.393 . . . . 0.64000000000000001 111.054 -178.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.9 mmm -101.14 110.5 22.53 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.28 -0.637 . . . . 0.82999999999999996 109.28 175.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.461 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.21 146.66 41.01 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-N 116.015 -0.539 . . . . 0.54000000000000004 111.91 -174.952 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.458 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 86.8 mttt -91.19 142.52 27.28 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-N 116.032 -0.531 . . . . 0.67000000000000004 109.709 175.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.458 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 11.5 Cg_exo -71.14 139.59 59.39 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.505 -1.456 . . . . 0.75 112.992 3.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.596 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -132.79 136.44 46.31 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 115.574 -0.739 . . . . 0.34999999999999998 109.619 177.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.452 ' O ' HG23 ' A' ' 110' ' ' VAL . 10.5 t70 -79.38 131.58 36.15 Favored 'General case' 0 C--N 1.315 -0.909 0 N-CA-C 108.472 -0.936 . . . . 0.51000000000000001 108.472 175.518 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.509 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.3 p -64.84 -23.56 67.27 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.672 -0.695 . . . . 0.26000000000000001 112.24 -171.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 89.9 p -72.68 -33.31 66.43 Favored 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 109.551 -0.537 . . . . 1.3200000000000001 109.551 176.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 -70.49 -45.8 64.95 Favored 'General case' 0 CA--C 1.511 -0.522 0 CA-C-N 115.809 -0.632 . . . . 0.62 109.36 177.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 106' ' ' ASP . 30.6 t -60.12 -43.44 92.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 CA-C-N 115.227 -0.897 . . . . 0.13 110.264 178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.701 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -61.89 -50.06 73.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.702 -0.681 . . . . 0.13 111.369 -179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.5 mttp -59.79 -49.95 75.72 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.23 -0.441 . . . . 1.95 111.167 -179.209 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmm180 -59.7 -38.36 81.38 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.294 -0.412 . . . . 2.23 111.475 -176.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.62 -47.67 66.07 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.899 0.381 . . . . 0.14000000000000001 110.603 178.786 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.522 HD22 ' HG2' ' A' ' 6' ' ' PRO . 63.0 mt -65.26 -25.44 67.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.044 -0.525 . . . . 0.27000000000000002 112.167 -178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.546 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 20.5 mm-40 -59.16 -30.23 68.01 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.823 0.344 . . . . 2.79 111.208 177.212 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 54.5 mtm -88.81 1.94 54.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.274 -0.421 . . . . 0.42999999999999999 110.992 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.543 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 51.1 t -118.69 -50.03 2.42 Favored 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 116.146 -0.479 . . . . 1.46 111.573 -177.152 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -77.05 98.24 1.32 Allowed Glycine 0 N--CA 1.447 -0.615 0 C-N-CA 121.036 -0.602 . . . . 2.5699999999999998 112.408 -176.726 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.06 -90.16 1.58 Allowed Glycine 0 N--CA 1.444 -0.799 0 C-N-CA 120.819 -0.705 . . . . 4.4800000000000004 111.832 179.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.433 ' CG ' ' H ' ' A' ' 122' ' ' LYS . 24.1 t70 56.67 -156.96 0.28 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 122.647 0.379 . . . . 6.4199999999999999 109.986 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.546 ' H ' ' HD3' ' A' ' 122' ' ' LYS . 0.0 OUTLIER -114.5 121.27 43.01 Favored 'General case' 0 C--N 1.325 -0.498 0 O-C-N 121.989 -0.445 . . . . 9.1899999999999995 110.26 -179.955 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -74.69 118.2 68.29 Favored Pre-proline 0 C--N 1.324 -0.508 0 CA-C-N 116.096 -0.502 . . . . 9.5999999999999996 110.699 -177.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -76.98 173.19 14.87 Favored 'Trans proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.742 2.295 . . . . 11.17 112.346 -179.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.976 0 CA-C-O 118.461 -0.781 . . . . 13.279999999999999 110.239 179.967 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.692 0 N-CA-C 111.98 -0.448 . . . . 8.8000000000000007 111.98 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.78 117.39 22.03 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 109.981 -0.377 . . . . 6.7800000000000002 109.981 179.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.7 mtm -77.96 115.77 17.95 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.318 -0.401 . . . . 7.21 110.541 -177.626 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -88.23 86.2 1.49 Allowed Glycine 0 N--CA 1.444 -0.785 0 N-CA-C 111.001 -0.84 . . . . 1.8500000000000001 111.001 178.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.429 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 91.2 mtp -87.0 118.56 70.22 Favored Pre-proline 0 C--N 1.323 -0.571 0 CA-C-O 120.98 0.419 . . . . 1.6499999999999999 110.811 -177.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.66 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -63.94 142.22 80.83 Favored 'Trans proline' 0 N--CA 1.463 -0.321 0 C-N-CA 123.413 2.742 . . . . 0.33000000000000002 112.224 -179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 42.1 tptt -87.93 103.04 15.3 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.904 -0.776 . . . . 0.89000000000000001 108.904 175.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.458 HG22 ' CG1' ' A' ' 52' ' ' VAL . 54.9 t -99.23 135.49 34.24 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 116.003 -0.544 . . . . 0.20000000000000001 110.859 -173.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.497 ' HB2' HD12 ' A' ' 50' ' ' ILE . 40.4 tp -110.96 111.21 22.16 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 116.184 -0.462 . . . . 0.75 110.573 178.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.1 t -92.6 125.65 45.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-O 121.114 0.483 . . . . 0.13 111.324 179.154 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.659 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -107.33 104.17 13.7 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-N 115.023 -0.989 . . . . 0.20999999999999999 109.231 173.69 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.5 tp10 -165.16 123.23 1.63 Allowed 'General case' 0 C--N 1.316 -0.859 0 CA-C-N 115.88 -0.6 . . . . 1.4099999999999999 110.075 -175.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.441 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 29.5 t70 -83.42 -22.06 32.8 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.798 -0.637 . . . . 1.27 110.781 -178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -84.81 107.0 9.9 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 110.119 -0.326 . . . . 2.5600000000000001 110.119 176.663 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.441 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.2 Cg_exo -58.5 -28.86 86.95 Favored 'Trans proline' 0 C--N 1.345 0.378 0 C-N-CA 123.026 2.484 . . . . 0.32000000000000001 113.484 -174.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 67.9 tp -64.64 -49.96 68.99 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.998 0.428 . . . . 1.51 110.115 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 68.9 mt -66.18 -41.37 89.18 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.834 -0.621 . . . . 1.01 110.559 177.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -60.71 -48.17 82.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.895 -0.593 . . . . 0.20999999999999999 110.854 178.058 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.3 ttp -62.08 -42.8 99.58 Favored 'General case' 0 N--CA 1.451 -0.399 0 CA-C-N 115.919 -0.582 . . . . 0.60999999999999999 110.862 177.377 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.406 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.8 m-20 -64.21 -40.9 97.02 Favored 'General case' 0 N--CA 1.448 -0.573 0 CA-C-N 115.848 -0.615 . . . . 1.22 111.432 -179.288 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.423 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 38.8 mt -64.56 -45.02 88.89 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-O 120.612 0.244 . . . . 0.17999999999999999 110.525 173.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.561 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.2 tt0 -55.6 -50.28 70.54 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.974 -0.557 . . . . 1.04 110.466 178.295 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.9 m-85 -65.04 -27.17 68.61 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.344 -0.389 . . . . 0.78000000000000003 111.508 179.265 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -73.18 -45.02 58.84 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.867 0.365 . . . . 0.14000000000000001 110.643 -179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.525 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -70.45 -42.16 71.87 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.112 -0.495 . . . . 0.13 110.917 179.477 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 56.6 mt-10 -61.46 -35.92 78.96 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-O 120.916 0.389 . . . . 0.68999999999999995 110.032 175.796 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -63.92 -31.86 73.19 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.633 -0.712 . . . . 0.51000000000000001 110.732 177.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 55.2 mm-40 -86.19 5.66 33.05 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.743 -0.662 . . . . 0.65000000000000002 111.159 177.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 77.76 52.7 5.31 Favored Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.948 -0.644 . . . . 0.28999999999999998 112.46 179.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.4 ' CB ' ' HD2' ' A' ' 6' ' ' PRO . . . -138.4 163.54 31.63 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-O 120.692 0.282 . . . . 0.23000000000000001 110.658 179.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -101.91 144.26 30.76 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.985 -0.746 . . . . 2.1400000000000001 108.985 177.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.561 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 21.9 t -127.58 143.75 39.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 CA-C-O 121.027 0.441 . . . . 0.19 111.843 -172.623 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.472 HG11 ' OG ' ' A' ' 44' ' ' SER . 27.7 t -117.7 128.61 74.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.805 -0.813 . . . . 0.23000000000000001 108.805 168.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 76.4 t -97.23 122.75 49.09 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.729 0 C-N-CA 120.548 -0.461 . . . . 0.94999999999999996 110.986 178.933 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.476 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -134.14 135.41 43.13 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.626 -0.716 . . . . 0.16 109.819 176.533 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -102.42 -21.61 14.22 Favored 'General case' 0 C--N 1.318 -0.798 0 CA-C-N 116.331 -0.395 . . . . 0.23999999999999999 110.922 -178.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.461 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 17.1 p -115.39 170.99 7.99 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 120.991 0.424 . . . . 0.25 111.125 -177.593 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.593 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 22.3 p -65.06 -47.62 76.67 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-O 121.477 0.656 . . . . 1.6000000000000001 109.367 174.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -55.91 -45.72 78.6 Favored 'General case' 0 C--N 1.319 -0.735 0 CA-C-N 114.279 -1.328 . . . . 0.69999999999999996 111.997 -177.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.476 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 55.6 mt-30 -59.54 -45.31 92.15 Favored 'General case' 0 CA--C 1.518 -0.253 0 CA-C-O 121.426 0.631 . . . . 1.4099999999999999 110.304 177.442 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.659 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -61.12 -50.84 71.6 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-N 115.062 -0.972 . . . . 0.17999999999999999 111.141 -179.684 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.593 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 57.7 mt -63.14 -31.34 72.45 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.761 -0.654 . . . . 0.82999999999999996 110.83 -178.302 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 6.4 tmtm? -68.59 -53.44 22.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.995 -0.548 . . . . 2.4100000000000001 109.841 178.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.472 ' OG ' HG11 ' A' ' 33' ' ' VAL . 33.3 t -65.45 -32.91 74.78 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.894 0.378 . . . . 1.1299999999999999 110.621 -179.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.446 HD23 ' HB1' ' A' ' 71' ' ' ALA . 16.3 tp -65.4 -33.51 76.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.028 -0.533 . . . . 1.23 110.797 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.32 -35.95 30.36 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.896 -0.593 . . . . 0.42999999999999999 111.258 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -79.98 -38.07 32.99 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.201 -0.454 . . . . 0.62 111.524 -176.407 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.3 m-80 -112.62 164.69 14.74 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 115.984 -0.553 . . . . 0.41999999999999998 110.89 -174.822 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.9 Cg_endo -94.78 78.29 0.16 Allowed 'Trans proline' 0 N--CA 1.448 -1.175 0 C-N-CA 123.571 2.847 . . . . 0.23999999999999999 111.594 176.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.497 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -64.04 119.29 7.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.794 0 CA-C-N 115.751 -0.659 . . . . 0.22 111.236 -176.592 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.546 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.4 m-20 -87.75 -29.67 20.87 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.726 -0.67 . . . . 0.28999999999999998 110.457 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.466 HG11 HD23 ' A' ' 115' ' ' LEU . 14.3 p -160.53 156.49 3.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.48 -0.327 . . . . 0.12 110.349 -178.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.05 165.56 27.02 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 121.281 0.562 . . . . 0.14000000000000001 112.059 -178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -138.66 112.11 7.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 115.427 -0.806 . . . . 0.95999999999999996 109.583 177.036 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.534 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 9.7 mp -112.52 116.93 31.02 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.296 0.48 . . . . 0.16 112.296 -168.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -81.11 107.1 13.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.216 0.531 . . . . 1.77 109.637 171.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.465 ' CG1' HD23 ' A' ' 92' ' ' LEU . 12.9 t -68.82 -9.03 11.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 CA-C-N 116.041 -0.527 . . . . 0.80000000000000004 111.964 -172.087 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 64.7 t30 -114.96 63.27 0.68 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 120.871 0.367 . . . . 2.3700000000000001 110.981 178.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.41 HD11 ' SG ' ' A' ' 65' ' ' CYS . 97.5 mt -64.52 -27.85 69.25 Favored 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.265 0.555 . . . . 0.84999999999999998 110.874 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -172.51 -167.22 32.22 Favored Glycine 0 N--CA 1.443 -0.867 0 N-CA-C 111.192 -0.763 . . . . 0.81999999999999995 111.192 176.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_exo -54.54 -40.66 82.69 Favored 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.931 2.421 . . . . 1.1799999999999999 112.513 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -123.83 -31.55 3.41 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-O 120.655 0.264 . . . . 3.5299999999999998 110.783 178.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -65.95 127.03 30.45 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 121.058 0.456 . . . . 0.95999999999999996 111.706 -179.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 5.4 p80 -144.57 153.38 41.75 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.707 -0.678 . . . . 0.48999999999999999 110.061 177.88 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.629 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 2.6 m -73.7 85.94 1.65 Allowed 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 108.984 -0.747 . . . . 1.3 108.984 172.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -109.47 -63.93 0.54 Allowed Glycine 0 CA--C 1.508 -0.371 0 C-N-CA 120.841 -0.695 . . . . 0.23000000000000001 111.842 -179.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -54.45 -24.91 37.68 Favored 'Trans proline' 0 N--CA 1.459 -0.526 0 C-N-CA 122.348 2.032 . . . . 0.23999999999999999 111.381 173.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.425 HG11 ' CD2' ' A' ' 11' ' ' LEU . 20.9 t -68.45 -45.01 82.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 115.748 -0.66 . . . . 0.12 109.995 176.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.49 -49.41 77.67 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.201 -0.909 . . . . 0.16 110.165 179.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.473 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 50.7 m-20 -61.95 -41.6 98.16 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.414 -0.812 . . . . 2.0299999999999998 110.238 177.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.446 ' HB1' HD23 ' A' ' 45' ' ' LEU . . . -56.63 -44.16 80.98 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.019 -0.537 . . . . 0.23000000000000001 111.256 178.193 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.6 mt -69.11 -42.19 76.41 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.56 -0.745 . . . . 0.20000000000000001 110.268 178.027 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.596 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.9 mmtt -59.88 -36.74 77.55 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.681 -0.691 . . . . 2.0099999999999998 111.447 176.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.473 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 71.2 mt-30 -63.29 -39.07 93.56 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.146 -0.479 . . . . 2.3700000000000001 111.237 178.542 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.9 mtt85 -96.02 6.14 49.54 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 116.29 -0.414 . . . . 1.49 111.235 -178.019 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 35.57 22.22 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.797 -0.638 . . . . 0.33000000000000002 111.754 179.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 75.0 mt -89.12 133.79 34.5 Favored Pre-proline 0 N--CA 1.448 -0.525 0 CA-C-N 116.501 -0.318 . . . . 0.17000000000000001 110.441 179.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.402 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 26.7 Cg_endo -74.2 141.46 29.21 Favored 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 122.49 2.127 . . . . 0.20999999999999999 111.765 177.341 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.412 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 16.9 p90 -159.16 160.58 35.68 Favored 'General case' 0 C--N 1.316 -0.874 0 CA-C-N 115.675 -0.693 . . . . 0.17999999999999999 110.225 -179.772 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.462 HG21 ' HG2' ' A' ' 101' ' ' MET . 16.0 mt -125.52 141.42 45.41 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 115.482 -0.781 . . . . 0.23999999999999999 109.987 -179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.404 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.84 108.71 19.67 Favored 'General case' 0 C--N 1.316 -0.852 0 N-CA-C 109.309 -0.626 . . . . 0.20999999999999999 109.309 177.752 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.669 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.9 t-160 -103.66 74.01 1.22 Allowed 'General case' 0 C--N 1.311 -1.076 0 CA-C-O 121.481 0.658 . . . . 0.59999999999999998 109.261 179.391 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.429 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 4.5 t -105.86 163.56 12.64 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 114.646 -1.161 . . . . 0.60999999999999999 111.048 -172.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.442 ' HA2' ' HB2' ' A' ' 103' ' ' LYS . . . -97.85 -4.99 57.7 Favored Glycine 0 N--CA 1.447 -0.611 0 CA-C-N 115.901 -0.59 . . . . 0.93999999999999995 112.31 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -137.95 132.72 32.77 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.108 0.48 . . . . 2.3300000000000001 109.826 172.728 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.423 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.1 mp -111.83 -25.85 9.24 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.631 -0.713 . . . . 1.6100000000000001 110.856 -176.525 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -84.18 -45.97 12.38 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.126 0.489 . . . . 2.6299999999999999 110.898 177.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? -62.34 -40.15 95.44 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.513 -0.767 . . . . 4.4199999999999999 110.938 -177.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.526 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 49.7 m-70 -102.31 25.19 9.22 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.565 -0.288 . . . . 1.05 111.163 174.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -62.74 -37.88 95.56 Favored Glycine 0 N--CA 1.453 -0.168 0 C-N-CA 120.967 -0.635 . . . . 0.97999999999999998 112.975 -176.008 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.634 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 11.7 tt0 -66.94 -39.8 87.39 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.081 0.467 . . . . 2.5 110.258 178.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.465 HD23 ' CG1' ' A' ' 57' ' ' VAL . 41.4 tp -68.12 -40.01 82.61 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.227 -0.442 . . . . 0.70999999999999996 109.863 179.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.526 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 89.0 mt -59.15 -39.6 82.96 Favored 'General case' 0 N--CA 1.452 -0.343 0 CA-C-N 116.453 -0.34 . . . . 1.5800000000000001 111.189 177.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.634 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 24.4 ptt180 -73.95 -26.05 60.29 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.868 0.366 . . . . 4.3799999999999999 110.584 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 51.3 mttp -70.34 -34.15 72.31 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.295 0.569 . . . . 2.4500000000000002 110.163 172.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.596 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 95.8 mt -77.36 -53.38 14.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.633 0 CA-C-N 115.366 -0.834 . . . . 0.45000000000000001 110.677 179.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 22.0 t70 64.47 75.26 0.38 Allowed 'General case' 0 C--O 1.237 0.409 0 CA-C-O 121.764 0.792 . . . . 1.0900000000000001 110.917 -178.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.87 162.11 25.22 Favored Pre-proline 0 C--N 1.324 -0.516 0 CA-C-N 114.902 -1.044 . . . . 0.28999999999999998 109.383 178.676 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_exo -58.75 147.19 89.48 Favored 'Trans proline' 0 C--N 1.344 0.3 0 C-N-CA 122.658 2.239 . . . . 0.26000000000000001 112.539 -179.26 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 30.1 t -124.25 134.97 65.2 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 116.202 -0.454 . . . . 0.64000000000000001 110.971 -177.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.462 ' HG2' HG21 ' A' ' 80' ' ' ILE . 92.2 mmm -114.77 107.47 15.49 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.286 -0.635 . . . . 0.82999999999999996 109.286 175.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.446 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -73.04 143.86 47.33 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.944 -0.571 . . . . 0.54000000000000004 111.729 -174.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.442 ' HB2' ' HA2' ' A' ' 84' ' ' GLY . 94.0 mttt -91.45 146.74 33.9 Favored Pre-proline 0 C--N 1.324 -0.504 0 CA-C-N 116.046 -0.525 . . . . 0.67000000000000004 110.186 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -74.19 127.31 13.8 Favored 'Cis proline' 0 C--O 1.234 0.278 0 C-N-CA 123.619 -1.409 . . . . 0.75 112.699 2.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.669 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -119.35 130.04 55.15 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.728 -0.669 . . . . 0.34999999999999998 110.297 177.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -74.15 129.97 38.87 Favored 'General case' 0 C--N 1.318 -0.802 0 N-CA-C 108.04 -1.096 . . . . 0.51000000000000001 108.04 175.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.423 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 39.9 p -64.28 -20.47 66.09 Favored 'General case' 0 C--N 1.319 -0.747 0 N-CA-C 112.875 0.695 . . . . 0.26000000000000001 112.875 -168.133 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 76.1 p -65.87 -42.32 90.5 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.995 0.426 . . . . 1.3200000000000001 110.176 177.578 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -67.71 -39.79 84.33 Favored 'General case' 0 CA--C 1.515 -0.397 0 CA-C-N 115.862 -0.608 . . . . 0.62 110.159 178.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 24.2 t -63.44 -45.14 98.73 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-N 115.593 -0.73 . . . . 0.13 110.327 178.563 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.525 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.31 -48.81 76.5 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.554 -0.748 . . . . 0.13 111.479 -178.619 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -62.84 -40.95 99.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.345 -0.389 . . . . 1.95 111.269 -178.246 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 27.7 mmt180 -67.8 -27.2 66.54 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.849 0.357 . . . . 2.23 111.402 178.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.2 -46.81 17.14 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.13 0.49 . . . . 0.14000000000000001 110.392 177.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.466 HD23 HG11 ' A' ' 52' ' ' VAL . 77.1 mt -70.59 -26.08 63.35 Favored 'General case' 0 C--N 1.326 -0.43 0 N-CA-C 112.634 0.605 . . . . 0.27000000000000002 112.634 -175.64 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -63.07 -33.19 74.92 Favored 'General case' 0 C--N 1.331 -0.233 0 C-N-CA 120.815 -0.354 . . . . 2.79 110.415 176.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.3 mtm -76.08 -30.69 58.41 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.193 0.52 . . . . 0.42999999999999999 110.139 176.529 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.5 t -73.27 -46.73 48.15 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.517 -0.765 . . . . 1.46 111.033 -178.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -93.64 11.79 70.64 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.813 -0.708 . . . . 2.5699999999999998 112.31 -178.12 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -111.65 72.35 0.21 Allowed Glycine 0 N--CA 1.445 -0.717 0 C-N-CA 120.794 -0.717 . . . . 4.4800000000000004 112.239 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.5 t70 -81.15 117.75 21.96 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 109.876 -0.416 . . . . 6.4199999999999999 109.876 177.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -146.47 163.04 36.94 Favored 'General case' 0 C--N 1.318 -0.777 0 CA-C-N 115.795 -0.639 . . . . 9.1899999999999995 110.82 -176.025 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -78.69 117.24 65.37 Favored Pre-proline 0 C--N 1.32 -0.686 0 CA-C-N 115.76 -0.655 . . . . 9.5999999999999996 109.429 177.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 77.8 Cg_exo -50.41 113.79 1.18 Allowed 'Trans proline' 0 C--N 1.345 0.377 0 C-N-CA 123.328 2.685 . . . . 11.17 113.136 -175.302 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.933 0 CA-C-O 118.572 -0.728 . . . . 13.279999999999999 110.044 178.494 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.742 0 N-CA-C 111.767 -0.533 . . . . 8.8000000000000007 111.767 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 56.03 59.88 3.51 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-O 121.228 0.537 . . . . 6.7800000000000002 110.643 -178.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.489 ' HB2' ' SD ' ' A' ' 5' ' ' MET . 17.7 ptp -96.89 125.45 41.34 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.883 -0.599 . . . . 7.21 111.013 -178.043 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -114.54 74.28 0.24 Allowed Glycine 0 N--CA 1.445 -0.7 0 CA-C-N 115.632 -0.713 . . . . 1.8500000000000001 111.713 -179.684 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.489 ' SD ' ' HB2' ' A' ' 3' ' ' MET . 0.1 OUTLIER -63.45 134.18 95.76 Favored Pre-proline 0 C--N 1.322 -0.621 0 CA-C-O 120.793 0.33 . . . . 1.6499999999999999 111.662 -179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.461 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 17.3 Cg_exo -70.45 136.06 30.3 Favored 'Trans proline' 0 N--CA 1.458 -0.588 0 C-N-CA 123.045 2.496 . . . . 0.33000000000000002 110.984 172.109 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.9 tptt -85.98 109.48 18.81 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 109.431 -0.581 . . . . 0.89000000000000001 109.431 178.613 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.515 HG22 ' CG1' ' A' ' 52' ' ' VAL . 38.0 t -100.14 130.79 48.79 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 115.9 -0.591 . . . . 0.20000000000000001 110.916 -173.673 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.499 ' HB2' HD12 ' A' ' 50' ' ' ILE . 54.1 tp -105.04 112.14 25.16 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.83 0.348 . . . . 0.75 110.306 175.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.413 HG22 HG23 ' A' ' 54' ' ' VAL . 25.3 t -93.12 121.03 43.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-O 121.118 0.485 . . . . 0.13 111.507 178.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.658 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.1 mm? -102.45 101.11 11.28 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.297 -0.865 . . . . 0.20999999999999999 108.889 171.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -159.51 120.98 3.27 Favored 'General case' 0 C--N 1.313 -1.013 0 CA-C-N 115.479 -0.782 . . . . 1.4099999999999999 109.921 -174.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.467 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 19.0 t70 -87.49 -19.03 28.53 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.9 -0.591 . . . . 1.27 109.941 -179.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -83.51 105.65 5.89 Favored Pre-proline 0 C--N 1.331 -0.206 0 CA-C-N 116.15 -0.477 . . . . 2.5600000000000001 109.835 176.04 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.467 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.1 Cg_exo -59.03 -32.97 98.49 Favored 'Trans proline' 0 C--N 1.345 0.376 0 C-N-CA 122.736 2.291 . . . . 0.32000000000000001 113.063 -174.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -58.37 -49.19 78.1 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 109.621 -0.511 . . . . 1.51 109.621 176.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -70.23 -46.04 73.36 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 115.693 -0.685 . . . . 1.01 110.88 179.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.7 -48.59 72.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.069 0.461 . . . . 0.20999999999999999 110.783 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.0 ttp -63.27 -44.92 93.74 Favored 'General case' 0 N--CA 1.448 -0.552 0 CA-C-N 115.553 -0.749 . . . . 0.60999999999999999 111.231 178.019 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.429 ' HB3' HG21 ' A' ' 107' ' ' THR . 10.9 m-20 -67.68 -36.78 81.31 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-N 116.098 -0.501 . . . . 1.22 111.497 -176.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.421 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.4 mt -65.54 -46.14 80.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-O 120.739 0.304 . . . . 0.17999999999999999 110.188 172.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.583 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 48.2 tt0 -55.17 -48.38 73.86 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.643 -0.708 . . . . 1.04 110.406 -179.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -63.48 -37.88 89.01 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.441 -0.345 . . . . 0.78000000000000003 111.199 176.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.54 -49.36 69.22 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.435 -0.348 . . . . 0.14000000000000001 111.275 -175.452 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.588 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 62.4 m-85 -63.96 -45.73 87.81 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.247 -0.433 . . . . 0.13 110.86 178.944 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -63.66 -28.42 69.9 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.366 -0.379 . . . . 0.68999999999999995 111.164 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -72.8 -33.33 66.17 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.906 0.384 . . . . 0.51000000000000001 110.229 178.571 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 62.3 mm-40 -78.78 -14.73 59.11 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.126 -0.488 . . . . 0.65000000000000002 110.817 179.087 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.14 53.11 0.8 Allowed Glycine 0 N--CA 1.448 -0.543 0 C-N-CA 120.91 -0.662 . . . . 0.28999999999999998 112.373 -179.166 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -139.4 175.95 9.13 Favored 'General case' 0 C--N 1.328 -0.364 0 O-C-N 122.872 -0.193 . . . . 0.23000000000000001 110.683 177.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -126.45 129.91 49.63 Favored 'General case' 0 C--N 1.327 -0.388 0 N-CA-C 109.064 -0.717 . . . . 2.1400000000000001 109.064 178.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.583 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.3 t -118.25 142.15 34.2 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 N-CA-C 112.664 0.616 . . . . 0.19 112.664 -164.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.468 HG11 ' HB3' ' A' ' 44' ' ' SER . 10.4 t -114.38 136.38 51.15 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 108.867 -0.79 . . . . 0.23000000000000001 108.867 169.544 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 84.0 t -104.02 125.09 58.76 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-O 120.761 0.315 . . . . 0.94999999999999996 111.191 -179.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.78 139.53 45.2 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.109 -0.496 . . . . 0.16 110.424 175.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -104.94 -13.16 15.88 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.347 -0.388 . . . . 0.23999999999999999 111.2 -179.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.0 p -127.79 167.44 16.51 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.485 -0.325 . . . . 0.25 110.555 -179.073 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 74.6 m -68.73 -34.19 75.2 Favored 'General case' 0 C--N 1.322 -0.602 0 N-CA-C 109.845 -0.428 . . . . 1.6000000000000001 109.845 175.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -62.37 -48.01 81.64 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.066 -0.516 . . . . 0.69999999999999996 110.613 178.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.8 mt-30 -59.08 -41.03 87.05 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-O 121.353 0.596 . . . . 1.4099999999999999 110.621 175.874 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.658 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -62.0 -54.75 37.34 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-N 115.15 -0.932 . . . . 0.17999999999999999 111.419 -179.347 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.491 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 62.7 mt -64.46 -30.7 71.73 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.013 -0.54 . . . . 0.82999999999999996 110.767 -177.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.1 tmtm? -64.43 -47.43 79.15 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.292 -0.633 . . . . 2.4100000000000001 109.292 176.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.468 ' HB3' HG11 ' A' ' 33' ' ' VAL . 11.0 m -72.28 -30.46 64.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-N 115.922 -0.581 . . . . 1.1299999999999999 110.923 179.253 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.428 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 21.6 tp -67.1 -35.93 80.85 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.134 -0.485 . . . . 1.23 110.637 177.845 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.24 -35.15 48.65 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.055 -0.52 . . . . 0.42999999999999999 110.814 178.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -79.53 -36.28 38.66 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.745 -0.661 . . . . 0.62 111.17 -176.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 41.0 m-80 -120.59 148.56 48.24 Favored Pre-proline 0 C--N 1.321 -0.648 0 CA-C-O 121.358 0.599 . . . . 0.41999999999999998 111.284 -176.589 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -84.65 88.59 0.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.321 2.681 . . . . 0.23999999999999999 111.498 176.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.499 HD12 ' HB2' ' A' ' 9' ' ' LEU . 42.6 mm -68.56 127.95 31.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.396 -0.82 . . . . 0.22 111.663 -175.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 43.2 m-20 -98.89 -27.03 14.09 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.084 -0.507 . . . . 0.28999999999999998 110.414 179.428 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.515 ' CG1' HG22 ' A' ' 8' ' ' VAL . 11.7 p -159.48 159.06 2.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.957 -0.565 . . . . 0.12 109.49 -178.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.434 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -145.71 165.84 27.61 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-O 121.376 0.607 . . . . 0.14000000000000001 112.128 -178.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -138.14 111.76 7.87 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 115.221 -0.899 . . . . 0.95999999999999996 109.192 175.899 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.625 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -114.43 124.08 51.04 Favored 'General case' 0 C--N 1.319 -0.76 0 N-CA-C 112.329 0.492 . . . . 0.16 112.329 -168.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.631 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 65.5 t0 -85.1 115.1 22.72 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.815 0.817 . . . . 1.77 109.336 169.231 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.753 HG13 HD23 ' A' ' 92' ' ' LEU . 65.8 t -59.97 -24.17 29.04 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.892 0 CA-C-N 114.588 -1.187 . . . . 0.80000000000000004 110.96 177.94 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.496 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 7.7 t30 -113.01 75.53 0.92 Allowed 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 116.131 -0.486 . . . . 2.3700000000000001 110.518 -179.155 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.4 mt -69.3 -29.57 67.45 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 121.809 0.814 . . . . 0.84999999999999998 109.052 174.411 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -167.37 -172.22 34.28 Favored Glycine 0 N--CA 1.439 -1.123 0 CA-C-N 114.567 -1.197 . . . . 0.81999999999999995 110.241 175.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . 0.448 ' HB2' ' HD2' ' A' ' 62' ' ' LYS . 86.1 Cg_exo -52.92 -44.52 47.9 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.905 2.403 . . . . 1.1799999999999999 112.399 176.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.448 ' HD2' ' HB2' ' A' ' 61' ' ' PRO . 0.5 OUTLIER -109.59 -34.1 6.59 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.283 -0.417 . . . . 3.5299999999999998 110.563 177.572 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 70.8 m -65.89 127.46 32.13 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 121.351 0.596 . . . . 0.95999999999999996 111.146 -178.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.4 p80 -144.23 149.89 37.09 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.792 -0.64 . . . . 0.48999999999999999 110.34 -176.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.625 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -71.74 86.57 0.94 Allowed 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.514 0.674 . . . . 1.3 109.431 171.678 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.65 -73.06 0.7 Allowed Glycine 0 CA--C 1.508 -0.402 0 C-N-CA 120.355 -0.926 . . . . 0.23000000000000001 112.164 -177.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 42.8 Cg_exo -53.29 -25.3 30.08 Favored 'Trans proline' 0 N--CA 1.461 -0.441 0 C-N-CA 122.583 2.189 . . . . 0.23999999999999999 112.221 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 11' ' ' LEU . 12.6 t -72.12 -46.72 57.51 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.364 0 CA-C-O 121.228 0.537 . . . . 0.12 110.365 177.599 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -57.42 -51.81 67.93 Favored 'General case' 0 CA--C 1.512 -0.504 0 CA-C-N 115.314 -0.857 . . . . 0.16 109.802 178.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 26.4 t70 -62.28 -37.34 85.11 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.356 -0.838 . . . . 2.0299999999999998 110.49 179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.428 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -56.96 -48.23 78.83 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.409 0.623 . . . . 0.23000000000000001 110.969 176.847 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 92.7 mt -69.04 -41.61 77.43 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.399 -0.818 . . . . 0.20000000000000001 110.402 179.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.503 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 29.9 mmmt -57.89 -39.39 77.76 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 115.585 -0.734 . . . . 2.0099999999999998 110.807 175.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -62.64 -46.68 87.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.685 -0.688 . . . . 2.3700000000000001 111.462 177.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -86.41 2.8 46.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.38 -0.373 . . . . 1.49 111.086 -177.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.0 33.16 21.35 Favored 'General case' 0 C--O 1.233 0.23 0 CA-C-N 115.763 -0.653 . . . . 0.33000000000000002 111.308 -179.354 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 77.4 mt -85.74 131.39 47.45 Favored Pre-proline 0 N--CA 1.448 -0.53 0 CA-C-N 116.085 -0.507 . . . . 0.17000000000000001 109.845 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.421 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.2 Cg_endo -72.72 139.39 30.69 Favored 'Trans proline' 0 N--CA 1.453 -0.863 0 C-N-CA 122.17 1.913 . . . . 0.20999999999999999 111.616 178.869 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.434 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 12.5 p90 -156.44 155.28 31.8 Favored 'General case' 0 C--N 1.317 -0.82 0 CA-C-N 115.902 -0.59 . . . . 0.17999999999999999 110.719 -179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 30.2 mt -118.34 139.61 44.95 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.932 0 CA-C-N 115.538 -0.756 . . . . 0.23999999999999999 109.505 178.772 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.456 HD21 HG21 ' A' ' 96' ' ' ILE . 2.5 mm? -88.69 107.45 18.94 Favored 'General case' 0 C--N 1.318 -0.793 0 N-CA-C 109.281 -0.637 . . . . 0.20999999999999999 109.281 177.887 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.488 ' HA ' ' O ' ' A' ' 101' ' ' MET . 14.7 t-160 -103.46 72.52 1.15 Allowed 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 108.275 -1.009 . . . . 0.59999999999999998 108.275 179.05 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.631 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 9.7 t -103.52 159.63 15.42 Favored 'General case' 0 C--N 1.313 -1.0 0 CA-C-N 113.989 -1.46 . . . . 0.60999999999999999 111.401 -171.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.689 ' CA ' ' HG2' ' A' ' 103' ' ' LYS . . . -106.24 9.42 42.41 Favored Glycine 0 N--CA 1.443 -0.89 0 C-N-CA 120.623 -0.799 . . . . 0.93999999999999995 111.42 173.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.496 ' HB3' ' HB2' ' A' ' 58' ' ' ASN . 17.7 t70 -137.06 141.31 42.41 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.877 0.37 . . . . 2.3300000000000001 110.861 -179.036 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.6 mt -130.08 -31.88 1.87 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 116.079 -0.51 . . . . 1.6100000000000001 110.71 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -86.54 -39.39 16.26 Favored 'General case' 0 C--O 1.234 0.259 0 N-CA-C 112.478 0.548 . . . . 2.6299999999999999 112.478 -175.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 64.0 ttt180 -70.16 -52.58 22.35 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.692 0.282 . . . . 4.4199999999999999 111.141 -173.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -97.21 29.1 3.3 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.426 -0.352 . . . . 1.05 110.304 178.185 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.515 ' O ' ' HG ' ' A' ' 93' ' ' LEU . . . -56.18 -34.08 62.1 Favored Glycine 0 CA--C 1.517 0.204 0 C-N-CA 121.448 -0.406 . . . . 0.97999999999999998 113.796 -173.723 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 25.6 mm-40 -62.88 -26.04 68.59 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 2.5 111.259 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.753 HD23 HG13 ' A' ' 57' ' ' VAL . 15.3 tp -74.96 -47.87 27.21 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.22 -0.445 . . . . 0.70999999999999996 110.954 -176.383 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.515 ' HG ' ' O ' ' A' ' 90' ' ' GLY . 0.0 OUTLIER -60.48 -36.37 78.11 Favored 'General case' 0 CA--C 1.519 -0.244 0 CA-C-O 120.911 0.386 . . . . 1.5800000000000001 110.955 -176.918 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 99.0 mtt180 -60.43 -34.12 73.51 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.311 -0.859 . . . . 4.3799999999999999 111.183 179.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.5 mttp -81.34 -29.36 34.16 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.977 0.418 . . . . 2.4500000000000002 111.063 -179.489 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.567 HG13 ' O ' ' A' ' 92' ' ' LEU . 70.7 mt -67.71 -50.29 61.89 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.798 -0.637 . . . . 0.45000000000000001 111.327 -176.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.7 t70 55.21 75.96 0.29 Allowed 'General case' 0 N--CA 1.467 0.39 0 CA-C-O 121.413 0.625 . . . . 1.0900000000000001 110.617 -177.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -162.71 161.99 19.07 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 115.437 -0.802 . . . . 0.28999999999999998 109.44 -178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.448 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 31.8 Cg_exo -59.99 137.3 75.07 Favored 'Trans proline' 0 C--N 1.343 0.282 0 C-N-CA 122.79 2.327 . . . . 0.26000000000000001 112.465 -178.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.1 t -117.9 135.33 58.65 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 115.891 -0.595 . . . . 0.64000000000000001 110.904 -177.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.59 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 97.6 mtp -127.24 90.91 3.22 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 109.294 -0.632 . . . . 0.82999999999999996 109.294 173.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -60.62 139.78 57.69 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.739 -0.664 . . . . 0.54000000000000004 111.62 -176.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.689 ' HG2' ' CA ' ' A' ' 84' ' ' GLY . 15.3 ptpt -91.56 149.84 40.06 Favored Pre-proline 0 C--N 1.325 -0.488 0 CA-C-N 115.594 -0.73 . . . . 0.67000000000000004 109.673 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.564 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 16.7 Cg_exo -66.54 138.43 39.56 Favored 'Cis proline' 0 C--N 1.342 0.225 0 C-N-CA 123.534 -1.444 . . . . 0.75 113.118 3.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.406 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -142.07 133.93 27.2 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.253 -0.885 . . . . 0.34999999999999998 108.778 177.676 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.579 ' O ' HG23 ' A' ' 110' ' ' VAL . 12.9 t70 -65.09 123.36 19.3 Favored 'General case' 0 C--N 1.322 -0.588 0 N-CA-C 109.585 -0.524 . . . . 0.51000000000000001 109.585 -178.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.429 HG21 ' HB3' ' A' ' 20' ' ' ASN . 28.9 p -64.05 -24.21 67.62 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-N 115.495 -0.775 . . . . 0.26000000000000001 112.555 -171.456 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 28.8 t -70.81 -39.74 72.89 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 109.455 -0.572 . . . . 1.3200000000000001 109.455 176.178 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -67.01 -44.26 80.76 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 116.136 -0.484 . . . . 0.62 109.84 177.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.59 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 25.4 t -59.95 -42.11 88.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.538 0 CA-C-N 115.197 -0.911 . . . . 0.13 110.378 178.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.588 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.85 -50.47 66.5 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.598 -0.728 . . . . 0.13 111.558 -179.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -62.85 -41.1 99.23 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 116.065 -0.516 . . . . 1.95 111.538 -176.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.4 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 31.1 mmt180 -71.82 -24.91 61.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.7 0.285 . . . . 2.23 111.492 -179.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.37 -48.98 13.1 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.926 0.394 . . . . 0.14000000000000001 110.279 175.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.627 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 69.0 mt -64.55 -26.82 68.58 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.931 0.715 . . . . 0.27000000000000002 112.931 -175.562 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -68.69 -28.98 67.34 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.779 -0.368 . . . . 2.79 110.969 178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.448 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 57.7 mtm -75.21 -21.81 58.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.777 0.323 . . . . 0.42999999999999999 111.03 179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.627 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 25.4 p -106.54 25.27 11.38 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.06 0.457 . . . . 1.46 110.529 176.964 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -64.11 -32.32 83.78 Favored Glycine 0 N--CA 1.449 -0.48 0 CA-C-N 115.699 -0.682 . . . . 2.5699999999999998 112.113 -179.376 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 103.36 64.14 0.7 Allowed Glycine 0 N--CA 1.445 -0.746 0 C-N-CA 120.731 -0.747 . . . . 4.4800000000000004 112.13 178.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -88.18 52.81 2.55 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-O 121.529 0.681 . . . . 6.4199999999999999 109.955 177.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -83.29 70.31 10.12 Favored 'General case' 0 N--CA 1.45 -0.471 0 CA-C-N 115.143 -0.935 . . . . 9.1899999999999995 110.106 -178.161 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 36.6 mt-10 -98.62 127.0 37.08 Favored Pre-proline 0 C--N 1.32 -0.68 0 CA-C-N 115.612 -0.722 . . . . 9.5999999999999996 110.223 -179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 36.8 Cg_endo -66.14 118.68 5.71 Favored 'Trans proline' 0 C--O 1.234 0.325 0 C-N-CA 122.581 2.188 . . . . 11.17 112.079 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.999 0 CA-C-O 118.52 -0.753 . . . . 13.279999999999999 110.317 -179.598 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.717 0 N-CA-C 112.523 -0.231 . . . . 8.8000000000000007 112.523 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 63.36 25.17 14.52 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 122.88 0.472 . . . . 6.7800000000000002 111.242 178.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.6 mmt -123.45 171.2 9.65 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.167 -0.469 . . . . 7.21 110.009 -179.355 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.608 ' O ' ' HG2' ' A' ' 5' ' ' MET . . . 90.91 -37.86 3.31 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 121.007 -0.616 . . . . 1.8500000000000001 112.314 178.929 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.608 ' HG2' ' O ' ' A' ' 4' ' ' GLY . 12.1 ptp 56.74 141.38 0.04 OUTLIER Pre-proline 0 N--CA 1.474 0.732 0 C-N-CA 125.317 1.447 . . . . 1.6499999999999999 112.554 -177.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.425 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 1.1 Cg_endo -69.53 141.13 45.3 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.153 1.902 . . . . 0.33000000000000002 112.743 -176.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.1 tptt -89.56 105.92 18.12 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.635 -0.711 . . . . 0.89000000000000001 109.087 175.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 48.6 t -100.66 134.77 39.46 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 116.096 -0.502 . . . . 0.20000000000000001 111.228 -174.292 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.479 ' HB2' HD12 ' A' ' 50' ' ' ILE . 50.5 tp -110.55 113.31 25.84 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.008 -0.542 . . . . 0.75 110.564 176.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.4 t -95.05 129.11 45.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 120.962 0.411 . . . . 0.13 111.113 178.621 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.619 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.5 OUTLIER -110.0 101.54 10.35 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.563 -0.744 . . . . 0.20999999999999999 109.982 176.349 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -165.14 133.25 3.19 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.658 -0.497 . . . . 1.4099999999999999 109.658 -176.938 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t70 -87.47 -31.95 19.72 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.884 -0.598 . . . . 1.27 110.497 -177.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -75.1 111.46 13.7 Favored Pre-proline 0 C--N 1.333 -0.149 0 N-CA-C 110.22 -0.289 . . . . 2.5600000000000001 110.22 178.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -58.48 -31.92 95.29 Favored 'Trans proline' 0 C--N 1.345 0.348 0 C-N-CA 122.998 2.465 . . . . 0.32000000000000001 113.027 -175.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -64.81 -49.64 69.84 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.891 -0.411 . . . . 1.51 109.891 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 63.5 mt -65.08 -47.69 86.82 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 CA-C-N 116.134 -0.484 . . . . 1.01 110.415 178.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.76 -49.43 77.68 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.49 -0.777 . . . . 0.20999999999999999 111.477 -179.288 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.5 ttp -66.22 -34.12 77.31 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 116.382 -0.372 . . . . 0.60999999999999999 111.093 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.539 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.2 m-20 -66.77 -43.88 82.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.311 -0.404 . . . . 1.22 110.609 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 50.5 mt -62.39 -44.06 97.35 Favored 'General case' 0 N--CA 1.449 -0.516 0 CA-C-N 116.184 -0.462 . . . . 0.17999999999999999 110.021 173.272 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.481 ' HA ' HG11 ' A' ' 32' ' ' VAL . 56.6 tt0 -52.18 -53.83 38.33 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.399 -0.819 . . . . 1.04 110.684 178.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 15.5 m-85 -63.76 -33.35 75.47 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.777 0.323 . . . . 0.78000000000000003 111.138 179.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.87 71.57 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.215 -0.448 . . . . 0.14000000000000001 111.046 -177.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.716 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.3 m-85 -66.95 -40.41 87.51 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 116.28 -0.418 . . . . 0.13 110.849 179.21 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.6 mt-10 -61.6 -35.66 78.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.447 -0.342 . . . . 0.68999999999999995 110.539 177.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.9 t70 -68.73 -29.25 67.63 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.055 -0.52 . . . . 0.51000000000000001 110.761 178.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.0 mm-40 -82.78 -2.0 53.23 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.386 -0.37 . . . . 0.65000000000000002 110.923 177.194 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 87.16 50.54 3.62 Favored Glycine 0 N--CA 1.448 -0.535 0 C-N-CA 120.878 -0.677 . . . . 0.28999999999999998 112.404 179.207 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -138.87 162.32 35.11 Favored 'General case' 0 C--N 1.323 -0.55 0 N-CA-C 110.204 -0.295 . . . . 0.23000000000000001 110.204 177.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -105.78 132.98 51.25 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 109.572 -0.529 . . . . 2.1400000000000001 109.572 178.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.481 HG11 ' HA ' ' A' ' 22' ' ' GLN . 21.8 t -113.78 139.95 36.75 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 N-CA-C 112.014 0.375 . . . . 0.19 112.014 -171.254 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.485 HG11 ' OG ' ' A' ' 44' ' ' SER . 10.2 t -114.45 127.29 71.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.588 -0.893 . . . . 0.23000000000000001 108.588 167.281 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 99.3 t -97.61 123.4 50.01 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.738 0 C-N-CA 120.727 -0.389 . . . . 0.94999999999999996 110.769 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -129.36 134.32 47.83 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.064 -0.516 . . . . 0.16 109.994 175.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -97.02 -18.95 19.08 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 115.833 -0.621 . . . . 0.23999999999999999 110.909 -179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.2 p -125.12 164.89 19.25 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 120.705 -0.398 . . . . 0.25 111.163 -178.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.646 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 76.5 m -65.16 -35.46 81.15 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.838 -0.619 . . . . 1.6000000000000001 109.681 174.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.4 mt-10 -60.6 -46.91 88.47 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.984 -0.553 . . . . 0.69999999999999996 110.641 178.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 71.1 mt-30 -61.42 -41.65 97.5 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.955 -0.566 . . . . 1.4099999999999999 110.822 176.403 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.619 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.46 -49.65 72.84 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.559 -0.746 . . . . 0.17999999999999999 111.484 -179.725 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.646 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 81.7 mt -60.58 -33.42 72.69 Favored 'General case' 0 N--CA 1.453 -0.314 0 CA-C-N 116.192 -0.458 . . . . 0.82999999999999996 110.885 -179.27 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.443 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 6.8 tmtm? -66.73 -52.58 42.77 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.814 -0.63 . . . . 2.4100000000000001 109.945 178.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.485 ' OG ' HG11 ' A' ' 33' ' ' VAL . 14.1 t -65.4 -34.42 78.25 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.367 -0.379 . . . . 1.1299999999999999 110.44 -178.654 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.406 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 17.7 tp -62.05 -36.44 81.62 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.074 -0.512 . . . . 1.23 110.852 179.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -82.05 -39.84 22.89 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 116.292 -0.413 . . . . 0.42999999999999999 111.194 -179.39 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -73.58 -37.79 65.38 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.998 -0.546 . . . . 0.62 111.397 -176.551 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 25.0 m-80 -115.29 163.14 21.14 Favored Pre-proline 0 C--N 1.322 -0.608 0 CA-C-N 116.044 -0.525 . . . . 0.41999999999999998 110.411 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -95.84 82.54 0.1 Allowed 'Trans proline' 0 N--CA 1.446 -1.29 0 C-N-CA 123.446 2.764 . . . . 0.23999999999999999 111.531 177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.479 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.7 mm -63.96 122.43 14.84 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.804 0 CA-C-N 115.463 -0.79 . . . . 0.22 111.526 -176.076 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 45.5 m-20 -90.22 -34.71 15.7 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.56 -0.746 . . . . 0.28999999999999998 110.32 178.995 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.495 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -154.7 154.27 7.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 CA-C-N 116.001 -0.545 . . . . 0.12 109.987 -178.225 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.484 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -137.21 162.89 32.25 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.374 0.606 . . . . 0.14000000000000001 111.657 -179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.425 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -135.17 112.71 14.8 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 115.411 -0.813 . . . . 0.95999999999999996 109.185 176.774 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.489 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.0 mp -107.54 97.95 7.62 Favored 'General case' 0 C--N 1.315 -0.908 0 CA-C-O 121.442 0.639 . . . . 0.16 110.975 -172.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.734 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.7 OUTLIER -74.22 82.98 1.85 Allowed 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 114.929 -1.032 . . . . 1.77 109.35 174.036 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.401 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 60.5 t -42.46 -42.07 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.422 0 CA-C-N 114.541 -1.208 . . . . 0.80000000000000004 113.71 -169.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -78.35 74.43 4.89 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.014 0.435 . . . . 2.3700000000000001 110.755 -177.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 78.7 mt -78.52 -22.85 46.73 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.55 0.691 . . . . 0.84999999999999998 109.444 175.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 179.8 -174.39 45.95 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 114.904 -1.044 . . . . 0.81999999999999995 110.503 177.041 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.8 Cg_exo -55.49 -40.13 87.2 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.598 2.199 . . . . 1.1799999999999999 112.339 178.018 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.6 mttm -118.06 -23.69 7.31 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 116.088 -0.506 . . . . 3.5299999999999998 110.723 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 25.9 m -70.32 124.74 24.9 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 121.214 0.53 . . . . 0.95999999999999996 110.973 179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 27.0 p80 -144.97 148.31 33.65 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.726 -0.67 . . . . 0.48999999999999999 110.353 -178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.501 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.0 OUTLIER -76.44 87.32 3.19 Favored 'General case' 0 C--N 1.322 -0.613 0 N-CA-C 108.857 -0.794 . . . . 1.3 108.857 171.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.417 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -110.71 -67.52 0.56 Allowed Glycine 0 C--O 1.227 -0.319 0 C-N-CA 120.47 -0.871 . . . . 0.23000000000000001 112.541 -176.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.586 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 38.9 Cg_exo -53.96 -21.35 20.86 Favored 'Trans proline' 0 C--N 1.345 0.345 0 C-N-CA 122.354 2.036 . . . . 0.23999999999999999 111.902 174.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.464 HG11 ' CD2' ' A' ' 11' ' ' LEU . 38.5 t -70.17 -42.67 79.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 115.889 -0.596 . . . . 0.12 110.071 176.293 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.99 -45.68 91.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.564 -0.744 . . . . 0.16 109.905 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.655 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 46.0 m-20 -61.74 -43.78 98.18 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.63 -0.714 . . . . 2.0299999999999998 109.804 176.087 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.406 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -56.4 -48.71 76.35 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.95 -0.568 . . . . 0.23000000000000001 111.165 178.65 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.11 -41.44 97.25 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.514 -0.766 . . . . 0.20000000000000001 110.297 178.362 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 19.0 mttm -60.94 -34.47 74.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.829 -0.623 . . . . 2.0099999999999998 111.757 175.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.655 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 15.8 mm100 -65.47 -35.5 81.09 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.457 -0.338 . . . . 2.3700000000000001 110.929 178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 67.1 mtt180 -100.24 7.93 44.12 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.342 -0.39 . . . . 1.49 111.421 -179.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.89 36.31 27.56 Favored 'General case' 0 N--CA 1.463 0.206 0 CA-C-N 115.798 -0.637 . . . . 0.33000000000000002 111.694 179.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 72.0 mt -88.82 133.41 35.82 Favored Pre-proline 0 N--CA 1.447 -0.576 0 CA-C-N 116.413 -0.358 . . . . 0.17000000000000001 110.152 179.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -76.9 141.35 21.29 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 122.607 2.205 . . . . 0.20999999999999999 112.113 178.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.484 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 21.8 p90 -156.7 157.9 35.98 Favored 'General case' 0 C--N 1.314 -0.976 0 CA-C-N 115.378 -0.828 . . . . 0.17999999999999999 110.453 -178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.8 mt -120.05 139.05 48.63 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.957 0 CA-C-N 115.246 -0.888 . . . . 0.23999999999999999 109.646 -179.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.502 HD21 HG21 ' A' ' 96' ' ' ILE . 1.6 mm? -89.23 108.01 19.37 Favored 'General case' 0 C--N 1.319 -0.749 0 N-CA-C 108.905 -0.776 . . . . 0.20999999999999999 108.905 177.098 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.743 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 12.0 t-160 -101.77 102.59 13.24 Favored 'General case' 0 C--N 1.312 -1.032 0 CA-C-O 121.359 0.599 . . . . 0.59999999999999998 110.111 -179.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.622 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 7.9 t -164.21 149.96 10.74 Favored 'General case' 0 C--N 1.318 -0.8 0 O-C-N 121.964 -0.46 . . . . 0.60999999999999999 110.423 -173.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.3 -13.32 36.3 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.483 -1.047 . . . . 0.93999999999999995 110.483 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.432 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 33.0 t70 -94.36 103.81 15.8 Favored 'General case' 0 C--N 1.323 -0.558 0 N-CA-C 108.815 -0.809 . . . . 2.3300000000000001 108.815 177.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.2 mt -115.41 -62.14 1.64 Allowed 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.216 -0.447 . . . . 1.6100000000000001 112.036 -171.098 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -60.13 -29.86 68.91 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-O 121.051 0.453 . . . . 2.6299999999999999 111.17 -176.382 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.432 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 65.6 ttt180 -67.81 -18.73 64.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.647 -0.706 . . . . 4.4199999999999999 110.944 178.619 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 79.1 m-70 -131.25 33.18 4.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.075 -0.511 . . . . 1.05 110.289 178.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.588 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.43 -41.8 98.72 Favored Glycine 0 N--CA 1.449 -0.442 0 CA-C-N 115.887 -0.597 . . . . 0.97999999999999998 113.012 -175.203 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -59.89 -37.08 78.34 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.695 0.284 . . . . 2.5 111.108 -179.406 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.498 ' O ' HG13 ' A' ' 96' ' ' ILE . 24.2 tp -64.08 -49.53 71.93 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 121.264 0.554 . . . . 0.70999999999999996 110.052 176.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . . . . . . . . . 31.7 mt -61.47 -31.32 71.28 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.133 -0.939 . . . . 1.5800000000000001 111.252 -177.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.588 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 95.9 mtt180 -63.97 -37.98 89.39 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.359 -0.382 . . . . 4.3799999999999999 110.866 178.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 50.8 mtpt -66.33 -47.4 73.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.53 0.681 . . . . 2.4500000000000002 110.273 176.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.502 HG21 HD21 ' A' ' 81' ' ' LEU . 41.2 mt -66.31 -56.33 14.95 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-N 114.519 -1.219 . . . . 0.45000000000000001 111.215 -175.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 35.9 t70 47.99 59.55 4.15 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 121.882 0.848 . . . . 1.0900000000000001 110.715 -178.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.455 ' HB1' ' HD2' ' A' ' 99' ' ' PRO . . . -132.66 168.98 15.17 Favored Pre-proline 0 C--N 1.32 -0.711 0 CA-C-N 115.077 -0.965 . . . . 0.28999999999999998 109.336 -179.15 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 78.3 Cg_exo -51.67 136.64 50.15 Favored 'Trans proline' 0 C--N 1.346 0.441 0 C-N-CA 122.238 1.959 . . . . 0.26000000000000001 112.756 177.87 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 48.1 t -123.14 136.26 60.46 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.813 0 CA-C-N 115.352 -0.84 . . . . 0.64000000000000001 110.146 -178.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.686 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 94.5 mtp -118.35 106.06 12.37 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.343 -0.614 . . . . 0.82999999999999996 109.343 173.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.622 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.67 153.04 44.51 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.474 -0.785 . . . . 0.54000000000000004 110.842 -177.139 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 57.5 mttp -91.04 146.32 33.42 Favored Pre-proline 0 C--N 1.322 -0.603 0 CA-C-N 116.127 -0.488 . . . . 0.67000000000000004 109.838 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -76.52 148.65 89.58 Favored 'Cis proline' 0 CA--C 1.528 0.221 0 C-N-CA 123.548 -1.438 . . . . 0.75 112.858 0.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.743 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -140.61 135.97 32.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.695 -0.684 . . . . 0.34999999999999998 109.615 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.545 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.9 t0 -75.93 132.55 40.33 Favored 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.8 -0.815 . . . . 0.51000000000000001 108.8 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.7 p -67.7 -21.17 65.33 Favored 'General case' 0 C--N 1.317 -0.836 0 CA-C-N 115.707 -0.679 . . . . 0.26000000000000001 112.189 -172.851 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 83.9 p -76.0 -29.08 58.05 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.154 0.502 . . . . 1.3200000000000001 109.672 176.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -73.97 -45.5 49.79 Favored 'General case' 0 CA--C 1.513 -0.479 0 CA-C-N 115.841 -0.618 . . . . 0.62 109.57 174.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.686 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 23.2 t -59.03 -44.59 91.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 115.687 -0.688 . . . . 0.13 110.428 178.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.716 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -59.11 -52.68 64.67 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.625 -0.716 . . . . 0.13 111.346 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.671 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 37.3 mtmm -62.96 -47.03 84.95 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 116.033 -0.53 . . . . 1.95 111.039 -177.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -56.49 -37.65 70.67 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 120.781 0.325 . . . . 2.23 111.513 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -70.45 -49.46 48.42 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.12 -0.491 . . . . 0.14000000000000001 110.794 179.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.495 HD23 HG11 ' A' ' 52' ' ' VAL . 74.6 mt -64.02 -25.29 68.05 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.261 -0.427 . . . . 0.27000000000000002 112.0 -178.123 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.671 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 42.5 mm-40 -59.31 -31.09 68.83 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.642 0.258 . . . . 2.79 111.066 175.541 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.491 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 62.0 mtm -84.96 -23.07 28.93 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.576 -0.284 . . . . 0.42999999999999999 111.402 -178.378 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 49.4 t -175.73 98.21 0.07 Allowed 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 121.152 0.501 . . . . 1.46 110.119 178.901 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.413 ' CA ' ' HG3' ' A' ' 6' ' ' PRO . . . -179.29 71.67 0.07 OUTLIER Glycine 0 N--CA 1.443 -0.849 0 N-CA-C 111.249 -0.741 . . . . 2.5699999999999998 111.249 179.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 90.52 -47.27 3.03 Favored Glycine 0 N--CA 1.447 -0.606 0 N-CA-C 110.287 -1.125 . . . . 4.4800000000000004 110.287 -172.936 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 34.3 m-20 68.76 -177.92 0.22 Allowed 'General case' 0 C--O 1.233 0.189 0 C-N-CA 123.33 0.652 . . . . 6.4199999999999999 111.698 173.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 51.5 mttp -121.23 53.2 1.16 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.41 -0.814 . . . . 9.1899999999999995 109.676 -178.874 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.2 tp10 -77.9 127.74 81.04 Favored Pre-proline 0 C--N 1.324 -0.538 0 CA-C-N 115.365 -0.834 . . . . 9.5999999999999996 110.078 -177.301 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_exo -65.42 73.48 0.28 Allowed 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.964 2.443 . . . . 11.17 112.285 174.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.898 0 CA-C-O 118.434 -0.793 . . . . 13.279999999999999 110.538 -176.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.764 0 N-CA-C 111.893 -0.483 . . . . 8.8000000000000007 111.893 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.424 ' O ' ' HB2' ' A' ' 3' ' ' MET . . . -142.74 160.85 39.53 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.649 0.224 . . . . 6.7800000000000002 110.673 -178.694 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.424 ' HB2' ' O ' ' A' ' 2' ' ' ALA . 1.8 mpt? 74.26 -23.46 0.23 Allowed 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 123.64 0.776 . . . . 7.21 112.274 178.073 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 85.05 -88.58 1.58 Allowed Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 111.232 -0.747 . . . . 1.8500000000000001 111.232 -175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.465 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 46.7 mtt -103.61 131.17 22.3 Favored Pre-proline 0 C--N 1.32 -0.69 0 N-CA-C 110.184 -0.302 . . . . 1.6499999999999999 110.184 177.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.465 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.5 Cg_exo -66.36 136.93 45.33 Favored 'Trans proline' 0 N--CA 1.462 -0.373 0 C-N-CA 122.643 2.229 . . . . 0.33000000000000002 111.741 177.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.477 ' HB3' HD13 ' A' ' 50' ' ' ILE . 9.3 mttp -84.22 109.67 17.94 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-O 121.129 0.49 . . . . 0.89000000000000001 110.839 175.766 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 39.1 t -101.66 117.83 47.55 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 CA-C-N 115.111 -0.95 . . . . 0.20000000000000001 110.515 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.442 HD21 ' HB1' ' A' ' 41' ' ' ALA . 58.2 tp -97.66 109.9 22.56 Favored 'General case' 0 C--N 1.313 -1.01 0 CA-C-N 115.698 -0.683 . . . . 0.75 110.432 178.557 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 25.5 t -92.08 123.86 44.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-O 121.199 0.523 . . . . 0.13 111.479 -179.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.705 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.2 mm? -101.72 106.2 17.19 Favored 'General case' 0 C--N 1.319 -0.736 0 CA-C-N 115.095 -0.957 . . . . 0.20999999999999999 108.897 172.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -165.5 131.28 2.6 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-N 115.889 -0.596 . . . . 1.4099999999999999 109.873 -177.153 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.457 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 24.4 t70 -94.13 -21.25 19.22 Favored 'General case' 0 C--N 1.317 -0.823 0 CA-C-N 115.418 -0.81 . . . . 1.27 109.722 -179.364 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.435 ' HB3' HD13 ' A' ' 17' ' ' ILE . 9.6 mm-40 -81.81 105.58 4.66 Favored Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.592 -0.731 . . . . 2.5600000000000001 110.193 175.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.457 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 34.5 Cg_exo -59.81 -25.19 78.57 Favored 'Trans proline' 0 C--N 1.342 0.23 0 C-N-CA 122.771 2.314 . . . . 0.32000000000000001 113.366 -174.632 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -69.32 -52.04 31.22 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.312 -0.625 . . . . 1.51 109.312 178.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.435 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.9 mp -63.85 -43.8 97.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 115.989 -0.55 . . . . 1.01 110.069 178.226 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.27 66.11 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.622 -0.717 . . . . 0.20999999999999999 110.715 179.094 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 42.2 ttp -62.96 -38.77 92.4 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.691 -0.686 . . . . 0.60999999999999999 111.257 178.698 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.476 ' HB3' HG21 ' A' ' 107' ' ' THR . 7.3 m-20 -65.11 -42.56 93.86 Favored 'General case' 0 N--CA 1.449 -0.503 0 CA-C-N 116.21 -0.45 . . . . 1.22 111.289 -179.673 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.479 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 52.8 mt -65.21 -43.8 90.38 Favored 'General case' 0 CA--C 1.514 -0.425 0 CA-C-O 120.984 0.421 . . . . 0.17999999999999999 109.967 173.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.454 ' HA ' HG21 ' A' ' 32' ' ' VAL . 38.6 tt0 -52.86 -50.93 62.82 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.163 -0.926 . . . . 1.04 110.662 178.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -64.5 -33.37 75.74 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.261 -0.427 . . . . 0.78000000000000003 111.629 178.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.17 -49.29 61.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.957 0.408 . . . . 0.14000000000000001 111.061 -177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.641 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 73.2 m-85 -66.93 -42.09 85.93 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.342 -0.39 . . . . 0.13 110.967 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -64.84 -26.96 68.56 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.576 -0.284 . . . . 0.68999999999999995 110.703 177.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 37.7 t70 -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.841 0.353 . . . . 0.51000000000000001 110.951 175.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 32.1 mm-40 -80.06 -12.15 59.71 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.272 -0.422 . . . . 0.65000000000000002 111.223 179.619 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.89 51.74 1.35 Allowed Glycine 0 N--CA 1.449 -0.499 0 C-N-CA 120.785 -0.722 . . . . 0.28999999999999998 112.135 179.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.02 165.7 26.65 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 110.209 -0.293 . . . . 0.23000000000000001 110.209 178.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -109.08 130.58 55.48 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 109.654 -0.499 . . . . 2.1400000000000001 109.654 178.177 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.454 HG21 ' HA ' ' A' ' 22' ' ' GLN . 40.7 t -109.01 138.37 36.5 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 116.173 -0.467 . . . . 0.19 111.71 -171.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 13.7 t -115.63 123.39 71.01 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.61 0 N-CA-C 108.771 -0.826 . . . . 0.23000000000000001 108.771 170.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 13.5 p -92.85 128.68 44.22 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 CA-C-O 121.166 0.508 . . . . 0.94999999999999996 111.17 -177.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.8 135.05 34.21 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.059 -0.519 . . . . 0.16 110.605 177.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.08 -10.91 20.05 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 116.292 -0.413 . . . . 0.23999999999999999 111.37 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -130.26 166.1 21.05 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.484 -0.325 . . . . 0.25 111.075 -176.98 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.657 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 85.9 m -66.36 -34.92 79.05 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 116.37 -0.377 . . . . 1.6000000000000001 110.301 174.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -61.08 -51.57 68.58 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.063 -0.517 . . . . 0.69999999999999996 110.578 177.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -55.93 -37.07 68.45 Favored 'General case' 0 C--O 1.232 0.157 0 CA-C-N 115.999 -0.546 . . . . 1.4099999999999999 111.245 179.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.705 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -69.28 -52.74 24.54 Favored 'General case' 0 C--N 1.32 -0.712 0 CA-C-N 115.542 -0.753 . . . . 0.17999999999999999 111.133 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.1 mp -57.73 -34.96 70.06 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.87 -0.604 . . . . 0.82999999999999996 110.873 178.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 88.7 tttt -61.6 -52.74 63.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.167 -0.469 . . . . 2.4100000000000001 110.557 178.387 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 25.9 t -65.65 -36.74 84.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.88 -0.6 . . . . 1.1299999999999999 110.481 179.591 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 16.1 mt -61.9 -36.09 80.29 Favored 'General case' 0 N--CA 1.448 -0.557 0 CA-C-O 121.074 0.464 . . . . 1.23 110.939 178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.47 -35.91 45.96 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.996 0.426 . . . . 0.42999999999999999 111.442 -178.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 27.9 t70 -85.88 -31.47 22.19 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.059 0.457 . . . . 0.62 111.106 -175.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 31.5 m-80 -123.25 162.8 37.71 Favored Pre-proline 0 C--N 1.321 -0.651 0 CA-C-N 115.848 -0.614 . . . . 0.41999999999999998 111.415 -174.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.454 ' HD2' ' HD2' ' A' ' 7' ' ' LYS . 89.2 Cg_endo -95.47 90.55 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.68 2.92 . . . . 0.23999999999999999 111.383 176.337 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 7' ' ' LYS . 40.4 mm -73.94 123.85 30.04 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.885 0 CA-C-N 115.784 -0.644 . . . . 0.22 111.329 -175.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.532 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 24.8 m-20 -88.75 -28.48 20.48 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.552 -0.749 . . . . 0.28999999999999998 110.884 -177.341 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.531 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -164.05 158.2 1.55 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 N-CA-C 109.979 -0.378 . . . . 0.12 109.979 -177.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.453 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -139.8 167.13 22.82 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.331 0.586 . . . . 0.14000000000000001 111.806 -178.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.447 HG21 ' CE2' ' A' ' 25' ' ' PHE . 0.0 OUTLIER -140.58 112.26 4.31 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-N 115.383 -0.826 . . . . 0.95999999999999996 109.028 176.351 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.7 mp -111.22 119.59 39.45 Favored 'General case' 0 C--N 1.316 -0.869 0 N-CA-C 112.43 0.53 . . . . 0.16 112.43 -167.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 29.0 t70 -85.02 141.67 30.13 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 108.861 -0.792 . . . . 1.77 108.861 167.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.522 HG21 HD21 ' A' ' 93' ' ' LEU . 13.1 t -100.89 2.92 10.66 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-O 121.584 0.707 . . . . 0.80000000000000004 111.148 -170.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 43.2 t-20 -124.37 62.7 1.11 Allowed 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.682 -0.69 . . . . 2.3700000000000001 109.862 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 67.6 mt -74.54 -15.84 60.84 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.833 -0.621 . . . . 0.84999999999999998 110.24 -178.829 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -178.31 -171.5 41.7 Favored Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 111.105 -0.798 . . . . 0.81999999999999995 111.105 176.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_exo -50.83 -45.55 35.25 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 123.061 2.507 . . . . 1.1799999999999999 112.148 178.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 23.6 ttmm -117.95 -26.67 6.37 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.757 -0.656 . . . . 3.5299999999999998 110.106 177.035 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 22.2 m -62.47 125.16 22.96 Favored 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 121.481 0.658 . . . . 0.95999999999999996 111.402 -177.272 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -143.97 157.0 44.62 Favored 'General case' 0 C--N 1.318 -0.779 0 CA-C-N 115.439 -0.8 . . . . 0.48999999999999999 109.647 -178.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -71.4 87.48 0.86 Allowed 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.388 0.613 . . . . 1.3 109.493 171.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -112.24 -72.68 0.63 Allowed Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.468 -0.872 . . . . 0.23000000000000001 112.19 -179.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.657 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 44.0 Cg_exo -53.62 -26.39 37.16 Favored 'Trans proline' 0 C--N 1.345 0.363 0 C-N-CA 122.565 2.176 . . . . 0.23999999999999999 112.212 175.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.514 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.3 t -68.66 -43.35 83.27 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.325 0 CA-C-O 121.097 0.475 . . . . 0.12 110.201 178.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.77 -48.05 82.57 Favored 'General case' 0 N--CA 1.449 -0.525 0 CA-C-N 115.344 -0.844 . . . . 0.16 109.823 179.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.402 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 29.4 t70 -65.35 -40.5 93.68 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.47 -0.786 . . . . 2.0299999999999998 110.484 178.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.22 -47.98 68.52 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.398 0.618 . . . . 0.23000000000000001 110.955 176.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 95.9 mt -70.65 -42.26 71.05 Favored 'General case' 0 N--CA 1.447 -0.622 0 CA-C-N 115.215 -0.902 . . . . 0.20000000000000001 110.733 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -59.22 -36.56 75.63 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.881 -0.599 . . . . 2.0099999999999998 111.225 176.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.402 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 13.4 mm100 -64.82 -37.4 87.48 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.164 -0.471 . . . . 2.3700000000000001 111.574 178.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 73.6 mtt180 -97.56 5.31 49.7 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 116.397 -0.365 . . . . 1.49 111.397 -176.711 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.73 31.09 20.64 Favored 'General case' 0 C--O 1.235 0.311 0 CA-C-N 115.971 -0.558 . . . . 0.33000000000000002 111.399 -178.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 73.8 mt -83.36 130.08 57.93 Favored Pre-proline 0 N--CA 1.448 -0.549 0 N-CA-C 109.595 -0.52 . . . . 0.17000000000000001 109.595 178.252 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.28 142.95 38.43 Favored 'Trans proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.309 2.006 . . . . 0.20999999999999999 111.362 179.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.453 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 25.6 p90 -159.3 157.16 30.0 Favored 'General case' 0 C--N 1.314 -0.952 0 CA-C-O 121.124 0.487 . . . . 0.17999999999999999 110.621 179.378 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.424 HG21 ' HG2' ' A' ' 101' ' ' MET . 34.8 mt -121.39 138.59 51.24 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 CA-C-N 115.311 -0.859 . . . . 0.23999999999999999 109.853 179.691 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mm? -88.34 108.68 19.46 Favored 'General case' 0 C--N 1.315 -0.898 0 N-CA-C 108.758 -0.83 . . . . 0.20999999999999999 108.758 176.199 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.609 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 17.4 t-160 -105.82 85.33 2.2 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-O 121.369 0.604 . . . . 0.59999999999999998 109.476 -179.343 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.439 ' HB ' HG23 ' A' ' 57' ' ' VAL . 9.6 t -134.05 160.49 37.59 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 114.841 -1.072 . . . . 0.60999999999999999 110.212 -173.348 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -106.08 2.27 38.05 Favored Glycine 0 N--CA 1.448 -0.556 0 N-CA-C 110.569 -1.013 . . . . 0.93999999999999995 110.569 170.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 4.0 m-20 -97.29 51.09 1.09 Allowed 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.11 -0.545 . . . . 2.3300000000000001 110.692 -176.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 89.2 mt -64.66 -41.45 96.08 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.702 -0.681 . . . . 1.6100000000000001 111.145 -177.7 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 16.4 t70 -84.01 -40.81 17.94 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.562 -0.29 . . . . 2.6299999999999999 110.793 177.059 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.74 -43.59 80.85 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.102 -0.499 . . . . 4.4199999999999999 111.521 -178.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 91.8 m-70 -119.46 32.04 6.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.355 -0.384 . . . . 1.05 111.149 -177.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.404 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -59.13 -41.09 96.44 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.999 -0.619 . . . . 0.97999999999999998 112.809 -177.221 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -59.61 -47.17 86.63 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.134 0.493 . . . . 2.5 110.624 178.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.443 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.3 tp -60.29 -45.69 92.45 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.602 -0.727 . . . . 0.70999999999999996 110.32 179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.522 HD21 HG21 ' A' ' 57' ' ' VAL . 74.2 mt -58.64 -39.93 81.95 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.529 -0.76 . . . . 1.5800000000000001 111.368 179.72 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.472 ' HA ' ' NE ' ' A' ' 94' ' ' ARG . 4.7 mmp_? -64.26 -33.46 75.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 4.3799999999999999 111.361 178.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 62.5 mttp -75.8 -34.12 60.16 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.38 -0.373 . . . . 2.4500000000000002 111.069 179.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.443 HG13 ' O ' ' A' ' 92' ' ' LEU . 80.8 mt -64.76 -52.82 49.49 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 116.089 -0.505 . . . . 0.45000000000000001 110.314 176.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 23.1 t70 58.51 76.0 0.36 Allowed 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.815 0.697 . . . . 1.0900000000000001 110.787 -178.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -157.6 162.3 27.53 Favored Pre-proline 0 C--N 1.32 -0.707 0 CA-C-N 115.403 -0.817 . . . . 0.28999999999999998 108.95 179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.706 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -57.26 136.19 74.82 Favored 'Trans proline' 0 N--CA 1.465 -0.177 0 C-N-CA 122.448 2.098 . . . . 0.26000000000000001 112.429 -178.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.91 132.6 68.35 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.777 0 CA-C-N 115.58 -0.736 . . . . 0.64000000000000001 110.76 -177.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.463 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.9 mmm -113.04 105.54 13.59 Favored 'General case' 0 C--N 1.325 -0.476 0 N-CA-C 108.895 -0.78 . . . . 0.82999999999999996 108.895 173.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -65.06 146.14 55.39 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 116.003 -0.544 . . . . 0.54000000000000004 111.475 -175.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.536 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.3 mttt -91.05 141.61 26.62 Favored Pre-proline 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.67000000000000004 109.473 173.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_endo -75.57 156.41 99.23 Favored 'Cis proline' 0 CA--C 1.528 0.217 0 C-N-CA 123.413 -1.494 . . . . 0.75 113.339 2.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.609 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.76 135.1 15.06 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-N 115.709 -0.678 . . . . 0.34999999999999998 109.915 178.436 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -70.94 130.23 41.08 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 107.897 -1.149 . . . . 0.51000000000000001 107.897 174.073 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.479 ' HB ' ' HA ' ' A' ' 21' ' ' LEU . 33.5 p -65.05 -18.35 65.22 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 112.737 0.643 . . . . 0.26000000000000001 112.737 -171.084 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 77.3 p -71.15 -38.81 72.21 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.459 -0.496 . . . . 1.3200000000000001 109.689 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -62.38 -46.76 87.16 Favored 'General case' 0 CA--C 1.51 -0.566 0 CA-C-O 121.412 0.625 . . . . 0.62 109.575 175.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 16.3 t -61.72 -45.39 98.78 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-N 114.853 -1.067 . . . . 0.13 110.394 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.641 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.64 -50.03 72.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.623 -0.717 . . . . 0.13 111.518 -178.872 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 27.4 mtpp -59.59 -43.32 93.73 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.934 -0.576 . . . . 1.95 111.349 -177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.441 ' O ' ' HG3' ' A' ' 117' ' ' MET . 23.9 mmt180 -68.16 -31.79 71.59 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.965 0.412 . . . . 2.23 111.321 -179.787 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -74.67 -48.53 25.6 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.354 -0.385 . . . . 0.14000000000000001 110.473 179.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.471 HD23 HG11 ' A' ' 52' ' ' VAL . 70.1 mt -66.42 -32.09 73.25 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 112.489 0.551 . . . . 0.27000000000000002 112.489 -177.251 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -70.2 -22.16 62.96 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.599 -0.441 . . . . 2.79 110.978 179.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.706 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 56.5 mtm -77.55 -16.35 58.71 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-O 120.871 0.367 . . . . 0.42999999999999999 110.613 174.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.532 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 43.2 t -90.7 -42.74 10.56 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.265 0.555 . . . . 1.46 109.64 175.079 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -132.64 -104.86 0.93 Allowed Glycine 0 N--CA 1.444 -0.808 0 CA-C-N 115.64 -0.709 . . . . 2.5699999999999998 111.331 176.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 81.75 -29.47 2.99 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 121.003 -0.618 . . . . 4.4800000000000004 113.063 175.442 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 30.4 t70 68.71 16.99 8.94 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-O 121.573 0.702 . . . . 6.4199999999999999 110.045 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 28.7 tptp -165.53 135.56 3.57 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.746 -0.661 . . . . 9.1899999999999995 110.723 -176.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 19.6 mm-40 -104.55 137.36 19.2 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.086 -0.506 . . . . 9.5999999999999996 110.028 175.267 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.34 129.73 13.27 Favored 'Trans proline' 0 C--O 1.235 0.361 0 C-N-CA 122.37 2.046 . . . . 11.17 112.13 179.018 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.054 0 CA-C-O 118.511 -0.757 . . . . 13.279999999999999 110.501 179.483 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.62 0 N-CA-C 111.861 -0.496 . . . . 8.8000000000000007 111.861 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.66 34.13 17.74 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 122.826 0.451 . . . . 6.7800000000000002 111.329 -179.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 63.6 mtm -95.09 135.15 36.99 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.135 -0.484 . . . . 7.21 109.974 178.27 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.402 ' O ' ' HB2' ' A' ' 5' ' ' MET . . . -163.07 62.38 0.26 Allowed Glycine 0 N--CA 1.445 -0.704 0 C-N-CA 120.846 -0.692 . . . . 1.8500000000000001 112.027 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.402 ' HB2' ' O ' ' A' ' 4' ' ' GLY . 56.4 mtt 68.22 131.55 0.04 OUTLIER Pre-proline 0 CA--C 1.531 0.25 0 C-N-CA 123.483 0.713 . . . . 1.6499999999999999 112.595 179.507 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_exo -63.86 138.8 65.05 Favored 'Trans proline' 0 C--N 1.343 0.281 0 C-N-CA 122.917 2.411 . . . . 0.33000000000000002 112.04 176.595 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -87.17 105.09 16.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 109.48 -0.563 . . . . 0.89000000000000001 109.48 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.497 HG22 ' CG1' ' A' ' 52' ' ' VAL . 50.2 t -99.88 135.34 35.91 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.768 0 CA-C-N 115.903 -0.59 . . . . 0.20000000000000001 110.939 -174.037 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 52.1 tp -110.54 111.94 23.52 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.198 -0.455 . . . . 0.75 110.709 177.715 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.9 t -93.97 122.43 45.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.215 0.531 . . . . 0.13 111.467 178.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.75 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.19 101.27 11.56 Favored 'General case' 0 C--N 1.319 -0.745 0 CA-C-N 115.172 -0.922 . . . . 0.20999999999999999 108.642 172.129 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.8 tp10 -159.03 120.0 3.29 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-N 115.866 -0.606 . . . . 1.4099999999999999 109.956 -173.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.537 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 36.8 t70 -88.41 -16.9 31.68 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 116.307 -0.406 . . . . 1.27 110.332 179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.444 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.9 mt-10 -82.95 103.16 2.23 Favored Pre-proline 0 C--N 1.333 -0.112 0 N-CA-C 109.421 -0.585 . . . . 2.5600000000000001 109.421 173.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.537 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.9 Cg_exo -58.48 -29.04 87.47 Favored 'Trans proline' 0 C--N 1.344 0.31 0 C-N-CA 122.667 2.244 . . . . 0.32000000000000001 113.07 -174.058 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -66.93 -51.28 57.21 Favored 'General case' 0 C--N 1.326 -0.433 0 N-CA-C 109.682 -0.488 . . . . 1.51 109.682 179.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.444 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.8 mp -64.25 -43.4 97.23 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 115.822 -0.626 . . . . 1.01 110.182 177.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.42 -47.53 81.52 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.825 -0.625 . . . . 0.20999999999999999 110.678 179.382 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 53.7 ttp -64.28 -39.32 93.7 Favored 'General case' 0 N--CA 1.444 -0.742 0 CA-C-N 115.516 -0.765 . . . . 0.60999999999999999 110.874 178.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.415 ' HB3' HG21 ' A' ' 107' ' ' THR . 60.7 m-20 -66.32 -47.04 74.82 Favored 'General case' 0 N--CA 1.446 -0.642 0 CA-C-N 115.969 -0.56 . . . . 1.22 111.207 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.408 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 54.3 mt -60.01 -45.32 93.14 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 110.039 -0.356 . . . . 0.17999999999999999 110.039 175.073 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.486 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -52.19 -50.6 61.56 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.616 -0.72 . . . . 1.04 110.535 178.611 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 13.4 m-85 -68.82 -31.21 70.02 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.282 -0.417 . . . . 0.78000000000000003 111.522 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.8 -43.09 76.35 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.833 0.349 . . . . 0.14000000000000001 110.838 -178.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.541 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 50.1 m-85 -69.37 -42.68 74.87 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.147 -0.479 . . . . 0.13 110.881 178.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.433 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 43.3 mt-10 -62.51 -32.02 72.88 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.857 0.361 . . . . 0.68999999999999995 110.24 176.873 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -66.31 -35.13 79.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.036 -0.529 . . . . 0.51000000000000001 110.818 176.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.8 mm-40 -83.98 6.52 21.61 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.11 -0.496 . . . . 0.65000000000000002 110.625 177.263 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 80.95 57.38 2.85 Favored Glycine 0 N--CA 1.446 -0.66 0 CA-C-N 115.817 -0.629 . . . . 0.28999999999999998 112.485 177.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.27 170.48 15.73 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.714 0.292 . . . . 0.23000000000000001 111.051 177.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -115.92 132.54 56.62 Favored 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.186 -0.672 . . . . 2.1400000000000001 109.186 177.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.486 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.5 t -117.12 137.29 51.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 112.749 0.648 . . . . 0.19 112.749 -166.833 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 6.7 t -110.91 135.66 49.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 108.464 -0.939 . . . . 0.23000000000000001 108.464 169.668 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 57.7 t -106.28 128.74 60.5 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 120.911 0.386 . . . . 0.94999999999999996 110.754 179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.42 134.74 41.97 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.932 -0.577 . . . . 0.16 110.41 176.245 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.471 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -103.17 -6.54 22.06 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 121.132 0.492 . . . . 0.23999999999999999 110.769 178.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 67.1 p -132.31 163.95 27.51 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.876 -0.602 . . . . 0.25 110.315 -178.262 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.578 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 79.6 m -68.46 -33.05 73.5 Favored 'General case' 0 C--N 1.321 -0.66 0 C-N-CA 120.744 -0.382 . . . . 1.6000000000000001 110.139 176.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -67.66 -39.38 84.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.433 -0.349 . . . . 0.69999999999999996 111.176 178.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.471 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 36.7 mt-30 -62.45 -36.67 83.16 Favored 'General case' 0 CA--C 1.519 -0.237 0 CA-C-O 121.258 0.552 . . . . 1.4099999999999999 110.473 174.247 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.75 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -67.88 -53.22 28.32 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.405 -0.816 . . . . 0.17999999999999999 111.267 -179.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.567 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 79.0 mt -59.45 -33.2 70.98 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.1 -0.5 . . . . 0.82999999999999996 110.663 179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 27.5 ttpp -63.97 -49.71 71.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.936 -0.394 . . . . 2.4100000000000001 109.936 176.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 8.7 m -67.21 -27.04 66.92 Favored 'General case' 0 N--CA 1.447 -0.609 0 CA-C-N 115.958 -0.565 . . . . 1.1299999999999999 111.319 179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 17.1 mt -72.2 -35.79 69.02 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 116.224 -0.444 . . . . 1.23 111.052 178.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -86.08 -33.12 21.04 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.097 -0.501 . . . . 0.42999999999999999 111.06 179.23 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -83.01 -28.24 29.8 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.86 -0.609 . . . . 0.62 111.464 -176.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -131.66 160.2 68.5 Favored Pre-proline 0 C--N 1.325 -0.481 0 N-CA-C 110.109 -0.33 . . . . 0.41999999999999998 110.109 -178.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.3 Cg_endo -94.47 89.3 0.12 Allowed 'Trans proline' 0 N--CA 1.45 -1.082 0 C-N-CA 123.484 2.789 . . . . 0.23999999999999999 111.552 179.465 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.2 mm -67.78 123.29 20.69 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.655 -0.702 . . . . 0.22 111.801 -175.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.7 m-20 -87.32 -34.81 18.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.645 -0.707 . . . . 0.28999999999999998 110.296 177.255 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.543 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -159.13 158.74 2.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 115.929 -0.578 . . . . 0.12 110.082 -176.576 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.458 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.78 166.01 25.9 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 121.203 0.525 . . . . 0.14000000000000001 112.069 -178.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.407 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.75 112.3 5.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-N 115.334 -0.848 . . . . 0.95999999999999996 109.302 176.359 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.737 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -113.58 121.86 45.49 Favored 'General case' 0 C--N 1.318 -0.792 0 N-CA-C 112.432 0.53 . . . . 0.16 112.432 -167.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 62.8 t0 -80.49 109.96 15.5 Favored 'General case' 0 CA--C 1.518 -0.279 0 CA-C-O 121.809 0.814 . . . . 1.77 108.959 169.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.673 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 17.3 t -59.05 -19.65 16.01 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.046 0 CA-C-N 114.353 -1.294 . . . . 0.80000000000000004 112.253 179.393 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -123.88 80.41 1.81 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.047 0.451 . . . . 2.3700000000000001 110.573 -179.534 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 56.8 mt -74.28 -32.3 62.86 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.751 -0.659 . . . . 0.84999999999999998 110.01 178.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -164.8 -169.66 28.71 Favored Glycine 0 N--CA 1.446 -0.695 0 N-CA-C 111.233 -0.747 . . . . 0.81999999999999995 111.233 179.36 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -57.47 -37.76 96.29 Favored 'Trans proline' 0 N--CA 1.457 -0.667 0 C-N-CA 123.165 2.577 . . . . 1.1799999999999999 112.599 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . 0.446 ' HD3' ' C ' ' A' ' 62' ' ' LYS . 13.8 tmtt? -113.57 -34.31 5.59 Favored 'General case' 0 C--N 1.325 -0.498 0 N-CA-C 109.695 -0.483 . . . . 3.5299999999999998 109.695 174.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.3 m -63.52 124.52 21.56 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.803 -0.635 . . . . 0.95999999999999996 111.65 -175.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 20.9 p80 -144.94 149.8 35.86 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 115.34 -0.845 . . . . 0.48999999999999999 109.598 179.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.737 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.1 p -71.47 87.15 0.87 Allowed 'General case' 0 C--N 1.32 -0.676 0 CA-C-O 121.491 0.663 . . . . 1.3 109.257 171.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -113.94 -71.6 0.55 Allowed Glycine 0 CA--C 1.509 -0.303 0 C-N-CA 120.451 -0.88 . . . . 0.23000000000000001 112.045 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 52.4 Cg_exo -52.34 -25.14 23.3 Favored 'Trans proline' 0 C--N 1.344 0.337 0 C-N-CA 122.625 2.217 . . . . 0.23999999999999999 112.064 174.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.456 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.4 t -71.74 -44.7 68.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 121.123 0.487 . . . . 0.12 110.24 177.167 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.78 -49.43 77.53 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.281 -0.872 . . . . 0.16 110.118 -179.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.523 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 17.5 m-20 -62.08 -40.18 94.96 Favored 'General case' 0 C--O 1.221 -0.416 0 CA-C-N 115.678 -0.692 . . . . 2.0299999999999998 110.28 177.114 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -57.24 -50.01 74.21 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.279 0.562 . . . . 0.23000000000000001 111.073 178.672 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.7 mt -64.22 -42.74 96.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.492 -0.776 . . . . 0.20000000000000001 110.312 178.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.426 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 64.0 mmtt -61.41 -33.48 73.76 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-N 115.588 -0.733 . . . . 2.0099999999999998 111.498 177.253 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 79.4 mm-40 -71.62 -37.44 70.9 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.16 -0.473 . . . . 2.3700000000000001 111.358 177.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 50.1 mtt180 -90.1 2.14 55.59 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.711 0.291 . . . . 1.49 111.256 -179.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.35 36.47 17.52 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-N 115.489 -0.778 . . . . 0.33000000000000002 111.205 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 68.0 mt -91.06 134.06 30.78 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.072 -0.513 . . . . 0.17000000000000001 110.274 178.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.38 140.85 24.9 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.351 2.034 . . . . 0.20999999999999999 111.728 176.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.458 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 31.6 p90 -156.74 161.92 39.79 Favored 'General case' 0 C--N 1.318 -0.763 0 CA-C-N 115.985 -0.552 . . . . 0.17999999999999999 110.662 179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.5 mt -125.62 140.77 47.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.919 0 CA-C-N 115.364 -0.835 . . . . 0.23999999999999999 109.913 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.413 HD21 HG21 ' A' ' 96' ' ' ILE . 2.3 mm? -88.91 109.07 19.92 Favored 'General case' 0 C--N 1.32 -0.693 0 CA-C-O 121.03 0.443 . . . . 0.20999999999999999 110.027 178.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.61 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.2 t-160 -109.43 86.11 2.23 Favored 'General case' 0 C--N 1.315 -0.898 0 CA-C-O 121.223 0.535 . . . . 0.59999999999999998 109.798 179.4 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.597 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -126.75 160.15 31.66 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.341 -0.845 . . . . 0.60999999999999999 111.217 -172.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -103.55 16.19 52.36 Favored Glycine 0 N--CA 1.447 -0.633 0 C-N-CA 121.082 -0.58 . . . . 0.93999999999999995 112.541 177.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 14.6 t70 -149.99 113.53 4.98 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.876 0.37 . . . . 2.3300000000000001 110.785 175.616 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.7 mt -109.7 -5.03 15.75 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.25 -0.432 . . . . 1.6100000000000001 110.677 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . 0.44 ' HB3' ' HD2' ' A' ' 88' ' ' ARG . 14.2 t70 -83.18 -53.59 5.66 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 116.126 -0.488 . . . . 2.6299999999999999 111.082 -175.457 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.461 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 5.2 mpt_? -80.35 -3.4 49.44 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-O 121.174 0.511 . . . . 4.4199999999999999 110.852 -175.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.546 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 96.9 m-70 -119.17 16.57 13.21 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.94 -0.573 . . . . 1.05 111.226 -178.567 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.496 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -55.49 -44.84 85.49 Favored Glycine 0 N--CA 1.453 -0.178 0 C-N-CA 120.852 -0.69 . . . . 0.97999999999999998 112.474 -179.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.447 ' HA ' ' CZ ' ' A' ' 94' ' ' ARG . 43.8 tt0 -63.28 -42.68 99.12 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-O 120.956 0.408 . . . . 2.5 110.669 178.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.519 HD23 ' CG1' ' A' ' 57' ' ' VAL . 32.8 tp -64.09 -40.19 95.69 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.796 -0.638 . . . . 0.70999999999999996 110.462 179.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.546 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 76.6 mt -61.06 -34.88 75.58 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.119 -0.491 . . . . 1.5800000000000001 111.338 179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.496 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 65.1 mtm-85 -72.5 -26.19 61.69 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.087 0.47 . . . . 4.3799999999999999 110.414 179.584 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 97.5 mttt -76.79 -26.47 54.5 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.854 -0.612 . . . . 2.4500000000000002 110.284 175.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.426 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 77.9 mt -83.28 -63.26 1.24 Allowed 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 CA-C-N 115.74 -0.664 . . . . 0.45000000000000001 110.746 177.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 25.2 t70 61.4 83.11 0.15 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 115.734 -0.666 . . . . 1.0900000000000001 110.622 -176.3 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.38 165.11 13.28 Favored Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 115.694 -0.685 . . . . 0.28999999999999998 109.735 -178.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_exo -57.58 140.36 93.13 Favored 'Trans proline' 0 C--N 1.349 0.593 0 C-N-CA 122.841 2.361 . . . . 0.26000000000000001 112.85 179.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 63.0 t -119.96 133.68 65.94 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.842 -0.617 . . . . 0.64000000000000001 111.357 -177.563 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.542 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 83.5 mmm -121.08 92.37 3.74 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.418 -0.956 . . . . 0.82999999999999996 108.418 171.815 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.439 ' O ' ' HB2' ' A' ' 105' ' ' ALA . . . -67.48 154.84 40.47 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.104 -0.498 . . . . 0.54000000000000004 111.786 -173.967 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.408 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 94.8 mttt -89.96 142.85 29.21 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.873 -0.603 . . . . 0.67000000000000004 109.475 177.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.408 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 10.8 Cg_exo -71.71 145.61 83.35 Favored 'Cis proline' 0 C--O 1.235 0.338 0 C-N-CA 123.487 -1.464 . . . . 0.75 112.909 0.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.61 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 134.32 25.85 Favored 'General case' 0 CA--C 1.514 -0.441 0 CA-C-N 115.648 -0.706 . . . . 0.34999999999999998 109.965 178.379 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.572 ' O ' HG23 ' A' ' 110' ' ' VAL . 16.7 t70 -73.44 128.25 34.98 Favored 'General case' 0 C--N 1.318 -0.804 0 N-CA-C 109.417 -0.586 . . . . 0.51000000000000001 109.417 176.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.415 HG21 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -65.64 -21.52 66.57 Favored 'General case' 0 C--N 1.319 -0.723 0 CA-C-N 115.551 -0.75 . . . . 0.26000000000000001 112.823 -170.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.8 t -72.9 -41.09 64.97 Favored 'General case' 0 N--CA 1.451 -0.393 0 N-CA-C 109.527 -0.545 . . . . 1.3200000000000001 109.527 177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -65.93 -40.7 91.63 Favored 'General case' 0 CA--C 1.515 -0.377 0 CA-C-O 121.118 0.485 . . . . 0.62 110.056 177.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.572 HG23 ' O ' ' A' ' 106' ' ' ASP . 24.8 t -63.82 -42.5 96.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 115.443 -0.799 . . . . 0.13 110.375 178.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.541 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.64 -48.65 68.75 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 115.798 -0.637 . . . . 0.13 111.58 -178.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -60.46 -45.56 93.28 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.183 -0.462 . . . . 1.95 111.453 -177.734 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.484 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 34.1 mmt180 -67.49 -25.4 65.85 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.835 0.35 . . . . 2.23 111.391 -179.342 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.23 -51.47 9.43 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.002 0.429 . . . . 0.14000000000000001 110.43 177.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.543 HD23 HG11 ' A' ' 52' ' ' VAL . 75.4 mt -64.54 -27.54 69.04 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 112.869 0.692 . . . . 0.27000000000000002 112.869 -176.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.484 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 9.3 pt-20 -67.44 -32.06 72.67 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.442 -0.503 . . . . 2.79 110.719 178.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . . . . . . . . . 58.8 mtm -72.6 -29.53 63.59 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.246 -0.434 . . . . 0.42999999999999999 111.285 -176.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.442 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 17.8 p -86.13 0.48 53.45 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 120.954 0.407 . . . . 1.46 110.757 177.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -69.17 -20.5 75.0 Favored Glycine 0 N--CA 1.449 -0.451 0 N-CA-C 110.997 -0.841 . . . . 2.5699999999999998 110.997 173.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -136.82 -134.73 3.32 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 110.879 -0.888 . . . . 4.4800000000000004 110.879 175.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -156.63 -157.59 0.71 Allowed 'General case' 0 C--N 1.322 -0.614 0 N-CA-C 109.541 -0.54 . . . . 6.4199999999999999 109.541 177.03 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 62.5 mttm -56.09 111.37 0.93 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.107 0.479 . . . . 9.1899999999999995 110.966 177.593 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 6.2 pt-20 -73.55 138.17 77.58 Favored Pre-proline 0 C--N 1.324 -0.537 0 CA-C-N 115.697 -0.683 . . . . 9.5999999999999996 110.558 -179.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -73.59 158.07 47.9 Favored 'Trans proline' 0 N--CA 1.463 -0.304 0 C-N-CA 122.3 2.0 . . . . 11.17 111.588 177.213 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.931 0 CA-C-O 118.511 -0.756 . . . . 13.279999999999999 110.181 178.735 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.705 0 N-CA-C 112.215 -0.354 . . . . 8.8000000000000007 112.215 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -85.23 54.79 3.23 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.109 0.48 . . . . 6.7800000000000002 110.729 -179.698 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.0 tpt -146.57 127.44 14.46 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 109.112 -0.699 . . . . 7.21 109.112 178.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 81.8 -56.8 4.94 Favored Glycine 0 N--CA 1.45 -0.392 0 N-CA-C 110.845 -0.902 . . . . 1.8500000000000001 110.845 -173.928 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 80.5 mtp -81.9 124.67 79.01 Favored Pre-proline 0 C--N 1.322 -0.617 0 N-CA-C 109.037 -0.727 . . . . 1.6499999999999999 109.037 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.462 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 26.0 Cg_exo -62.6 134.47 47.76 Favored 'Trans proline' 0 N--CA 1.462 -0.354 0 C-N-CA 122.678 2.252 . . . . 0.33000000000000002 111.799 -177.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -87.12 107.1 18.3 Favored 'General case' 0 N--CA 1.444 -0.748 0 CA-C-O 121.388 0.614 . . . . 0.89000000000000001 109.405 179.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.55 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 58.7 t -99.93 130.83 48.46 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 115.216 -0.902 . . . . 0.20000000000000001 111.033 -172.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.495 ' HB2' HD12 ' A' ' 50' ' ' ILE . 49.4 tp -105.61 111.24 23.86 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.172 -0.467 . . . . 0.75 110.357 176.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 35.6 t -92.37 123.36 44.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-O 121.117 0.484 . . . . 0.13 111.422 179.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.661 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.9 OUTLIER -103.48 106.04 16.45 Favored 'General case' 0 C--N 1.318 -0.802 0 CA-C-N 115.21 -0.905 . . . . 0.20999999999999999 108.57 171.489 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -161.21 125.61 3.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-O 121.195 0.522 . . . . 1.4099999999999999 110.444 -175.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.458 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 23.2 t70 -90.72 -13.8 33.38 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.564 -0.744 . . . . 1.27 109.895 -179.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -89.74 104.02 7.43 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-N 115.912 -0.585 . . . . 2.5600000000000001 109.89 174.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.458 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 37.7 Cg_exo -59.44 -31.53 94.91 Favored 'Trans proline' 0 C--N 1.344 0.308 0 C-N-CA 122.919 2.412 . . . . 0.32000000000000001 113.045 -174.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -61.59 -49.88 74.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.593 -0.521 . . . . 1.51 109.593 176.79 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 53.9 mt -67.24 -44.07 87.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 CA-C-N 115.697 -0.683 . . . . 1.01 110.888 178.588 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.06 -51.28 68.39 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 116.225 -0.443 . . . . 0.20999999999999999 110.737 178.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.2 ttp -61.46 -43.33 99.06 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.358 178.083 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.507 ' HB3' HG21 ' A' ' 107' ' ' THR . 7.1 m-20 -67.47 -39.02 85.27 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-N 116.341 -0.39 . . . . 1.22 111.227 -177.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.415 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 51.4 mt -62.91 -45.78 90.92 Favored 'General case' 0 CA--C 1.513 -0.456 0 N-CA-C 110.071 -0.344 . . . . 0.17999999999999999 110.071 173.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.597 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 36.4 tt0 -54.31 -52.68 60.74 Favored 'General case' 0 C--N 1.323 -0.579 0 CA-C-N 115.547 -0.752 . . . . 1.04 110.314 179.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -64.77 -30.34 71.34 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.467 -0.333 . . . . 0.78000000000000003 111.416 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.2 -46.47 70.53 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.942 0.401 . . . . 0.14000000000000001 110.82 -178.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.664 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 63.7 m-85 -68.46 -41.48 80.14 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.036 -0.529 . . . . 0.13 110.682 178.335 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -63.11 -32.52 73.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 120.815 0.341 . . . . 0.68999999999999995 110.525 177.433 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -67.49 -32.71 73.71 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.089 0.471 . . . . 0.51000000000000001 110.231 177.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -84.03 1.25 44.74 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.031 -0.531 . . . . 0.65000000000000002 111.167 179.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.31 50.73 3.95 Favored Glycine 0 N--CA 1.449 -0.5 0 C-N-CA 120.927 -0.654 . . . . 0.28999999999999998 112.539 178.394 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.37 167.16 22.16 Favored 'General case' 0 C--N 1.324 -0.517 0 N-CA-C 110.246 -0.279 . . . . 0.23000000000000001 110.246 178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -113.44 132.3 55.69 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.297 -0.631 . . . . 2.1400000000000001 109.297 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.597 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 4.8 t -121.79 147.49 25.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 N-CA-C 112.852 0.686 . . . . 0.19 112.852 -167.111 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 8.7 t -120.44 143.34 32.7 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.302 0 CA-C-N 115.348 -0.842 . . . . 0.23000000000000001 108.793 168.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 62.5 t -111.85 126.32 69.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-O 120.975 0.417 . . . . 0.94999999999999996 111.123 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.53 142.98 45.5 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.702 -0.681 . . . . 0.16 110.139 177.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -111.86 -2.92 15.05 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-O 120.682 0.277 . . . . 0.23999999999999999 111.402 -179.094 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 71.8 p -136.9 169.95 16.9 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.52 -0.309 . . . . 0.25 111.046 -177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.531 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 18.6 p -59.99 -49.82 76.17 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 121.315 0.579 . . . . 1.6000000000000001 109.536 172.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.9 mt-10 -54.77 -49.91 69.75 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 114.597 -1.183 . . . . 0.69999999999999996 111.813 -179.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -59.31 -38.57 80.6 Favored 'General case' 0 C--O 1.233 0.19 0 CA-C-O 121.107 0.48 . . . . 1.4099999999999999 111.092 178.333 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.661 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -68.75 -51.35 42.16 Favored 'General case' 0 C--N 1.32 -0.692 0 CA-C-N 115.672 -0.694 . . . . 0.17999999999999999 111.18 -178.897 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.531 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 67.3 mt -63.97 -28.19 69.64 Favored 'General case' 0 N--CA 1.447 -0.582 0 CA-C-N 115.642 -0.708 . . . . 0.82999999999999996 110.733 -177.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 62.2 tttp -66.77 -51.28 57.58 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.055 -0.521 . . . . 2.4100000000000001 110.123 175.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.3 t -65.48 -34.11 77.5 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.877 -0.601 . . . . 1.1299999999999999 110.907 179.196 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.411 ' CD2' ' HB1' ' A' ' 71' ' ' ALA . 14.6 tp -61.94 -33.16 73.76 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 121.232 0.539 . . . . 1.23 110.211 177.926 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.75 -34.56 22.82 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.049 -0.523 . . . . 0.42999999999999999 111.065 178.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.1 t70 -76.35 -37.97 56.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.0 -0.546 . . . . 0.62 111.108 -177.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 18.2 m-80 -123.5 159.44 55.21 Favored Pre-proline 0 C--N 1.32 -0.689 0 CA-C-N 116.096 -0.502 . . . . 0.41999999999999998 110.091 -177.304 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_endo -93.22 86.67 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.295 0 C-N-CA 123.358 2.705 . . . . 0.23999999999999999 111.075 177.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.495 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.6 mm -63.94 122.53 15.0 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.78 0 CA-C-N 115.537 -0.756 . . . . 0.22 111.485 -175.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.429 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 43.2 m-20 -92.57 -29.97 15.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.558 -0.746 . . . . 0.28999999999999998 110.142 178.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.55 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.0 p -158.41 156.99 3.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.004 -0.544 . . . . 0.12 109.716 -179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.493 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -141.39 168.99 18.46 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 121.355 0.597 . . . . 0.14000000000000001 112.146 -177.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.43 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -140.38 112.61 4.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 CA-C-N 115.206 -0.906 . . . . 0.95999999999999996 109.207 177.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.614 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.2 mp -112.81 116.91 30.81 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 112.531 0.567 . . . . 0.16 112.531 -168.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 18.0 t70 -77.91 133.7 38.05 Favored 'General case' 0 C--N 1.329 -0.326 0 N-CA-C 109.217 -0.66 . . . . 1.77 109.217 169.428 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.467 ' H ' ' HB ' ' A' ' 83' ' ' THR . 19.8 t -93.8 -10.86 9.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.963 0 CA-C-N 115.771 -0.649 . . . . 0.80000000000000004 111.249 -170.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 66.6 t30 -116.32 53.82 0.86 Allowed 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.24 -0.436 . . . . 2.3700000000000001 110.551 -177.248 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 87.2 mt -59.66 -41.26 90.19 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.262 0.553 . . . . 0.84999999999999998 110.473 -179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -161.82 -172.99 29.92 Favored Glycine 0 N--CA 1.445 -0.723 0 N-CA-C 110.96 -0.856 . . . . 0.81999999999999995 110.96 177.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -52.59 -43.76 52.65 Favored 'Trans proline' 0 C--N 1.343 0.265 0 C-N-CA 122.827 2.351 . . . . 1.1799999999999999 112.263 179.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 9.9 mtpm? -113.42 -27.96 7.73 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.24 -0.436 . . . . 3.5299999999999998 110.879 177.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 63.7 m -68.54 123.95 22.25 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-O 121.463 0.649 . . . . 0.95999999999999996 111.3 -178.444 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 7.9 p80 -144.3 152.26 40.52 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 115.099 -0.955 . . . . 0.48999999999999999 109.373 179.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.614 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.2 p -68.76 86.31 0.33 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-O 121.406 0.622 . . . . 1.3 109.521 172.276 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -119.3 -66.47 0.3 Allowed Glycine 0 N--CA 1.453 -0.194 0 C-N-CA 120.791 -0.718 . . . . 0.23000000000000001 112.023 179.528 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 39.1 Cg_exo -54.47 -28.14 53.06 Favored 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.234 1.956 . . . . 0.23999999999999999 111.541 174.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.526 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -71.11 -44.37 74.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.788 -0.642 . . . . 0.12 110.195 177.184 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -60.18 -46.99 87.81 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.29 -0.868 . . . . 0.16 110.092 178.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.455 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 21.7 t70 -61.52 -43.67 98.45 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.359 -0.837 . . . . 2.0299999999999998 110.395 176.601 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.411 ' HB1' ' CD2' ' A' ' 45' ' ' LEU . . . -55.19 -49.34 72.15 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.836 -0.62 . . . . 0.23000000000000001 111.036 178.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.9 mt -65.66 -43.39 89.53 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 115.421 -0.808 . . . . 0.20000000000000001 110.656 178.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.497 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 56.2 mmtt -60.65 -32.98 72.13 Favored 'General case' 0 N--CA 1.444 -0.73 0 CA-C-N 115.675 -0.693 . . . . 2.0099999999999998 111.397 178.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.455 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 14.4 mm100 -71.55 -33.48 69.16 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.385 -0.37 . . . . 2.3700000000000001 111.526 179.341 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 92.6 mtt180 -93.23 1.07 57.22 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.678 -0.237 . . . . 1.49 111.131 178.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 63.16 34.5 13.51 Favored 'General case' 0 N--CA 1.462 0.155 0 CA-C-N 115.7 -0.682 . . . . 0.33000000000000002 111.307 -178.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 66.4 mt -87.55 133.9 37.12 Favored Pre-proline 0 C--N 1.325 -0.487 0 CA-C-N 116.233 -0.439 . . . . 0.17000000000000001 110.223 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.429 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 27.5 Cg_endo -75.36 143.37 27.87 Favored 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.373 2.049 . . . . 0.20999999999999999 112.051 177.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 28.7 p90 -159.65 159.29 32.88 Favored 'General case' 0 C--N 1.318 -0.77 0 CA-C-N 115.748 -0.66 . . . . 0.17999999999999999 110.462 179.269 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.1 mt -124.0 139.72 49.59 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.92 0 CA-C-N 115.408 -0.815 . . . . 0.23999999999999999 109.728 179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.3 mm? -88.43 109.69 20.22 Favored 'General case' 0 C--N 1.319 -0.757 0 N-CA-C 109.451 -0.574 . . . . 0.20999999999999999 109.451 179.372 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.618 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 19.7 t-160 -102.25 90.88 4.06 Favored 'General case' 0 C--N 1.314 -0.97 0 CA-C-N 115.987 -0.552 . . . . 0.59999999999999998 109.732 -179.448 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.567 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 9.3 t -139.63 160.98 38.62 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.364 -0.835 . . . . 0.60999999999999999 110.409 -174.109 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -115.07 9.47 20.83 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.89 -0.671 . . . . 0.93999999999999995 111.82 175.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -122.62 60.26 1.02 Allowed 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.195 0.521 . . . . 2.3300000000000001 110.822 179.626 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 6.4 mp -68.68 -41.39 79.29 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.566 -0.743 . . . . 1.6100000000000001 110.08 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 6.5 p-10 -69.3 -20.14 63.89 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.603 -0.726 . . . . 2.6299999999999999 111.371 -176.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.573 ' HA ' ' NE ' ' A' ' 88' ' ' ARG . 3.6 tpm_? -90.56 -22.07 21.46 Favored 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.943 -0.571 . . . . 4.4199999999999999 110.761 179.602 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.499 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 92.1 m-70 -126.01 28.86 6.0 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.008 -0.542 . . . . 1.05 111.637 -175.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.424 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -58.17 -37.99 88.32 Favored Glycine 0 N--CA 1.454 -0.165 0 C-N-CA 121.119 -0.562 . . . . 0.97999999999999998 112.602 -177.206 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -67.0 -46.01 75.83 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.855 0.36 . . . . 2.5 110.699 178.872 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.43 HD23 ' CG1' ' A' ' 57' ' ' VAL . 56.8 tp -60.89 -39.66 90.11 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.153 -0.476 . . . . 0.70999999999999996 110.501 179.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.499 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 70.9 mt -61.78 -32.77 73.07 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.036 -0.529 . . . . 1.5800000000000001 111.067 179.46 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 79.4 mtp180 -72.53 -38.54 68.0 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.88 0.372 . . . . 4.3799999999999999 110.297 176.753 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 99.2 mttt -58.91 -42.26 89.22 Favored 'General case' 0 C--O 1.232 0.173 0 CA-C-O 121.532 0.682 . . . . 2.4500000000000002 110.233 174.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.497 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 84.7 mt -72.07 -58.79 4.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 CA-C-N 114.892 -1.049 . . . . 0.45000000000000001 111.067 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 37.3 t70 62.54 82.07 0.19 Allowed 'General case' 0 C--O 1.235 0.297 0 CA-C-O 121.618 0.723 . . . . 1.0900000000000001 111.093 -175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.413 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -163.45 162.09 17.48 Favored Pre-proline 0 C--N 1.324 -0.529 0 CA-C-N 114.985 -1.007 . . . . 0.28999999999999998 108.986 178.392 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.518 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.3 Cg_exo -58.27 146.25 89.88 Favored 'Trans proline' 0 C--N 1.344 0.319 0 C-N-CA 122.57 2.18 . . . . 0.26000000000000001 112.528 -179.399 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 33.7 t -123.05 132.4 71.47 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.435 0 CA-C-O 120.958 0.409 . . . . 0.64000000000000001 111.028 -178.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 81.6 mmm -113.87 106.25 14.23 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.129 -0.693 . . . . 0.82999999999999996 109.129 175.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.567 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.03 146.35 53.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.984 -0.553 . . . . 0.54000000000000004 111.938 -174.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.457 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 94.6 mttt -91.59 145.11 30.62 Favored Pre-proline 0 C--N 1.326 -0.42 0 CA-C-N 115.827 -0.624 . . . . 0.67000000000000004 110.204 177.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_exo -75.22 142.61 75.04 Favored 'Cis proline' 0 C--N 1.342 0.21 0 C-N-CA 123.572 -1.428 . . . . 0.75 112.422 -0.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.618 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -133.08 135.44 45.31 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 115.867 -0.606 . . . . 0.34999999999999998 109.806 179.462 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.4 t0 -70.38 127.31 32.33 Favored 'General case' 0 C--N 1.319 -0.739 0 N-CA-C 108.287 -1.005 . . . . 0.51000000000000001 108.287 176.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.507 HG21 ' HB3' ' A' ' 20' ' ' ASN . 22.9 p -63.22 -20.5 65.49 Favored 'General case' 0 C--N 1.315 -0.91 0 CA-C-N 115.348 -0.842 . . . . 0.26000000000000001 112.646 -172.272 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 63.9 p -70.53 -40.29 73.52 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.954 0.407 . . . . 1.3200000000000001 109.943 176.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 58.7 m-20 -68.34 -39.56 81.85 Favored 'General case' 0 CA--C 1.512 -0.499 0 CA-C-N 115.906 -0.588 . . . . 0.62 109.903 179.229 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.437 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.6 t -65.15 -45.31 94.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-N 115.306 -0.861 . . . . 0.13 110.09 177.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.664 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.14 -50.42 71.95 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 115.685 -0.689 . . . . 0.13 111.374 -179.305 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.635 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 67.9 mttm -57.42 -51.5 69.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.94 -0.573 . . . . 1.95 111.304 -178.071 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -61.26 -39.46 90.44 Favored 'General case' 0 C--N 1.33 -0.258 0 O-C-N 123.112 0.257 . . . . 2.23 111.686 -177.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -63.63 -47.94 79.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.95 0.405 . . . . 0.14000000000000001 110.172 177.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.505 HD23 HG11 ' A' ' 52' ' ' VAL . 85.1 mt -67.02 -25.34 66.24 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.932 -0.576 . . . . 0.27000000000000002 111.768 -179.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.635 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 36.7 mm-40 -60.79 -38.47 85.41 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.986 0.422 . . . . 2.79 110.692 175.115 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.518 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.4 mtm -79.59 -10.66 59.83 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 116.169 -0.469 . . . . 0.42999999999999999 110.717 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.462 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 36.7 t -88.86 18.57 4.69 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.86 -0.609 . . . . 1.46 110.202 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -72.62 85.89 0.53 Allowed Glycine 0 N--CA 1.448 -0.505 0 N-CA-C 111.436 -0.666 . . . . 2.5699999999999998 111.436 176.508 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 75.48 -90.96 0.84 Allowed Glycine 0 N--CA 1.444 -0.783 0 N-CA-C 111.225 -0.75 . . . . 4.4800000000000004 111.225 -176.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.7 p-10 -155.67 24.19 0.39 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 121.362 0.601 . . . . 6.4199999999999999 109.761 179.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.07 129.71 24.36 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.924 -0.58 . . . . 9.1899999999999995 111.145 -174.732 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 -68.43 139.94 92.25 Favored Pre-proline 0 C--N 1.325 -0.477 0 CA-C-N 115.619 -0.719 . . . . 9.5999999999999996 109.448 173.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 41.1 Cg_endo -67.93 89.27 0.37 Allowed 'Trans proline' 0 CA--C 1.531 0.336 0 C-N-CA 122.585 2.19 . . . . 11.17 112.405 179.564 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.971 0 CA-C-O 118.573 -0.727 . . . . 13.279999999999999 110.734 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.48 1.631 0 N-CA-C 111.411 -0.675 . . . . 8.8000000000000007 111.411 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -81.14 49.34 1.24 Allowed 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.251 0.548 . . . . 6.7800000000000002 110.255 177.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 84.9 mmm -103.4 -4.67 23.8 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.771 -0.65 . . . . 7.21 110.352 -176.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 102.16 -53.52 0.79 Allowed Glycine 0 N--CA 1.45 -0.385 0 N-CA-C 111.173 -0.771 . . . . 1.8500000000000001 111.173 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.437 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 16.7 mmt -123.83 141.29 36.43 Favored Pre-proline 0 C--N 1.325 -0.458 0 N-CA-C 109.807 -0.442 . . . . 1.6499999999999999 109.807 175.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.525 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 1.4 Cg_endo -68.06 135.68 35.54 Favored 'Trans proline' 0 N--CA 1.448 -1.195 0 C-N-CA 121.609 1.539 . . . . 0.33000000000000002 110.635 172.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.409 ' HB3' ' HA ' ' A' ' 50' ' ' ILE . 34.1 tptt -84.63 104.53 14.69 Favored 'General case' 0 C--N 1.315 -0.908 0 N-CA-C 109.724 -0.472 . . . . 0.89000000000000001 109.724 -178.452 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.46 HG22 ' CG1' ' A' ' 52' ' ' VAL . 46.7 t -100.14 128.97 51.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.736 0 CA-C-N 115.84 -0.618 . . . . 0.20000000000000001 110.978 -174.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.436 ' HB2' HD12 ' A' ' 50' ' ' ILE . 50.5 tp -107.43 119.01 38.23 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 116.451 -0.34 . . . . 0.75 110.462 176.959 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.402 HG22 HG23 ' A' ' 54' ' ' VAL . 44.5 t -100.17 124.93 53.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.149 0.5 . . . . 0.13 111.43 178.272 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.675 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.0 OUTLIER -104.51 106.41 16.89 Favored 'General case' 0 C--N 1.322 -0.607 0 CA-C-N 115.284 -0.871 . . . . 0.20999999999999999 109.013 172.841 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -167.3 128.95 1.59 Allowed 'General case' 0 C--N 1.318 -0.773 0 CA-C-N 115.975 -0.557 . . . . 1.4099999999999999 109.687 -176.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.409 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.5 t70 -84.58 -28.88 26.28 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.101 -0.499 . . . . 1.27 109.661 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.527 ' HB3' HD13 ' A' ' 17' ' ' ILE . 1.2 mp0 -74.07 109.55 7.15 Favored Pre-proline 0 N--CA 1.462 0.147 0 CA-C-N 116.249 -0.432 . . . . 2.5600000000000001 110.583 175.458 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.6 Cg_exo -60.39 -29.59 89.11 Favored 'Trans proline' 0 N--CA 1.463 -0.317 0 C-N-CA 122.527 2.151 . . . . 0.32000000000000001 112.733 -178.467 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -66.96 -52.47 42.48 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.059 -0.349 . . . . 1.51 110.059 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.527 HD13 ' HB3' ' A' ' 14' ' ' GLU . 2.5 mp -62.69 -42.6 96.75 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.447 0 CA-C-O 121.048 0.452 . . . . 1.01 109.927 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -58.84 -51.09 71.48 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.502 -0.772 . . . . 0.20999999999999999 110.832 178.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.497 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 47.6 ttp -65.05 -38.37 90.61 Favored 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.647 -0.706 . . . . 0.60999999999999999 111.202 179.635 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.447 ' HB3' HG21 ' A' ' 107' ' ' THR . 6.3 m-20 -64.82 -44.07 91.06 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.047 -0.524 . . . . 1.22 110.982 179.469 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.42 ' HA ' ' HB ' ' A' ' 107' ' ' THR . 39.3 mt -61.91 -44.99 95.65 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-N 116.437 -0.347 . . . . 0.17999999999999999 110.253 172.945 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.623 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 43.4 tt0 -53.44 -51.18 63.47 Favored 'General case' 0 N--CA 1.447 -0.579 0 CA-C-N 115.633 -0.712 . . . . 1.04 110.815 179.389 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.497 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 13.7 m-85 -63.43 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.282 -0.417 . . . . 0.78000000000000003 111.33 -179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.53 -42.19 78.82 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.306 -0.406 . . . . 0.14000000000000001 110.95 179.802 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.524 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 57.0 m-85 -71.19 -42.09 69.47 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.273 -0.422 . . . . 0.13 110.874 179.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.414 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 46.0 mt-10 -65.4 -28.24 69.11 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.996 0.427 . . . . 0.68999999999999995 110.079 177.254 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 36.6 t70 -69.8 -32.18 70.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.698 -0.683 . . . . 0.51000000000000001 110.616 176.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 22.2 mm-40 -83.97 -2.5 56.69 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.227 0.537 . . . . 0.65000000000000002 110.461 176.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.48 62.76 1.61 Allowed Glycine 0 N--CA 1.445 -0.748 0 CA-C-N 115.601 -0.727 . . . . 0.28999999999999998 111.998 -179.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.525 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -145.32 172.16 13.56 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.811 0.338 . . . . 0.23000000000000001 111.359 176.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 21.7 tt0 -114.57 137.24 52.12 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.938 -0.573 . . . . 2.1400000000000001 109.612 177.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.623 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 5.1 t -120.19 146.91 24.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 CA-C-O 121.27 0.557 . . . . 0.19 111.913 -169.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.438 HG11 ' OG ' ' A' ' 44' ' ' SER . 24.1 t -119.6 126.47 75.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.464 -0.789 . . . . 0.23000000000000001 108.919 169.674 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.8 t -97.24 124.72 50.27 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.734 0 CA-C-O 120.937 0.399 . . . . 0.94999999999999996 110.885 -179.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -134.59 134.64 41.5 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.007 -0.542 . . . . 0.16 110.415 177.255 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.432 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -100.48 -11.02 20.51 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.97 0.414 . . . . 0.23999999999999999 110.792 179.527 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 68.3 p -129.87 160.77 32.5 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.164 -0.471 . . . . 0.25 110.732 -176.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.594 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 72.1 m -63.92 -35.5 80.87 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.736 -0.468 . . . . 1.6000000000000001 109.736 174.366 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 -61.0 -47.87 84.47 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.134 -0.484 . . . . 0.69999999999999996 111.19 178.318 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.432 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 39.4 mt-30 -59.01 -41.24 87.24 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.147 0.499 . . . . 1.4099999999999999 110.642 176.024 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.675 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.36 -51.77 64.52 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.274 -0.875 . . . . 0.17999999999999999 111.444 -178.66 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.594 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 85.9 mt -62.24 -32.23 72.88 Favored 'General case' 0 N--CA 1.449 -0.479 0 CA-C-N 116.067 -0.515 . . . . 0.82999999999999996 110.894 -178.242 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.3 ttmt -63.27 -50.64 69.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.921 0.391 . . . . 2.4100000000000001 110.219 177.258 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.438 ' OG ' HG11 ' A' ' 33' ' ' VAL . 23.2 t -68.5 -35.07 76.98 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.848 -0.615 . . . . 1.1299999999999999 110.551 179.101 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.41 HD22 HG13 ' A' ' 50' ' ' ILE . 0.3 OUTLIER -57.3 -39.67 76.26 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.885 -0.598 . . . . 1.23 109.817 177.613 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -80.25 -38.82 30.19 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.056 -0.52 . . . . 0.42999999999999999 111.408 -179.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -75.84 -38.34 58.11 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 120.998 0.428 . . . . 0.62 111.777 -174.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 37.2 m-80 -114.48 163.94 17.83 Favored Pre-proline 0 C--N 1.322 -0.623 0 CA-C-N 116.096 -0.502 . . . . 0.41999999999999998 110.758 -175.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -96.0 76.01 0.13 Allowed 'Trans proline' 0 N--CA 1.446 -1.265 0 C-N-CA 123.494 2.796 . . . . 0.23999999999999999 111.341 178.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.436 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.2 mm -56.78 120.24 3.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.681 0 CA-C-N 115.228 -0.896 . . . . 0.22 111.725 -174.733 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.793 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 16.8 m-20 -90.09 -31.19 17.23 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.372 -0.831 . . . . 0.28999999999999998 110.629 -179.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.52 HG11 HD23 ' A' ' 115' ' ' LEU . 14.6 p -160.34 156.7 3.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 116.084 -0.507 . . . . 0.12 109.914 -176.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -142.81 160.92 39.39 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 121.46 0.648 . . . . 0.14000000000000001 112.168 -178.084 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.437 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -133.07 112.04 17.5 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.74 0 CA-C-N 115.013 -0.994 . . . . 0.95999999999999996 109.243 174.782 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.689 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.5 mp -111.78 117.73 33.64 Favored 'General case' 0 C--N 1.316 -0.859 0 CA-C-O 120.986 0.422 . . . . 0.16 112.039 -170.026 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 32.6 t70 -80.87 129.96 34.8 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 108.839 -0.8 . . . . 1.77 108.839 169.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.485 ' H ' ' HB ' ' A' ' 83' ' ' THR . 61.8 t -88.97 -35.72 8.05 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.85 0 CA-C-N 116.139 -0.482 . . . . 0.80000000000000004 111.475 -171.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -90.68 60.66 4.58 Favored 'General case' 0 N--CA 1.446 -0.672 0 CA-C-O 121.072 0.463 . . . . 2.3700000000000001 111.382 -178.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 88.3 mt -64.09 -31.4 72.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.362 0.601 . . . . 0.84999999999999998 110.148 177.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -165.69 -171.58 32.05 Favored Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 110.65 -0.98 . . . . 0.81999999999999995 110.65 177.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -56.11 -36.83 96.85 Favored 'Trans proline' 0 N--CA 1.456 -0.72 0 C-N-CA 122.856 2.371 . . . . 1.1799999999999999 113.104 178.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 27.2 mtpp -127.24 -21.76 3.85 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.366 -0.379 . . . . 3.5299999999999998 111.557 177.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 2.6 p -73.54 126.41 30.17 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.483 0.658 . . . . 0.95999999999999996 110.709 179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 14.1 p80 -144.93 155.09 43.23 Favored 'General case' 0 C--N 1.319 -0.72 0 CA-C-N 115.363 -0.835 . . . . 0.48999999999999999 110.301 -176.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.689 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.5 p -69.49 87.27 0.46 Allowed 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 109.488 -0.56 . . . . 1.3 109.488 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.78 -69.88 0.57 Allowed Glycine 0 C--N 1.33 0.223 0 C-N-CA 120.504 -0.855 . . . . 0.23000000000000001 112.499 -178.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.522 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 50.9 Cg_exo -51.47 -27.51 24.96 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 122.8 2.333 . . . . 0.23999999999999999 111.979 175.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.502 HG11 ' CD2' ' A' ' 11' ' ' LEU . 14.3 t -69.28 -44.75 80.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 115.577 -0.738 . . . . 0.12 110.042 178.105 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -61.32 -45.55 93.98 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.143 -0.935 . . . . 0.16 110.156 179.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.449 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 37.8 m-20 -64.12 -42.07 96.98 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.218 -0.447 . . . . 2.0299999999999998 110.345 176.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.54 -46.81 70.33 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.389 0.614 . . . . 0.23000000000000001 110.881 177.193 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 97.6 mt -67.66 -46.72 71.57 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.023 -0.989 . . . . 0.20000000000000001 110.742 178.443 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 7.1 mtmp? -56.53 -36.02 68.75 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.515 -0.766 . . . . 2.0099999999999998 111.849 177.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.449 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 94.1 mt-30 -61.42 -44.39 97.22 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.085 -0.507 . . . . 2.3700000000000001 111.696 179.064 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -94.59 7.14 46.7 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.569 -0.287 . . . . 1.49 111.214 -178.265 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 60.14 34.79 21.18 Favored 'General case' 0 C--N 1.333 -0.148 0 CA-C-N 115.824 -0.626 . . . . 0.33000000000000002 111.264 -179.891 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 85.9 mt -80.79 133.38 55.35 Favored Pre-proline 0 N--CA 1.448 -0.567 0 CA-C-N 116.234 -0.439 . . . . 0.17000000000000001 109.984 179.396 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.423 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 13.3 Cg_endo -73.81 137.02 23.97 Favored 'Trans proline' 0 N--CA 1.449 -1.092 0 C-N-CA 122.117 1.878 . . . . 0.20999999999999999 111.423 177.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 29.6 p90 -156.49 158.85 37.94 Favored 'General case' 0 C--N 1.315 -0.918 0 CA-C-N 115.937 -0.574 . . . . 0.17999999999999999 110.617 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 28.0 mt -124.24 140.9 46.2 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.907 0 CA-C-N 115.21 -0.904 . . . . 0.23999999999999999 109.795 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.4 mm? -88.97 107.94 19.3 Favored 'General case' 0 C--N 1.315 -0.892 0 N-CA-C 109.041 -0.725 . . . . 0.20999999999999999 109.041 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.617 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 21.7 t-160 -101.61 78.95 1.89 Allowed 'General case' 0 C--N 1.317 -0.844 0 N-CA-C 108.995 -0.742 . . . . 0.59999999999999998 108.995 179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.485 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 4.7 t -118.32 158.76 24.61 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 114.788 -1.096 . . . . 0.60999999999999999 110.915 -171.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -100.36 -1.35 55.66 Favored Glycine 0 N--CA 1.448 -0.51 0 C-N-CA 121.012 -0.613 . . . . 0.93999999999999995 111.883 178.136 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -128.95 120.45 26.13 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.771 0.32 . . . . 2.3300000000000001 110.783 175.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HA ' HD11 ' A' ' 93' ' ' LEU . 7.1 mp -114.38 -6.85 12.92 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.573 -0.739 . . . . 1.6100000000000001 109.904 173.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 18.2 m-20 -84.39 -60.92 1.93 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.99 -0.55 . . . . 2.6299999999999999 111.387 -176.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -69.02 -40.24 78.77 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 121.092 0.472 . . . . 4.4199999999999999 110.421 -174.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.407 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 97.3 m-70 -92.27 22.4 4.51 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.211 -0.449 . . . . 1.05 111.256 -179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.528 ' O ' ' HG3' ' A' ' 94' ' ' ARG . . . -60.55 -41.83 98.92 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 121.121 -0.561 . . . . 0.97999999999999998 112.698 -177.49 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.06 -45.8 89.88 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.985 0.421 . . . . 2.5 110.678 177.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 59.7 tp -59.26 -44.24 92.42 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.591 -0.731 . . . . 0.70999999999999996 110.472 179.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.417 HD11 ' HA ' ' A' ' 86' ' ' LEU . 63.2 mt -61.97 -31.48 71.84 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 115.838 -0.619 . . . . 1.5800000000000001 111.239 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.528 ' HG3' ' O ' ' A' ' 90' ' ' GLY . 25.4 mtm180 -70.55 -32.6 70.1 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.4 -0.364 . . . . 4.3799999999999999 110.622 178.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -77.05 -39.4 50.07 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-N 115.997 -0.547 . . . . 2.4500000000000002 110.375 -179.736 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . . . . . . . . . 76.7 mt -65.92 -52.89 43.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 115.612 -0.722 . . . . 0.45000000000000001 110.014 176.259 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 30.7 t70 56.74 74.36 0.41 Allowed 'General case' 0 C--O 1.234 0.266 0 CA-C-N 115.593 -0.73 . . . . 1.0900000000000001 110.952 179.123 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -153.13 163.79 22.44 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 115.152 -0.931 . . . . 0.28999999999999998 109.22 179.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.697 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 66.3 Cg_exo -54.96 141.08 79.27 Favored 'Trans proline' 0 C--N 1.344 0.301 0 C-N-CA 122.491 2.127 . . . . 0.26000000000000001 112.768 178.054 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 42.2 t -121.56 140.26 46.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.806 -0.633 . . . . 0.64000000000000001 110.621 -178.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . . . . . . . . . 72.3 mmm -121.32 95.32 4.64 Favored 'General case' 0 C--N 1.325 -0.5 0 N-CA-C 108.887 -0.783 . . . . 0.82999999999999996 108.887 174.017 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -63.3 147.07 52.1 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 115.953 -0.567 . . . . 0.54000000000000004 111.466 -176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 85.9 mttt -91.17 147.0 34.64 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.641 -0.708 . . . . 0.67000000000000004 110.434 179.018 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 7.6 Cg_exo -73.05 152.25 98.06 Favored 'Cis proline' 0 C--N 1.343 0.257 0 C-N-CA 123.483 -1.466 . . . . 0.75 112.459 1.565 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.617 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -148.57 129.34 14.21 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.902 -0.59 . . . . 0.34999999999999998 110.511 179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.495 ' O ' HG23 ' A' ' 110' ' ' VAL . 16.4 t70 -66.28 128.96 38.19 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 109.143 -0.688 . . . . 0.51000000000000001 109.143 177.551 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.447 HG21 ' HB3' ' A' ' 20' ' ' ASN . 20.4 p -64.83 -24.7 67.63 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.59 -0.732 . . . . 0.26000000000000001 112.581 -170.498 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.423 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 32.3 t -68.13 -40.91 82.34 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.651 -0.5 . . . . 1.3200000000000001 109.651 176.683 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -65.8 -40.76 92.21 Favored 'General case' 0 CA--C 1.511 -0.535 0 CA-C-O 121.076 0.465 . . . . 0.62 110.097 177.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 106' ' ' ASP . 22.0 t -64.36 -42.57 95.76 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-N 115.579 -0.737 . . . . 0.13 110.475 178.921 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.524 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.34 -48.5 72.8 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.727 -0.67 . . . . 0.13 111.349 -178.617 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.423 ' HG3' ' O ' ' A' ' 108' ' ' SER . 99.0 mttt -60.39 -46.48 89.83 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.14 -0.482 . . . . 1.95 110.887 -179.716 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.511 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.3 mmt180 -62.4 -28.55 69.86 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.126 -0.488 . . . . 2.23 111.309 -179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.37 -51.65 9.76 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.195 -0.457 . . . . 0.14000000000000001 110.576 179.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.52 HD23 HG11 ' A' ' 52' ' ' VAL . 88.3 mt -65.41 -29.35 70.04 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 112.493 0.553 . . . . 0.27000000000000002 112.493 -176.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.511 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.3 pt-20 -67.44 -25.8 66.08 Favored 'General case' 0 C--N 1.333 -0.146 0 CA-C-O 120.8 0.333 . . . . 2.79 111.255 -179.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.697 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 43.5 mtm -81.53 -14.54 56.77 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.019 0.438 . . . . 0.42999999999999999 110.711 177.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.793 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 46.9 t -102.53 -55.67 2.4 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.897 -0.592 . . . . 1.46 111.609 -174.148 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -128.74 17.21 5.79 Favored Glycine 0 N--CA 1.448 -0.534 0 C-N-CA 120.544 -0.836 . . . . 2.5699999999999998 112.821 -176.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -78.95 -25.26 60.29 Favored Glycine 0 N--CA 1.449 -0.483 0 C-N-CA 120.758 -0.734 . . . . 4.4800000000000004 111.682 -179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -94.5 101.28 13.17 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.463 -0.569 . . . . 6.4199999999999999 109.463 178.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 64.1 tttp -141.18 131.39 24.91 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 116.351 -0.386 . . . . 9.1899999999999995 110.241 -179.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -79.57 119.56 77.3 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 116.235 -0.439 . . . . 9.5999999999999996 109.971 179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -70.87 74.52 1.77 Allowed 'Trans proline' 0 C--O 1.236 0.383 0 C-N-CA 122.796 2.331 . . . . 11.17 112.541 -178.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.99 0 CA-C-N 115.719 -0.673 . . . . 13.279999999999999 109.985 -179.523 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.481 1.696 0 N-CA-C 112.292 -0.323 . . . . 8.8000000000000007 112.292 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -90.47 -49.48 6.49 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.753 0.311 . . . . 6.7800000000000002 111.269 -177.693 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.1 mtt -79.53 -25.75 41.65 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 121.682 0.754 . . . . 7.21 109.722 179.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 175.36 -109.74 0.3 Allowed Glycine 0 N--CA 1.441 -0.982 0 CA-C-N 114.85 -1.068 . . . . 1.8500000000000001 111.243 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.438 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 7.2 ptm -151.01 138.03 11.77 Favored Pre-proline 0 C--N 1.32 -0.679 0 N-CA-C 109.737 -0.468 . . . . 1.6499999999999999 109.737 178.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.438 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 1.6 Cg_endo -73.01 143.96 37.22 Favored 'Trans proline' 0 N--CA 1.457 -0.633 0 C-N-CA 122.271 1.981 . . . . 0.33000000000000002 112.426 178.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.44 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 34.5 tptt -90.23 105.54 17.88 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.738 -0.665 . . . . 0.89000000000000001 109.271 175.881 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.415 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.7 t -100.61 137.61 27.56 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 116.138 -0.483 . . . . 0.20000000000000001 111.153 -174.406 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.637 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.2 tm? -115.66 110.76 19.62 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 115.596 -0.729 . . . . 0.75 109.906 178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 46.1 t -95.04 128.83 45.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-O 121.235 0.54 . . . . 0.13 111.039 178.682 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.791 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -108.12 100.8 10.09 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-N 115.197 -0.91 . . . . 0.20999999999999999 108.884 175.852 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -164.17 134.77 4.27 Favored 'General case' 0 C--N 1.316 -0.867 0 CA-C-O 121.172 0.51 . . . . 1.4099999999999999 110.101 -177.036 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 28.4 t70 -97.16 -23.83 16.02 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.468 -0.787 . . . . 1.27 109.993 -177.582 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.477 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.0 mt-10 -76.03 108.15 5.61 Favored Pre-proline 0 C--O 1.234 0.264 0 N-CA-C 109.658 -0.497 . . . . 2.5600000000000001 109.658 175.342 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.413 ' HD3' ' HA ' ' A' ' 14' ' ' GLU . 32.2 Cg_exo -57.48 -35.84 98.8 Favored 'Trans proline' 0 CA--C 1.516 -0.387 0 C-N-CA 123.073 2.515 . . . . 0.32000000000000001 113.537 -171.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.426 HD23 ' O ' ' A' ' 16' ' ' LEU . 4.7 tt -65.0 -50.85 64.67 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.813 -0.44 . . . . 1.51 109.813 -179.978 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.477 HD13 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -62.02 -46.97 95.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 CA-C-N 116.103 -0.498 . . . . 1.01 109.814 -178.534 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -59.1 -45.55 90.59 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.239 -0.891 . . . . 0.20999999999999999 110.824 178.227 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.429 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 38.2 ttp -63.41 -44.86 93.42 Favored 'General case' 0 N--CA 1.45 -0.431 0 CA-C-N 115.669 -0.696 . . . . 0.60999999999999999 111.083 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.57 ' HB3' HG21 ' A' ' 107' ' ' THR . 15.7 t-20 -65.28 -42.56 93.04 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.439 -0.8 . . . . 1.22 110.425 -176.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 65.5 mt -64.39 -43.48 94.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 CA-C-N 116.194 -0.457 . . . . 0.17999999999999999 110.227 174.144 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.497 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.6 tt0 -53.22 -50.57 64.45 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.663 -0.699 . . . . 1.04 110.318 177.567 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.429 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 14.4 m-85 -63.18 -34.96 78.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.321 -0.4 . . . . 0.78000000000000003 111.206 178.757 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -67.72 -46.53 71.93 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 120.919 0.39 . . . . 0.14000000000000001 110.656 -176.681 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.669 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 55.0 m-85 -66.96 -41.9 86.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.123 -0.49 . . . . 0.13 110.613 178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.3 mt-10 -60.75 -36.8 79.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.754 0.312 . . . . 0.68999999999999995 110.632 176.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -64.73 -33.22 75.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.129 -0.487 . . . . 0.51000000000000001 110.835 178.654 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 70.8 mm-40 -80.41 -1.41 41.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.18 0.514 . . . . 0.65000000000000002 110.531 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.15 50.48 4.08 Favored Glycine 0 N--CA 1.447 -0.608 0 CA-C-N 116.004 -0.544 . . . . 0.28999999999999998 112.414 179.476 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -136.74 158.99 43.16 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-O 120.779 0.323 . . . . 0.23000000000000001 110.783 179.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.9 tt0 -98.46 138.81 35.13 Favored 'General case' 0 C--N 1.325 -0.497 0 N-CA-C 108.988 -0.745 . . . . 2.1400000000000001 108.988 178.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.497 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 23.4 t -120.86 132.14 71.12 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 121.113 0.482 . . . . 0.19 111.988 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 15.2 t -107.38 136.1 43.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.636 0 N-CA-C 108.338 -0.986 . . . . 0.23000000000000001 108.338 169.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 69.1 t -111.02 123.97 67.4 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.602 0 C-N-CA 120.631 -0.428 . . . . 0.94999999999999996 111.002 -178.466 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -127.26 134.92 50.0 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 115.867 -0.606 . . . . 0.16 110.338 177.777 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -101.48 -11.85 18.99 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-O 120.998 0.428 . . . . 0.23999999999999999 111.147 -179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 70.9 p -128.83 173.39 10.41 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.169 -0.468 . . . . 0.25 110.227 -178.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.607 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 75.5 m -73.63 -32.08 63.86 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 109.387 -0.598 . . . . 1.6000000000000001 109.387 174.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.7 mt-10 -61.13 -51.04 70.77 Favored 'General case' 0 C--O 1.233 0.215 0 CA-C-N 115.913 -0.585 . . . . 0.69999999999999996 110.912 178.109 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -55.89 -42.13 75.52 Favored 'General case' 0 CA--C 1.52 -0.185 0 CA-C-N 115.864 -0.607 . . . . 1.4099999999999999 110.7 176.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.791 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -62.66 -52.93 61.38 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 115.434 -0.803 . . . . 0.17999999999999999 111.278 -179.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.607 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.6 mt -59.43 -29.16 67.57 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.961 -0.563 . . . . 0.82999999999999996 110.942 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . 0.451 ' HD3' ' C ' ' A' ' 43' ' ' LYS . 1.1 tmtp? -65.6 -55.7 16.2 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.773 -0.454 . . . . 2.4100000000000001 109.773 177.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 36.9 t -64.55 -35.26 80.39 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.325 -0.398 . . . . 1.1299999999999999 110.55 179.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.446 HD11 HD23 ' A' ' 72' ' ' LEU . 0.8 OUTLIER -60.63 -37.03 80.12 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.937 -0.574 . . . . 1.23 110.984 178.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.55 -38.17 18.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.97 0.414 . . . . 0.42999999999999999 111.237 -178.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.8 t70 -75.19 -37.65 61.1 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.883 -0.598 . . . . 0.62 111.598 -175.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.44 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 43.9 m-80 -120.09 165.22 18.64 Favored Pre-proline 0 C--N 1.321 -0.662 0 CA-C-N 116.05 -0.523 . . . . 0.41999999999999998 111.214 -175.417 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -95.45 86.15 0.1 Allowed 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.625 2.883 . . . . 0.23999999999999999 111.466 177.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.637 HD12 ' HB2' ' A' ' 9' ' ' LEU . 39.5 mm -65.07 118.37 7.29 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.806 0 CA-C-N 115.329 -0.85 . . . . 0.22 111.258 -177.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 33.2 m-20 -84.27 -32.38 24.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.951 -0.568 . . . . 0.28999999999999998 110.23 178.358 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG11 HD23 ' A' ' 115' ' ' LEU . 14.3 p -158.65 154.02 5.36 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 115.928 -0.578 . . . . 0.12 110.2 -177.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.5 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -137.85 162.57 33.64 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.515 0.674 . . . . 0.14000000000000001 111.61 -179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.445 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -135.14 111.99 14.04 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.79 0 N-CA-C 108.739 -0.837 . . . . 0.95999999999999996 108.739 176.012 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.42 ' HA ' ' CB ' ' A' ' 11' ' ' LEU . 10.5 mp -106.42 98.42 8.1 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-O 121.268 0.556 . . . . 0.16 111.084 -172.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.871 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.5 OUTLIER -76.14 93.35 3.33 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-N 115.079 -0.964 . . . . 1.77 109.448 174.077 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . . . . . . . . . 35.1 t -54.29 -25.94 14.54 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 114.971 -1.013 . . . . 0.80000000000000004 111.945 -172.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.403 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 0.2 OUTLIER -79.01 68.9 5.07 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-N 116.076 -0.511 . . . . 2.3700000000000001 111.456 178.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 81.8 mt -85.34 -32.65 22.34 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.176 0.513 . . . . 0.84999999999999998 110.311 177.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.39 -174.02 40.1 Favored Glycine 0 N--CA 1.445 -0.741 0 CA-C-N 115.678 -0.692 . . . . 0.81999999999999995 111.599 178.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -56.51 -35.13 96.51 Favored 'Trans proline' 0 C--O 1.235 0.336 0 C-N-CA 123.076 2.517 . . . . 1.1799999999999999 112.741 179.479 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 53.6 mttm -123.4 -29.42 3.81 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.933 -0.576 . . . . 3.5299999999999998 110.253 177.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 39.7 m -64.97 125.67 25.61 Favored 'General case' 0 N--CA 1.452 -0.361 0 CA-C-N 115.791 -0.64 . . . . 0.95999999999999996 111.656 -178.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 30.5 p80 -144.57 154.78 43.21 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.537 -0.756 . . . . 0.48999999999999999 110.079 179.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.459 ' HB3' ' HG ' ' A' ' 11' ' ' LEU . 0.7 OUTLIER -78.7 87.85 4.6 Favored 'General case' 0 C--N 1.323 -0.573 0 N-CA-C 109.297 -0.631 . . . . 1.3 109.297 174.737 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -105.21 -72.66 0.87 Allowed Glycine 0 C--O 1.226 -0.376 0 C-N-CA 120.689 -0.767 . . . . 0.23000000000000001 112.363 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.446 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.3 Cg_exo -52.82 -24.58 24.3 Favored 'Trans proline' 0 C--N 1.346 0.428 0 C-N-CA 122.83 2.353 . . . . 0.23999999999999999 112.331 175.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.496 HG11 ' CD2' ' A' ' 11' ' ' LEU . 30.3 t -64.42 -40.08 87.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 121.542 0.687 . . . . 0.12 110.014 177.317 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.431 ' HB1' HG23 ' A' ' 96' ' ' ILE . . . -63.58 -41.93 98.33 Favored 'General case' 0 C--N 1.323 -0.576 0 CA-C-N 114.854 -1.067 . . . . 0.16 110.159 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -64.12 -47.18 80.97 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.81 -0.632 . . . . 2.0299999999999998 109.972 177.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -50.3 -49.93 52.12 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 121.605 0.716 . . . . 0.23000000000000001 110.848 177.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.446 HD23 HD11 ' A' ' 45' ' ' LEU . 97.6 mt -66.12 -47.83 72.86 Favored 'General case' 0 C--N 1.32 -0.714 0 CA-C-N 115.045 -0.98 . . . . 0.20000000000000001 111.015 179.473 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 34.6 mtmt -59.13 -34.52 72.15 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.916 -0.583 . . . . 2.0099999999999998 111.787 178.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 69.0 mm-40 -69.43 -34.68 74.8 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.316 -0.402 . . . . 2.3700000000000001 111.347 178.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.42 HH11 ' HD3' ' A' ' 75' ' ' ARG . 55.5 mtt180 -95.71 7.53 46.04 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.604 -0.271 . . . . 1.49 111.077 179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 59.06 34.11 23.28 Favored 'General case' 0 N--CA 1.465 0.283 0 CA-C-N 115.694 -0.685 . . . . 0.33000000000000002 111.563 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 70.8 mt -88.41 132.67 38.43 Favored Pre-proline 0 C--N 1.324 -0.518 0 CA-C-N 116.489 -0.323 . . . . 0.17000000000000001 110.295 179.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -75.16 139.77 24.26 Favored 'Trans proline' 0 N--CA 1.453 -0.862 0 C-N-CA 122.59 2.193 . . . . 0.20999999999999999 112.2 178.114 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.5 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 39.2 p90 -155.42 156.91 36.18 Favored 'General case' 0 C--N 1.319 -0.759 0 CA-C-N 115.726 -0.67 . . . . 0.17999999999999999 110.402 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 53.0 mt -117.84 138.39 48.68 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.041 0 CA-C-N 115.404 -0.816 . . . . 0.23999999999999999 109.401 178.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.427 HD21 ' HB3' ' A' ' 98' ' ' ALA . 2.1 mm? -88.78 107.96 19.25 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 108.492 -0.929 . . . . 0.20999999999999999 108.492 174.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.871 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 11.7 t-160 -101.34 123.16 44.98 Favored 'General case' 0 C--N 1.302 -1.482 0 N-CA-C 108.41 -0.959 . . . . 0.59999999999999998 108.41 178.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.487 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 5.4 t -163.12 144.0 9.45 Favored 'General case' 0 C--N 1.322 -0.593 0 C-N-CA 120.073 -0.651 . . . . 0.60999999999999999 111.947 -175.777 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.549 ' CA ' ' HB2' ' A' ' 103' ' ' LYS . . . -89.68 -6.77 69.77 Favored Glycine 0 CA--C 1.508 -0.392 0 CA-C-N 115.573 -0.74 . . . . 0.93999999999999995 111.398 175.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.426 ' OD1' ' HB3' ' A' ' 88' ' ' ARG . 9.7 t70 -112.57 114.72 27.51 Favored 'General case' 0 C--N 1.321 -0.632 0 N-CA-C 109.564 -0.532 . . . . 2.3300000000000001 109.564 177.165 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.407 HD11 ' HB2' ' A' ' 102' ' ' ALA . 80.7 mt -115.53 -17.93 11.07 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 116.343 -0.39 . . . . 1.6100000000000001 111.268 -177.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -85.76 -52.01 6.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.88 -0.328 . . . . 2.6299999999999999 111.464 -179.238 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.426 ' HB3' ' OD1' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -67.69 -33.2 74.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.03 0.443 . . . . 4.4199999999999999 110.382 -177.761 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.569 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 93.0 m-70 -102.11 16.51 25.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.273 -0.421 . . . . 1.05 111.347 177.43 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.411 ' HA2' HD12 ' A' ' 93' ' ' LEU . . . -60.52 -49.94 73.11 Favored Glycine 0 N--CA 1.453 -0.19 0 C-N-CA 120.943 -0.646 . . . . 0.97999999999999998 113.056 -175.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 95' ' ' LYS . 3.1 mp0 -60.55 -40.59 92.12 Favored 'General case' 0 C--N 1.326 -0.44 0 N-CA-C 110.078 -0.341 . . . . 2.5 110.078 179.16 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 58.4 tp -60.17 -43.35 95.88 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 115.931 -0.577 . . . . 0.70999999999999996 110.892 179.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.569 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 67.6 mt -57.87 -37.39 73.85 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.131 -0.486 . . . . 1.5800000000000001 110.893 179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.412 ' NH2' ' HG3' ' A' ' 91' ' ' GLU . 48.3 mtm105 -78.43 -26.9 46.46 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.09 -0.505 . . . . 4.3799999999999999 111.225 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . 0.552 ' HG3' ' O ' ' A' ' 91' ' ' GLU . 96.7 mttt -69.11 -39.21 79.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.448 0.642 . . . . 2.4500000000000002 109.826 175.247 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.431 HG23 ' HB1' ' A' ' 69' ' ' ALA . 95.8 mt -69.09 -54.12 21.92 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 CA-C-N 115.008 -0.997 . . . . 0.45000000000000001 110.621 177.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.9 t70 64.74 78.8 0.27 Allowed 'General case' 0 C--O 1.234 0.276 0 CA-C-O 121.686 0.755 . . . . 1.0900000000000001 111.206 -178.452 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.427 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -162.01 169.29 9.64 Favored Pre-proline 0 C--N 1.324 -0.52 0 CA-C-N 114.942 -1.026 . . . . 0.28999999999999998 108.721 177.032 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.468 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 32.3 Cg_exo -58.45 137.27 79.45 Favored 'Trans proline' 0 C--N 1.348 0.508 0 C-N-CA 122.164 1.91 . . . . 0.26000000000000001 112.331 179.525 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 39.5 t -119.78 130.71 73.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-N 116.056 -0.52 . . . . 0.64000000000000001 110.757 -179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.543 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 91.9 mtp -115.89 124.2 50.03 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.449 -0.574 . . . . 0.82999999999999996 109.449 174.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.487 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -82.5 152.88 25.86 Favored 'General case' 0 C--N 1.318 -0.795 0 CA-C-N 116.238 -0.437 . . . . 0.54000000000000004 111.201 -175.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.742 ' HE3' ' OD1' ' A' ' 56' ' ' ASP . 89.7 mttt -91.27 141.8 26.54 Favored Pre-proline 0 C--N 1.325 -0.469 0 N-CA-C 109.704 -0.48 . . . . 0.67000000000000004 109.704 172.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -76.27 153.5 97.25 Favored 'Cis proline' 0 N--CA 1.461 -0.438 0 C-N-CA 123.074 -1.636 . . . . 0.75 112.788 1.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.6 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -145.45 130.73 18.56 Favored 'General case' 0 C--N 1.32 -0.681 0 CA-C-N 115.572 -0.74 . . . . 0.34999999999999998 109.461 177.758 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.457 ' O ' HG23 ' A' ' 110' ' ' VAL . 15.5 t70 -67.11 127.62 33.31 Favored 'General case' 0 C--N 1.319 -0.746 0 N-CA-C 108.974 -0.75 . . . . 0.51000000000000001 108.974 178.762 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.57 HG21 ' HB3' ' A' ' 20' ' ' ASN . 23.0 p -63.57 -25.12 68.09 Favored 'General case' 0 C--N 1.317 -0.814 0 CA-C-N 115.492 -0.777 . . . . 0.26000000000000001 112.269 -170.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 34.4 t -70.95 -36.53 72.63 Favored 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 109.565 -0.532 . . . . 1.3200000000000001 109.565 176.806 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.402 ' OD2' ' HB3' ' A' ' 106' ' ' ASP . 15.4 m-20 -66.54 -46.2 76.89 Favored 'General case' 0 CA--C 1.511 -0.554 0 N-CA-C 109.512 -0.551 . . . . 0.62 109.512 175.812 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.509 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 21.3 t -60.14 -41.22 85.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 CA-C-N 115.421 -0.809 . . . . 0.13 110.472 179.369 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.669 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.29 -51.4 60.98 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.566 -0.743 . . . . 0.13 111.446 179.772 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 57.7 mtpt -65.67 -38.72 90.11 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.244 -0.434 . . . . 1.95 111.251 -177.099 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.52 ' HD3' ' OE1' ' A' ' 116' ' ' GLU . 26.9 mmt180 -66.83 -28.64 68.52 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 121.002 0.43 . . . . 2.23 111.432 178.443 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -78.97 -47.17 16.8 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-O 121.08 0.467 . . . . 0.14000000000000001 110.108 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.583 ' HA ' ' SG ' ' A' ' 118' ' ' CYS . 78.7 mt -67.0 -26.09 66.62 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 112.935 0.717 . . . . 0.27000000000000002 112.935 -175.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.52 ' OE1' ' HD3' ' A' ' 113' ' ' ARG . 10.4 pt-20 -69.01 -28.7 66.82 Favored 'General case' 0 C--N 1.325 -0.479 0 C-N-CA 120.688 -0.405 . . . . 2.79 110.677 178.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.468 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 63.5 mtm -76.09 -29.48 57.95 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 116.277 -0.42 . . . . 0.42999999999999999 111.352 -178.769 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 10.7 p -89.35 -21.03 23.31 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 121.027 0.441 . . . . 1.46 110.192 176.576 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -67.53 -15.1 65.71 Favored Glycine 0 C--N 1.332 0.329 0 N-CA-C 111.464 -0.654 . . . . 2.5699999999999998 111.464 173.464 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -145.87 57.47 0.51 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 110.541 -1.023 . . . . 4.4800000000000004 110.541 174.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -65.59 145.89 55.51 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.172 0.51 . . . . 6.4199999999999999 111.334 -174.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -162.94 166.53 23.76 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.4 -0.818 . . . . 9.1899999999999995 109.007 -176.579 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.42 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 35.9 mt-10 -59.39 129.83 87.05 Favored Pre-proline 0 C--N 1.331 -0.238 0 O-C-N 123.073 0.233 . . . . 9.5999999999999996 110.398 177.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.42 ' HD3' ' HA ' ' A' ' 123' ' ' GLU . 12.2 Cg_exo -71.42 47.09 0.82 Allowed 'Trans proline' 0 C--N 1.349 0.553 0 C-N-CA 122.962 2.441 . . . . 11.17 112.57 176.448 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.013 0 CA-C-O 118.603 -0.713 . . . . 13.279999999999999 110.166 -177.735 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.767 0 N-CA-C 112.123 -0.391 . . . . 8.8000000000000007 112.123 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 57.53 56.14 5.18 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-O 121.175 0.512 . . . . 6.7800000000000002 111.192 179.001 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 50.2 ttm -104.49 80.49 1.69 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.037 -0.529 . . . . 7.21 110.903 -178.254 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -85.14 -29.83 27.1 Favored Glycine 0 N--CA 1.449 -0.439 0 N-CA-C 110.871 -0.891 . . . . 1.8500000000000001 110.871 174.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.447 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 18.3 mmt -68.46 144.14 96.13 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.057 -0.572 . . . . 1.6499999999999999 110.541 175.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 27.4 Cg_exo -62.64 132.22 36.83 Favored 'Trans proline' 0 N--CA 1.458 -0.585 0 C-N-CA 122.306 2.004 . . . . 0.33000000000000002 110.881 172.72 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 45.2 tptt -86.68 103.31 15.03 Favored 'General case' 0 C--N 1.317 -0.848 0 N-CA-C 109.399 -0.593 . . . . 0.89000000000000001 109.399 -179.129 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 52.6 t -99.49 128.31 51.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.549 -0.75 . . . . 0.20000000000000001 110.616 -174.114 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.568 ' HB2' HD12 ' A' ' 50' ' ' ILE . 55.2 tp -104.33 115.39 30.31 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.802 0.335 . . . . 0.75 111.034 178.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 24.6 t -95.43 122.66 47.1 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 121.294 0.569 . . . . 0.13 111.324 177.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.648 ' O ' ' HB2' ' A' ' 56' ' ' ASP . 1.5 mm? -101.65 118.98 38.06 Favored 'General case' 0 C--N 1.318 -0.765 0 N-CA-C 107.549 -1.278 . . . . 0.20999999999999999 107.549 169.429 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.746 ' CD ' ' HB2' ' A' ' 18' ' ' ALA . 0.0 OUTLIER -161.43 158.43 26.7 Favored 'General case' 0 C--N 1.315 -0.914 0 C-N-CA 120.952 -0.299 . . . . 1.4099999999999999 110.368 -174.328 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 5.3 p-10 -122.44 -5.36 8.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.904 0.383 . . . . 1.27 110.635 178.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.457 ' H ' ' HG2' ' A' ' 12' ' ' GLU . 42.2 mm-40 -109.82 103.18 52.7 Favored Pre-proline 0 C--N 1.327 -0.412 0 CA-C-N 115.936 -0.575 . . . . 2.5600000000000001 110.574 175.444 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . . . . . . . . . 51.2 Cg_exo -57.29 -26.85 72.42 Favored 'Trans proline' 0 C--N 1.342 0.234 0 C-N-CA 123.058 2.506 . . . . 0.32000000000000001 113.235 -176.754 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.2 tt -66.58 -47.59 72.27 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 108.968 -0.753 . . . . 1.51 108.968 176.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 50.6 mt -60.59 -46.22 95.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.371 -0.831 . . . . 1.01 111.005 173.716 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . 0.746 ' HB2' ' CD ' ' A' ' 12' ' ' GLU . . . -56.17 -49.84 72.87 Favored 'General case' 0 CA--C 1.514 -0.427 0 CA-C-N 116.285 -0.416 . . . . 0.20999999999999999 111.053 178.843 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 51.6 ttp -55.96 -42.4 76.21 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-N 115.588 -0.733 . . . . 0.60999999999999999 110.695 177.413 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.537 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.8 m-80 -68.95 -42.54 76.53 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.688 -0.687 . . . . 1.22 111.412 -178.104 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.0 mt -64.68 -44.96 88.65 Favored 'General case' 0 N--CA 1.448 -0.531 0 CA-C-O 120.611 0.243 . . . . 0.17999999999999999 110.538 173.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.487 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 34.0 tt0 -55.65 -50.73 69.44 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 115.941 -0.572 . . . . 1.04 109.991 -179.714 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 29.1 m-85 -68.4 -27.75 66.49 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.78000000000000003 111.363 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -69.08 -49.12 60.1 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-O 120.869 0.366 . . . . 0.14000000000000001 110.527 179.67 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.62 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 58.9 m-85 -66.26 -43.45 86.45 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.219 -0.446 . . . . 0.13 110.867 178.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.439 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 30.9 mt-10 -65.38 -28.6 69.39 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.936 -0.306 . . . . 0.68999999999999995 110.635 179.047 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -72.58 -32.96 66.42 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.333 -0.394 . . . . 0.51000000000000001 110.593 176.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 63.6 mm-40 -77.78 -20.16 53.8 Favored 'General case' 0 C--O 1.232 0.166 0 CA-C-O 121.042 0.449 . . . . 0.65000000000000002 110.417 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 105.46 62.24 0.63 Allowed Glycine 0 N--CA 1.444 -0.787 0 CA-C-N 115.575 -0.739 . . . . 0.28999999999999998 112.377 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.447 ' HA ' ' HB3' ' A' ' 5' ' ' MET . . . -148.71 177.28 9.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.799 0.333 . . . . 0.23000000000000001 111.255 175.682 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -119.17 129.36 54.96 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 109.388 -0.597 . . . . 2.1400000000000001 109.388 179.403 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.487 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 15.1 t -115.04 135.55 54.6 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.584 0.587 . . . . 0.19 112.584 -167.31 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.412 HG11 ' OG ' ' A' ' 44' ' ' SER . 41.6 t -105.44 141.92 19.73 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 N-CA-C 108.825 -0.806 . . . . 0.23000000000000001 108.825 170.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.2 t -112.74 126.01 70.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 CA-C-O 120.537 0.208 . . . . 0.94999999999999996 110.709 179.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -140.49 134.77 31.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.993 0.425 . . . . 0.16 111.047 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.504 ' HA ' ' O ' ' A' ' 12' ' ' GLU . . . -97.64 -22.67 16.34 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-O 121.282 0.563 . . . . 0.23999999999999999 111.082 178.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.3 p -117.31 159.76 22.2 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 115.856 -0.611 . . . . 0.25 110.668 -175.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.622 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 71.5 m -64.36 -31.27 72.41 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.293 -0.632 . . . . 1.6000000000000001 109.293 173.013 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.52 -52.88 63.67 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-N 116.117 -0.492 . . . . 0.69999999999999996 110.96 176.658 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -57.79 -39.87 78.52 Favored 'General case' 0 C--O 1.233 0.236 0 CA-C-O 121.263 0.554 . . . . 1.4099999999999999 110.954 177.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.643 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -65.59 -50.49 64.9 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.374 -0.83 . . . . 0.17999999999999999 111.333 -179.333 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.622 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.2 mt -63.47 -30.4 71.52 Favored 'General case' 0 N--CA 1.451 -0.401 0 CA-C-N 116.137 -0.483 . . . . 0.82999999999999996 111.08 -178.765 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 60.4 tttp -66.76 -48.21 69.81 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.124 0.488 . . . . 2.4100000000000001 109.686 176.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.412 ' OG ' HG11 ' A' ' 33' ' ' VAL . 8.3 t -66.09 -33.48 75.89 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.603 -0.726 . . . . 1.1299999999999999 110.452 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.2 -39.08 78.04 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-O 121.272 0.558 . . . . 1.23 110.135 176.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -84.05 -43.65 14.89 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.831 -0.622 . . . . 0.42999999999999999 111.563 -178.098 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -71.55 -36.51 71.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.324 -0.398 . . . . 0.62 111.355 -176.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 27.8 m-80 -118.12 163.65 23.84 Favored Pre-proline 0 C--N 1.319 -0.72 0 CA-C-N 116.218 -0.447 . . . . 0.41999999999999998 110.615 -177.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_endo -96.88 85.58 0.08 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.247 0 C-N-CA 123.6 2.866 . . . . 0.23999999999999999 111.302 175.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.568 HD12 ' HB2' ' A' ' 9' ' ' LEU . 41.3 mm -62.32 119.95 7.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-N 115.719 -0.673 . . . . 0.22 111.552 -175.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.483 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 23.2 m-20 -89.2 -30.52 18.48 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.675 -0.693 . . . . 0.28999999999999998 110.629 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.491 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 13.5 p -163.83 156.34 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.693 -0.685 . . . . 0.12 109.285 -178.134 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -140.29 160.17 40.56 Favored 'General case' 0 N--CA 1.445 -0.713 0 CA-C-O 121.557 0.694 . . . . 0.14000000000000001 112.291 -177.477 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.471 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -132.0 112.45 20.1 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.787 0 CA-C-N 114.838 -1.074 . . . . 0.95999999999999996 109.124 175.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.814 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.7 mp -109.72 104.63 13.65 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 121.095 0.474 . . . . 0.16 111.943 -170.403 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.832 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 0.1 OUTLIER -71.64 93.96 1.29 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.39 -0.823 . . . . 1.77 109.232 172.271 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.599 ' HA ' ' SG ' ' A' ' 65' ' ' CYS . 40.9 t -58.63 -27.41 34.07 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 115.987 -0.552 . . . . 0.80000000000000004 111.499 -175.521 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.406 HD22 ' C ' ' A' ' 58' ' ' ASN . 0.3 OUTLIER -80.43 51.97 1.54 Allowed 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.761 -0.654 . . . . 2.3700000000000001 112.397 -176.581 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 72.4 mt -70.11 -24.48 63.21 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.157 0.503 . . . . 0.84999999999999998 110.475 179.206 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 174.07 -178.12 46.05 Favored Glycine 0 N--CA 1.444 -0.801 0 N-CA-C 110.97 -0.852 . . . . 0.81999999999999995 110.97 176.015 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -56.64 -36.13 97.89 Favored 'Trans proline' 0 C--O 1.235 0.344 0 C-N-CA 122.613 2.209 . . . . 1.1799999999999999 112.015 177.379 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -114.51 -34.39 5.25 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.015 -0.539 . . . . 3.5299999999999998 110.122 176.65 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 45.0 m -65.64 125.81 26.41 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.899 -0.591 . . . . 0.95999999999999996 111.163 -178.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -146.54 151.18 36.92 Favored 'General case' 0 C--N 1.319 -0.744 0 CA-C-N 115.886 -0.597 . . . . 0.48999999999999999 110.812 -178.761 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.814 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 25.5 p -74.89 87.34 2.28 Favored 'General case' 0 C--N 1.323 -0.583 0 N-CA-C 108.916 -0.772 . . . . 1.3 108.916 170.03 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -110.83 -70.34 0.61 Allowed Glycine 0 CA--C 1.507 -0.43 0 C-N-CA 120.369 -0.919 . . . . 0.23000000000000001 112.472 -177.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.54 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 49.2 Cg_exo -52.62 -23.53 20.04 Favored 'Trans proline' 0 C--N 1.346 0.417 0 C-N-CA 122.604 2.203 . . . . 0.23999999999999999 112.049 175.153 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.499 HG11 ' CD2' ' A' ' 11' ' ' LEU . 24.5 t -70.3 -45.22 76.28 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.268 0 CA-C-O 121.326 0.584 . . . . 0.12 110.123 176.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -63.68 -43.67 95.99 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.162 -0.926 . . . . 0.16 110.104 179.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.491 ' O ' ' HG2' ' A' ' 74' ' ' GLN . 31.1 m-20 -63.53 -40.17 96.32 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.734 -0.667 . . . . 2.0299999999999998 110.175 177.163 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -56.39 -49.17 75.23 Favored 'General case' 0 C--O 1.233 0.232 0 CA-C-O 121.512 0.672 . . . . 0.23000000000000001 110.601 176.59 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.6 mt -65.58 -40.59 92.89 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 115.105 -0.952 . . . . 0.20000000000000001 110.526 179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.401 ' HE3' ' HB3' ' A' ' 73' ' ' LYS . 16.3 mmmt -59.29 -38.56 80.5 Favored 'General case' 0 N--CA 1.442 -0.85 0 CA-C-N 115.572 -0.74 . . . . 2.0099999999999998 111.157 175.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.491 ' HG2' ' O ' ' A' ' 70' ' ' ASP . 13.0 mm100 -62.3 -45.6 92.52 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.994 -0.548 . . . . 2.3700000000000001 111.487 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 95.1 mtt180 -92.95 7.51 43.71 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.442 -0.345 . . . . 1.49 111.391 -176.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 57.88 34.79 24.75 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.777 -0.647 . . . . 0.33000000000000002 111.427 179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 84.1 mt -81.64 134.43 50.83 Favored Pre-proline 0 N--CA 1.447 -0.593 0 N-CA-C 109.552 -0.536 . . . . 0.17000000000000001 109.552 178.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.46 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 15.2 Cg_endo -73.25 139.52 29.37 Favored 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 122.076 1.851 . . . . 0.20999999999999999 111.406 177.846 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . . . . . . . . . 19.6 p90 -160.82 156.66 25.48 Favored 'General case' 0 C--N 1.316 -0.853 0 CA-C-N 116.054 -0.521 . . . . 0.17999999999999999 110.385 -178.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 38.3 mt -123.42 141.05 45.11 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.931 0 CA-C-N 115.403 -0.817 . . . . 0.23999999999999999 109.881 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD21 HG21 ' A' ' 96' ' ' ILE . 2.0 mm? -88.79 108.78 19.69 Favored 'General case' 0 C--N 1.318 -0.774 0 N-CA-C 109.097 -0.705 . . . . 0.20999999999999999 109.097 176.967 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.832 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 15.1 t-160 -101.27 104.66 15.69 Favored 'General case' 0 C--N 1.31 -1.13 0 N-CA-C 109.128 -0.693 . . . . 0.59999999999999998 109.128 178.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.513 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 4.3 t -151.85 151.86 31.86 Favored 'General case' 0 C--N 1.317 -0.842 0 C-N-CA 120.32 -0.552 . . . . 0.60999999999999999 111.679 -172.525 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.17 9.13 63.16 Favored Glycine 0 N--CA 1.446 -0.68 0 CA-C-N 115.551 -0.75 . . . . 0.93999999999999995 111.471 176.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 33.9 t70 -149.89 122.33 8.48 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 120.853 0.358 . . . . 2.3300000000000001 111.429 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.615 HD12 HD21 ' A' ' 93' ' ' LEU . 3.2 mm? -118.68 7.66 11.74 Favored 'General case' 0 C--N 1.323 -0.58 0 N-CA-C 109.386 -0.598 . . . . 1.6100000000000001 109.386 172.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 35.4 m-20 -85.04 -54.62 4.52 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.711 -0.677 . . . . 2.6299999999999999 111.566 -177.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.479 ' HD2' ' N ' ' A' ' 88' ' ' ARG . 8.0 mpt_? -77.47 -11.83 59.89 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-O 121.102 0.477 . . . . 4.4199999999999999 111.113 -173.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 96.9 m-70 -125.26 26.03 6.99 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.97 -0.559 . . . . 1.05 109.794 177.675 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.492 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -60.96 -38.61 95.74 Favored Glycine 0 C--N 1.331 0.26 0 CA-C-N 116.108 -0.496 . . . . 0.97999999999999998 113.447 -173.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -64.8 -25.87 68.1 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.911 0.386 . . . . 2.5 110.709 179.671 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . . . . . . . . . 34.5 tp -66.68 -42.48 86.47 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.908 -0.587 . . . . 0.70999999999999996 110.85 179.427 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.615 HD21 HD12 ' A' ' 86' ' ' LEU . 2.3 mm? -60.41 -26.92 67.05 Favored 'General case' 0 C--N 1.334 -0.071 0 CA-C-N 116.441 -0.345 . . . . 1.5800000000000001 111.108 -177.235 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 36.1 mtm180 -66.66 -33.2 75.12 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.17 -0.468 . . . . 4.3799999999999999 111.026 -178.309 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 57.6 mtpt -80.42 -27.45 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.236 0.541 . . . . 2.4500000000000002 110.287 178.574 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.519 HG21 HD21 ' A' ' 81' ' ' LEU . 62.2 mt -79.74 -63.64 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.755 0 CA-C-N 115.447 -0.797 . . . . 0.45000000000000001 111.115 -177.631 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 32.0 t70 55.87 74.15 0.4 Allowed 'General case' 0 C--O 1.234 0.283 0 CA-C-O 121.743 0.782 . . . . 1.0900000000000001 110.788 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.77 165.82 16.68 Favored Pre-proline 0 C--N 1.321 -0.673 0 CA-C-N 115.141 -0.936 . . . . 0.28999999999999998 109.225 178.715 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.52 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 43.4 Cg_exo -59.16 141.25 97.8 Favored 'Trans proline' 0 C--N 1.344 0.299 0 C-N-CA 122.535 2.156 . . . . 0.26000000000000001 112.346 -179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 47.8 t -122.13 121.01 62.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 CA-C-N 116.039 -0.528 . . . . 0.64000000000000001 111.16 -177.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.444 ' O ' ' HD2' ' A' ' 82' ' ' HIS . 73.9 mmm -102.41 99.02 9.04 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.151 -0.685 . . . . 0.82999999999999996 109.151 174.053 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.513 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -74.97 159.5 31.71 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.169 -0.468 . . . . 0.54000000000000004 111.04 -177.529 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.446 ' HA ' ' C ' ' A' ' 104' ' ' PRO . 98.3 mttt -93.1 153.35 41.74 Favored Pre-proline 0 C--N 1.323 -0.554 0 CA-C-N 115.782 -0.644 . . . . 0.67000000000000004 110.469 -179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.446 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 15.5 Cg_exo -69.18 136.07 35.77 Favored 'Cis proline' 0 C--N 1.343 0.237 0 C-N-CA 123.648 -1.397 . . . . 0.75 112.328 -1.666 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.668 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -128.69 133.53 48.21 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 115.955 -0.566 . . . . 0.34999999999999998 110.038 178.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.527 ' O ' HG23 ' A' ' 110' ' ' VAL . 17.1 t70 -78.54 129.67 35.1 Favored 'General case' 0 C--N 1.313 -0.984 0 N-CA-C 108.616 -0.883 . . . . 0.51000000000000001 108.616 176.628 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.537 HG21 ' HB3' ' A' ' 20' ' ' ASN . 19.9 p -64.11 -22.39 66.92 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-N 115.696 -0.683 . . . . 0.26000000000000001 112.236 -172.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 40.6 t -70.98 -40.68 71.77 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.452 -0.573 . . . . 1.3200000000000001 109.452 174.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.56 -44.27 91.27 Favored 'General case' 0 CA--C 1.513 -0.48 0 CA-C-N 116.149 -0.478 . . . . 0.62 109.967 177.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.7 t -61.62 -44.32 98.48 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 115.355 -0.839 . . . . 0.13 110.396 178.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.62 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -62.67 -51.43 67.26 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.749 -0.66 . . . . 0.13 111.215 -179.963 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.65 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 60.7 mtpt -57.63 -52.56 64.92 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.889 -0.596 . . . . 1.95 110.735 179.932 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 19.7 mmt180 -55.38 -40.03 70.84 Favored 'General case' 0 C--O 1.233 0.209 0 O-C-N 123.314 0.384 . . . . 2.23 111.452 -178.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.88 -48.4 63.48 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.12 -0.491 . . . . 0.14000000000000001 110.845 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 78.1 mt -67.41 -25.87 66.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.305 -0.407 . . . . 0.27000000000000002 111.988 -177.691 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.65 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 17.2 mm-40 -57.18 -47.72 80.54 Favored 'General case' 0 C--O 1.233 0.208 0 CA-C-O 120.958 0.409 . . . . 2.79 110.395 174.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.52 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 52.8 mtm -72.34 -28.5 63.09 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.019 -0.537 . . . . 0.42999999999999999 110.718 -179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.483 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 50.5 t -65.99 -43.76 86.85 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 115.809 -0.632 . . . . 1.46 110.493 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.05 71.2 0.02 OUTLIER Glycine 0 N--CA 1.444 -0.819 0 C-N-CA 120.776 -0.726 . . . . 2.5699999999999998 111.848 179.345 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -88.71 -150.04 20.81 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.672 -0.775 . . . . 4.4800000000000004 111.859 178.021 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 14.0 m-20 -84.91 98.57 10.42 Favored 'General case' 0 C--N 1.322 -0.615 0 CA-C-O 121.129 0.49 . . . . 6.4199999999999999 110.524 -178.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 57.4 tptt -107.45 82.86 1.72 Allowed 'General case' 0 C--N 1.321 -0.658 0 CA-C-N 115.783 -0.644 . . . . 9.1899999999999995 109.554 178.628 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.435 ' HA ' ' HD3' ' A' ' 124' ' ' PRO . 40.6 mt-10 -82.35 124.82 77.8 Favored Pre-proline 0 C--N 1.324 -0.522 0 CA-C-N 115.727 -0.669 . . . . 9.5999999999999996 110.784 -176.1 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.435 ' HD3' ' HA ' ' A' ' 123' ' ' GLU . 24.5 Cg_exo -64.23 99.69 0.3 Allowed 'Trans proline' 0 N--CA 1.462 -0.376 0 C-N-CA 122.751 2.301 . . . . 11.17 111.866 175.287 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.895 0 CA-C-O 118.528 -0.749 . . . . 13.279999999999999 110.267 179.081 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.868 -0.493 . . . . 8.8000000000000007 111.868 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . 61.22 35.78 18.2 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 122.895 0.478 . . . . 6.7800000000000002 111.435 179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 65.6 mtt -135.33 10.14 3.48 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.041 -0.527 . . . . 7.21 110.783 179.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.4 -70.18 2.66 Favored Glycine 0 N--CA 1.45 -0.404 0 C-N-CA 120.887 -0.673 . . . . 1.8500000000000001 112.276 179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.416 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 56.6 mtt -97.08 135.82 21.79 Favored Pre-proline 0 C--N 1.321 -0.639 0 CA-C-O 120.506 0.193 . . . . 1.6499999999999999 110.798 179.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.545 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 34.0 Cg_exo -63.25 138.26 65.57 Favored 'Trans proline' 0 N--CA 1.463 -0.316 0 C-N-CA 122.801 2.334 . . . . 0.33000000000000002 111.411 175.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.6 tptt -88.53 105.43 17.63 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 109.754 -0.461 . . . . 0.89000000000000001 109.754 179.304 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.8 t -100.18 135.72 34.72 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.695 -0.684 . . . . 0.20000000000000001 110.905 -175.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.494 ' HB2' HD12 ' A' ' 50' ' ' ILE . 41.1 tp -110.4 113.22 25.71 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-O 120.903 0.383 . . . . 0.75 110.482 177.267 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 40.7 t -94.83 120.04 43.7 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-O 121.342 0.592 . . . . 0.13 111.589 179.07 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.7 HD21 ' HB2' ' A' ' 41' ' ' ALA . 1.3 mm? -102.33 101.12 11.34 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 114.872 -1.058 . . . . 0.20999999999999999 108.89 172.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.4 tp10 -158.55 118.43 3.2 Favored 'General case' 0 C--N 1.314 -0.978 0 CA-C-N 115.389 -0.823 . . . . 1.4099999999999999 109.732 -174.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 25.8 t70 -83.76 -19.76 34.55 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.068 -0.515 . . . . 1.27 110.068 -179.159 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -84.2 102.87 2.37 Favored Pre-proline 0 C--N 1.331 -0.219 0 N-CA-C 109.537 -0.542 . . . . 2.5600000000000001 109.537 176.502 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.542 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 36.6 Cg_exo -58.9 -31.15 94.88 Favored 'Trans proline' 0 C--N 1.344 0.29 0 C-N-CA 122.878 2.385 . . . . 0.32000000000000001 113.026 -173.076 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -59.39 -49.26 78.49 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.068 0.461 . . . . 1.51 109.77 176.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 51.5 mt -70.12 -43.49 78.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-N 115.653 -0.703 . . . . 1.01 110.67 179.374 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.89 -48.84 74.89 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.088 -0.506 . . . . 0.20999999999999999 110.732 178.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 44.4 ttp -64.6 -41.65 96.1 Favored 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 115.665 -0.698 . . . . 0.60999999999999999 111.315 178.473 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.539 ' HB3' HG21 ' A' ' 107' ' ' THR . 16.9 m-20 -65.12 -46.44 80.99 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 116.297 -0.411 . . . . 1.22 110.977 -179.536 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . 0.409 ' O ' ' HD2' ' A' ' 25' ' ' PHE . 45.7 mt -59.78 -46.43 89.21 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 116.464 -0.335 . . . . 0.17999999999999999 110.267 174.757 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.574 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 64.0 tt0 -52.29 -48.49 65.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.673 -0.694 . . . . 1.04 110.356 178.801 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 12.7 m-85 -69.32 -31.89 70.65 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.15 -0.477 . . . . 0.78000000000000003 111.761 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -68.11 -43.86 77.49 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.942 0.401 . . . . 0.14000000000000001 110.535 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.614 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 49.5 m-85 -67.4 -44.49 78.72 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.001 -0.545 . . . . 0.13 110.849 177.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 28.2 mt-10 -62.98 -32.62 74.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.618 0.247 . . . . 0.68999999999999995 110.602 177.388 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -64.32 -35.19 80.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.24 -0.436 . . . . 0.51000000000000001 110.163 177.357 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 71.1 mm-40 -81.08 -0.07 38.32 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 116.017 -0.538 . . . . 0.65000000000000002 110.886 179.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 85.42 50.0 4.2 Favored Glycine 0 N--CA 1.448 -0.557 0 C-N-CA 120.991 -0.623 . . . . 0.28999999999999998 112.322 179.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -135.22 167.34 21.17 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.829 0.347 . . . . 0.23000000000000001 110.903 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.0 tp10 -108.01 144.68 34.98 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 109.156 -0.683 . . . . 2.1400000000000001 109.156 177.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.574 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 31.3 t -128.8 139.95 50.54 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 CA-C-O 121.095 0.474 . . . . 0.19 112.24 -170.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.405 HG11 ' HB3' ' A' ' 44' ' ' SER . 14.2 t -111.71 136.39 48.0 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 108.665 -0.865 . . . . 0.23000000000000001 108.665 169.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 58.6 t -104.62 124.41 59.18 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-O 120.829 0.347 . . . . 0.94999999999999996 110.71 179.562 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -138.56 138.05 37.6 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.09 -0.504 . . . . 0.16 110.342 176.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.428 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -108.43 -5.55 16.59 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.395 -0.366 . . . . 0.23999999999999999 111.193 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 74.3 p -133.78 166.26 23.05 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 116.537 -0.302 . . . . 0.25 111.309 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.612 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 19.6 p -59.21 -49.28 78.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.334 -0.617 . . . . 1.6000000000000001 109.334 171.59 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -49.83 -55.36 14.5 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 114.42 -1.264 . . . . 0.69999999999999996 111.944 179.623 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.428 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 44.7 mt-30 -55.17 -46.44 75.79 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 110.876 178.288 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.7 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -63.11 -46.18 88.53 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 115.279 -0.873 . . . . 0.17999999999999999 111.838 -177.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.612 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 83.6 mt -66.0 -30.46 71.01 Favored 'General case' 0 N--CA 1.451 -0.419 0 CA-C-N 116.209 -0.451 . . . . 0.82999999999999996 110.451 -178.735 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 8.8 tmtm? -67.32 -54.88 16.78 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.859 -0.61 . . . . 2.4100000000000001 109.48 175.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.405 ' HB3' HG11 ' A' ' 33' ' ' VAL . 15.1 m -62.29 -30.94 71.49 Favored 'General case' 0 N--CA 1.447 -0.594 0 CA-C-N 116.492 -0.322 . . . . 1.1299999999999999 111.373 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.435 ' HB2' ' O ' ' A' ' 41' ' ' ALA . 0.3 OUTLIER -62.12 -42.22 99.02 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.123 -0.49 . . . . 1.23 110.201 178.221 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.54 -32.03 22.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.964 0.411 . . . . 0.42999999999999999 111.265 -178.55 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -75.18 -35.57 61.54 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.97 -0.559 . . . . 0.62 111.062 -177.726 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 35.0 m-80 -120.48 162.95 31.6 Favored Pre-proline 0 C--N 1.325 -0.463 0 CA-C-N 116.103 -0.499 . . . . 0.41999999999999998 110.427 -174.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -95.39 82.96 0.11 Allowed 'Trans proline' 0 N--CA 1.449 -1.119 0 C-N-CA 123.34 2.693 . . . . 0.23999999999999999 111.363 176.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.494 HD12 ' HB2' ' A' ' 9' ' ' LEU . 45.9 mm -66.25 127.63 27.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.815 -0.63 . . . . 0.22 111.452 -175.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.493 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 46.0 m-20 -99.25 -28.41 13.34 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.912 -0.585 . . . . 0.28999999999999998 110.703 178.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 14.9 p -162.11 157.09 2.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 N-CA-C 109.587 -0.523 . . . . 0.12 109.587 -178.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.437 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -144.03 165.63 27.25 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 121.366 0.603 . . . . 0.14000000000000001 112.32 -176.93 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.531 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.49 112.19 9.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.546 0 CA-C-N 115.2 -0.909 . . . . 0.95999999999999996 109.533 176.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.757 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.1 mp -116.0 120.06 37.91 Favored 'General case' 0 C--N 1.317 -0.83 0 N-CA-C 112.189 0.441 . . . . 0.16 112.189 -167.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -83.24 130.54 35.09 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.097 -0.705 . . . . 1.77 109.097 169.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.583 ' H ' ' HB ' ' A' ' 83' ' ' THR . 12.7 t -87.47 -6.46 10.67 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.155 0 CA-C-N 115.16 -0.927 . . . . 0.80000000000000004 110.365 -173.055 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.404 HD22 ' CG ' ' A' ' 85' ' ' ASP . 53.3 t-20 -121.87 73.47 1.08 Allowed 'General case' 0 C--N 1.317 -0.815 0 CA-C-O 121.088 0.47 . . . . 2.3700000000000001 109.966 174.714 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 70.2 mt -73.65 -24.09 59.94 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 121.506 0.669 . . . . 0.84999999999999998 109.468 176.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -173.42 -175.3 41.07 Favored Glycine 0 N--CA 1.442 -0.959 0 N-CA-C 110.681 -0.967 . . . . 0.81999999999999995 110.681 178.119 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 89.3 Cg_exo -52.6 -38.81 76.39 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 123.119 2.546 . . . . 1.1799999999999999 112.715 -179.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 35.9 mtmm -117.97 -34.57 4.12 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.486 -0.325 . . . . 3.5299999999999998 111.361 178.29 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 10.9 p -68.61 128.0 35.04 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 121.137 0.494 . . . . 0.95999999999999996 111.488 -177.654 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 2.4 p80 -144.32 157.15 44.42 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-N 115.71 -0.677 . . . . 0.48999999999999999 110.104 178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.757 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 27.6 p -70.89 86.62 0.7 Allowed 'General case' 0 N--CA 1.446 -0.648 0 CA-C-O 121.686 0.755 . . . . 1.3 109.549 173.007 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -118.38 -63.94 0.3 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.559 -0.829 . . . . 0.23000000000000001 112.009 179.208 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_exo -57.24 -26.87 72.24 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.246 1.964 . . . . 0.23999999999999999 111.254 175.176 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.47 HG11 ' CD2' ' A' ' 11' ' ' LEU . 16.9 t -69.75 -45.92 76.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.627 -0.715 . . . . 0.12 110.171 177.89 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.71 -41.34 90.6 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.162 -0.926 . . . . 0.16 110.29 179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.603 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.5 t70 -69.05 -41.7 77.27 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.52 -0.764 . . . . 2.0299999999999998 110.205 177.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -55.78 -44.7 77.99 Favored 'General case' 0 C--O 1.234 0.277 0 CA-C-O 121.297 0.57 . . . . 0.23000000000000001 110.715 176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.418 HD23 HD21 ' A' ' 45' ' ' LEU . 91.4 mt -66.02 -46.33 78.3 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-N 115.3 -0.863 . . . . 0.20000000000000001 110.51 176.416 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 25.9 mmtm -59.26 -28.7 66.97 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.065 -0.516 . . . . 2.0099999999999998 112.011 177.511 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.603 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 76.2 mt-30 -63.63 -48.06 78.82 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.768 0.318 . . . . 2.3700000000000001 110.974 178.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 98.6 mtt180 -91.05 7.66 39.33 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.34 -0.391 . . . . 1.49 111.361 -179.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.54 42.69 20.45 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.863 -0.608 . . . . 0.33000000000000002 111.031 -178.274 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . 0.406 HG21 HG22 ' A' ' 50' ' ' ILE . 70.6 mt -88.33 132.34 39.61 Favored Pre-proline 0 N--CA 1.449 -0.516 0 CA-C-N 116.148 -0.478 . . . . 0.17000000000000001 110.142 178.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.432 ' O ' ' HA ' ' A' ' 52' ' ' VAL . 18.3 Cg_endo -74.85 140.05 25.42 Favored 'Trans proline' 0 N--CA 1.452 -0.94 0 C-N-CA 122.477 2.118 . . . . 0.20999999999999999 111.759 177.402 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.437 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 25.7 p90 -157.22 160.86 39.1 Favored 'General case' 0 C--N 1.318 -0.787 0 CA-C-N 115.969 -0.56 . . . . 0.17999999999999999 110.695 -179.473 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 22.7 mt -124.33 138.88 52.38 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.98 0 CA-C-N 115.442 -0.799 . . . . 0.23999999999999999 110.013 -179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.503 HD21 HG21 ' A' ' 96' ' ' ILE . 2.0 mm? -89.15 108.7 19.75 Favored 'General case' 0 C--N 1.317 -0.815 0 N-CA-C 109.367 -0.605 . . . . 0.20999999999999999 109.367 178.118 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.576 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 14.7 t-160 -103.08 84.39 2.34 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-O 121.558 0.694 . . . . 0.59999999999999998 109.51 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.583 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 13.3 t -129.81 165.12 22.6 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 114.563 -1.199 . . . . 0.60999999999999999 110.329 -172.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -111.53 6.82 28.18 Favored Glycine 0 N--CA 1.446 -0.687 0 N-CA-C 111.149 -0.78 . . . . 0.93999999999999995 111.149 173.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.445 ' O ' ' HB2' ' A' ' 89' ' ' HIS . 2.2 m-20 -114.87 71.33 0.76 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.959 0.409 . . . . 2.3300000000000001 110.48 -179.582 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.409 HD12 ' N ' ' A' ' 86' ' ' LEU . 6.0 mp -84.7 -33.27 23.18 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.982 -0.554 . . . . 1.6100000000000001 110.354 -178.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -80.38 -34.51 36.36 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.014 -0.539 . . . . 2.6299999999999999 110.655 -177.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 20.8 tpt180 -75.64 -23.05 56.3 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.993 -0.549 . . . . 4.4199999999999999 110.589 179.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.513 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 11.3 m170 -124.46 24.12 8.01 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 112.503 0.557 . . . . 1.05 112.503 -172.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -59.4 -36.72 90.25 Favored Glycine 0 CA--C 1.516 0.156 0 C-N-CA 120.792 -0.718 . . . . 0.97999999999999998 112.486 -178.958 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.641 ' O ' ' HG2' ' A' ' 94' ' ' ARG . 44.2 mt-10 -63.18 -51.7 65.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.907 0.384 . . . . 2.5 110.501 177.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.434 ' O ' HG13 ' A' ' 96' ' ' ILE . 42.9 tp -60.46 -42.79 96.9 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.061 -0.518 . . . . 0.70999999999999996 110.472 179.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.513 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 77.1 mt -60.27 -38.3 83.12 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.299 -0.409 . . . . 1.5800000000000001 111.692 -179.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.641 ' HG2' ' O ' ' A' ' 91' ' ' GLU . 7.8 ptm180 -72.45 -26.9 62.01 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.815 0.34 . . . . 4.3799999999999999 110.463 179.47 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 58.9 mtpt -78.3 -41.05 34.96 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.248 0.547 . . . . 2.4500000000000002 110.001 176.263 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.503 HG21 HD21 ' A' ' 81' ' ' LEU . 76.9 mt -60.61 -44.52 97.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.177 -0.92 . . . . 0.45000000000000001 110.529 177.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 39.0 t70 55.43 77.09 0.24 Allowed 'General case' 0 C--O 1.236 0.364 0 CA-C-O 121.443 0.639 . . . . 1.0900000000000001 111.161 178.974 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -164.56 160.7 15.75 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 114.979 -1.01 . . . . 0.28999999999999998 109.113 -179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.42 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 36.4 Cg_exo -60.17 147.33 93.79 Favored 'Trans proline' 0 C--N 1.343 0.253 0 C-N-CA 122.675 2.25 . . . . 0.26000000000000001 112.451 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 61.6 t -122.97 130.61 74.35 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-N 116.22 -0.445 . . . . 0.64000000000000001 110.915 -178.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.528 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 82.5 mmm -114.3 107.54 15.72 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 108.782 -0.822 . . . . 0.82999999999999996 108.782 174.286 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.521 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -68.43 150.17 48.46 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 120.822 0.344 . . . . 0.54000000000000004 111.613 -176.482 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 91.5 mttt -91.07 139.96 25.85 Favored Pre-proline 0 C--N 1.329 -0.288 0 N-CA-C 109.586 -0.524 . . . . 0.67000000000000004 109.586 174.727 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -77.17 158.54 96.15 Favored 'Cis proline' 0 N--CA 1.46 -0.443 0 C-N-CA 123.665 -1.39 . . . . 0.75 112.515 1.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.576 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.75 132.62 13.27 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.71 -0.677 . . . . 0.34999999999999998 110.097 179.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.465 ' O ' HG23 ' A' ' 110' ' ' VAL . 13.2 t70 -65.49 127.91 33.77 Favored 'General case' 0 C--N 1.321 -0.662 0 N-CA-C 108.89 -0.781 . . . . 0.51000000000000001 108.89 176.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.539 HG21 ' HB3' ' A' ' 20' ' ' ASN . 19.3 p -64.67 -21.05 66.64 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 115.485 -0.78 . . . . 0.26000000000000001 112.444 -171.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -73.53 -37.79 65.5 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.339 -0.615 . . . . 1.3200000000000001 109.339 177.26 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 4.6 m-20 -64.02 -44.81 91.45 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-O 121.276 0.56 . . . . 0.62 109.53 175.756 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.531 HG12 HG11 ' A' ' 54' ' ' VAL . 21.3 t -63.24 -42.4 96.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 115.094 -0.957 . . . . 0.13 110.629 -179.585 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.614 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.43 -50.53 67.19 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.959 -0.564 . . . . 0.13 111.454 -179.548 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . . . . . . . . . 99.6 mttt -63.63 -42.64 98.14 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.977 -0.556 . . . . 1.95 111.212 -177.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 15.5 mmm180 -62.42 -31.07 71.7 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.164 -0.471 . . . . 2.23 111.247 178.214 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -79.57 -49.38 12.29 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 116.233 -0.44 . . . . 0.14000000000000001 111.016 178.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.461 HD23 HG11 ' A' ' 52' ' ' VAL . 67.4 mt -66.58 -26.16 66.98 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 112.884 0.698 . . . . 0.27000000000000002 112.884 -175.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.434 ' HG3' ' N ' ' A' ' 117' ' ' MET . 4.1 pt-20 -62.39 -33.47 74.81 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.12 0.486 . . . . 2.79 109.927 175.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.459 ' HG2' ' HG3' ' A' ' 122' ' ' LYS . 47.6 mtm -77.47 -14.17 59.75 Favored 'General case' 0 N--CA 1.452 -0.326 0 CA-C-N 115.925 -0.58 . . . . 0.42999999999999999 110.893 -179.815 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.545 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 52.1 t -86.63 -6.98 58.71 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.283 0.563 . . . . 1.46 109.799 177.087 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -116.31 -165.01 14.02 Favored Glycine 0 N--CA 1.439 -1.151 0 C-N-CA 120.893 -0.67 . . . . 2.5699999999999998 111.959 -179.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -104.43 8.5 48.1 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.958 -0.639 . . . . 4.4800000000000004 112.608 -176.65 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -106.07 21.04 18.0 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.252 0.548 . . . . 6.4199999999999999 110.654 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . 0.459 ' HG3' ' HG2' ' A' ' 117' ' ' MET . 1.7 tmtp? -76.81 121.52 23.48 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.531 -0.759 . . . . 9.1899999999999995 111.028 -178.862 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 48.2 mt-10 -88.88 135.63 31.71 Favored Pre-proline 0 C--N 1.325 -0.493 0 N-CA-C 109.425 -0.584 . . . . 9.5999999999999996 109.425 173.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 14.3 Cg_endo -57.53 104.4 0.16 Allowed 'Trans proline' 0 C--N 1.343 0.266 0 C-N-CA 122.822 2.348 . . . . 11.17 112.539 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.921 0 CA-C-O 118.661 -0.685 . . . . 13.279999999999999 110.252 -179.478 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.485 1.961 0 N-CA-C 112.035 -0.426 . . . . 8.8000000000000007 112.035 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -68.2 -42.47 79.81 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.846 0.355 . . . . 6.7800000000000002 111.762 -176.527 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 88.5 mtp -91.96 -7.3 49.42 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 121.156 0.503 . . . . 7.21 110.572 -179.517 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 152.33 148.29 4.81 Favored Glycine 0 N--CA 1.442 -0.954 0 C-N-CA 120.998 -0.62 . . . . 1.8500000000000001 111.799 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.467 ' HA ' ' HD3' ' A' ' 6' ' ' PRO . 0.0 OUTLIER -62.75 130.85 94.08 Favored Pre-proline 0 C--N 1.319 -0.722 0 CA-C-O 120.546 0.212 . . . . 1.6499999999999999 111.21 176.573 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 5' ' ' MET . 21.8 Cg_exo -67.03 135.45 37.58 Favored 'Trans proline' 0 N--CA 1.459 -0.508 0 C-N-CA 122.792 2.328 . . . . 0.33000000000000002 111.222 175.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 48' ' ' ASN . 39.8 tptt -85.92 106.14 16.9 Favored 'General case' 0 C--N 1.319 -0.736 0 N-CA-C 109.513 -0.551 . . . . 0.89000000000000001 109.513 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.572 ' HA ' ' O ' ' A' ' 52' ' ' VAL . 46.3 t -99.92 134.82 38.06 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.673 0 CA-C-N 115.935 -0.575 . . . . 0.20000000000000001 110.979 -174.882 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 41.7 tp -109.57 111.94 23.73 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 116.11 -0.496 . . . . 0.75 110.471 176.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 41.7 t -94.44 122.55 46.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.275 0.56 . . . . 0.13 111.736 179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.75 102.93 13.12 Favored 'General case' 0 C--N 1.32 -0.707 0 CA-C-N 114.921 -1.036 . . . . 0.20999999999999999 109.022 173.317 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -160.57 121.74 3.0 Favored 'General case' 0 C--N 1.314 -0.938 0 CA-C-N 116.043 -0.526 . . . . 1.4099999999999999 110.289 -173.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.485 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 38.3 t70 -92.85 -11.75 32.81 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.365 -0.38 . . . . 1.27 110.169 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.498 ' HB3' HD13 ' A' ' 17' ' ' ILE . 42.0 mt-10 -85.73 101.71 2.03 Favored Pre-proline 0 C--N 1.329 -0.286 0 N-CA-C 109.075 -0.713 . . . . 2.5600000000000001 109.075 171.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.485 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 38.0 Cg_exo -59.74 -28.87 88.3 Favored 'Trans proline' 0 C--N 1.345 0.347 0 C-N-CA 122.752 2.301 . . . . 0.32000000000000001 113.459 -171.444 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . 0.509 ' O ' ' HB2' ' A' ' 20' ' ' ASN . 3.5 tm? -65.76 -51.02 62.52 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.344 -0.613 . . . . 1.51 109.344 177.171 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.498 HD13 ' HB3' ' A' ' 14' ' ' GLU . 3.0 mp -64.18 -43.78 97.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 CA-C-N 115.91 -0.586 . . . . 1.01 110.055 179.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.64 -52.82 63.85 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.672 -0.695 . . . . 0.20999999999999999 111.035 179.68 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . 0.438 ' HG2' ' CE2' ' A' ' 23' ' ' TYR . 41.7 ttp -64.07 -39.28 93.73 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.597 -0.729 . . . . 0.60999999999999999 110.947 178.51 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.64 ' HB3' HG21 ' A' ' 107' ' ' THR . 11.5 t-20 -65.28 -41.19 94.42 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.11 -0.496 . . . . 1.22 110.377 -178.677 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 38.8 mt -62.6 -43.84 97.81 Favored 'General case' 0 CA--C 1.515 -0.373 0 CA-C-N 116.056 -0.52 . . . . 0.17999999999999999 110.407 173.505 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.532 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 8.1 tt0 -53.64 -51.43 63.15 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.735 -0.666 . . . . 1.04 110.062 177.641 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.438 ' CE2' ' HG2' ' A' ' 19' ' ' MET . 29.4 m-85 -58.18 -39.35 78.67 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.99 -0.55 . . . . 0.78000000000000003 111.437 177.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.57 -47.87 58.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.475 -0.329 . . . . 0.14000000000000001 110.994 -174.071 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.58 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 43.7 m-85 -63.27 -43.94 96.52 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.37 -0.377 . . . . 0.13 110.385 178.137 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -59.21 -39.23 82.03 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 121.005 0.431 . . . . 0.68999999999999995 110.575 175.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -66.83 -28.6 68.49 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.811 -0.631 . . . . 0.51000000000000001 110.812 -178.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 30.5 mm-40 -84.04 4.43 30.05 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.99 0.424 . . . . 0.65000000000000002 110.513 176.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . 0.407 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . 82.87 48.63 5.4 Favored Glycine 0 N--CA 1.445 -0.752 0 C-N-CA 120.905 -0.665 . . . . 0.28999999999999998 112.432 178.935 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.412 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -135.75 175.8 9.26 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 120.705 0.288 . . . . 0.23000000000000001 111.135 178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -113.23 145.64 40.66 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 108.77 -0.826 . . . . 2.1400000000000001 108.77 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.532 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 25.3 t -131.72 135.97 57.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 N-CA-C 112.618 0.599 . . . . 0.19 112.618 -173.067 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 11.8 t -112.54 136.58 48.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 N-CA-C 108.549 -0.908 . . . . 0.23000000000000001 108.549 168.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 60.4 t -106.79 126.96 62.68 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.703 0 CA-C-O 120.938 0.399 . . . . 0.94999999999999996 110.863 -179.18 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.477 ' HA ' HE21 ' A' ' 40' ' ' GLN . . . -133.48 134.53 43.62 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.908 -0.587 . . . . 0.16 110.285 175.924 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.423 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -100.62 -10.24 21.13 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.126 0.488 . . . . 0.23999999999999999 110.806 178.648 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.508 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 70.7 p -127.64 165.53 19.8 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.853 -0.612 . . . . 0.25 110.185 -178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.578 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 78.1 m -72.1 -30.89 65.54 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 109.829 -0.434 . . . . 1.6000000000000001 109.829 176.617 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.4 mt-10 -66.2 -44.17 84.67 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.954 -0.566 . . . . 0.69999999999999996 111.031 179.214 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.508 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 18.4 mt-30 -62.99 -35.8 81.42 Favored 'General case' 0 CA--C 1.52 -0.178 0 CA-C-O 121.308 0.575 . . . . 1.4099999999999999 110.31 174.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.668 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -64.74 -54.66 27.91 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.433 -0.803 . . . . 0.17999999999999999 111.401 -179.331 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.9 mt -59.33 -33.42 71.11 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.961 -0.563 . . . . 0.82999999999999996 110.263 179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm -61.88 -53.85 50.06 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.454 -0.794 . . . . 2.4100000000000001 110.433 176.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 47.0 t -63.85 -38.72 92.12 Favored 'General case' 0 C--N 1.323 -0.545 0 CA-C-N 115.934 -0.575 . . . . 1.1299999999999999 110.616 179.219 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 18.4 tp -62.25 -36.28 81.55 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 121.126 0.489 . . . . 1.23 110.692 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -78.19 -40.5 37.41 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.219 -0.446 . . . . 0.42999999999999999 111.319 -179.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -80.46 -37.94 30.94 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.898 0.38 . . . . 0.62 111.637 -175.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . 0.404 ' HB3' ' HE2' ' A' ' 7' ' ' LYS . 24.0 m-80 -110.75 160.07 30.09 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 116.302 -0.408 . . . . 0.41999999999999998 110.448 -176.561 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -94.85 84.32 0.12 Allowed 'Trans proline' 0 N--CA 1.447 -1.207 0 C-N-CA 123.5 2.8 . . . . 0.23999999999999999 111.695 178.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 41.1 mm -67.81 128.29 30.88 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.776 0 CA-C-N 115.698 -0.683 . . . . 0.22 111.499 -174.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 35.1 m-20 -95.4 -32.9 12.71 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.585 -0.734 . . . . 0.28999999999999998 110.362 178.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.572 ' O ' ' HA ' ' A' ' 8' ' ' VAL . 12.4 p -158.08 158.38 2.95 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 115.663 -0.699 . . . . 0.12 109.382 -178.352 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.493 ' O ' ' HA ' ' A' ' 79' ' ' PHE . . . -140.26 168.03 20.75 Favored 'General case' 0 C--N 1.317 -0.809 0 CA-C-O 121.421 0.629 . . . . 0.14000000000000001 111.476 -179.253 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.526 HG21 HG12 ' A' ' 110' ' ' VAL . 0.4 OUTLIER -140.69 121.75 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.873 0 N-CA-C 107.853 -1.166 . . . . 0.95999999999999996 107.853 176.155 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.616 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -123.78 122.61 38.49 Favored 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 112.1 0.407 . . . . 0.16 112.1 -167.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.641 ' OD1' ' HA ' ' A' ' 83' ' ' THR . 53.4 t0 -85.18 119.17 25.26 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.561 0.696 . . . . 1.77 109.553 170.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.797 HG13 HD23 ' A' ' 92' ' ' LEU . 95.8 t -69.49 -28.84 39.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.886 0 CA-C-N 115.052 -0.976 . . . . 0.80000000000000004 110.391 179.073 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -99.72 62.05 1.17 Allowed 'General case' 0 C--N 1.321 -0.671 0 CA-C-N 115.846 -0.616 . . . . 2.3700000000000001 110.393 -177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.1 mt -66.81 -28.31 68.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 121.318 0.58 . . . . 0.84999999999999998 109.626 176.39 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -177.43 -171.94 41.44 Favored Glycine 0 N--CA 1.444 -0.772 0 N-CA-C 110.559 -1.016 . . . . 0.81999999999999995 110.559 176.474 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_exo -55.1 -45.37 41.18 Favored 'Trans proline' 0 N--CA 1.463 -0.3 0 C-N-CA 122.556 2.17 . . . . 1.1799999999999999 111.858 175.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 5.0 ttmp? -107.18 -34.32 7.17 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.046 -0.525 . . . . 3.5299999999999998 110.454 179.574 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 24.1 m -68.55 125.27 25.98 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.227 0.537 . . . . 0.95999999999999996 111.364 -177.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.491 ' HB2' HD22 ' A' ' 92' ' ' LEU . 16.8 p80 -146.6 148.52 32.19 Favored 'General case' 0 C--N 1.319 -0.75 0 CA-C-N 115.778 -0.646 . . . . 0.48999999999999999 110.309 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.616 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.8 p -71.43 86.64 0.85 Allowed 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.395 0.617 . . . . 1.3 109.734 172.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -108.85 -72.15 0.74 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.364 -0.922 . . . . 0.23000000000000001 112.407 -178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.578 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 47.9 Cg_exo -53.31 -26.38 34.48 Favored 'Trans proline' 0 C--N 1.346 0.407 0 C-N-CA 122.731 2.287 . . . . 0.23999999999999999 112.023 176.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.522 HG11 ' CD2' ' A' ' 11' ' ' LEU . 13.9 t -69.2 -48.32 69.26 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.322 0 CA-C-O 121.113 0.483 . . . . 0.12 110.158 178.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -58.03 -48.21 80.75 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-N 115.256 -0.884 . . . . 0.16 110.173 179.116 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . 0.467 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 23.3 t70 -63.3 -39.05 93.48 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.154 -0.93 . . . . 2.0299999999999998 110.81 179.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -62.15 -46.83 87.22 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 121.36 0.6 . . . . 0.23000000000000001 110.905 178.416 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.0 mt -64.87 -41.18 95.87 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.432 -0.804 . . . . 0.20000000000000001 110.162 177.363 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.56 ' HE2' ' HA ' ' A' ' 73' ' ' LYS . 2.7 mmpt? -59.37 -33.75 71.55 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.477 -0.783 . . . . 2.0099999999999998 111.195 176.733 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.467 ' HG3' ' O ' ' A' ' 70' ' ' ASP . 24.1 mt-30 -64.09 -47.51 79.78 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.278 -0.419 . . . . 2.3700000000000001 110.964 176.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 85.3 mtt180 -87.88 5.58 39.69 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.247 -0.433 . . . . 1.49 111.089 -177.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 58.01 32.6 22.19 Favored 'General case' 0 N--CA 1.463 0.186 0 CA-C-N 115.689 -0.687 . . . . 0.33000000000000002 111.392 -179.461 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 82.7 mt -82.11 133.07 51.74 Favored Pre-proline 0 N--CA 1.449 -0.506 0 CA-C-N 115.925 -0.579 . . . . 0.17000000000000001 109.798 178.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . . . . . . . . . 25.1 Cg_endo -72.9 142.04 34.4 Favored 'Trans proline' 0 N--CA 1.453 -0.899 0 C-N-CA 122.229 1.953 . . . . 0.20999999999999999 111.884 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.493 ' HA ' ' O ' ' A' ' 53' ' ' ALA . 35.0 p90 -157.23 153.25 27.26 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 110.449 178.322 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 32.3 mt -117.39 138.72 47.15 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 CA-C-N 115.565 -0.743 . . . . 0.23999999999999999 109.526 177.137 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.555 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.5 mm? -88.48 108.09 19.21 Favored 'General case' 0 C--N 1.314 -0.964 0 N-CA-C 109.113 -0.699 . . . . 0.20999999999999999 109.113 178.06 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.592 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.2 t-160 -101.47 76.87 1.72 Allowed 'General case' 0 C--N 1.313 -0.99 0 N-CA-C 108.804 -0.813 . . . . 0.59999999999999998 108.804 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.641 ' HA ' ' OD1' ' A' ' 56' ' ' ASP . 6.5 t -111.7 155.02 24.11 Favored 'General case' 0 C--N 1.319 -0.729 0 CA-C-N 114.683 -1.144 . . . . 0.60999999999999999 111.795 -169.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -98.56 2.16 58.78 Favored Glycine 0 N--CA 1.445 -0.721 0 CA-C-N 115.543 -0.753 . . . . 0.93999999999999995 111.355 174.284 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -149.28 127.68 12.23 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 120.915 0.388 . . . . 2.3300000000000001 111.779 179.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.585 HD21 HG11 ' A' ' 100' ' ' VAL . 4.3 mp -117.72 0.63 12.06 Favored 'General case' 0 C--N 1.321 -0.638 0 N-CA-C 109.083 -0.71 . . . . 1.6100000000000001 109.083 169.46 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 7.3 m-20 -86.54 -61.47 1.73 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.937 -0.574 . . . . 2.6299999999999999 111.51 -177.308 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.5 tmt_? -66.33 -37.77 86.13 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.0 -0.546 . . . . 4.4199999999999999 110.213 -175.018 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 -104.22 33.02 3.67 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.125 -0.489 . . . . 1.05 110.355 176.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.462 ' HA2' HD23 ' A' ' 93' ' ' LEU . . . -62.53 -31.5 79.93 Favored Glycine 0 CA--C 1.511 -0.179 0 C-N-CA 121.15 -0.547 . . . . 0.97999999999999998 113.282 -176.406 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.45 -27.84 69.27 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 121.127 0.489 . . . . 2.5 110.021 178.64 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.797 HD23 HG13 ' A' ' 57' ' ' VAL . 15.8 tp -71.32 -42.87 68.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.767 -0.651 . . . . 0.70999999999999996 110.419 -178.618 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.462 HD23 ' HA2' ' A' ' 90' ' ' GLY . 3.1 mm? -55.61 -40.34 71.97 Favored 'General case' 0 CA--C 1.522 -0.12 0 CA-C-O 121.068 0.461 . . . . 1.5800000000000001 110.241 178.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 29.3 mmt180 -66.94 -26.63 66.93 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.273 -0.876 . . . . 4.3799999999999999 111.821 -178.16 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 67.4 mttm -79.65 -37.03 36.86 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 121.256 0.55 . . . . 2.4500000000000002 110.239 176.475 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 92' ' ' LEU . 69.5 mt -75.98 -62.66 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.587 0 CA-C-N 115.293 -0.867 . . . . 0.45000000000000001 111.876 -174.075 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 33.1 t70 59.23 81.56 0.16 Allowed 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.676 -173.821 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -159.8 169.09 10.9 Favored Pre-proline 0 C--N 1.323 -0.569 0 CA-C-N 115.493 -0.776 . . . . 0.28999999999999998 109.341 -178.678 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.476 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 33.7 Cg_exo -61.57 136.26 61.89 Favored 'Trans proline' 0 C--N 1.345 0.37 0 C-N-CA 122.286 1.991 . . . . 0.26000000000000001 112.118 -179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.585 HG11 HD21 ' A' ' 86' ' ' LEU . 40.0 t -124.17 130.09 73.86 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-N 116.325 -0.398 . . . . 0.64000000000000001 110.994 -177.347 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.536 ' SD ' ' HA ' ' A' ' 110' ' ' VAL . 98.1 mtp -117.05 106.43 13.37 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.445 -0.576 . . . . 0.82999999999999996 109.445 175.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . . . . . . . . . . . -66.16 152.98 43.61 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.924 -0.58 . . . . 0.54000000000000004 111.507 -176.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.549 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 91.7 mttt -90.98 142.82 27.78 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-N 115.868 -0.605 . . . . 0.67000000000000004 110.032 177.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -78.15 158.66 93.6 Favored 'Cis proline' 0 N--CA 1.461 -0.433 0 C-N-CA 123.457 -1.476 . . . . 0.75 112.711 1.654 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.592 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -152.62 131.16 12.22 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.415 -0.811 . . . . 0.34999999999999998 109.184 178.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.488 ' O ' HG23 ' A' ' 110' ' ' VAL . 36.6 t70 -68.05 128.23 35.77 Favored 'General case' 0 C--N 1.32 -0.705 0 N-CA-C 109.42 -0.585 . . . . 0.51000000000000001 109.42 -178.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.64 HG21 ' HB3' ' A' ' 20' ' ' ASN . 21.1 p -59.01 -27.99 65.96 Favored 'General case' 0 C--N 1.318 -0.803 0 CA-C-N 114.815 -1.084 . . . . 0.26000000000000001 112.544 -172.052 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.679 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 0.7 OUTLIER -64.9 -45.62 85.12 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 109.634 -0.506 . . . . 1.3200000000000001 109.634 176.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 21.3 m-20 -61.68 -45.57 93.44 Favored 'General case' 0 CA--C 1.512 -0.5 0 N-CA-C 109.721 -0.474 . . . . 0.62 109.721 178.819 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.536 ' HA ' ' SD ' ' A' ' 101' ' ' MET . 20.2 t -59.27 -43.09 89.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.204 -0.907 . . . . 0.13 110.423 179.821 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.58 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -65.62 -50.35 65.36 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.626 -0.716 . . . . 0.13 111.354 -179.765 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.679 ' HG3' ' O ' ' A' ' 108' ' ' SER . 19.7 mtpp -60.19 -42.2 94.57 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 1.95 111.073 -177.659 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.429 ' HD3' ' HA ' ' A' ' 113' ' ' ARG . 32.0 mmt180 -71.81 -28.11 63.37 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.161 -0.472 . . . . 2.23 111.403 -177.248 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -77.31 -48.49 17.27 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.872 0.368 . . . . 0.14000000000000001 110.119 176.661 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.527 HD23 HG11 ' A' ' 52' ' ' VAL . 82.1 mt -65.1 -26.29 68.15 Favored 'General case' 0 C--N 1.327 -0.394 0 N-CA-C 112.862 0.69 . . . . 0.27000000000000002 112.862 -176.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.12 -25.02 59.54 Favored 'General case' 0 C--N 1.326 -0.423 0 C-N-CA 120.31 -0.556 . . . . 2.79 110.982 -178.69 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.476 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 70.2 mtm -69.55 -36.08 76.01 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.536 -0.302 . . . . 0.42999999999999999 110.75 176.03 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.45 ' SG ' ' HA ' ' A' ' 115' ' ' LEU . 24.7 p -94.36 12.28 27.59 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 121.147 0.498 . . . . 1.46 110.397 176.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -82.9 52.86 4.79 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-N 115.995 -0.548 . . . . 2.5699999999999998 112.266 -178.624 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -143.97 -80.21 0.05 OUTLIER Glycine 0 N--CA 1.444 -0.769 0 C-N-CA 120.855 -0.688 . . . . 4.4800000000000004 111.621 179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -160.81 160.39 31.11 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 110.005 -0.369 . . . . 6.4199999999999999 110.005 -179.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 63.0 mttm -75.67 111.1 10.66 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.094 -0.503 . . . . 9.1899999999999995 110.366 179.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -72.31 124.4 90.76 Favored Pre-proline 0 C--N 1.325 -0.496 0 N-CA-C 109.578 -0.527 . . . . 9.5999999999999996 109.578 178.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 37.8 Cg_endo -66.27 95.7 0.32 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.8 2.333 . . . . 11.17 112.877 -175.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.246 0.896 0 CA-C-O 118.375 -0.821 . . . . 13.279999999999999 109.67 176.023 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.482 1.74 0 N-CA-C 111.897 -0.481 . . . . 8.8000000000000007 111.897 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -91.76 -25.85 18.85 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.665 0.269 . . . . 6.7800000000000002 111.589 -177.125 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.5 ptt? -157.0 171.05 21.16 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.016 0.436 . . . . 7.21 111.259 -176.261 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -137.75 46.36 1.0 Allowed Glycine 0 N--CA 1.445 -0.732 0 N-CA-C 110.947 -0.861 . . . . 1.8500000000000001 110.947 175.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . . . . . . . . . 17.6 ptp -106.06 155.41 38.5 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-O 120.937 0.399 . . . . 1.6499999999999999 110.753 -176.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . . . . . . . . . 9.3 Cg_endo -76.65 148.01 28.64 Favored 'Trans proline' 0 N--CA 1.457 -0.652 0 C-N-CA 122.659 2.239 . . . . 0.33000000000000002 113.1 -178.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.7 tptt -95.78 107.82 20.09 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 115.437 -0.801 . . . . 0.89000000000000001 109.243 174.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.463 HG22 ' CG1' ' A' ' 52' ' ' VAL . 57.1 t -100.6 133.56 43.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-N 116.096 -0.502 . . . . 0.20000000000000001 111.057 -174.568 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.498 ' HB2' HD12 ' A' ' 50' ' ' ILE . 43.5 tp -108.76 114.68 28.68 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-O 120.927 0.394 . . . . 0.75 110.402 175.701 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 37.3 t -95.82 120.76 45.64 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.34 0.59 . . . . 0.13 111.433 178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.667 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.7 OUTLIER -102.05 100.68 10.96 Favored 'General case' 0 C--N 1.32 -0.71 0 CA-C-N 114.828 -1.078 . . . . 0.20999999999999999 108.873 172.383 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -157.4 117.48 3.44 Favored 'General case' 0 C--N 1.31 -1.118 0 CA-C-N 115.408 -0.815 . . . . 1.4099999999999999 109.668 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.53 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 20.2 t70 -81.37 -20.91 39.59 Favored 'General case' 0 C--N 1.321 -0.631 0 CA-C-N 116.062 -0.517 . . . . 1.27 110.225 -178.916 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -82.31 105.44 4.72 Favored Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.573 -0.529 . . . . 2.5600000000000001 109.573 176.171 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.53 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 31.7 Cg_exo -58.32 -30.76 92.09 Favored 'Trans proline' 0 C--N 1.344 0.293 0 C-N-CA 122.619 2.213 . . . . 0.32000000000000001 112.455 -176.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.7 tt -62.38 -49.89 73.73 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-O 121.048 0.451 . . . . 1.51 109.869 178.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 49.1 mt -69.39 -43.68 80.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.799 -0.637 . . . . 1.01 111.169 178.703 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.92 -45.23 78.77 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.086 0.47 . . . . 0.20999999999999999 110.303 177.863 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 39.8 ttp -61.95 -46.71 88.09 Favored 'General case' 0 N--CA 1.446 -0.636 0 CA-C-N 115.384 -0.826 . . . . 0.60999999999999999 111.214 177.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.457 ' HB3' HG21 ' A' ' 107' ' ' THR . 3.4 m-80 -65.27 -40.99 94.63 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.136 -0.484 . . . . 1.22 111.372 -177.879 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 53.0 mt -62.88 -44.57 95.74 Favored 'General case' 0 N--CA 1.45 -0.434 0 CA-C-N 116.357 -0.383 . . . . 0.17999999999999999 110.266 173.996 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . . . . . . . . . 28.2 tt0 -56.36 -49.59 73.95 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 115.606 -0.725 . . . . 1.04 110.2 179.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 34.2 m-85 -62.76 -34.37 77.09 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.204 -0.453 . . . . 0.78000000000000003 111.201 177.042 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . 0.482 ' O ' ' HG2' ' A' ' 28' ' ' GLU . . . -69.02 -51.03 43.37 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.738 0.304 . . . . 0.14000000000000001 110.82 -176.771 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.688 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 53.7 m-85 -63.54 -42.08 98.42 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.344 -0.389 . . . . 0.13 110.834 178.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . . . . . . . . . 31.2 mt-10 -63.92 -32.07 73.47 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.96 -0.296 . . . . 0.68999999999999995 110.626 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -72.8 -26.94 61.7 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.126 -0.488 . . . . 0.51000000000000001 110.818 178.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . 0.482 ' HG2' ' O ' ' A' ' 24' ' ' ALA . 69.6 mm-40 -82.51 -10.22 59.09 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 121.094 0.473 . . . . 0.65000000000000002 110.356 176.904 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 97.32 51.36 1.59 Allowed Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.838 -0.619 . . . . 0.28999999999999998 112.421 179.036 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -140.04 167.9 21.06 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-O 120.819 0.342 . . . . 0.23000000000000001 110.958 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -106.35 141.89 36.93 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 108.943 -0.762 . . . . 2.1400000000000001 108.943 175.736 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 18.4 t -125.83 136.88 59.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 112.191 0.441 . . . . 0.19 112.191 -170.91 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.406 HG11 ' OG ' ' A' ' 44' ' ' SER . 26.2 t -108.27 132.42 56.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.53 0 N-CA-C 108.917 -0.771 . . . . 0.23000000000000001 108.917 168.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.8 t -103.14 124.0 56.96 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.808 0 CA-C-O 120.964 0.412 . . . . 0.94999999999999996 111.088 179.7 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -136.89 143.61 43.08 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.029 -0.532 . . . . 0.16 110.344 178.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . 0.507 ' H ' ' NE2' ' A' ' 40' ' ' GLN . . . -112.09 -8.59 14.02 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.461 -0.336 . . . . 0.23999999999999999 111.308 -179.93 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 65.7 p -131.18 168.11 18.02 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.472 -0.331 . . . . 0.25 111.33 -175.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.552 ' O ' ' HG ' ' A' ' 42' ' ' LEU . 21.5 p -59.22 -50.08 75.39 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-O 121.379 0.609 . . . . 1.6000000000000001 109.434 172.554 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -51.05 -54.12 27.64 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 114.423 -1.262 . . . . 0.69999999999999996 112.215 -179.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.507 ' NE2' ' H ' ' A' ' 36' ' ' ALA . 44.0 mt-30 -56.91 -41.18 77.66 Favored 'General case' 0 N--CA 1.454 -0.229 0 CA-C-O 121.25 0.547 . . . . 1.4099999999999999 111.173 179.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.667 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -68.23 -45.9 72.0 Favored 'General case' 0 C--N 1.319 -0.725 0 CA-C-N 115.43 -0.805 . . . . 0.17999999999999999 111.496 -178.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.552 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 82.4 mt -66.52 -28.13 68.31 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.069 0.461 . . . . 0.82999999999999996 110.481 -178.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.4 ttpt -66.76 -51.65 53.34 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.805 -0.634 . . . . 2.4100000000000001 109.831 173.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.406 ' OG ' HG11 ' A' ' 33' ' ' VAL . 17.3 t -63.56 -37.89 89.05 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.738 -0.664 . . . . 1.1299999999999999 110.792 179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . 0.402 HD21 ' CD2' ' A' ' 72' ' ' LEU . 0.1 OUTLIER -57.51 -39.88 77.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.04 -0.527 . . . . 1.23 110.366 178.048 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -81.82 -34.87 30.0 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.801 -0.636 . . . . 0.42999999999999999 111.39 -177.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 17.0 t70 -80.21 -38.44 31.15 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 120.839 0.352 . . . . 0.62 111.568 -175.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -116.13 161.29 31.87 Favored Pre-proline 0 C--N 1.323 -0.576 0 CA-C-N 116.188 -0.46 . . . . 0.41999999999999998 110.679 -172.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.6 Cg_endo -93.6 82.29 0.18 Allowed 'Trans proline' 0 N--CA 1.448 -1.167 0 C-N-CA 123.59 2.86 . . . . 0.23999999999999999 110.839 175.841 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.498 HD12 ' HB2' ' A' ' 9' ' ' LEU . 43.6 mm -64.84 116.1 3.8 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-N 115.348 -0.842 . . . . 0.22 111.563 -174.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 22.6 m-20 -83.73 -32.53 25.43 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.699 -0.682 . . . . 0.28999999999999998 110.375 178.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.547 HG11 HD23 ' A' ' 115' ' ' LEU . 15.0 p -160.59 155.53 3.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 CA-C-N 115.717 -0.674 . . . . 0.12 109.77 -176.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.496 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.11 167.8 21.28 Favored 'General case' 0 C--N 1.32 -0.699 0 CA-C-O 121.325 0.583 . . . . 0.14000000000000001 111.677 -179.03 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.463 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -139.4 111.18 5.13 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.652 0 CA-C-N 115.447 -0.797 . . . . 0.95999999999999996 109.285 177.735 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.501 ' HA ' ' HB2' ' A' ' 11' ' ' LEU . 10.2 mp -115.09 123.41 48.92 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 112.141 0.423 . . . . 0.16 112.141 -168.284 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 65.9 t0 -81.99 107.94 15.09 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.781 0.801 . . . . 1.77 109.816 171.568 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.758 HG13 HD23 ' A' ' 92' ' ' LEU . 38.2 t -59.17 -19.56 16.09 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.926 0 CA-C-N 114.803 -1.09 . . . . 0.80000000000000004 111.868 178.499 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -122.0 70.03 0.96 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.216 0.531 . . . . 2.3700000000000001 110.72 -177.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.437 HD11 ' SG ' ' A' ' 65' ' ' CYS . 94.9 mt -67.37 -27.85 67.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.029 -0.532 . . . . 0.84999999999999998 110.295 178.621 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -168.24 -160.7 16.54 Favored Glycine 0 N--CA 1.444 -0.792 0 CA-C-N 115.763 -0.653 . . . . 0.81999999999999995 111.684 178.868 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -54.62 -46.03 36.47 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.897 2.398 . . . . 1.1799999999999999 112.203 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 84.9 tttt -126.22 -19.75 4.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.137 -0.483 . . . . 3.5299999999999998 110.271 176.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 16.6 m -63.47 125.89 25.69 Favored 'General case' 0 N--CA 1.453 -0.283 0 CA-C-N 115.985 -0.552 . . . . 0.95999999999999996 110.988 179.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 12.1 p80 -145.71 153.51 41.05 Favored 'General case' 0 C--N 1.319 -0.727 0 CA-C-N 115.959 -0.564 . . . . 0.48999999999999999 110.643 -179.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.661 ' SG ' ' HB3' ' A' ' 11' ' ' LEU . 15.3 m -77.47 85.81 3.85 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.637 -0.875 . . . . 1.3 108.637 171.811 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -106.76 -65.47 0.62 Allowed Glycine 0 C--N 1.331 0.293 0 C-N-CA 120.837 -0.697 . . . . 0.23000000000000001 112.689 -175.881 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . . . . . . . . . 38.8 Cg_exo -54.77 -25.18 41.38 Favored 'Trans proline' 0 C--N 1.347 0.496 0 C-N-CA 122.361 2.041 . . . . 0.23999999999999999 111.247 174.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 11' ' ' LEU . 21.2 t -69.03 -46.91 77.96 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.351 0 CA-C-N 115.723 -0.671 . . . . 0.12 109.998 176.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . 0.456 ' O ' ' HG2' ' A' ' 73' ' ' LYS . . . -58.2 -47.72 82.58 Favored 'General case' 0 N--CA 1.448 -0.541 0 CA-C-N 115.099 -0.955 . . . . 0.16 109.862 177.824 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -63.24 -39.26 94.1 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.786 -0.643 . . . . 2.0299999999999998 110.555 178.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . 0.53 ' O ' ' HG2' ' A' ' 74' ' ' GLN . . . -58.61 -44.62 89.97 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.885 -0.598 . . . . 0.23000000000000001 111.05 176.953 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . 0.402 ' CD2' HD21 ' A' ' 45' ' ' LEU . 90.7 mt -69.58 -46.24 66.82 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.631 -0.713 . . . . 0.20000000000000001 110.293 177.869 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.456 ' HG2' ' O ' ' A' ' 69' ' ' ALA . 30.1 mmmt -56.06 -35.83 67.38 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.357 -0.838 . . . . 2.0099999999999998 111.582 177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.53 ' HG2' ' O ' ' A' ' 71' ' ' ALA . 1.5 pt20 -63.97 -41.46 97.53 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.908 -0.587 . . . . 2.3700000000000001 110.76 -177.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . 0.506 ' HG3' ' HG2' ' A' ' 74' ' ' GLN . 96.5 mtt180 -95.51 4.69 52.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.883 -0.598 . . . . 1.49 111.027 -178.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 61.05 32.95 19.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.628 -0.715 . . . . 0.33000000000000002 111.266 -178.43 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 79.0 mt -80.17 131.65 62.03 Favored Pre-proline 0 N--CA 1.448 -0.546 0 N-CA-C 109.396 -0.594 . . . . 0.17000000000000001 109.396 177.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.439 ' HB2' ' HE3' ' A' ' 117' ' ' MET . 43.2 Cg_endo -76.09 142.19 24.42 Favored 'Trans proline' 0 N--CA 1.449 -1.126 0 C-N-CA 122.287 1.992 . . . . 0.20999999999999999 112.014 -179.822 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.496 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 9.3 p90 -158.38 154.67 27.36 Favored 'General case' 0 C--N 1.311 -1.105 0 CA-C-N 115.369 -0.832 . . . . 0.17999999999999999 110.185 -179.44 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 17.0 mt -117.07 138.64 47.06 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.139 0 CA-C-N 115.463 -0.79 . . . . 0.23999999999999999 109.781 179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.463 HD21 HG21 ' A' ' 96' ' ' ILE . 2.6 mm? -88.5 109.86 20.39 Favored 'General case' 0 C--N 1.314 -0.96 0 CA-C-N 115.987 -0.551 . . . . 0.20999999999999999 109.702 -179.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.608 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 20.9 t-160 -104.88 86.52 2.47 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.387 0.613 . . . . 0.59999999999999998 109.756 -179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.537 ' HB ' ' H ' ' A' ' 57' ' ' VAL . 8.8 t -135.85 161.7 34.88 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 115.001 -1.0 . . . . 0.60999999999999999 110.577 -172.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -119.34 22.16 9.01 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.604 -0.808 . . . . 0.93999999999999995 112.409 178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.631 ' OD2' ' HB3' ' A' ' 88' ' ' ARG . 19.8 t70 -141.69 74.2 1.44 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.337 0.589 . . . . 2.3300000000000001 109.484 179.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.486 HD12 ' N ' ' A' ' 86' ' ' LEU . 3.3 mp -92.42 -22.94 19.35 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.823 -0.626 . . . . 1.6100000000000001 110.887 -174.486 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -73.86 -48.29 32.1 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.93 0.395 . . . . 2.6299999999999999 110.625 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.631 ' HB3' ' OD2' ' A' ' 85' ' ' ASP . 0.7 OUTLIER -75.88 -38.64 57.66 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 116.169 -0.469 . . . . 4.4199999999999999 110.74 -178.701 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.493 ' O ' HD13 ' A' ' 93' ' ' LEU . 73.6 m-70 -89.48 17.29 6.43 Favored 'General case' 0 C--N 1.327 -0.405 0 C-N-CA 120.978 -0.289 . . . . 1.05 110.984 177.371 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.619 ' O ' ' HG2' ' A' ' 94' ' ' ARG . . . -52.56 -42.51 58.03 Favored Glycine 0 C--N 1.331 0.29 0 C-N-CA 121.39 -0.434 . . . . 0.97999999999999998 113.478 -173.388 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -55.94 -34.71 65.9 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.939 0.4 . . . . 2.5 110.693 178.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.758 HD23 HG13 ' A' ' 57' ' ' VAL . 35.3 tp -72.64 -54.18 9.77 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-N 116.042 -0.526 . . . . 0.70999999999999996 111.514 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.674 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -65.66 -27.65 68.52 Favored 'General case' 0 C--N 1.342 0.264 0 C-N-CA 119.973 -0.691 . . . . 1.5800000000000001 111.823 -176.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.619 ' HG2' ' O ' ' A' ' 90' ' ' GLY . 27.2 mmm180 -64.17 -46.35 84.37 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.849 -0.614 . . . . 4.3799999999999999 110.961 173.64 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 65.8 mttm -64.68 -36.14 83.3 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.139 -0.482 . . . . 2.4500000000000002 110.755 178.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.49 HG13 ' O ' ' A' ' 92' ' ' LEU . 79.0 mt -64.08 -49.42 81.54 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.513 -0.767 . . . . 0.45000000000000001 110.503 177.214 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 36.5 t70 58.76 74.52 0.43 Allowed 'General case' 0 C--O 1.236 0.348 0 CA-C-O 121.607 0.718 . . . . 1.0900000000000001 110.897 179.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -160.06 163.94 21.12 Favored Pre-proline 0 C--N 1.324 -0.524 0 CA-C-N 114.916 -1.038 . . . . 0.28999999999999998 109.165 179.129 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 39.3 Cg_exo -58.74 143.83 98.55 Favored 'Trans proline' 0 C--N 1.347 0.468 0 C-N-CA 122.455 2.103 . . . . 0.26000000000000001 112.452 179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 24.7 t -125.61 132.89 70.37 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.238 -0.437 . . . . 0.64000000000000001 111.226 -177.565 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.503 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 81.4 mmm -114.51 106.7 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 N-CA-C 108.857 -0.794 . . . . 0.82999999999999996 108.857 174.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.498 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -67.9 147.61 52.25 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-O 121.023 0.439 . . . . 0.54000000000000004 112.161 -173.967 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . . . . . . . . . 90.4 mttt -90.85 141.98 27.23 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 115.848 -0.614 . . . . 0.67000000000000004 110.116 175.892 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 7.2 Cg_exo -75.16 155.82 99.76 Favored 'Cis proline' 0 C--O 1.231 0.142 0 C-N-CA 123.137 -1.61 . . . . 0.75 112.389 -0.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.608 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -146.14 139.97 26.33 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.876 -0.602 . . . . 0.34999999999999998 109.969 -179.29 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.546 ' O ' HG23 ' A' ' 110' ' ' VAL . 18.7 t70 -70.51 128.24 35.47 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 109.251 -0.648 . . . . 0.51000000000000001 109.251 174.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.457 HG21 ' HB3' ' A' ' 20' ' ' ASN . 18.7 p -68.86 -19.39 64.24 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-N 115.718 -0.674 . . . . 0.26000000000000001 112.756 -170.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 8.5 t -73.94 -37.49 64.55 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.206 -0.664 . . . . 1.3200000000000001 109.206 177.098 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.536 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 1.0 OUTLIER -65.66 -46.48 79.0 Favored 'General case' 0 CA--C 1.512 -0.518 0 CA-C-N 116.112 -0.495 . . . . 0.62 109.779 175.779 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.546 HG23 ' O ' ' A' ' 106' ' ' ASP . 21.5 t -58.88 -43.52 88.6 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-N 115.377 -0.829 . . . . 0.13 110.647 179.893 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.688 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -64.23 -54.03 39.79 Favored 'General case' 0 C--O 1.233 0.213 0 CA-C-N 115.853 -0.612 . . . . 0.13 111.454 -179.057 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.563 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 61.7 mttp -57.5 -48.06 80.27 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.859 -0.61 . . . . 1.95 111.289 -177.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.536 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 26.2 mmt180 -63.82 -34.71 78.52 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.397 -0.365 . . . . 2.23 111.415 -176.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -68.05 -46.71 70.34 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 121.058 0.456 . . . . 0.14000000000000001 110.27 179.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.547 HD23 HG11 ' A' ' 52' ' ' VAL . 86.8 mt -66.12 -25.6 67.07 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.697 -0.683 . . . . 0.27000000000000002 111.877 -178.042 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.563 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 32.8 mm-40 -54.48 -41.04 69.07 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.537 -0.302 . . . . 2.79 111.388 177.121 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.455 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 77.6 mtm -70.89 -29.41 65.49 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 112.105 0.409 . . . . 0.42999999999999999 112.105 -176.365 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 46.7 t -179.92 104.23 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.031 0.443 . . . . 1.46 110.433 -176.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 141.21 -39.86 1.39 Allowed Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.517 -0.849 . . . . 2.5699999999999998 112.156 176.03 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -61.6 -59.33 9.99 Favored Glycine 0 N--CA 1.445 -0.726 0 C-N-CA 120.809 -0.71 . . . . 4.4800000000000004 111.427 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 31.6 t70 54.8 36.8 27.26 Favored 'General case' 0 N--CA 1.463 0.224 0 CA-C-O 121.685 0.755 . . . . 6.4199999999999999 110.403 177.16 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 29.3 tptp -93.98 129.32 40.51 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 115.534 -0.757 . . . . 9.1899999999999995 110.548 -177.554 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -63.02 126.09 88.22 Favored Pre-proline 0 C--N 1.322 -0.598 0 CA-C-N 115.579 -0.737 . . . . 9.5999999999999996 110.018 174.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -75.6 72.74 4.9 Favored 'Trans proline' 0 C--O 1.233 0.234 0 C-N-CA 122.616 2.21 . . . . 11.17 112.256 178.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.247 0.945 0 CA-C-O 118.5 -0.762 . . . . 13.279999999999999 110.282 179.859 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.483 1.8 0 N-CA-C 112.423 -0.271 . . . . 8.8000000000000007 112.423 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . 0.585 ' O ' ' HG3' ' A' ' 5' ' ' MET . . . 49.2 71.82 0.35 Allowed 'General case' 0 C--O 1.231 0.126 0 CA-C-O 121.268 0.556 . . . . 6.7800000000000002 111.569 -178.288 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -72.81 -19.92 61.24 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.27 0.557 . . . . 7.21 110.34 -179.87 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -117.05 59.0 0.47 Allowed Glycine 0 N--CA 1.446 -0.649 0 CA-C-N 115.57 -0.741 . . . . 1.8500000000000001 111.478 176.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.585 ' HG3' ' O ' ' A' ' 2' ' ' ALA . 54.5 mtt -62.05 130.41 92.74 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 120.568 0.223 . . . . 1.6499999999999999 111.365 -179.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.652 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 31.7 Cg_exo -61.99 140.59 85.46 Favored 'Trans proline' 0 C--O 1.234 0.28 0 C-N-CA 123.104 2.536 . . . . 0.33000000000000002 111.714 176.168 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 48.2 tptt -86.62 103.51 15.17 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-O 121.001 0.429 . . . . 0.89000000000000001 109.899 178.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.485 HG22 ' CG1' ' A' ' 52' ' ' VAL . 46.9 t -100.26 136.18 32.78 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.715 0 CA-C-N 115.773 -0.649 . . . . 0.20000000000000001 110.977 -174.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.546 ' HB2' HD12 ' A' ' 50' ' ' ILE . 53.7 tp -112.02 113.49 25.81 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.256 -0.429 . . . . 0.75 110.59 176.152 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 39.3 t -94.34 122.53 45.89 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-O 121.39 0.614 . . . . 0.13 111.164 177.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.677 HD21 ' HB2' ' A' ' 41' ' ' ALA . 0.6 OUTLIER -101.79 107.42 18.61 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-N 114.812 -1.085 . . . . 0.20999999999999999 108.341 172.94 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -166.38 134.47 2.83 Favored 'General case' 0 C--N 1.317 -0.81 0 CA-C-O 121.161 0.505 . . . . 1.4099999999999999 109.956 -176.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.419 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 14.6 t70 -99.55 -23.58 15.03 Favored 'General case' 0 C--N 1.318 -0.785 0 CA-C-N 115.383 -0.826 . . . . 1.27 110.069 -177.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . 0.481 ' CB ' HD13 ' A' ' 17' ' ' ILE . 33.9 mt-10 -80.31 104.81 2.85 Favored Pre-proline 0 C--N 1.33 -0.246 0 N-CA-C 109.345 -0.613 . . . . 2.5600000000000001 109.345 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.419 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 32.2 Cg_exo -58.0 -32.68 95.93 Favored 'Trans proline' 0 C--N 1.346 0.446 0 C-N-CA 123.014 2.476 . . . . 0.32000000000000001 113.435 -171.416 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -62.66 -49.68 74.17 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.697 -0.483 . . . . 1.51 109.697 179.222 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.481 HD13 ' CB ' ' A' ' 14' ' ' GLU . 3.3 mp -66.32 -47.59 83.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.544 -0.753 . . . . 1.01 110.126 179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.87 -49.83 74.31 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 115.525 -0.761 . . . . 0.20999999999999999 111.228 -179.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 38.4 ttp -64.46 -37.08 86.28 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 116.013 -0.539 . . . . 0.60999999999999999 110.949 179.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.524 ' HB3' HG21 ' A' ' 107' ' ' THR . 2.6 m-80 -69.16 -37.0 78.0 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 116.25 -0.432 . . . . 1.22 110.915 -179.721 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 51.2 mt -65.11 -45.89 83.26 Favored 'General case' 0 N--CA 1.451 -0.414 0 CA-C-N 116.42 -0.354 . . . . 0.17999999999999999 110.058 173.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.475 ' HA ' HG11 ' A' ' 32' ' ' VAL . 35.9 tt0 -51.86 -56.8 11.83 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.765 -0.652 . . . . 1.04 110.205 177.279 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 27.0 m-85 -63.55 -27.65 69.4 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.859 -0.61 . . . . 0.78000000000000003 111.894 179.943 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -70.3 -48.9 54.55 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.834 0.35 . . . . 0.14000000000000001 110.314 179.054 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.706 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 47.0 m-85 -66.08 -41.1 91.16 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 116.094 -0.503 . . . . 0.13 111.031 178.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 60.3 mt-10 -61.29 -37.04 81.75 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.672 0.272 . . . . 0.68999999999999995 110.582 178.283 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 9.6 t70 -68.44 -29.78 68.51 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.3 -0.409 . . . . 0.51000000000000001 110.338 179.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 66.5 mm-40 -79.48 -13.48 59.54 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.269 -0.423 . . . . 0.65000000000000002 110.66 178.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 98.49 50.19 1.58 Allowed Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 121.092 -0.575 . . . . 0.28999999999999998 112.399 179.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -137.81 165.52 26.26 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.591 0.234 . . . . 0.23000000000000001 110.898 179.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -109.27 128.2 54.88 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.261 -0.644 . . . . 2.1400000000000001 109.261 179.916 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.475 HG11 ' HA ' ' A' ' 22' ' ' GLN . 37.8 t -113.23 133.98 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 N-CA-C 112.787 0.662 . . . . 0.19 112.787 -167.821 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 21.5 t -105.97 139.91 25.73 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 108.169 -1.049 . . . . 0.23000000000000001 108.169 167.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 93.1 t -114.67 125.22 71.92 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.626 -0.43 . . . . 0.94999999999999996 110.879 179.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.41 ' HB1' ' HB2' ' A' ' 40' ' ' GLN . . . -133.54 136.39 44.96 Favored 'General case' 0 C--N 1.324 -0.527 0 CA-C-N 115.878 -0.601 . . . . 0.16 110.174 177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -100.16 -10.8 21.04 Favored 'General case' 0 C--N 1.322 -0.627 0 CA-C-O 120.869 0.366 . . . . 0.23999999999999999 111.287 -179.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . . . . . . . . . 63.2 p -131.23 163.37 27.91 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.199 -0.455 . . . . 0.25 110.751 -177.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.634 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.6 m -63.41 -33.76 76.26 Favored 'General case' 0 C--N 1.324 -0.504 0 N-CA-C 109.757 -0.46 . . . . 1.6000000000000001 109.757 173.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -61.43 -51.61 67.98 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.685 -0.689 . . . . 0.69999999999999996 110.618 179.595 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.41 ' HB2' ' HB1' ' A' ' 35' ' ' ALA . 46.8 mt-30 -58.98 -39.12 80.78 Favored 'General case' 0 N--CA 1.455 -0.215 0 CA-C-O 121.122 0.487 . . . . 1.4099999999999999 110.805 177.035 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.677 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -64.74 -49.83 69.25 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 115.517 -0.765 . . . . 0.17999999999999999 111.718 -178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.62 ' HG ' ' O ' ' A' ' 38' ' ' CYS . 88.4 mt -63.25 -27.86 69.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.126 0.489 . . . . 0.82999999999999996 110.497 -178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 1.4 tmmt? -67.42 -50.29 60.1 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.787 -0.642 . . . . 2.4100000000000001 109.769 176.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 35.0 t -65.47 -33.45 75.97 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.262 -0.426 . . . . 1.1299999999999999 110.586 178.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.22 -37.51 77.66 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.24 -0.436 . . . . 1.23 110.656 177.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.8 -41.8 14.73 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.287 -0.415 . . . . 0.42999999999999999 111.212 179.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 37.6 t70 -68.16 -37.19 80.76 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.879 -0.601 . . . . 0.62 111.551 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 16.9 m-80 -122.72 162.5 38.28 Favored Pre-proline 0 C--N 1.322 -0.629 0 CA-C-N 116.166 -0.47 . . . . 0.41999999999999998 110.724 -175.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 33.1 Cg_endo -93.28 86.05 0.17 Allowed 'Trans proline' 0 N--CA 1.446 -1.278 0 C-N-CA 123.255 2.637 . . . . 0.23999999999999999 111.018 174.758 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.546 HD12 ' HB2' ' A' ' 9' ' ' LEU . 42.4 mm -64.01 119.9 9.38 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-N 115.379 -0.828 . . . . 0.22 111.523 -175.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.42 ' O ' ' HD2' ' A' ' 78' ' ' PRO . 41.5 m-20 -87.24 -35.7 18.36 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.679 -0.691 . . . . 0.28999999999999998 110.28 178.643 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.485 ' CG1' HG22 ' A' ' 8' ' ' VAL . 14.5 p -156.31 155.43 5.41 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 CA-C-N 115.753 -0.658 . . . . 0.12 109.581 -178.394 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.479 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -138.24 163.51 31.57 Favored 'General case' 0 C--N 1.316 -0.858 0 CA-C-O 121.451 0.643 . . . . 0.14000000000000001 111.519 -179.493 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.488 HG11 HG12 ' A' ' 110' ' ' VAL . 0.0 OUTLIER -134.84 111.52 14.02 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.848 0 N-CA-C 108.511 -0.922 . . . . 0.95999999999999996 108.511 175.467 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.71 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 10.9 mp -108.01 107.31 17.94 Favored 'General case' 0 C--N 1.312 -1.047 0 C-N-CA 120.711 -0.396 . . . . 0.16 111.802 -169.673 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . 0.843 ' HA ' ' O ' ' A' ' 82' ' ' HIS . 2.1 t70 -84.97 139.04 32.1 Favored 'General case' 0 N--CA 1.439 -1.003 0 N-CA-C 109.098 -0.704 . . . . 1.77 109.098 173.327 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.471 HG22 ' SG ' ' A' ' 65' ' ' CYS . 14.4 t -93.93 -9.84 9.5 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.185 0 CA-C-N 115.731 -0.668 . . . . 0.80000000000000004 110.287 -175.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 8.7 t30 -89.96 60.18 4.82 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.715 0.769 . . . . 2.3700000000000001 110.164 -179.094 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 43.3 mt -89.77 -23.85 21.65 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.87 -0.605 . . . . 0.84999999999999998 110.067 179.848 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -179.68 -173.13 44.49 Favored Glycine 0 N--CA 1.445 -0.751 0 N-CA-C 111.029 -0.828 . . . . 0.81999999999999995 111.029 177.648 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 45.7 Cg_exo -55.58 -43.52 57.08 Favored 'Trans proline' 0 N--CA 1.464 -0.223 0 C-N-CA 122.565 2.177 . . . . 1.1799999999999999 111.91 177.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 58.9 mttp -120.11 -23.55 6.27 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.918 -0.583 . . . . 3.5299999999999998 110.404 178.152 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -61.91 122.35 15.21 Favored 'General case' 0 N--CA 1.452 -0.372 0 CA-C-O 121.282 0.563 . . . . 0.95999999999999996 111.068 178.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . 0.467 ' HB2' HG13 ' A' ' 57' ' ' VAL . 20.0 p80 -144.39 154.22 42.76 Favored 'General case' 0 C--N 1.319 -0.758 0 CA-C-N 115.495 -0.775 . . . . 0.48999999999999999 109.993 -178.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 29.0 p -70.05 87.46 0.57 Allowed 'General case' 0 C--N 1.319 -0.727 0 CA-C-O 121.266 0.555 . . . . 1.3 109.866 172.611 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . . . . . . . . . . . -111.57 -74.71 0.74 Allowed Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.525 -0.845 . . . . 0.23000000000000001 112.523 179.701 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.634 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 46.5 Cg_exo -53.35 -24.76 28.56 Favored 'Trans proline' 0 C--N 1.346 0.445 0 C-N-CA 122.695 2.264 . . . . 0.23999999999999999 112.302 176.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.49 ' CG2' ' HA ' ' A' ' 38' ' ' CYS . 21.2 t -66.33 -44.54 90.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-O 121.375 0.607 . . . . 0.12 109.918 177.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -59.82 -45.43 92.41 Favored 'General case' 0 N--CA 1.448 -0.569 0 CA-C-N 114.918 -1.037 . . . . 0.16 109.966 179.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -60.88 -45.59 93.99 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.514 -0.766 . . . . 2.0299999999999998 110.458 177.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -54.05 -41.65 68.37 Favored 'General case' 0 C--O 1.236 0.345 0 CA-C-O 121.459 0.647 . . . . 0.23000000000000001 111.366 178.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 93.2 mt -73.58 -44.84 56.32 Favored 'General case' 0 C--N 1.321 -0.65 0 CA-C-N 115.375 -0.83 . . . . 0.20000000000000001 110.561 178.973 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -54.29 -41.37 68.82 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 115.455 -0.793 . . . . 2.0099999999999998 110.861 176.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.537 HE21 ' HA ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -59.89 -46.44 89.32 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.708 -0.678 . . . . 2.3700000000000001 111.483 179.121 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.5 mtt85 -92.93 12.06 25.12 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 116.35 -0.386 . . . . 1.49 111.451 -177.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 54.43 37.44 27.72 Favored 'General case' 0 C--O 1.233 0.225 0 CA-C-N 115.692 -0.685 . . . . 0.33000000000000002 111.66 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 71.7 mt -87.25 133.53 38.49 Favored Pre-proline 0 N--CA 1.448 -0.554 0 CA-C-N 116.282 -0.417 . . . . 0.17000000000000001 109.944 178.538 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.42 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 22.2 Cg_endo -74.99 142.11 27.47 Favored 'Trans proline' 0 N--CA 1.453 -0.889 0 C-N-CA 122.298 1.999 . . . . 0.20999999999999999 112.04 177.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.479 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 18.7 p90 -159.34 154.94 25.93 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-N 115.834 -0.621 . . . . 0.17999999999999999 110.562 -179.952 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . . . . . . . . . 36.4 mt -117.74 137.03 52.99 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.976 0 CA-C-N 115.358 -0.837 . . . . 0.23999999999999999 109.624 179.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.432 HD21 ' HB3' ' A' ' 98' ' ' ALA . 1.8 mm? -89.03 109.4 20.25 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 109.238 -0.653 . . . . 0.20999999999999999 109.238 179.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.843 ' O ' ' HA ' ' A' ' 56' ' ' ASP . 20.4 t-160 -97.87 126.85 43.45 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 107.904 -1.147 . . . . 0.59999999999999998 107.904 178.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.632 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -169.39 151.23 4.44 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 121.753 -0.592 . . . . 0.60999999999999999 111.529 -176.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -94.83 -8.78 59.05 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.896 -0.669 . . . . 0.93999999999999995 111.565 175.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -116.32 112.39 21.48 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.849 0.357 . . . . 2.3300000000000001 110.725 179.651 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 75.5 mt -108.04 -10.31 15.49 Favored 'General case' 0 C--N 1.321 -0.663 0 CA-C-N 115.807 -0.633 . . . . 1.6100000000000001 110.057 176.832 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 58.9 m-20 -84.03 -60.33 2.13 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.906 -0.588 . . . . 2.6299999999999999 111.457 -175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 55.9 ttt180 -71.78 -40.67 69.11 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.329 -0.396 . . . . 4.4199999999999999 110.778 -174.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . 0.486 ' O ' ' HG ' ' A' ' 93' ' ' LEU . 89.8 m-70 -92.48 21.78 5.1 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.334 -0.394 . . . . 1.05 111.676 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . . . . . . . . . . . -63.41 -39.12 97.4 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.924 -0.655 . . . . 0.97999999999999998 112.475 -179.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -61.42 -41.61 97.43 Favored 'General case' 0 C--O 1.235 0.323 0 CA-C-O 120.936 0.398 . . . . 2.5 110.346 178.694 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.422 ' O ' HG13 ' A' ' 96' ' ' ILE . 63.8 tp -59.77 -48.64 80.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.699 -0.682 . . . . 0.70999999999999996 110.502 177.365 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.486 ' HG ' ' O ' ' A' ' 89' ' ' HIS . 40.6 mt -60.32 -40.84 92.02 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 115.819 -0.628 . . . . 1.5800000000000001 111.122 -179.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . . . . . . . . . 56.2 mtp180 -69.78 -25.53 63.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.016 -0.538 . . . . 4.3799999999999999 111.21 179.136 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 32.0 ttmt -77.15 -32.01 56.0 Favored 'General case' 0 N--CA 1.442 -0.83 0 CA-C-O 121.445 0.641 . . . . 2.4500000000000002 110.232 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.422 HG13 ' O ' ' A' ' 92' ' ' LEU . 93.6 mt -77.35 -54.44 12.77 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 115.271 -0.877 . . . . 0.45000000000000001 110.912 179.452 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 38.7 t70 62.95 76.58 0.36 Allowed 'General case' 0 N--CA 1.465 0.28 0 CA-C-O 121.506 0.67 . . . . 1.0900000000000001 110.839 -177.637 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . 0.432 ' HB3' HD21 ' A' ' 81' ' ' LEU . . . -158.93 168.16 12.97 Favored Pre-proline 0 C--N 1.325 -0.483 0 CA-C-N 115.157 -0.929 . . . . 0.28999999999999998 108.941 178.592 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.574 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 47.8 Cg_exo -58.74 140.57 95.55 Favored 'Trans proline' 0 C--N 1.346 0.411 0 C-N-CA 122.425 2.083 . . . . 0.26000000000000001 112.625 -179.939 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 46.3 t -119.85 142.84 33.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 115.826 -0.624 . . . . 0.64000000000000001 110.873 -178.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.451 ' O ' ' HA ' ' A' ' 82' ' ' HIS . 80.9 mmm -125.57 110.01 13.34 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.389 -0.597 . . . . 0.82999999999999996 109.389 175.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.632 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -75.67 150.2 37.97 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.317 -0.401 . . . . 0.54000000000000004 111.849 -175.052 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.551 ' HE3' ' OD2' ' A' ' 56' ' ' ASP . 77.8 mttt -91.18 140.97 25.9 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 115.965 -0.561 . . . . 0.67000000000000004 110.154 176.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.406 ' C ' ' HA ' ' A' ' 103' ' ' LYS . 2.9 Cg_exo -75.35 146.93 87.5 Favored 'Cis proline' 0 C--O 1.233 0.247 0 C-N-CA 123.472 -1.47 . . . . 0.75 112.641 3.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.506 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -136.41 132.58 35.66 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 116.017 -0.538 . . . . 0.34999999999999998 110.275 -179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 110' ' ' VAL . 9.7 t70 -73.32 128.07 34.46 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.486 -0.931 . . . . 0.51000000000000001 108.486 176.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.524 HG21 ' HB3' ' A' ' 20' ' ' ASN . 35.9 p -65.96 -17.77 64.89 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 115.876 -0.602 . . . . 0.26000000000000001 112.294 -171.098 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.42 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 77.5 p -71.92 -41.78 67.46 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.947 -0.39 . . . . 1.3200000000000001 109.947 176.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.5 -42.16 87.77 Favored 'General case' 0 CA--C 1.51 -0.56 0 CA-C-O 121.139 0.495 . . . . 0.62 110.01 177.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 106' ' ' ASP . 20.5 t -62.62 -44.11 99.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 115.383 -0.826 . . . . 0.13 110.182 178.698 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.706 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -66.63 -51.33 57.51 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.619 -0.719 . . . . 0.13 111.854 -178.011 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.5 ' O ' ' HG2' ' A' ' 116' ' ' GLU . 52.8 mtpt -60.03 -48.16 82.87 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.15 -0.477 . . . . 1.95 111.244 -176.64 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . . . . . . . . . 31.4 mmt180 -62.46 -35.82 80.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 120.68 0.276 . . . . 2.23 111.399 179.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . 0.4 ' O ' HG21 ' A' ' 52' ' ' VAL . . . -66.32 -46.84 75.49 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 120.94 0.4 . . . . 0.14000000000000001 110.041 177.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . . . . . . . . . 80.2 mt -68.64 -26.36 65.3 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.132 -0.486 . . . . 0.27000000000000002 111.887 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . 0.5 ' HG2' ' O ' ' A' ' 112' ' ' LYS . 50.7 mm-40 -56.78 -46.94 81.18 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.116 0.484 . . . . 2.79 110.375 173.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.574 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 46.1 mtm -76.06 -26.69 56.77 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.906 -0.588 . . . . 0.42999999999999999 110.76 179.158 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.652 ' SG ' ' HB3' ' A' ' 6' ' ' PRO . 53.4 t -58.64 -52.73 64.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.028 -0.533 . . . . 1.46 111.146 -177.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -146.26 129.91 3.52 Favored Glycine 0 N--CA 1.441 -1.025 0 C-N-CA 120.47 -0.871 . . . . 2.5699999999999998 112.055 -178.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . -65.88 -28.97 74.11 Favored Glycine 0 N--CA 1.449 -0.438 0 N-CA-C 111.158 -0.777 . . . . 4.4800000000000004 111.158 176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 16.4 m-20 -92.41 128.75 38.38 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.915 -0.402 . . . . 6.4199999999999999 109.915 177.765 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -83.85 155.94 22.69 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.484 -0.325 . . . . 9.1899999999999995 110.27 176.98 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 8.2 mp0 -72.5 115.41 39.13 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.127 -0.488 . . . . 9.5999999999999996 110.109 179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -81.7 37.64 0.69 Allowed 'Trans proline' 0 N--CA 1.463 -0.289 0 C-N-CA 122.978 2.452 . . . . 11.17 112.772 -176.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.243 0.726 0 CA-C-O 118.568 -0.73 . . . . 13.279999999999999 110.483 -178.287 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.484 1.841 0 N-CA-C 111.681 -0.568 . . . . 8.8000000000000007 111.681 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' ALA . . . . . . . . . . . . . . . -54.39 -43.37 71.37 Favored 'General case' 0 C--N 1.332 -0.183 0 N-CA-C 112.517 0.562 . . . . 6.7800000000000002 112.517 -173.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 26.1 mmt -102.09 27.23 6.8 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 120.741 0.305 . . . . 7.21 111.289 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.47 20.34 78.28 Favored Glycine 0 CA--C 1.509 -0.294 0 C-N-CA 121.005 -0.617 . . . . 1.8500000000000001 111.948 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' MET . . . . . 0.429 ' HB3' ' HA ' ' A' ' 30' ' ' ALA . 86.3 mtp -143.2 139.41 16.63 Favored Pre-proline 0 C--N 1.317 -0.836 0 N-CA-C 108.708 -0.849 . . . . 1.6499999999999999 108.708 -178.373 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' PRO . . . . . 0.456 ' HD2' ' HA ' ' A' ' 30' ' ' ALA . 8.8 Cg_exo -63.52 131.42 31.62 Favored 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 121.854 1.703 . . . . 0.33000000000000002 111.372 176.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.5 tptt -86.01 102.94 14.25 Favored 'General case' 0 C--N 1.313 -1.019 0 N-CA-C 108.507 -0.923 . . . . 0.89000000000000001 108.507 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.451 HG22 ' CG1' ' A' ' 52' ' ' VAL . 49.8 t -99.69 126.81 53.01 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.822 0 CA-C-N 116.037 -0.529 . . . . 0.20000000000000001 111.087 -172.326 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.627 ' HB2' HD12 ' A' ' 50' ' ' ILE . 3.5 tm? -102.2 112.24 24.84 Favored 'General case' 0 C--N 1.318 -0.776 0 CA-C-N 115.578 -0.737 . . . . 0.75 109.476 178.095 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 32.4 t -96.83 125.82 49.71 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.113 0.482 . . . . 0.13 111.409 179.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . 0.642 HD23 HG11 ' A' ' 68' ' ' VAL . 0.2 OUTLIER -105.96 100.53 10.08 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 108.694 -0.854 . . . . 0.20999999999999999 108.694 173.002 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.9 tp10 -157.5 118.17 3.52 Favored 'General case' 0 C--N 1.317 -0.837 0 CA-C-N 115.907 -0.588 . . . . 1.4099999999999999 109.626 -176.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.474 ' O ' ' HD3' ' A' ' 15' ' ' PRO . 32.9 t70 -77.27 -21.2 53.99 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.848 -0.615 . . . . 1.27 110.223 -177.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLU . . . . . . . . . . . . . 21.1 mm-40 -88.05 106.88 13.42 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 115.905 -0.589 . . . . 2.5600000000000001 111.117 177.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' PRO . . . . . 0.474 ' HD3' ' O ' ' A' ' 13' ' ' ASP . 39.2 Cg_exo -58.53 -28.89 87.2 Favored 'Trans proline' 0 CA--C 1.518 -0.312 0 C-N-CA 122.86 2.374 . . . . 0.32000000000000001 112.914 -177.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -65.43 -49.67 68.28 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.516 -0.55 . . . . 1.51 109.516 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . . . . . . . . . 65.5 mt -66.37 -45.47 89.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-N 115.733 -0.667 . . . . 1.01 110.514 176.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.35 73.04 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.87 -0.605 . . . . 0.20999999999999999 110.82 178.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' MET . . . . . . . . . . . . . 35.6 ttp -59.37 -43.84 92.82 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.654 -0.703 . . . . 0.60999999999999999 111.238 177.175 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' HB3' HG21 ' A' ' 107' ' ' THR . 4.9 m-80 -67.86 -38.71 83.45 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.926 -0.579 . . . . 1.22 111.34 -177.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 41.6 mt -65.31 -44.83 86.61 Favored 'General case' 0 N--CA 1.449 -0.497 0 CA-C-O 120.928 0.394 . . . . 0.17999999999999999 110.297 172.243 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLN . . . . . 0.615 ' HG3' ' HB ' ' A' ' 32' ' ' VAL . 52.2 tt0 -54.49 -51.89 63.65 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.563 -0.744 . . . . 1.04 110.466 179.521 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -61.09 -34.38 74.83 Favored 'General case' 0 C--N 1.334 -0.108 0 CA-C-N 116.612 -0.267 . . . . 0.78000000000000003 111.116 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ALA . . . . . . . . . . . . . . . -65.9 -46.9 76.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.504 -0.317 . . . . 0.14000000000000001 110.699 -178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.604 ' CZ ' ' HA ' ' A' ' 111' ' ' ALA . 56.9 m-85 -68.64 -42.5 77.94 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.242 -0.435 . . . . 0.13 110.994 179.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLU . . . . . 0.511 ' HG3' ' O ' ' A' ' 22' ' ' GLN . 44.1 mt-10 -61.79 -35.54 78.48 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.586 -0.279 . . . . 0.68999999999999995 110.461 178.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -67.49 -32.34 73.1 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.99 -0.55 . . . . 0.51000000000000001 110.657 178.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLU . . . . . . . . . . . . . 72.2 mm-40 -78.81 -10.0 59.64 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.186 -0.461 . . . . 0.65000000000000002 110.455 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' GLY . . . . . . . . . . . . . . . 96.63 50.56 1.81 Allowed Glycine 0 N--CA 1.449 -0.488 0 CA-C-N 115.84 -0.618 . . . . 0.28999999999999998 112.399 178.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.456 ' HA ' ' HD2' ' A' ' 6' ' ' PRO . . . -139.79 165.14 28.08 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.671 0.272 . . . . 0.23000000000000001 110.833 179.687 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -111.86 134.97 53.08 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.422 -0.584 . . . . 2.1400000000000001 109.422 179.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.615 ' HB ' ' HG3' ' A' ' 22' ' ' GLN . 17.4 t -117.39 140.74 39.02 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 N-CA-C 112.41 0.522 . . . . 0.19 112.41 -167.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 10.8 t -113.43 131.53 64.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.544 -0.91 . . . . 0.23000000000000001 108.544 168.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 78.6 t -105.43 121.15 57.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.618 0 CA-C-O 120.932 0.396 . . . . 0.94999999999999996 111.609 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -126.39 142.66 51.45 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.819 -0.628 . . . . 0.16 110.471 177.437 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ALA . . . . . . . . . . . . . . . -107.76 -12.6 15.19 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-N 115.899 -0.591 . . . . 0.23999999999999999 110.54 178.183 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' THR . . . . . 0.409 ' OG1' ' HG3' ' A' ' 40' ' ' GLN . 32.8 p -124.89 174.96 7.61 Favored 'General case' 0 N--CA 1.452 -0.368 0 CA-C-N 116.277 -0.42 . . . . 0.25 110.955 -179.703 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' CYS . . . . . 0.611 ' SG ' ' HD2' ' A' ' 67' ' ' PRO . 83.9 m -75.11 -37.0 61.62 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-O 121.033 0.444 . . . . 1.6000000000000001 110.263 176.415 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -66.15 -41.19 90.74 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.655 -0.702 . . . . 0.69999999999999996 111.161 -178.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.409 ' HG3' ' OG1' ' A' ' 37' ' ' THR . 86.5 mt-30 -59.83 -37.29 78.78 Favored 'General case' 0 C--O 1.233 0.224 0 CA-C-O 121.078 0.466 . . . . 1.4099999999999999 110.857 177.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.57 ' HB2' HD21 ' A' ' 11' ' ' LEU . . . -71.46 -48.43 49.39 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.995 -0.548 . . . . 0.17999999999999999 110.879 179.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . . . . . . . . . 2.9 mp -56.02 -37.34 69.05 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.182 -0.463 . . . . 0.82999999999999996 110.68 177.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 52.8 tttm -63.1 -54.07 43.73 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.051 -0.522 . . . . 2.4100000000000001 110.444 176.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 16.4 m -63.99 -29.18 70.36 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.713 -0.676 . . . . 1.1299999999999999 111.711 -179.417 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LEU . . . . . . . . . . . . . 8.3 mt -68.4 -30.64 69.6 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 121.342 0.591 . . . . 1.23 110.513 175.566 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -85.53 -28.57 24.84 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.4 0.619 . . . . 0.42999999999999999 111.07 179.767 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 38.2 t70 -87.04 -21.68 25.94 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.581 -0.736 . . . . 0.62 111.52 -177.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' ASN . . . . . . . . . . . . . 29.1 m-80 -137.68 163.67 46.69 Favored Pre-proline 0 C--N 1.326 -0.422 0 CA-C-O 120.695 0.283 . . . . 0.41999999999999998 111.115 -174.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 38.7 Cg_endo -96.32 87.13 0.09 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.11 0 C-N-CA 123.767 2.978 . . . . 0.23999999999999999 111.388 175.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.627 HD12 ' HB2' ' A' ' 9' ' ' LEU . 37.9 mm -66.08 124.36 20.99 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 CA-C-N 115.594 -0.73 . . . . 0.22 111.631 -174.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.701 ' HB3' ' SG ' ' A' ' 118' ' ' CYS . 14.3 m-20 -89.48 -34.67 16.34 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.542 -0.754 . . . . 0.28999999999999998 110.421 179.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.56 HG11 HD23 ' A' ' 115' ' ' LEU . 13.6 p -159.67 157.61 2.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.805 -0.634 . . . . 0.12 109.871 -176.306 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . 0.424 ' HB3' ' HB3' ' A' ' 79' ' ' PHE . . . -140.8 164.53 29.97 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-O 121.359 0.599 . . . . 0.14000000000000001 112.008 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.492 HG11 HG12 ' A' ' 110' ' ' VAL . 0.1 OUTLIER -137.65 110.75 7.7 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.353 -0.84 . . . . 0.95999999999999996 109.301 175.635 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.66 ' HB3' ' SG ' ' A' ' 65' ' ' CYS . 9.5 mp -112.7 121.86 45.99 Favored 'General case' 0 C--N 1.316 -0.855 0 CA-C-N 116.415 -0.357 . . . . 0.16 111.631 -169.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -83.88 116.49 22.79 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 121.624 0.726 . . . . 1.77 109.645 171.25 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' VAL . . . . . 0.579 HG13 HD23 ' A' ' 92' ' ' LEU . 92.9 t -67.37 -23.74 30.6 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.938 0 CA-C-N 115.061 -0.972 . . . . 0.80000000000000004 110.463 177.486 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -103.38 56.94 0.74 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.544 -0.753 . . . . 2.3700000000000001 110.695 -176.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.2 mt -62.35 -37.32 85.22 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.939 -0.763 . . . . 0.84999999999999998 108.939 173.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -162.85 -171.61 29.29 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.149 -1.18 . . . . 0.81999999999999995 110.149 174.044 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_exo -54.0 -46.26 34.92 Favored 'Trans proline' 0 N--CA 1.464 -0.254 0 C-N-CA 122.498 2.132 . . . . 1.1799999999999999 111.862 176.215 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -107.99 -34.93 6.75 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.409 -0.36 . . . . 3.5299999999999998 110.874 177.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' SER . . . . . . . . . . . . . 51.0 m -62.33 123.56 18.56 Favored 'General case' 0 N--CA 1.453 -0.289 0 CA-C-O 121.325 0.584 . . . . 0.95999999999999996 110.92 -178.704 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' HIS . . . . . . . . . . . . . 21.0 p80 -144.79 152.27 40.09 Favored 'General case' 0 C--N 1.319 -0.724 0 CA-C-N 115.551 -0.75 . . . . 0.48999999999999999 110.616 -175.746 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' CYS . . . . . 0.66 ' SG ' ' HB3' ' A' ' 55' ' ' LEU . 31.6 p -73.82 87.5 1.76 Allowed 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 121.283 0.564 . . . . 1.3 109.811 173.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLY . . . . . 0.476 ' HA2' HD11 ' A' ' 92' ' ' LEU . . . -106.51 -73.52 0.86 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.278 -0.963 . . . . 0.23000000000000001 112.598 -178.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' PRO . . . . . 0.611 ' HD2' ' SG ' ' A' ' 38' ' ' CYS . 39.4 Cg_exo -52.19 -27.1 28.68 Favored 'Trans proline' 0 C--N 1.344 0.329 0 C-N-CA 122.691 2.261 . . . . 0.23999999999999999 112.082 176.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.642 HG11 HD23 ' A' ' 11' ' ' LEU . 17.0 t -68.23 -44.07 84.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 121.274 0.559 . . . . 0.12 110.195 179.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ALA . . . . . . . . . . . . . . . -62.65 -47.79 82.15 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.28 -0.873 . . . . 0.16 110.268 -179.862 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASP . . . . . . . . . . . . . 20.1 t70 -63.52 -42.47 98.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.312 -0.858 . . . . 2.0299999999999998 110.253 178.984 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ALA . . . . . . . . . . . . . . . -53.41 -45.37 69.34 Favored 'General case' 0 C--O 1.232 0.17 0 CA-C-O 121.51 0.672 . . . . 0.23000000000000001 110.92 177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LEU . . . . . . . . . . . . . 96.2 mt -70.6 -42.7 70.63 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.22 -0.9 . . . . 0.20000000000000001 110.642 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' LYS . . . . . 0.59 ' HE3' ' O ' ' A' ' 96' ' ' ILE . 61.8 mmtt -60.47 -37.95 82.67 Favored 'General case' 0 N--CA 1.446 -0.654 0 CA-C-N 115.809 -0.632 . . . . 2.0099999999999998 111.11 177.783 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 20.1 mm-40 -62.52 -39.06 92.35 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.126 -0.488 . . . . 2.3700000000000001 111.441 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -97.46 10.98 38.31 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 116.257 -0.429 . . . . 1.49 111.159 -176.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . 56.82 33.18 22.65 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.611 -0.722 . . . . 0.33000000000000002 112.02 177.769 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ILE . . . . . . . . . . . . . 67.0 mt -87.73 132.67 39.75 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 116.228 -0.442 . . . . 0.17000000000000001 110.071 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PRO . . . . . 0.41 ' HD2' ' O ' ' A' ' 51' ' ' ASP . 18.6 Cg_endo -74.41 140.06 26.74 Favored 'Trans proline' 0 N--CA 1.451 -0.994 0 C-N-CA 122.391 2.06 . . . . 0.20999999999999999 111.421 177.351 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' PHE . . . . . 0.424 ' HB3' ' HB3' ' A' ' 53' ' ' ALA . 23.6 p90 -157.34 161.16 39.07 Favored 'General case' 0 C--N 1.314 -0.973 0 CA-C-N 115.831 -0.622 . . . . 0.17999999999999999 110.493 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ILE . . . . . 0.471 HG21 ' HG2' ' A' ' 101' ' ' MET . 41.0 mt -124.21 140.95 46.01 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.092 0 CA-C-N 115.288 -0.869 . . . . 0.23999999999999999 109.784 -179.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.468 ' HA ' ' O ' ' A' ' 55' ' ' LEU . 2.4 mm? -88.69 108.01 19.24 Favored 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 108.91 -0.774 . . . . 0.20999999999999999 108.91 175.067 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' HIS . . . . . 0.604 ' NE2' ' HB3' ' A' ' 105' ' ' ALA . 17.7 t-160 -99.49 82.42 2.65 Favored 'General case' 0 C--N 1.311 -1.079 0 CA-C-O 121.593 0.711 . . . . 0.59999999999999998 109.722 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.641 ' O ' ' HA ' ' A' ' 102' ' ' ALA . 6.8 t -137.98 157.97 45.28 Favored 'General case' 0 C--N 1.32 -0.711 0 CA-C-N 114.426 -1.261 . . . . 0.60999999999999999 109.257 -175.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -112.23 4.61 26.84 Favored Glycine 0 N--CA 1.446 -0.661 0 C-N-CA 120.362 -0.923 . . . . 0.93999999999999995 111.955 178.006 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.43 ' HB3' ' HB2' ' A' ' 88' ' ' ARG . 12.9 m-20 -137.09 69.03 1.41 Allowed 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 120.843 0.354 . . . . 2.3300000000000001 111.458 -176.701 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.46 HD11 HG11 ' A' ' 100' ' ' VAL . 82.2 mt -63.04 -34.77 78.28 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.236 -0.438 . . . . 1.6100000000000001 110.254 174.378 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ASP . . . . . . . . . . . . . 3.7 p30 -63.81 -29.17 70.4 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.956 -0.565 . . . . 2.6299999999999999 111.745 -176.181 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.43 ' HB2' ' HB3' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -72.34 -21.6 61.29 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.232 0.539 . . . . 4.4199999999999999 110.508 -177.801 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -137.45 45.65 2.18 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 116.179 -0.464 . . . . 1.05 110.072 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLY . . . . . 0.763 ' HA2' HD11 ' A' ' 93' ' ' LEU . . . -59.67 -27.06 63.35 Favored Glycine 0 C--O 1.226 -0.356 0 CA-C-N 116.005 -0.543 . . . . 0.97999999999999998 113.263 -173.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 38.4 mt-10 -69.68 -25.16 63.76 Favored 'General case' 0 C--N 1.32 -0.706 0 CA-C-O 120.968 0.413 . . . . 2.5 110.642 179.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' LEU . . . . . 0.579 HD23 HG13 ' A' ' 57' ' ' VAL . 27.5 tp -77.22 -52.74 8.71 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.19 -0.459 . . . . 0.70999999999999996 111.884 -174.499 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LEU . . . . . 0.842 HD13 ' H ' ' A' ' 93' ' ' LEU . 0.0 OUTLIER -63.78 -23.94 67.56 Favored 'General case' 0 CA--C 1.518 -0.269 0 CA-C-O 121.178 0.513 . . . . 1.5800000000000001 111.545 -177.041 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' ARG . . . . . 0.543 ' N ' HD22 ' A' ' 93' ' ' LEU . 99.6 mtt180 -62.57 -34.26 76.61 Favored 'General case' 0 C--N 1.313 -1.002 0 CA-C-N 115.186 -0.915 . . . . 4.3799999999999999 110.762 173.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' LYS . . . . . . . . . . . . . 61.0 mttp -81.93 -33.68 30.24 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.02 -0.536 . . . . 2.4500000000000002 110.447 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ILE . . . . . 0.59 ' O ' ' HE3' ' A' ' 73' ' ' LYS . 59.4 mt -74.34 -62.15 1.43 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 CA-C-N 115.485 -0.78 . . . . 0.45000000000000001 111.606 -177.004 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' ASP . . . . . . . . . . . . . 59.6 m-20 54.13 76.81 0.21 Allowed 'General case' 0 C--O 1.236 0.352 0 CA-C-O 121.408 0.623 . . . . 1.0900000000000001 111.471 -172.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ALA . . . . . . . . . . . . . . . -149.42 164.83 19.37 Favored Pre-proline 0 C--N 1.32 -0.675 0 CA-C-N 115.031 -0.986 . . . . 0.28999999999999998 109.238 177.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.677 ' HG2' ' SD ' ' A' ' 117' ' ' MET . 51.7 Cg_exo -56.52 144.26 85.14 Favored 'Trans proline' 0 C--N 1.347 0.492 0 C-N-CA 122.668 2.245 . . . . 0.26000000000000001 113.003 178.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.46 HG11 HD11 ' A' ' 86' ' ' LEU . 46.5 t -121.99 137.74 54.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 115.915 -0.584 . . . . 0.64000000000000001 110.751 -179.806 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' MET . . . . . 0.471 ' HG2' HG21 ' A' ' 80' ' ' ILE . 86.6 mmm -117.56 105.55 12.19 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.702 -0.851 . . . . 0.82999999999999996 108.702 172.727 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ALA . . . . . 0.641 ' HA ' ' O ' ' A' ' 83' ' ' THR . . . -65.13 145.3 56.47 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.98 -0.554 . . . . 0.54000000000000004 111.861 -173.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' LYS . . . . . 0.534 ' HE3' ' O ' ' A' ' 82' ' ' HIS . 87.4 mttt -91.34 140.89 25.68 Favored Pre-proline 0 C--N 1.326 -0.442 0 CA-C-N 115.874 -0.603 . . . . 0.67000000000000004 109.897 175.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -76.6 154.11 97.21 Favored 'Cis proline' 0 N--CA 1.464 -0.258 0 C-N-CA 123.567 -1.431 . . . . 0.75 112.472 2.024 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' ALA . . . . . 0.604 ' HB3' ' NE2' ' A' ' 82' ' ' HIS . . . -143.13 137.29 29.0 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.033 -0.531 . . . . 0.34999999999999998 110.216 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ASP . . . . . 0.485 ' O ' HG23 ' A' ' 110' ' ' VAL . 11.4 t70 -71.43 129.71 39.48 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.468 -0.938 . . . . 0.51000000000000001 108.468 173.736 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' THR . . . . . 0.489 HG21 ' HB3' ' A' ' 20' ' ' ASN . 17.9 p -67.18 -22.37 65.75 Favored 'General case' 0 C--N 1.314 -0.937 0 CA-C-N 115.554 -0.748 . . . . 0.26000000000000001 112.542 -170.244 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . 0.418 ' O ' ' HG3' ' A' ' 112' ' ' LYS . 91.6 p -71.19 -37.42 72.14 Favored 'General case' 0 C--N 1.331 -0.211 0 N-CA-C 109.653 -0.499 . . . . 1.3200000000000001 109.653 176.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ASP . . . . . 0.416 ' O ' ' HG2' ' A' ' 113' ' ' ARG . 2.6 m-20 -63.4 -46.68 85.28 Favored 'General case' 0 CA--C 1.513 -0.446 0 CA-C-O 121.323 0.583 . . . . 0.62 109.556 176.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.492 HG12 HG11 ' A' ' 54' ' ' VAL . 21.1 t -62.0 -44.88 99.54 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 114.991 -1.004 . . . . 0.13 110.62 -179.391 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.604 ' HA ' ' CZ ' ' A' ' 25' ' ' PHE . . . -63.46 -47.79 80.36 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.764 -0.653 . . . . 0.13 111.461 -178.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LYS . . . . . 0.418 ' HG3' ' O ' ' A' ' 108' ' ' SER . 95.2 mttt -62.75 -44.76 95.37 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.059 -0.519 . . . . 1.95 111.403 -178.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' ARG . . . . . 0.416 ' HG2' ' O ' ' A' ' 109' ' ' ASP . 33.4 mmt180 -64.1 -32.72 74.39 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.104 0.478 . . . . 2.23 111.091 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ALA . . . . . . . . . . . . . . . -72.57 -47.9 44.3 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 121.088 0.47 . . . . 0.14000000000000001 110.463 178.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LEU . . . . . 0.56 HD23 HG11 ' A' ' 52' ' ' VAL . 80.8 mt -69.75 -30.03 67.52 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 112.785 0.661 . . . . 0.27000000000000002 112.785 -176.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLU . . . . . . . . . . . . . 10.9 pt-20 -65.96 -31.61 72.62 Favored 'General case' 0 N--CA 1.464 0.249 0 C-N-CA 120.763 -0.375 . . . . 2.79 110.715 179.651 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' MET . . . . . 0.677 ' SD ' ' HG2' ' A' ' 99' ' ' PRO . 55.7 mtm -70.79 -32.3 69.35 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.987 0.422 . . . . 0.42999999999999999 110.802 176.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.701 ' SG ' ' HB3' ' A' ' 51' ' ' ASP . 42.0 t -76.45 -42.09 45.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.107 -0.497 . . . . 1.46 110.486 -179.362 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 81.81 -73.27 2.64 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 121.044 -0.598 . . . . 2.5699999999999998 112.704 177.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' GLY . . . . . . . . . . . . . . . 155.85 71.39 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 121.07 -0.586 . . . . 4.4800000000000004 111.645 -178.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -84.71 133.12 34.39 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.87 0.367 . . . . 6.4199999999999999 110.423 -176.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 61.7 tttp -124.39 126.77 46.51 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 116.155 -0.475 . . . . 9.1899999999999995 110.057 178.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -96.6 109.87 50.28 Favored Pre-proline 0 C--N 1.322 -0.606 0 N-CA-C 109.851 -0.426 . . . . 9.5999999999999996 109.851 177.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 92.2 Cg_endo -78.78 52.59 4.28 Favored 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.957 2.438 . . . . 11.17 112.267 -178.79 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.078 0 CA-C-O 118.667 -0.683 . . . . 13.279999999999999 110.15 -179.917 . . . . . . . . 0 0 . 1 stop_ save_